data_1djm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1djm _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -89.71 132.01 35.39 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 34.9 m-85 -85.13 139.18 31.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.13 140.16 38.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 161.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -135.53 100.38 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.88 84.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.45 171.83 8.93 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.993 0.902 . . . . 0.0 111.516 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.91 -28.56 68.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.237 1.815 . . . . 0.0 112.259 165.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 14.0 t80 -131.95 113.82 13.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.904 1.681 . . . . 0.0 107.802 -163.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -50.37 -40.46 49.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.149 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 39.7 m -52.73 -37.63 59.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.184 0.994 . . . . 0.0 111.22 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -58.83 -41.34 86.62 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.663 1.12 . . . . 0.0 110.243 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.603 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.03 -48.39 80.47 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.338 0.972 . . . . 0.0 109.959 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.28 -58.19 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.69 1.196 . . . . 0.0 108.893 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.23 -50.64 70.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.323 1.049 . . . . 0.0 109.975 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -53.97 -48.57 70.19 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.852 0.751 . . . . 0.0 110.412 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.45 -46.01 84.96 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.682 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.99 -40.27 95.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.383 0.992 . . . . 0.0 110.525 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -60.78 -37.75 82.94 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.72 0.808 . . . . 0.0 110.838 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -70.74 -35.45 72.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 117.735 -1.126 . . . . 0.0 111.927 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -60.07 -42.26 94.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.654 1.115 . . . . 0.0 108.892 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.61 -56.34 14.53 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.281 0.632 . . . . 0.0 109.867 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.24 4.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.186 -1.341 . . . . 0.0 116.291 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.97 171.98 12.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.897 1.848 . . . . 0.0 112.382 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.21 -179.95 6.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.206 1.802 . . . . 0.0 108.267 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.2 t30 65.15 82.34 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.073 2.549 . . . . 0.0 112.353 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.41 162.08 13.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -140.91 170.73 15.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.223 1.809 . . . . 0.0 110.362 167.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -122.17 168.27 12.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.941 2.496 . . . . 0.0 107.582 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.21 171.0 14.67 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.616 1.166 . . . . 0.0 109.308 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.64 -35.64 65.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.938 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.26 178.38 0.71 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.473 1.909 . . . . 0.0 107.881 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.23 -43.37 4.59 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.31 1.91 . . . . 0.0 116.076 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.43 -47.29 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.865 1.833 . . . . 0.0 109.259 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -68.55 -37.23 79.77 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.1 -0.375 . . . . 0.0 110.85 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.9 -51.93 67.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.712 1.605 . . . . 0.0 109.818 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.62 -43.42 80.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.77 0.795 . . . . 0.0 110.54 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -71.74 -24.7 61.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -65.97 -42.07 90.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.376 166.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.03 -46.82 78.71 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.305 1.412 . . . . 0.0 108.249 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.37 10.81 0.9 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.733 1.213 . . . . 0.0 114.067 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.0 38.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.051 1.296 . . . . 0.0 110.988 160.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.49 -82.86 0.11 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.43 94.28 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.34 170.9 14.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.292 1.037 . . . . 0.0 110.484 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.09 -30.02 5.87 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.993 -0.893 . . . . 0.0 113.953 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 87.2 m-85 -146.55 148.58 32.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.258 1.023 . . . . 0.0 108.689 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.19 80.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -91.73 130.84 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 p -144.5 161.36 39.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.513 1.506 . . . . 0.0 114.957 -173.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -73.46 -158.25 0.06 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.258 1.023 . . . . 0.0 110.278 159.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -134.08 -30.27 1.21 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.329 2.252 . . . . 0.0 112.528 -167.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.43 32.02 6.36 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.889 2.076 . . . . 0.0 112.094 -158.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.439 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 2.4 mpt? -44.69 154.33 0.43 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 113.329 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.35 -25.74 35.81 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.127 2.551 . . . . 0.0 112.943 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -119.98 -99.57 0.44 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.2 ttt -78.35 106.17 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 161.03 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.469 1.108 . . . . 0.0 111.867 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.33 73.83 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 119.48 -0.622 . . . . 0.0 112.483 -166.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.28 -34.59 48.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.896 0.879 . . . . 0.0 109.942 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.36 -37.56 71.65 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 111.05 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.48 -50.71 72.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.757 0.708 . . . . 0.0 109.354 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.58 -61.09 2.5 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.041 0.936 . . . . 0.0 108.717 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.33 -26.13 67.6 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.879 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.8 m -66.82 -48.36 69.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.582 1.083 . . . . 0.0 110.864 170.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.89 -40.83 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 4.16 1.6 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.604 2.362 . . . . 0.0 113.572 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 120.238 1.381 . . . . 0.0 111.161 170.092 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.82 -54.1 0.46 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.485 2.714 . . . . 0.0 113.827 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -15.99 62.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.611 1.564 . . . . 0.0 114.383 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -68.2 121.71 81.31 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 119.148 0.886 . . . . 0.0 109.452 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.51 106.81 1.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.871 1.714 . . . . 0.0 108.739 166.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.05 134.09 28.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tp -131.65 106.28 8.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.9 mtp -82.14 117.75 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.94 105.05 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -145.49 172.61 12.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.932 0.872 . . . . 0.0 111.007 -164.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -11.45 59.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.44 -0.788 . . . . 0.0 112.918 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -88.24 107.98 19.07 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.203 2.201 . . . . 0.0 112.356 -165.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.4 3.91 53.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.52 120.32 6.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.243 1.383 . . . . 0.0 109.922 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -55.64 -44.31 77.03 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.324 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -63.68 -33.43 75.62 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.927 1.239 . . . . 0.0 111.023 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.02 -47.07 84.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.287 0.949 . . . . 0.0 109.373 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.58 -45.18 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.17 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.75 -56.82 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.83 -46.55 60.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.768 1.227 . . . . 0.0 110.146 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.82 71.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.523 0.729 . . . . 0.0 112.029 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.52 97.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -61.85 -46.47 89.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.818 1.647 . . . . 0.0 111.408 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.02 -16.21 59.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.788 0.835 . . . . 0.0 112.458 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.65 33.57 18.68 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.446 1.021 . . . . 0.0 111.722 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 142.74 53.53 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.0 p -72.91 -14.13 61.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.515 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.21 169.58 38.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -136.78 144.61 43.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.927 1.291 . . . . 0.0 107.922 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.98 140.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.978 2.111 . . . . 0.0 105.712 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 t -123.24 144.64 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 149.4 21.17 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.053 169.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 140.67 67.19 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 109.691 -0.927 . . . . 0.0 109.691 -16.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -134.73 167.14 21.39 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.997 -1.064 . . . . 0.0 111.041 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 p -137.2 172.78 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.644 1.178 . . . . 0.0 110.991 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.83 -33.47 64.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.817 1.247 . . . . 0.0 109.511 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.03 -54.52 38.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.718 1.207 . . . . 0.0 111.246 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -31.82 58.3 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.564 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -56.49 19.53 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -66.5 -21.1 66.17 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.758 -0.588 . . . . 0.0 112.464 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -68.49 -47.98 65.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.244 0.929 . . . . 0.0 109.526 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -68.92 -38.36 79.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.651 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 mt -57.6 -54.51 46.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.254 0.934 . . . . 0.0 110.146 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -65.51 -30.2 70.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.754 0.706 . . . . 0.0 110.725 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -55.53 -58.24 8.58 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.933 165.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.82 -22.7 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 120.691 1.587 . . . . 0.0 113.619 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -57.83 -65.24 0.67 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -76.11 -30.6 58.3 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.18 -169.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -71.43 -68.17 0.47 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.319 1.048 . . . . 0.0 109.462 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.8 -31.59 45.99 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.354 1.062 . . . . 0.0 111.756 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.21 29.88 8.16 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.382 -1.232 . . . . 0.0 111.709 -165.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.7 mmt . . . . . 0 C--O 1.247 0.971 0 CA-C-N 119.868 1.834 . . . . 0.0 111.756 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 155.1 19.0 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 110.371 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -104.33 101.64 11.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 164.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.47 133.9 46.19 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 117.361 -1.736 . . . . 0.0 106.727 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.4 t -132.06 105.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.41 58.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.055 1.342 . . . . 0.0 107.782 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.55 157.21 17.76 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.883 -0.511 . . . . 0.0 110.445 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.13 -28.21 68.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.879 1.271 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -132.41 123.21 26.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.524 1.53 . . . . 0.0 107.488 -167.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -52.15 -52.77 49.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.715 0.689 . . . . 0.0 111.514 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.2 m -59.33 -29.8 67.91 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.546 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 ttt -61.94 -44.48 96.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.26 0.936 . . . . 0.0 109.957 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -39.88 94.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.329 0.968 . . . . 0.0 109.111 174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -44.82 93.0 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.44 -62.22 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.342 172.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.01 -49.23 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 121.423 1.92 . . . . 0.0 111.13 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -48.61 76.74 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.443 1.097 . . . . 0.0 110.379 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -56.22 -51.22 68.87 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.927 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.31 -36.31 79.74 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.496 1.518 . . . . 0.0 112.033 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.65 -52.4 60.91 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.712 -0.617 . . . . 0.0 109.659 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -64.74 -20.6 66.44 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.1 -52.32 56.19 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.261 1.424 . . . . 0.0 109.879 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.37 2.43 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -166.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.86 -84.66 1.08 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 124.542 1.068 . . . . 0.0 110.997 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -151.28 175.44 12.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.205 1.402 . . . . 0.0 109.559 -169.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -139.09 -179.15 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.376 1.07 . . . . 0.0 109.944 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 64.39 77.17 0.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.996 2.519 . . . . 0.0 110.335 -165.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.97 172.36 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.069 160.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.39 174.29 10.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.723 2.009 . . . . 0.0 106.192 158.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.7 164.66 23.49 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.39 170.72 13.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.166 1.786 . . . . 0.0 106.817 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.1 -37.75 84.45 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.948 0.794 . . . . 0.0 110.389 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -172.64 166.92 5.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.985 1.314 . . . . 0.0 108.578 -160.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.527 ' H ' ' HG3' ' A' ' 60' ' ' MET . . . -49.35 -40.86 31.15 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.9 1.714 . . . . 0.0 113.966 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.02 -52.99 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.82 0.848 . . . . 0.0 108.77 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.63 -23.91 56.41 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.349 1.46 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.97 51.42 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.71 -46.2 70.69 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.895 0.747 . . . . 0.0 111.045 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.82 -46.58 74.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.475 1.51 . . . . 0.0 111.764 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.63 -48.36 82.14 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.741 -1.123 . . . . 0.0 109.736 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -53.83 -46.31 71.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.347 1.431 . . . . 0.0 110.81 -173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.91 7.55 2.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.39 -4.92 18.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.933 1.242 . . . . 0.0 113.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.88 32.06 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 120.418 1.463 . . . . 0.0 113.247 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.46 43.66 2.35 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.586 1.565 . . . . 0.0 113.614 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.08 82.0 2.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.47 -1.12 78.57 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.928 1.251 . . . . 0.0 113.065 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.77 134.87 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.68 96.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.76 134.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.12 168.96 18.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.036 0.922 . . . . 0.0 110.012 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -46.93 -176.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 130.986 3.714 . . . . 0.0 113.304 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -115.98 -42.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.39 158.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.63 47.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.217 1.007 . . . . 0.0 111.691 -159.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.527 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -61.07 138.69 94.3 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.862 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.12 26.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 125.265 3.976 . . . . 0.0 118.017 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.33 -71.89 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 122.058 2.208 . . . . 0.0 110.03 159.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.8 ttt -91.34 85.07 5.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.929 2.091 . . . . 0.0 107.164 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -47.07 153.55 0.43 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.006 1.322 . . . . 0.0 110.32 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.04 -27.53 62.53 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.429 -0.795 . . . . 0.0 112.167 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.81 -36.57 78.4 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.965 0.882 . . . . 0.0 110.29 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.18 -31.41 55.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.866 0.867 . . . . 0.0 110.795 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -57.86 -53.22 60.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.674 0.67 . . . . 0.0 109.272 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -56.47 15.05 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.289 1.036 . . . . 0.0 108.701 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -63.44 -30.92 71.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.726 1.148 . . . . 0.0 112.703 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -69.22 -42.22 76.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.103 0.961 . . . . 0.0 110.053 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.6 mt -61.57 -50.62 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -60.09 -24.68 64.81 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.377 1.871 . . . . 0.0 112.334 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 124.52 1.128 . . . . 0.0 112.627 176.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 -36.55 67.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.941 1.297 . . . . 0.0 112.616 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.99 60.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.336 0.971 . . . . 0.0 113.146 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 mt -57.95 135.01 83.68 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-N 119.693 1.133 . . . . 0.0 111.49 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.67 109.84 2.74 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.764 2.309 . . . . 0.0 107.589 161.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.68 113.57 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.103 1.761 . . . . 0.0 107.364 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.73 111.9 19.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.219 1.008 . . . . 0.0 108.836 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.03 132.03 34.38 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.43 127.54 59.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -161.55 169.61 21.42 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.59 -12.98 47.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.254 -0.904 . . . . 0.0 111.409 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.32 119.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.973 1.261 . . . . 0.0 111.796 -165.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.06 11.04 14.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.537 0.735 . . . . 0.0 112.018 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -52.21 117.97 3.18 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.302 1.841 . . . . 0.0 110.62 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -52.83 -47.73 67.5 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.807 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -46.7 -46.12 19.96 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.17 0.988 . . . . 0.0 111.56 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -65.36 -43.82 89.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.03 -48.57 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.08 -54.44 34.36 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.26 -48.41 45.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.357 1.463 . . . . 0.0 110.84 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.06 27.01 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.219 0.607 . . . . 0.0 109.701 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.75 66.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -73.39 -56.85 4.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.699 2.0 . . . . 0.0 109.641 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.41 -35.61 60.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.573 0.749 . . . . 0.0 110.18 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.6 27.85 3.69 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 125.166 1.365 . . . . 0.0 111.545 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.72 138.59 55.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.112 0.956 . . . . 0.0 110.322 -172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -72.89 -5.53 38.97 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.59 1.556 . . . . 0.0 112.003 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.32 165.46 34.79 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 158.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -137.79 110.78 7.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.66 104.35 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.442 1.897 . . . . 0.0 106.23 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.62 147.83 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -66.91 147.14 99.15 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 162.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.65 139.7 58.79 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.195 1.105 . . . . 0.0 110.498 -3.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.81 148.09 40.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -144.97 -176.25 5.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 109.811 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.43 -33.23 43.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.936 1.294 . . . . 0.0 110.166 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.54 76.23 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.69 0.796 . . . . 0.0 112.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.01 -27.98 19.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.949 . . . . 0.0 110.003 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.92 -53.39 58.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.365 1.066 . . . . 0.0 109.374 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -37.48 85.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.63 1.172 . . . . 0.0 111.462 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.42 -45.38 69.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.677 1.591 . . . . 0.0 108.896 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.63 87.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.392 -1.766 . . . . 0.0 111.245 170.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.23 -56.51 17.92 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.354 1.034 . . . . 0.0 109.281 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -59.54 -35.02 73.4 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.45 1.023 . . . . 0.0 111.109 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -54.93 -50.82 67.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.689 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.18 -24.42 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.704 1.138 . . . . 0.0 113.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -56.68 -55.56 32.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -74.83 -46.52 36.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -68.49 -70.41 0.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.02 -26.64 66.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.127 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.03 12.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -164.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.5 mmt . . . . . 0 C--O 1.252 1.228 0 CA-C-N 118.998 1.399 . . . . 0.0 109.09 176.258 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.627 0.727 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -89.38 117.65 28.47 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.728 -162.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.13 152.56 41.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.6 tp -123.29 134.8 54.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.73 119.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.678 1.191 . . . . 0.0 108.306 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.09 61.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.35 156.85 36.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -62.05 -44.4 96.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.654 1.181 . . . . 0.0 110.485 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -116.08 132.59 56.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 109.029 -159.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -51.28 -60.65 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.128 0.971 . . . . 0.0 111.97 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 m -51.22 -37.25 45.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.997 0.519 . . . . 0.0 110.936 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.59 -47.17 82.86 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.018 0.826 . . . . 0.0 111.045 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.3 ptt85 -72.92 -27.43 61.86 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 120.997 1.726 . . . . 0.0 111.545 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -62.59 -40.95 98.55 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.467 -0.771 . . . . 0.0 109.431 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.23 -63.43 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.49 -42.63 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.804 1.184 . . . . 0.0 110.671 -171.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -60.56 -49.21 78.44 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 117.709 -1.138 . . . . 0.0 111.07 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -50.86 -54.68 21.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.377 0.989 . . . . 0.0 109.66 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.82 -42.62 75.95 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.099 0.96 . . . . 0.0 111.535 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.86 -47.63 79.94 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.52 -19.29 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.441 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.76 -33.08 74.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.178 1.354 . . . . 0.0 110.156 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.05 -50.28 6.75 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.461 1.504 . . . . 0.0 108.738 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.94 -97.14 0.13 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 35.92 64.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 128.363 2.665 . . . . 0.0 112.316 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -68.41 1.48 2.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.83 100.47 4.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.894 1.679 . . . . 0.0 110.694 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.63 91.56 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 125.799 1.639 . . . . 0.0 107.64 -172.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 164.4 17.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.429 0.691 . . . . 0.0 109.56 169.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.82 166.31 22.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 158.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.54 178.58 4.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.368 1.067 . . . . 0.0 108.668 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.65 -43.1 23.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -167.24 164.03 15.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.264 1.826 . . . . 0.0 108.121 -161.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.88 -39.42 11.2 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.191 1.377 . . . . 0.0 114.034 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.018 0.909 . . . . 0.0 109.314 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.16 -26.15 66.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.171 0.589 . . . . 0.0 111.038 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.6 43.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.802 1.183 . . . . 0.0 108.433 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.89 -39.87 82.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.337 0.589 . . . . 0.0 111.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -56.1 -47.11 78.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.435 1.094 . . . . 0.0 110.353 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -59.38 -48.83 80.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.941 1.297 . . . . 0.0 109.911 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.91 -39.32 77.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.837 1.199 . . . . 0.0 109.755 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -76.25 10.07 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.15 -37.15 84.96 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.501 -1.375 . . . . 0.0 109.835 159.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.24 -19.68 0.73 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 118.112 -1.382 . . . . 0.0 116.136 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.01 86.42 0.06 OUTLIER Glycine 0 C--N 1.338 0.691 0 CA-C-N 120.389 2.095 . . . . 0.0 113.541 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.26 163.5 14.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.588 0.694 . . . . 0.0 109.925 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.42 -38.84 4.63 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.419 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -142.5 151.17 41.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.463 1.131 . . . . 0.0 109.113 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.27 79.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -97.31 120.62 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -169.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -151.65 156.54 40.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.114 1.324 . . . . 0.0 113.216 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.12 168.44 20.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.631 1.173 . . . . 0.0 110.051 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -82.28 -56.21 4.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.075 0.95 . . . . 0.0 113.409 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.19 67.23 4.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.699 0.799 . . . . 0.0 112.41 -158.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -66.89 147.63 99.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.712 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.45 -6.32 14.83 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 114.096 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -139.88 -89.95 0.18 Allowed 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.196 1.362 . . . . 0.0 111.746 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.7 ttm -82.0 95.85 7.54 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.77 155.66 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.89 -24.18 48.54 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.359 -0.838 . . . . 0.0 112.022 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.69 -35.45 57.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.609 1.204 . . . . 0.0 111.515 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.04 -40.24 75.26 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.098 0.959 . . . . 0.0 109.705 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.82 -54.08 48.93 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.211 1.404 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.07 -58.36 7.26 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.719 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HE2' ' HB1' ' A' ' 101' ' ' ALA . 26.7 mttm -60.9 -31.76 71.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.389 0.995 . . . . 0.0 111.844 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.5 m -65.28 -48.71 72.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.566 0.746 . . . . 0.0 110.608 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.0 mt -59.16 -45.03 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -7.08 13.16 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.896 1.678 . . . . 0.0 113.57 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 119.741 1.155 . . . . 0.0 111.689 173.705 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.7 mtt . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.0 -57.13 3.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.09 2.556 . . . . 0.0 112.966 -159.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.83 -9.97 59.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.254 -1.355 . . . . 0.0 113.874 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.7 mt -56.8 117.78 19.38 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.181 1.355 . . . . 0.0 110.571 -172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.54 100.88 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.07 2.513 . . . . 0.0 109.098 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 130.86 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.5 tp -131.17 112.22 12.64 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.735 1.214 . . . . 0.0 108.444 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.6 mmm -83.01 96.88 8.48 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -100.34 107.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -154.41 167.27 30.56 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.161 -0.962 . . . . 0.0 111.153 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.75 47.43 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.543 -0.723 . . . . 0.0 111.872 165.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -76.05 94.4 3.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.866 1.266 . . . . 0.0 110.737 -164.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.54 14.93 3.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.978 1.311 . . . . 0.0 112.974 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 118.98 4.62 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.579 1.152 . . . . 0.0 108.19 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -57.26 -43.38 82.96 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.431 1.014 . . . . 0.0 110.02 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.71 -29.48 69.37 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.766 1.166 . . . . 0.0 112.11 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -67.7 -45.24 75.71 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.715 0.689 . . . . 0.0 109.719 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.62 -48.12 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.251 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.87 -55.17 19.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.82 69.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.227 1.011 . . . . 0.0 110.38 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.31 -53.42 58.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.712 0.805 . . . . 0.0 110.763 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.66 93.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.312 0.505 . . . . 0.0 110.484 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -59.89 -49.67 76.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.951 2.1 . . . . 0.0 111.272 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB1' ' HE2' ' A' ' 70' ' ' LYS . . . -61.6 -31.24 71.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.471 1.108 . . . . 0.0 111.56 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.03 16.01 7.53 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.699 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.81 136.8 58.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 119.712 1.756 . . . . 0.0 108.553 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -66.63 -19.57 65.8 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 123.313 0.383 . . . . 0.0 110.954 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.59 176.88 48.25 Favored Glycine 0 N--CA 1.439 -1.101 0 O-C-N 121.187 -0.946 . . . . 0.0 113.186 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.89 137.74 51.61 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.483 1.513 . . . . 0.0 107.34 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.0 85.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.513 2.325 . . . . 0.0 104.943 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.73 144.82 13.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 167.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 155.03 6.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.192 0.997 . . . . 0.0 110.506 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.01 145.44 83.93 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 N-CA-C 109.464 -1.014 . . . . 0.0 109.464 -10.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -132.24 150.79 52.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.346 1.058 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -147.28 169.46 19.35 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.182 2.193 . . . . 0.0 108.334 -164.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.19 74.12 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.76 17.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.016 1.326 . . . . 0.0 114.313 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.63 -25.49 8.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.757 1.162 . . . . 0.0 110.892 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -57.7 11.67 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 170.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -32.07 71.56 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.22 -49.25 67.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 109.425 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 3.8 mmpt? -68.53 -37.31 79.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 116.724 -1.607 . . . . 0.0 110.278 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.94 -57.36 12.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.307 0.958 . . . . 0.0 109.077 171.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -50.42 -45.27 55.64 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.058 0.943 . . . . 0.0 110.866 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 11.5 mtmm -59.43 -48.03 83.2 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.559 -1.21 . . . . 0.0 112.596 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 pt -75.05 -31.91 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.896 2.134 . . . . 0.0 113.283 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -55.4 -50.53 69.53 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.879 1.272 . . . . 0.0 108.82 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.04 -57.78 4.2 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.935 0.494 . . . . 0.0 109.916 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -58.65 3.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -159.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.43 -26.33 62.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.45 40.69 8.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -169.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 C--O 1.253 1.243 0 CA-C-N 118.897 1.349 . . . . 0.0 108.135 171.24 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -75.0 135.09 41.32 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 53' ' ' PHE . 8.3 m-85 -92.78 149.44 21.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 166.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -121.78 138.29 54.43 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 166.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.26 108.09 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.51 57.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.37 162.69 5.87 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 159.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -47.83 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.376 -0.827 . . . . 0.0 110.167 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -64.17 -19.94 65.66 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -158.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 t 70.64 -47.27 0.64 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.926 2.491 . . . . 0.0 111.55 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.8 m -52.69 -36.95 58.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.467 -1.396 . . . . 0.0 109.29 160.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.2 ttp -67.92 -17.66 64.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.213 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.24 -48.03 81.75 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 120.663 1.574 . . . . 0.0 108.327 168.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -56.85 -52.88 63.38 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 107.893 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.36 -68.47 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 124.059 0.849 . . . . 0.0 108.811 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.49 -46.66 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.995 0.816 . . . . 0.0 110.746 -170.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -63.89 -35.52 80.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.156 0.889 . . . . 0.0 111.018 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -72.3 -32.98 67.04 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.52 1.055 . . . . 0.0 111.751 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.92 -36.8 80.78 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.978 -1.076 . . . . 0.0 109.868 172.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.54 -36.47 81.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.865 -0.522 . . . . 0.0 110.517 172.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -64.66 -34.49 78.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.728 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -56.66 -64.93 0.71 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.931 1.241 . . . . 0.0 110.925 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.67 28.53 1.05 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -165.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.03 -116.34 2.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.463 1.506 . . . . 0.0 110.226 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -141.54 176.4 8.92 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.461 1.105 . . . . 0.0 111.708 -159.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.42 -177.64 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.066 1.746 . . . . 0.0 110.391 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 60.05 74.29 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.118 2.167 . . . . 0.0 109.781 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.28 125.06 73.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 172.87 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.697 1.199 . . . . 0.0 107.952 165.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -134.43 173.91 11.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.729 1.212 . . . . 0.0 107.992 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.38 177.19 8.06 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.111 0.964 . . . . 0.0 109.601 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.04 -38.59 52.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.883 0.473 . . . . 0.0 111.461 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.05 162.88 1.67 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.784 2.033 . . . . 0.0 107.131 -158.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.89 -42.31 22.09 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.077 1.322 . . . . 0.0 114.663 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.8 -36.56 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.067 1.933 . . . . 0.0 109.533 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.5 t70 -78.95 -36.3 41.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.556 1.542 . . . . 0.0 110.261 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.62 -46.96 83.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.262 1.425 . . . . 0.0 109.081 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -52.62 -47.91 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.22 1.408 . . . . 0.0 110.383 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.2 -19.8 63.98 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.114 0.965 . . . . 0.0 112.926 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HE2' ' OD1' ' A' ' 41' ' ' ASP . 4.2 mptp? -69.25 -49.03 59.97 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.388 -1.445 . . . . 0.0 110.094 162.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 mt -54.71 -54.69 38.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.113 1.324 . . . . 0.0 109.581 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.51 -0.96 9.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.5 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.308 1.413 . . . . 0.0 110.52 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.39 -82.59 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.11 91.7 0.11 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -84.21 155.7 22.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.55 -66.99 0.5 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 7.2 m-85 -87.38 136.57 32.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.947 0.873 . . . . 0.0 108.821 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.75 113.84 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.4 125.78 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.3 p -156.57 168.71 26.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.376 0.989 . . . . 0.0 112.907 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.78 167.54 21.62 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.768 0.827 . . . . 0.0 110.362 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.407 ' CZ3' HD22 ' A' ' 66' ' ' LEU . 4.0 t-105 -78.93 -42.58 26.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 158.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -78.53 56.27 1.77 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.311 2.244 . . . . 0.0 112.327 -159.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.81 165.82 49.5 Favored Pre-proline 0 C--O 1.238 0.456 0 O-C-N 120.869 -1.144 . . . . 0.0 110.792 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.82 -39.52 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.45 2.1 . . . . 0.0 110.84 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.82 -69.07 0.87 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.839 1.2 . . . . 0.0 112.295 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.2 ttm -91.14 83.48 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.93 140.6 1.02 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.918 2.087 . . . . 0.0 108.671 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.5 -20.81 66.14 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.052 -1.03 . . . . 0.0 114.77 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD22 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.43 -38.38 74.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.104 0.952 . . . . 0.0 109.708 172.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.83 -41.14 83.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 109.911 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.88 -51.08 71.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.496 1.044 . . . . 0.0 110.045 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -53.23 -56.35 17.22 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.821 173.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.56 -24.86 65.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.812 1.642 . . . . 0.0 113.666 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 m -64.01 -52.16 60.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 mt -64.29 -28.66 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 12.39 19.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.433 1.893 . . . . 0.0 111.22 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.535 0 CA-C-N 120.512 1.505 . . . . 0.0 112.412 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -57.66 -18.27 19.51 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.435 -1.415 . . . . 0.0 113.743 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.89 4.34 50.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.0 113.386 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -73.27 127.9 88.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 120.334 -1.479 . . . . 0.0 108.988 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' C ' ' HG ' ' A' ' 104' ' ' SER . 41.8 Cg_endo -81.86 62.82 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.339 4.026 . . . . 0.0 111.716 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.84 112.08 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.349 1.86 . . . . 0.0 111.675 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 114.52 27.17 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 125.367 1.467 . . . . 0.0 109.201 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 mmt -76.17 131.03 39.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 105.14 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.246 1.819 . . . . 0.0 106.401 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 t -139.99 178.84 6.98 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.008 0.909 . . . . 0.0 110.696 -171.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.05 -26.2 19.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.124 0.97 . . . . 0.0 111.788 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -91.17 134.95 34.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.201 0.91 . . . . 0.0 111.646 -168.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 -95.8 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.408 -0.806 . . . . 0.0 108.915 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? 59.15 112.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.326 2.25 . . . . 0.0 111.789 -171.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -51.8 -47.42 64.28 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.76 -28.33 69.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.599 1.545 . . . . 0.0 113.423 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -65.02 -47.35 77.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.606 1.094 . . . . 0.0 108.927 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.2 -51.64 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.71 -58.01 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.027 0.931 . . . . 0.0 110.56 -172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.79 88.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.33 -39.28 92.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.591 0.632 . . . . 0.0 112.519 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -60.23 -54.75 42.04 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.929 1.691 . . . . 0.0 109.594 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.46 -12.18 29.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.035 1.334 . . . . 0.0 112.27 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.47 29.65 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 119.099 -0.834 . . . . 0.0 112.531 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.52 152.16 26.66 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.45 ' HG ' ' C ' ' A' ' 82' ' ' PRO . 65.9 m -55.52 -34.94 65.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.145 0.978 . . . . 0.0 112.23 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.25 179.78 44.15 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.11 92.29 3.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.474 1.51 . . . . 0.0 107.874 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -81.93 137.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.42 144.14 38.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 156.92 43.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.426 0.557 . . . . 0.0 110.801 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.72 137.17 46.21 Favored 'Cis proline' 0 N--CA 1.453 -0.891 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 -12.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -139.07 155.02 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.986 0.422 . . . . 0.0 110.194 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 p -151.72 -172.3 4.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.73 1.612 . . . . 0.0 111.022 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.2 18.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.558 1.143 . . . . 0.0 110.475 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.1 87.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.705 0.802 . . . . 0.0 112.889 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 -34.55 22.22 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.767 1.167 . . . . 0.0 109.269 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.95 -55.96 19.5 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -41.28 99.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.688 1.195 . . . . 0.0 112.518 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.41 -45.11 73.5 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.829 -0.545 . . . . 0.0 110.04 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.36 -38.38 89.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.0 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.29 -60.39 3.47 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.7 -34.83 73.4 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.393 0.542 . . . . 0.0 111.766 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -68.73 0.16 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.966 0.906 . . . . 0.0 109.349 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -24.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -57.56 -64.03 1.03 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.55 0.74 . . . . 0.0 109.219 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.83 -54.73 12.2 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -59.39 -52.6 64.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.537 0.735 . . . . 0.0 111.97 -164.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.74 -47.44 11.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.398 0.679 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.52 19.51 3.1 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.257 1.408 . . . . 0.0 112.704 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.1 mmm . . . . . 0 C--O 1.253 1.254 0 CA-C-N 120.152 1.976 . . . . 0.0 112.837 -172.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--O 1.234 0.242 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -90.62 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -86.74 159.48 19.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -125.67 142.2 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.77 110.11 16.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.0 70.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 123.223 1.487 . . . . 0.0 107.346 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.54 173.23 10.67 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.34 1.856 . . . . 0.0 110.996 168.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.18 -18.38 24.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.361 2.264 . . . . 0.0 114.069 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.31 112.62 8.69 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.057 -1.652 . . . . 0.0 109.029 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.85 -46.31 1.96 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.272 1.396 . . . . 0.0 114.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.0 m -51.76 -45.81 63.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.607 1.094 . . . . 0.0 111.673 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.6 ttm -52.39 -41.16 62.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 109.359 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -71.2 -40.56 71.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.88 1.218 . . . . 0.0 111.479 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -54.7 -54.9 35.69 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.41 -65.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.926 1.291 . . . . 0.0 107.923 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.41 -45.41 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.603 1.547 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -64.75 -39.42 93.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.251 1.387 . . . . 0.0 110.698 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -58.56 -51.57 69.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.204 1.366 . . . . 0.0 110.601 171.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.39 -26.35 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.181 0.592 . . . . 0.0 111.994 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -77.91 -45.95 22.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.344 1.057 . . . . 0.0 110.426 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -73.55 -9.63 58.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.16 -36.91 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.397 0.999 . . . . 0.0 109.925 158.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.93 -4.37 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.868 1.667 . . . . 0.0 111.597 -165.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.53 -110.2 1.54 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.999 1.761 . . . . 0.0 108.888 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 40.51 49.86 2.72 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.898 2.479 . . . . 0.0 112.972 165.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -70.67 -4.96 26.13 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.777 0.831 . . . . 0.0 113.241 -160.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -131.09 77.01 1.76 Allowed 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.354 1.461 . . . . 0.0 107.81 -169.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.69 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 164.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.87 171.9 12.64 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.78 2.032 . . . . 0.0 108.04 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.66 148.25 42.15 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.735 1.214 . . . . 0.0 107.733 -164.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.82 167.78 17.6 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.127 0.571 . . . . 0.0 109.891 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -74.3 -31.43 62.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.657 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.62 172.72 2.53 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.598 1.559 . . . . 0.0 107.873 -172.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.05 -39.63 26.77 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.796 1.188 . . . . 0.0 113.789 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.38 -45.27 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.6 -0.941 . . . . 0.0 109.892 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.02 -25.66 64.6 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.655 -0.653 . . . . 0.0 110.181 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -55.07 34.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.517 1.053 . . . . 0.0 108.51 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.97 -42.36 76.15 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.682 0.753 . . . . 0.0 110.751 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.94 -40.49 84.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.541 0.737 . . . . 0.0 112.023 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -62.15 -44.06 97.46 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.232 0.924 . . . . 0.0 109.285 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.5 mt -58.0 -43.94 86.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.11 0.868 . . . . 0.0 110.71 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -69.84 -13.54 62.31 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.52 48.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.774 1.23 . . . . 0.0 112.906 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.93 34.87 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 119.706 1.139 . . . . 0.0 110.882 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.7 76.19 1.09 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -70.91 159.0 35.47 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.2 -1.66 3.92 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.784 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.55 136.96 17.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.141 1.47 . . . . 0.0 108.839 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.88 80.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.07 139.94 16.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.3 p -148.96 167.44 25.75 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.511 0.596 . . . . 0.0 111.935 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.9 t70 -78.98 -157.6 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 158.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.528 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 16.3 t-105 -122.59 -42.01 2.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.33 2.252 . . . . 0.0 110.293 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.63 43.74 1.0 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 112.203 -159.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -91.79 144.1 28.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 121.25 -0.906 . . . . 0.0 108.567 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.23 159.06 50.62 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.28 1.987 . . . . 0.0 111.379 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.82 -78.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 127.356 2.262 . . . . 0.0 111.862 -171.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.5 86.37 6.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -55.93 165.86 0.86 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 167.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.0 -30.32 53.86 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.809 -1.182 . . . . 0.0 112.416 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -29.09 41.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.669 1.235 . . . . 0.0 111.645 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.45 -44.52 57.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.86 -51.07 62.43 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.281 1.432 . . . . 0.0 109.178 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.12 -58.75 6.85 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.417 1.087 . . . . 0.0 110.216 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -66.63 -28.88 68.84 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.472 1.487 . . . . 0.0 111.939 -173.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.1 m -62.27 -55.41 28.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.467 1.03 . . . . 0.0 108.699 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.8 mt -50.66 -55.4 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.693 1.597 . . . . 0.0 108.564 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -30.72 65.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.264 1.426 . . . . 0.0 112.266 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 C-N-CA 124.207 1.003 . . . . 0.0 111.745 -169.673 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -34.12 1.96 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.117 2.167 . . . . 0.0 112.159 169.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.38 4.95 19.38 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.68 1.592 . . . . 0.0 113.705 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.13 125.63 90.5 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.89 124.64 11.66 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 108.697 -1.309 . . . . 0.0 108.697 170.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.79 142.1 18.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.9 tp -137.86 111.76 8.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -73.91 122.53 22.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.45 102.43 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -144.3 171.93 13.64 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.688 0.756 . . . . 0.0 112.565 -161.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.56 -24.36 39.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.312 1.045 . . . . 0.0 110.482 163.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.08 94.8 1.95 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.355 1.462 . . . . 0.0 110.514 -168.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 3.62 7.32 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.344 -0.848 . . . . 0.0 111.85 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -49.52 115.91 1.54 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 109.598 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -49.09 -53.07 22.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.418 0.687 . . . . 0.0 111.326 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.99 -25.8 67.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -72.78 -40.21 66.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.326 0.966 . . . . 0.0 109.658 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.58 -49.64 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.7 -57.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.21 76.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.816 0.735 . . . . 0.0 111.105 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.907 0.483 . . . . 0.0 110.149 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -27.48 67.27 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -68.93 -54.55 14.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.756 1.623 . . . . 0.0 109.404 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.83 80.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.881 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.24 35.08 2.78 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 124.691 1.138 . . . . 0.0 112.458 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.39 141.67 46.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -78.46 -4.84 50.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.978 0.174 . . . . 0.0 111.215 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.44 172.76 41.44 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 161.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -139.08 132.0 29.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.29 1.036 . . . . 0.0 108.519 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -132.97 130.67 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 127.065 2.146 . . . . 0.0 106.32 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.32 152.23 10.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -50.72 143.48 14.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.457 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.56 132.79 27.98 Favored 'Cis proline' 0 CA--C 1.534 0.484 0 CA-C-N 120.707 1.288 . . . . 0.0 111.012 -8.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -134.32 157.92 45.11 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.411 0.684 . . . . 0.0 111.243 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -155.51 171.91 19.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.516 1.927 . . . . 0.0 110.765 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.31 75.6 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.46 -50.5 31.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.937 1.295 . . . . 0.0 111.981 169.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.29 -35.3 48.13 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.808 -0.557 . . . . 0.0 109.749 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -57.65 11.01 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.257 1.023 . . . . 0.0 108.841 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.27 -29.69 70.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.042 0.937 . . . . 0.0 111.868 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.59 -45.45 65.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.564 0.346 . . . . 0.0 110.617 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.06 -35.33 80.81 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.954 -1.091 . . . . 0.0 110.306 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.3 mt -58.33 -56.71 18.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 109.729 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -50.71 -43.82 57.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.874 0.761 . . . . 0.0 110.916 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -51.68 -61.4 2.27 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.307 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 pt -70.96 -26.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.715 1.598 . . . . 0.0 114.531 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.67 -58.62 7.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.31 -41.74 66.25 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.876 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -67.73 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.554 1.542 . . . . 0.0 108.77 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.9 -29.13 62.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.74 0.416 . . . . 0.0 110.374 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.84 26.13 25.36 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 117.737 -1.59 . . . . 0.0 110.361 -161.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--O 1.242 0.692 0 CA-C-N 120.174 1.987 . . . . 0.0 109.801 175.347 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -91.11 138.5 31.55 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.087 0.555 . . . . 0.0 110.726 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.3 102.36 14.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.349 1.86 . . . . 0.0 107.747 165.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.89 136.75 54.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.3 106.16 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.03 89.26 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.24 158.81 16.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.65 0.738 . . . . 0.0 110.734 170.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.79 -4.34 58.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.384 1.074 . . . . 0.0 112.685 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 10.0 t80 -131.52 -3.92 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.844 1.258 . . . . 0.0 112.309 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 62.31 -60.18 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.214 2.205 . . . . 0.0 110.76 -159.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 68.8 m -62.63 -29.07 70.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 111.189 -171.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.02 64.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.648 1.567 . . . . 0.0 110.904 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.7 ttp85 -67.95 -43.86 78.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 121.288 1.858 . . . . 0.0 107.309 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.85 -45.63 67.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.239 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.08 -65.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.887 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.14 -47.53 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.204 1.365 . . . . 0.0 111.148 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -55.15 -49.5 71.65 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 109.755 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -60.17 -39.74 87.51 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.847 0.748 . . . . 0.0 110.744 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.45 -34.07 77.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.045 0.839 . . . . 0.0 110.989 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -67.27 -37.01 82.76 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.354 -0.841 . . . . 0.0 110.706 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -70.06 -29.2 66.15 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.538 -1.351 . . . . 0.0 111.084 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.34 -51.75 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.35 1.06 . . . . 0.0 110.582 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 47.37 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.613 0.721 . . . . 0.0 112.264 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.0 -111.72 0.83 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.6 158.27 44.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.178 0.989 . . . . 0.0 111.156 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -82.65 177.81 8.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.196 0.999 . . . . 0.0 109.357 159.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 60.78 79.25 0.25 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.745 2.018 . . . . 0.0 111.631 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -97.56 169.17 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.352 163.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -141.8 -179.6 6.29 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.97 1.708 . . . . 0.0 108.514 163.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -134.12 158.11 44.47 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.464 1.506 . . . . 0.0 107.775 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.59 159.14 40.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.598 1.559 . . . . 0.0 107.262 162.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.26 -24.13 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -171.5 168.68 6.37 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.468 1.507 . . . . 0.0 107.21 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.72 -37.89 21.57 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.291 0.948 . . . . 0.0 113.526 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.98 -51.22 47.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.261 1.024 . . . . 0.0 109.997 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -74.14 -28.23 61.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.143 1.377 . . . . 0.0 110.073 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -50.84 71.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.492 1.117 . . . . 0.0 108.942 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.18 -37.76 75.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.353 0.261 . . . . 0.0 110.492 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -67.77 -36.11 79.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.277 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 mmtt -63.45 -40.1 96.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.874 1.215 . . . . 0.0 109.605 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.55 -39.1 92.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.763 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -71.26 5.96 1.94 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.28 59.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.54 -1.35 . . . . 0.0 112.943 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -105.31 0.29 Allowed Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.379 0.991 . . . . 0.0 110.698 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.31 87.37 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.364 0.983 . . . . 0.0 110.98 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -67.69 164.82 18.47 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.365 1.066 . . . . 0.0 110.993 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.97 -43.71 3.76 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 119.044 -0.865 . . . . 0.0 111.221 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.05 145.59 44.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 117.894 0.847 . . . . 0.0 112.307 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -136.09 81.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.135 1.374 . . . . 0.0 107.894 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.88 127.1 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -136.81 144.39 43.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -171.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.15 166.66 19.44 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 158.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -71.92 -45.58 60.69 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.578 0.751 . . . . 0.0 109.317 162.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -73.97 98.75 3.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.054 0.942 . . . . 0.0 112.17 -160.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 mmt -131.4 155.51 81.38 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.96 -45.11 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.469 2.113 . . . . 0.0 111.273 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.65 -99.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.428 1.091 . . . . 0.0 108.657 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.9 ttm -79.18 96.12 5.8 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.4 166.75 4.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.057 0.943 . . . . 0.0 111.291 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.95 -24.28 71.5 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.259 -171.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -43.88 34.9 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.118 1.459 . . . . 0.0 107.758 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.43 -41.13 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.576 0.75 . . . . 0.0 110.977 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.55 -49.54 77.39 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.066 0.946 . . . . 0.0 109.638 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.58 -56.01 20.8 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.719 -1.134 . . . . 0.0 109.448 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 45.2 mttt -64.13 -37.97 89.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.677 1.581 . . . . 0.0 111.192 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.9 m -56.89 -49.17 76.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.451 0.569 . . . . 0.0 109.798 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -65.89 -42.82 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.41 0.684 . . . . 0.0 109.432 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.83 84.53 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 111.993 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.03 1.332 . . . . 0.0 111.479 -179.027 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.9 p -57.99 -21.13 43.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.404 1.081 . . . . 0.0 112.825 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.29 -16.19 62.45 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.2 mt -64.86 149.01 96.97 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 119.892 1.223 . . . . 0.0 112.299 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.14 86.7 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.535 2.823 . . . . 0.0 108.777 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 m -77.25 99.51 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -107.97 110.6 22.37 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.382 1.073 . . . . 0.0 108.267 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -72.53 123.24 22.75 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.94 96.65 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.3 t -134.46 -170.31 2.51 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.243 1.017 . . . . 0.0 109.88 -169.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.12 -12.13 14.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.844 1.258 . . . . 0.0 112.348 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.81 105.47 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.438 1.017 . . . . 0.0 110.761 -172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.93 4.44 8.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.812 0.845 . . . . 0.0 113.271 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -53.64 115.28 1.89 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.959 1.704 . . . . 0.0 109.724 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -55.25 -45.03 76.07 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.011 0.924 . . . . 0.0 110.119 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -41.91 39.87 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.56 1.144 . . . . 0.0 112.392 172.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.28 -34.38 63.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.583 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.75 -48.93 85.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.248 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mt -57.25 -50.31 77.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 CA-C-N 120.952 1.705 . . . . 0.0 109.336 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.26 -46.29 72.61 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 119.158 0.89 . . . . 0.0 110.304 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.69 76.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 110.867 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.41 99.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.388 0.995 . . . . 0.0 111.803 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.23 -48.36 81.85 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.51 1.924 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.446 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -62.56 -38.49 90.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.04 0.936 . . . . 0.0 110.923 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 33.51 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.851 1.215 . . . . 0.0 112.343 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 145.39 44.35 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.11 1.455 . . . . 0.0 109.217 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -73.41 -16.09 61.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.302 0.641 . . . . 0.0 111.736 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.76 173.55 39.34 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.62 136.42 35.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.37 144.82 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.84 138.84 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -52.14 139.51 34.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 165.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.96 137.75 51.43 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 CA-C-N 119.963 1.022 . . . . 0.0 110.5 -8.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.07 150.92 46.3 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.481 0.712 . . . . 0.0 110.077 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -147.98 -173.3 4.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.298 0.639 . . . . 0.0 111.057 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.54 -35.41 29.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.479 1.112 . . . . 0.0 109.669 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.81 -19.46 28.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -114.46 -23.36 9.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.24 0.927 . . . . 0.0 112.039 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.09 -50.59 72.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -47.34 74.68 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.287 1.035 . . . . 0.0 111.244 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.25 -52.8 63.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 122.991 0.516 . . . . 0.0 109.851 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.99 -33.17 74.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.222 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.34 -58.02 10.32 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.715 1.143 . . . . 0.0 109.69 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -56.94 -40.01 75.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.867 0.758 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -55.31 -56.46 19.76 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.031 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 -26.11 18.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 120.39 1.45 . . . . 0.0 112.812 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -53.96 -53.53 51.54 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.084 0.856 . . . . 0.0 108.912 169.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.3 -43.83 26.95 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.552 0.341 . . . . 0.0 110.737 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -73.88 -62.01 1.65 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.074 0.549 . . . . 0.0 110.045 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mt -71.93 -43.22 65.62 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.972 0.509 . . . . 0.0 109.776 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.55 32.47 3.39 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.491 -163.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--O 1.253 1.282 0 CA-C-N 118.631 1.215 . . . . 0.0 111.239 172.293 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 111.097 0.036 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 169.89 17.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 111.779 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -136.95 101.9 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.988 1.715 . . . . 0.0 108.258 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.9 tp -71.01 131.08 43.13 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.3 99.74 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.37 70.12 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.492 1.917 . . . . 0.0 108.576 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.44 151.67 41.04 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.948 -1.095 . . . . 0.0 108.102 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.5 -42.13 65.18 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.138 -0.976 . . . . 0.0 110.793 169.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -90.96 115.97 28.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.618 1.567 . . . . 0.0 107.02 -173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -57.75 -47.61 81.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.262 0.483 . . . . 0.0 110.078 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -53.57 -40.88 65.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.75 0.705 . . . . 0.0 111.177 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 ttt -58.3 -39.96 80.71 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.546 0.738 . . . . 0.0 110.143 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' HG2' ' HE ' ' A' ' 22' ' ' ARG . 14.1 ttp180 -62.13 -46.79 87.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.004 1.322 . . . . 0.0 109.797 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -55.81 -51.93 65.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.744 0.818 . . . . 0.0 108.887 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.51 -62.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.254 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -48.64 -44.23 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 120.828 1.649 . . . . 0.0 110.671 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HE ' ' HG2' ' A' ' 18' ' ' ARG . 59.5 mtt-85 -60.85 -45.44 94.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.669 1.122 . . . . 0.0 111.664 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -63.88 -42.5 97.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.758 0.708 . . . . 0.0 111.748 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.76 -32.41 73.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.922 0.889 . . . . 0.0 111.478 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.16 -56.76 11.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -64.79 -19.47 65.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -51.73 -33.44 34.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.898 1.226 . . . . 0.0 110.804 164.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.9 -41.4 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.975 2.11 . . . . 0.0 110.129 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.86 -139.27 6.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 64.86 60.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 123.173 1.464 . . . . 0.0 110.32 166.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.24 176.18 4.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.539 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 56.41 48.34 17.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 127.483 2.313 . . . . 0.0 113.477 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -55.51 161.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 121.13 -0.981 . . . . 0.0 111.369 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.04 157.5 44.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.279 1.832 . . . . 0.0 107.617 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.17 116.86 19.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.24 163.77 13.49 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 158.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.3 -37.04 58.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.006 0.821 . . . . 0.0 110.432 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.86 174.71 14.57 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.156 1.383 . . . . 0.0 109.237 -169.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.47 -35.31 71.78 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.5 t -66.38 -48.87 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 120.822 2.311 . . . . 0.0 107.152 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.73 -28.86 70.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.816 0.847 . . . . 0.0 111.287 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.68 -56.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.947 1.699 . . . . 0.0 109.43 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.73 -45.62 74.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.105 0.562 . . . . 0.0 109.77 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -65.75 -28.92 69.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.15 0.58 . . . . 0.0 112.161 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -62.93 -52.56 62.58 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.074 0.95 . . . . 0.0 108.804 166.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.86 -41.45 67.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.704 1.138 . . . . 0.0 111.131 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -72.12 -7.09 47.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -17.6 58.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.463 1.029 . . . . 0.0 111.653 167.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.08 169.96 16.85 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.546 1.067 . . . . 0.0 111.548 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.22 108.2 2.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.244 0.926 . . . . 0.0 113.279 -171.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.49 163.4 27.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.444 1.098 . . . . 0.0 108.749 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.53 -45.06 19.35 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 166.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -135.91 150.59 49.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.599 0.76 . . . . 0.0 112.437 -166.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.63 70.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.082 1.353 . . . . 0.0 108.687 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.18 130.97 34.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.5 m -150.39 158.77 44.53 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.614 -0.679 . . . . 0.0 110.979 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.91 169.08 18.97 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.458 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -83.28 -48.92 9.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.719 1.608 . . . . 0.0 112.372 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.86 79.32 6.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.71 1.604 . . . . 0.0 109.582 -159.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.34 125.29 28.28 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.63 -40.57 29.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.125 2.55 . . . . 0.0 113.7 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -83.54 -101.91 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttp -79.78 106.97 12.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.79 160.61 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.19 -29.72 56.71 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.082 -1.011 . . . . 0.0 112.117 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.01 -43.01 83.97 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.764 0.782 . . . . 0.0 110.842 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.54 -37.55 71.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.611 0.765 . . . . 0.0 110.304 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.3 tp -53.06 -58.62 6.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.211 1.004 . . . . 0.0 108.701 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -48.09 -56.96 6.51 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.089 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -67.41 -24.68 65.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.035 1.289 . . . . 0.0 114.02 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -65.98 -48.27 71.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.257 6.3 mt -55.57 -57.83 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 167.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -23.86 67.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.163 1.385 . . . . 0.0 113.038 -165.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.314 0 CA-C-N 119.507 1.049 . . . . 0.0 110.264 -178.067 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 119.72 -0.181 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.8 p -59.52 -25.03 64.14 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.092 0.957 . . . . 0.0 113.285 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -9.43 59.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 113.618 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.2 mt -56.59 144.22 65.15 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 119.199 0.909 . . . . 0.0 109.821 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.98 79.96 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.261 2.641 . . . . 0.0 109.042 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.91 110.37 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 128.627 2.771 . . . . 0.0 107.746 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.7 tp -135.94 113.21 10.6 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.263 -0.898 . . . . 0.0 111.935 -158.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -80.97 129.73 34.68 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.36 105.18 5.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -152.26 166.79 30.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.302 0.501 . . . . 0.0 110.831 -166.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.56 57.05 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.282 -0.886 . . . . 0.0 112.178 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -72.82 96.6 2.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.338 1.455 . . . . 0.0 110.084 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.59 -0.81 52.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.861 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -50.71 118.03 2.85 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.559 1.072 . . . . 0.0 109.812 -174.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -50.71 -52.98 35.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.103 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.24 -29.85 69.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.422 1.01 . . . . 0.0 112.625 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -72.13 -36.33 69.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.203 0.91 . . . . 0.0 110.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.3 -44.5 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.66 -48.92 84.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.25 -44.55 83.99 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.427 1.012 . . . . 0.0 110.152 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.95 88.18 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 119.225 0.921 . . . . 0.0 111.236 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.73 92.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.272 0.487 . . . . 0.0 109.874 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -62.15 -49.91 73.97 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.926 2.491 . . . . 0.0 111.283 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.39 -22.1 62.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.608 1.163 . . . . 0.0 111.89 174.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.22 6.11 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.7 1.143 . . . . 0.0 110.327 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.52 142.46 58.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.6 p -66.4 -24.36 66.46 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.105 0.562 . . . . 0.0 111.093 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 169.45 38.3 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.92 126.18 28.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.224 1.41 . . . . 0.0 108.563 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -121.08 107.31 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.04 153.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 166.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.43 150.37 34.1 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.548 1.539 . . . . 0.0 109.105 160.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.51 147.75 79.22 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 CA-C-N 121.105 1.43 . . . . 0.0 109.903 -12.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -146.92 138.41 24.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -140.94 -174.75 4.08 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.559 1.544 . . . . 0.0 109.613 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.19 -25.64 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.304 -0.872 . . . . 0.0 110.153 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.12 53.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.202 1.001 . . . . 0.0 112.723 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.6 t -98.6 -27.0 14.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.839 0.745 . . . . 0.0 110.754 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.72 86.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.302 0.956 . . . . 0.0 108.797 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -38.53 91.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.717 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.62 -54.1 22.52 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.747 0.703 . . . . 0.0 110.355 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -38.08 77.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.829 1.195 . . . . 0.0 111.042 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.98 -54.67 44.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.01 0.823 . . . . 0.0 110.629 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.82 -39.64 68.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.85 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -64.99 -45.49 85.4 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.332 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -19.63 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 121.041 1.746 . . . . 0.0 113.414 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -56.54 -62.9 1.41 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 159.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -72.54 -30.37 64.4 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.259 -0.9 . . . . 0.0 112.609 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -68.66 0.65 Allowed 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.95 -23.57 61.47 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 122.954 0.159 . . . . 0.0 110.89 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.53 23.26 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.532 -1.704 . . . . 0.0 110.056 -165.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-N 119.866 1.833 . . . . 0.0 110.476 172.356 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.234 0.238 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.271 2.4 ptpt -91.86 164.01 13.83 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.31 108.53 12.31 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.371 1.468 . . . . 0.0 108.77 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -82.43 139.33 34.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.79 1.632 . . . . 0.0 109.963 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -135.72 112.45 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.361 1.465 . . . . 0.0 108.448 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.27 41.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.081 1.352 . . . . 0.0 110.324 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.32 154.67 7.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.955 -1.09 . . . . 0.0 108.959 164.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.08 -45.31 11.52 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.22 -1.55 . . . . 0.0 110.744 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -70.6 115.22 9.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.645 1.978 . . . . 0.0 107.636 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -59.64 -39.53 84.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.192 1.36 . . . . 0.0 111.884 -172.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.4 m -55.13 -32.41 62.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.74 0.7 . . . . 0.0 111.45 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 tpp -60.5 -42.46 96.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.231 -0.918 . . . . 0.0 109.947 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -66.18 -34.44 78.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.719 1.145 . . . . 0.0 111.124 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -59.79 -58.77 7.12 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.74 -63.26 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 C-N-CA 125.978 1.711 . . . . 0.0 109.05 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.78 -46.04 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 121.071 1.759 . . . . 0.0 111.267 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -65.51 -41.24 93.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 120.179 1.354 . . . . 0.0 111.518 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -58.15 -54.57 45.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.421 1.088 . . . . 0.0 109.437 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -52.26 -48.53 65.18 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.861 2.064 . . . . 0.0 110.829 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.03 -44.15 82.6 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.318 0.647 . . . . 0.0 110.811 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -77.62 -17.24 57.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.51 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.81 -43.89 94.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.34 1.427 . . . . 0.0 109.287 166.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.07 -37.24 78.39 Favored 'General case' 0 N--CA 1.46 0.038 0 O-C-N 122.179 -0.325 . . . . 0.0 110.596 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.98 6.1 10.32 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.92 1.248 . . . . 0.0 113.885 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.24 155.82 39.77 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.7 1.75 . . . . 0.0 108.942 163.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -149.88 -167.53 2.85 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.322 1.049 . . . . 0.0 108.394 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 55.15 37.93 29.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.108 1.363 . . . . 0.0 111.16 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.29 158.11 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -140.76 166.68 24.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.624 2.37 . . . . 0.0 107.478 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -128.78 155.11 45.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.91 167.75 10.38 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 161.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -42.97 89.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.68 0.792 . . . . 0.0 111.435 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.3 173.87 5.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.038 1.335 . . . . 0.0 108.835 -169.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.33 -42.01 72.98 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 119.923 1.238 . . . . 0.0 113.389 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.11 -51.42 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.86 1.264 . . . . 0.0 109.659 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -70.33 -35.65 73.75 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.754 0.821 . . . . 0.0 111.076 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.31 65.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.568 1.147 . . . . 0.0 109.409 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -54.61 -48.92 71.59 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.721 0.638 . . . . 0.0 111.6 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -66.3 -28.5 68.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -64.19 -46.56 83.39 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.372 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.55 -41.69 81.51 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 110.665 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 3.06 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 158.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.82 164.32 11.22 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.969 1.271 . . . . 0.0 111.395 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.17 14.53 78.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.035 0.826 . . . . 0.0 113.167 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -81.46 117.32 21.79 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.44 -25.11 26.78 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.225 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -148.94 149.7 31.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.17 0.988 . . . . 0.0 110.803 -169.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.99 85.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.27 127.22 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -152.03 163.64 38.89 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.082 -1.011 . . . . 0.0 110.308 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.35 173.58 5.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.795 0.807 . . . . 0.0 110.278 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 -71.58 -60.69 2.1 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.664 158.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.258 23.7 p30 29.21 -157.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 130.392 3.477 . . . . 0.0 116.215 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 65.15 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.034 1.334 . . . . 0.0 112.504 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 58.3 Cg_endo -65.36 -66.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 121.796 1.664 . . . . 0.0 108.78 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.474 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 5.7 m120 -155.61 -69.69 0.12 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.661 2.385 . . . . 0.0 104.953 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.0 ttm -70.01 88.36 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 160.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -65.61 172.01 3.72 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.793 0.837 . . . . 0.0 110.428 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.53 -32.75 53.43 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.988 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -49.87 44.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.537 1.169 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.61 -38.06 89.67 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.472 0.709 . . . . 0.0 110.874 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.0 tp -55.94 -61.31 2.46 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.115 1.366 . . . . 0.0 108.722 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.42 -53.52 10.91 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.843 1.257 . . . . 0.0 109.511 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 101' ' ' ALA . 66.6 mttt -66.62 -26.25 66.99 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.126 0.875 . . . . 0.0 113.12 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.2 m -72.87 -43.36 62.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.361 1.064 . . . . 0.0 109.612 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.37 -45.79 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.969 1.308 . . . . 0.0 113.593 166.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -49.3 77.16 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.311 1.044 . . . . 0.0 109.529 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.585 0 C-N-CA 124.088 0.955 . . . . 0.0 113.303 178.646 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mtm . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 p -65.34 -17.29 64.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.492 1.042 . . . . 0.0 113.167 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.7 59.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.526 1.13 . . . . 0.0 113.471 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.01 133.24 92.48 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.314 0.961 . . . . 0.0 110.271 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.01 125.3 12.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.011 1.807 . . . . 0.0 108.682 166.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.07 107.71 22.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.205 2.202 . . . . 0.0 106.804 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 tp -125.12 115.2 20.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.341 1.057 . . . . 0.0 109.712 -164.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.38 122.35 26.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.92 113.59 24.87 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -156.0 168.9 25.8 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.259 -0.9 . . . . 0.0 110.626 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.32 -21.23 46.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.379 -0.825 . . . . 0.0 111.684 163.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.53 107.35 19.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.231 1.012 . . . . 0.0 111.227 -167.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -73.56 0.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.989 171.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.1 tttt 32.73 98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.828 2.451 . . . . 0.0 113.381 -167.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -52.45 -41.51 63.36 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.287 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.73 -36.27 69.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.151 1.342 . . . . 0.0 112.752 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.81 -36.41 70.24 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 121.536 -0.727 . . . . 0.0 110.085 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.1 mt -63.46 -39.17 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.642 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.3 -53.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.51 -46.45 70.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.987 0.812 . . . . 0.0 110.654 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.47 73.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.916 0.886 . . . . 0.0 110.741 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.88 99.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.43 0.692 . . . . 0.0 110.147 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -60.84 -50.89 71.63 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.312 1.845 . . . . 0.0 111.17 175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . . . -59.62 -22.65 62.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.918 0.887 . . . . 0.0 112.267 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.78 11.73 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.544 -1.142 . . . . 0.0 112.281 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 134.96 57.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.415 1.107 . . . . 0.0 108.805 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 m -67.64 -10.08 49.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.201 1.001 . . . . 0.0 112.255 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.06 170.54 38.2 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.332 0.969 . . . . 0.0 111.345 166.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.14 132.32 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.276 1.43 . . . . 0.0 107.681 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.39 104.79 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 156.68 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -58.21 151.08 49.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 158.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.27 148.36 91.04 Favored 'Cis proline' 0 N--CA 1.457 -0.632 0 CA-C-N 119.653 0.912 . . . . 0.0 110.633 -9.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -149.44 154.47 38.89 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.322 0.649 . . . . 0.0 110.088 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 p -143.81 -175.19 4.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.363 1.065 . . . . 0.0 109.46 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -29.62 60.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.599 0.76 . . . . 0.0 110.3 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.77 67.98 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 t -99.57 -27.61 13.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.85 1.204 . . . . 0.0 110.224 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -50.63 70.21 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -37.21 84.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.863 1.265 . . . . 0.0 112.249 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.98 -57.19 13.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.865 1.266 . . . . 0.0 109.14 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -66.01 -34.16 77.45 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.489 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 mt -59.54 -55.1 38.85 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.187 175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 124' ' ' PHE . 18.7 t-20 -64.37 -30.56 71.6 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 118.283 0.492 . . . . 0.0 110.412 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -60.2 3.51 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.029 167.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.4 pt -71.15 -26.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.426 1.466 . . . . 0.0 113.86 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 121' ' ' ASN . 21.6 m-30 -59.47 -39.07 82.5 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.092 0.86 . . . . 0.0 109.918 170.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.58 -40.22 17.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.008 0.523 . . . . 0.0 110.71 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -77.14 -71.7 0.39 Allowed 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.564 1.145 . . . . 0.0 108.125 -168.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.28 -20.41 64.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.269 0.486 . . . . 0.0 111.105 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 38.47 30.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -167.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.7 mmm . . . . . 0 C--O 1.25 1.093 0 CA-C-N 117.882 0.841 . . . . 0.0 109.377 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 177.14 6.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.987 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.76 124.39 43.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.168 2.187 . . . . 0.0 106.091 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.13 134.52 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 158.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.66 92.54 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.84 51.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.24 105.24 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -47.99 -43.12 29.42 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.784 1.634 . . . . 0.0 112.103 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.75 116.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.304 1.041 . . . . 0.0 108.521 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -52.35 -51.45 58.76 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.164 0.986 . . . . 0.0 110.77 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -52.17 -39.35 59.95 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.417 -0.802 . . . . 0.0 111.346 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 ttp -61.43 -42.06 98.16 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.11 98.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.854 1.207 . . . . 0.0 109.944 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -57.46 -57.44 12.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -49.07 -60.81 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.772 1.629 . . . . 0.0 108.866 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.38 -51.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 120.388 1.449 . . . . 0.0 111.055 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -41.17 91.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.07 0.85 . . . . 0.0 111.052 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.27 -53.94 47.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.91 -34.28 69.67 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.586 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -60.09 -62.71 1.67 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.873 0.869 . . . . 0.0 109.314 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -65.24 -14.33 60.43 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.08 -7.98 34.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.425 1.49 . . . . 0.0 113.152 166.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.5 mt -126.01 7.79 7.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.485 3.114 . . . . 0.0 112.086 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 -144.13 22.67 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.33 40.39 18.28 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.189 1.495 . . . . 0.0 113.3 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.08 171.08 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.498 -0.751 . . . . 0.0 110.936 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 98.57 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.29 3.036 . . . . 0.0 107.139 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.754 -0.591 . . . . 0.0 110.156 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -132.14 175.43 9.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.81 2.044 . . . . 0.0 107.615 167.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -127.3 166.33 18.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.54 1.536 . . . . 0.0 107.379 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.68 168.36 9.84 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 159.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.75 -26.33 62.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.731 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.32 174.76 0.45 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.031 1.732 . . . . 0.0 107.674 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.25 -39.41 42.83 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.005 1.288 . . . . 0.0 115.428 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.57 -43.95 92.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.048 1.424 . . . . 0.0 109.918 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.07 -28.05 60.2 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.561 1.144 . . . . 0.0 110.652 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.25 89.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.009 0.924 . . . . 0.0 110.102 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.11 -45.16 95.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.768 -0.635 . . . . 0.0 109.324 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -57.75 -44.55 86.16 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.646 0.657 . . . . 0.0 111.661 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -53.51 -50.87 64.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.751 0.82 . . . . 0.0 109.778 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -35.62 80.28 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.209 0.604 . . . . 0.0 112.017 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.02 -1.34 7.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.816 0.846 . . . . 0.0 112.19 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.6 12.93 7.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.572 1.949 . . . . 0.0 112.495 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.33 163.97 23.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.214 1.37 . . . . 0.0 113.857 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.97 78.96 1.85 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -70.76 119.62 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.61 -19.89 79.73 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.523 -168.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -132.09 150.46 52.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 127.046 2.138 . . . . 0.0 106.416 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 t -137.56 72.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -77.33 143.73 12.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 p -149.71 163.13 38.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.659 0.663 . . . . 0.0 111.011 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 24.6 t70 -69.45 179.97 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.419 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 29.0 t-105 -71.04 -78.13 0.08 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 162.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.2 t30 43.1 178.16 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.956 2.902 . . . . 0.0 112.606 -164.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.2 mtm -140.33 68.26 32.63 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 119.053 -2.28 . . . . 0.0 110.553 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.49 49.0 2.32 Favored 'Trans proline' 0 CA--C 1.543 0.964 1 C-N-CA 125.467 4.111 . . . . 0.0 110.791 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.88 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.439 1.495 . . . . 0.0 108.709 -159.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.2 ttm -79.52 81.73 5.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.16 159.78 2.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.543 1.137 . . . . 0.0 110.675 167.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.96 59.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.369 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.39 -46.86 37.61 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.584 1.154 . . . . 0.0 109.313 174.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.27 -38.3 90.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.559 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.02 -53.81 54.07 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.301 0.955 . . . . 0.0 109.21 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.85 -56.1 9.72 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -66.17 -28.69 68.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 120.384 1.447 . . . . 0.0 114.078 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.5 m -71.98 -33.75 68.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.262 0.937 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 74' ' ' ALA . 17.4 mt -73.36 -48.37 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.962 173.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.66 24.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.508 3.123 . . . . 0.0 111.475 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 72' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 108.146 172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 120.489 0.185 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -61.53 -25.08 67.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.424 1.089 . . . . 0.0 113.341 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -16.5 61.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.5 141.7 91.55 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 118.472 0.578 . . . . 0.0 111.465 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 72.69 5.78 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.707 2.271 . . . . 0.0 108.423 166.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.53 137.77 22.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 160.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' CD1' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp -147.97 111.6 5.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -160.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.93 123.14 24.55 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.7 102.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -142.35 174.74 10.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.179 0.99 . . . . 0.0 110.281 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.78 -23.5 19.7 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.814 0.846 . . . . 0.0 111.617 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -86.5 111.32 20.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.756 0.707 . . . . 0.0 109.141 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.96 -73.52 0.07 Allowed 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 166.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 tptp 43.78 91.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.538 1.637 . . . . 0.0 112.432 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -52.16 -34.65 45.89 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.2 -0.938 . . . . 0.0 112.889 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.34 -36.03 80.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.293 1.406 . . . . 0.0 111.692 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -63.31 -38.91 93.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.236 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.54 -49.99 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.565 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.46 -55.53 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 119.542 1.065 . . . . 0.0 108.341 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.12 79.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.924 0.489 . . . . 0.0 110.769 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.16 90.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.919 -0.488 . . . . 0.0 110.543 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.45 77.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -61.4 -49.99 74.65 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.718 1.607 . . . . 0.0 109.672 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -28.19 69.07 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.927 0.491 . . . . 0.0 111.233 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.5 42.03 6.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 124.74 1.162 . . . . 0.0 111.338 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.18 156.87 11.44 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.8 p -64.93 -22.77 67.05 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.301 -0.874 . . . . 0.0 111.948 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.12 -175.95 37.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.69 1.614 . . . . 0.0 109.426 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -136.74 91.03 2.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.673 1.189 . . . . 0.0 108.046 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -75.3 125.97 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.88 144.15 16.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -75.8 162.34 72.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -64.12 145.75 60.93 Favored 'Cis proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.714 0.934 . . . . 0.0 109.782 -12.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -139.2 162.16 35.66 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.086 0.955 . . . . 0.0 109.235 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -142.88 171.98 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.354 1.061 . . . . 0.0 110.109 -164.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.83 69.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.642 0.777 . . . . 0.0 112.401 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t -81.76 -33.27 31.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.981 1.264 . . . . 0.0 110.119 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -50.99 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.552 1.069 . . . . 0.0 109.017 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -41.57 92.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.125 1.77 . . . . 0.0 111.073 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.95 -42.44 98.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.303 1.041 . . . . 0.0 109.156 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HE3' ' CD1' ' A' ' 84' ' ' LEU . 3.2 mmmp? -68.95 -29.72 68.02 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.712 -1.613 . . . . 0.0 112.384 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -54.48 24.41 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -55.32 -42.92 74.41 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 118.225 0.466 . . . . 0.0 111.258 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -51.23 -60.04 3.55 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.39 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.57 -32.66 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 121.343 1.883 . . . . 0.0 113.757 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -58.63 -45.09 90.01 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.701 0.682 . . . . 0.0 109.632 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.47 -34.17 15.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -76.1 -72.43 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -37.0 79.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.266 0.627 . . . . 0.0 109.333 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.01 41.58 4.58 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -164.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.246 0.9 0 CA-C-N 118.501 1.151 . . . . 0.0 110.883 175.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.93 161.71 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.574 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.8 95.28 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -69.31 138.91 54.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.0 1.273 . . . . 0.0 109.492 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -131.67 115.5 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.69 76.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.23 159.84 18.68 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.853 0.835 . . . . 0.0 111.342 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.55 97.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.199 1.4 . . . . 0.0 111.212 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CD2' ' HB ' ' A' ' 16' ' ' THR . 1.2 t80 -90.0 -63.85 1.22 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.683 0.393 . . . . 0.0 110.528 -159.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 m 127.28 -59.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 1 C-N-CA 133.273 4.629 . . . . 0.0 106.875 -161.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 91.8 m -65.59 -33.75 76.63 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.771 -174.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -61.5 -27.25 68.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.23 1.377 . . . . 0.0 110.207 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -63.47 -47.73 80.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.477 1.035 . . . . 0.0 109.589 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -48.43 80.94 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.762 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.36 -47.01 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.0 1.32 . . . . 0.0 111.228 -172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -54.03 -50.75 65.98 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.35 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.28 -43.44 91.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.235 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 mt -55.12 -43.14 73.83 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.244 0.929 . . . . 0.0 109.848 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.7 -48.81 70.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.548 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -64.85 -33.63 76.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.118 -0.944 . . . . 0.0 112.473 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -58.41 -30.76 67.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.491 1.041 . . . . 0.0 110.908 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.96 12.25 37.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.24 1.816 . . . . 0.0 111.699 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -33.67 5.04 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.641 1.591 . . . . 0.0 113.317 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -61.38 140.01 58.09 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.929 1.365 . . . . 0.0 110.633 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 177.47 7.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.075 0.94 . . . . 0.0 111.403 -168.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.251 21.4 t30 67.96 34.0 4.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.77 2.828 . . . . 0.0 113.503 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 154.97 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.474 0.654 . . . . 0.0 109.723 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.33 179.41 6.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.454 2.701 . . . . 0.0 108.019 -163.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.88 152.27 39.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.848 -0.532 . . . . 0.0 111.614 -164.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.21 172.5 12.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.793 1.237 . . . . 0.0 108.93 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -68.46 -47.69 66.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.746 0.818 . . . . 0.0 112.726 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.84 168.01 10.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.85 2.06 . . . . 0.0 107.335 -158.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.6 -38.02 27.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.723 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.0 t -63.41 -51.01 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.706 2.253 . . . . 0.0 107.555 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.97 -28.69 69.99 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 0.0 110.829 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.57 -42.9 73.92 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.947 1.699 . . . . 0.0 111.37 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -65.62 -43.54 89.26 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -56.52 -39.71 73.8 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.155 0.982 . . . . 0.0 111.058 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.31 -61.46 2.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.365 0.984 . . . . 0.0 109.252 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.46 HD12 ' H ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -51.37 -49.8 60.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -168.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.72 -2.87 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.4 -11.5 59.25 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.822 1.192 . . . . 0.0 112.969 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.71 5.82 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 119.199 2.44 . . . . 0.0 119.199 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.42 73.71 0.64 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 120.603 2.202 . . . . 0.0 110.377 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.46 ' H ' HD12 ' A' ' 46' ' ' LEU . 1.2 m-85 -66.17 109.21 2.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -10.75 24.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.338 -0.701 . . . . 0.0 114.398 -166.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.4 144.68 42.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.143 1.377 . . . . 0.0 109.159 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.13 91.24 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -108.49 125.69 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -143.03 168.05 20.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.852 0.834 . . . . 0.0 110.896 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.83 170.18 10.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 158.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -84.91 -51.68 6.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.455 1.502 . . . . 0.0 108.307 162.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -87.24 72.49 9.88 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.61 1.564 . . . . 0.0 110.192 -159.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 tpt -124.77 125.51 25.45 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 -0.31 9.73 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.748 2.299 . . . . 0.0 115.067 -161.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -107.25 -96.24 0.37 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.3 ttm -91.07 89.9 7.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.28 155.11 5.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.089 172.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.78 -31.79 58.34 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.03 -0.872 . . . . 0.0 112.203 -172.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -36.5 72.4 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.871 1.335 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -68.09 -41.5 81.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.011 175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.63 -49.11 79.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.784 0.72 . . . . 0.0 109.575 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.59 -63.11 1.23 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.836 1.254 . . . . 0.0 108.106 172.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -63.22 -27.48 69.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.94 1.246 . . . . 0.0 113.398 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.1 m -61.74 -53.87 50.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.394 0.997 . . . . 0.0 108.884 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -62.51 -46.05 97.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.671 1.188 . . . . 0.0 110.21 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.58 7.91 0.56 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.698 1.999 . . . . 0.0 113.215 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.148 0 CA-C-N 120.961 1.709 . . . . 0.0 111.862 -177.304 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 mtm . . . . . 0 C--O 1.223 -0.301 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -55.06 -23.99 22.96 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 121.743 2.065 . . . . 0.0 114.451 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -9.57 53.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.596 1.089 . . . . 0.0 113.255 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.02 128.93 77.36 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 121.129 -0.982 . . . . 0.0 110.606 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 91.02 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.387 2.058 . . . . 0.0 109.749 170.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -75.76 107.85 7.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 tp -112.6 113.97 26.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.269 1.427 . . . . 0.0 108.562 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.9 mmt -85.67 125.93 33.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.03 88.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -122.62 174.21 7.22 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 113.657 -161.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.58 -21.69 26.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 111.662 164.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -86.18 106.74 17.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.781 1.232 . . . . 0.0 110.972 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.23 8.62 15.23 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.476 -0.765 . . . . 0.0 112.587 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -51.96 121.35 6.54 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.242 1.017 . . . . 0.0 108.927 -171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -38.71 76.89 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.275 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.36 -32.32 64.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.489 1.04 . . . . 0.0 112.329 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.72 -39.56 61.82 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.732 0.696 . . . . 0.0 109.495 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.43 -46.96 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.36 -57.44 4.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.34 -45.44 80.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.335 1.054 . . . . 0.0 110.71 -172.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.78 96.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.22 -15.25 61.0 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -75.05 -51.73 12.82 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.266 1.426 . . . . 0.0 108.011 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.53 78.04 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.501 0.72 . . . . 0.0 111.905 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.79 58.84 2.07 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.106 1.336 . . . . 0.0 110.502 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.61 162.35 5.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.398 0.599 . . . . 0.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -62.42 -43.06 99.73 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.41 173.18 46.1 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 125.472 1.51 . . . . 0.0 110.152 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 135.23 46.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.327 1.851 . . . . 0.0 107.288 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.0 t -134.47 145.86 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 128.327 2.651 . . . . 0.0 104.763 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t -127.63 164.48 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -49.85 141.18 14.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.284 160.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -78.35 173.49 56.27 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 120.702 1.287 . . . . 0.0 109.337 -20.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -177.28 151.5 0.79 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.596 -1.315 . . . . 0.0 108.619 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -153.77 -179.33 7.72 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 127.285 2.234 . . . . 0.0 108.275 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.5 -29.7 62.13 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.321 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.59 33.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.857 1.263 . . . . 0.0 113.076 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.26 -30.8 13.25 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.808 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -48.74 79.08 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.751 1.16 . . . . 0.0 108.331 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -40.7 97.03 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.617 1.167 . . . . 0.0 111.51 -176.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HG2' ' HZ2' ' A' ' 122' ' ' LYS . 6.1 tp10 -69.3 -40.4 77.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.9 0.88 . . . . 0.0 109.042 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.412 ' HE2' ' HE3' ' A' ' 122' ' ' LYS . 50.4 mmtt -65.7 -40.82 92.69 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.648 -1.282 . . . . 0.0 110.527 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.0 mt -55.44 -49.7 71.77 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.776 0.831 . . . . 0.0 108.968 170.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.81 -38.58 88.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.065 0.848 . . . . 0.0 112.612 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HZ2' ' HG2' ' A' ' 118' ' ' GLU . 9.2 mtmm -55.5 -52.49 63.49 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.027 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.7 pt -73.68 -24.78 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 120.192 1.36 . . . . 0.0 113.473 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -56.95 -59.55 4.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.24 -43.72 73.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.085 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -69.82 0.33 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.61 -29.38 65.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.7 30.53 13.11 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 117.907 -1.496 . . . . 0.0 109.756 -160.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mmm . . . . . 0 C--O 1.247 0.95 0 CA-C-N 120.135 1.967 . . . . 0.0 109.417 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.01 0.433 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.61 29.9 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.97 152.84 19.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.14 134.65 54.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 162.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.84 108.33 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -125.33 69.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.02 156.85 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -67.11 -55.46 14.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.06 1.3 . . . . 0.0 109.258 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.2 t80 -70.9 115.82 10.49 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.95 -48.43 70.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.739 1.216 . . . . 0.0 111.326 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 25.1 m -62.66 -26.03 68.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.006 0.922 . . . . 0.0 111.82 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.3 ttm -58.42 -29.32 66.01 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.713 1.142 . . . . 0.0 109.893 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -70.39 -30.76 67.74 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.032 0.833 . . . . 0.0 110.26 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -61.49 -51.22 69.54 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.447 1.021 . . . . 0.0 108.354 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.63 -60.38 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.34 0.656 . . . . 0.0 109.798 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.92 -52.81 12.53 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 126.057 1.743 . . . . 0.0 109.774 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -56.47 -47.76 78.5 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.089 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -59.12 -44.75 92.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 119.933 1.242 . . . . 0.0 110.143 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.55 -36.87 83.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 110.68 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -66.36 0.51 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.391 1.076 . . . . 0.0 109.996 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -25.59 68.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.502 1.121 . . . . 0.0 112.092 -167.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -15.11 51.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.684 1.129 . . . . 0.0 112.57 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -147.03 19.05 1.25 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 112.103 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.1 28.64 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.349 -0.844 . . . . 0.0 111.804 -161.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -57.37 123.35 15.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.981 1.712 . . . . 0.0 110.918 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -72.12 -3.06 20.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.916 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -118.74 128.48 54.53 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.019 1.327 . . . . 0.0 107.766 -158.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.79 165.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 125.77 1.628 . . . . 0.0 107.304 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -127.04 161.18 29.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -125.63 127.13 45.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.6 173.92 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.48 -46.46 66.58 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.4 -0.812 . . . . 0.0 110.568 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.24 175.25 6.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.024 1.73 . . . . 0.0 108.187 -163.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.75 -43.23 29.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.376 0.989 . . . . 0.0 114.111 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.78 -52.07 64.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 119.022 1.411 . . . . 0.0 108.694 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.67 -21.95 66.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.361 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.02 -47.42 68.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.347 1.431 . . . . 0.0 109.543 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.62 -46.02 87.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.319 0.581 . . . . 0.0 109.668 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -60.35 -44.78 95.24 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.719 0.807 . . . . 0.0 111.536 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -59.41 -41.38 89.35 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.001 1.32 . . . . 0.0 110.219 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -43.9 91.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.344 0.975 . . . . 0.0 111.347 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.66 -0.21 29.1 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.66 4.38 40.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.735 1.152 . . . . 0.0 112.958 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.14 -172.39 34.63 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 120.496 -1.377 . . . . 0.0 112.035 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.85 79.41 1.58 Allowed Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -75.53 165.48 25.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 159.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.52 -7.59 1.04 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.852 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -144.33 135.22 25.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.598 1.199 . . . . 0.0 108.423 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.72 117.96 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -165.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.83 134.04 67.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.727 1.611 . . . . 0.0 106.902 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 m -150.81 159.69 44.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.978 0.354 . . . . 0.0 111.432 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.98 157.92 32.54 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 166.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -67.99 -47.14 69.33 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 110.408 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.412 HD22 ' HG2' ' A' ' 89' ' ' GLU . 86.7 m-20 -80.81 59.04 3.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.674 1.19 . . . . 0.0 110.998 -159.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mmt -93.46 160.05 33.84 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 122.791 0.437 . . . . 0.0 110.661 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 162.39 36.32 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.803 2.335 . . . . 0.0 108.916 165.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 50.99 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.298 1.839 . . . . 0.0 113.143 170.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.8 ttm -82.01 86.5 6.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.447 1.099 . . . . 0.0 108.313 168.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.12 154.81 1.46 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.192 1.397 . . . . 0.0 110.143 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.43 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.501 -1.374 . . . . 0.0 113.161 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.51 -33.61 71.38 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.313 1.057 . . . . 0.0 110.263 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -72.12 -35.11 69.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.894 . . . . 0.0 110.57 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -53.46 57.3 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.707 0.685 . . . . 0.0 109.582 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.17 -56.53 10.62 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 34.6 mttm -66.29 -27.97 68.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.742 1.156 . . . . 0.0 114.038 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -70.77 -46.89 62.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.423 1.01 . . . . 0.0 108.742 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.41 -43.88 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.342 0.657 . . . . 0.0 109.356 172.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -24.03 60.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.218 1.407 . . . . 0.0 112.228 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 C-N-CA 124.765 1.226 . . . . 0.0 112.042 173.844 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.7 mmt . . . . . 0 C--O 1.226 -0.167 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -48.13 -29.76 3.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.419 1.009 . . . . 0.0 112.098 165.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.05 -11.85 61.18 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -66.98 134.05 93.9 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 119.959 1.254 . . . . 0.0 109.077 -174.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.78 56.6 6.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 0.0 111.587 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.254 2.4 m -47.58 107.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.213 1.005 . . . . 0.0 112.233 170.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -106.42 117.46 34.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.711 1.604 . . . . 0.0 107.839 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.44 123.08 31.99 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.98 107.06 11.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -144.78 178.42 8.01 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.016 0.912 . . . . 0.0 111.466 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.9 -29.39 32.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.084 0.953 . . . . 0.0 111.893 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 91' ' ' LYS . 48.5 mm-40 -74.88 107.86 7.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.946 0.498 . . . . 0.0 110.237 -170.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.63 18.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.048 -1.033 . . . . 0.0 111.708 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 89' ' ' GLU . 23.2 tptm -57.37 110.31 0.84 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 125.267 1.427 . . . . 0.0 109.001 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -40.34 -59.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 112.621 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.05 -31.18 62.92 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.841 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.1 -38.67 61.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.709 1.14 . . . . 0.0 109.619 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.35 -55.87 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.97 -47.12 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.84 -41.26 77.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.098 1.317 . . . . 0.0 109.789 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.74 -53.28 59.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.801 0.728 . . . . 0.0 110.902 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.99 -27.15 67.92 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.325 0.65 . . . . 0.0 112.534 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -73.65 -52.89 11.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.704 2.002 . . . . 0.0 109.407 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -55.58 -40.36 71.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.684 0.794 . . . . 0.0 111.134 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.0 2.47 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.412 1.482 . . . . 0.0 113.217 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.98 156.6 6.63 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.536 1.168 . . . . 0.0 111.195 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.2 p -70.83 -28.11 64.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.654 0.382 . . . . 0.0 110.966 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.71 171.7 38.42 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -130.78 139.22 50.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.009 1.324 . . . . 0.0 108.037 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.86 137.73 42.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 126.44 1.896 . . . . 0.0 106.004 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.22 144.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -173.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -52.46 145.85 18.88 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.105 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.61 10.09 60.82 Favored 'Cis proline' 0 C--N 1.348 0.508 0 N-CA-C 116.992 1.882 . . . . 0.0 116.992 8.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.8 p90 15.79 114.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 130.768 3.627 . . . . 0.0 116.564 -175.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -89.73 166.5 13.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.821 -1.174 . . . . 0.0 112.553 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.02 -33.83 73.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 166.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.36 -13.39 5.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.684 1.594 . . . . 0.0 115.013 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -28.67 7.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.497 1.499 . . . . 0.0 111.225 171.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.38 -51.13 71.1 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.292 1.037 . . . . 0.0 111.181 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -66.83 -44.18 81.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -66.92 -35.55 80.26 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.223 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.08 -57.9 11.01 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.039 0.935 . . . . 0.0 109.029 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -47.74 -45.26 28.78 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.288 1.035 . . . . 0.0 111.049 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -68.8 0.14 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.657 174.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.7 pt -66.94 -26.75 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 120.212 1.369 . . . . 0.0 113.704 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -56.22 -57.33 12.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -84.39 -34.02 23.66 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.788 -0.57 . . . . 0.0 111.326 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -64.23 -72.81 0.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.381 1.472 . . . . 0.0 109.739 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.51 -38.49 62.82 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.023 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.2 22.14 6.65 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.609 -1.106 . . . . 0.0 112.366 -166.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.3 mmt . . . . . 0 C--O 1.251 1.182 0 CA-C-N 119.587 1.694 . . . . 0.0 112.275 -175.182 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.67 165.2 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.856 0.463 . . . . 0.0 110.993 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.95 91.79 3.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 163.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.31 131.0 44.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -135.89 125.28 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.36 67.66 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -84.92 166.71 16.58 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.896 -1.128 . . . . 0.0 111.241 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -19.74 65.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.969 0.908 . . . . 0.0 113.355 -169.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.84 131.64 21.42 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.624 1.97 . . . . 0.0 105.894 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -52.55 -41.23 63.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.678 0.672 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.6 m -51.33 -47.11 62.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.647 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.1 mtm -59.7 -35.36 74.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.446 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -68.03 -31.11 70.56 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 120.055 1.298 . . . . 0.0 110.482 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -69.39 -50.21 48.15 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.93 -61.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.165 1.386 . . . . 0.0 109.643 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.6 t -51.9 -49.38 37.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.33 1.452 . . . . 0.0 109.793 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -54.95 -48.51 73.09 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 119.385 0.993 . . . . 0.0 110.635 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -52.7 63.72 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.479 0.712 . . . . 0.0 109.688 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.1 mt -58.27 -42.41 86.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.373 1.069 . . . . 0.0 110.435 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.96 -48.49 81.33 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 110.722 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -65.73 -33.48 75.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.599 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -45.87 92.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.081 1.309 . . . . 0.0 109.224 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.4 mt -66.21 -43.26 87.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.757 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.38 -5.44 1.39 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.398 0.999 . . . . 0.0 114.226 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -73.85 152.52 40.2 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.765 1.226 . . . . 0.0 109.789 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -145.5 179.04 7.68 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.397 -0.814 . . . . 0.0 110.518 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 53.98 58.85 4.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.656 1.982 . . . . 0.0 111.463 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.45 160.08 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.322 162.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.51 169.69 16.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.126 1.77 . . . . 0.0 108.367 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -130.05 142.15 50.65 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.547 1.939 . . . . 0.0 106.939 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.53 170.22 8.59 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 159.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -24.87 30.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.987 0.358 . . . . 0.0 111.228 170.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.69 175.57 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.307 1.443 . . . . 0.0 108.697 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -62.89 -35.16 91.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.332 1.92 . . . . 0.0 114.606 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.02 -49.53 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 120.309 2.055 . . . . 0.0 107.934 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -58.57 -39.28 79.87 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.858 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.1 99.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.269 1.395 . . . . 0.0 111.547 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.41 -43.39 90.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -65.11 -42.55 93.85 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.388 -0.195 . . . . 0.0 111.469 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -52.94 -50.35 64.18 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 127.533 2.333 . . . . 0.0 108.854 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.97 -48.0 83.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.433 0.56 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.46 -11.04 56.91 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.87 24.23 12.92 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.763 2.425 . . . . 0.0 110.858 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.43 161.08 28.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 31.05 8.44 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 162.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -70.16 89.05 0.62 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.02 1.328 . . . . 0.0 109.069 -161.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -3.44 50.22 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.555 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -138.98 129.87 26.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.601 1.2 . . . . 0.0 109.083 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 t -133.98 124.42 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.76 134.32 60.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 127.379 2.272 . . . . 0.0 106.25 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.9 p -152.03 163.54 39.09 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.385 0.538 . . . . 0.0 111.069 173.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.4 159.98 28.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.032 160.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.406 ' CH2' ' HG ' ' A' ' 66' ' ' LEU . 23.6 t-105 -72.64 -58.53 3.29 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.587 1.955 . . . . 0.0 111.422 169.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.5 19.39 0.13 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.998 2.119 . . . . 0.0 112.822 -160.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -61.68 129.21 91.24 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 126.113 1.765 . . . . 0.0 107.553 -170.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.8 157.85 54.02 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 N-CA-C 109.402 -1.038 . . . . 0.0 109.402 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.77 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.249 1.42 . . . . 0.0 109.992 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.2 ttp -91.33 91.32 8.1 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.159 0.984 . . . . 0.0 108.878 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.88 153.47 1.29 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 109.027 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.54 -31.54 63.53 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 120.885 -1.134 . . . . 0.0 112.456 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.411 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -68.78 -36.84 78.8 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.633 0.717 . . . . 0.0 110.644 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.19 -41.65 70.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.047 0.939 . . . . 0.0 109.546 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp -56.39 -50.12 72.49 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.578 1.151 . . . . 0.0 109.469 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.69 -61.47 2.27 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 124.957 1.303 . . . . 0.0 108.866 173.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 90.7 mttt -62.66 -27.66 69.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.903 1.229 . . . . 0.0 112.382 -173.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.3 m -64.46 -55.73 18.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.117 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.76 -36.45 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.323 1.449 . . . . 0.0 111.448 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -21.92 61.9 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 120.883 -1.135 . . . . 0.0 111.258 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 119.493 1.042 . . . . 0.0 110.108 171.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.1 mtt . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 t -61.11 -21.17 63.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.119 1.327 . . . . 0.0 112.214 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.96 -2.01 25.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.849 1.26 . . . . 0.0 113.817 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.7 mt -79.77 129.76 69.81 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 119.783 1.174 . . . . 0.0 109.471 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.47 58.02 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.128 2.552 . . . . 0.0 111.925 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -47.24 108.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.979 1.712 . . . . 0.0 111.028 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 tp -112.97 119.6 38.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.852 1.661 . . . . 0.0 108.901 -165.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -82.92 118.73 23.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.16 110.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.219 1.408 . . . . 0.0 108.47 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -157.62 169.76 23.92 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.555 0.693 . . . . 0.0 110.401 -167.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.76 -23.0 62.33 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.239 -0.913 . . . . 0.0 112.179 160.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -81.26 112.03 18.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.007 0.821 . . . . 0.0 112.001 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.51 -88.25 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 160.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? 49.81 99.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.126 1.371 . . . . 0.0 111.2 -169.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -41.32 -48.83 3.71 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.4 -0.812 . . . . 0.0 111.765 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -58.87 -37.69 77.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -60.18 -43.99 95.43 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.031 0.832 . . . . 0.0 109.487 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.21 -43.69 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.18 -58.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.33 70.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 111.059 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.82 80.08 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.047 0.939 . . . . 0.0 110.059 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.93 79.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.879 0.472 . . . . 0.0 111.162 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -61.16 -51.16 70.22 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.709 1.604 . . . . 0.0 110.495 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.94 71.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.206 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.25 34.97 4.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.552 1.072 . . . . 0.0 112.804 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.78 159.41 11.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.109 1.454 . . . . 0.0 110.68 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 p -63.93 -35.68 81.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.45 0.568 . . . . 0.0 110.595 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.59 -177.57 45.1 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.23 132.32 33.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.07 102.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.99 154.54 4.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.26 155.39 79.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 120.93 -1.106 . . . . 0.0 110.452 159.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.13 151.28 96.79 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 N-CA-C 110.346 -0.675 . . . . 0.0 110.346 -7.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -151.94 157.55 41.94 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.428 0.691 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -144.51 -173.02 3.92 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.891 0.876 . . . . 0.0 110.384 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.45 -29.24 61.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.397 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.8 -25.25 64.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 t -95.87 -39.19 9.94 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.043 1.292 . . . . 0.0 109.246 170.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -50.14 53.57 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 109.765 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.22 72.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.918 1.687 . . . . 0.0 112.772 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.83 -48.53 21.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -61.6 -37.66 84.72 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.687 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.14 -52.21 59.47 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.451 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.28 -42.47 86.64 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.291 0.95 . . . . 0.0 112.414 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -54.38 -53.09 58.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.374 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 pt -74.63 -20.89 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 117.568 -1.206 . . . . 0.0 114.0 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.83 -50.79 71.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.525 1.511 . . . . 0.0 108.097 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -77.29 -42.84 35.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -73.61 -62.07 1.62 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.959 0.504 . . . . 0.0 110.634 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -20.57 39.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.715 0.806 . . . . 0.0 110.446 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.17 36.75 12.2 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -170.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 118.192 0.996 . . . . 0.0 111.014 175.555 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -91.1 133.67 35.14 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.172 1.789 . . . . 0.0 110.239 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.66 106.9 18.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.286 1.834 . . . . 0.0 107.484 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -74.34 138.07 43.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.568 1.076 . . . . 0.0 108.175 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.15 105.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 t -113.78 59.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 122.619 1.2 . . . . 0.0 107.768 -170.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -85.96 108.97 18.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -174.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.95 -45.27 71.23 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.422 1.089 . . . . 0.0 112.377 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 13.3 t80 -70.24 101.39 1.88 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 164.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -42.66 70.11 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.21 0.604 . . . . 0.0 111.378 -168.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 23.9 m -59.83 -33.77 72.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.583 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mtm -59.12 -32.22 69.64 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 120.111 1.323 . . . . 0.0 110.476 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.501 HH21 ' NH1' ' A' ' 19' ' ' ARG . 24.9 ttp85 -62.63 -43.5 98.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.889 1.222 . . . . 0.0 110.717 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NH1' HH21 ' A' ' 18' ' ' ARG . 8.9 mpt_? -59.69 -41.56 91.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.716 176.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.21 -63.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.21 -43.48 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.899 1.68 . . . . 0.0 110.945 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -56.89 -48.36 78.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 0.0 110.392 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.97 -44.13 97.8 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.956 0.798 . . . . 0.0 110.841 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.66 -38.39 90.92 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.196 1.398 . . . . 0.0 111.689 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.83 -57.94 10.73 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -56.64 -36.09 69.09 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.162 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.67 -22.06 65.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.109 1.322 . . . . 0.0 112.464 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.35 -75.45 0.24 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 164.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.75 -168.41 33.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 65.33 164.43 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.264 1.826 . . . . 0.0 111.925 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -151.16 -3.05 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.371 1.469 . . . . 0.0 112.063 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.69 98.96 10.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.59 158.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.92 -155.47 0.61 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.43 1.092 . . . . 0.0 109.088 167.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -178.37 159.16 1.19 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -158.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.86 33.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.142 1.777 . . . . 0.0 106.362 170.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.33 -31.59 72.47 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.795 -0.565 . . . . 0.0 112.352 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.58 171.26 10.43 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.872 2.469 . . . . 0.0 105.955 -174.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.517 ' H ' ' CE ' ' A' ' 60' ' ' MET . . . -57.52 -37.12 80.87 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.587 -1.119 . . . . 0.0 114.565 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.66 -42.99 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.969 2.385 . . . . 0.0 108.714 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.1 -28.22 69.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.333 -0.855 . . . . 0.0 111.725 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.7 -47.68 77.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.195 -1.566 . . . . 0.0 109.655 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.72 -41.25 73.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.409 1.084 . . . . 0.0 109.496 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.67 -44.1 97.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.694 1.197 . . . . 0.0 111.742 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.311 -0.868 . . . . 0.0 110.67 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -51.27 70.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -68.48 3.14 1.92 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.18 1.48 56.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.06 1.3 . . . . 0.0 112.947 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.04 -81.79 0.07 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 121.353 1.888 . . . . 0.0 115.249 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.07 82.38 0.05 OUTLIER Glycine 0 C--N 1.331 0.261 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -164.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -90.32 153.8 20.18 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.23 1.015 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.78 -20.98 15.11 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.757 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -145.27 148.96 34.04 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.051 1.34 . . . . 0.0 109.277 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.26 67.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -75.93 144.25 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 153.32 31.6 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.665 -0.647 . . . . 0.0 110.462 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -74.13 149.97 40.74 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 164.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -61.21 -58.75 7.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.837 0.855 . . . . 0.0 109.498 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 25.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.188 1.395 . . . . 0.0 113.366 -159.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.517 ' CE ' ' H ' ' A' ' 39' ' ' GLY . 8.4 ptm -60.12 159.41 21.59 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.159 -0.963 . . . . 0.0 110.97 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -167.8 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.764 3.642 . . . . 0.0 111.192 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.49 -146.71 0.46 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.419 1.488 . . . . 0.0 110.09 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.98 96.41 0.43 Allowed 'General case' 0 C--N 1.34 0.175 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.71 174.1 0.07 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.17 1.788 . . . . 0.0 113.561 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.11 -29.76 59.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.386 -0.821 . . . . 0.0 113.57 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -42.78 69.08 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 117.957 0.879 . . . . 0.0 110.034 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.93 -40.1 83.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.148 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.14 -55.03 27.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.656 1.116 . . . . 0.0 110.024 169.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tp -50.31 -56.27 11.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.601 0.761 . . . . 0.0 109.085 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.09 -41.56 96.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.748 0.704 . . . . 0.0 111.126 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.7 m -57.57 -51.44 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.061 0.944 . . . . 0.0 109.293 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 mt -58.53 -45.22 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.646 0.778 . . . . 0.0 109.659 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.5 -27.37 69.09 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 125.629 1.572 . . . . 0.0 112.148 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 C-N-CA 125.325 1.45 . . . . 0.0 114.565 -171.312 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.334 0.112 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 p -52.29 -37.69 56.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.981 1.712 . . . . 0.0 111.953 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.73 62.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt -52.52 141.18 34.85 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.517 1.053 . . . . 0.0 112.177 -162.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.03 74.0 3.02 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.489 2.126 . . . . 0.0 110.425 163.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.42 116.26 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 158.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.63 111.72 15.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mmt -75.12 128.35 35.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 101.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -141.45 169.86 16.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.65 -169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.06 -17.19 41.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.258 163.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -80.67 104.21 11.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.212 0.915 . . . . 0.0 111.615 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.88 16.03 2.45 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -57.84 110.13 0.85 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.348 0.977 . . . . 0.0 108.881 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.6 -47.76 66.71 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.677 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -53.25 -33.08 51.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.33 -30.55 25.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.794 -0.566 . . . . 0.0 110.996 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.22 -44.23 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 118.362 -0.828 . . . . 0.0 108.989 161.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.51 -54.4 35.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.375 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.2 63.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 120.176 1.353 . . . . 0.0 110.774 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.56 -51.96 65.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 110.21 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.32 85.22 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.257 0.623 . . . . 0.0 111.269 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -57.35 -50.65 72.28 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.723 2.009 . . . . 0.0 110.513 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.03 -18.58 65.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.614 0.766 . . . . 0.0 112.68 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.02 27.66 13.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.236 0.922 . . . . 0.0 112.527 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 140.44 56.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.847 1.324 . . . . 0.0 108.191 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.6 p -68.46 -18.76 64.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.145 -174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.57 173.87 40.13 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.6 104.83 4.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.73 144.88 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.9 143.21 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.6 151.22 71.92 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.46 1.504 . . . . 0.0 111.463 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.92 173.3 37.89 Favored 'Cis proline' 0 C--N 1.345 0.378 0 N-CA-C 109.421 -1.031 . . . . 0.0 109.421 -16.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -177.91 146.72 0.43 Allowed 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.162 -1.586 . . . . 0.0 108.267 -164.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -149.52 -176.51 5.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.184 1.793 . . . . 0.0 109.232 -170.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.49 68.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.781 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.18 62.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.222 1.009 . . . . 0.0 113.189 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.72 -28.99 12.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.876 0.762 . . . . 0.0 110.286 177.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.45 -54.84 38.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -29.85 71.06 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.885 1.274 . . . . 0.0 112.396 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.38 -55.25 12.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.606 1.162 . . . . 0.0 109.351 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.6 -31.44 72.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.743 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.2 mt -58.49 -58.06 10.2 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 123.835 0.854 . . . . 0.0 109.484 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -61.29 -29.19 69.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.043 1.292 . . . . 0.0 112.257 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.01 -60.56 3.3 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.148 -0.97 . . . . 0.0 110.333 168.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -23.3 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.319 0.963 . . . . 0.0 113.081 -171.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -57.21 -58.03 9.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.82 -30.0 56.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.525 -0.734 . . . . 0.0 112.354 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -65.35 1.02 Allowed 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.57 -25.55 64.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.984 0.514 . . . . 0.0 111.051 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.23 23.21 35.26 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-O 117.805 -1.553 . . . . 0.0 110.703 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 28.7 mmt . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.704 1.752 . . . . 0.0 110.47 -176.511 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -79.51 132.47 36.33 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.45 93.81 6.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.67 131.75 45.1 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.316 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.6 t -132.52 119.36 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.95 63.53 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.699 1.599 . . . . 0.0 108.6 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.29 159.1 33.72 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.792 -1.193 . . . . 0.0 108.5 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.47 -64.77 1.03 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.62 112.77 3.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -53.17 -41.61 65.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.857 1.208 . . . . 0.0 112.055 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -59.82 -31.8 70.06 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.757 -1.214 . . . . 0.0 111.773 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.0 92.62 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.562 1.074 . . . . 0.0 110.159 171.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 tpt85 -65.83 -36.69 84.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.299 1.04 . . . . 0.0 110.049 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -48.02 83.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.503 -0.761 . . . . 0.0 109.524 171.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.09 -58.36 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.32 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.9 t -52.29 -46.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.127 1.33 . . . . 0.0 110.206 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -60.75 -43.9 97.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.238 0.472 . . . . 0.0 111.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.27 -45.11 95.86 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.265 0.626 . . . . 0.0 111.133 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.41 -36.37 83.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.43 0.692 . . . . 0.0 111.062 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.91 -44.7 96.25 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.411 0.684 . . . . 0.0 110.09 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -41.65 98.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 116.994 -1.479 . . . . 0.0 111.462 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -57.07 -44.64 83.25 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 119.439 1.018 . . . . 0.0 110.51 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.14 -34.35 63.83 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.255 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.63 57.34 0.37 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.01 153.02 47.23 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.895 1.278 . . . . 0.0 107.824 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.81 178.9 7.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.785 1.634 . . . . 0.0 108.559 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 53.87 54.2 10.14 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.584 1.553 . . . . 0.0 111.683 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 m -68.68 164.36 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.122 159.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.46 174.81 10.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -136.71 147.81 46.97 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.11 167.44 12.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 164.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -68.37 -47.29 67.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 110.117 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.33 169.01 22.88 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 125.797 1.639 . . . . 0.0 109.171 -159.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.7 -41.05 49.69 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.953 1.263 . . . . 0.0 115.546 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -67.95 -44.66 84.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.97 1.885 . . . . 0.0 107.854 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.78 -26.17 68.51 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.173 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -49.03 67.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.99 1.268 . . . . 0.0 110.14 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.02 -42.77 95.05 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.208 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.85 -47.37 85.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.479 1.112 . . . . 0.0 110.893 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.95 -46.43 78.56 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.802 0.841 . . . . 0.0 109.799 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.33 -37.87 73.2 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.001 0.819 . . . . 0.0 111.342 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 4.6 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.16 82.0 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 119.715 -1.865 . . . . 0.0 110.399 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.49 104.4 1.24 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.773 1.177 . . . . 0.0 111.66 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.65 13.68 1.08 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.438 1.018 . . . . 0.0 115.134 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -69.43 167.28 16.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.214 1.507 . . . . 0.0 110.988 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.31 -19.21 0.88 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.561 167.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -131.84 144.0 50.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.536 1.668 . . . . 0.0 107.727 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.37 62.41 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.74 135.36 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -144.92 168.91 19.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.019 0.827 . . . . 0.0 110.434 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.44 169.46 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.555 0.693 . . . . 0.0 109.359 159.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -74.08 -53.68 9.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.878 158.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.25 86.99 6.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.487 1.115 . . . . 0.0 111.54 -158.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.2 mmt -127.17 149.71 70.27 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.289 0.636 . . . . 0.0 111.2 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.96 147.1 60.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.492 2.128 . . . . 0.0 109.822 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 54.92 -84.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.283 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 41.4 ttm -88.19 97.64 11.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.941 1.296 . . . . 0.0 107.65 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.39 161.97 2.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.31 -33.68 53.04 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.558 -0.714 . . . . 0.0 111.847 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.57 -42.21 99.41 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.715 0.757 . . . . 0.0 109.942 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -81.19 -30.36 34.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.774 -0.579 . . . . 0.0 111.264 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.51 -52.1 67.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.16 0.984 . . . . 0.0 108.556 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tp -51.13 -60.04 3.53 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.01 1.324 . . . . 0.0 109.463 173.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HE2' ' HB1' ' A' ' 101' ' ' ALA . 24.3 mmtt -59.72 -40.34 87.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.523 1.056 . . . . 0.0 112.363 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.5 m -59.62 -49.05 79.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.631 0.772 . . . . 0.0 109.364 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.16 -39.37 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.15 -25.91 68.29 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.448 1.899 . . . . 0.0 112.234 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.556 175.22 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.8 mtm . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 p -50.97 -31.66 18.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.732 1.213 . . . . 0.0 112.422 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.7 65.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.983 1.313 . . . . 0.0 114.029 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.55 138.01 76.51 Favored Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.317 -171.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.03 84.21 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.616 2.211 . . . . 0.0 108.951 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.69 126.76 37.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tp -142.28 110.56 6.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -159.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -79.32 126.34 30.67 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.372 1.045 . . . . 0.0 108.423 -171.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.2 t -136.1 101.34 2.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.254 1.822 . . . . 0.0 106.646 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -149.26 164.6 34.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.363 0.601 . . . . 0.0 111.391 -159.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.11 -20.91 57.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.582 1.153 . . . . 0.0 111.689 161.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -76.38 87.76 3.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.967 1.307 . . . . 0.0 111.031 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.98 5.3 4.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.094 0.958 . . . . 0.0 113.287 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -48.4 112.81 0.64 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.144 1.777 . . . . 0.0 108.307 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.81 -43.28 80.83 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -56.21 -37.79 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.374 1.07 . . . . 0.0 112.287 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -66.99 -40.5 87.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.393 0.542 . . . . 0.0 109.541 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.91 -49.43 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.156 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.0 -58.52 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.07 -49.3 63.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.587 1.155 . . . . 0.0 111.011 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.96 95.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.181 0.901 . . . . 0.0 110.883 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.15 91.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.902 0.319 . . . . 0.0 111.166 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -60.51 -55.81 28.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.19 1.396 . . . . 0.0 110.052 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' HE2' ' A' ' 70' ' ' LYS . . . -59.33 -28.87 67.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 111.51 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.66 38.76 4.6 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.278 0.942 . . . . 0.0 111.933 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.3 27.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.818 0.809 . . . . 0.0 109.306 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -69.98 -14.88 62.91 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.01 171.46 37.01 Favored Glycine 0 N--CA 1.443 -0.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.673 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -137.06 135.23 37.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.357 1.463 . . . . 0.0 107.343 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.45 103.43 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.13 144.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -60.67 154.17 58.37 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.826 1.251 . . . . 0.0 109.619 163.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.92 174.54 46.7 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.373 0.812 . . . . 0.0 111.329 -14.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -178.43 151.33 0.6 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -167.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 p -144.79 -171.69 3.68 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.441 1.096 . . . . 0.0 109.825 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.99 72.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.446 -0.784 . . . . 0.0 109.583 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.97 -19.68 45.43 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.47 -27.4 9.03 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.493 1.042 . . . . 0.0 110.999 171.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.46 -50.61 62.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.225 1.375 . . . . 0.0 107.939 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -31.56 72.47 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.631 1.172 . . . . 0.0 112.151 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -77.27 -36.1 54.67 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.712 0.687 . . . . 0.0 110.591 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -64.96 -43.46 92.62 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.122 -0.986 . . . . 0.0 109.211 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -58.66 -56.76 18.02 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.715 1.206 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -52.1 -42.31 63.16 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.937 1.295 . . . . 0.0 111.329 176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -52.82 -63.18 1.23 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.366 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 pt -68.48 -30.14 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 120.487 1.494 . . . . 0.0 114.402 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.88 -53.92 52.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -83.09 -34.46 26.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 121.282 -0.167 . . . . 0.0 110.577 -171.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -74.0 -74.1 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.831 1.253 . . . . 0.0 108.862 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.92 -20.93 62.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.697 0.799 . . . . 0.0 110.967 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.34 26.98 26.54 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.499 -172.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 C--O 1.249 1.079 0 CA-C-N 119.639 1.72 . . . . 0.0 111.678 -175.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.06 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HE2' ' CG ' ' A' ' 34' ' ' GLU . 12.3 tttt -82.47 135.45 35.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.336 -164.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.23 85.14 2.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -169.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.67 139.58 53.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.11 120.74 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 65.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.679 1.228 . . . . 0.0 107.949 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.24 111.32 22.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -47.74 -46.16 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.36 1.464 . . . . 0.0 112.59 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.5 -13.31 13.09 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t 76.34 -68.1 0.2 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.128 1.771 . . . . 0.0 108.42 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -55.87 -28.08 54.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.964 -1.085 . . . . 0.0 111.674 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.5 mtp -56.86 -46.57 81.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 116.854 -1.546 . . . . 0.0 111.011 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -22.88 63.13 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 121.645 2.021 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -65.7 -52.44 51.4 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.43 -60.51 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.736 1.214 . . . . 0.0 108.666 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.91 -49.19 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.239 1.016 . . . . 0.0 111.063 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -60.43 -42.97 97.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.768 1.167 . . . . 0.0 110.891 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -57.96 -53.12 61.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.09 -38.85 77.2 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.006 0.923 . . . . 0.0 111.902 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.24 -47.24 86.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.506 0.722 . . . . 0.0 110.087 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -64.89 -36.61 84.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.55 -41.24 89.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.652 1.569 . . . . 0.0 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.44 -54.04 10.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.76 62.86 0.07 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -137.52 156.96 47.53 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.347 1.059 . . . . 0.0 109.325 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 -175.33 4.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.378 1.071 . . . . 0.0 111.271 -168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 50.82 46.82 25.57 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.781 2.032 . . . . 0.0 111.45 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.31 161.9 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.0 -1.063 . . . . 0.0 109.474 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 3.4 mm-40 -145.52 171.72 14.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.713 2.005 . . . . 0.0 108.68 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.51 145.6 37.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.7 160.26 23.67 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.59 -39.45 93.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.711 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.99 165.77 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.558 1.143 . . . . 0.0 107.921 -161.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.48 68.67 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.828 1.649 . . . . 0.0 113.835 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.56 -44.87 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.964 -1.315 . . . . 0.0 109.63 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.93 -27.55 64.86 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.574 0.625 . . . . 0.0 110.737 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.09 75.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.728 -1.232 . . . . 0.0 108.322 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -43.5 72.05 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.769 0.795 . . . . 0.0 111.375 175.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -65.79 -25.48 67.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 112.683 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -74.88 -47.4 30.29 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.229 -1.545 . . . . 0.0 108.805 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.96 -35.98 69.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.176 1.353 . . . . 0.0 111.969 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -74.72 9.61 1.75 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.56 42.47 2.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.493 1.517 . . . . 0.0 111.171 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.17 -171.14 22.62 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 121.49 -0.756 . . . . 0.0 111.861 163.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.2 70.23 1.87 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -65.43 145.38 56.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.23 3.09 2.99 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.844 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.74 142.14 23.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.692 1.246 . . . . 0.0 108.854 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.4 78.68 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.7 141.52 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -152.35 158.22 42.41 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.735 -0.603 . . . . 0.0 111.041 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.26 169.81 17.67 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 164.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -79.34 -51.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.413 -0.804 . . . . 0.0 111.806 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -74.85 79.6 2.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.16 1.384 . . . . 0.0 110.232 -159.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.8 ptp -135.01 153.32 78.44 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 121.13 -0.981 . . . . 0.0 111.174 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.2 -172.1 1.07 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.04 2.493 . . . . 0.0 109.394 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 57.61 -104.26 0.21 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.917 1.687 . . . . 0.0 109.674 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.32 95.07 9.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.55 153.14 3.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.425 1.09 . . . . 0.0 109.779 170.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.39 -30.15 64.35 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.42 -0.8 . . . . 0.0 113.723 -167.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.26 -39.77 68.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.286 1.043 . . . . 0.0 110.02 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.81 -39.35 90.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.787 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.9 tp -57.79 -51.07 71.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.83 0.741 . . . . 0.0 109.917 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.08 -57.88 6.71 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 109.038 172.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 101' ' ' ALA . 27.3 mttm -65.44 -27.39 68.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 m -59.96 -59.59 5.18 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.3 mt -58.62 -40.99 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.23 1.412 . . . . 0.0 109.722 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -13.35 26.68 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.623 1.569 . . . . 0.0 113.43 -170.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 119.656 1.116 . . . . 0.0 110.951 -177.835 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.3 mtt . . . . . 0 C--O 1.226 -0.167 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -55.54 -28.76 56.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.413 1.085 . . . . 0.0 111.579 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.26 -2.02 43.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.364 1.466 . . . . 0.0 113.398 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.38 136.08 75.42 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 119.859 1.209 . . . . 0.0 110.18 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.13 89.0 0.8 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 108.614 164.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.17 111.01 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 164.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -115.35 113.38 23.72 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mmt -79.46 117.29 20.29 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.89 96.49 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -132.64 -166.47 1.75 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.761 0.824 . . . . 0.0 110.089 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.24 -3.08 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.833 2.053 . . . . 0.0 111.016 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -86.91 81.57 8.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.533 0.682 . . . . 0.0 109.554 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.83 -4.49 6.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.523 1.529 . . . . 0.0 113.776 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -46.78 123.9 5.6 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.617 1.567 . . . . 0.0 110.354 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -53.17 54.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.228 0.537 . . . . 0.0 110.869 -173.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.84 -26.92 66.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.91 -46.42 78.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.792 1.237 . . . . 0.0 109.547 171.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.87 -46.8 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.45 -53.79 36.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.82 -44.23 73.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.493 0.717 . . . . 0.0 110.619 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.47 88.2 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.846 0.748 . . . . 0.0 111.865 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.32 -41.11 81.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.386 0.539 . . . . 0.0 111.049 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -57.29 -46.49 83.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.542 1.937 . . . . 0.0 109.778 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.458 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . . . -67.78 -34.09 76.11 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.899 0.48 . . . . 0.0 111.472 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.87 39.27 4.4 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.924 1.25 . . . . 0.0 111.544 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 143.45 50.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.539 1.17 . . . . 0.0 109.201 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -66.69 -19.73 65.82 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 170.04 41.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.97 130.83 27.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.315 1.446 . . . . 0.0 107.396 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.08 137.63 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 t -127.76 124.15 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -51.18 146.01 12.11 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.831 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.91 168.19 72.37 Favored 'Cis proline' 0 CA--C 1.534 0.509 0 CA-C-N 119.273 0.776 . . . . 0.0 111.913 -3.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -177.97 152.41 0.74 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.665 1.186 . . . . 0.0 109.104 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -148.37 -177.51 5.81 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.62 1.968 . . . . 0.0 109.751 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.13 -26.63 39.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.77 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.51 -53.02 51.54 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.743 1.217 . . . . 0.0 112.135 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.24 -33.77 61.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.059 0.845 . . . . 0.0 109.654 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -52.11 66.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.377 0.989 . . . . 0.0 109.318 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.57 -28.42 69.63 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.6 0.76 . . . . 0.0 111.867 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.67 -43.96 24.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.077 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -65.91 -30.49 71.09 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.429 -1.419 . . . . 0.0 110.015 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -58.75 -52.88 63.81 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.118 168.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -51.68 -48.51 63.45 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.768 1.167 . . . . 0.0 111.178 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -54.71 -51.01 66.93 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.494 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.88 -30.26 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.931 1.696 . . . . 0.0 113.043 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -58.04 -48.05 81.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.77 -23.99 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -170.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -68.68 0.77 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 mt -67.2 -26.64 66.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.709 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.54 39.47 18.08 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -165.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.245 0.851 0 CA-C-N 117.912 0.856 . . . . 0.0 109.558 175.597 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -69.31 123.24 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.28 159.35 16.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -121.62 137.04 54.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 164.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 t -134.34 114.1 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.68 72.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -80.1 165.84 22.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.643 1.177 . . . . 0.0 109.065 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.48 -9.69 59.76 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.819 -1.175 . . . . 0.0 111.047 166.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 16.3 t80 -132.95 107.75 8.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.34 -1.475 . . . . 0.0 108.807 -170.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -49.77 -45.62 49.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.879 0.763 . . . . 0.0 112.758 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.422 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 57.3 m -52.43 -36.77 55.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.811 0.844 . . . . 0.0 111.502 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 ttm -57.16 -34.63 68.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 116.791 -1.576 . . . . 0.0 110.386 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.79 -42.82 99.87 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.129 1.786 . . . . 0.0 110.954 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -63.53 -54.15 40.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.58 -63.37 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.613 1.565 . . . . 0.0 109.143 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.47 -51.9 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 119.704 1.138 . . . . 0.0 110.768 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.58 -40.93 84.52 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 118.676 0.671 . . . . 0.0 111.231 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.08 -53.5 37.42 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 118.732 0.696 . . . . 0.0 109.146 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.45 -36.25 68.83 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 124.143 0.977 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.45 -67.15 0.35 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.258 169.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -57.38 -27.93 62.74 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.521 1.055 . . . . 0.0 113.089 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -58.02 -20.58 39.85 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.741 1.155 . . . . 0.0 112.563 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.1 mt -108.83 -35.7 6.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.223 3.009 . . . . 0.0 111.612 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.8 177.62 28.31 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.428 1.489 . . . . 0.0 110.985 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 62.22 -177.8 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.914 1.286 . . . . 0.0 112.392 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 170.29 -167.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 130.581 3.552 . . . . 0.0 105.568 -164.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 56.12 46.65 21.15 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.751 1.62 . . . . 0.0 111.977 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -71.77 149.21 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' HB3' ' HH ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -124.36 173.13 8.6 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.493 2.317 . . . . 0.0 106.523 166.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.75 176.7 8.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.986 1.314 . . . . 0.0 109.111 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.4 169.66 16.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.725 2.01 . . . . 0.0 106.696 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.93 -32.12 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.539 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -170.94 174.83 4.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.936 1.695 . . . . 0.0 107.558 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.65 -36.06 69.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.32 1.438 . . . . 0.0 114.75 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.08 -40.76 90.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -71.33 -34.81 70.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 110.713 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.19 66.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.408 1.083 . . . . 0.0 109.232 -175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.44 -42.65 64.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.542 0.737 . . . . 0.0 111.527 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.67 -28.57 65.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.055 0.542 . . . . 0.0 111.713 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.61 -53.21 59.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.801 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.44 -54.72 32.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.941 0.792 . . . . 0.0 110.616 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.45 11.89 0.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.93 86.6 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 158.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.33 88.73 0.34 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.498 1.523 . . . . 0.0 109.827 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.68 0.24 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.715 1.626 . . . . 0.0 111.014 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.401 ' HH ' ' HB3' ' A' ' 34' ' ' GLU . 41.4 m-85 -54.32 141.14 31.08 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.128 0.971 . . . . 0.0 109.344 166.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.2 -18.14 5.11 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.769 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.21 147.53 27.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.718 1.259 . . . . 0.0 107.878 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -131.9 128.2 59.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.7 132.48 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 p -151.78 161.16 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.294 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.74 169.98 13.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 110.076 169.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -80.23 -57.7 3.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 159.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -77.51 111.37 13.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.417 0.687 . . . . 0.0 109.2 -159.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.9 mmm -119.42 170.55 6.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.808 0.843 . . . . 0.0 110.726 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.82 -3.63 10.52 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.59 2.86 . . . . 0.0 113.015 166.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.84 -91.83 0.06 Allowed 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -160.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.7 ttm -91.07 95.12 9.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.202 1.801 . . . . 0.0 107.613 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -51.63 154.28 2.01 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 108.449 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.78 -24.5 26.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.031 0.824 . . . . 0.0 112.922 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.88 -52.23 31.83 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.564 1.182 . . . . 0.0 110.801 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -68.78 -32.37 72.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.179 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.31 -59.55 5.28 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 118.129 -0.938 . . . . 0.0 109.108 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.06 -55.51 5.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.761 1.224 . . . . 0.0 109.108 173.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -64.66 -27.55 69.0 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 117.868 -1.063 . . . . 0.0 113.286 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.9 m -69.19 -50.97 42.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 119.383 0.992 . . . . 0.0 109.04 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.2 mt -45.89 -57.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.384 1.088 . . . . 0.0 112.279 165.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 8.03 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.594 2.357 . . . . 0.0 112.839 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.255 0 CA-C-N 120.629 1.559 . . . . 0.0 110.868 177.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . 0.284 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.083 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.2 p -52.49 -31.97 37.71 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.33 -13.87 60.45 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.916 1.235 . . . . 0.0 112.745 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.5 mt -58.05 129.79 82.75 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 109.244 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.24 109.74 2.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.958 1.772 . . . . 0.0 108.938 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.12 94.66 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.182 0.993 . . . . 0.0 109.043 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tp -87.18 113.97 23.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.804 -1.185 . . . . 0.0 108.222 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mtt -84.8 124.61 31.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.5 114.91 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -147.25 -179.41 6.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.513 1.149 . . . . 0.0 109.904 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.05 -24.95 16.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 112.014 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -91.24 151.83 20.76 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 119.08 0.855 . . . . 0.0 111.152 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.61 -80.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.424 171.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? 52.55 100.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.422 1.489 . . . . 0.0 110.432 -167.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -54.46 -37.79 65.61 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.471 -1.393 . . . . 0.0 110.2 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -33.81 74.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 0.627 . . . . 0.0 112.553 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -65.14 -44.52 88.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.28 0.632 . . . . 0.0 109.442 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.73 -50.48 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.766 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.16 -56.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.62 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.14 95.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.415 0.552 . . . . 0.0 109.964 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.15 77.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.927 0.491 . . . . 0.0 112.129 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -69.7 -52.3 26.83 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.699 1.999 . . . . 0.0 111.086 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.15 77.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.35 41.94 1.01 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.432 1.491 . . . . 0.0 111.782 169.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 165.27 4.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.7 1.2 . . . . 0.0 110.695 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.0 t -51.41 -44.6 62.3 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.524 1.13 . . . . 0.0 108.712 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.35 172.7 39.08 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 169.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -100.86 141.36 33.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -131.19 128.27 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.17 139.2 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -58.29 139.96 83.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.526 168.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.51 131.31 23.49 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.4 1.179 . . . . 0.0 111.267 -1.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -131.5 159.15 38.96 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.164 0.985 . . . . 0.0 109.511 169.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 p -152.16 171.12 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.836 2.454 . . . . 0.0 108.364 -168.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.87 75.02 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.03 -15.27 12.56 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.31 -33.09 6.74 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.193 1.36 . . . . 0.0 110.869 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.94 -49.09 66.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.544 1.538 . . . . 0.0 108.65 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -57.07 -33.11 66.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 125.954 1.702 . . . . 0.0 112.689 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 32.9 tt0 -78.07 -33.62 50.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.412 0.285 . . . . 0.0 110.246 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -63.15 -43.4 98.41 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.823 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.9 mt -55.71 -52.91 62.26 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.94 -35.43 73.12 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.418 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 23.8 mtmt -61.77 -59.39 5.23 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.09 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 pt -65.25 -30.16 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.547 1.521 . . . . 0.0 112.869 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -55.3 -62.89 1.37 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.46 -35.45 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -61.4 1.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.875 1.27 . . . . 0.0 109.193 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mt -79.66 -20.88 45.61 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.436 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.72 38.06 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.818 -169.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.7 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.059 -1.448 . . . . 0.0 109.966 -178.049 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp . . . . . 0 C--O 1.233 0.218 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -90.74 132.37 35.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.616 -165.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -107.68 104.44 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.6 134.15 38.28 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.36 118.7 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.85 56.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.312 1.445 . . . . 0.0 108.222 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.68 146.17 55.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -69.01 -58.24 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.782 0.833 . . . . 0.0 109.073 172.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.4 t80 -72.81 114.22 10.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 m -50.43 -51.45 46.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 112.337 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 24.8 m -61.6 -26.59 68.08 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.564 -1.208 . . . . 0.0 112.176 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 ttm -59.77 -44.55 93.82 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.629 1.559 . . . . 0.0 109.903 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -65.42 -36.94 85.44 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 119.267 0.939 . . . . 0.0 111.054 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.3 -42.79 99.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.189 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.84 -66.19 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 116.688 -1.625 . . . . 0.0 107.798 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.36 -49.55 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.309 1.868 . . . . 0.0 110.993 -172.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -57.92 -42.91 85.8 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.728 0.811 . . . . 0.0 110.607 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.93 -45.74 91.06 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.388 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 mt -59.49 -44.37 93.08 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.721 0.692 . . . . 0.0 109.296 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.49 -47.45 78.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.644 0.778 . . . . 0.0 111.131 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -60.99 -42.44 98.41 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.038 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.56 -44.5 85.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.78 1.232 . . . . 0.0 110.02 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.91 4.64 16.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.266 1.027 . . . . 0.0 112.234 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.01 -18.08 47.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.617 1.58 . . . . 0.0 114.53 166.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -67.74 156.95 35.8 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.015 1.408 . . . . 0.0 111.234 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -136.09 -172.72 3.19 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.352 1.861 . . . . 0.0 109.9 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.8 t30 55.17 58.68 4.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 127.177 2.191 . . . . 0.0 112.559 165.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.7 148.14 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.897 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -121.26 160.06 24.69 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.152 1.781 . . . . 0.0 108.187 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 28.2 tt0 -121.59 151.9 39.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.56 164.81 21.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -72.56 -35.82 68.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.516 0.327 . . . . 0.0 111.234 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.81 176.89 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.719 1.208 . . . . 0.0 109.797 -170.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.63 43.64 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.259 1.885 . . . . 0.0 115.866 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.5 -51.45 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.666 2.233 . . . . 0.0 107.981 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.29 -34.36 76.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.645 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.97 82.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.665 -1.272 . . . . 0.0 110.197 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.32 -41.52 89.28 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.69 -30.0 69.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.353 0.661 . . . . 0.0 112.666 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 35' ' ' GLU . 4.3 mptp? -67.69 -42.34 82.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.357 -0.839 . . . . 0.0 110.167 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.9 -39.02 93.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.732 1.151 . . . . 0.0 110.225 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -70.25 12.33 0.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.796 0.839 . . . . 0.0 112.673 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.03 16.54 7.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.122 2.169 . . . . 0.0 111.836 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.47 -178.68 38.16 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.525 1.511 . . . . 0.0 115.57 162.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.01 73.5 0.97 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -69.44 154.66 41.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.614 0.766 . . . . 0.0 109.659 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.87 -32.28 11.24 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.612 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -142.86 149.85 39.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.42 64.57 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.32 132.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 153.98 37.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.787 0.435 . . . . 0.0 110.394 -169.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' ' 13' ' ' ASP . 7.9 t0 -84.84 167.47 15.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 161.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -73.08 -44.43 60.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.871 0.868 . . . . 0.0 110.325 164.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -68.61 29.38 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 131.403 3.881 . . . . 0.0 115.909 -158.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 38.0 mtt -65.94 170.54 4.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 127.891 2.476 . . . . 0.0 109.826 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.1 -39.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.825 2.35 . . . . 0.0 112.915 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -124.56 -76.94 0.59 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 123.924 0.889 . . . . 0.0 109.436 -167.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 tpt -72.75 103.78 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.36 164.14 19.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.332 0.587 . . . . 0.0 109.745 173.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.59 -25.54 67.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 121.069 -0.586 . . . . 0.0 114.111 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.08 60.51 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.054 1.342 . . . . 0.0 108.919 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.55 -42.64 98.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.57 0.748 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -54.63 -52.4 62.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.856 0.753 . . . . 0.0 109.259 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.7 -58.96 4.9 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 123.411 0.684 . . . . 0.0 110.179 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -63.26 -30.57 71.69 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.994 0.815 . . . . 0.0 112.39 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 68.9 m -69.07 -51.23 41.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.11 0.964 . . . . 0.0 108.426 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.4 mt -56.13 -47.51 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.533 0.733 . . . . 0.0 109.982 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -58.88 -23.62 61.21 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.428 1.491 . . . . 0.0 112.839 -175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 123.925 0.89 . . . . 0.0 111.568 -169.133 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.5 p -54.03 -47.33 71.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.414 0.686 . . . . 0.0 112.153 -166.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.04 7.32 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.35 142.78 48.6 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-N 119.839 1.2 . . . . 0.0 111.381 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 72.18 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.696 2.264 . . . . 0.0 109.803 160.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.46 137.45 24.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 158.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 tp -141.69 113.53 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.72 128.92 36.73 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 124.269 0.981 . . . . 0.0 108.444 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.63 110.49 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -153.13 167.96 27.51 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.578 -0.701 . . . . 0.0 110.3 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.72 -23.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.343 -0.848 . . . . 0.0 112.474 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.67 116.3 22.58 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.444 1.02 . . . . 0.0 109.329 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.53 -81.42 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.438 166.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.5 tptt 45.94 95.04 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.3 1.44 . . . . 0.0 111.213 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.71 -33.78 35.95 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 120.225 -1.547 . . . . 0.0 112.138 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -42.98 85.73 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.701 1.137 . . . . 0.0 112.491 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -59.56 -44.88 93.14 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.701 0.8 . . . . 0.0 109.098 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.41 -46.07 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.954 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -61.36 -52.51 60.47 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.576 1.08 . . . . 0.0 108.52 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.28 -45.93 69.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.521 1.055 . . . . 0.0 110.962 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.85 82.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.332 0.653 . . . . 0.0 109.951 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.05 86.76 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.89 0.768 . . . . 0.0 110.609 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -55.31 -51.49 66.55 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 126.742 2.017 . . . . 0.0 110.857 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -21.01 66.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.09 25.18 8.51 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.849 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.8 136.39 57.97 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 p -74.55 -1.75 22.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . 172.75 169.05 34.89 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 121.182 -0.949 . . . . 0.0 111.619 172.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -139.72 92.7 2.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.026 1.331 . . . . 0.0 108.699 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.04 112.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.75 157.85 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -64.12 159.58 55.43 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.037 158.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.1 166.81 81.46 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.826 0.974 . . . . 0.0 110.097 -11.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -178.09 158.73 1.24 Allowed 'General case' 0 C--N 1.333 -0.135 0 O-C-N 121.266 -0.897 . . . . 0.0 111.285 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -154.86 -177.34 6.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.766 2.026 . . . . 0.0 109.026 -173.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.83 -23.55 53.24 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.753 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.32 -53.51 49.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.877 0.871 . . . . 0.0 112.075 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -30.5 60.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 0.0 109.935 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -53.84 53.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.407 1.003 . . . . 0.0 108.94 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.98 -39.77 87.25 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.533 0.606 . . . . 0.0 111.469 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.0 -47.83 74.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.171 0.989 . . . . 0.0 109.87 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 1.8 mmmp? -68.15 -37.48 81.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.15 -1.881 . . . . 0.0 112.336 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.45 -58.32 9.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.521 1.055 . . . . 0.0 108.207 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -58.19 -36.05 72.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.15 0.98 . . . . 0.0 109.937 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -56.94 -56.0 27.35 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 117.589 -1.196 . . . . 0.0 112.901 168.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.0 pt -68.95 -25.67 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 121.398 1.908 . . . . 0.0 112.934 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -57.87 -55.73 31.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.85 -47.13 79.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 122.547 0.339 . . . . 0.0 111.676 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -78.23 -71.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.202 1.001 . . . . 0.0 109.727 -168.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.1 mt -64.9 -20.67 66.56 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.211 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.88 42.36 16.73 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 -166.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.249 1.072 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.234 169.306 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 119.574 -0.251 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -81.57 149.96 28.39 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.884 0.874 . . . . 0.0 109.549 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.401 ' CZ ' ' CE1' ' A' ' 53' ' ' PHE . 12.0 m-85 -120.97 106.62 11.77 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.415 1.086 . . . . 0.0 109.528 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.77 136.15 43.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.611 1.55 . . . . 0.0 108.84 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -136.15 105.5 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.343 1.457 . . . . 0.0 107.3 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.29 70.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.239 1.016 . . . . 0.0 108.378 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.38 138.75 35.58 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 1.3 t70 -53.07 -33.08 50.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.939 2.095 . . . . 0.0 112.656 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -115.24 120.49 39.86 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 107.156 -168.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -53.07 -47.69 68.29 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.62 -175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.3 m -51.85 -44.64 63.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.625 1.102 . . . . 0.0 111.539 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.83 94.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -69.56 -44.16 71.42 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.913 1.285 . . . . 0.0 109.314 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -52.45 -52.34 54.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.13 2.172 . . . . 0.0 109.723 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.89 -62.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.218 -1.372 . . . . 0.0 108.261 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -52.03 -48.1 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 120.822 1.647 . . . . 0.0 110.761 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -49.86 73.23 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.674 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -60.39 -42.67 96.37 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 118.521 0.601 . . . . 0.0 110.713 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.69 -39.4 94.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.765 0.826 . . . . 0.0 111.013 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -64.84 -48.43 74.38 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 121.913 -0.492 . . . . 0.0 110.378 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -58.84 -39.76 82.22 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.07 0.948 . . . . 0.0 110.951 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.5 -51.04 68.33 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.36 1.064 . . . . 0.0 109.338 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.25 -48.21 80.95 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.06 3.14 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.4 1.953 . . . . 0.0 111.977 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.07 133.47 51.7 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 109.63 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 -176.38 5.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -167.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.7 t30 62.06 80.39 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 128.622 2.769 . . . . 0.0 108.76 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.06 160.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.354 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -114.31 147.08 39.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 158.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.37 164.31 12.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 158.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.75 167.86 14.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 158.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.44 -27.41 46.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.865 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -176.17 156.93 1.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.779 1.232 . . . . 0.0 108.084 -158.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -42.52 -45.33 5.47 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.107 1.337 . . . . 0.0 114.807 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.47 -36.87 78.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 119.608 1.704 . . . . 0.0 110.417 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -70.87 -31.97 68.82 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 122.763 0.425 . . . . 0.0 110.23 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.16 61.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -58.43 -40.12 81.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.779 0.432 . . . . 0.0 111.605 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -56.12 -51.35 68.26 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.971 0.508 . . . . 0.0 109.877 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -55.74 -46.68 77.74 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.184 0.994 . . . . 0.0 110.297 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -58.07 -46.99 84.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.958 0.799 . . . . 0.0 110.286 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -81.47 5.18 18.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.652 0.781 . . . . 0.0 112.423 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -57.22 12.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 159.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.26 88.89 0.07 OUTLIER Glycine 0 C--N 1.339 0.701 0 O-C-N 121.142 -0.974 . . . . 0.0 113.825 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.3 84.08 0.03 OUTLIER Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.946 1.736 . . . . 0.0 114.993 158.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -81.91 175.8 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.569 0.699 . . . . 0.0 112.649 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.45 -72.61 1.15 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 165.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE1' ' CZ ' ' A' ' 8' ' ' PHE . 27.1 m-85 -110.91 154.24 24.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.855 -171.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.28 91.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.37 129.39 52.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.3 p -151.38 162.2 41.34 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.655 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 18.0 t70 -72.89 -177.0 2.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.529 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 9.1 t-105 -116.11 -33.13 5.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.334 2.654 . . . . 0.0 112.366 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -76.2 21.48 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.306 2.242 . . . . 0.0 114.133 -159.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.27 147.06 79.01 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.342 1.057 . . . . 0.0 110.214 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.57 -172.21 1.24 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.014 2.476 . . . . 0.0 110.14 159.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 55.78 -105.86 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.613 1.965 . . . . 0.0 109.981 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.8 ttm -87.88 85.89 7.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.8 156.9 22.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.014 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.62 64.18 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.685 -169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.74 -35.59 44.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.32 1.56 . . . . 0.0 110.951 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -26.03 39.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.164 0.893 . . . . 0.0 111.254 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.14 -54.38 47.57 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.23 1.412 . . . . 0.0 108.622 164.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tp -52.46 -58.51 6.51 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.088 0.955 . . . . 0.0 108.578 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -64.25 -28.15 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.352 1.433 . . . . 0.0 112.774 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.3 m -62.22 -53.96 47.75 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.917 1.235 . . . . 0.0 108.354 168.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 mt -56.29 -47.47 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.688 1.195 . . . . 0.0 107.853 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -5.98 12.12 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.389 1.876 . . . . 0.0 113.652 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.304 0 CA-C-N 120.234 1.379 . . . . 0.0 109.858 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtm . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -42.72 -39.04 2.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.631 1.973 . . . . 0.0 112.421 159.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.53 -15.56 54.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -64.39 131.91 95.2 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 120.116 1.325 . . . . 0.0 110.703 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.83 87.65 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.974 3.116 . . . . 0.0 109.779 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.24 104.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 128.516 2.726 . . . . 0.0 108.762 163.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.43 109.9 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.922 1.289 . . . . 0.0 108.198 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 59.6 mmm -87.78 129.84 35.05 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.25 94.51 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.16 1.784 . . . . 0.0 106.189 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -130.93 174.49 9.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.848 0.832 . . . . 0.0 111.09 -167.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.78 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.394 -0.816 . . . . 0.0 111.726 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.0 113.86 23.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.558 0.743 . . . . 0.0 111.73 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 8.48 1.63 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.495 1.518 . . . . 0.0 111.973 161.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -54.32 116.88 2.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.183 0.993 . . . . 0.0 108.452 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -60.87 -36.45 79.22 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.581 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -44.71 85.57 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.455 1.025 . . . . 0.0 109.531 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.64 -40.99 96.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 mt -64.89 -48.79 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.267 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.16 -51.65 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 120.009 1.277 . . . . 0.0 108.11 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.04 -42.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 110.904 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.605 0.762 . . . . 0.0 110.32 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.46 98.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.28 0.632 . . . . 0.0 110.722 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -57.07 -55.01 40.28 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 127.549 2.34 . . . . 0.0 108.83 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.73 -7.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.722 1.209 . . . . 0.0 113.234 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.41 30.81 56.16 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.302 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.87 143.55 36.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.899 1.349 . . . . 0.0 109.309 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 p -73.42 -14.85 61.34 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 122.15 -0.344 . . . . 0.0 111.908 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.34 167.55 38.75 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.84 137.88 40.19 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.24 125.68 51.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 170.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -96.2 150.35 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 166.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.65 69.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.538 -0.726 . . . . 0.0 109.79 166.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.84 175.43 44.8 Favored 'Cis proline' 0 CA--C 1.538 0.7 0 CA-C-N 119.846 0.981 . . . . 0.0 110.266 -15.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -178.07 159.01 1.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.528 1.531 . . . . 0.0 108.399 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -149.33 174.76 12.08 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.695 1.998 . . . . 0.0 109.297 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.34 74.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -6.15 2.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.287 1.835 . . . . 0.0 115.686 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 t -115.33 -34.56 4.92 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 121.395 1.907 . . . . 0.0 110.15 161.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.05 -56.92 5.64 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.643 1.577 . . . . 0.0 108.19 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -60.42 -31.61 70.57 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.03 1.332 . . . . 0.0 113.002 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 30.1 tt0 -72.54 -43.31 63.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.557 -0.715 . . . . 0.0 109.409 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -68.81 -34.75 76.03 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.067 -1.02 . . . . 0.0 110.015 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.3 mt -55.04 -58.06 9.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.78 -35.36 68.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.711 0.687 . . . . 0.0 112.038 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.452 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 22.7 mttm -59.97 -47.49 85.61 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.369 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.06 -28.02 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.496 1.953 . . . . 0.0 114.033 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -60.47 -54.01 50.72 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.834 0.854 . . . . 0.0 109.101 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -67.63 -51.65 47.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.97 -0.456 . . . . 0.0 110.426 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -64.31 1.0 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -162.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.31 -22.01 66.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 119.429 -0.319 . . . . 0.0 110.903 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 26.81 50.25 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.931 -167.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.3 mmt . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.768 1.784 . . . . 0.0 110.411 177.328 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 CA--C 1.508 -0.639 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -83.89 131.37 34.87 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -83.8 138.46 33.23 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 158.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.07 135.75 51.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.11 122.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.77 48.0 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.99 157.49 21.77 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.493 -1.379 . . . . 0.0 108.727 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -33.32 71.18 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 121.493 -0.755 . . . . 0.0 111.182 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.1 t80 -102.43 127.84 49.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.058 1.343 . . . . 0.0 107.622 -171.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -49.04 79.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.362 0.601 . . . . 0.0 110.057 -172.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.457 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 8.8 m -63.04 -24.15 67.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.62 -0.705 . . . . 0.0 111.743 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 18.7 ttm -64.95 -34.09 77.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.362 1.437 . . . . 0.0 109.938 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -36.8 80.77 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 120.352 1.433 . . . . 0.0 110.565 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -52.01 -53.06 46.2 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 168.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.22 -63.71 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-O 117.439 -1.267 . . . . 0.0 108.673 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.5 t -52.71 -46.34 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.664 1.574 . . . . 0.0 110.65 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.78 91.12 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.82 1.191 . . . . 0.0 110.318 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.73 -39.54 91.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.309 0.959 . . . . 0.0 111.922 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.57 -41.33 96.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.036 0.934 . . . . 0.0 110.079 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.84 -45.75 92.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.075 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -63.43 -39.39 94.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.799 0.727 . . . . 0.0 110.802 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.61 -12.98 61.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.598 -171.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.84 13.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.35 -90.61 0.43 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.558 1.075 . . . . 0.0 111.197 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -147.69 175.47 10.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.198 0.999 . . . . 0.0 112.824 -159.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -118.74 171.61 8.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 128.43 2.692 . . . . 0.0 109.194 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 77.29 99.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 128.388 2.675 . . . . 0.0 113.228 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -121.1 154.87 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.566 0.698 . . . . 0.0 112.449 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' HH ' ' A' ' 51' ' ' TYR . 4.9 mm-40 -122.3 145.42 48.25 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 158.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -119.71 93.89 4.22 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.29 163.45 27.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.67 0.748 . . . . 0.0 111.079 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.65 -33.05 60.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.308 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.36 160.97 1.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.343 1.457 . . . . 0.0 107.535 -163.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.4 -40.36 10.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.755 1.161 . . . . 0.0 115.156 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.1 t -65.77 -39.41 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.237 2.018 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.22 -29.77 65.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.142 0.977 . . . . 0.0 111.028 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.44 68.92 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.949 -1.095 . . . . 0.0 109.401 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.38 -41.06 83.98 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.317 1.047 . . . . 0.0 111.144 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -56.51 -50.8 70.76 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.297 1.039 . . . . 0.0 110.282 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -54.78 -49.67 70.35 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.126 175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.45 -43.84 68.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.074 1.306 . . . . 0.0 109.935 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.59 10.56 0.35 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -4.9 47.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.987 1.267 . . . . 0.0 112.764 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.92 163.16 8.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.229 1.395 . . . . 0.0 113.438 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.2 22.74 76.26 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.466 -1.02 . . . . 0.0 112.281 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HH ' ' HG3' ' A' ' 34' ' ' GLU . 34.0 m-85 -90.96 156.57 17.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.536 1.168 . . . . 0.0 107.974 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.81 9.54 0.15 Allowed Glycine 0 C--O 1.225 -0.445 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.23 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.06 132.26 17.4 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.9 t -133.29 86.11 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 CA-C-O 122.436 1.112 . . . . 0.0 108.0 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -97.76 131.61 44.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.194 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -151.86 145.6 25.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.854 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.91 162.17 27.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.91 0.862 . . . . 0.0 109.485 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -70.27 -52.75 20.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.78 1.232 . . . . 0.0 109.478 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.45 82.25 6.52 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.742 1.617 . . . . 0.0 108.656 -169.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.5 mmt -86.95 168.64 17.26 Favored Pre-proline 0 C--O 1.234 0.263 0 O-C-N 121.806 -0.558 . . . . 0.0 111.013 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.37 0.94 9.28 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.217 2.611 . . . . 0.0 113.023 165.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -150.73 -80.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 121.008 1.731 . . . . 0.0 112.05 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.5 ttm -90.73 94.28 9.61 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.43 148.82 0.86 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.855 2.062 . . . . 0.0 111.434 176.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.98 -36.04 41.91 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.521 1.058 . . . . 0.0 113.754 -172.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.36 -34.14 55.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.775 0.83 . . . . 0.0 110.417 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.82 -42.95 85.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.56 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.11 -49.02 79.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.476 1.035 . . . . 0.0 110.013 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 tp -52.43 -56.72 13.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.95 -26.25 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 120.241 1.382 . . . . 0.0 113.243 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 m -65.3 -49.06 70.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.34 0.973 . . . . 0.0 108.609 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.35 -44.42 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.519 1.127 . . . . 0.0 109.261 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 10.21 2.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.249 1.819 . . . . 0.0 111.712 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.346 0 CA-C-N 119.602 1.092 . . . . 0.0 111.735 177.572 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 C--O 1.232 0.163 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -59.76 -23.95 63.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -15.3 60.84 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.389 1.45 . . . . 0.0 113.538 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.52 135.38 70.67 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.961 0.904 . . . . 0.0 111.559 -170.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.87 87.18 0.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.692 2.261 . . . . 0.0 108.942 162.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.0 140.88 16.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 162.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.17 118.56 14.71 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -172.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.3 mmt -78.28 127.01 31.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.63 110.44 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.7 t -155.71 172.15 18.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.932 0.787 . . . . 0.0 111.232 -168.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.71 -28.18 62.52 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.235 -0.916 . . . . 0.0 111.539 159.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.75 93.29 0.94 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -164.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.9 4.53 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.987 170.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -45.16 105.25 0.05 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.999 1.72 . . . . 0.0 108.524 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -50.7 -43.15 57.62 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 122.462 0.305 . . . . 0.0 110.218 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -49.32 -43.0 43.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.715 1.206 . . . . 0.0 113.317 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -69.59 -40.94 76.4 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.372 1.069 . . . . 0.0 109.802 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.91 -46.45 76.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.683 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.91 -55.99 17.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.73 76.75 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.735 0.698 . . . . 0.0 111.313 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.61 64.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.514 0.726 . . . . 0.0 110.536 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.67 97.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.041 0.536 . . . . 0.0 110.037 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -58.16 -53.84 53.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 126.787 2.035 . . . . 0.0 111.527 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.75 -38.27 78.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.112 0.565 . . . . 0.0 110.254 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.69 30.2 3.11 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.713 1.149 . . . . 0.0 112.298 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.3 150.16 22.65 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.678 1.239 . . . . 0.0 109.699 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -72.79 -18.51 61.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.964 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.2 43.15 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.77 139.52 47.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 77.3 t -133.25 137.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.921 2.088 . . . . 0.0 105.368 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.5 152.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -62.22 149.64 86.52 Favored Pre-proline 0 CA--C 1.542 0.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.233 164.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.61 127.63 14.13 Favored 'Cis proline' 0 N--CA 1.456 -0.723 0 N-CA-C 109.538 -0.985 . . . . 0.0 109.538 -15.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -117.75 156.24 28.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -146.26 178.76 8.0 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 108.872 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.7 -25.49 67.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.215 -0.897 . . . . 0.0 109.216 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.69 -38.83 64.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.186 0.994 . . . . 0.0 112.575 170.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -31.9 20.79 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.828 1.195 . . . . 0.0 109.712 173.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.07 -48.77 75.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.713 1.142 . . . . 0.0 109.404 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.51 -36.14 81.6 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.349 0.66 . . . . 0.0 111.675 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.498 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 10.0 tt0 -66.38 -46.99 74.79 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.81 0.732 . . . . 0.0 109.189 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -44.94 89.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.203 -0.903 . . . . 0.0 108.769 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.05 -53.51 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.701 0.8 . . . . 0.0 110.183 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.93 -45.97 82.35 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.568 0.747 . . . . 0.0 110.997 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.498 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -53.27 -55.99 20.16 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.878 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -27.77 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.935 1.243 . . . . 0.0 112.574 -169.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -54.73 -60.36 3.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 165.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.8 -52.55 42.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 109.725 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.294 1.437 . . . . 0.0 110.983 -164.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.07 -32.13 71.36 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.05 44.45 5.98 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -162.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.1 mmt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 119.115 1.457 . . . . 0.0 109.996 169.268 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.8 tp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -81.55 129.01 34.51 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -111.31 109.76 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.654 1.182 . . . . 0.0 107.847 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.31 138.53 47.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.732 1.606 . . . . 0.0 109.012 171.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.93 109.22 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.291 1.036 . . . . 0.0 109.308 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.06 52.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -66.55 158.39 29.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.293 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.19 -43.03 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.797 -0.565 . . . . 0.0 111.486 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -92.0 114.66 27.26 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 116.739 -1.6 . . . . 0.0 108.958 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -53.14 -37.55 61.92 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 122.703 2.502 . . . . 0.0 114.622 -167.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 m -48.52 -38.42 20.25 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.578 -1.326 . . . . 0.0 111.708 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.0 ttm -65.36 -25.31 67.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.711 2.004 . . . . 0.0 111.572 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -56.42 22.1 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.452 1.933 . . . . 0.0 107.912 167.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -53.34 54.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.548 1.139 . . . . 0.0 108.584 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.9 -67.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 117.088 -1.434 . . . . 0.0 108.417 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.22 -48.27 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 120.673 1.579 . . . . 0.0 111.0 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -56.33 -48.79 76.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 109.837 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -63.04 -44.58 95.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.64 -44.17 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.17 0.988 . . . . 0.0 110.186 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.43 -42.84 96.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.639 0.776 . . . . 0.0 111.174 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -62.89 -35.13 79.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.57 -5.08 22.06 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.27 0.941 . . . . 0.0 111.464 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.67 15.58 8.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.258 2.623 . . . . 0.0 111.375 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.91 85.14 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.807 169.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -97.91 163.56 12.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.355 1.577 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -159.39 -160.28 0.82 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 110.197 -173.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.42 37.29 23.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.519 1.527 . . . . 0.0 113.085 165.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.44 146.51 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.582 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -110.26 167.17 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 158.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.65 168.86 11.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 163.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.28 164.5 20.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.73 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.997 0.519 . . . . 0.0 110.556 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.66 173.31 8.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.836 1.654 . . . . 0.0 108.54 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.93 -29.11 54.64 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.53 -49.77 56.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.537 2.168 . . . . 0.0 107.321 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -60.63 -32.37 71.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.29 0.636 . . . . 0.0 110.879 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 -52.65 59.6 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.728 -1.232 . . . . 0.0 109.042 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.42 -35.38 71.98 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.56 -44.62 93.58 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.34 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -62.58 -38.64 90.9 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.113 0.869 . . . . 0.0 111.528 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.99 -46.68 88.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.3 1.409 . . . . 0.0 108.991 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -77.66 29.18 0.16 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.037 1.335 . . . . 0.0 111.486 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.77 32.8 4.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.559 1.944 . . . . 0.0 109.724 159.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.61 19.69 8.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.913 164.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.59 83.02 0.62 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.125 1.463 . . . . 0.0 109.528 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -69.56 170.33 10.88 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.158 0.583 . . . . 0.0 109.858 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 -40.62 26.34 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.668 -0.645 . . . . 0.0 112.565 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -139.73 155.84 47.12 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.328 0.564 . . . . 0.0 111.547 -166.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.3 71.08 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.56 129.37 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -150.42 157.67 43.3 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.262 -1.524 . . . . 0.0 110.525 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -73.76 171.96 12.36 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -66.7 -59.15 3.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.55 71.36 5.01 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -158.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.82 154.35 47.79 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.3 160.04 45.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.8 1.666 . . . . 0.0 109.257 162.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.24 -79.07 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 C-N-CA 129.104 2.962 . . . . 0.0 114.227 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 ttp -88.45 79.79 7.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.86 150.17 2.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.026 1.73 . . . . 0.0 109.517 167.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.98 -27.93 71.2 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.205 -0.934 . . . . 0.0 113.785 -161.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -31.42 59.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.974 0.887 . . . . 0.0 111.36 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.65 -40.54 84.53 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.792 0.723 . . . . 0.0 109.119 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.8 tp -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.521 0.6 . . . . 0.0 109.73 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tp -53.19 -56.98 12.15 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.946 0.898 . . . . 0.0 109.526 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.48 -30.17 71.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.026 0.83 . . . . 0.0 112.25 -174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 m -62.18 -55.77 25.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 109.126 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.81 -44.04 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.125 1.37 . . . . 0.0 108.183 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -57.7 -26.24 61.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.999 1.719 . . . . 0.0 112.756 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 119.181 0.901 . . . . 0.0 112.311 179.486 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.9 mtt . . . . . 0 C--O 1.221 -0.441 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -57.23 -26.86 61.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.837 1.199 . . . . 0.0 111.264 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.62 -10.09 59.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.002 1.321 . . . . 0.0 113.975 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.58 143.5 95.25 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 119.625 1.102 . . . . 0.0 110.125 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.78 87.94 0.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.996 2.464 . . . . 0.0 110.099 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.85 88.77 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 126.321 1.848 . . . . 0.0 107.083 163.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.5 tp -96.26 118.33 32.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.62 122.76 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.2 t -132.55 99.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.412 1.885 . . . . 0.0 107.405 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -139.61 -173.54 3.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.132 0.968 . . . . 0.0 110.382 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.09 -15.02 15.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.116 1.367 . . . . 0.0 111.666 163.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.54 103.75 7.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.61 -73.58 0.11 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 39.98 92.7 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 126.433 1.893 . . . . 0.0 110.782 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -28.43 -57.75 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.071 1.348 . . . . 0.0 114.276 173.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 22.1 tt0 -54.73 -40.26 69.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.656 2.382 . . . . 0.0 113.654 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.04 -39.47 72.27 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.856 1.263 . . . . 0.0 110.474 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.97 -50.41 79.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.276 2.1 mt -53.9 -46.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 116.857 -1.544 . . . . 0.0 114.93 168.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.69 82.55 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 121.325 1.875 . . . . 0.0 110.488 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.66 -42.6 99.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.009 0.924 . . . . 0.0 110.729 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.58 78.79 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.565 -0.709 . . . . 0.0 112.394 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.44 -44.07 75.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.487 1.515 . . . . 0.0 110.091 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.13 58.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.548 0.739 . . . . 0.0 112.739 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.41 39.79 34.85 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.26 0.936 . . . . 0.0 112.453 173.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.62 150.4 31.97 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.428 0.614 . . . . 0.0 109.972 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -77.15 -14.33 59.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.96 0.904 . . . . 0.0 111.466 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.67 171.37 43.0 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 160.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -132.07 133.12 44.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.2 t -134.99 134.92 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.0 141.84 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -53.84 142.22 44.95 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.308 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.32 135.87 40.69 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.497 1.213 . . . . 0.0 110.77 -10.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.96 152.24 51.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 109.275 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 p -149.74 -176.71 5.52 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.66 1.584 . . . . 0.0 108.943 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.89 73.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.402 -0.809 . . . . 0.0 108.901 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.46 -19.89 17.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.751 1.22 . . . . 0.0 114.218 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.58 -25.46 9.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.783 1.174 . . . . 0.0 111.668 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -47.59 81.21 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.17 -30.32 71.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 112.162 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -78.8 -43.36 25.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.465 0.706 . . . . 0.0 110.114 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -25.63 60.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.224 -1.369 . . . . 0.0 110.133 175.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 mt -57.52 -53.24 60.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.457 1.026 . . . . 0.0 108.677 166.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -50.09 -45.47 52.64 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.801 0.728 . . . . 0.0 111.302 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -62.67 1.5 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.316 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 pt -67.47 -27.03 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 120.319 1.418 . . . . 0.0 113.089 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -53.78 -62.51 1.61 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 167.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.02 -29.6 58.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -168.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -69.49 0.67 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.553 1.541 . . . . 0.0 107.829 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.97 -28.14 66.35 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.465 0.575 . . . . 0.0 111.546 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 43.16 6.52 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -162.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 38.2 mmt . . . . . 0 C--O 1.253 1.257 0 CA-C-N 118.66 1.23 . . . . 0.0 109.296 169.573 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 166.1 12.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.453 1.12 . . . . 0.0 111.263 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.17 161.67 25.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.25 139.38 43.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 158.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -127.87 104.24 11.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.04 78.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.21 157.83 35.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 165.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -80.79 -23.21 39.43 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -83.41 -151.75 0.11 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.127 1.371 . . . . 0.0 109.575 178.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -139.78 -43.81 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.097 -1.002 . . . . 0.0 108.539 159.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.46 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.2 m -50.12 -31.93 14.68 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 169.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 ttm -64.72 -39.69 94.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.289 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -33.35 71.16 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 122.122 2.237 . . . . 0.0 110.937 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -56.43 -54.0 50.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.1 -60.25 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.51 1.124 . . . . 0.0 108.548 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.63 -46.92 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.597 1.089 . . . . 0.0 111.064 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.499 HH22 ' HB2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -64.24 -42.88 96.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.835 1.198 . . . . 0.0 109.914 -179.405 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.49 -53.96 51.34 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.195 0.907 . . . . 0.0 110.69 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.77 -37.46 71.12 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.157 0.983 . . . . 0.0 111.325 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -52.04 40.91 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.843 171.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HG3' HH11 ' A' ' 22' ' ' ARG . 26.1 mttt -62.47 -23.84 67.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.324 1.42 . . . . 0.0 111.997 -172.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -52.22 -48.98 64.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.22 0.918 . . . . 0.0 110.324 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.1 mt -75.84 -50.09 16.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.554 1.542 . . . . 0.0 109.465 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.17 -163.43 31.02 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.622 1.105 . . . . 0.0 111.274 -174.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.499 ' HB2' HH22 ' A' ' 22' ' ' ARG . 61.4 m-85 59.2 174.48 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.209 1.803 . . . . 0.0 111.894 -171.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -170.89 -162.7 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.674 1.19 . . . . 0.0 108.378 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.69 27.57 17.3 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.876 2.071 . . . . 0.0 114.439 159.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.422 HG11 ' HE ' ' A' ' 22' ' ' ARG . 7.5 m -70.08 174.14 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.104 0.562 . . . . 0.0 111.35 -175.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -136.98 177.05 8.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 108.064 164.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -132.09 177.19 7.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.777 1.231 . . . . 0.0 107.962 167.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 172.27 13.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.952 1.301 . . . . 0.0 108.005 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.69 -40.39 88.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.552 0.341 . . . . 0.0 111.181 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -174.74 172.04 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.517 1.927 . . . . 0.0 107.702 -163.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.53 -42.43 26.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.828 1.204 . . . . 0.0 115.539 178.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.47 -47.64 88.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 119.857 1.829 . . . . 0.0 108.517 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.35 -24.74 66.56 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.763 -0.585 . . . . 0.0 111.659 175.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.69 -53.63 44.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tp -51.75 -47.21 64.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.743 1.617 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -56.35 -42.08 77.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.496 1.518 . . . . 0.0 111.388 176.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.0 -45.46 88.89 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.645 -1.284 . . . . 0.0 111.246 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.12 -51.52 66.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.421 1.464 . . . . 0.0 109.521 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.01 29.56 0.11 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.968 0.907 . . . . 0.0 113.172 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.34 18.03 12.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.735 1.614 . . . . 0.0 111.631 170.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.23 -6.53 0.7 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-O 117.984 -1.453 . . . . 0.0 114.904 166.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.83 107.57 0.73 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.381 1.591 . . . . 0.0 109.709 -174.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.91 164.41 14.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.036 1.335 . . . . 0.0 108.646 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.91 -28.87 27.56 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.479 -0.763 . . . . 0.0 112.625 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -145.98 159.46 43.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.192 1.797 . . . . 0.0 108.476 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.37 62.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.4 mt -69.52 131.76 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.62 141.43 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.599 0.359 . . . . 0.0 110.13 -163.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -62.89 165.19 7.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 164.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -80.96 -59.63 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 159.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.97 37.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.341 1.056 . . . . 0.0 112.55 -170.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.7 ptp -63.56 149.68 91.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 158.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.74 175.04 11.7 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.586 2.19 . . . . 0.0 110.607 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 m120 53.56 -92.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.992 2.117 . . . . 0.0 111.437 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -90.8 97.3 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.61 164.04 6.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.577 0.626 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.24 -38.38 56.63 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.641 0.639 . . . . 0.0 113.63 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.53 -38.92 92.7 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.976 0.888 . . . . 0.0 110.42 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.67 -35.58 52.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.13 0.572 . . . . 0.0 110.269 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.23 -49.93 74.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.568 0.747 . . . . 0.0 109.152 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.87 -56.57 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.597 1.159 . . . . 0.0 109.643 172.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -64.48 -31.34 72.51 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.109 1.322 . . . . 0.0 113.454 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.2 m -62.44 -51.5 67.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.37 1.068 . . . . 0.0 109.005 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.3 mt -58.63 -43.54 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 126.217 1.807 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -8.95 41.66 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.486 -172.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 124.293 1.037 . . . . 0.0 111.561 -172.425 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.3 mtt . . . . . 0 C--O 1.22 -0.493 0 N-CA-C 111.112 0.042 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -35.28 11.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.356 2.262 . . . . 0.0 112.579 173.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.11 -7.17 58.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.656 1.582 . . . . 0.0 114.002 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.07 131.52 95.19 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 119.735 1.152 . . . . 0.0 108.674 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.98 83.65 0.9 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.452 1.434 . . . . 0.0 110.375 167.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.5 115.55 7.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 159.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tp -130.53 107.63 9.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -167.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -73.1 123.71 24.13 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.16 105.3 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -148.25 -166.47 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.35 -21.59 13.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.359 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -82.96 145.74 29.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.81 1.186 . . . . 0.0 110.868 176.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.31 -81.85 0.31 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.984 1.313 . . . . 0.0 109.809 172.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 tptm 46.33 110.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 130.078 3.351 . . . . 0.0 112.551 -164.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -47.57 -45.08 26.75 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 111.825 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -60.81 -31.45 70.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.964 1.256 . . . . 0.0 113.185 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -70.26 -37.39 74.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.747 1.158 . . . . 0.0 110.617 170.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.11 -47.8 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.409 1.004 . . . . 0.0 108.454 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.1 -58.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.88 -51.03 55.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.912 1.233 . . . . 0.0 111.336 -176.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.298 0.499 . . . . 0.0 110.295 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.31 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.441 0.564 . . . . 0.0 111.785 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -63.85 -47.19 81.71 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.615 1.966 . . . . 0.0 111.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.86 66.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.777 0.431 . . . . 0.0 112.002 172.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.48 47.15 9.15 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 125.9 1.714 . . . . 0.0 110.691 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.03 144.7 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -65.61 -21.23 66.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.664 0.269 . . . . 0.0 111.569 -178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 175.49 44.4 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -135.05 142.98 46.46 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.02 133.89 44.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 129.461 3.105 . . . . 0.0 104.302 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.02 147.55 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -50.29 134.97 23.89 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.098 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.22 147.39 85.41 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 120.557 1.235 . . . . 0.0 110.902 -6.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.86 145.12 32.09 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.841 -0.537 . . . . 0.0 112.06 176.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -141.36 174.58 10.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.244 1.818 . . . . 0.0 110.23 -170.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.29 67.62 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 175.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.89 66.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.181 1.392 . . . . 0.0 113.997 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 t -93.23 -40.77 10.26 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.569 1.077 . . . . 0.0 109.182 168.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -53.84 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.04 0.936 . . . . 0.0 109.483 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -28.6 70.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.71 1.204 . . . . 0.0 112.653 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.57 -46.58 31.08 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.031 0.933 . . . . 0.0 109.064 178.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -69.83 -32.94 71.62 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 109.823 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.5 -56.91 15.75 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.111 0.964 . . . . 0.0 109.424 167.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -57.17 -29.94 64.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -68.48 0.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 117.511 -1.233 . . . . 0.0 109.148 166.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.5 pt -62.13 -28.12 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 119.831 1.196 . . . . 0.0 112.726 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -59.46 -54.33 47.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.111 0.564 . . . . 0.0 109.797 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.14 -47.03 38.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.985 0.811 . . . . 0.0 110.942 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -68.16 -73.27 0.15 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.774 1.629 . . . . 0.0 110.093 -172.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.03 -21.2 66.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.541 0.61 . . . . 0.0 111.444 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.26 33.62 28.36 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.5 mmm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.057 179.513 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--O 1.235 0.337 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -70.03 130.54 42.42 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.83 160.51 17.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 162.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.72 137.5 51.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.12 103.59 6.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 125.683 1.593 . . . . 0.0 106.947 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.14 53.84 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.629 1.204 . . . . 0.0 107.872 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.51 126.36 30.65 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.87 -45.1 93.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.989 0.516 . . . . 0.0 112.035 -174.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -75.61 106.18 7.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 t -58.05 -33.22 68.78 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.583 1.538 . . . . 0.0 112.885 -171.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.6 m -57.67 -36.84 72.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.406 -1.434 . . . . 0.0 110.851 174.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.1 tpp -55.29 -43.15 74.53 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.346 1.059 . . . . 0.0 109.539 173.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -66.6 -41.88 87.75 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.574 0.625 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -57.2 -47.06 82.24 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.028 173.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.85 -58.14 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.036 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.8 t -54.64 -50.6 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 125.34 1.456 . . . . 0.0 110.699 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -59.99 -41.73 92.69 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.826 0.739 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -64.39 -45.68 86.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.434 0.561 . . . . 0.0 111.346 176.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.29 -43.78 92.56 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.752 0.821 . . . . 0.0 110.269 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.34 -58.74 6.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.009 1.324 . . . . 0.0 110.558 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HE2' ' OD1' ' A' ' 31' ' ' ASN . 11.5 ptmm? -66.27 -22.65 66.31 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 117.37 -1.3 . . . . 0.0 112.087 -177.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.45 90.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.391 1.451 . . . . 0.0 109.197 175.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.33 -42.4 23.04 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.436 1.094 . . . . 0.0 110.089 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.18 -25.13 0.19 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.258 -1.301 . . . . 0.0 115.757 169.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.93 101.59 5.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.425 2.113 . . . . 0.0 111.093 -174.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' HE2' ' A' ' 26' ' ' LYS . 45.8 m-80 -85.82 -27.4 25.15 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.235 -0.915 . . . . 0.0 112.985 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.54 76.38 2.24 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.297 1.522 . . . . 0.0 108.505 -159.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.23 108.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.813 2.045 . . . . 0.0 105.826 -162.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -86.4 -168.49 2.25 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.332 1.853 . . . . 0.0 109.894 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.92 172.35 1.67 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 130.589 3.555 . . . . 0.0 105.081 -167.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.96 175.75 9.99 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -168.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.78 -39.08 87.68 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.375 -0.828 . . . . 0.0 110.973 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.87 166.57 4.39 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -158.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.59 49.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.296 0.953 . . . . 0.0 112.554 171.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 t -57.81 -45.12 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.435 1.094 . . . . 0.0 110.536 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.93 -30.39 61.23 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.64 0.776 . . . . 0.0 109.633 176.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.91 -50.14 74.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.565 -0.71 . . . . 0.0 109.508 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.26 -45.61 76.08 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.144 0.578 . . . . 0.0 110.362 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.24 -38.0 87.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.051 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.26 -48.02 81.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.422 1.01 . . . . 0.0 109.512 171.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -60.82 -47.99 83.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 35.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.04 -49.28 4.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.64 153.91 20.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.047 1.784 . . . . 0.0 110.246 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -8.2 74.86 Favored Glycine 0 N--CA 1.466 0.685 0 O-C-N 121.047 -1.266 . . . . 0.0 114.03 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -72.7 161.8 30.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 159.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.21 3.79 4.46 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 117.758 -1.579 . . . . 0.0 113.544 164.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.38 141.89 31.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.855 1.828 . . . . 0.0 111.043 -174.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.77 72.07 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -75.81 140.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 t -154.49 147.34 24.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.215 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -72.47 165.11 25.26 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 158.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -77.37 -52.53 8.99 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.467 1.507 . . . . 0.0 110.113 163.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.68 84.52 5.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.527 -158.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.71 162.95 51.96 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.391 1.476 . . . . 0.0 109.73 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.53 176.75 9.69 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.238 1.958 . . . . 0.0 111.166 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 58.41 -98.54 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.1 2.56 . . . . 0.0 110.796 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 9.6 ttm -91.21 104.84 17.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 172.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.08 158.12 14.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.605 0.717 . . . . 0.0 110.685 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.82 -26.04 73.09 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.939 -168.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.438 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -72.58 -38.2 67.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.861 1.33 . . . . 0.0 108.932 175.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -66.44 -40.08 89.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.545 0.611 . . . . 0.0 111.294 174.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.78 -49.61 74.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.07 0.85 . . . . 0.0 109.493 172.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 tp -53.85 -58.2 8.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.073 174.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 29.6 mttt -61.99 -32.37 72.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.922 1.692 . . . . 0.0 112.414 -172.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.6 m -59.27 -49.1 79.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.186 0.995 . . . . 0.0 109.118 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.3 mt -64.92 -46.87 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -20.6 62.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.485 1.114 . . . . 0.0 112.736 -174.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-N 119.564 1.074 . . . . 0.0 110.739 172.884 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 p -55.52 -22.45 21.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.769 1.628 . . . . 0.0 113.317 171.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.53 63.02 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.25 0.932 . . . . 0.0 112.576 175.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.1 mt -61.72 139.38 95.38 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 118.94 0.791 . . . . 0.0 111.65 -171.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.32 77.46 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.704 2.936 . . . . 0.0 109.008 159.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -60.99 114.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.285 1.834 . . . . 0.0 107.546 159.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 ' CD2' ' HZ1' ' A' ' 119' ' ' LYS . 61.8 tp -132.81 114.22 13.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 109.483 -166.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mtp -91.25 119.45 31.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.45 101.5 8.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.911 1.685 . . . . 0.0 106.643 -174.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.28 172.12 13.6 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.455 -0.778 . . . . 0.0 111.127 -165.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.6 -13.88 36.22 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.142 -0.974 . . . . 0.0 113.027 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -91.1 123.35 34.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.07 0.948 . . . . 0.0 111.154 -174.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 20.74 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.784 0.833 . . . . 0.0 110.497 163.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -51.27 115.24 1.48 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.635 1.574 . . . . 0.0 108.825 -175.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -58.14 -41.95 84.8 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 119.139 -0.457 . . . . 0.0 109.976 -175.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.42 -32.35 70.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.876 173.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -68.67 -39.31 80.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.939 1.245 . . . . 0.0 109.422 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.81 -44.83 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 118.237 -0.887 . . . . 0.0 108.652 172.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.95 -58.7 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.239 0.927 . . . . 0.0 108.717 175.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.57 83.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.109 0.868 . . . . 0.0 111.055 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.95 74.83 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.096 0.558 . . . . 0.0 110.348 172.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.82 87.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.317 0.508 . . . . 0.0 111.863 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -54.08 -55.54 26.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.608 1.963 . . . . 0.0 108.685 171.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.04 -13.46 61.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.89 1.276 . . . . 0.0 112.734 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.81 36.95 40.62 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.261 -1.299 . . . . 0.0 112.397 178.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.47 43.69 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.204 1.502 . . . . 0.0 109.564 176.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.5 p -71.05 -24.73 62.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 117.716 0.235 . . . . 0.0 111.528 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.8 163.71 36.84 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 118.109 0.413 . . . . 0.0 112.199 174.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -134.21 110.93 9.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.623 1.569 . . . . 0.0 107.988 -176.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.59 99.95 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 106.596 -163.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.59 144.47 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -56.78 162.25 3.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 0.0 111.281 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.09 108.8 0.92 Allowed 'Cis proline' 0 N--CA 1.457 -0.669 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 -21.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.68 76.3 7.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.686 0.794 . . . . 0.0 109.357 -169.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -64.67 172.47 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.257 1.423 . . . . 0.0 112.393 -173.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.75 70.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.09 -18.53 61.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.53 -31.4 9.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.091 1.314 . . . . 0.0 109.553 172.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.74 -47.36 80.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 108.382 175.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -42.56 73.3 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.073 0.949 . . . . 0.0 111.583 -176.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.03 -64.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.605 1.962 . . . . 0.0 109.177 168.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.433 ' HZ1' ' CD2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.181 -173.403 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.35 -53.83 46.48 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.284 0.947 . . . . 0.0 109.445 174.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -35.47 77.38 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.866 0.757 . . . . 0.0 110.044 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -51.75 -57.07 10.31 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.899 0.879 . . . . 0.0 110.652 171.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -17.52 11.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -57.28 -67.31 0.34 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 159.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.37 -36.72 79.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.785 -0.572 . . . . 0.0 112.434 -167.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -67.28 0.73 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -176.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.35 -29.61 67.45 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.8 -171.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.77 25.1 13.83 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 117.762 -1.577 . . . . 0.0 111.4 -166.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 C--O 1.249 1.072 0 CA-C-N 120.266 2.033 . . . . 0.0 111.291 179.213 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -91.07 152.9 20.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.721 0.772 . . . . 0.0 111.814 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.72 156.48 19.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 158.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 tp -119.33 143.19 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.454 ' HB ' HH11 ' A' ' 18' ' ' ARG . 19.4 t -137.34 93.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -171.003 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.07 57.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -174.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.9 131.4 37.47 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.61 -56.64 17.62 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.661 1.185 . . . . 0.0 111.76 177.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.4 t80 -69.6 114.37 7.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -48.89 76.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.377 0.99 . . . . 0.0 111.093 -170.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.49 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.7 m -58.53 -28.42 65.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.551 0.741 . . . . 0.0 111.574 176.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.0 ttp -63.89 -36.27 83.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.568 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.454 HH11 ' HB ' ' A' ' 10' ' ' VAL . 5.6 ttt85 -64.64 -42.17 95.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.729 1.604 . . . . 0.0 109.52 172.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -58.92 -37.91 77.73 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.871 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.41 -65.31 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.574 169.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.8 t -48.21 -52.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.686 2.039 . . . . 0.0 111.189 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -56.57 -47.5 79.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.941 177.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.35 -49.38 77.42 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.777 0.717 . . . . 0.0 111.533 176.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.77 -39.1 83.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 110.988 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -48.58 72.08 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.65 -0.656 . . . . 0.0 110.386 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.99 -28.39 68.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.831 178.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.16 -45.23 95.49 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 119.942 1.246 . . . . 0.0 109.488 173.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.54 -27.74 64.39 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 0.0 111.062 177.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 1.92 6.41 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.412 1.482 . . . . 0.0 113.959 169.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -70.14 170.13 12.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.359 1.08 . . . . 0.0 110.645 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -143.01 -178.79 6.0 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.062 1.345 . . . . 0.0 109.801 -172.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 75.5 -64.22 0.38 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.63 2.372 . . . . 0.0 113.92 170.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m 33.87 65.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.658 1.983 . . . . 0.0 113.984 162.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.28 -174.8 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.015 1.726 . . . . 0.0 110.614 175.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.59 169.55 21.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.386 1.874 . . . . 0.0 108.232 -172.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.94 166.43 26.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 170.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.26 -35.95 80.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.14 0.976 . . . . 0.0 111.33 176.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.17 176.16 3.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.927 2.091 . . . . 0.0 107.615 -169.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.62 -36.22 58.57 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.9 -51.72 69.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 120.396 2.098 . . . . 0.0 107.718 177.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.84 -35.28 77.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.963 0.505 . . . . 0.0 111.02 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.66 -47.68 79.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -42.9 80.25 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.777 0.673 . . . . 0.0 111.453 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.56 -46.86 85.98 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.453 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -55.84 -45.72 78.35 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.226 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -57.34 -38.55 74.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.846 1.203 . . . . 0.0 110.262 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -72.34 27.21 0.05 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.867 1.267 . . . . 0.0 113.951 173.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.65 -8.61 16.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.901 1.28 . . . . 0.0 111.313 158.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.22 169.68 4.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.075 1.321 . . . . 0.0 112.808 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.4 -1.92 17.81 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.633 -0.922 . . . . 0.0 113.21 -177.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.53 112.06 3.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 166.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.58 -9.56 71.86 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.334 171.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.8 145.09 21.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.815 1.308 . . . . 0.0 111.238 -166.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.86 111.42 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -114.35 136.22 51.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -146.48 162.52 38.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.109 0.413 . . . . 0.0 111.183 171.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 21.8 t70 -75.96 -167.73 0.78 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 158.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.498 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 10.2 t-105 -114.06 -52.84 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.405 2.282 . . . . 0.0 110.857 -175.197 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 86.58 0.15 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.531 2.332 . . . . 0.0 110.33 -167.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -142.99 153.12 60.13 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 124.916 1.287 . . . . 0.0 109.183 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -78.0 -179.22 5.24 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.481 2.12 . . . . 0.0 108.301 165.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 54.9 -94.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.29 1.836 . . . . 0.0 109.983 176.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.0 tpp -91.38 80.7 5.48 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.85 149.72 4.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 159.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.64 -27.62 61.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.284 -0.885 . . . . 0.0 113.34 -169.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -34.39 68.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.644 1.222 . . . . 0.0 110.513 176.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -66.06 -42.49 89.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.546 172.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.84 -50.04 75.47 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -61.97 1.92 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.611 1.164 . . . . 0.0 109.199 173.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.54 -34.24 77.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.677 1.126 . . . . 0.0 112.522 -172.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.4 m -59.04 -48.38 81.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.5 mt -64.09 -48.7 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.412 1.085 . . . . 0.0 109.112 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -29.0 67.64 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.55 -171.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 124.463 1.105 . . . . 0.0 112.214 -175.865 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.1 p -60.64 -22.04 63.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.786 0.834 . . . . 0.0 112.728 -174.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.68 -3.38 59.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.159 1.384 . . . . 0.0 113.553 174.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.6 mt -68.33 130.47 92.28 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 119.911 1.232 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.44 98.0 0.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 108.67 164.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.87 107.1 10.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.591 1.557 . . . . 0.0 107.742 164.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.15 116.45 31.95 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.092 1.357 . . . . 0.0 107.873 -176.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.0 mtp -88.11 120.19 29.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -130.42 105.19 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -171.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -146.67 173.72 12.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.805 0.812 . . . . 0.0 110.923 -167.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.71 -19.72 20.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.484 0.713 . . . . 0.0 112.107 175.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -90.11 139.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.939 0.79 . . . . 0.0 109.737 -177.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.09 -59.71 2.66 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 tptt 45.99 80.92 0.04 OUTLIER 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.775 1.63 . . . . 0.0 109.558 173.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -54.91 -35.04 63.72 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.845 -167.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.64 -29.98 70.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.742 1.61 . . . . 0.0 113.385 174.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -65.47 -42.51 92.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 120.044 1.293 . . . . 0.0 109.412 167.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.1 mt -62.98 -52.25 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.868 0.758 . . . . 0.0 109.584 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.252 1.7 mt -54.6 -46.85 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 117.273 -1.346 . . . . 0.0 113.489 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.1 82.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.003 1.274 . . . . 0.0 110.472 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.6 -48.48 77.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.73 0.812 . . . . 0.0 110.918 175.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -22.86 63.09 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.84 -0.538 . . . . 0.0 112.394 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -77.15 -53.76 7.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.924 2.09 . . . . 0.0 108.772 171.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.35 -26.79 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.154 1.382 . . . . 0.0 112.659 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.56 34.3 5.05 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 124.677 1.132 . . . . 0.0 113.291 173.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 151.62 29.36 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.662 1.231 . . . . 0.0 110.576 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.7 p -77.08 -14.22 59.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.83 171.69 37.1 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 172.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -134.23 127.87 32.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.12 96.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 175.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.19 149.15 8.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 160.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -55.52 163.2 1.97 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 122.654 0.382 . . . . 0.0 110.45 160.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.08 137.06 47.44 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 -14.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -133.86 154.7 50.86 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.287 0.635 . . . . 0.0 110.567 -175.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 p -145.23 176.69 9.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.189 1.795 . . . . 0.0 109.367 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.68 -29.82 68.34 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.039 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.46 80.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.143 0.977 . . . . 0.0 112.475 175.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.08 -29.92 26.43 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.962 0.801 . . . . 0.0 110.291 175.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -55.92 25.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -27.33 69.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.216 0.606 . . . . 0.0 112.184 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.87 -43.8 87.27 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.607 -0.683 . . . . 0.0 110.255 172.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -66.66 -35.12 79.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.781 173.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.33 -53.09 61.74 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.556 1.071 . . . . 0.0 109.182 177.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.61 -34.44 72.77 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.204 0.457 . . . . 0.0 111.119 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -69.77 0.11 Allowed 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.112 0.965 . . . . 0.0 109.64 168.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 pt -74.12 -26.9 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 118.729 0.695 . . . . 0.0 112.444 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -58.75 -56.76 18.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -81.69 -38.01 26.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.585 -174.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -67.49 -74.51 0.11 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.59 1.156 . . . . 0.0 109.12 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.46 -31.34 72.37 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.218 0.463 . . . . 0.0 110.152 -175.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.84 37.64 8.44 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -165.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 C--O 1.248 1.006 0 CA-C-N 118.592 1.196 . . . . 0.0 109.104 164.888 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 134.06 34.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -95.53 98.75 10.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -76.74 140.06 40.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.52 115.52 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.33 1.052 . . . . 0.0 108.984 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.43 55.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.743 1.156 . . . . 0.0 109.928 -173.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.84 152.74 45.02 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.954 -1.092 . . . . 0.0 109.598 170.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.38 -47.63 17.23 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.413 1.085 . . . . 0.0 110.973 -173.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 6.3 t80 -77.84 117.28 19.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -56.07 -44.17 78.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.971 0.805 . . . . 0.0 110.637 -173.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 28.2 m -59.38 -38.32 80.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.028 -1.045 . . . . 0.0 111.283 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.14 -39.46 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.309 1.413 . . . . 0.0 110.121 171.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -65.67 -41.27 92.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.879 0.763 . . . . 0.0 109.872 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -46.26 88.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.504 174.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.58 -59.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 117.137 -1.411 . . . . 0.0 109.5 177.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.16 -52.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.87 1.668 . . . . 0.0 110.142 -177.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -61.63 -35.8 78.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.713 -0.617 . . . . 0.0 111.341 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -64.78 -44.47 89.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.709 1.141 . . . . 0.0 110.954 173.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.03 -38.7 92.24 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.503 1.121 . . . . 0.0 110.334 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.6 -45.22 94.82 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.021 0.928 . . . . 0.0 110.691 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -64.06 -28.01 69.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.77 -0.581 . . . . 0.0 111.417 174.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.33 -8.44 53.74 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.16 -1.587 . . . . 0.0 111.894 172.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.74 7.67 10.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.151 1.781 . . . . 0.0 112.025 -175.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 47.7 7.8 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 174.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.61 109.21 10.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.99 -7.8 8.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -78.52 49.2 0.84 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 166.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.54 159.59 4.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.738 -1.226 . . . . 0.0 109.115 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.59 169.01 19.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.598 1.959 . . . . 0.0 107.401 167.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -132.71 166.27 22.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.85 168.82 18.82 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.527 0.731 . . . . 0.0 109.147 173.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.83 -33.13 57.96 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.91 178.09 1.0 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.916 2.486 . . . . 0.0 108.565 -177.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -50.68 -38.22 35.84 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.56 176.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 120.047 1.924 . . . . 0.0 108.433 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 32.7 t0 -65.56 -37.51 86.9 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.222 -0.299 . . . . 0.0 110.448 174.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.71 72.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.24 -43.2 74.38 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.672 0.789 . . . . 0.0 110.195 175.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.47 -24.31 65.59 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 3.4 mptp? -66.17 -54.57 23.71 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.595 1.089 . . . . 0.0 108.43 165.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 mt -55.23 -48.0 74.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.623 0.647 . . . . 0.0 110.089 -169.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.63 0.82 28.56 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.07 -20.84 31.96 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.883 1.22 . . . . 0.0 111.71 163.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.07 154.49 24.58 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.059 1.314 . . . . 0.0 113.778 166.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.47 -13.77 65.66 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.283 2.373 . . . . 0.0 113.729 175.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.49 124.48 27.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.585 1.193 . . . . 0.0 107.975 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.77 -2.14 9.58 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.25 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.69 137.85 35.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.857 1.328 . . . . 0.0 108.438 173.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.91 80.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.19 125.96 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 p -145.87 165.15 29.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.507 0.594 . . . . 0.0 110.973 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.83 179.7 0.83 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.231 1.015 . . . . 0.0 110.284 161.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -89.68 -49.96 6.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.948 157.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.08 137.53 47.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.107 0.867 . . . . 0.0 109.735 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.476 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -147.21 167.45 13.55 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 124.112 0.965 . . . . 0.0 109.064 168.862 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.25 -23.01 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.226 1.95 . . . . 0.0 112.951 172.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -139.14 -83.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.421 1.464 . . . . 0.0 111.121 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.7 ttm -78.08 96.23 5.08 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.11 161.15 9.01 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.328 1.018 . . . . 0.0 110.32 170.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.44 -30.03 73.25 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.599 0.619 . . . . 0.0 112.842 -172.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -39.56 67.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.355 1.077 . . . . 0.0 109.799 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.6 -37.29 84.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.405 173.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.42 -54.08 50.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.896 1.225 . . . . 0.0 109.678 174.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.48 -51.8 52.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.401 1.08 . . . . 0.0 110.677 173.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -68.43 -25.07 64.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.174 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m -71.36 -50.3 33.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.4 -32.1 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.444 1.498 . . . . 0.0 108.596 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -58.88 -20.2 49.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.761 1.624 . . . . 0.0 112.78 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.738 0 C-N-CA 127.262 2.225 . . . . 0.0 110.968 -161.902 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 117.69 -1.147 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -56.94 -26.14 58.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.799 1.636 . . . . 0.0 113.797 -165.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.79 65.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.954 0.902 . . . . 0.0 113.348 177.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.46 138.59 75.5 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.523 1.129 . . . . 0.0 111.022 -172.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.8 100.25 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.829 2.353 . . . . 0.0 108.379 169.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 m -92.72 111.86 25.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 125.898 1.679 . . . . 0.0 106.586 174.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.4 tp -120.5 112.1 18.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.066 0.946 . . . . 0.0 108.836 -168.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.87 117.54 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.86 104.19 9.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -149.05 174.08 12.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.819 0.819 . . . . 0.0 109.74 -164.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.63 -14.04 41.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.121 -0.987 . . . . 0.0 112.19 162.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.75 96.51 6.29 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.203 1.401 . . . . 0.0 108.215 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.38 -92.07 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 162.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 51.15 101.41 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.692 1.997 . . . . 0.0 111.108 -174.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -41.14 -47.06 3.18 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.338 -0.851 . . . . 0.0 111.745 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -61.79 -34.98 76.86 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.67 -43.32 93.95 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 172.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.63 -45.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.755 174.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 mt -58.85 -56.78 14.54 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.249 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.76 -41.24 70.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.321 1.419 . . . . 0.0 110.822 -174.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.76 -53.77 54.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.738 0.815 . . . . 0.0 110.249 173.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.58 83.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.26 0.624 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -56.0 -56.37 21.51 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.824 1.65 . . . . 0.0 109.71 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.72 -21.45 64.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.684 0.794 . . . . 0.0 112.2 178.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.68 33.61 6.65 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-O 118.628 -1.096 . . . . 0.0 111.785 175.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.93 148.98 41.86 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.468 1.134 . . . . 0.0 108.904 -179.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -83.61 -6.69 59.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -172.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.17 175.22 35.64 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 119.082 0.855 . . . . 0.0 111.842 173.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.16 150.26 46.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.038 1.335 . . . . 0.0 108.847 -177.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.87 138.77 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 128.396 2.678 . . . . 0.0 104.846 166.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -118.59 143.39 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 156.92 14.45 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.803 170.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.82 154.32 97.75 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 N-CA-C 109.772 -0.895 . . . . 0.0 109.772 -16.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -158.75 160.54 36.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.561 0.744 . . . . 0.0 109.345 -169.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -147.49 -179.56 6.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.955 0.502 . . . . 0.0 110.429 -171.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.85 67.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.348 0.659 . . . . 0.0 109.438 176.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.28 -17.92 64.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 174.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 t -95.64 -37.83 10.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 121.407 1.912 . . . . 0.0 109.752 164.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -51.78 60.63 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -34.3 77.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.237 1.415 . . . . 0.0 112.455 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -71.43 -40.86 70.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 17.6 mmtp -65.3 -39.74 92.91 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 174.314 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.6 mt -54.96 -57.48 11.5 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -56.97 -33.77 67.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 24.9 mttm -56.71 -68.72 0.19 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 117.86 -1.067 . . . . 0.0 108.834 170.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -24.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 120.683 1.583 . . . . 0.0 113.339 -171.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -59.37 -49.19 78.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.98 1.312 . . . . 0.0 111.098 171.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.59 -54.84 5.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.611 0.642 . . . . 0.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.21 5.34 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.616 1.566 . . . . 0.0 108.561 -164.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -72.28 -54.14 10.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.35 15.87 2.96 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.682 -1.066 . . . . 0.0 112.347 -171.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.9 mmm . . . . . 0 C--O 1.247 0.921 0 CA-C-N 118.617 1.208 . . . . 0.0 111.495 -163.683 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -90.6 143.64 26.54 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.169 0.918 . . . . 0.0 110.387 -162.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -111.39 100.66 9.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.584 1.154 . . . . 0.0 109.087 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -74.08 142.83 45.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.981 0.81 . . . . 0.0 109.383 175.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.44 99.61 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.761 1.625 . . . . 0.0 107.219 170.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.74 87.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -91.62 109.2 20.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.656 1.182 . . . . 0.0 112.174 -162.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.91 -24.06 59.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -120.33 -7.09 9.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -158.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 m 68.46 -58.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 128.042 2.537 . . . . 0.0 110.263 -173.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.0 m -55.56 -24.9 35.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.47 1.508 . . . . 0.0 111.16 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.4 tpp -64.82 -37.56 88.01 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.929 1.695 . . . . 0.0 109.934 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.438 HH11 ' CD ' ' A' ' 35' ' ' GLU . 23.3 ttp180 -77.34 -33.07 55.5 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 121.126 1.785 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -52.17 -58.06 7.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.842 1.201 . . . . 0.0 108.579 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.66 -67.75 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.509 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.32 -41.71 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 120.444 1.474 . . . . 0.0 110.392 -169.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -48.19 82.76 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 119.651 1.114 . . . . 0.0 109.445 174.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.59 -48.53 74.69 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.385 175.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.37 -43.14 96.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.024 0.829 . . . . 0.0 110.67 -176.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.76 -44.99 95.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.298 1.039 . . . . 0.0 110.104 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -63.87 -29.4 70.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.152 -1.404 . . . . 0.0 112.546 177.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.9 -62.36 1.93 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.061 1.3 . . . . 0.0 108.373 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.07 2.34 1.51 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.65 -108.62 3.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -151.38 175.95 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.314 2.246 . . . . 0.0 107.255 -164.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -138.09 -178.57 5.33 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.06 0.846 . . . . 0.0 112.085 -169.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 m120 59.72 75.91 0.38 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.953 2.901 . . . . 0.0 109.717 -167.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.18 166.17 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.041 168.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -135.5 174.24 10.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.438 ' CD ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.0 156.05 42.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.257 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.77 151.38 40.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 163.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.36 -30.49 66.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.634 0.584 . . . . 0.0 111.211 176.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.28 156.91 14.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -161.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.97 -42.46 30.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.23 0.919 . . . . 0.0 114.381 171.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.96 -37.6 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 120.2 2.0 . . . . 0.0 109.438 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.22 -43.95 96.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.526 0.731 . . . . 0.0 109.47 171.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.48 80.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.693 1.597 . . . . 0.0 110.324 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.71 -43.24 72.39 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.717 0.636 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.17 -37.18 86.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.315 0.646 . . . . 0.0 110.985 176.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -57.42 -45.06 85.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.028 1.286 . . . . 0.0 110.043 170.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -58.69 -51.45 69.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -78.8 16.76 0.81 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.66 62.13 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.521 -1.362 . . . . 0.0 110.048 159.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.73 -88.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -175.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.74 86.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -173.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -64.81 166.68 8.61 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.008 1.323 . . . . 0.0 110.736 172.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.47 -20.0 10.71 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.561 -1.133 . . . . 0.0 113.37 172.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -146.49 142.4 28.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.72 1.208 . . . . 0.0 109.702 -174.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.47 70.02 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -177.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -78.59 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 155.65 44.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.252 0.933 . . . . 0.0 110.19 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.9 176.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 158.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -96.18 -60.57 1.6 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.215 1.006 . . . . 0.0 108.78 170.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.26 74.92 9.99 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.458 0.703 . . . . 0.0 109.868 -159.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.1 mmt -107.4 162.31 20.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.245 1.818 . . . . 0.0 109.942 175.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -69.94 177.77 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.375 2.717 . . . . 0.0 112.062 173.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 44.8 -110.8 0.21 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.062 2.145 . . . . 0.0 110.944 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.51 85.73 6.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -54.5 173.68 0.07 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.518 1.927 . . . . 0.0 112.498 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -27.91 60.58 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.143 -0.973 . . . . 0.0 113.423 -173.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -82.17 -35.77 28.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.186 0.993 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -67.15 -42.08 84.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.852 169.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.1 tp -50.82 -52.65 39.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.532 1.533 . . . . 0.0 109.301 172.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 tp -53.0 -58.72 6.04 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.239 0.616 . . . . 0.0 109.794 173.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.33 -35.62 77.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.479 1.036 . . . . 0.0 111.552 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.1 m -58.04 -48.44 80.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.29 1.036 . . . . 0.0 108.843 175.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.92 -51.42 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.44 66.85 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.226 1.81 . . . . 0.0 112.535 -176.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.358 0 C-N-CA 125.311 1.444 . . . . 0.0 112.415 178.475 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -10.06 2.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.738 1.615 . . . . 0.0 114.273 -177.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.017 1.281 . . . . 0.0 112.757 170.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -70.41 129.94 89.75 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 123.447 0.699 . . . . 0.0 110.978 -170.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.77 107.8 2.13 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.81 2.34 . . . . 0.0 108.859 163.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.96 140.08 16.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.28 111.14 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 -171.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 126.64 31.14 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.06 93.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -138.63 -174.28 3.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.869 0.868 . . . . 0.0 109.902 -166.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.8 -16.77 14.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.699 1.2 . . . . 0.0 112.851 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.25 117.27 28.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.339 1.056 . . . . 0.0 109.276 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.29 -81.73 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 tptt 54.11 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.236 1.814 . . . . 0.0 111.317 -176.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -50.28 -43.34 53.33 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.405 -1.434 . . . . 0.0 112.03 178.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -52.11 -35.43 48.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.953 0.901 . . . . 0.0 112.125 176.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -78.62 -37.86 41.24 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.838 1.255 . . . . 0.0 110.536 176.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.22 -50.75 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.966 1.257 . . . . 0.0 109.138 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.327 1.9 mt -51.3 -54.47 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.916 166.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.41 -44.11 72.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 121.086 1.766 . . . . 0.0 112.112 -178.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.05 -55.48 34.53 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 118.935 0.789 . . . . 0.0 110.448 174.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -27.89 69.25 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -71.78 -53.63 12.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.333 1.853 . . . . 0.0 109.665 174.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.27 -24.53 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.179 0.992 . . . . 0.0 112.18 176.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.82 34.79 6.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.756 1.17 . . . . 0.0 111.851 176.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.05 145.02 56.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 118.43 1.115 . . . . 0.0 108.092 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 p -76.01 -12.98 60.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.306 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.6 171.86 40.69 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.273 0.939 . . . . 0.0 111.075 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.26 134.71 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.53 1.532 . . . . 0.0 107.723 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.55 140.26 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 127.734 2.414 . . . . 0.0 106.96 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.99 145.31 28.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 145.59 89.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.963 0.801 . . . . 0.0 110.318 168.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 136.58 43.38 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 119.68 0.922 . . . . 0.0 111.139 -6.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -141.4 155.56 45.88 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 110.781 175.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -151.39 -178.29 6.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.494 1.118 . . . . 0.0 111.527 -171.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.06 -28.75 64.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.789 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.51 64.16 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 174.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 t -97.38 -30.58 12.85 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.208 0.913 . . . . 0.0 110.289 171.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -52.85 -53.19 52.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.459 1.027 . . . . 0.0 108.869 177.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.69 -35.23 74.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.754 1.222 . . . . 0.0 111.675 178.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 37.3 tt0 -74.58 -41.61 60.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.477 -0.765 . . . . 0.0 109.672 -176.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -64.2 -39.34 93.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.805 176.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.5 mt -55.08 -58.34 8.05 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -55.68 -38.33 69.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.366 0.667 . . . . 0.0 112.331 -178.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.402 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -55.83 -64.28 0.9 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.711 172.626 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.05 -29.59 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.184 1.356 . . . . 0.0 113.282 -173.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -56.88 -52.65 64.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.632 0.773 . . . . 0.0 109.026 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -73.39 -46.09 50.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.935 0.334 . . . . 0.0 111.287 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -69.27 -73.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.62 -23.64 64.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.02 0.528 . . . . 0.0 110.969 -175.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.33 31.42 19.48 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -166.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 116.491 -1.719 . . . . 0.0 110.457 -175.7 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--O 1.231 0.117 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -90.69 132.96 35.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.87 138.53 38.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 163.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.12 140.04 37.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.65 103.19 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.13 60.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.37 1.068 . . . . 0.0 108.816 -178.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.76 146.23 29.1 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.357 -1.465 . . . . 0.0 110.746 169.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -67.15 -58.66 4.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.064 1.346 . . . . 0.0 110.03 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -83.87 83.23 8.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.231 -174.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 t -40.08 -27.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.49 2.316 . . . . 0.0 115.847 -166.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 m -43.52 -47.66 7.28 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 119.887 -1.758 . . . . 0.0 111.804 164.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -37.61 46.4 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 0.0 111.016 172.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -66.26 -44.02 84.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.4 1.454 . . . . 0.0 109.549 -178.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -58.08 9.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.497 1.119 . . . . 0.0 108.364 172.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.11 -61.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 124.509 1.124 . . . . 0.0 108.978 -176.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.5 t -54.82 -43.72 68.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 119.758 1.163 . . . . 0.0 110.452 -175.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -60.34 -48.2 82.76 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.204 1.365 . . . . 0.0 109.689 175.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.27 -42.72 91.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.205 1.002 . . . . 0.0 111.047 -178.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.76 -41.22 98.03 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.999 0.92 . . . . 0.0 110.067 175.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.04 -29.6 70.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.045 0.839 . . . . 0.0 111.405 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -73.53 -28.77 62.06 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.857 -1.152 . . . . 0.0 111.636 173.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.58 -48.98 67.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.28 0.946 . . . . 0.0 109.735 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.02 95.12 1.37 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 123.288 1.518 . . . . 0.0 108.375 -174.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -132.18 3.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.244 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -131.77 165.75 23.08 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.832 0.853 . . . . 0.0 111.883 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.34 -174.49 2.54 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.921 1.688 . . . . 0.0 110.195 173.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.46 81.63 0.15 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.464 2.306 . . . . 0.0 109.59 -175.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 146.33 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.64 176.15 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.576 1.551 . . . . 0.0 109.754 -177.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -131.47 166.36 21.51 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.143 0.977 . . . . 0.0 108.888 173.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.94 172.2 9.59 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 160.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.07 -41.09 82.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 174.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -170.94 177.17 3.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.793 2.037 . . . . 0.0 108.19 -169.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.39 -37.09 72.43 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.944 0.783 . . . . 0.0 113.111 -178.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -63.42 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 O-C-N 121.724 -0.868 . . . . 0.0 108.91 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.53 -29.31 64.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.523 174.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.57 85.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.726 1.21 . . . . 0.0 109.83 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 tp -58.26 -41.24 83.83 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.255 0.479 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -40.61 96.03 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.364 175.589 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -53.64 -54.94 30.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.996 172.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.4 mt -57.76 -40.54 79.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.777 1.171 . . . . 0.0 110.89 -174.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -65.17 -19.56 66.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.55 6.03 34.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.265 1.826 . . . . 0.0 113.907 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.69 175.06 45.45 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 119.167 -1.492 . . . . 0.0 116.736 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.84 4.99 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.473 1.511 . . . . 0.0 109.968 177.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -75.96 72.27 2.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.462 1.505 . . . . 0.0 107.099 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.47 -4.29 37.37 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.405 1.002 . . . . 0.0 113.454 -172.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.79 136.5 48.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.089 1.355 . . . . 0.0 108.263 170.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.21 64.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.03 139.16 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.4 p -152.01 167.58 27.95 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.956 -0.465 . . . . 0.0 110.722 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.89 169.46 9.8 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 158.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.72 -64.45 0.85 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.824 -1.173 . . . . 0.0 107.87 163.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.86 165.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.79 2.436 . . . . 0.0 112.431 -166.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.1 75.73 12.7 Favored Pre-proline 0 N--CA 1.45 -0.455 0 O-C-N 119.63 -1.919 . . . . 0.0 107.497 167.322 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.07 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.895 2.397 . . . . 0.0 110.419 176.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -165.17 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 129.986 3.314 . . . . 0.0 104.102 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.2 ttp -72.98 89.19 1.41 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 160.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.78 168.8 4.62 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.11 0.964 . . . . 0.0 110.666 164.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.6 -19.76 60.77 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.677 -176.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.434 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -77.37 -49.0 15.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.256 1.528 . . . . 0.0 108.722 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.94 0.496 . . . . 0.0 110.551 174.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -56.14 -53.05 61.77 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.087 0.955 . . . . 0.0 109.306 175.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tp -54.03 -55.79 24.0 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 110.574 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 72.4 mttt -63.96 -36.99 85.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.636 1.562 . . . . 0.0 112.301 -174.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.7 m -61.44 -39.25 90.13 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 109.718 175.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.2 mt -71.17 -47.84 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.21 68.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.752 1.621 . . . . 0.0 111.449 -178.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.302 0 O-C-N 121.36 -0.837 . . . . 0.0 112.77 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 C--O 1.226 -0.175 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -59.03 -20.42 52.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.769 1.168 . . . . 0.0 112.227 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.76 60.01 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.6 138.46 91.04 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.914 1.234 . . . . 0.0 110.5 -170.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 82.71 1.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.564 2.176 . . . . 0.0 108.726 166.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -65.54 108.83 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 159.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 tp -130.83 105.97 8.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -160.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.6 mmt -78.69 120.9 24.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -174.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.63 87.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.8 t -129.19 170.52 13.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.601 0.715 . . . . 0.0 112.924 -159.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.11 57.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.789 0.835 . . . . 0.0 112.822 161.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.54 98.34 2.28 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.851 1.26 . . . . 0.0 111.424 -167.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.18 23.16 0.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.968 -1.083 . . . . 0.0 111.306 163.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -70.93 104.25 2.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.437 -1.414 . . . . 0.0 107.792 -174.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -31.93 -65.49 0.14 Allowed 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 125.716 1.606 . . . . 0.0 111.974 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.74 -29.17 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.743 -172.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -62.42 -46.29 89.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.392 0.996 . . . . 0.0 109.436 171.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.33 -46.4 95.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.55 -57.23 9.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.56 -40.05 74.51 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.908 0.777 . . . . 0.0 111.215 -172.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.73 -52.16 53.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.572 1.149 . . . . 0.0 110.436 176.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 177.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -62.38 -50.92 69.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 111.345 177.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.39 61.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.482 1.113 . . . . 0.0 112.892 178.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.33 30.76 9.6 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.356 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.67 146.79 44.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.93 1.365 . . . . 0.0 108.135 175.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.1 p -70.39 -8.37 50.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.32 165.84 20.03 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -140.22 85.53 2.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.078 0.951 . . . . 0.0 109.755 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -85.21 141.29 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 169.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.19 157.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 171.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -56.22 137.32 74.64 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.657 159.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.3 159.47 97.64 Favored 'Cis proline' 0 C--N 1.348 0.503 0 CA-C-N 121.166 1.452 . . . . 0.0 112.327 -6.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -177.75 155.09 0.99 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.264 1.025 . . . . 0.0 109.909 -174.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -150.35 -174.02 4.62 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.6 1.16 . . . . 0.0 112.076 -168.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.04 -35.83 62.4 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -47.22 -30.79 3.21 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.006 2.122 . . . . 0.0 115.074 174.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.411 HG23 ' HE2' ' A' ' 119' ' ' LYS . 1.2 t -111.21 -19.79 12.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.968 0.507 . . . . 0.0 110.939 176.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.33 -55.94 25.71 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.738 -1.226 . . . . 0.0 108.226 167.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -44.84 79.07 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.909 1.283 . . . . 0.0 111.684 178.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -38.64 76.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.443 -0.785 . . . . 0.0 110.807 -177.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HE2' HG23 ' A' ' 115' ' ' THR . 46.2 mtmt -61.99 -39.25 91.56 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.151 -0.968 . . . . 0.0 110.3 173.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.12 -51.25 70.85 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.419 172.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.7 -36.53 72.1 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.097 1.317 . . . . 0.0 112.36 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -69.8 0.11 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.32 1.448 . . . . 0.0 108.382 169.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -22.29 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -171.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.49 -45.59 86.66 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.152 0.981 . . . . 0.0 109.679 174.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.19 -39.26 25.74 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.333 0.969 . . . . 0.0 110.979 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -74.59 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -171.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.84 -37.83 88.37 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.23 44.42 4.08 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -163.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.728 -1.129 . . . . 0.0 111.372 -175.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.54 143.18 30.35 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.139 -163.111 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.58 95.5 5.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.83 135.89 50.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.887 1.221 . . . . 0.0 108.464 174.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.32 114.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.194 1.398 . . . . 0.0 108.331 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.44 64.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 124.912 1.285 . . . . 0.0 108.032 -173.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.44 156.74 29.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.62 -51.92 66.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 108.766 170.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.44 108.64 19.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -51.33 -42.68 61.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.213 178.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -50.97 -45.77 61.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.181 1.355 . . . . 0.0 111.625 172.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.2 ttm -62.59 -25.19 67.95 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.701 0.801 . . . . 0.0 111.572 -178.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -68.8 -39.03 80.33 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.44 -1.413 . . . . 0.0 110.56 170.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -66.48 -36.59 83.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.16 178.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -47.06 -49.32 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.294 1.406 . . . . 0.0 110.883 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -57.0 -46.96 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.444 0.698 . . . . 0.0 110.74 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.4 -40.36 94.12 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.394 0.678 . . . . 0.0 111.131 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.55 -38.67 87.61 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.854 -0.529 . . . . 0.0 110.375 177.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.2 -26.71 67.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.366 0.53 . . . . 0.0 111.613 172.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -73.05 -38.28 66.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.736 1.153 . . . . 0.0 110.839 169.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.45 -36.7 85.01 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.339 0.972 . . . . 0.0 111.244 176.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.62 99.71 0.58 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.214 2.205 . . . . 0.0 108.81 177.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.2 -113.37 0.54 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.71 171.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -145.08 -176.97 5.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.101 1.76 . . . . 0.0 109.484 -162.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -133.92 -176.12 4.07 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.386 1.474 . . . . 0.0 109.932 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 54.5 63.65 2.08 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.836 1.654 . . . . 0.0 110.548 -171.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.11 160.29 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.485 165.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -133.03 173.08 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.63 2.372 . . . . 0.0 106.106 175.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -139.2 166.88 23.38 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.95 169.39 17.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.97 1.308 . . . . 0.0 109.133 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.24 -40.63 77.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.549 0.74 . . . . 0.0 109.745 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -178.44 179.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.506 2.322 . . . . 0.0 108.426 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.65 -41.99 10.13 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.85 1.69 . . . . 0.0 115.432 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.85 -47.25 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.147 1.473 . . . . 0.0 108.642 179.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -67.98 -32.34 72.67 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 175.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.1 -43.21 91.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.792 -1.193 . . . . 0.0 110.071 177.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.702 0.683 . . . . 0.0 111.076 173.566 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.07 -43.37 77.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.919 0.887 . . . . 0.0 111.471 178.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -63.36 -52.77 60.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -53.06 60.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.594 1.158 . . . . 0.0 112.565 -172.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.32 -1.69 3.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 112.257 -177.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.3 25.32 7.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.176 2.19 . . . . 0.0 111.412 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.64 168.43 38.23 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 121.107 1.776 . . . . 0.0 114.023 169.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.95 53.66 1.39 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 124.773 1.178 . . . . 0.0 110.355 -178.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -62.01 142.49 57.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.443 1.097 . . . . 0.0 110.117 -177.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.05 -29.76 9.44 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 119.491 -0.616 . . . . 0.0 111.689 173.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -138.19 149.07 45.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.384 1.074 . . . . 0.0 109.431 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.17 108.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -178.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.65 136.38 58.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.52 153.5 38.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.724 0.238 . . . . 0.0 110.931 -159.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -64.86 170.82 3.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.926 0.87 . . . . 0.0 111.194 163.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -83.47 -76.46 0.28 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 160.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.97 -170.42 0.08 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.01 1.324 . . . . 0.0 110.999 176.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.3 ttp -162.89 75.67 1.96 Allowed Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 158.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.48 -71.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.117 2.545 . . . . 0.0 107.935 175.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -131.96 -67.97 0.65 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.231 1.412 . . . . 0.0 107.737 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 ttm -91.09 104.75 17.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.403 2.281 . . . . 0.0 107.614 161.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.73 171.44 5.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.513 0.597 . . . . 0.0 110.73 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.67 69.19 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.749 -0.594 . . . . 0.0 112.364 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -40.94 74.12 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.998 0.899 . . . . 0.0 109.782 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.79 -32.3 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.886 1.274 . . . . 0.0 111.005 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -58.48 -55.54 33.78 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -53.42 -57.16 11.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.41 1.084 . . . . 0.0 109.491 174.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.8 -21.38 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.973 1.26 . . . . 0.0 113.83 -173.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -61.37 -64.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 163.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.0 mt -56.48 -36.6 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.917 1.287 . . . . 0.0 110.6 -174.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -22.54 61.86 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.446 1.899 . . . . 0.0 113.519 -177.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.339 0 CA-C-N 119.104 0.866 . . . . 0.0 111.385 -178.756 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.3 p -63.53 -18.28 63.67 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.42 1.009 . . . . 0.0 113.314 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.17 52.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.404 1.482 . . . . 0.0 113.277 172.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -73.79 147.22 86.37 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 111.345 -175.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.55 56.36 1.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.605 2.87 . . . . 0.0 111.085 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.1 m -53.28 113.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 119.081 0.855 . . . . 0.0 110.242 176.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.7 122.97 48.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.589 1.156 . . . . 0.0 108.674 -169.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mmt -80.99 128.29 33.53 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 174.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.26 108.44 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -152.06 165.6 34.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.969 0.89 . . . . 0.0 112.017 -166.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.82 60.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.45 -0.781 . . . . 0.0 111.433 161.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.97 96.87 10.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.249 1.419 . . . . 0.0 109.414 -163.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -73.92 0.07 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.265 1.026 . . . . 0.0 110.781 177.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.5 tttt 39.25 93.37 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 127.151 2.18 . . . . 0.0 112.537 -175.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -44.29 -40.85 5.54 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.711 176.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.31 -45.28 76.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.3 0.955 . . . . 0.0 112.992 176.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.17 -37.71 81.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.329 1.452 . . . . 0.0 109.557 176.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.4 mt -64.52 -41.84 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.332 176.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -59.71 -48.38 87.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-N 120.61 1.55 . . . . 0.0 108.076 171.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.19 -43.8 74.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.089 1.313 . . . . 0.0 111.443 -177.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.87 85.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.859 0.464 . . . . 0.0 110.38 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.51 83.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.295 0.638 . . . . 0.0 112.105 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -64.51 -45.12 88.6 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.131 1.772 . . . . 0.0 110.721 174.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.78 -6.16 39.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.444 0.697 . . . . 0.0 112.298 170.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.03 64.84 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.351 -1.468 . . . . 0.0 113.049 172.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.88 160.21 0.73 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.465 1.106 . . . . 0.0 110.214 176.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -63.36 -30.7 71.79 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.361 -0.837 . . . . 0.0 111.575 176.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.46 -174.98 46.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 178.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -139.65 94.94 2.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 107.748 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.2 t -77.76 133.22 30.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 150.05 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -55.52 168.38 0.62 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 173.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.61 94.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.545 0 N-CA-C 107.442 -1.791 . . . . 0.0 107.442 -20.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -81.77 158.74 24.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.909 0.861 . . . . 0.0 111.613 -165.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.7 p -146.89 -179.05 6.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.589 1.556 . . . . 0.0 109.623 -172.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -34.14 65.67 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 110.046 176.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.18 58.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.819 0.848 . . . . 0.0 113.229 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -34.88 7.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.249 0.932 . . . . 0.0 110.506 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.04 -47.54 68.33 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.962 1.305 . . . . 0.0 108.995 176.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.01 74.57 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.411 1.084 . . . . 0.0 112.207 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.11 -44.11 89.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.862 1.21 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -67.62 -42.62 82.06 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.947 -176.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.72 -52.4 64.02 Favored 'General case' 0 C--O 1.221 -0.403 0 O-C-N 123.861 0.726 . . . . 0.0 110.216 172.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.99 -47.45 71.42 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.532 1.06 . . . . 0.0 111.251 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -56.23 -62.95 1.37 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.75 178.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -27.08 36.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 120.375 1.443 . . . . 0.0 113.633 -175.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.32 -50.57 73.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.31 -48.74 39.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -65.43 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.413 1.485 . . . . 0.0 108.509 -160.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.61 -41.23 96.35 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.287 0.949 . . . . 0.0 108.609 175.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.77 18.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.269 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-O 116.813 -1.565 . . . . 0.0 112.181 -163.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 mtt . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.24 50.95 1.69 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.561 1.528 . . . . 0.0 110.629 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.24 177.78 7.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.303 1.841 . . . . 0.0 109.527 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -11.92 61.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.966 -1.084 . . . . 0.0 111.405 159.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 44.78 33.98 1.09 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.637 2.375 . . . . 0.0 111.331 -173.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.6 108.56 0.65 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.341 1.057 . . . . 0.0 112.582 -159.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -89.71 132.01 35.39 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 34.9 m-85 -85.13 139.18 31.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.13 140.16 38.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 161.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -135.53 100.38 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.88 84.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.45 171.83 8.93 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.993 0.902 . . . . 0.0 111.516 172.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.91 -28.56 68.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.237 1.815 . . . . 0.0 112.259 165.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 14.0 t80 -131.95 113.82 13.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.904 1.681 . . . . 0.0 107.802 -163.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -50.37 -40.46 49.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.149 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 39.7 m -52.73 -37.63 59.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.184 0.994 . . . . 0.0 111.22 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -58.83 -41.34 86.62 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.663 1.12 . . . . 0.0 110.243 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.603 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.03 -48.39 80.47 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.338 0.972 . . . . 0.0 109.959 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.28 -58.19 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.69 1.196 . . . . 0.0 108.893 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.23 -50.64 70.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.323 1.049 . . . . 0.0 109.975 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -53.97 -48.57 70.19 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.852 0.751 . . . . 0.0 110.412 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.45 -46.01 84.96 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.682 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.99 -40.27 95.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.383 0.992 . . . . 0.0 110.525 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -60.78 -37.75 82.94 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.72 0.808 . . . . 0.0 110.838 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -70.74 -35.45 72.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 117.735 -1.126 . . . . 0.0 111.927 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -60.07 -42.26 94.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.654 1.115 . . . . 0.0 108.892 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.61 -56.34 14.53 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.281 0.632 . . . . 0.0 109.867 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.24 4.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.186 -1.341 . . . . 0.0 116.291 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.97 171.98 12.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.897 1.848 . . . . 0.0 112.382 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.21 -179.95 6.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.206 1.802 . . . . 0.0 108.267 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.2 t30 65.15 82.34 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.073 2.549 . . . . 0.0 112.353 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.41 162.08 13.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -140.91 170.73 15.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.223 1.809 . . . . 0.0 110.362 167.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -122.17 168.27 12.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.941 2.496 . . . . 0.0 107.582 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.21 171.0 14.67 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.616 1.166 . . . . 0.0 109.308 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.64 -35.64 65.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.938 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.26 178.38 0.71 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.473 1.909 . . . . 0.0 107.881 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.23 -43.37 4.59 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.31 1.91 . . . . 0.0 116.076 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.43 -47.29 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.865 1.833 . . . . 0.0 109.259 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -68.55 -37.23 79.77 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.1 -0.375 . . . . 0.0 110.85 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.9 -51.93 67.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.712 1.605 . . . . 0.0 109.818 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.62 -43.42 80.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.77 0.795 . . . . 0.0 110.54 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -71.74 -24.7 61.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -65.97 -42.07 90.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.376 166.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.03 -46.82 78.71 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.305 1.412 . . . . 0.0 108.249 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.37 10.81 0.9 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.733 1.213 . . . . 0.0 114.067 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.0 38.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.051 1.296 . . . . 0.0 110.988 160.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.49 -82.86 0.11 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.43 94.28 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.34 170.9 14.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.292 1.037 . . . . 0.0 110.484 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.09 -30.02 5.87 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.993 -0.893 . . . . 0.0 113.953 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 87.2 m-85 -146.55 148.58 32.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.258 1.023 . . . . 0.0 108.689 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.19 80.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -91.73 130.84 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 p -144.5 161.36 39.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.513 1.506 . . . . 0.0 114.957 -173.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -73.46 -158.25 0.06 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.258 1.023 . . . . 0.0 110.278 159.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -134.08 -30.27 1.21 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.329 2.252 . . . . 0.0 112.528 -167.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.43 32.02 6.36 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.889 2.076 . . . . 0.0 112.094 -158.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.439 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 2.4 mpt? -44.69 154.33 0.43 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 113.329 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.35 -25.74 35.81 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.127 2.551 . . . . 0.0 112.943 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -119.98 -99.57 0.44 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.2 ttt -78.35 106.17 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 161.03 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.469 1.108 . . . . 0.0 111.867 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.33 73.83 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 119.48 -0.622 . . . . 0.0 112.483 -166.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.28 -34.59 48.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.896 0.879 . . . . 0.0 109.942 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.36 -37.56 71.65 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 111.05 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.48 -50.71 72.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.757 0.708 . . . . 0.0 109.354 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tp -52.58 -61.09 2.5 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.041 0.936 . . . . 0.0 108.717 173.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.33 -26.13 67.6 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.879 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.8 m -66.82 -48.36 69.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.582 1.083 . . . . 0.0 110.864 170.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.89 -40.83 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 4.16 1.6 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.604 2.362 . . . . 0.0 113.572 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.4 57.32 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.238 1.381 . . . . 0.0 111.161 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 64.34 -176.35 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.952 2.501 . . . . 0.0 111.419 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.1 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.291 1.424 . . . . 0.0 113.796 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.41 -72.02 0.68 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.786 1.634 . . . . 0.0 109.149 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 mtt -89.68 -6.51 56.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.82 -54.1 0.46 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.485 2.714 . . . . 0.0 113.827 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -15.99 62.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.611 1.564 . . . . 0.0 114.383 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -68.2 121.71 81.31 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 119.148 0.886 . . . . 0.0 109.452 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.51 106.81 1.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.871 1.714 . . . . 0.0 108.739 166.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.05 134.09 28.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.4 tp -131.65 106.28 8.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.9 mtp -82.14 117.75 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.94 105.05 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -145.49 172.61 12.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.932 0.872 . . . . 0.0 111.007 -164.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -11.45 59.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.44 -0.788 . . . . 0.0 112.918 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -88.24 107.98 19.07 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.203 2.201 . . . . 0.0 112.356 -165.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.4 3.91 53.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.52 120.32 6.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.243 1.383 . . . . 0.0 109.922 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -55.64 -44.31 77.03 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.324 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -63.68 -33.43 75.62 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.927 1.239 . . . . 0.0 111.023 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.02 -47.07 84.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.287 0.949 . . . . 0.0 109.373 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.58 -45.18 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.17 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.75 -56.82 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.83 -46.55 60.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.768 1.227 . . . . 0.0 110.146 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.82 71.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.523 0.729 . . . . 0.0 112.029 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.52 97.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -61.85 -46.47 89.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.818 1.647 . . . . 0.0 111.408 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.02 -16.21 59.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.788 0.835 . . . . 0.0 112.458 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.65 33.57 18.68 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.446 1.021 . . . . 0.0 111.722 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 142.74 53.53 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.0 p -72.91 -14.13 61.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.515 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.21 169.58 38.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -136.78 144.61 43.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.927 1.291 . . . . 0.0 107.922 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.98 140.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.978 2.111 . . . . 0.0 105.712 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 t -123.24 144.64 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 149.4 21.17 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.053 169.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 140.67 67.19 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 109.691 -0.927 . . . . 0.0 109.691 -16.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -134.73 167.14 21.39 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.997 -1.064 . . . . 0.0 111.041 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 p -137.2 172.78 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.644 1.178 . . . . 0.0 110.991 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.83 -33.47 64.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.817 1.247 . . . . 0.0 109.511 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.03 -54.52 38.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.718 1.207 . . . . 0.0 111.246 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -31.82 58.3 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.564 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -56.49 19.53 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -66.5 -21.1 66.17 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.758 -0.588 . . . . 0.0 112.464 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -68.49 -47.98 65.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.244 0.929 . . . . 0.0 109.526 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -68.92 -38.36 79.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.651 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 mt -57.6 -54.51 46.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.254 0.934 . . . . 0.0 110.146 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -65.51 -30.2 70.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.754 0.706 . . . . 0.0 110.725 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -55.53 -58.24 8.58 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.933 165.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.82 -22.7 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 120.691 1.587 . . . . 0.0 113.619 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -57.83 -65.24 0.67 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -76.11 -30.6 58.3 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.18 -169.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -71.43 -68.17 0.47 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.319 1.048 . . . . 0.0 109.462 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.8 -31.59 45.99 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.354 1.062 . . . . 0.0 111.756 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.21 29.88 8.16 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.382 -1.232 . . . . 0.0 111.709 -165.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.7 mmt . . . . . 0 C--O 1.247 0.971 0 CA-C-N 119.868 1.834 . . . . 0.0 111.756 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.23 15.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.136 1.374 . . . . 0.0 108.497 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -108.28 168.3 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -20.34 66.02 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.852 -0.53 . . . . 0.0 111.682 165.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 37.92 47.48 0.9 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.167 2.587 . . . . 0.0 111.551 -169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.43 126.37 26.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 155.1 19.0 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 110.371 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -104.33 101.64 11.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 164.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.47 133.9 46.19 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 117.361 -1.736 . . . . 0.0 106.727 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.4 t -132.06 105.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.41 58.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.055 1.342 . . . . 0.0 107.782 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.55 157.21 17.76 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.883 -0.511 . . . . 0.0 110.445 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.13 -28.21 68.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.879 1.271 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -132.41 123.21 26.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.524 1.53 . . . . 0.0 107.488 -167.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -52.15 -52.77 49.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.715 0.689 . . . . 0.0 111.514 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.2 m -59.33 -29.8 67.91 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.546 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 ttt -61.94 -44.48 96.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.26 0.936 . . . . 0.0 109.957 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -39.88 94.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.329 0.968 . . . . 0.0 109.111 174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -44.82 93.0 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.44 -62.22 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.342 172.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.01 -49.23 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 121.423 1.92 . . . . 0.0 111.13 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -48.61 76.74 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.443 1.097 . . . . 0.0 110.379 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -56.22 -51.22 68.87 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.927 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.31 -36.31 79.74 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.496 1.518 . . . . 0.0 112.033 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.65 -52.4 60.91 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.712 -0.617 . . . . 0.0 109.659 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -64.74 -20.6 66.44 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.1 -52.32 56.19 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.261 1.424 . . . . 0.0 109.879 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.37 2.43 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -166.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.86 -84.66 1.08 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 124.542 1.068 . . . . 0.0 110.997 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -151.28 175.44 12.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.205 1.402 . . . . 0.0 109.559 -169.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -139.09 -179.15 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.376 1.07 . . . . 0.0 109.944 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 64.39 77.17 0.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.996 2.519 . . . . 0.0 110.335 -165.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.97 172.36 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.069 160.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.39 174.29 10.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.723 2.009 . . . . 0.0 106.192 158.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.7 164.66 23.49 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.39 170.72 13.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.166 1.786 . . . . 0.0 106.817 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.1 -37.75 84.45 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.948 0.794 . . . . 0.0 110.389 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -172.64 166.92 5.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.985 1.314 . . . . 0.0 108.578 -160.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' H ' ' HG3' ' A' ' 60' ' ' MET . . . -49.35 -40.86 31.15 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.9 1.714 . . . . 0.0 113.966 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.02 -52.99 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.82 0.848 . . . . 0.0 108.77 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.63 -23.91 56.41 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.349 1.46 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.97 51.42 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.71 -46.2 70.69 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.895 0.747 . . . . 0.0 111.045 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.82 -46.58 74.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.475 1.51 . . . . 0.0 111.764 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.63 -48.36 82.14 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.741 -1.123 . . . . 0.0 109.736 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 mt -53.83 -46.31 71.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.347 1.431 . . . . 0.0 110.81 -173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.91 7.55 2.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.39 -4.92 18.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.933 1.242 . . . . 0.0 113.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.88 32.06 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 120.418 1.463 . . . . 0.0 113.247 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.46 43.66 2.35 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.586 1.565 . . . . 0.0 113.614 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.08 82.0 2.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.47 -1.12 78.57 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.928 1.251 . . . . 0.0 113.065 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.77 134.87 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.68 96.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.76 134.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.12 168.96 18.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.036 0.922 . . . . 0.0 110.012 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -46.93 -176.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 130.986 3.714 . . . . 0.0 113.304 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -115.98 -42.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.39 158.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.63 47.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.217 1.007 . . . . 0.0 111.691 -159.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.527 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -61.07 138.69 94.3 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.862 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.12 26.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 125.265 3.976 . . . . 0.0 118.017 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.33 -71.89 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 122.058 2.208 . . . . 0.0 110.03 159.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.8 ttt -91.34 85.07 5.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.929 2.091 . . . . 0.0 107.164 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -47.07 153.55 0.43 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.006 1.322 . . . . 0.0 110.32 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.04 -27.53 62.53 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.429 -0.795 . . . . 0.0 112.167 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.81 -36.57 78.4 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.965 0.882 . . . . 0.0 110.29 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.18 -31.41 55.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.866 0.867 . . . . 0.0 110.795 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -57.86 -53.22 60.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.674 0.67 . . . . 0.0 109.272 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -56.47 15.05 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.289 1.036 . . . . 0.0 108.701 174.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -63.44 -30.92 71.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.726 1.148 . . . . 0.0 112.703 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -69.22 -42.22 76.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.103 0.961 . . . . 0.0 110.053 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.6 mt -61.57 -50.62 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -60.09 -24.68 64.81 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.377 1.871 . . . . 0.0 112.334 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.88 -3.38 3.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.52 1.128 . . . . 0.0 112.627 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 t0 89.54 30.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.547 1.539 . . . . 0.0 112.525 158.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.72 43.32 1.37 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.34 1.924 . . . . 0.0 112.741 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 75.33 8.22 3.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 130.044 3.338 . . . . 0.0 112.419 -170.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.9 mtt -119.29 2.9 11.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.715 1.206 . . . . 0.0 112.363 -163.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 -36.55 67.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.941 1.297 . . . . 0.0 112.616 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.99 60.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.336 0.971 . . . . 0.0 113.146 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 mt -57.95 135.01 83.68 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-N 119.693 1.133 . . . . 0.0 111.49 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.67 109.84 2.74 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.764 2.309 . . . . 0.0 107.589 161.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.68 113.57 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.103 1.761 . . . . 0.0 107.364 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.73 111.9 19.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.219 1.008 . . . . 0.0 108.836 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.03 132.03 34.38 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.43 127.54 59.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -161.55 169.61 21.42 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.59 -12.98 47.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.254 -0.904 . . . . 0.0 111.409 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.32 119.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.973 1.261 . . . . 0.0 111.796 -165.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.06 11.04 14.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.537 0.735 . . . . 0.0 112.018 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -52.21 117.97 3.18 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.302 1.841 . . . . 0.0 110.62 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -52.83 -47.73 67.5 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.807 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -46.7 -46.12 19.96 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.17 0.988 . . . . 0.0 111.56 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -65.36 -43.82 89.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.03 -48.57 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.08 -54.44 34.36 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.26 -48.41 45.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.357 1.463 . . . . 0.0 110.84 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.06 27.01 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.219 0.607 . . . . 0.0 109.701 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.75 66.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -73.39 -56.85 4.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.699 2.0 . . . . 0.0 109.641 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.41 -35.61 60.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.573 0.749 . . . . 0.0 110.18 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.6 27.85 3.69 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 125.166 1.365 . . . . 0.0 111.545 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.72 138.59 55.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.112 0.956 . . . . 0.0 110.322 -172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -72.89 -5.53 38.97 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.59 1.556 . . . . 0.0 112.003 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.32 165.46 34.79 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 158.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -137.79 110.78 7.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.66 104.35 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.442 1.897 . . . . 0.0 106.23 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.62 147.83 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -66.91 147.14 99.15 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 162.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.65 139.7 58.79 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.195 1.105 . . . . 0.0 110.498 -3.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.81 148.09 40.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -144.97 -176.25 5.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 109.811 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.43 -33.23 43.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.936 1.294 . . . . 0.0 110.166 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.54 76.23 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.69 0.796 . . . . 0.0 112.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.01 -27.98 19.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.949 . . . . 0.0 110.003 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.92 -53.39 58.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.365 1.066 . . . . 0.0 109.374 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -37.48 85.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.63 1.172 . . . . 0.0 111.462 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.42 -45.38 69.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.677 1.591 . . . . 0.0 108.896 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.63 87.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.392 -1.766 . . . . 0.0 111.245 170.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.23 -56.51 17.92 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.354 1.034 . . . . 0.0 109.281 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -59.54 -35.02 73.4 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.45 1.023 . . . . 0.0 111.109 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -54.93 -50.82 67.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.689 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.18 -24.42 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.704 1.138 . . . . 0.0 113.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -56.68 -55.56 32.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -74.83 -46.52 36.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -68.49 -70.41 0.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.02 -26.64 66.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.127 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.03 12.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -164.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.5 mmt . . . . . 0 C--O 1.252 1.228 0 CA-C-N 118.998 1.399 . . . . 0.0 109.09 176.258 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.43 179.83 6.86 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.997 1.719 . . . . 0.0 107.277 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -66.7 172.52 4.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 159.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.02 -12.74 20.39 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.551 -1.343 . . . . 0.0 111.495 159.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 27.8 mt-10 46.87 49.19 14.68 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.6 1.96 . . . . 0.0 109.151 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.98 106.37 0.22 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.806 0.842 . . . . 0.0 109.458 -169.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -89.38 117.65 28.47 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.728 -162.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.13 152.56 41.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.6 tp -123.29 134.8 54.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.73 119.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.678 1.191 . . . . 0.0 108.306 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.09 61.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.35 156.85 36.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -62.05 -44.4 96.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.654 1.181 . . . . 0.0 110.485 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -116.08 132.59 56.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 109.029 -159.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -51.28 -60.65 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.128 0.971 . . . . 0.0 111.97 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 m -51.22 -37.25 45.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.997 0.519 . . . . 0.0 110.936 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.59 -47.17 82.86 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.018 0.826 . . . . 0.0 111.045 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.3 ptt85 -72.92 -27.43 61.86 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 120.997 1.726 . . . . 0.0 111.545 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -62.59 -40.95 98.55 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.467 -0.771 . . . . 0.0 109.431 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.23 -63.43 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.49 -42.63 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.804 1.184 . . . . 0.0 110.671 -171.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -60.56 -49.21 78.44 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 117.709 -1.138 . . . . 0.0 111.07 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -50.86 -54.68 21.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.377 0.989 . . . . 0.0 109.66 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.82 -42.62 75.95 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.099 0.96 . . . . 0.0 111.535 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.86 -47.63 79.94 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.52 -19.29 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.441 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.76 -33.08 74.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.178 1.354 . . . . 0.0 110.156 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.05 -50.28 6.75 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.461 1.504 . . . . 0.0 108.738 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.94 -97.14 0.13 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 35.92 64.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 128.363 2.665 . . . . 0.0 112.316 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -68.41 1.48 2.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.83 100.47 4.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.894 1.679 . . . . 0.0 110.694 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.63 91.56 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 125.799 1.639 . . . . 0.0 107.64 -172.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 164.4 17.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.429 0.691 . . . . 0.0 109.56 169.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.82 166.31 22.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 158.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.54 178.58 4.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.368 1.067 . . . . 0.0 108.668 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.65 -43.1 23.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -167.24 164.03 15.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.264 1.826 . . . . 0.0 108.121 -161.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.88 -39.42 11.2 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.191 1.377 . . . . 0.0 114.034 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.018 0.909 . . . . 0.0 109.314 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.16 -26.15 66.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.171 0.589 . . . . 0.0 111.038 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.6 43.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.802 1.183 . . . . 0.0 108.433 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.89 -39.87 82.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.337 0.589 . . . . 0.0 111.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -56.1 -47.11 78.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.435 1.094 . . . . 0.0 110.353 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -59.38 -48.83 80.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.941 1.297 . . . . 0.0 109.911 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.91 -39.32 77.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.837 1.199 . . . . 0.0 109.755 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -76.25 10.07 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.15 -37.15 84.96 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.501 -1.375 . . . . 0.0 109.835 159.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.24 -19.68 0.73 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 118.112 -1.382 . . . . 0.0 116.136 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.01 86.42 0.06 OUTLIER Glycine 0 C--N 1.338 0.691 0 CA-C-N 120.389 2.095 . . . . 0.0 113.541 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.26 163.5 14.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.588 0.694 . . . . 0.0 109.925 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.42 -38.84 4.63 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.419 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -142.5 151.17 41.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.463 1.131 . . . . 0.0 109.113 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.27 79.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -97.31 120.62 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -169.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -151.65 156.54 40.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.114 1.324 . . . . 0.0 113.216 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.12 168.44 20.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.631 1.173 . . . . 0.0 110.051 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -82.28 -56.21 4.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.075 0.95 . . . . 0.0 113.409 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.19 67.23 4.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.699 0.799 . . . . 0.0 112.41 -158.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -66.89 147.63 99.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.712 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.45 -6.32 14.83 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 114.096 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -139.88 -89.95 0.18 Allowed 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.196 1.362 . . . . 0.0 111.746 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.7 ttm -82.0 95.85 7.54 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.77 155.66 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.89 -24.18 48.54 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.359 -0.838 . . . . 0.0 112.022 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.69 -35.45 57.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.609 1.204 . . . . 0.0 111.515 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.04 -40.24 75.26 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.098 0.959 . . . . 0.0 109.705 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.82 -54.08 48.93 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.211 1.404 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.07 -58.36 7.26 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.719 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HE2' ' HB1' ' A' ' 101' ' ' ALA . 26.7 mttm -60.9 -31.76 71.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.389 0.995 . . . . 0.0 111.844 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.5 m -65.28 -48.71 72.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.566 0.746 . . . . 0.0 110.608 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.0 mt -59.16 -45.03 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -7.08 13.16 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.896 1.678 . . . . 0.0 113.57 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.96 -16.78 46.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.741 1.155 . . . . 0.0 111.689 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.4 175.08 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.692 1.597 . . . . 0.0 111.635 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.47 -9.13 29.94 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 120.797 -1.19 . . . . 0.0 112.949 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.1 -28.01 0.33 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.7 mtt -145.25 6.31 1.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.194 0.998 . . . . 0.0 111.361 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.0 -57.13 3.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.09 2.556 . . . . 0.0 112.966 -159.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.83 -9.97 59.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.254 -1.355 . . . . 0.0 113.874 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.7 mt -56.8 117.78 19.38 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.181 1.355 . . . . 0.0 110.571 -172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.54 100.88 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.07 2.513 . . . . 0.0 109.098 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.01 130.86 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 166.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.5 tp -131.17 112.22 12.64 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.735 1.214 . . . . 0.0 108.444 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.6 mmm -83.01 96.88 8.48 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -100.34 107.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -154.41 167.27 30.56 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.161 -0.962 . . . . 0.0 111.153 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.75 47.43 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.543 -0.723 . . . . 0.0 111.872 165.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -76.05 94.4 3.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.866 1.266 . . . . 0.0 110.737 -164.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.54 14.93 3.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.978 1.311 . . . . 0.0 112.974 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 118.98 4.62 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.579 1.152 . . . . 0.0 108.19 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -57.26 -43.38 82.96 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.431 1.014 . . . . 0.0 110.02 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.71 -29.48 69.37 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.766 1.166 . . . . 0.0 112.11 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -67.7 -45.24 75.71 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.715 0.689 . . . . 0.0 109.719 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.62 -48.12 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.251 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.87 -55.17 19.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.82 69.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.227 1.011 . . . . 0.0 110.38 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.31 -53.42 58.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.712 0.805 . . . . 0.0 110.763 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.66 93.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.312 0.505 . . . . 0.0 110.484 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -59.89 -49.67 76.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.951 2.1 . . . . 0.0 111.272 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB1' ' HE2' ' A' ' 70' ' ' LYS . . . -61.6 -31.24 71.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.471 1.108 . . . . 0.0 111.56 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.03 16.01 7.53 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.699 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.81 136.8 58.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 119.712 1.756 . . . . 0.0 108.553 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -66.63 -19.57 65.8 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 123.313 0.383 . . . . 0.0 110.954 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.59 176.88 48.25 Favored Glycine 0 N--CA 1.439 -1.101 0 O-C-N 121.187 -0.946 . . . . 0.0 113.186 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.89 137.74 51.61 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.483 1.513 . . . . 0.0 107.34 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.0 85.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.513 2.325 . . . . 0.0 104.943 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -70.73 144.82 13.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 167.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 155.03 6.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.192 0.997 . . . . 0.0 110.506 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.01 145.44 83.93 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 N-CA-C 109.464 -1.014 . . . . 0.0 109.464 -10.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -132.24 150.79 52.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.346 1.058 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -147.28 169.46 19.35 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.182 2.193 . . . . 0.0 108.334 -164.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.19 74.12 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.76 17.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.016 1.326 . . . . 0.0 114.313 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.63 -25.49 8.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.757 1.162 . . . . 0.0 110.892 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -57.7 11.67 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 170.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -32.07 71.56 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.22 -49.25 67.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 109.425 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 3.8 mmpt? -68.53 -37.31 79.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 116.724 -1.607 . . . . 0.0 110.278 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.94 -57.36 12.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.307 0.958 . . . . 0.0 109.077 171.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -50.42 -45.27 55.64 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.058 0.943 . . . . 0.0 110.866 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 11.5 mtmm -59.43 -48.03 83.2 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.559 -1.21 . . . . 0.0 112.596 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 pt -75.05 -31.91 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.896 2.134 . . . . 0.0 113.283 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -55.4 -50.53 69.53 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.879 1.272 . . . . 0.0 108.82 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.04 -57.78 4.2 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.935 0.494 . . . . 0.0 109.916 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -58.65 3.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -159.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.43 -26.33 62.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.45 40.69 8.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -169.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 C--O 1.253 1.243 0 CA-C-N 118.897 1.349 . . . . 0.0 108.135 171.24 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tmm? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 122.369 1.081 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.07 165.41 35.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.986 2.514 . . . . 0.0 107.916 -171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -61.54 173.47 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.757 1.223 . . . . 0.0 109.491 170.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.11 -29.79 70.57 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 120.348 -1.47 . . . . 0.0 110.109 159.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 46.99 47.11 15.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.904 1.282 . . . . 0.0 110.642 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.22 109.43 0.43 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -75.0 135.09 41.32 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 53' ' ' PHE . 8.3 m-85 -92.78 149.44 21.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 166.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -121.78 138.29 54.43 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 166.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.26 108.09 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.51 57.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.37 162.69 5.87 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 159.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -47.83 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.376 -0.827 . . . . 0.0 110.167 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -64.17 -19.94 65.66 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -158.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 t 70.64 -47.27 0.64 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.926 2.491 . . . . 0.0 111.55 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.8 m -52.69 -36.95 58.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.467 -1.396 . . . . 0.0 109.29 160.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.2 ttp -67.92 -17.66 64.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.213 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.24 -48.03 81.75 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 120.663 1.574 . . . . 0.0 108.327 168.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -56.85 -52.88 63.38 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 107.893 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.36 -68.47 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 124.059 0.849 . . . . 0.0 108.811 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.49 -46.66 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.995 0.816 . . . . 0.0 110.746 -170.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -63.89 -35.52 80.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.156 0.889 . . . . 0.0 111.018 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -72.3 -32.98 67.04 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.52 1.055 . . . . 0.0 111.751 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.92 -36.8 80.78 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.978 -1.076 . . . . 0.0 109.868 172.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.54 -36.47 81.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.865 -0.522 . . . . 0.0 110.517 172.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -64.66 -34.49 78.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.728 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -56.66 -64.93 0.71 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.931 1.241 . . . . 0.0 110.925 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.67 28.53 1.05 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -165.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.03 -116.34 2.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.463 1.506 . . . . 0.0 110.226 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -141.54 176.4 8.92 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.461 1.105 . . . . 0.0 111.708 -159.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.42 -177.64 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.066 1.746 . . . . 0.0 110.391 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 60.05 74.29 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.118 2.167 . . . . 0.0 109.781 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.28 125.06 73.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 172.87 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.697 1.199 . . . . 0.0 107.952 165.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -134.43 173.91 11.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.729 1.212 . . . . 0.0 107.992 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.38 177.19 8.06 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.111 0.964 . . . . 0.0 109.601 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.04 -38.59 52.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.883 0.473 . . . . 0.0 111.461 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.05 162.88 1.67 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.784 2.033 . . . . 0.0 107.131 -158.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -47.89 -42.31 22.09 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.077 1.322 . . . . 0.0 114.663 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.8 -36.56 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.067 1.933 . . . . 0.0 109.533 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.5 t70 -78.95 -36.3 41.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.556 1.542 . . . . 0.0 110.261 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.62 -46.96 83.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.262 1.425 . . . . 0.0 109.081 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -52.62 -47.91 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.22 1.408 . . . . 0.0 110.383 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.2 -19.8 63.98 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.114 0.965 . . . . 0.0 112.926 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HE2' ' OD1' ' A' ' 41' ' ' ASP . 4.2 mptp? -69.25 -49.03 59.97 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.388 -1.445 . . . . 0.0 110.094 162.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 mt -54.71 -54.69 38.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.113 1.324 . . . . 0.0 109.581 -174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.51 -0.96 9.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.5 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.308 1.413 . . . . 0.0 110.52 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.39 -82.59 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.11 91.7 0.11 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -84.21 155.7 22.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.55 -66.99 0.5 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 7.2 m-85 -87.38 136.57 32.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.947 0.873 . . . . 0.0 108.821 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.75 113.84 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.4 125.78 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.3 p -156.57 168.71 26.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.376 0.989 . . . . 0.0 112.907 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.78 167.54 21.62 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.768 0.827 . . . . 0.0 110.362 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.407 ' CZ3' HD22 ' A' ' 66' ' ' LEU . 4.0 t-105 -78.93 -42.58 26.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 158.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -78.53 56.27 1.77 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.311 2.244 . . . . 0.0 112.327 -159.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.81 165.82 49.5 Favored Pre-proline 0 C--O 1.238 0.456 0 O-C-N 120.869 -1.144 . . . . 0.0 110.792 -177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.82 -39.52 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.45 2.1 . . . . 0.0 110.84 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.82 -69.07 0.87 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.839 1.2 . . . . 0.0 112.295 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.2 ttm -91.14 83.48 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.93 140.6 1.02 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.918 2.087 . . . . 0.0 108.671 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.5 -20.81 66.14 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.052 -1.03 . . . . 0.0 114.77 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD22 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.43 -38.38 74.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.104 0.952 . . . . 0.0 109.708 172.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.83 -41.14 83.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 109.911 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.88 -51.08 71.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.496 1.044 . . . . 0.0 110.045 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -53.23 -56.35 17.22 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.821 173.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.56 -24.86 65.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.812 1.642 . . . . 0.0 113.666 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 m -64.01 -52.16 60.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 mt -64.29 -28.66 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 12.39 19.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.433 1.893 . . . . 0.0 111.22 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.49 -16.48 60.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.512 1.505 . . . . 0.0 112.412 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.6 t0 68.59 163.15 0.22 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 129.842 3.257 . . . . 0.0 111.803 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.29 2.97 22.43 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.001 -1.444 . . . . 0.0 113.756 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -165.85 82.02 0.31 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.916 1.858 . . . . 0.0 106.741 167.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.2 mtt 103.81 17.31 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.743 2.417 . . . . 0.0 114.657 164.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -57.66 -18.27 19.51 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.435 -1.415 . . . . 0.0 113.743 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.89 4.34 50.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.0 113.386 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mt -73.27 127.9 88.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 120.334 -1.479 . . . . 0.0 108.988 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' C ' ' HG ' ' A' ' 104' ' ' SER . 41.8 Cg_endo -81.86 62.82 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.339 4.026 . . . . 0.0 111.716 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -55.84 112.08 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.349 1.86 . . . . 0.0 111.675 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 114.52 27.17 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 125.367 1.467 . . . . 0.0 109.201 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 mmt -76.17 131.03 39.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 105.14 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.246 1.819 . . . . 0.0 106.401 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 t -139.99 178.84 6.98 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.008 0.909 . . . . 0.0 110.696 -171.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.05 -26.2 19.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.124 0.97 . . . . 0.0 111.788 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -91.17 134.95 34.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.201 0.91 . . . . 0.0 111.646 -168.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 -95.8 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.408 -0.806 . . . . 0.0 108.915 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? 59.15 112.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.326 2.25 . . . . 0.0 111.789 -171.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -51.8 -47.42 64.28 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.76 -28.33 69.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.599 1.545 . . . . 0.0 113.423 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -65.02 -47.35 77.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.606 1.094 . . . . 0.0 108.927 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.2 -51.64 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.71 -58.01 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.027 0.931 . . . . 0.0 110.56 -172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.79 88.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.33 -39.28 92.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.591 0.632 . . . . 0.0 112.519 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -60.23 -54.75 42.04 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.929 1.691 . . . . 0.0 109.594 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.46 -12.18 29.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.035 1.334 . . . . 0.0 112.27 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.47 29.65 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 119.099 -0.834 . . . . 0.0 112.531 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.52 152.16 26.66 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.45 ' HG ' ' C ' ' A' ' 82' ' ' PRO . 65.9 m -55.52 -34.94 65.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.145 0.978 . . . . 0.0 112.23 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.25 179.78 44.15 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.11 92.29 3.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.474 1.51 . . . . 0.0 107.874 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -81.93 137.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.42 144.14 38.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 156.92 43.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.426 0.557 . . . . 0.0 110.801 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.72 137.17 46.21 Favored 'Cis proline' 0 N--CA 1.453 -0.891 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 -12.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -139.07 155.02 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.986 0.422 . . . . 0.0 110.194 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 p -151.72 -172.3 4.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.73 1.612 . . . . 0.0 111.022 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.2 18.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.558 1.143 . . . . 0.0 110.475 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.1 87.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.705 0.802 . . . . 0.0 112.889 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 -34.55 22.22 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.767 1.167 . . . . 0.0 109.269 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.95 -55.96 19.5 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -41.28 99.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.688 1.195 . . . . 0.0 112.518 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.41 -45.11 73.5 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.829 -0.545 . . . . 0.0 110.04 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.36 -38.38 89.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.0 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.29 -60.39 3.47 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.7 -34.83 73.4 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.393 0.542 . . . . 0.0 111.766 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -68.73 0.16 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.966 0.906 . . . . 0.0 109.349 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -24.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -57.56 -64.03 1.03 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.55 0.74 . . . . 0.0 109.219 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.83 -54.73 12.2 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -59.39 -52.6 64.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.537 0.735 . . . . 0.0 111.97 -164.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.74 -47.44 11.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.398 0.679 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.52 19.51 3.1 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.257 1.408 . . . . 0.0 112.704 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.1 mmm . . . . . 0 C--O 1.253 1.254 0 CA-C-N 120.152 1.976 . . . . 0.0 112.837 -172.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 -163.54 0.43 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.265 1.426 . . . . 0.0 108.623 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.91 175.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.348 -0.845 . . . . 0.0 109.293 166.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -63.35 -16.7 61.22 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.877 -1.139 . . . . 0.0 112.999 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 49.4 57.6 6.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.576 1.15 . . . . 0.0 110.107 -172.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.23 111.56 1.4 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -90.62 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -86.74 159.48 19.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -125.67 142.2 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.77 110.11 16.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.0 70.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 123.223 1.487 . . . . 0.0 107.346 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.54 173.23 10.67 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.34 1.856 . . . . 0.0 110.996 168.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.18 -18.38 24.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.361 2.264 . . . . 0.0 114.069 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.31 112.62 8.69 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.057 -1.652 . . . . 0.0 109.029 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.85 -46.31 1.96 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.272 1.396 . . . . 0.0 114.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.0 m -51.76 -45.81 63.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.607 1.094 . . . . 0.0 111.673 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.6 ttm -52.39 -41.16 62.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 109.359 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -71.2 -40.56 71.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.88 1.218 . . . . 0.0 111.479 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -54.7 -54.9 35.69 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.41 -65.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.926 1.291 . . . . 0.0 107.923 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.41 -45.41 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.603 1.547 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -64.75 -39.42 93.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.251 1.387 . . . . 0.0 110.698 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -58.56 -51.57 69.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.204 1.366 . . . . 0.0 110.601 171.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.39 -26.35 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.181 0.592 . . . . 0.0 111.994 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -77.91 -45.95 22.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.344 1.057 . . . . 0.0 110.426 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -73.55 -9.63 58.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.16 -36.91 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.397 0.999 . . . . 0.0 109.925 158.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.93 -4.37 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.868 1.667 . . . . 0.0 111.597 -165.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.53 -110.2 1.54 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.999 1.761 . . . . 0.0 108.888 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 40.51 49.86 2.72 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.898 2.479 . . . . 0.0 112.972 165.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -70.67 -4.96 26.13 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.777 0.831 . . . . 0.0 113.241 -160.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -131.09 77.01 1.76 Allowed 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.354 1.461 . . . . 0.0 107.81 -169.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.69 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 164.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.87 171.9 12.64 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.78 2.032 . . . . 0.0 108.04 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.66 148.25 42.15 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.735 1.214 . . . . 0.0 107.733 -164.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.82 167.78 17.6 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.127 0.571 . . . . 0.0 109.891 176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -74.3 -31.43 62.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.657 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.62 172.72 2.53 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.598 1.559 . . . . 0.0 107.873 -172.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.05 -39.63 26.77 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.796 1.188 . . . . 0.0 113.789 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.38 -45.27 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.6 -0.941 . . . . 0.0 109.892 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.02 -25.66 64.6 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.655 -0.653 . . . . 0.0 110.181 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -55.07 34.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.517 1.053 . . . . 0.0 108.51 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.97 -42.36 76.15 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.682 0.753 . . . . 0.0 110.751 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.94 -40.49 84.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.541 0.737 . . . . 0.0 112.023 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -62.15 -44.06 97.46 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.232 0.924 . . . . 0.0 109.285 173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.5 mt -58.0 -43.94 86.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.11 0.868 . . . . 0.0 110.71 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -69.84 -13.54 62.31 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.52 48.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.774 1.23 . . . . 0.0 112.906 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.93 34.87 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 119.706 1.139 . . . . 0.0 110.882 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.7 76.19 1.09 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -70.91 159.0 35.47 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.2 -1.66 3.92 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.784 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.55 136.96 17.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.141 1.47 . . . . 0.0 108.839 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.88 80.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.07 139.94 16.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.3 p -148.96 167.44 25.75 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.511 0.596 . . . . 0.0 111.935 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.9 t70 -78.98 -157.6 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 158.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.528 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 16.3 t-105 -122.59 -42.01 2.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.33 2.252 . . . . 0.0 110.293 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.63 43.74 1.0 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 112.203 -159.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -91.79 144.1 28.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 121.25 -0.906 . . . . 0.0 108.567 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.23 159.06 50.62 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.28 1.987 . . . . 0.0 111.379 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.82 -78.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 127.356 2.262 . . . . 0.0 111.862 -171.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.5 86.37 6.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -55.93 165.86 0.86 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 167.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.0 -30.32 53.86 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.809 -1.182 . . . . 0.0 112.416 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -29.09 41.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.669 1.235 . . . . 0.0 111.645 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.45 -44.52 57.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.86 -51.07 62.43 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.281 1.432 . . . . 0.0 109.178 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.12 -58.75 6.85 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.417 1.087 . . . . 0.0 110.216 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -66.63 -28.88 68.84 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.472 1.487 . . . . 0.0 111.939 -173.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.1 m -62.27 -55.41 28.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.467 1.03 . . . . 0.0 108.699 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.8 mt -50.66 -55.4 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.693 1.597 . . . . 0.0 108.564 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -30.72 65.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.264 1.426 . . . . 0.0 112.266 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.24 8.2 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.207 1.003 . . . . 0.0 111.745 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -175.16 -161.92 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.335 1.854 . . . . 0.0 109.347 165.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.3 33.41 4.56 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 123.87 0.748 . . . . 0.0 111.414 163.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 69.74 -37.33 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 129.38 3.072 . . . . 0.0 111.492 -160.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.48 -16.61 48.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.52 1.528 . . . . 0.0 112.281 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -34.12 1.96 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.117 2.167 . . . . 0.0 112.159 169.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.38 4.95 19.38 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.68 1.592 . . . . 0.0 113.705 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.13 125.63 90.5 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.89 124.64 11.66 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 108.697 -1.309 . . . . 0.0 108.697 170.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -104.79 142.1 18.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.9 tp -137.86 111.76 8.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -73.91 122.53 22.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.45 102.43 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -144.3 171.93 13.64 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.688 0.756 . . . . 0.0 112.565 -161.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.56 -24.36 39.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.312 1.045 . . . . 0.0 110.482 163.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.08 94.8 1.95 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.355 1.462 . . . . 0.0 110.514 -168.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 3.62 7.32 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.344 -0.848 . . . . 0.0 111.85 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -49.52 115.91 1.54 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 109.598 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -49.09 -53.07 22.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.418 0.687 . . . . 0.0 111.326 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.99 -25.8 67.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -72.78 -40.21 66.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.326 0.966 . . . . 0.0 109.658 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.58 -49.64 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.7 -57.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.21 76.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.816 0.735 . . . . 0.0 111.105 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.907 0.483 . . . . 0.0 110.149 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -27.48 67.27 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -68.93 -54.55 14.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.756 1.623 . . . . 0.0 109.404 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.83 80.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.881 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.24 35.08 2.78 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 124.691 1.138 . . . . 0.0 112.458 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.39 141.67 46.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -78.46 -4.84 50.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.978 0.174 . . . . 0.0 111.215 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.44 172.76 41.44 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 161.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -139.08 132.0 29.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.29 1.036 . . . . 0.0 108.519 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -132.97 130.67 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 127.065 2.146 . . . . 0.0 106.32 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.32 152.23 10.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -50.72 143.48 14.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.457 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.56 132.79 27.98 Favored 'Cis proline' 0 CA--C 1.534 0.484 0 CA-C-N 120.707 1.288 . . . . 0.0 111.012 -8.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -134.32 157.92 45.11 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.411 0.684 . . . . 0.0 111.243 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -155.51 171.91 19.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.516 1.927 . . . . 0.0 110.765 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.31 75.6 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.46 -50.5 31.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.937 1.295 . . . . 0.0 111.981 169.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.29 -35.3 48.13 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.808 -0.557 . . . . 0.0 109.749 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -57.65 11.01 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.257 1.023 . . . . 0.0 108.841 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.27 -29.69 70.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.042 0.937 . . . . 0.0 111.868 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.59 -45.45 65.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.564 0.346 . . . . 0.0 110.617 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.06 -35.33 80.81 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.954 -1.091 . . . . 0.0 110.306 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.3 mt -58.33 -56.71 18.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 109.729 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -50.71 -43.82 57.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.874 0.761 . . . . 0.0 110.916 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -51.68 -61.4 2.27 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.307 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 pt -70.96 -26.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.715 1.598 . . . . 0.0 114.531 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.67 -58.62 7.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.31 -41.74 66.25 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.876 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -67.73 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.554 1.542 . . . . 0.0 108.77 -173.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.9 -29.13 62.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.74 0.416 . . . . 0.0 110.374 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.84 26.13 25.36 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 117.737 -1.59 . . . . 0.0 110.361 -161.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--O 1.242 0.692 0 CA-C-N 120.174 1.987 . . . . 0.0 109.801 175.347 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.73 38.98 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 147.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -109.07 170.23 8.18 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 158.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -63.91 -19.22 64.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 45.88 37.24 3.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.275 1.83 . . . . 0.0 110.632 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.56 110.91 2.89 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.351 1.86 . . . . 0.0 108.878 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -91.11 138.5 31.55 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.087 0.555 . . . . 0.0 110.726 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.3 102.36 14.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.349 1.86 . . . . 0.0 107.747 165.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.89 136.75 54.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.3 106.16 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.03 89.26 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.24 158.81 16.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.65 0.738 . . . . 0.0 110.734 170.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.79 -4.34 58.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.384 1.074 . . . . 0.0 112.685 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 10.0 t80 -131.52 -3.92 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.844 1.258 . . . . 0.0 112.309 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 62.31 -60.18 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.214 2.205 . . . . 0.0 110.76 -159.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 68.8 m -62.63 -29.07 70.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 111.189 -171.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.02 64.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.648 1.567 . . . . 0.0 110.904 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.7 ttp85 -67.95 -43.86 78.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 121.288 1.858 . . . . 0.0 107.309 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.85 -45.63 67.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.239 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.08 -65.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.887 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.14 -47.53 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.204 1.365 . . . . 0.0 111.148 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -55.15 -49.5 71.65 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 109.755 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -60.17 -39.74 87.51 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.847 0.748 . . . . 0.0 110.744 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -66.45 -34.07 77.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.045 0.839 . . . . 0.0 110.989 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -67.27 -37.01 82.76 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.354 -0.841 . . . . 0.0 110.706 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -70.06 -29.2 66.15 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.538 -1.351 . . . . 0.0 111.084 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.34 -51.75 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.35 1.06 . . . . 0.0 110.582 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 47.37 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.613 0.721 . . . . 0.0 112.264 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.0 -111.72 0.83 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.6 158.27 44.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.178 0.989 . . . . 0.0 111.156 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -82.65 177.81 8.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.196 0.999 . . . . 0.0 109.357 159.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 60.78 79.25 0.25 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.745 2.018 . . . . 0.0 111.631 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -97.56 169.17 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.352 163.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -141.8 -179.6 6.29 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.97 1.708 . . . . 0.0 108.514 163.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -134.12 158.11 44.47 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.464 1.506 . . . . 0.0 107.775 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.59 159.14 40.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.598 1.559 . . . . 0.0 107.262 162.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.26 -24.13 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -171.5 168.68 6.37 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.468 1.507 . . . . 0.0 107.21 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.72 -37.89 21.57 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.291 0.948 . . . . 0.0 113.526 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.98 -51.22 47.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.261 1.024 . . . . 0.0 109.997 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -74.14 -28.23 61.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.143 1.377 . . . . 0.0 110.073 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -50.84 71.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.492 1.117 . . . . 0.0 108.942 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.18 -37.76 75.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.353 0.261 . . . . 0.0 110.492 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -67.77 -36.11 79.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.277 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 mmtt -63.45 -40.1 96.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.874 1.215 . . . . 0.0 109.605 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.55 -39.1 92.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.763 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -71.26 5.96 1.94 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.28 59.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.54 -1.35 . . . . 0.0 112.943 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -105.31 0.29 Allowed Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.379 0.991 . . . . 0.0 110.698 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.31 87.37 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.364 0.983 . . . . 0.0 110.98 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -67.69 164.82 18.47 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.365 1.066 . . . . 0.0 110.993 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.97 -43.71 3.76 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 119.044 -0.865 . . . . 0.0 111.221 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.05 145.59 44.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 117.894 0.847 . . . . 0.0 112.307 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -136.09 81.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.135 1.374 . . . . 0.0 107.894 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.88 127.1 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -136.81 144.39 43.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -171.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.15 166.66 19.44 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 158.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -71.92 -45.58 60.69 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.578 0.751 . . . . 0.0 109.317 162.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -73.97 98.75 3.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.054 0.942 . . . . 0.0 112.17 -160.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 mmt -131.4 155.51 81.38 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.96 -45.11 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.469 2.113 . . . . 0.0 111.273 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.65 -99.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.428 1.091 . . . . 0.0 108.657 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.9 ttm -79.18 96.12 5.8 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.4 166.75 4.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.057 0.943 . . . . 0.0 111.291 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.95 -24.28 71.5 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.259 -171.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -43.88 34.9 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.118 1.459 . . . . 0.0 107.758 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.43 -41.13 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.576 0.75 . . . . 0.0 110.977 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.55 -49.54 77.39 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.066 0.946 . . . . 0.0 109.638 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.58 -56.01 20.8 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.719 -1.134 . . . . 0.0 109.448 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 45.2 mttt -64.13 -37.97 89.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.677 1.581 . . . . 0.0 111.192 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.9 m -56.89 -49.17 76.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.451 0.569 . . . . 0.0 109.798 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -65.89 -42.82 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.41 0.684 . . . . 0.0 109.432 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.83 84.53 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 111.993 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.15 1.82 56.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.03 1.332 . . . . 0.0 111.479 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.64 155.79 39.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 162.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.89 -25.3 58.32 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.487 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.15 -47.44 2.94 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.975 1.31 . . . . 0.0 110.795 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 mtt -66.5 -14.21 61.95 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.9 p -57.99 -21.13 43.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.404 1.081 . . . . 0.0 112.825 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.29 -16.19 62.45 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.2 mt -64.86 149.01 96.97 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 119.892 1.223 . . . . 0.0 112.299 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.14 86.7 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.535 2.823 . . . . 0.0 108.777 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 m -77.25 99.51 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -107.97 110.6 22.37 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.382 1.073 . . . . 0.0 108.267 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -72.53 123.24 22.75 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.94 96.65 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.3 t -134.46 -170.31 2.51 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.243 1.017 . . . . 0.0 109.88 -169.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.12 -12.13 14.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.844 1.258 . . . . 0.0 112.348 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.81 105.47 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.438 1.017 . . . . 0.0 110.761 -172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.93 4.44 8.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.812 0.845 . . . . 0.0 113.271 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -53.64 115.28 1.89 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.959 1.704 . . . . 0.0 109.724 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -55.25 -45.03 76.07 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.011 0.924 . . . . 0.0 110.119 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -41.91 39.87 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.56 1.144 . . . . 0.0 112.392 172.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.28 -34.38 63.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.583 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.75 -48.93 85.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.248 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mt -57.25 -50.31 77.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 CA-C-N 120.952 1.705 . . . . 0.0 109.336 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.26 -46.29 72.61 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 119.158 0.89 . . . . 0.0 110.304 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.69 76.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 110.867 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.41 99.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.388 0.995 . . . . 0.0 111.803 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.23 -48.36 81.85 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.51 1.924 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.446 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -62.56 -38.49 90.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.04 0.936 . . . . 0.0 110.923 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 33.51 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.851 1.215 . . . . 0.0 112.343 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 145.39 44.35 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.11 1.455 . . . . 0.0 109.217 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -73.41 -16.09 61.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.302 0.641 . . . . 0.0 111.736 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.76 173.55 39.34 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.62 136.42 35.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.37 144.82 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.84 138.84 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -52.14 139.51 34.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 165.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.96 137.75 51.43 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 CA-C-N 119.963 1.022 . . . . 0.0 110.5 -8.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.07 150.92 46.3 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.481 0.712 . . . . 0.0 110.077 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -147.98 -173.3 4.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.298 0.639 . . . . 0.0 111.057 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.54 -35.41 29.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.479 1.112 . . . . 0.0 109.669 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.81 -19.46 28.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -114.46 -23.36 9.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.24 0.927 . . . . 0.0 112.039 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.09 -50.59 72.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -47.34 74.68 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.287 1.035 . . . . 0.0 111.244 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.25 -52.8 63.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 122.991 0.516 . . . . 0.0 109.851 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.99 -33.17 74.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.222 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.34 -58.02 10.32 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.715 1.143 . . . . 0.0 109.69 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -56.94 -40.01 75.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.867 0.758 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -55.31 -56.46 19.76 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.031 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 -26.11 18.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 120.39 1.45 . . . . 0.0 112.812 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -53.96 -53.53 51.54 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.084 0.856 . . . . 0.0 108.912 169.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.3 -43.83 26.95 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.552 0.341 . . . . 0.0 110.737 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -73.88 -62.01 1.65 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.074 0.549 . . . . 0.0 110.045 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mt -71.93 -43.22 65.62 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.972 0.509 . . . . 0.0 109.776 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.55 32.47 3.39 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.491 -163.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--O 1.253 1.282 0 CA-C-N 118.631 1.215 . . . . 0.0 111.239 172.293 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtp . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.62 163.13 24.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.432 0.693 . . . . 0.0 109.65 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 58.91 86.68 0.08 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 128.329 2.652 . . . . 0.0 108.532 -159.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -76.94 32.53 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.843 1.257 . . . . 0.0 111.937 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 42.86 59.01 3.0 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 128.604 2.762 . . . . 0.0 109.312 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.07 108.22 0.38 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.097 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 169.89 17.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 111.779 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -136.95 101.9 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.988 1.715 . . . . 0.0 108.258 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.9 tp -71.01 131.08 43.13 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.3 99.74 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.37 70.12 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.492 1.917 . . . . 0.0 108.576 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.44 151.67 41.04 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.948 -1.095 . . . . 0.0 108.102 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.5 -42.13 65.18 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.138 -0.976 . . . . 0.0 110.793 169.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -90.96 115.97 28.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.618 1.567 . . . . 0.0 107.02 -173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -57.75 -47.61 81.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.262 0.483 . . . . 0.0 110.078 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -53.57 -40.88 65.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.75 0.705 . . . . 0.0 111.177 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 ttt -58.3 -39.96 80.71 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.546 0.738 . . . . 0.0 110.143 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.446 ' HG2' ' HE ' ' A' ' 22' ' ' ARG . 14.1 ttp180 -62.13 -46.79 87.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.004 1.322 . . . . 0.0 109.797 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -55.81 -51.93 65.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.744 0.818 . . . . 0.0 108.887 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.51 -62.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.254 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -48.64 -44.23 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 120.828 1.649 . . . . 0.0 110.671 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HE ' ' HG2' ' A' ' 18' ' ' ARG . 59.5 mtt-85 -60.85 -45.44 94.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.669 1.122 . . . . 0.0 111.664 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -63.88 -42.5 97.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.758 0.708 . . . . 0.0 111.748 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.76 -32.41 73.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.922 0.889 . . . . 0.0 111.478 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.16 -56.76 11.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -64.79 -19.47 65.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -51.73 -33.44 34.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.898 1.226 . . . . 0.0 110.804 164.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.9 -41.4 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.975 2.11 . . . . 0.0 110.129 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.86 -139.27 6.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 64.86 60.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 123.173 1.464 . . . . 0.0 110.32 166.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.24 176.18 4.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.539 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 56.41 48.34 17.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 127.483 2.313 . . . . 0.0 113.477 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -55.51 161.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 121.13 -0.981 . . . . 0.0 111.369 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.04 157.5 44.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.279 1.832 . . . . 0.0 107.617 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.17 116.86 19.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.24 163.77 13.49 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 158.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.3 -37.04 58.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.006 0.821 . . . . 0.0 110.432 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.86 174.71 14.57 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.156 1.383 . . . . 0.0 109.237 -169.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.47 -35.31 71.78 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.5 t -66.38 -48.87 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 120.822 2.311 . . . . 0.0 107.152 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.73 -28.86 70.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.816 0.847 . . . . 0.0 111.287 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.68 -56.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.947 1.699 . . . . 0.0 109.43 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.73 -45.62 74.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.105 0.562 . . . . 0.0 109.77 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -65.75 -28.92 69.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.15 0.58 . . . . 0.0 112.161 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -62.93 -52.56 62.58 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.074 0.95 . . . . 0.0 108.804 166.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.1 mt -53.86 -41.45 67.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.704 1.138 . . . . 0.0 111.131 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -72.12 -7.09 47.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -17.6 58.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.463 1.029 . . . . 0.0 111.653 167.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.08 169.96 16.85 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.546 1.067 . . . . 0.0 111.548 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.22 108.2 2.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.244 0.926 . . . . 0.0 113.279 -171.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.49 163.4 27.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.444 1.098 . . . . 0.0 108.749 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.53 -45.06 19.35 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 166.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -135.91 150.59 49.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.599 0.76 . . . . 0.0 112.437 -166.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.63 70.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.082 1.353 . . . . 0.0 108.687 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.18 130.97 34.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.5 m -150.39 158.77 44.53 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.614 -0.679 . . . . 0.0 110.979 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.91 169.08 18.97 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.458 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -83.28 -48.92 9.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.719 1.608 . . . . 0.0 112.372 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.86 79.32 6.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.71 1.604 . . . . 0.0 109.582 -159.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.34 125.29 28.28 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.63 -40.57 29.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.125 2.55 . . . . 0.0 113.7 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -83.54 -101.91 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttp -79.78 106.97 12.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.79 160.61 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.19 -29.72 56.71 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.082 -1.011 . . . . 0.0 112.117 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.01 -43.01 83.97 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.764 0.782 . . . . 0.0 110.842 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.54 -37.55 71.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.611 0.765 . . . . 0.0 110.304 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.3 tp -53.06 -58.62 6.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.211 1.004 . . . . 0.0 108.701 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -48.09 -56.96 6.51 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.089 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -67.41 -24.68 65.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.035 1.289 . . . . 0.0 114.02 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -65.98 -48.27 71.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.257 6.3 mt -55.57 -57.83 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 167.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -23.86 67.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.163 1.385 . . . . 0.0 113.038 -165.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.25 -79.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.507 1.049 . . . . 0.0 110.264 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -168.79 8.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -161.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.73 23.73 1.03 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.99 1.281 . . . . 0.0 115.163 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 65.58 14.7 9.65 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 128.088 2.555 . . . . 0.0 112.251 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.0 mtm -126.71 3.52 6.74 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.9 1.68 . . . . 0.0 110.835 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.8 p -59.52 -25.03 64.14 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.092 0.957 . . . . 0.0 113.285 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -9.43 59.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 113.618 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.2 mt -56.59 144.22 65.15 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 119.199 0.909 . . . . 0.0 109.821 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.98 79.96 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.261 2.641 . . . . 0.0 109.042 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.91 110.37 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 128.627 2.771 . . . . 0.0 107.746 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.7 tp -135.94 113.21 10.6 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.263 -0.898 . . . . 0.0 111.935 -158.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -80.97 129.73 34.68 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.36 105.18 5.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -152.26 166.79 30.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.302 0.501 . . . . 0.0 110.831 -166.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.56 57.05 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.282 -0.886 . . . . 0.0 112.178 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -72.82 96.6 2.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.338 1.455 . . . . 0.0 110.084 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.59 -0.81 52.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.861 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -50.71 118.03 2.85 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.559 1.072 . . . . 0.0 109.812 -174.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -50.71 -52.98 35.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.103 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.24 -29.85 69.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.422 1.01 . . . . 0.0 112.625 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -72.13 -36.33 69.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.203 0.91 . . . . 0.0 110.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.3 -44.5 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.66 -48.92 84.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.25 -44.55 83.99 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.427 1.012 . . . . 0.0 110.152 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.95 88.18 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 119.225 0.921 . . . . 0.0 111.236 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.73 92.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.272 0.487 . . . . 0.0 109.874 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -62.15 -49.91 73.97 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.926 2.491 . . . . 0.0 111.283 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.39 -22.1 62.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.608 1.163 . . . . 0.0 111.89 174.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.22 6.11 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.7 1.143 . . . . 0.0 110.327 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.52 142.46 58.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.6 p -66.4 -24.36 66.46 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.105 0.562 . . . . 0.0 111.093 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 169.45 38.3 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.92 126.18 28.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.224 1.41 . . . . 0.0 108.563 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -121.08 107.31 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.04 153.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 166.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.43 150.37 34.1 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.548 1.539 . . . . 0.0 109.105 160.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.51 147.75 79.22 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 CA-C-N 121.105 1.43 . . . . 0.0 109.903 -12.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -146.92 138.41 24.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -140.94 -174.75 4.08 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.559 1.544 . . . . 0.0 109.613 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.19 -25.64 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.304 -0.872 . . . . 0.0 110.153 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.12 53.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.202 1.001 . . . . 0.0 112.723 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.6 t -98.6 -27.0 14.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.839 0.745 . . . . 0.0 110.754 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.72 86.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.302 0.956 . . . . 0.0 108.797 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -38.53 91.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.717 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.62 -54.1 22.52 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.747 0.703 . . . . 0.0 110.355 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -38.08 77.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.829 1.195 . . . . 0.0 111.042 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.98 -54.67 44.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.01 0.823 . . . . 0.0 110.629 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.82 -39.64 68.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.85 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -64.99 -45.49 85.4 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.332 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -19.63 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 121.041 1.746 . . . . 0.0 113.414 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -56.54 -62.9 1.41 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 159.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -72.54 -30.37 64.4 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.259 -0.9 . . . . 0.0 112.609 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -68.66 0.65 Allowed 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.95 -23.57 61.47 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 122.954 0.159 . . . . 0.0 110.89 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.53 23.26 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.532 -1.704 . . . . 0.0 110.056 -165.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-N 119.866 1.833 . . . . 0.0 110.476 172.356 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.078 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.73 36.65 0.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 121.533 1.969 . . . . 0.0 110.629 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.58 161.86 33.92 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.29 -159.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -91.36 -1.7 57.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.276 0.63 . . . . 0.0 110.683 159.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 51.97 33.98 12.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.209 1.404 . . . . 0.0 111.325 -161.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.93 123.07 11.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.153 1.781 . . . . 0.0 110.415 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.271 2.4 ptpt -91.86 164.01 13.83 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.31 108.53 12.31 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.371 1.468 . . . . 0.0 108.77 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -82.43 139.33 34.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.79 1.632 . . . . 0.0 109.963 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -135.72 112.45 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.361 1.465 . . . . 0.0 108.448 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.27 41.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.081 1.352 . . . . 0.0 110.324 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.32 154.67 7.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.955 -1.09 . . . . 0.0 108.959 164.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.08 -45.31 11.52 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.22 -1.55 . . . . 0.0 110.744 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -70.6 115.22 9.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.645 1.978 . . . . 0.0 107.636 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -59.64 -39.53 84.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.192 1.36 . . . . 0.0 111.884 -172.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.4 m -55.13 -32.41 62.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.74 0.7 . . . . 0.0 111.45 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 tpp -60.5 -42.46 96.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.231 -0.918 . . . . 0.0 109.947 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -66.18 -34.44 78.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.719 1.145 . . . . 0.0 111.124 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -59.79 -58.77 7.12 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.74 -63.26 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 C-N-CA 125.978 1.711 . . . . 0.0 109.05 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.78 -46.04 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 121.071 1.759 . . . . 0.0 111.267 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -65.51 -41.24 93.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 120.179 1.354 . . . . 0.0 111.518 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -58.15 -54.57 45.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.421 1.088 . . . . 0.0 109.437 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -52.26 -48.53 65.18 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.861 2.064 . . . . 0.0 110.829 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.03 -44.15 82.6 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.318 0.647 . . . . 0.0 110.811 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -77.62 -17.24 57.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.51 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.81 -43.89 94.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.34 1.427 . . . . 0.0 109.287 166.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.07 -37.24 78.39 Favored 'General case' 0 N--CA 1.46 0.038 0 O-C-N 122.179 -0.325 . . . . 0.0 110.596 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.98 6.1 10.32 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.92 1.248 . . . . 0.0 113.885 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.24 155.82 39.77 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.7 1.75 . . . . 0.0 108.942 163.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -149.88 -167.53 2.85 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.322 1.049 . . . . 0.0 108.394 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 55.15 37.93 29.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.108 1.363 . . . . 0.0 111.16 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.29 158.11 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -140.76 166.68 24.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.624 2.37 . . . . 0.0 107.478 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -128.78 155.11 45.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.91 167.75 10.38 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 161.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -42.97 89.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.68 0.792 . . . . 0.0 111.435 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.3 173.87 5.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.038 1.335 . . . . 0.0 108.835 -169.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.33 -42.01 72.98 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 119.923 1.238 . . . . 0.0 113.389 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.11 -51.42 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.86 1.264 . . . . 0.0 109.659 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -70.33 -35.65 73.75 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.754 0.821 . . . . 0.0 111.076 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.31 65.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.568 1.147 . . . . 0.0 109.409 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -54.61 -48.92 71.59 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.721 0.638 . . . . 0.0 111.6 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -66.3 -28.5 68.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -64.19 -46.56 83.39 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.372 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.55 -41.69 81.51 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 110.665 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 3.06 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 158.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.82 164.32 11.22 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.969 1.271 . . . . 0.0 111.395 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.17 14.53 78.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.035 0.826 . . . . 0.0 113.167 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -81.46 117.32 21.79 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.44 -25.11 26.78 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.225 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -148.94 149.7 31.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.17 0.988 . . . . 0.0 110.803 -169.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.99 85.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.27 127.22 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -152.03 163.64 38.89 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.082 -1.011 . . . . 0.0 110.308 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.35 173.58 5.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.795 0.807 . . . . 0.0 110.278 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 -71.58 -60.69 2.1 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.664 158.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.258 23.7 p30 29.21 -157.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 130.392 3.477 . . . . 0.0 116.215 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 65.15 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.034 1.334 . . . . 0.0 112.504 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 58.3 Cg_endo -65.36 -66.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 121.796 1.664 . . . . 0.0 108.78 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.474 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 5.7 m120 -155.61 -69.69 0.12 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.661 2.385 . . . . 0.0 104.953 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.0 ttm -70.01 88.36 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 160.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -65.61 172.01 3.72 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.793 0.837 . . . . 0.0 110.428 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.53 -32.75 53.43 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.988 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -49.87 44.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.537 1.169 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.61 -38.06 89.67 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.472 0.709 . . . . 0.0 110.874 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.0 tp -55.94 -61.31 2.46 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.115 1.366 . . . . 0.0 108.722 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -46.42 -53.52 10.91 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.843 1.257 . . . . 0.0 109.511 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 101' ' ' ALA . 66.6 mttt -66.62 -26.25 66.99 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.126 0.875 . . . . 0.0 113.12 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.2 m -72.87 -43.36 62.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.361 1.064 . . . . 0.0 109.612 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.37 -45.79 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.969 1.308 . . . . 0.0 113.593 166.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -49.3 77.16 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.311 1.044 . . . . 0.0 109.529 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.3 1.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.088 0.955 . . . . 0.0 113.303 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -81.84 -165.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.474 1.033 . . . . 0.0 109.287 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.6 -41.84 0.08 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.989 1.757 . . . . 0.0 110.865 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.88 -8.74 59.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.836 1.255 . . . . 0.0 112.642 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mtm -126.33 -8.39 6.39 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 p -65.34 -17.29 64.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.492 1.042 . . . . 0.0 113.167 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.7 59.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.526 1.13 . . . . 0.0 113.471 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.01 133.24 92.48 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.314 0.961 . . . . 0.0 110.271 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.01 125.3 12.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.011 1.807 . . . . 0.0 108.682 166.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.07 107.71 22.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.205 2.202 . . . . 0.0 106.804 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 tp -125.12 115.2 20.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.341 1.057 . . . . 0.0 109.712 -164.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.38 122.35 26.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.92 113.59 24.87 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -156.0 168.9 25.8 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.259 -0.9 . . . . 0.0 110.626 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.32 -21.23 46.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.379 -0.825 . . . . 0.0 111.684 163.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.53 107.35 19.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.231 1.012 . . . . 0.0 111.227 -167.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -73.56 0.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.989 171.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.1 tttt 32.73 98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.828 2.451 . . . . 0.0 113.381 -167.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -52.45 -41.51 63.36 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.287 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.73 -36.27 69.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.151 1.342 . . . . 0.0 112.752 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.81 -36.41 70.24 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 121.536 -0.727 . . . . 0.0 110.085 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.1 mt -63.46 -39.17 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.642 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.3 -53.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.51 -46.45 70.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.987 0.812 . . . . 0.0 110.654 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.47 73.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.916 0.886 . . . . 0.0 110.741 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.88 99.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.43 0.692 . . . . 0.0 110.147 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -60.84 -50.89 71.63 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.312 1.845 . . . . 0.0 111.17 175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . . . -59.62 -22.65 62.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.918 0.887 . . . . 0.0 112.267 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.78 11.73 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.544 -1.142 . . . . 0.0 112.281 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 134.96 57.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.415 1.107 . . . . 0.0 108.805 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 m -67.64 -10.08 49.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.201 1.001 . . . . 0.0 112.255 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.06 170.54 38.2 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.332 0.969 . . . . 0.0 111.345 166.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.14 132.32 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.276 1.43 . . . . 0.0 107.681 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.39 104.79 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 156.68 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -58.21 151.08 49.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 158.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.27 148.36 91.04 Favored 'Cis proline' 0 N--CA 1.457 -0.632 0 CA-C-N 119.653 0.912 . . . . 0.0 110.633 -9.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -149.44 154.47 38.89 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.322 0.649 . . . . 0.0 110.088 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 p -143.81 -175.19 4.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.363 1.065 . . . . 0.0 109.46 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -29.62 60.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.599 0.76 . . . . 0.0 110.3 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.77 67.98 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 t -99.57 -27.61 13.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.85 1.204 . . . . 0.0 110.224 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -50.63 70.21 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -37.21 84.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.863 1.265 . . . . 0.0 112.249 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.98 -57.19 13.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.865 1.266 . . . . 0.0 109.14 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -66.01 -34.16 77.45 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.489 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 mt -59.54 -55.1 38.85 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.187 175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 124' ' ' PHE . 18.7 t-20 -64.37 -30.56 71.6 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 118.283 0.492 . . . . 0.0 110.412 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -60.2 3.51 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.029 167.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.4 pt -71.15 -26.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.426 1.466 . . . . 0.0 113.86 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 121' ' ' ASN . 21.6 m-30 -59.47 -39.07 82.5 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.092 0.86 . . . . 0.0 109.918 170.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.58 -40.22 17.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.008 0.523 . . . . 0.0 110.71 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -77.14 -71.7 0.39 Allowed 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.564 1.145 . . . . 0.0 108.125 -168.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.3 mt -68.28 -20.41 64.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.269 0.486 . . . . 0.0 111.105 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 38.47 30.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -167.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.7 mmm . . . . . 0 C--O 1.25 1.093 0 CA-C-N 117.882 0.841 . . . . 0.0 109.377 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.62 -157.82 0.71 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.586 1.554 . . . . 0.0 108.676 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -84.53 -178.22 6.83 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.381 1.072 . . . . 0.0 108.747 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -14.85 61.77 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.909 158.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 50.01 61.19 3.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.676 1.991 . . . . 0.0 107.546 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt -49.12 104.14 0.06 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.145 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 177.14 6.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.987 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.76 124.39 43.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.168 2.187 . . . . 0.0 106.091 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.13 134.52 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 158.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.66 92.54 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.84 51.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.24 105.24 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -47.99 -43.12 29.42 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.784 1.634 . . . . 0.0 112.103 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.75 116.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.304 1.041 . . . . 0.0 108.521 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -52.35 -51.45 58.76 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.164 0.986 . . . . 0.0 110.77 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -52.17 -39.35 59.95 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.417 -0.802 . . . . 0.0 111.346 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 ttp -61.43 -42.06 98.16 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.11 98.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.854 1.207 . . . . 0.0 109.944 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -57.46 -57.44 12.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -49.07 -60.81 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.772 1.629 . . . . 0.0 108.866 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.38 -51.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 120.388 1.449 . . . . 0.0 111.055 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -41.17 91.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.07 0.85 . . . . 0.0 111.052 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.27 -53.94 47.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.91 -34.28 69.67 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.586 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -60.09 -62.71 1.67 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.873 0.869 . . . . 0.0 109.314 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -65.24 -14.33 60.43 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.08 -7.98 34.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.425 1.49 . . . . 0.0 113.152 166.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.5 mt -126.01 7.79 7.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.485 3.114 . . . . 0.0 112.086 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 -144.13 22.67 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.33 40.39 18.28 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.189 1.495 . . . . 0.0 113.3 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.08 171.08 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.498 -0.751 . . . . 0.0 110.936 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 98.57 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.29 3.036 . . . . 0.0 107.139 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.754 -0.591 . . . . 0.0 110.156 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -132.14 175.43 9.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.81 2.044 . . . . 0.0 107.615 167.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -127.3 166.33 18.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.54 1.536 . . . . 0.0 107.379 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.68 168.36 9.84 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 159.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.75 -26.33 62.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.731 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.32 174.76 0.45 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.031 1.732 . . . . 0.0 107.674 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.25 -39.41 42.83 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.005 1.288 . . . . 0.0 115.428 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.57 -43.95 92.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.048 1.424 . . . . 0.0 109.918 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.07 -28.05 60.2 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.561 1.144 . . . . 0.0 110.652 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.25 89.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.009 0.924 . . . . 0.0 110.102 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.11 -45.16 95.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.768 -0.635 . . . . 0.0 109.324 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -57.75 -44.55 86.16 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.646 0.657 . . . . 0.0 111.661 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -53.51 -50.87 64.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.751 0.82 . . . . 0.0 109.778 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -35.62 80.28 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.209 0.604 . . . . 0.0 112.017 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.02 -1.34 7.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.816 0.846 . . . . 0.0 112.19 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.6 12.93 7.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.572 1.949 . . . . 0.0 112.495 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.33 163.97 23.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.214 1.37 . . . . 0.0 113.857 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.97 78.96 1.85 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -70.76 119.62 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.61 -19.89 79.73 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.523 -168.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -132.09 150.46 52.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 127.046 2.138 . . . . 0.0 106.416 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 t -137.56 72.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -77.33 143.73 12.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 p -149.71 163.13 38.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.659 0.663 . . . . 0.0 111.011 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 24.6 t70 -69.45 179.97 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.419 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 29.0 t-105 -71.04 -78.13 0.08 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 162.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.2 t30 43.1 178.16 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.956 2.902 . . . . 0.0 112.606 -164.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.2 mtm -140.33 68.26 32.63 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 119.053 -2.28 . . . . 0.0 110.553 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.49 49.0 2.32 Favored 'Trans proline' 0 CA--C 1.543 0.964 1 C-N-CA 125.467 4.111 . . . . 0.0 110.791 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.88 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.439 1.495 . . . . 0.0 108.709 -159.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.2 ttm -79.52 81.73 5.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.16 159.78 2.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.543 1.137 . . . . 0.0 110.675 167.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.96 59.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.369 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.39 -46.86 37.61 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.584 1.154 . . . . 0.0 109.313 174.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.27 -38.3 90.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.559 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.02 -53.81 54.07 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.301 0.955 . . . . 0.0 109.21 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.85 -56.1 9.72 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -66.17 -28.69 68.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 120.384 1.447 . . . . 0.0 114.078 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.5 m -71.98 -33.75 68.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.262 0.937 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 74' ' ' ALA . 17.4 mt -73.36 -48.37 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.962 173.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.66 24.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.508 3.123 . . . . 0.0 111.475 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 72' ' ' ILE . . . -66.8 -72.42 0.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 108.146 172.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 157.21 -11.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 129.398 3.079 . . . . 0.0 112.455 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 20.43 0.18 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 126.946 2.212 . . . . 0.0 116.569 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 92.86 -12.31 0.17 Allowed 'General case' 0 N--CA 1.461 0.099 1 C-N-CA 133.37 4.668 . . . . 0.0 110.961 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.1 mtt -76.48 -18.87 58.54 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.649 -0.657 . . . . 0.0 110.815 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -61.53 -25.08 67.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.424 1.089 . . . . 0.0 113.341 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -16.5 61.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.5 141.7 91.55 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 118.472 0.578 . . . . 0.0 111.465 -169.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 72.69 5.78 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.707 2.271 . . . . 0.0 108.423 166.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.53 137.77 22.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 160.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' CD1' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp -147.97 111.6 5.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -160.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.93 123.14 24.55 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.7 102.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -142.35 174.74 10.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.179 0.99 . . . . 0.0 110.281 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.78 -23.5 19.7 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.814 0.846 . . . . 0.0 111.617 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -86.5 111.32 20.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.756 0.707 . . . . 0.0 109.141 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.96 -73.52 0.07 Allowed 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 166.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 tptp 43.78 91.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.538 1.637 . . . . 0.0 112.432 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -52.16 -34.65 45.89 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.2 -0.938 . . . . 0.0 112.889 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.34 -36.03 80.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.293 1.406 . . . . 0.0 111.692 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -63.31 -38.91 93.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.236 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.54 -49.99 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.565 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.46 -55.53 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 119.542 1.065 . . . . 0.0 108.341 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.12 79.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.924 0.489 . . . . 0.0 110.769 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.16 90.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.919 -0.488 . . . . 0.0 110.543 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.45 77.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -61.4 -49.99 74.65 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.718 1.607 . . . . 0.0 109.672 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -28.19 69.07 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.927 0.491 . . . . 0.0 111.233 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.5 42.03 6.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 124.74 1.162 . . . . 0.0 111.338 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.18 156.87 11.44 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 72.8 p -64.93 -22.77 67.05 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.301 -0.874 . . . . 0.0 111.948 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.12 -175.95 37.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.69 1.614 . . . . 0.0 109.426 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -136.74 91.03 2.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.673 1.189 . . . . 0.0 108.046 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -75.3 125.97 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.88 144.15 16.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -75.8 162.34 72.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -64.12 145.75 60.93 Favored 'Cis proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.714 0.934 . . . . 0.0 109.782 -12.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -139.2 162.16 35.66 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.086 0.955 . . . . 0.0 109.235 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -142.88 171.98 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.354 1.061 . . . . 0.0 110.109 -164.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.83 69.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.642 0.777 . . . . 0.0 112.401 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t -81.76 -33.27 31.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.981 1.264 . . . . 0.0 110.119 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -50.99 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.552 1.069 . . . . 0.0 109.017 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -41.57 92.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.125 1.77 . . . . 0.0 111.073 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.95 -42.44 98.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.303 1.041 . . . . 0.0 109.156 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HE3' ' CD1' ' A' ' 84' ' ' LEU . 3.2 mmmp? -68.95 -29.72 68.02 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.712 -1.613 . . . . 0.0 112.384 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -54.48 24.41 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -55.32 -42.92 74.41 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 118.225 0.466 . . . . 0.0 111.258 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -51.23 -60.04 3.55 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.39 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.4 pt -67.57 -32.66 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 121.343 1.883 . . . . 0.0 113.757 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -58.63 -45.09 90.01 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.701 0.682 . . . . 0.0 109.632 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.47 -34.17 15.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -76.1 -72.43 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -37.0 79.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.266 0.627 . . . . 0.0 109.333 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.01 41.58 4.58 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -164.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.246 0.9 0 CA-C-N 118.501 1.151 . . . . 0.0 110.883 175.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.44 111.33 22.09 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.563 1.545 . . . . 0.0 109.367 -166.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -72.14 -9.29 58.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.25 0.62 . . . . 0.0 112.482 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.19 6.59 0.72 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.091 2.156 . . . . 0.0 114.468 -164.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -71.22 -21.96 62.07 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.641 1.11 . . . . 0.0 112.904 168.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.13 123.27 10.19 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.595 1.158 . . . . 0.0 107.938 -174.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.93 161.71 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.574 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.8 95.28 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -69.31 138.91 54.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.0 1.273 . . . . 0.0 109.492 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -131.67 115.5 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.69 76.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.23 159.84 18.68 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.853 0.835 . . . . 0.0 111.342 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.55 97.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.199 1.4 . . . . 0.0 111.212 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CD2' ' HB ' ' A' ' 16' ' ' THR . 1.2 t80 -90.0 -63.85 1.22 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.683 0.393 . . . . 0.0 110.528 -159.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 m 127.28 -59.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 1 C-N-CA 133.273 4.629 . . . . 0.0 106.875 -161.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 91.8 m -65.59 -33.75 76.63 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.771 -174.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -61.5 -27.25 68.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.23 1.377 . . . . 0.0 110.207 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -63.47 -47.73 80.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.477 1.035 . . . . 0.0 109.589 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -48.43 80.94 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.762 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.36 -47.01 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.0 1.32 . . . . 0.0 111.228 -172.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -54.03 -50.75 65.98 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.35 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.28 -43.44 91.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.235 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 mt -55.12 -43.14 73.83 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.244 0.929 . . . . 0.0 109.848 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.7 -48.81 70.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.548 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -64.85 -33.63 76.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.118 -0.944 . . . . 0.0 112.473 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -58.41 -30.76 67.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.491 1.041 . . . . 0.0 110.908 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.96 12.25 37.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.24 1.816 . . . . 0.0 111.699 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -33.67 5.04 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.641 1.591 . . . . 0.0 113.317 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -61.38 140.01 58.09 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.929 1.365 . . . . 0.0 110.633 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 177.47 7.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.075 0.94 . . . . 0.0 111.403 -168.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.251 21.4 t30 67.96 34.0 4.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.77 2.828 . . . . 0.0 113.503 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 154.97 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.474 0.654 . . . . 0.0 109.723 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.33 179.41 6.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.454 2.701 . . . . 0.0 108.019 -163.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.88 152.27 39.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.848 -0.532 . . . . 0.0 111.614 -164.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.21 172.5 12.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.793 1.237 . . . . 0.0 108.93 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -68.46 -47.69 66.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.746 0.818 . . . . 0.0 112.726 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.84 168.01 10.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.85 2.06 . . . . 0.0 107.335 -158.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.6 -38.02 27.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.723 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.0 t -63.41 -51.01 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.706 2.253 . . . . 0.0 107.555 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.97 -28.69 69.99 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 0.0 110.829 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.57 -42.9 73.92 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.947 1.699 . . . . 0.0 111.37 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -65.62 -43.54 89.26 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -56.52 -39.71 73.8 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.155 0.982 . . . . 0.0 111.058 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.31 -61.46 2.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.365 0.984 . . . . 0.0 109.252 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.46 HD12 ' H ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -51.37 -49.8 60.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -168.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.72 -2.87 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.4 -11.5 59.25 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.822 1.192 . . . . 0.0 112.969 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.71 5.82 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 119.199 2.44 . . . . 0.0 119.199 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.42 73.71 0.64 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 120.603 2.202 . . . . 0.0 110.377 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.46 ' H ' HD12 ' A' ' 46' ' ' LEU . 1.2 m-85 -66.17 109.21 2.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -10.75 24.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.338 -0.701 . . . . 0.0 114.398 -166.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.4 144.68 42.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.143 1.377 . . . . 0.0 109.159 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.13 91.24 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -108.49 125.69 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -143.03 168.05 20.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.852 0.834 . . . . 0.0 110.896 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.83 170.18 10.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 158.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -84.91 -51.68 6.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.455 1.502 . . . . 0.0 108.307 162.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -87.24 72.49 9.88 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.61 1.564 . . . . 0.0 110.192 -159.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 tpt -124.77 125.51 25.45 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 -0.31 9.73 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.748 2.299 . . . . 0.0 115.067 -161.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -107.25 -96.24 0.37 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.3 ttm -91.07 89.9 7.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.28 155.11 5.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.089 172.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.78 -31.79 58.34 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.03 -0.872 . . . . 0.0 112.203 -172.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -36.5 72.4 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.871 1.335 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -68.09 -41.5 81.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.011 175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.63 -49.11 79.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.784 0.72 . . . . 0.0 109.575 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.59 -63.11 1.23 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.836 1.254 . . . . 0.0 108.106 172.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -63.22 -27.48 69.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.94 1.246 . . . . 0.0 113.398 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.1 m -61.74 -53.87 50.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.394 0.997 . . . . 0.0 108.884 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -62.51 -46.05 97.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.671 1.188 . . . . 0.0 110.21 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.58 7.91 0.56 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.698 1.999 . . . . 0.0 113.215 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.54 65.09 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 120.961 1.709 . . . . 0.0 111.862 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 130.35 -79.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.21 3.404 . . . . 0.0 107.998 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.95 39.85 2.06 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 126.502 2.001 . . . . 0.0 112.098 -170.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.89 -76.86 0.3 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.983 1.313 . . . . 0.0 108.055 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 mtm -142.6 15.03 1.97 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -55.06 -23.99 22.96 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 121.743 2.065 . . . . 0.0 114.451 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -9.57 53.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.596 1.089 . . . . 0.0 113.255 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.02 128.93 77.36 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 121.129 -0.982 . . . . 0.0 110.606 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 91.02 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.387 2.058 . . . . 0.0 109.749 170.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -75.76 107.85 7.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 tp -112.6 113.97 26.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.269 1.427 . . . . 0.0 108.562 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.9 mmt -85.67 125.93 33.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.03 88.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -122.62 174.21 7.22 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 113.657 -161.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.58 -21.69 26.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 111.662 164.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -86.18 106.74 17.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.781 1.232 . . . . 0.0 110.972 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.23 8.62 15.23 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.476 -0.765 . . . . 0.0 112.587 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -51.96 121.35 6.54 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.242 1.017 . . . . 0.0 108.927 -171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -38.71 76.89 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.275 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.36 -32.32 64.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.489 1.04 . . . . 0.0 112.329 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.72 -39.56 61.82 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.732 0.696 . . . . 0.0 109.495 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.43 -46.96 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.36 -57.44 4.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.34 -45.44 80.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.335 1.054 . . . . 0.0 110.71 -172.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.78 96.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.22 -15.25 61.0 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -75.05 -51.73 12.82 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.266 1.426 . . . . 0.0 108.011 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.53 78.04 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.501 0.72 . . . . 0.0 111.905 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.79 58.84 2.07 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.106 1.336 . . . . 0.0 110.502 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.61 162.35 5.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.398 0.599 . . . . 0.0 110.834 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -62.42 -43.06 99.73 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.41 173.18 46.1 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 125.472 1.51 . . . . 0.0 110.152 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 135.23 46.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.327 1.851 . . . . 0.0 107.288 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.0 t -134.47 145.86 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 128.327 2.651 . . . . 0.0 104.763 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t -127.63 164.48 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -49.85 141.18 14.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.284 160.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -78.35 173.49 56.27 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 120.702 1.287 . . . . 0.0 109.337 -20.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -177.28 151.5 0.79 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.596 -1.315 . . . . 0.0 108.619 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -153.77 -179.33 7.72 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 127.285 2.234 . . . . 0.0 108.275 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.5 -29.7 62.13 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.321 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.59 33.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.857 1.263 . . . . 0.0 113.076 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.26 -30.8 13.25 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.808 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -48.74 79.08 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.751 1.16 . . . . 0.0 108.331 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -40.7 97.03 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.617 1.167 . . . . 0.0 111.51 -176.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HG2' ' HZ2' ' A' ' 122' ' ' LYS . 6.1 tp10 -69.3 -40.4 77.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.9 0.88 . . . . 0.0 109.042 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' HE2' ' HE3' ' A' ' 122' ' ' LYS . 50.4 mmtt -65.7 -40.82 92.69 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.648 -1.282 . . . . 0.0 110.527 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.0 mt -55.44 -49.7 71.77 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.776 0.831 . . . . 0.0 108.968 170.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.81 -38.58 88.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.065 0.848 . . . . 0.0 112.612 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.413 ' HZ2' ' HG2' ' A' ' 118' ' ' GLU . 9.2 mtmm -55.5 -52.49 63.49 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.027 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.7 pt -73.68 -24.78 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 120.192 1.36 . . . . 0.0 113.473 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -56.95 -59.55 4.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.24 -43.72 73.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.085 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -69.82 0.33 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.61 -29.38 65.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.7 30.53 13.11 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 117.907 -1.496 . . . . 0.0 109.756 -160.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mmm . . . . . 0 C--O 1.247 0.95 0 CA-C-N 120.135 1.967 . . . . 0.0 109.417 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.12 -172.7 4.12 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -123.4 157.4 33.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.33 -23.32 66.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.199 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 47.66 60.34 3.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.496 1.918 . . . . 0.0 109.157 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.53 108.82 0.1 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.563 1.545 . . . . 0.0 110.209 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.61 29.9 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.97 152.84 19.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.14 134.65 54.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 162.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.84 108.33 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -125.33 69.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.02 156.85 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -67.11 -55.46 14.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.06 1.3 . . . . 0.0 109.258 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.2 t80 -70.9 115.82 10.49 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.95 -48.43 70.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.739 1.216 . . . . 0.0 111.326 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 25.1 m -62.66 -26.03 68.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.006 0.922 . . . . 0.0 111.82 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.3 ttm -58.42 -29.32 66.01 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.713 1.142 . . . . 0.0 109.893 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -70.39 -30.76 67.74 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.032 0.833 . . . . 0.0 110.26 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -61.49 -51.22 69.54 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.447 1.021 . . . . 0.0 108.354 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.63 -60.38 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.34 0.656 . . . . 0.0 109.798 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.92 -52.81 12.53 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 126.057 1.743 . . . . 0.0 109.774 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -56.47 -47.76 78.5 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.089 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -59.12 -44.75 92.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 119.933 1.242 . . . . 0.0 110.143 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.55 -36.87 83.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 110.68 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -66.36 0.51 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.391 1.076 . . . . 0.0 109.996 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -25.59 68.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.502 1.121 . . . . 0.0 112.092 -167.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -15.11 51.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.684 1.129 . . . . 0.0 112.57 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -147.03 19.05 1.25 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 112.103 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.1 28.64 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.349 -0.844 . . . . 0.0 111.804 -161.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -57.37 123.35 15.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.981 1.712 . . . . 0.0 110.918 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -72.12 -3.06 20.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.916 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -118.74 128.48 54.53 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.019 1.327 . . . . 0.0 107.766 -158.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.79 165.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 125.77 1.628 . . . . 0.0 107.304 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -127.04 161.18 29.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -125.63 127.13 45.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.6 173.92 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 170.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.48 -46.46 66.58 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.4 -0.812 . . . . 0.0 110.568 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.24 175.25 6.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.024 1.73 . . . . 0.0 108.187 -163.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.75 -43.23 29.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.376 0.989 . . . . 0.0 114.111 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.78 -52.07 64.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 119.022 1.411 . . . . 0.0 108.694 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.67 -21.95 66.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.361 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.02 -47.42 68.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.347 1.431 . . . . 0.0 109.543 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.62 -46.02 87.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.319 0.581 . . . . 0.0 109.668 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -60.35 -44.78 95.24 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.719 0.807 . . . . 0.0 111.536 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -59.41 -41.38 89.35 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.001 1.32 . . . . 0.0 110.219 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -43.9 91.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.344 0.975 . . . . 0.0 111.347 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.66 -0.21 29.1 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.66 4.38 40.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.735 1.152 . . . . 0.0 112.958 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.14 -172.39 34.63 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 120.496 -1.377 . . . . 0.0 112.035 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.85 79.41 1.58 Allowed Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -75.53 165.48 25.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 159.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.52 -7.59 1.04 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.852 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -144.33 135.22 25.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.598 1.199 . . . . 0.0 108.423 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.72 117.96 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -165.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.83 134.04 67.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.727 1.611 . . . . 0.0 106.902 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 m -150.81 159.69 44.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.978 0.354 . . . . 0.0 111.432 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.98 157.92 32.54 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 166.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -67.99 -47.14 69.33 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 110.408 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.412 HD22 ' HG2' ' A' ' 89' ' ' GLU . 86.7 m-20 -80.81 59.04 3.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.674 1.19 . . . . 0.0 110.998 -159.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mmt -93.46 160.05 33.84 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 122.791 0.437 . . . . 0.0 110.661 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 162.39 36.32 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.803 2.335 . . . . 0.0 108.916 165.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 50.99 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.298 1.839 . . . . 0.0 113.143 170.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.8 ttm -82.01 86.5 6.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.447 1.099 . . . . 0.0 108.313 168.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.12 154.81 1.46 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.192 1.397 . . . . 0.0 110.143 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.43 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.501 -1.374 . . . . 0.0 113.161 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.51 -33.61 71.38 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.313 1.057 . . . . 0.0 110.263 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -72.12 -35.11 69.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.894 . . . . 0.0 110.57 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -53.46 57.3 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.707 0.685 . . . . 0.0 109.582 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.17 -56.53 10.62 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 34.6 mttm -66.29 -27.97 68.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.742 1.156 . . . . 0.0 114.038 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -70.77 -46.89 62.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.423 1.01 . . . . 0.0 108.742 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.41 -43.88 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.342 0.657 . . . . 0.0 109.356 172.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -24.03 60.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.218 1.407 . . . . 0.0 112.228 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.64 -1.1 23.05 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.765 1.226 . . . . 0.0 112.042 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.3 135.65 40.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.124 0.875 . . . . 0.0 108.721 174.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.19 -23.69 74.74 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.038 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.32 -60.53 1.92 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.294 1.047 . . . . 0.0 108.89 168.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.7 mmt -68.24 -8.67 41.22 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -160.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -48.13 -29.76 3.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.419 1.009 . . . . 0.0 112.098 165.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.05 -11.85 61.18 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -66.98 134.05 93.9 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 119.959 1.254 . . . . 0.0 109.077 -174.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.78 56.6 6.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 0.0 111.587 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.254 2.4 m -47.58 107.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.213 1.005 . . . . 0.0 112.233 170.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -106.42 117.46 34.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.711 1.604 . . . . 0.0 107.839 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.44 123.08 31.99 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.98 107.06 11.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -144.78 178.42 8.01 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.016 0.912 . . . . 0.0 111.466 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.9 -29.39 32.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.084 0.953 . . . . 0.0 111.893 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 91' ' ' LYS . 48.5 mm-40 -74.88 107.86 7.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.946 0.498 . . . . 0.0 110.237 -170.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.63 18.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.048 -1.033 . . . . 0.0 111.708 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 89' ' ' GLU . 23.2 tptm -57.37 110.31 0.84 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 125.267 1.427 . . . . 0.0 109.001 -168.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -40.34 -59.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 112.621 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.05 -31.18 62.92 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.841 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.1 -38.67 61.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.709 1.14 . . . . 0.0 109.619 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.35 -55.87 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.97 -47.12 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.84 -41.26 77.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.098 1.317 . . . . 0.0 109.789 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.74 -53.28 59.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.801 0.728 . . . . 0.0 110.902 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.99 -27.15 67.92 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.325 0.65 . . . . 0.0 112.534 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -73.65 -52.89 11.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.704 2.002 . . . . 0.0 109.407 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -55.58 -40.36 71.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.684 0.794 . . . . 0.0 111.134 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.0 2.47 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.412 1.482 . . . . 0.0 113.217 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.98 156.6 6.63 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.536 1.168 . . . . 0.0 111.195 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.2 p -70.83 -28.11 64.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.654 0.382 . . . . 0.0 110.966 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.71 171.7 38.42 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -130.78 139.22 50.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.009 1.324 . . . . 0.0 108.037 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.86 137.73 42.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 126.44 1.896 . . . . 0.0 106.004 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.22 144.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -173.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -52.46 145.85 18.88 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.105 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.61 10.09 60.82 Favored 'Cis proline' 0 C--N 1.348 0.508 0 N-CA-C 116.992 1.882 . . . . 0.0 116.992 8.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.8 p90 15.79 114.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 130.768 3.627 . . . . 0.0 116.564 -175.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -89.73 166.5 13.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.821 -1.174 . . . . 0.0 112.553 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.02 -33.83 73.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 166.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.36 -13.39 5.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.684 1.594 . . . . 0.0 115.013 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -28.67 7.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.497 1.499 . . . . 0.0 111.225 171.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.38 -51.13 71.1 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.292 1.037 . . . . 0.0 111.181 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -66.83 -44.18 81.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -66.92 -35.55 80.26 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.223 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.08 -57.9 11.01 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.039 0.935 . . . . 0.0 109.029 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -47.74 -45.26 28.78 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.288 1.035 . . . . 0.0 111.049 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -68.8 0.14 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.657 174.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.7 pt -66.94 -26.75 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 120.212 1.369 . . . . 0.0 113.704 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -56.22 -57.33 12.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -84.39 -34.02 23.66 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.788 -0.57 . . . . 0.0 111.326 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -64.23 -72.81 0.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.381 1.472 . . . . 0.0 109.739 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.51 -38.49 62.82 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.023 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.2 22.14 6.65 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.609 -1.106 . . . . 0.0 112.366 -166.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.3 mmt . . . . . 0 C--O 1.251 1.182 0 CA-C-N 119.587 1.694 . . . . 0.0 112.275 -175.182 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.07 147.88 6.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.388 1.475 . . . . 0.0 107.547 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.22 162.68 24.86 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.894 0.877 . . . . 0.0 112.034 -161.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -56.25 -9.84 0.75 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.395 1.878 . . . . 0.0 113.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.35 26.25 15.08 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.703 1.601 . . . . 0.0 111.663 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.66 116.22 2.79 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 108.99 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.67 165.2 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.856 0.463 . . . . 0.0 110.993 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.95 91.79 3.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 163.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.31 131.0 44.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -135.89 125.28 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.36 67.66 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -84.92 166.71 16.58 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.896 -1.128 . . . . 0.0 111.241 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -19.74 65.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.969 0.908 . . . . 0.0 113.355 -169.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.84 131.64 21.42 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.624 1.97 . . . . 0.0 105.894 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -52.55 -41.23 63.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.678 0.672 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.6 m -51.33 -47.11 62.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.647 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.1 mtm -59.7 -35.36 74.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.446 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -68.03 -31.11 70.56 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 120.055 1.298 . . . . 0.0 110.482 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -69.39 -50.21 48.15 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.93 -61.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.165 1.386 . . . . 0.0 109.643 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.6 t -51.9 -49.38 37.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.33 1.452 . . . . 0.0 109.793 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -54.95 -48.51 73.09 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 119.385 0.993 . . . . 0.0 110.635 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -52.7 63.72 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.479 0.712 . . . . 0.0 109.688 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.1 mt -58.27 -42.41 86.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.373 1.069 . . . . 0.0 110.435 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.96 -48.49 81.33 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 110.722 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -65.73 -33.48 75.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.599 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -45.87 92.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.081 1.309 . . . . 0.0 109.224 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.4 mt -66.21 -43.26 87.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.757 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.38 -5.44 1.39 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.398 0.999 . . . . 0.0 114.226 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -73.85 152.52 40.2 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.765 1.226 . . . . 0.0 109.789 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -145.5 179.04 7.68 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.397 -0.814 . . . . 0.0 110.518 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 53.98 58.85 4.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.656 1.982 . . . . 0.0 111.463 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.45 160.08 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.322 162.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.51 169.69 16.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.126 1.77 . . . . 0.0 108.367 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -130.05 142.15 50.65 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.547 1.939 . . . . 0.0 106.939 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.53 170.22 8.59 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 159.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -24.87 30.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.987 0.358 . . . . 0.0 111.228 170.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.69 175.57 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.307 1.443 . . . . 0.0 108.697 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -62.89 -35.16 91.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.332 1.92 . . . . 0.0 114.606 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.02 -49.53 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 120.309 2.055 . . . . 0.0 107.934 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -58.57 -39.28 79.87 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.858 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.1 99.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.269 1.395 . . . . 0.0 111.547 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.41 -43.39 90.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -65.11 -42.55 93.85 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.388 -0.195 . . . . 0.0 111.469 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -52.94 -50.35 64.18 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 127.533 2.333 . . . . 0.0 108.854 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.97 -48.0 83.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.433 0.56 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.46 -11.04 56.91 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.87 24.23 12.92 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.763 2.425 . . . . 0.0 110.858 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.43 161.08 28.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 31.05 8.44 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 162.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -70.16 89.05 0.62 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.02 1.328 . . . . 0.0 109.069 -161.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -3.44 50.22 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.555 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -138.98 129.87 26.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.601 1.2 . . . . 0.0 109.083 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 t -133.98 124.42 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.76 134.32 60.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 127.379 2.272 . . . . 0.0 106.25 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.9 p -152.03 163.54 39.09 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.385 0.538 . . . . 0.0 111.069 173.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.4 159.98 28.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.032 160.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.406 ' CH2' ' HG ' ' A' ' 66' ' ' LEU . 23.6 t-105 -72.64 -58.53 3.29 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.587 1.955 . . . . 0.0 111.422 169.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.5 19.39 0.13 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.998 2.119 . . . . 0.0 112.822 -160.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -61.68 129.21 91.24 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 126.113 1.765 . . . . 0.0 107.553 -170.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.8 157.85 54.02 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 N-CA-C 109.402 -1.038 . . . . 0.0 109.402 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.77 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.249 1.42 . . . . 0.0 109.992 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.2 ttp -91.33 91.32 8.1 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.159 0.984 . . . . 0.0 108.878 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.88 153.47 1.29 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 109.027 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.54 -31.54 63.53 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 120.885 -1.134 . . . . 0.0 112.456 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.411 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -68.78 -36.84 78.8 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.633 0.717 . . . . 0.0 110.644 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.19 -41.65 70.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.047 0.939 . . . . 0.0 109.546 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp -56.39 -50.12 72.49 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.578 1.151 . . . . 0.0 109.469 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.69 -61.47 2.27 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 124.957 1.303 . . . . 0.0 108.866 173.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 90.7 mttt -62.66 -27.66 69.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.903 1.229 . . . . 0.0 112.382 -173.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.3 m -64.46 -55.73 18.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.117 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.76 -36.45 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.323 1.449 . . . . 0.0 111.448 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -21.92 61.9 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 120.883 -1.135 . . . . 0.0 111.258 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.76 2.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.493 1.042 . . . . 0.0 110.108 171.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 61.53 -121.32 0.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.842 2.057 . . . . 0.0 112.066 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.65 17.9 55.07 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.605 1.093 . . . . 0.0 111.056 -158.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.74 2.87 3.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 129.001 2.92 . . . . 0.0 113.844 -164.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.1 mtt -93.04 -3.12 54.88 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.418 1.087 . . . . 0.0 113.442 -168.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 t -61.11 -21.17 63.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.119 1.327 . . . . 0.0 112.214 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.96 -2.01 25.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.849 1.26 . . . . 0.0 113.817 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.7 mt -79.77 129.76 69.81 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 119.783 1.174 . . . . 0.0 109.471 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.47 58.02 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.128 2.552 . . . . 0.0 111.925 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -47.24 108.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.979 1.712 . . . . 0.0 111.028 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 tp -112.97 119.6 38.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.852 1.661 . . . . 0.0 108.901 -165.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -82.92 118.73 23.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.16 110.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.219 1.408 . . . . 0.0 108.47 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -157.62 169.76 23.92 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.555 0.693 . . . . 0.0 110.401 -167.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.76 -23.0 62.33 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.239 -0.913 . . . . 0.0 112.179 160.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -81.26 112.03 18.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.007 0.821 . . . . 0.0 112.001 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.51 -88.25 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 160.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? 49.81 99.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.126 1.371 . . . . 0.0 111.2 -169.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -41.32 -48.83 3.71 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.4 -0.812 . . . . 0.0 111.765 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -58.87 -37.69 77.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -60.18 -43.99 95.43 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.031 0.832 . . . . 0.0 109.487 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.21 -43.69 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.18 -58.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.33 70.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 111.059 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.82 80.08 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.047 0.939 . . . . 0.0 110.059 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.93 79.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.879 0.472 . . . . 0.0 111.162 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -61.16 -51.16 70.22 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.709 1.604 . . . . 0.0 110.495 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.94 71.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.206 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.25 34.97 4.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.552 1.072 . . . . 0.0 112.804 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.78 159.41 11.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.109 1.454 . . . . 0.0 110.68 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 p -63.93 -35.68 81.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.45 0.568 . . . . 0.0 110.595 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.59 -177.57 45.1 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.23 132.32 33.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.07 102.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.99 154.54 4.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.26 155.39 79.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 120.93 -1.106 . . . . 0.0 110.452 159.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.13 151.28 96.79 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 N-CA-C 110.346 -0.675 . . . . 0.0 110.346 -7.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -151.94 157.55 41.94 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.428 0.691 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -144.51 -173.02 3.92 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.891 0.876 . . . . 0.0 110.384 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.45 -29.24 61.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.397 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.8 -25.25 64.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 t -95.87 -39.19 9.94 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.043 1.292 . . . . 0.0 109.246 170.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -50.14 53.57 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 109.765 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.22 72.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.918 1.687 . . . . 0.0 112.772 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.83 -48.53 21.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -61.6 -37.66 84.72 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.687 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.14 -52.21 59.47 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.451 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.28 -42.47 86.64 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.291 0.95 . . . . 0.0 112.414 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -54.38 -53.09 58.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.374 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 pt -74.63 -20.89 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 117.568 -1.206 . . . . 0.0 114.0 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.83 -50.79 71.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.525 1.511 . . . . 0.0 108.097 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -77.29 -42.84 35.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -73.61 -62.07 1.62 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.959 0.504 . . . . 0.0 110.634 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -20.57 39.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.715 0.806 . . . . 0.0 110.446 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.17 36.75 12.2 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -170.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 118.192 0.996 . . . . 0.0 111.014 175.555 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.69 65.66 0.26 Allowed 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.206 -0.934 . . . . 0.0 109.253 165.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.04 160.06 17.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -75.33 -15.37 60.49 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.033 1.333 . . . . 0.0 112.357 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 49.14 31.82 3.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.779 1.632 . . . . 0.0 111.834 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.62 104.63 4.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.104 0.562 . . . . 0.0 109.894 -170.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -91.1 133.67 35.14 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.172 1.789 . . . . 0.0 110.239 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.66 106.9 18.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.286 1.834 . . . . 0.0 107.484 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -74.34 138.07 43.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.568 1.076 . . . . 0.0 108.175 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.15 105.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 t -113.78 59.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 122.619 1.2 . . . . 0.0 107.768 -170.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -85.96 108.97 18.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -174.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -53.95 -45.27 71.23 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.422 1.089 . . . . 0.0 112.377 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 13.3 t80 -70.24 101.39 1.88 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 164.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -42.66 70.11 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.21 0.604 . . . . 0.0 111.378 -168.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 23.9 m -59.83 -33.77 72.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.583 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mtm -59.12 -32.22 69.64 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 120.111 1.323 . . . . 0.0 110.476 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.501 HH21 ' NH1' ' A' ' 19' ' ' ARG . 24.9 ttp85 -62.63 -43.5 98.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.889 1.222 . . . . 0.0 110.717 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NH1' HH21 ' A' ' 18' ' ' ARG . 8.9 mpt_? -59.69 -41.56 91.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.716 176.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.21 -63.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.21 -43.48 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.899 1.68 . . . . 0.0 110.945 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -56.89 -48.36 78.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 0.0 110.392 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.97 -44.13 97.8 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.956 0.798 . . . . 0.0 110.841 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.66 -38.39 90.92 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.196 1.398 . . . . 0.0 111.689 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.83 -57.94 10.73 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -56.64 -36.09 69.09 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.162 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.67 -22.06 65.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.109 1.322 . . . . 0.0 112.464 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.35 -75.45 0.24 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 164.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.75 -168.41 33.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 65.33 164.43 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.264 1.826 . . . . 0.0 111.925 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -151.16 -3.05 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.371 1.469 . . . . 0.0 112.063 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.69 98.96 10.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.59 158.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.92 -155.47 0.61 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.43 1.092 . . . . 0.0 109.088 167.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -178.37 159.16 1.19 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -158.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.86 33.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.142 1.777 . . . . 0.0 106.362 170.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.33 -31.59 72.47 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.795 -0.565 . . . . 0.0 112.352 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.58 171.26 10.43 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.872 2.469 . . . . 0.0 105.955 -174.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.517 ' H ' ' CE ' ' A' ' 60' ' ' MET . . . -57.52 -37.12 80.87 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.587 -1.119 . . . . 0.0 114.565 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.66 -42.99 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.969 2.385 . . . . 0.0 108.714 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.1 -28.22 69.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.333 -0.855 . . . . 0.0 111.725 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.7 -47.68 77.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.195 -1.566 . . . . 0.0 109.655 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.72 -41.25 73.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.409 1.084 . . . . 0.0 109.496 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.67 -44.1 97.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.694 1.197 . . . . 0.0 111.742 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.311 -0.868 . . . . 0.0 110.67 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -51.27 70.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -68.48 3.14 1.92 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.18 1.48 56.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.06 1.3 . . . . 0.0 112.947 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.04 -81.79 0.07 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 121.353 1.888 . . . . 0.0 115.249 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.07 82.38 0.05 OUTLIER Glycine 0 C--N 1.331 0.261 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -164.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -90.32 153.8 20.18 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.23 1.015 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.78 -20.98 15.11 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.757 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -145.27 148.96 34.04 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.051 1.34 . . . . 0.0 109.277 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.26 67.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -75.93 144.25 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 153.32 31.6 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.665 -0.647 . . . . 0.0 110.462 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -74.13 149.97 40.74 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 164.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -61.21 -58.75 7.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.837 0.855 . . . . 0.0 109.498 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 25.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.188 1.395 . . . . 0.0 113.366 -159.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.517 ' CE ' ' H ' ' A' ' 39' ' ' GLY . 8.4 ptm -60.12 159.41 21.59 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.159 -0.963 . . . . 0.0 110.97 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -167.8 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.764 3.642 . . . . 0.0 111.192 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.49 -146.71 0.46 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.419 1.488 . . . . 0.0 110.09 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.98 96.41 0.43 Allowed 'General case' 0 C--N 1.34 0.175 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.71 174.1 0.07 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.17 1.788 . . . . 0.0 113.561 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.11 -29.76 59.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.386 -0.821 . . . . 0.0 113.57 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -42.78 69.08 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 117.957 0.879 . . . . 0.0 110.034 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.93 -40.1 83.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.148 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.14 -55.03 27.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.656 1.116 . . . . 0.0 110.024 169.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tp -50.31 -56.27 11.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.601 0.761 . . . . 0.0 109.085 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.09 -41.56 96.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.748 0.704 . . . . 0.0 111.126 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.7 m -57.57 -51.44 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.061 0.944 . . . . 0.0 109.293 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 mt -58.53 -45.22 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.646 0.778 . . . . 0.0 109.659 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.5 -27.37 69.09 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 125.629 1.572 . . . . 0.0 112.148 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.16 14.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.325 1.45 . . . . 0.0 114.565 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 132.83 -107.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 131.033 3.733 . . . . 0.0 107.613 159.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.47 4.33 9.05 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.775 1.179 . . . . 0.0 114.905 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.41 25.01 5.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.18 1.49 . . . . 0.0 111.516 -158.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.3 mmt -113.48 -9.17 13.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.215 2.606 . . . . 0.0 111.053 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 p -52.29 -37.69 56.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.981 1.712 . . . . 0.0 111.953 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.73 62.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.1 mt -52.52 141.18 34.85 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.517 1.053 . . . . 0.0 112.177 -162.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.03 74.0 3.02 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.489 2.126 . . . . 0.0 110.425 163.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -70.42 116.26 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 158.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.63 111.72 15.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mmt -75.12 128.35 35.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 101.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -141.45 169.86 16.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.65 -169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.06 -17.19 41.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.258 163.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -80.67 104.21 11.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.212 0.915 . . . . 0.0 111.615 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.88 16.03 2.45 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -57.84 110.13 0.85 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.348 0.977 . . . . 0.0 108.881 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.6 -47.76 66.71 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.677 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -53.25 -33.08 51.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.33 -30.55 25.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.794 -0.566 . . . . 0.0 110.996 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.22 -44.23 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 118.362 -0.828 . . . . 0.0 108.989 161.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.51 -54.4 35.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.375 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.2 63.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 120.176 1.353 . . . . 0.0 110.774 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.56 -51.96 65.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 110.21 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.32 85.22 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.257 0.623 . . . . 0.0 111.269 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -57.35 -50.65 72.28 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.723 2.009 . . . . 0.0 110.513 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.03 -18.58 65.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.614 0.766 . . . . 0.0 112.68 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.02 27.66 13.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.236 0.922 . . . . 0.0 112.527 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.81 140.44 56.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.847 1.324 . . . . 0.0 108.191 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.6 p -68.46 -18.76 64.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.145 -174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.57 173.87 40.13 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.6 104.83 4.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.73 144.88 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.9 143.21 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.6 151.22 71.92 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.46 1.504 . . . . 0.0 111.463 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.92 173.3 37.89 Favored 'Cis proline' 0 C--N 1.345 0.378 0 N-CA-C 109.421 -1.031 . . . . 0.0 109.421 -16.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -177.91 146.72 0.43 Allowed 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.162 -1.586 . . . . 0.0 108.267 -164.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -149.52 -176.51 5.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.184 1.793 . . . . 0.0 109.232 -170.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.49 68.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.781 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.18 62.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.222 1.009 . . . . 0.0 113.189 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.72 -28.99 12.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.876 0.762 . . . . 0.0 110.286 177.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.45 -54.84 38.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -29.85 71.06 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.885 1.274 . . . . 0.0 112.396 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.38 -55.25 12.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.606 1.162 . . . . 0.0 109.351 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.6 -31.44 72.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.743 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.2 mt -58.49 -58.06 10.2 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 123.835 0.854 . . . . 0.0 109.484 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -61.29 -29.19 69.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.043 1.292 . . . . 0.0 112.257 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.01 -60.56 3.3 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.148 -0.97 . . . . 0.0 110.333 168.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -23.3 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.319 0.963 . . . . 0.0 113.081 -171.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -57.21 -58.03 9.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.82 -30.0 56.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.525 -0.734 . . . . 0.0 112.354 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -65.35 1.02 Allowed 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.57 -25.55 64.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.984 0.514 . . . . 0.0 111.051 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.23 23.21 35.26 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-O 117.805 -1.553 . . . . 0.0 110.703 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 28.7 mmt . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.704 1.752 . . . . 0.0 110.47 -176.511 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 ttm . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.7 72.61 8.64 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.607 1.549 . . . . 0.0 107.738 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.23 158.58 23.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.399 0.619 . . . . 0.0 112.257 -160.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -51.51 -25.5 6.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 39.15 53.54 2.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.726 2.41 . . . . 0.0 109.406 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.62 104.13 0.77 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.169 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -79.51 132.47 36.33 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.45 93.81 6.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.67 131.75 45.1 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.316 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.6 t -132.52 119.36 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.95 63.53 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.699 1.599 . . . . 0.0 108.6 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.29 159.1 33.72 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.792 -1.193 . . . . 0.0 108.5 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.47 -64.77 1.03 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.62 112.77 3.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -53.17 -41.61 65.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.857 1.208 . . . . 0.0 112.055 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -59.82 -31.8 70.06 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.757 -1.214 . . . . 0.0 111.773 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.0 92.62 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.562 1.074 . . . . 0.0 110.159 171.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.8 tpt85 -65.83 -36.69 84.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.299 1.04 . . . . 0.0 110.049 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -48.02 83.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.503 -0.761 . . . . 0.0 109.524 171.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.09 -58.36 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.32 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.9 t -52.29 -46.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.127 1.33 . . . . 0.0 110.206 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -60.75 -43.9 97.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.238 0.472 . . . . 0.0 111.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.27 -45.11 95.86 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.265 0.626 . . . . 0.0 111.133 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.41 -36.37 83.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.43 0.692 . . . . 0.0 111.062 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.91 -44.7 96.25 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.411 0.684 . . . . 0.0 110.09 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -41.65 98.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 116.994 -1.479 . . . . 0.0 111.462 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -57.07 -44.64 83.25 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 119.439 1.018 . . . . 0.0 110.51 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.14 -34.35 63.83 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.255 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.63 57.34 0.37 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.01 153.02 47.23 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.895 1.278 . . . . 0.0 107.824 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.81 178.9 7.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.785 1.634 . . . . 0.0 108.559 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 53.87 54.2 10.14 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.584 1.553 . . . . 0.0 111.683 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 m -68.68 164.36 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.122 159.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.46 174.81 10.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -136.71 147.81 46.97 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.11 167.44 12.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 164.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -68.37 -47.29 67.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 110.117 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.33 169.01 22.88 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 125.797 1.639 . . . . 0.0 109.171 -159.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.7 -41.05 49.69 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.953 1.263 . . . . 0.0 115.546 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -67.95 -44.66 84.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.97 1.885 . . . . 0.0 107.854 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.78 -26.17 68.51 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.173 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.81 -49.03 67.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.99 1.268 . . . . 0.0 110.14 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.02 -42.77 95.05 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.208 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.85 -47.37 85.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.479 1.112 . . . . 0.0 110.893 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.95 -46.43 78.56 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.802 0.841 . . . . 0.0 109.799 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.33 -37.87 73.2 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.001 0.819 . . . . 0.0 111.342 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 4.6 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.16 82.0 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 119.715 -1.865 . . . . 0.0 110.399 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.49 104.4 1.24 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.773 1.177 . . . . 0.0 111.66 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.65 13.68 1.08 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.438 1.018 . . . . 0.0 115.134 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -69.43 167.28 16.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.214 1.507 . . . . 0.0 110.988 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.31 -19.21 0.88 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.561 167.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -131.84 144.0 50.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.536 1.668 . . . . 0.0 107.727 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 t -134.37 62.41 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.74 135.36 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -144.92 168.91 19.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.019 0.827 . . . . 0.0 110.434 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.44 169.46 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.555 0.693 . . . . 0.0 109.359 159.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -74.08 -53.68 9.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.878 158.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.25 86.99 6.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.487 1.115 . . . . 0.0 111.54 -158.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.2 mmt -127.17 149.71 70.27 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.289 0.636 . . . . 0.0 111.2 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.96 147.1 60.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.492 2.128 . . . . 0.0 109.822 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 54.92 -84.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.283 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 41.4 ttm -88.19 97.64 11.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.941 1.296 . . . . 0.0 107.65 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.39 161.97 2.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.31 -33.68 53.04 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.558 -0.714 . . . . 0.0 111.847 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.57 -42.21 99.41 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.715 0.757 . . . . 0.0 109.942 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -81.19 -30.36 34.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.774 -0.579 . . . . 0.0 111.264 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.51 -52.1 67.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.16 0.984 . . . . 0.0 108.556 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 tp -51.13 -60.04 3.53 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.01 1.324 . . . . 0.0 109.463 173.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HE2' ' HB1' ' A' ' 101' ' ' ALA . 24.3 mmtt -59.72 -40.34 87.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.523 1.056 . . . . 0.0 112.363 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.5 m -59.62 -49.05 79.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.631 0.772 . . . . 0.0 109.364 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.16 -39.37 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.15 -25.91 68.29 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.448 1.899 . . . . 0.0 112.234 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.03 60.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.556 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -71.46 148.14 47.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.804 0.842 . . . . 0.0 110.917 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.26 -17.96 70.79 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.027 -0.874 . . . . 0.0 113.203 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.07 -50.81 1.03 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.122 1.369 . . . . 0.0 111.285 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.8 mtm -67.0 -13.69 62.15 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 p -50.97 -31.66 18.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.732 1.213 . . . . 0.0 112.422 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.7 65.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.983 1.313 . . . . 0.0 114.029 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.55 138.01 76.51 Favored Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.317 -171.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.03 84.21 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.616 2.211 . . . . 0.0 108.951 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.69 126.76 37.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tp -142.28 110.56 6.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -159.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -79.32 126.34 30.67 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.372 1.045 . . . . 0.0 108.423 -171.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.2 t -136.1 101.34 2.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.254 1.822 . . . . 0.0 106.646 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -149.26 164.6 34.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.363 0.601 . . . . 0.0 111.391 -159.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.11 -20.91 57.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.582 1.153 . . . . 0.0 111.689 161.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -76.38 87.76 3.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.967 1.307 . . . . 0.0 111.031 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.98 5.3 4.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.094 0.958 . . . . 0.0 113.287 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -48.4 112.81 0.64 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.144 1.777 . . . . 0.0 108.307 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.81 -43.28 80.83 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -56.21 -37.79 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.374 1.07 . . . . 0.0 112.287 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -66.99 -40.5 87.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.393 0.542 . . . . 0.0 109.541 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.91 -49.43 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.156 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.0 -58.52 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.07 -49.3 63.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.587 1.155 . . . . 0.0 111.011 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.96 95.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.181 0.901 . . . . 0.0 110.883 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.15 91.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.902 0.319 . . . . 0.0 111.166 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -60.51 -55.81 28.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.19 1.396 . . . . 0.0 110.052 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' HE2' ' A' ' 70' ' ' LYS . . . -59.33 -28.87 67.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 111.51 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.66 38.76 4.6 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.278 0.942 . . . . 0.0 111.933 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.3 27.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.818 0.809 . . . . 0.0 109.306 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -69.98 -14.88 62.91 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.01 171.46 37.01 Favored Glycine 0 N--CA 1.443 -0.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.673 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -137.06 135.23 37.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.357 1.463 . . . . 0.0 107.343 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.45 103.43 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.13 144.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -60.67 154.17 58.37 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.826 1.251 . . . . 0.0 109.619 163.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.92 174.54 46.7 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.373 0.812 . . . . 0.0 111.329 -14.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -178.43 151.33 0.6 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -167.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 p -144.79 -171.69 3.68 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.441 1.096 . . . . 0.0 109.825 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.99 72.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.446 -0.784 . . . . 0.0 109.583 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.97 -19.68 45.43 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.47 -27.4 9.03 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.493 1.042 . . . . 0.0 110.999 171.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.46 -50.61 62.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.225 1.375 . . . . 0.0 107.939 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -31.56 72.47 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.631 1.172 . . . . 0.0 112.151 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -77.27 -36.1 54.67 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.712 0.687 . . . . 0.0 110.591 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -64.96 -43.46 92.62 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.122 -0.986 . . . . 0.0 109.211 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -58.66 -56.76 18.02 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.715 1.206 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -52.1 -42.31 63.16 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.937 1.295 . . . . 0.0 111.329 176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -52.82 -63.18 1.23 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.366 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 pt -68.48 -30.14 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 120.487 1.494 . . . . 0.0 114.402 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.88 -53.92 52.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -83.09 -34.46 26.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 121.282 -0.167 . . . . 0.0 110.577 -171.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -74.0 -74.1 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.831 1.253 . . . . 0.0 108.862 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.92 -20.93 62.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.697 0.799 . . . . 0.0 110.967 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.34 26.98 26.54 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.499 -172.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 C--O 1.249 1.079 0 CA-C-N 119.639 1.72 . . . . 0.0 111.678 -175.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.38 -156.8 0.75 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.762 1.225 . . . . 0.0 108.472 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -115.46 -177.6 3.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.879 2.071 . . . . 0.0 106.99 173.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -61.9 -38.37 88.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.551 1.069 . . . . 0.0 109.042 159.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 48.23 63.78 1.92 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.314 1.446 . . . . 0.0 107.123 -160.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.5 106.56 0.21 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.019 0.928 . . . . 0.0 109.116 -175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HE2' ' CG ' ' A' ' 34' ' ' GLU . 12.3 tttt -82.47 135.45 35.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.336 -164.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.23 85.14 2.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -169.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.67 139.58 53.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.11 120.74 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.17 65.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.679 1.228 . . . . 0.0 107.949 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.24 111.32 22.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -47.74 -46.16 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.36 1.464 . . . . 0.0 112.59 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.5 -13.31 13.09 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t 76.34 -68.1 0.2 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.128 1.771 . . . . 0.0 108.42 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -55.87 -28.08 54.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.964 -1.085 . . . . 0.0 111.674 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.5 mtp -56.86 -46.57 81.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 116.854 -1.546 . . . . 0.0 111.011 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -22.88 63.13 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 121.645 2.021 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -65.7 -52.44 51.4 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.43 -60.51 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.736 1.214 . . . . 0.0 108.666 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.91 -49.19 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.239 1.016 . . . . 0.0 111.063 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -60.43 -42.97 97.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.768 1.167 . . . . 0.0 110.891 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -57.96 -53.12 61.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.09 -38.85 77.2 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.006 0.923 . . . . 0.0 111.902 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.24 -47.24 86.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.506 0.722 . . . . 0.0 110.087 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -64.89 -36.61 84.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.55 -41.24 89.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.652 1.569 . . . . 0.0 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.44 -54.04 10.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.76 62.86 0.07 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -137.52 156.96 47.53 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.347 1.059 . . . . 0.0 109.325 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 -175.33 4.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.378 1.071 . . . . 0.0 111.271 -168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 50.82 46.82 25.57 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.781 2.032 . . . . 0.0 111.45 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.31 161.9 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.0 -1.063 . . . . 0.0 109.474 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 3.4 mm-40 -145.52 171.72 14.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.713 2.005 . . . . 0.0 108.68 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.51 145.6 37.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.7 160.26 23.67 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.59 -39.45 93.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.711 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.99 165.77 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.558 1.143 . . . . 0.0 107.921 -161.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.48 68.67 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.828 1.649 . . . . 0.0 113.835 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.56 -44.87 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.964 -1.315 . . . . 0.0 109.63 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.93 -27.55 64.86 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.574 0.625 . . . . 0.0 110.737 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.09 75.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.728 -1.232 . . . . 0.0 108.322 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -43.5 72.05 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.769 0.795 . . . . 0.0 111.375 175.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -65.79 -25.48 67.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 112.683 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -74.88 -47.4 30.29 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.229 -1.545 . . . . 0.0 108.805 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.3 mt -56.96 -35.98 69.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.176 1.353 . . . . 0.0 111.969 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -74.72 9.61 1.75 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.56 42.47 2.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.493 1.517 . . . . 0.0 111.171 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.17 -171.14 22.62 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 121.49 -0.756 . . . . 0.0 111.861 163.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.2 70.23 1.87 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -65.43 145.38 56.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.23 3.09 2.99 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.844 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.74 142.14 23.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.692 1.246 . . . . 0.0 108.854 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.4 78.68 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.7 141.52 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -152.35 158.22 42.41 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.735 -0.603 . . . . 0.0 111.041 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.26 169.81 17.67 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 164.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -79.34 -51.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.413 -0.804 . . . . 0.0 111.806 169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -74.85 79.6 2.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.16 1.384 . . . . 0.0 110.232 -159.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.8 ptp -135.01 153.32 78.44 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 121.13 -0.981 . . . . 0.0 111.174 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.2 -172.1 1.07 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.04 2.493 . . . . 0.0 109.394 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 57.61 -104.26 0.21 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.917 1.687 . . . . 0.0 109.674 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.32 95.07 9.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.55 153.14 3.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.425 1.09 . . . . 0.0 109.779 170.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.39 -30.15 64.35 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.42 -0.8 . . . . 0.0 113.723 -167.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.26 -39.77 68.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.286 1.043 . . . . 0.0 110.02 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.81 -39.35 90.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.787 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.9 tp -57.79 -51.07 71.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.83 0.741 . . . . 0.0 109.917 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.08 -57.88 6.71 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 109.038 172.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 101' ' ' ALA . 27.3 mttm -65.44 -27.39 68.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 m -59.96 -59.59 5.18 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.3 mt -58.62 -40.99 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.23 1.412 . . . . 0.0 109.722 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -13.35 26.68 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.623 1.569 . . . . 0.0 113.43 -170.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -81.85 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.656 1.116 . . . . 0.0 110.951 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -172.6 -163.63 0.23 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.811 1.645 . . . . 0.0 108.839 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 78' ' ' MET . . . 79.79 29.62 46.8 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -162.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.73 -18.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 129.936 3.294 . . . . 0.0 114.523 -166.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.425 ' H ' ' C ' ' A' ' 76' ' ' GLY . 10.3 mtt -62.41 -19.21 63.22 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.328 0.967 . . . . 0.0 112.276 -174.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -55.54 -28.76 56.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.413 1.085 . . . . 0.0 111.579 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.26 -2.02 43.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.364 1.466 . . . . 0.0 113.398 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.38 136.08 75.42 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 119.859 1.209 . . . . 0.0 110.18 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.13 89.0 0.8 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 108.614 164.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.17 111.01 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 164.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -115.35 113.38 23.72 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mmt -79.46 117.29 20.29 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.89 96.49 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -132.64 -166.47 1.75 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.761 0.824 . . . . 0.0 110.089 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.24 -3.08 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.833 2.053 . . . . 0.0 111.016 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -86.91 81.57 8.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.533 0.682 . . . . 0.0 109.554 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.83 -4.49 6.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.523 1.529 . . . . 0.0 113.776 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -46.78 123.9 5.6 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.617 1.567 . . . . 0.0 110.354 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -53.17 54.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.228 0.537 . . . . 0.0 110.869 -173.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.84 -26.92 66.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.91 -46.42 78.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.792 1.237 . . . . 0.0 109.547 171.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.87 -46.8 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.45 -53.79 36.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.82 -44.23 73.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.493 0.717 . . . . 0.0 110.619 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.47 88.2 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.846 0.748 . . . . 0.0 111.865 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.32 -41.11 81.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.386 0.539 . . . . 0.0 111.049 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -57.29 -46.49 83.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.542 1.937 . . . . 0.0 109.778 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.458 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . . . -67.78 -34.09 76.11 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.899 0.48 . . . . 0.0 111.472 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.87 39.27 4.4 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.924 1.25 . . . . 0.0 111.544 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.71 143.45 50.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.539 1.17 . . . . 0.0 109.201 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -66.69 -19.73 65.82 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 170.04 41.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.97 130.83 27.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.315 1.446 . . . . 0.0 107.396 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.08 137.63 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 t -127.76 124.15 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -51.18 146.01 12.11 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.831 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.91 168.19 72.37 Favored 'Cis proline' 0 CA--C 1.534 0.509 0 CA-C-N 119.273 0.776 . . . . 0.0 111.913 -3.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -177.97 152.41 0.74 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.665 1.186 . . . . 0.0 109.104 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -148.37 -177.51 5.81 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.62 1.968 . . . . 0.0 109.751 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.13 -26.63 39.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.77 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.51 -53.02 51.54 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.743 1.217 . . . . 0.0 112.135 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.24 -33.77 61.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.059 0.845 . . . . 0.0 109.654 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -52.11 66.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.377 0.989 . . . . 0.0 109.318 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.57 -28.42 69.63 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.6 0.76 . . . . 0.0 111.867 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.67 -43.96 24.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.077 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -65.91 -30.49 71.09 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.429 -1.419 . . . . 0.0 110.015 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -58.75 -52.88 63.81 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.118 168.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -51.68 -48.51 63.45 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.768 1.167 . . . . 0.0 111.178 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -54.71 -51.01 66.93 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.494 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.88 -30.26 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.931 1.696 . . . . 0.0 113.043 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -58.04 -48.05 81.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.77 -23.99 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -170.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -68.68 0.77 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 mt -67.2 -26.64 66.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.709 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.54 39.47 18.08 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -165.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.245 0.851 0 CA-C-N 117.912 0.856 . . . . 0.0 109.558 175.597 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 119.707 -0.187 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.26 98.19 6.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -125.23 28.57 6.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.248 1.019 . . . . 0.0 109.915 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 61.62 0.21 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.477 1.911 . . . . 0.0 109.933 168.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -178.93 24.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.776 3.23 . . . . 0.0 109.308 -162.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.42 115.04 0.71 Allowed 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.959 1.303 . . . . 0.0 109.327 164.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -69.31 123.24 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.28 159.35 16.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -121.62 137.04 54.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 164.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 t -134.34 114.1 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.68 72.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -80.1 165.84 22.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.643 1.177 . . . . 0.0 109.065 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.48 -9.69 59.76 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.819 -1.175 . . . . 0.0 111.047 166.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 16.3 t80 -132.95 107.75 8.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.34 -1.475 . . . . 0.0 108.807 -170.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -49.77 -45.62 49.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.879 0.763 . . . . 0.0 112.758 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.422 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 57.3 m -52.43 -36.77 55.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.811 0.844 . . . . 0.0 111.502 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 ttm -57.16 -34.63 68.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 116.791 -1.576 . . . . 0.0 110.386 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.79 -42.82 99.87 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.129 1.786 . . . . 0.0 110.954 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -63.53 -54.15 40.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.58 -63.37 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.613 1.565 . . . . 0.0 109.143 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.47 -51.9 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 119.704 1.138 . . . . 0.0 110.768 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.58 -40.93 84.52 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 118.676 0.671 . . . . 0.0 111.231 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.08 -53.5 37.42 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 118.732 0.696 . . . . 0.0 109.146 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.45 -36.25 68.83 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 124.143 0.977 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.45 -67.15 0.35 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.258 169.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -57.38 -27.93 62.74 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.521 1.055 . . . . 0.0 113.089 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -58.02 -20.58 39.85 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.741 1.155 . . . . 0.0 112.563 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.1 mt -108.83 -35.7 6.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.223 3.009 . . . . 0.0 111.612 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.8 177.62 28.31 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.428 1.489 . . . . 0.0 110.985 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 62.22 -177.8 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.914 1.286 . . . . 0.0 112.392 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 170.29 -167.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 130.581 3.552 . . . . 0.0 105.568 -164.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 56.12 46.65 21.15 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.751 1.62 . . . . 0.0 111.977 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -71.77 149.21 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' HB3' ' HH ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -124.36 173.13 8.6 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.493 2.317 . . . . 0.0 106.523 166.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.75 176.7 8.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.986 1.314 . . . . 0.0 109.111 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.4 169.66 16.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.725 2.01 . . . . 0.0 106.696 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.93 -32.12 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.539 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -170.94 174.83 4.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.936 1.695 . . . . 0.0 107.558 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.65 -36.06 69.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.32 1.438 . . . . 0.0 114.75 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.08 -40.76 90.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -71.33 -34.81 70.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 110.713 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.19 66.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.408 1.083 . . . . 0.0 109.232 -175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.44 -42.65 64.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.542 0.737 . . . . 0.0 111.527 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.67 -28.57 65.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.055 0.542 . . . . 0.0 111.713 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.61 -53.21 59.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.801 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.44 -54.72 32.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.941 0.792 . . . . 0.0 110.616 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.45 11.89 0.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.93 86.6 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 158.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.33 88.73 0.34 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.498 1.523 . . . . 0.0 109.827 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.68 0.24 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.715 1.626 . . . . 0.0 111.014 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.401 ' HH ' ' HB3' ' A' ' 34' ' ' GLU . 41.4 m-85 -54.32 141.14 31.08 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.128 0.971 . . . . 0.0 109.344 166.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.2 -18.14 5.11 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.769 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.21 147.53 27.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.718 1.259 . . . . 0.0 107.878 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 t -131.9 128.2 59.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.7 132.48 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 p -151.78 161.16 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.294 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.74 169.98 13.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 110.076 169.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -80.23 -57.7 3.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 159.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -77.51 111.37 13.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.417 0.687 . . . . 0.0 109.2 -159.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.9 mmm -119.42 170.55 6.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.808 0.843 . . . . 0.0 110.726 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.82 -3.63 10.52 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.59 2.86 . . . . 0.0 113.015 166.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.84 -91.83 0.06 Allowed 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -160.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.7 ttm -91.07 95.12 9.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.202 1.801 . . . . 0.0 107.613 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -51.63 154.28 2.01 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 108.449 172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.78 -24.5 26.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.031 0.824 . . . . 0.0 112.922 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.88 -52.23 31.83 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.564 1.182 . . . . 0.0 110.801 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -68.78 -32.37 72.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.179 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.31 -59.55 5.28 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 118.129 -0.938 . . . . 0.0 109.108 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.06 -55.51 5.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.761 1.224 . . . . 0.0 109.108 173.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -64.66 -27.55 69.0 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 117.868 -1.063 . . . . 0.0 113.286 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.9 m -69.19 -50.97 42.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 119.383 0.992 . . . . 0.0 109.04 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.2 mt -45.89 -57.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.384 1.088 . . . . 0.0 112.279 165.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 8.03 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.594 2.357 . . . . 0.0 112.839 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.64 -28.39 67.68 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.629 1.559 . . . . 0.0 110.868 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 127.98 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 1 C-N-CA 134.278 5.031 . . . . 0.0 107.044 175.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.43 25.41 1.1 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.667 1.127 . . . . 0.0 114.896 -172.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.22 34.17 2.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.273 1.829 . . . . 0.0 110.604 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . 0.284 0.5 OUTLIER 95.0 30.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.533 1.533 . . . . 0.0 111.083 168.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.2 p -52.49 -31.97 37.71 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.33 -13.87 60.45 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.916 1.235 . . . . 0.0 112.745 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.5 mt -58.05 129.79 82.75 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 109.244 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.24 109.74 2.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.958 1.772 . . . . 0.0 108.938 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.12 94.66 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.182 0.993 . . . . 0.0 109.043 174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tp -87.18 113.97 23.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.804 -1.185 . . . . 0.0 108.222 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mtt -84.8 124.61 31.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.5 114.91 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -147.25 -179.41 6.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.513 1.149 . . . . 0.0 109.904 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.05 -24.95 16.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 112.014 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -91.24 151.83 20.76 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 119.08 0.855 . . . . 0.0 111.152 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.61 -80.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.424 171.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? 52.55 100.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.422 1.489 . . . . 0.0 110.432 -167.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -54.46 -37.79 65.61 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.471 -1.393 . . . . 0.0 110.2 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -33.81 74.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 0.627 . . . . 0.0 112.553 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -65.14 -44.52 88.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.28 0.632 . . . . 0.0 109.442 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.73 -50.48 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.766 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.16 -56.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.62 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.14 95.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.415 0.552 . . . . 0.0 109.964 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.15 77.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.927 0.491 . . . . 0.0 112.129 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -69.7 -52.3 26.83 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.699 1.999 . . . . 0.0 111.086 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.15 77.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.35 41.94 1.01 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.432 1.491 . . . . 0.0 111.782 169.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 165.27 4.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.7 1.2 . . . . 0.0 110.695 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.0 t -51.41 -44.6 62.3 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.524 1.13 . . . . 0.0 108.712 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.35 172.7 39.08 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 169.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -100.86 141.36 33.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -131.19 128.27 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.17 139.2 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -58.29 139.96 83.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.526 168.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.51 131.31 23.49 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.4 1.179 . . . . 0.0 111.267 -1.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -131.5 159.15 38.96 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.164 0.985 . . . . 0.0 109.511 169.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 p -152.16 171.12 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.836 2.454 . . . . 0.0 108.364 -168.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.87 75.02 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.03 -15.27 12.56 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.31 -33.09 6.74 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.193 1.36 . . . . 0.0 110.869 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.94 -49.09 66.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.544 1.538 . . . . 0.0 108.65 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -57.07 -33.11 66.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 125.954 1.702 . . . . 0.0 112.689 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 32.9 tt0 -78.07 -33.62 50.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.412 0.285 . . . . 0.0 110.246 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -63.15 -43.4 98.41 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.823 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.9 mt -55.71 -52.91 62.26 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.94 -35.43 73.12 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.418 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 23.8 mtmt -61.77 -59.39 5.23 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.09 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 pt -65.25 -30.16 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.547 1.521 . . . . 0.0 112.869 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -55.3 -62.89 1.37 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.46 -35.45 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -61.4 1.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.875 1.27 . . . . 0.0 109.193 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mt -79.66 -20.88 45.61 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.436 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.72 38.06 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.818 -169.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.7 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.059 -1.448 . . . . 0.0 109.966 -178.049 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.57 92.67 1.41 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -151.46 158.88 44.24 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.077 0.951 . . . . 0.0 109.063 -159.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.64 -10.04 59.6 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.492 0.717 . . . . 0.0 110.75 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 48.87 48.08 20.76 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 126.592 1.957 . . . . 0.0 109.281 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp -29.08 104.88 0.03 OUTLIER 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.571 1.548 . . . . 0.0 113.952 -158.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -90.74 132.37 35.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.616 -165.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -107.68 104.44 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.6 134.15 38.28 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.36 118.7 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.85 56.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.312 1.445 . . . . 0.0 108.222 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.68 146.17 55.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -69.01 -58.24 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.782 0.833 . . . . 0.0 109.073 172.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.4 t80 -72.81 114.22 10.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 m -50.43 -51.45 46.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 112.337 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 24.8 m -61.6 -26.59 68.08 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.564 -1.208 . . . . 0.0 112.176 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 ttm -59.77 -44.55 93.82 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.629 1.559 . . . . 0.0 109.903 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -65.42 -36.94 85.44 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 119.267 0.939 . . . . 0.0 111.054 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.3 -42.79 99.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.189 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.84 -66.19 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 116.688 -1.625 . . . . 0.0 107.798 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.36 -49.55 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.309 1.868 . . . . 0.0 110.993 -172.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -57.92 -42.91 85.8 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.728 0.811 . . . . 0.0 110.607 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.93 -45.74 91.06 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.388 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 mt -59.49 -44.37 93.08 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.721 0.692 . . . . 0.0 109.296 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.49 -47.45 78.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.644 0.778 . . . . 0.0 111.131 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -60.99 -42.44 98.41 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.038 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.56 -44.5 85.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.78 1.232 . . . . 0.0 110.02 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.91 4.64 16.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.266 1.027 . . . . 0.0 112.234 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.01 -18.08 47.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.617 1.58 . . . . 0.0 114.53 166.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -67.74 156.95 35.8 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.015 1.408 . . . . 0.0 111.234 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -136.09 -172.72 3.19 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.352 1.861 . . . . 0.0 109.9 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.8 t30 55.17 58.68 4.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 127.177 2.191 . . . . 0.0 112.559 165.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.7 148.14 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.897 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -121.26 160.06 24.69 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.152 1.781 . . . . 0.0 108.187 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 28.2 tt0 -121.59 151.9 39.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.56 164.81 21.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -72.56 -35.82 68.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.516 0.327 . . . . 0.0 111.234 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.81 176.89 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.719 1.208 . . . . 0.0 109.797 -170.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.63 43.64 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.259 1.885 . . . . 0.0 115.866 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.5 -51.45 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.666 2.233 . . . . 0.0 107.981 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.29 -34.36 76.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.645 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.97 82.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.665 -1.272 . . . . 0.0 110.197 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.32 -41.52 89.28 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.69 -30.0 69.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.353 0.661 . . . . 0.0 112.666 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 35' ' ' GLU . 4.3 mptp? -67.69 -42.34 82.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.357 -0.839 . . . . 0.0 110.167 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.9 -39.02 93.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.732 1.151 . . . . 0.0 110.225 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -70.25 12.33 0.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.796 0.839 . . . . 0.0 112.673 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.03 16.54 7.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.122 2.169 . . . . 0.0 111.836 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.47 -178.68 38.16 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.525 1.511 . . . . 0.0 115.57 162.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.01 73.5 0.97 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -69.44 154.66 41.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.614 0.766 . . . . 0.0 109.659 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.87 -32.28 11.24 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.612 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -142.86 149.85 39.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.42 64.57 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.32 132.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 153.98 37.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.787 0.435 . . . . 0.0 110.394 -169.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' ' 13' ' ' ASP . 7.9 t0 -84.84 167.47 15.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 161.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -73.08 -44.43 60.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.871 0.868 . . . . 0.0 110.325 164.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -68.61 29.38 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 131.403 3.881 . . . . 0.0 115.909 -158.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 38.0 mtt -65.94 170.54 4.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 127.891 2.476 . . . . 0.0 109.826 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.1 -39.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.825 2.35 . . . . 0.0 112.915 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -124.56 -76.94 0.59 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 123.924 0.889 . . . . 0.0 109.436 -167.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 tpt -72.75 103.78 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.36 164.14 19.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.332 0.587 . . . . 0.0 109.745 173.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.59 -25.54 67.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 121.069 -0.586 . . . . 0.0 114.111 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.08 60.51 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.054 1.342 . . . . 0.0 108.919 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.55 -42.64 98.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.57 0.748 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -54.63 -52.4 62.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.856 0.753 . . . . 0.0 109.259 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.7 -58.96 4.9 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 123.411 0.684 . . . . 0.0 110.179 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -63.26 -30.57 71.69 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.994 0.815 . . . . 0.0 112.39 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 68.9 m -69.07 -51.23 41.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.11 0.964 . . . . 0.0 108.426 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.4 mt -56.13 -47.51 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.533 0.733 . . . . 0.0 109.982 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -58.88 -23.62 61.21 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.428 1.491 . . . . 0.0 112.839 -175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.07 -62.04 2.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.925 0.89 . . . . 0.0 111.568 -169.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 4.7 p-10 -161.66 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.108 1.363 . . . . 0.0 108.604 166.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.402 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . 63.56 1.92 5.24 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.627 2.06 . . . . 0.0 115.068 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.08 9.16 2.26 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.781 2.433 . . . . 0.0 112.329 -159.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt -96.8 -10.4 26.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.027 1.731 . . . . 0.0 111.092 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.5 p -54.03 -47.33 71.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.414 0.686 . . . . 0.0 112.153 -166.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.04 7.32 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.35 142.78 48.6 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-N 119.839 1.2 . . . . 0.0 111.381 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 72.18 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.696 2.264 . . . . 0.0 109.803 160.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.46 137.45 24.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 158.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 tp -141.69 113.53 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.72 128.92 36.73 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 124.269 0.981 . . . . 0.0 108.444 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.63 110.49 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -153.13 167.96 27.51 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.578 -0.701 . . . . 0.0 110.3 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.72 -23.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.343 -0.848 . . . . 0.0 112.474 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.67 116.3 22.58 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.444 1.02 . . . . 0.0 109.329 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.53 -81.42 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.438 166.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.5 tptt 45.94 95.04 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.3 1.44 . . . . 0.0 111.213 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.71 -33.78 35.95 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 120.225 -1.547 . . . . 0.0 112.138 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -42.98 85.73 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.701 1.137 . . . . 0.0 112.491 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -59.56 -44.88 93.14 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.701 0.8 . . . . 0.0 109.098 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.41 -46.07 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.954 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -61.36 -52.51 60.47 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.576 1.08 . . . . 0.0 108.52 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.28 -45.93 69.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.521 1.055 . . . . 0.0 110.962 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.85 82.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.332 0.653 . . . . 0.0 109.951 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.05 86.76 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.89 0.768 . . . . 0.0 110.609 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -55.31 -51.49 66.55 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 126.742 2.017 . . . . 0.0 110.857 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -21.01 66.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.09 25.18 8.51 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.849 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.8 136.39 57.97 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 p -74.55 -1.75 22.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . 172.75 169.05 34.89 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 121.182 -0.949 . . . . 0.0 111.619 172.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -139.72 92.7 2.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.026 1.331 . . . . 0.0 108.699 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.04 112.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.75 157.85 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -64.12 159.58 55.43 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.037 158.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.1 166.81 81.46 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.826 0.974 . . . . 0.0 110.097 -11.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -178.09 158.73 1.24 Allowed 'General case' 0 C--N 1.333 -0.135 0 O-C-N 121.266 -0.897 . . . . 0.0 111.285 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -154.86 -177.34 6.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.766 2.026 . . . . 0.0 109.026 -173.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.83 -23.55 53.24 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.753 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.32 -53.51 49.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.877 0.871 . . . . 0.0 112.075 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -30.5 60.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 0.0 109.935 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -53.84 53.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.407 1.003 . . . . 0.0 108.94 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.98 -39.77 87.25 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.533 0.606 . . . . 0.0 111.469 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.0 -47.83 74.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.171 0.989 . . . . 0.0 109.87 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 1.8 mmmp? -68.15 -37.48 81.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.15 -1.881 . . . . 0.0 112.336 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.45 -58.32 9.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.521 1.055 . . . . 0.0 108.207 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -58.19 -36.05 72.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.15 0.98 . . . . 0.0 109.937 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -56.94 -56.0 27.35 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 117.589 -1.196 . . . . 0.0 112.901 168.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.0 pt -68.95 -25.67 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 121.398 1.908 . . . . 0.0 112.934 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -57.87 -55.73 31.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.85 -47.13 79.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 122.547 0.339 . . . . 0.0 111.676 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -78.23 -71.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.202 1.001 . . . . 0.0 109.727 -168.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.1 mt -64.9 -20.67 66.56 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.211 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.88 42.36 16.73 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 -166.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.249 1.072 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.234 169.306 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.68 -142.77 0.17 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 152.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -71.52 -178.06 2.05 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 162.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -53.24 -23.84 9.79 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.076 -1.015 . . . . 0.0 111.115 165.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 58.63 49.13 10.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.645 1.978 . . . . 0.0 107.643 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 112.1 2.33 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 110.511 -167.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -81.57 149.96 28.39 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.884 0.874 . . . . 0.0 109.549 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.401 ' CZ ' ' CE1' ' A' ' 53' ' ' PHE . 12.0 m-85 -120.97 106.62 11.77 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.415 1.086 . . . . 0.0 109.528 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.77 136.15 43.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.611 1.55 . . . . 0.0 108.84 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -136.15 105.5 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.343 1.457 . . . . 0.0 107.3 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.29 70.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.239 1.016 . . . . 0.0 108.378 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.38 138.75 35.58 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 1.3 t70 -53.07 -33.08 50.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.939 2.095 . . . . 0.0 112.656 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -115.24 120.49 39.86 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 107.156 -168.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -53.07 -47.69 68.29 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.62 -175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.3 m -51.85 -44.64 63.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.625 1.102 . . . . 0.0 111.539 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.83 94.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -69.56 -44.16 71.42 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.913 1.285 . . . . 0.0 109.314 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -52.45 -52.34 54.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.13 2.172 . . . . 0.0 109.723 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.89 -62.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.218 -1.372 . . . . 0.0 108.261 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -52.03 -48.1 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 120.822 1.647 . . . . 0.0 110.761 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -49.86 73.23 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.674 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -60.39 -42.67 96.37 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 118.521 0.601 . . . . 0.0 110.713 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.69 -39.4 94.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.765 0.826 . . . . 0.0 111.013 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -64.84 -48.43 74.38 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 121.913 -0.492 . . . . 0.0 110.378 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -58.84 -39.76 82.22 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.07 0.948 . . . . 0.0 110.951 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.5 -51.04 68.33 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.36 1.064 . . . . 0.0 109.338 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.25 -48.21 80.95 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.06 3.14 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.4 1.953 . . . . 0.0 111.977 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.07 133.47 51.7 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 109.63 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 -176.38 5.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -167.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.7 t30 62.06 80.39 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 128.622 2.769 . . . . 0.0 108.76 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.06 160.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.354 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -114.31 147.08 39.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 158.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.37 164.31 12.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 158.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.75 167.86 14.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 158.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.44 -27.41 46.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.865 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -176.17 156.93 1.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.779 1.232 . . . . 0.0 108.084 -158.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -42.52 -45.33 5.47 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.107 1.337 . . . . 0.0 114.807 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.47 -36.87 78.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 119.608 1.704 . . . . 0.0 110.417 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -70.87 -31.97 68.82 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 122.763 0.425 . . . . 0.0 110.23 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.16 61.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -58.43 -40.12 81.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.779 0.432 . . . . 0.0 111.605 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -56.12 -51.35 68.26 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.971 0.508 . . . . 0.0 109.877 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -55.74 -46.68 77.74 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.184 0.994 . . . . 0.0 110.297 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.5 mt -58.07 -46.99 84.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.958 0.799 . . . . 0.0 110.286 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -81.47 5.18 18.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.652 0.781 . . . . 0.0 112.423 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -57.22 12.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 159.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.26 88.89 0.07 OUTLIER Glycine 0 C--N 1.339 0.701 0 O-C-N 121.142 -0.974 . . . . 0.0 113.825 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.3 84.08 0.03 OUTLIER Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.946 1.736 . . . . 0.0 114.993 158.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -81.91 175.8 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.569 0.699 . . . . 0.0 112.649 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.45 -72.61 1.15 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 165.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE1' ' CZ ' ' A' ' 8' ' ' PHE . 27.1 m-85 -110.91 154.24 24.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.855 -171.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.28 91.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.37 129.39 52.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.3 p -151.38 162.2 41.34 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.655 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 18.0 t70 -72.89 -177.0 2.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.529 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 9.1 t-105 -116.11 -33.13 5.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.334 2.654 . . . . 0.0 112.366 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -76.2 21.48 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.306 2.242 . . . . 0.0 114.133 -159.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.27 147.06 79.01 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.342 1.057 . . . . 0.0 110.214 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.57 -172.21 1.24 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.014 2.476 . . . . 0.0 110.14 159.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 55.78 -105.86 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.613 1.965 . . . . 0.0 109.981 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.8 ttm -87.88 85.89 7.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.8 156.9 22.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.014 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.62 64.18 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.685 -169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.74 -35.59 44.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.32 1.56 . . . . 0.0 110.951 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -26.03 39.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.164 0.893 . . . . 0.0 111.254 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.14 -54.38 47.57 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.23 1.412 . . . . 0.0 108.622 164.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tp -52.46 -58.51 6.51 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.088 0.955 . . . . 0.0 108.578 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -64.25 -28.15 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.352 1.433 . . . . 0.0 112.774 -174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.3 m -62.22 -53.96 47.75 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.917 1.235 . . . . 0.0 108.354 168.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 mt -56.29 -47.47 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.688 1.195 . . . . 0.0 107.853 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -5.98 12.12 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.389 1.876 . . . . 0.0 113.652 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -75.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.234 1.379 . . . . 0.0 109.858 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.22 -112.74 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.826 1.651 . . . . 0.0 108.167 161.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.59 22.29 52.09 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 120.052 1.296 . . . . 0.0 112.922 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.58 -6.97 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 127.874 2.47 . . . . 0.0 113.976 -165.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtm -71.71 -16.82 62.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.851 -1.156 . . . . 0.0 110.148 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -42.72 -39.04 2.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.631 1.973 . . . . 0.0 112.421 159.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.53 -15.56 54.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.7 mt -64.39 131.91 95.2 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 120.116 1.325 . . . . 0.0 110.703 -173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.83 87.65 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.974 3.116 . . . . 0.0 109.779 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.24 104.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 128.516 2.726 . . . . 0.0 108.762 163.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.43 109.9 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.922 1.289 . . . . 0.0 108.198 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 59.6 mmm -87.78 129.84 35.05 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.25 94.51 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.16 1.784 . . . . 0.0 106.189 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -130.93 174.49 9.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.848 0.832 . . . . 0.0 111.09 -167.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.78 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.394 -0.816 . . . . 0.0 111.726 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.0 113.86 23.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.558 0.743 . . . . 0.0 111.73 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 8.48 1.63 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.495 1.518 . . . . 0.0 111.973 161.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -54.32 116.88 2.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.183 0.993 . . . . 0.0 108.452 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -60.87 -36.45 79.22 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.581 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -44.71 85.57 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.455 1.025 . . . . 0.0 109.531 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.64 -40.99 96.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 mt -64.89 -48.79 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.267 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.16 -51.65 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 120.009 1.277 . . . . 0.0 108.11 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.04 -42.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 110.904 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.605 0.762 . . . . 0.0 110.32 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.46 98.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.28 0.632 . . . . 0.0 110.722 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -57.07 -55.01 40.28 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 127.549 2.34 . . . . 0.0 108.83 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.73 -7.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.722 1.209 . . . . 0.0 113.234 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.41 30.81 56.16 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.302 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.87 143.55 36.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.899 1.349 . . . . 0.0 109.309 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 p -73.42 -14.85 61.34 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 122.15 -0.344 . . . . 0.0 111.908 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.34 167.55 38.75 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.84 137.88 40.19 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.24 125.68 51.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 170.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -96.2 150.35 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 166.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.65 69.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.538 -0.726 . . . . 0.0 109.79 166.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.84 175.43 44.8 Favored 'Cis proline' 0 CA--C 1.538 0.7 0 CA-C-N 119.846 0.981 . . . . 0.0 110.266 -15.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -178.07 159.01 1.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.528 1.531 . . . . 0.0 108.399 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -149.33 174.76 12.08 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.695 1.998 . . . . 0.0 109.297 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.99 -34.34 74.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -6.15 2.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.287 1.835 . . . . 0.0 115.686 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.8 t -115.33 -34.56 4.92 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 121.395 1.907 . . . . 0.0 110.15 161.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.05 -56.92 5.64 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.643 1.577 . . . . 0.0 108.19 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -60.42 -31.61 70.57 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.03 1.332 . . . . 0.0 113.002 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 30.1 tt0 -72.54 -43.31 63.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.557 -0.715 . . . . 0.0 109.409 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -68.81 -34.75 76.03 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.067 -1.02 . . . . 0.0 110.015 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.3 mt -55.04 -58.06 9.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.78 -35.36 68.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.711 0.687 . . . . 0.0 112.038 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.452 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 22.7 mttm -59.97 -47.49 85.61 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.369 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.06 -28.02 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.496 1.953 . . . . 0.0 114.033 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -60.47 -54.01 50.72 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.834 0.854 . . . . 0.0 109.101 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -67.63 -51.65 47.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.97 -0.456 . . . . 0.0 110.426 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -64.31 1.0 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -162.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.31 -22.01 66.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 119.429 -0.319 . . . . 0.0 110.903 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 26.81 50.25 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.931 -167.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.3 mmt . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.768 1.784 . . . . 0.0 110.411 177.328 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.314 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.59 -70.86 0.23 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.03 0.932 . . . . 0.0 110.544 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -140.9 -171.36 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.349 1.86 . . . . 0.0 108.209 -163.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -55.39 -32.09 62.35 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.156 -0.965 . . . . 0.0 110.623 159.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 51.66 46.13 27.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.286 1.434 . . . . 0.0 108.421 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt -44.67 127.27 6.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.909 1.683 . . . . 0.0 109.757 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -83.89 131.37 34.87 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -83.8 138.46 33.23 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 158.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.07 135.75 51.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 169.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.11 122.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.77 48.0 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.99 157.49 21.77 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.493 -1.379 . . . . 0.0 108.727 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -33.32 71.18 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 121.493 -0.755 . . . . 0.0 111.182 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.1 t80 -102.43 127.84 49.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.058 1.343 . . . . 0.0 107.622 -171.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -49.04 79.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.362 0.601 . . . . 0.0 110.057 -172.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.457 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 8.8 m -63.04 -24.15 67.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.62 -0.705 . . . . 0.0 111.743 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 18.7 ttm -64.95 -34.09 77.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.362 1.437 . . . . 0.0 109.938 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -36.8 80.77 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 120.352 1.433 . . . . 0.0 110.565 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -52.01 -53.06 46.2 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 168.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.22 -63.71 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-O 117.439 -1.267 . . . . 0.0 108.673 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.5 t -52.71 -46.34 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.664 1.574 . . . . 0.0 110.65 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.78 91.12 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.82 1.191 . . . . 0.0 110.318 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.73 -39.54 91.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.309 0.959 . . . . 0.0 111.922 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.57 -41.33 96.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.036 0.934 . . . . 0.0 110.079 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.84 -45.75 92.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.075 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -63.43 -39.39 94.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.799 0.727 . . . . 0.0 110.802 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.61 -12.98 61.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.598 -171.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.84 13.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.35 -90.61 0.43 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.558 1.075 . . . . 0.0 111.197 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -147.69 175.47 10.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.198 0.999 . . . . 0.0 112.824 -159.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -118.74 171.61 8.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 128.43 2.692 . . . . 0.0 109.194 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 77.29 99.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 128.388 2.675 . . . . 0.0 113.228 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -121.1 154.87 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.566 0.698 . . . . 0.0 112.449 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' HH ' ' A' ' 51' ' ' TYR . 4.9 mm-40 -122.3 145.42 48.25 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 158.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -119.71 93.89 4.22 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.29 163.45 27.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.67 0.748 . . . . 0.0 111.079 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.65 -33.05 60.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.308 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.36 160.97 1.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.343 1.457 . . . . 0.0 107.535 -163.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.4 -40.36 10.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.755 1.161 . . . . 0.0 115.156 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.1 t -65.77 -39.41 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.237 2.018 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.22 -29.77 65.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.142 0.977 . . . . 0.0 111.028 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.24 -51.44 68.92 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.949 -1.095 . . . . 0.0 109.401 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.38 -41.06 83.98 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.317 1.047 . . . . 0.0 111.144 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -56.51 -50.8 70.76 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.297 1.039 . . . . 0.0 110.282 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -54.78 -49.67 70.35 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.126 175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.45 -43.84 68.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.074 1.306 . . . . 0.0 109.935 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.59 10.56 0.35 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -4.9 47.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.987 1.267 . . . . 0.0 112.764 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.92 163.16 8.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.229 1.395 . . . . 0.0 113.438 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.2 22.74 76.26 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.466 -1.02 . . . . 0.0 112.281 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HH ' ' HG3' ' A' ' 34' ' ' GLU . 34.0 m-85 -90.96 156.57 17.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.536 1.168 . . . . 0.0 107.974 170.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.81 9.54 0.15 Allowed Glycine 0 C--O 1.225 -0.445 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.23 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.06 132.26 17.4 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.9 t -133.29 86.11 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 CA-C-O 122.436 1.112 . . . . 0.0 108.0 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -97.76 131.61 44.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.194 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -151.86 145.6 25.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.854 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.91 162.17 27.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.91 0.862 . . . . 0.0 109.485 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -70.27 -52.75 20.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.78 1.232 . . . . 0.0 109.478 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.45 82.25 6.52 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.742 1.617 . . . . 0.0 108.656 -169.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.5 mmt -86.95 168.64 17.26 Favored Pre-proline 0 C--O 1.234 0.263 0 O-C-N 121.806 -0.558 . . . . 0.0 111.013 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.37 0.94 9.28 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.217 2.611 . . . . 0.0 113.023 165.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -150.73 -80.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 121.008 1.731 . . . . 0.0 112.05 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.5 ttm -90.73 94.28 9.61 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.43 148.82 0.86 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.855 2.062 . . . . 0.0 111.434 176.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.98 -36.04 41.91 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.521 1.058 . . . . 0.0 113.754 -172.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.36 -34.14 55.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.775 0.83 . . . . 0.0 110.417 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.82 -42.95 85.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.56 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.11 -49.02 79.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.476 1.035 . . . . 0.0 110.013 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 tp -52.43 -56.72 13.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.95 -26.25 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 120.241 1.382 . . . . 0.0 113.243 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 m -65.3 -49.06 70.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.34 0.973 . . . . 0.0 108.609 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.35 -44.42 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.519 1.127 . . . . 0.0 109.261 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 10.21 2.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.249 1.819 . . . . 0.0 111.712 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.81 -15.28 63.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.602 1.092 . . . . 0.0 111.735 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 59.86 -176.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.959 2.104 . . . . 0.0 110.574 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.24 -33.82 1.32 Allowed Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.26 -1.525 . . . . 0.0 110.797 -159.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.08 166.55 32.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.267 1.827 . . . . 0.0 108.113 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.6 mtt 72.45 -8.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 130.178 3.391 . . . . 0.0 116.209 158.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -59.76 -23.95 63.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -15.3 60.84 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.389 1.45 . . . . 0.0 113.538 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.52 135.38 70.67 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.961 0.904 . . . . 0.0 111.559 -170.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.87 87.18 0.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.692 2.261 . . . . 0.0 108.942 162.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.0 140.88 16.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 162.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.17 118.56 14.71 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -172.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.3 mmt -78.28 127.01 31.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.63 110.44 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.7 t -155.71 172.15 18.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.932 0.787 . . . . 0.0 111.232 -168.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.71 -28.18 62.52 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.235 -0.916 . . . . 0.0 111.539 159.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.75 93.29 0.94 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -164.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.9 4.53 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.987 170.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -45.16 105.25 0.05 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.999 1.72 . . . . 0.0 108.524 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -50.7 -43.15 57.62 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 122.462 0.305 . . . . 0.0 110.218 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -49.32 -43.0 43.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.715 1.206 . . . . 0.0 113.317 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -69.59 -40.94 76.4 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.372 1.069 . . . . 0.0 109.802 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.91 -46.45 76.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.683 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.91 -55.99 17.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.73 76.75 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.735 0.698 . . . . 0.0 111.313 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.61 64.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.514 0.726 . . . . 0.0 110.536 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.67 97.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.041 0.536 . . . . 0.0 110.037 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -58.16 -53.84 53.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 126.787 2.035 . . . . 0.0 111.527 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.75 -38.27 78.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.112 0.565 . . . . 0.0 110.254 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.69 30.2 3.11 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.713 1.149 . . . . 0.0 112.298 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.3 150.16 22.65 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.678 1.239 . . . . 0.0 109.699 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -72.79 -18.51 61.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.964 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.2 43.15 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.77 139.52 47.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 77.3 t -133.25 137.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.921 2.088 . . . . 0.0 105.368 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.5 152.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -62.22 149.64 86.52 Favored Pre-proline 0 CA--C 1.542 0.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.233 164.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.61 127.63 14.13 Favored 'Cis proline' 0 N--CA 1.456 -0.723 0 N-CA-C 109.538 -0.985 . . . . 0.0 109.538 -15.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -117.75 156.24 28.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -146.26 178.76 8.0 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 108.872 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.7 -25.49 67.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.215 -0.897 . . . . 0.0 109.216 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.69 -38.83 64.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.186 0.994 . . . . 0.0 112.575 170.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -31.9 20.79 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.828 1.195 . . . . 0.0 109.712 173.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.07 -48.77 75.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.713 1.142 . . . . 0.0 109.404 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.51 -36.14 81.6 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.349 0.66 . . . . 0.0 111.675 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.498 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 10.0 tt0 -66.38 -46.99 74.79 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.81 0.732 . . . . 0.0 109.189 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -44.94 89.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.203 -0.903 . . . . 0.0 108.769 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.05 -53.51 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.701 0.8 . . . . 0.0 110.183 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.93 -45.97 82.35 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.568 0.747 . . . . 0.0 110.997 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.498 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -53.27 -55.99 20.16 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.878 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -27.77 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.935 1.243 . . . . 0.0 112.574 -169.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -54.73 -60.36 3.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 165.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.8 -52.55 42.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 109.725 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.294 1.437 . . . . 0.0 110.983 -164.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.07 -32.13 71.36 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.05 44.45 5.98 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -162.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.1 mmt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 119.115 1.457 . . . . 0.0 109.996 169.268 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.84 174.78 6.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 162.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.43 39.88 0.85 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.167 -0.958 . . . . 0.0 110.962 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -69.9 8.28 0.75 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.388 -1.445 . . . . 0.0 113.714 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.4 71.37 1.38 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.32 135.7 4.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.725 2.01 . . . . 0.0 111.696 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -81.55 129.01 34.51 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -111.31 109.76 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.654 1.182 . . . . 0.0 107.847 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.31 138.53 47.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.732 1.606 . . . . 0.0 109.012 171.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.93 109.22 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.291 1.036 . . . . 0.0 109.308 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.06 52.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -66.55 158.39 29.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.293 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.19 -43.03 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.797 -0.565 . . . . 0.0 111.486 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -92.0 114.66 27.26 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 116.739 -1.6 . . . . 0.0 108.958 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -53.14 -37.55 61.92 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 122.703 2.502 . . . . 0.0 114.622 -167.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 m -48.52 -38.42 20.25 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.578 -1.326 . . . . 0.0 111.708 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.0 ttm -65.36 -25.31 67.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.711 2.004 . . . . 0.0 111.572 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -56.42 22.1 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.452 1.933 . . . . 0.0 107.912 167.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -53.34 54.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.548 1.139 . . . . 0.0 108.584 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.9 -67.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 117.088 -1.434 . . . . 0.0 108.417 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.22 -48.27 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 120.673 1.579 . . . . 0.0 111.0 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -56.33 -48.79 76.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 109.837 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -63.04 -44.58 95.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.64 -44.17 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.17 0.988 . . . . 0.0 110.186 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.43 -42.84 96.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.639 0.776 . . . . 0.0 111.174 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -62.89 -35.13 79.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.57 -5.08 22.06 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.27 0.941 . . . . 0.0 111.464 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.67 15.58 8.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.258 2.623 . . . . 0.0 111.375 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.91 85.14 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.807 169.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -97.91 163.56 12.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.355 1.577 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -159.39 -160.28 0.82 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 110.197 -173.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.42 37.29 23.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.519 1.527 . . . . 0.0 113.085 165.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.44 146.51 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.582 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -110.26 167.17 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 158.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.65 168.86 11.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 163.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.28 164.5 20.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.73 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.997 0.519 . . . . 0.0 110.556 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.66 173.31 8.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.836 1.654 . . . . 0.0 108.54 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.93 -29.11 54.64 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.53 -49.77 56.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.537 2.168 . . . . 0.0 107.321 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -60.63 -32.37 71.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.29 0.636 . . . . 0.0 110.879 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.71 -52.65 59.6 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.728 -1.232 . . . . 0.0 109.042 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.42 -35.38 71.98 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.56 -44.62 93.58 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.34 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -62.58 -38.64 90.9 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.113 0.869 . . . . 0.0 111.528 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.0 mt -59.99 -46.68 88.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.3 1.409 . . . . 0.0 108.991 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -77.66 29.18 0.16 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.037 1.335 . . . . 0.0 111.486 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.77 32.8 4.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.559 1.944 . . . . 0.0 109.724 159.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.61 19.69 8.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.913 164.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.59 83.02 0.62 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.125 1.463 . . . . 0.0 109.528 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -69.56 170.33 10.88 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.158 0.583 . . . . 0.0 109.858 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 -40.62 26.34 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.668 -0.645 . . . . 0.0 112.565 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -139.73 155.84 47.12 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.328 0.564 . . . . 0.0 111.547 -166.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.3 71.08 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.56 129.37 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -150.42 157.67 43.3 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.262 -1.524 . . . . 0.0 110.525 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -73.76 171.96 12.36 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -66.7 -59.15 3.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.55 71.36 5.01 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -158.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.82 154.35 47.79 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.3 160.04 45.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.8 1.666 . . . . 0.0 109.257 162.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.24 -79.07 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 C-N-CA 129.104 2.962 . . . . 0.0 114.227 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 ttp -88.45 79.79 7.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.86 150.17 2.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.026 1.73 . . . . 0.0 109.517 167.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.98 -27.93 71.2 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.205 -0.934 . . . . 0.0 113.785 -161.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -31.42 59.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.974 0.887 . . . . 0.0 111.36 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.65 -40.54 84.53 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.792 0.723 . . . . 0.0 109.119 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.8 tp -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.521 0.6 . . . . 0.0 109.73 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tp -53.19 -56.98 12.15 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.946 0.898 . . . . 0.0 109.526 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -63.48 -30.17 71.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.026 0.83 . . . . 0.0 112.25 -174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 m -62.18 -55.77 25.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 109.126 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.81 -44.04 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.125 1.37 . . . . 0.0 108.183 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -57.7 -26.24 61.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.999 1.719 . . . . 0.0 112.756 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.63 -21.7 28.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.181 0.901 . . . . 0.0 112.311 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.36 133.89 43.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.999 1.272 . . . . 0.0 110.488 -173.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.67 58.99 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.668 -0.645 . . . . 0.0 114.308 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.32 -58.71 1.86 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.696 1.248 . . . . 0.0 108.254 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.9 mtt -69.42 -12.75 61.91 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -164.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -57.23 -26.86 61.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.837 1.199 . . . . 0.0 111.264 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.62 -10.09 59.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.002 1.321 . . . . 0.0 113.975 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.58 143.5 95.25 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 119.625 1.102 . . . . 0.0 110.125 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.78 87.94 0.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.996 2.464 . . . . 0.0 110.099 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.85 88.77 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 126.321 1.848 . . . . 0.0 107.083 163.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.5 tp -96.26 118.33 32.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.62 122.76 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.2 t -132.55 99.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.412 1.885 . . . . 0.0 107.405 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -139.61 -173.54 3.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.132 0.968 . . . . 0.0 110.382 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.09 -15.02 15.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.116 1.367 . . . . 0.0 111.666 163.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.54 103.75 7.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.61 -73.58 0.11 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 39.98 92.7 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 126.433 1.893 . . . . 0.0 110.782 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -28.43 -57.75 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.071 1.348 . . . . 0.0 114.276 173.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 22.1 tt0 -54.73 -40.26 69.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.656 2.382 . . . . 0.0 113.654 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.04 -39.47 72.27 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.856 1.263 . . . . 0.0 110.474 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.97 -50.41 79.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.276 2.1 mt -53.9 -46.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 116.857 -1.544 . . . . 0.0 114.93 168.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.69 82.55 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 121.325 1.875 . . . . 0.0 110.488 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.66 -42.6 99.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.009 0.924 . . . . 0.0 110.729 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.58 78.79 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.565 -0.709 . . . . 0.0 112.394 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.44 -44.07 75.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.487 1.515 . . . . 0.0 110.091 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.13 58.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.548 0.739 . . . . 0.0 112.739 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.41 39.79 34.85 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.26 0.936 . . . . 0.0 112.453 173.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.62 150.4 31.97 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.428 0.614 . . . . 0.0 109.972 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -77.15 -14.33 59.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.96 0.904 . . . . 0.0 111.466 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.67 171.37 43.0 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 160.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -132.07 133.12 44.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.2 t -134.99 134.92 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.0 141.84 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -53.84 142.22 44.95 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.308 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.32 135.87 40.69 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.497 1.213 . . . . 0.0 110.77 -10.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.96 152.24 51.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 109.275 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 p -149.74 -176.71 5.52 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.66 1.584 . . . . 0.0 108.943 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.89 73.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.402 -0.809 . . . . 0.0 108.901 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.46 -19.89 17.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.751 1.22 . . . . 0.0 114.218 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.58 -25.46 9.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.783 1.174 . . . . 0.0 111.668 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -47.59 81.21 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.17 -30.32 71.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 112.162 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -78.8 -43.36 25.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.465 0.706 . . . . 0.0 110.114 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -25.63 60.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.224 -1.369 . . . . 0.0 110.133 175.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 mt -57.52 -53.24 60.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.457 1.026 . . . . 0.0 108.677 166.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -50.09 -45.47 52.64 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.801 0.728 . . . . 0.0 111.302 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -62.67 1.5 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.316 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 pt -67.47 -27.03 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 120.319 1.418 . . . . 0.0 113.089 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -53.78 -62.51 1.61 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 167.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.02 -29.6 58.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -168.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -69.49 0.67 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.553 1.541 . . . . 0.0 107.829 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.97 -28.14 66.35 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.465 0.575 . . . . 0.0 111.546 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 43.16 6.52 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -162.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 38.2 mmt . . . . . 0 C--O 1.253 1.257 0 CA-C-N 118.66 1.23 . . . . 0.0 109.296 169.573 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtt . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.37 19.58 3.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.661 1.573 . . . . 0.0 112.19 -172.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.29 61.81 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.066 1.747 . . . . 0.0 109.929 -159.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.53 -12.15 50.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.161 -0.962 . . . . 0.0 112.135 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.99 56.71 0.85 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.921 2.488 . . . . 0.0 106.347 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.46 120.54 7.31 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.605 2.362 . . . . 0.0 110.173 176.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 166.1 12.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.453 1.12 . . . . 0.0 111.263 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -124.17 161.67 25.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.25 139.38 43.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 158.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -127.87 104.24 11.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.04 78.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.21 157.83 35.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 165.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -80.79 -23.21 39.43 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.46 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -83.41 -151.75 0.11 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.127 1.371 . . . . 0.0 109.575 178.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -139.78 -43.81 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.097 -1.002 . . . . 0.0 108.539 159.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.46 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.2 m -50.12 -31.93 14.68 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 169.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 ttm -64.72 -39.69 94.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.289 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -33.35 71.16 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 122.122 2.237 . . . . 0.0 110.937 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -56.43 -54.0 50.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.1 -60.25 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.51 1.124 . . . . 0.0 108.548 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.63 -46.92 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.597 1.089 . . . . 0.0 111.064 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.499 HH22 ' HB2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -64.24 -42.88 96.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.835 1.198 . . . . 0.0 109.914 -179.405 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.49 -53.96 51.34 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.195 0.907 . . . . 0.0 110.69 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.77 -37.46 71.12 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.157 0.983 . . . . 0.0 111.325 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -52.04 40.91 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.843 171.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HG3' HH11 ' A' ' 22' ' ' ARG . 26.1 mttt -62.47 -23.84 67.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.324 1.42 . . . . 0.0 111.997 -172.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -52.22 -48.98 64.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.22 0.918 . . . . 0.0 110.324 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.1 mt -75.84 -50.09 16.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.554 1.542 . . . . 0.0 109.465 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.17 -163.43 31.02 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.622 1.105 . . . . 0.0 111.274 -174.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.499 ' HB2' HH22 ' A' ' 22' ' ' ARG . 61.4 m-85 59.2 174.48 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.209 1.803 . . . . 0.0 111.894 -171.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -170.89 -162.7 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.674 1.19 . . . . 0.0 108.378 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.69 27.57 17.3 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.876 2.071 . . . . 0.0 114.439 159.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.422 HG11 ' HE ' ' A' ' 22' ' ' ARG . 7.5 m -70.08 174.14 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.104 0.562 . . . . 0.0 111.35 -175.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -136.98 177.05 8.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 108.064 164.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -132.09 177.19 7.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.777 1.231 . . . . 0.0 107.962 167.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 172.27 13.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.952 1.301 . . . . 0.0 108.005 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.69 -40.39 88.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.552 0.341 . . . . 0.0 111.181 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -174.74 172.04 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.517 1.927 . . . . 0.0 107.702 -163.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.53 -42.43 26.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.828 1.204 . . . . 0.0 115.539 178.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.47 -47.64 88.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 119.857 1.829 . . . . 0.0 108.517 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.35 -24.74 66.56 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.763 -0.585 . . . . 0.0 111.659 175.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.69 -53.63 44.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tp -51.75 -47.21 64.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.743 1.617 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -56.35 -42.08 77.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.496 1.518 . . . . 0.0 111.388 176.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.0 -45.46 88.89 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.645 -1.284 . . . . 0.0 111.246 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.12 -51.52 66.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.421 1.464 . . . . 0.0 109.521 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.01 29.56 0.11 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.968 0.907 . . . . 0.0 113.172 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.34 18.03 12.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.735 1.614 . . . . 0.0 111.631 170.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.23 -6.53 0.7 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-O 117.984 -1.453 . . . . 0.0 114.904 166.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.83 107.57 0.73 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.381 1.591 . . . . 0.0 109.709 -174.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.91 164.41 14.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.036 1.335 . . . . 0.0 108.646 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.91 -28.87 27.56 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.479 -0.763 . . . . 0.0 112.625 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -145.98 159.46 43.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.192 1.797 . . . . 0.0 108.476 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.37 62.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.4 mt -69.52 131.76 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.62 141.43 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.599 0.359 . . . . 0.0 110.13 -163.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -62.89 165.19 7.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 164.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -80.96 -59.63 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 159.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.97 37.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.341 1.056 . . . . 0.0 112.55 -170.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.7 ptp -63.56 149.68 91.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 158.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.74 175.04 11.7 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.586 2.19 . . . . 0.0 110.607 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 m120 53.56 -92.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.992 2.117 . . . . 0.0 111.437 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -90.8 97.3 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.61 164.04 6.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.577 0.626 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.24 -38.38 56.63 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.641 0.639 . . . . 0.0 113.63 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.53 -38.92 92.7 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.976 0.888 . . . . 0.0 110.42 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.67 -35.58 52.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.13 0.572 . . . . 0.0 110.269 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.23 -49.93 74.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.568 0.747 . . . . 0.0 109.152 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.87 -56.57 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.597 1.159 . . . . 0.0 109.643 172.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -64.48 -31.34 72.51 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.109 1.322 . . . . 0.0 113.454 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.2 m -62.44 -51.5 67.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.37 1.068 . . . . 0.0 109.005 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.3 mt -58.63 -43.54 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 126.217 1.807 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -8.95 41.66 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.486 -172.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.36 -68.61 0.16 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.293 1.037 . . . . 0.0 111.561 -172.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 p30 170.98 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.281 1.432 . . . . 0.0 114.554 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -67.86 22.21 0.26 Allowed Glycine 0 CA--C 1.539 1.567 0 CA-C-N 120.821 1.646 . . . . 0.0 116.081 -173.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 75.3 -16.97 0.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 131.066 3.746 . . . . 0.0 111.484 -162.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.3 mtt -70.98 -11.95 61.26 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 111.112 -177.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -35.28 11.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.356 2.262 . . . . 0.0 112.579 173.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.11 -7.17 58.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.656 1.582 . . . . 0.0 114.002 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.07 131.52 95.19 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 119.735 1.152 . . . . 0.0 108.674 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.98 83.65 0.9 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.452 1.434 . . . . 0.0 110.375 167.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.5 115.55 7.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 159.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tp -130.53 107.63 9.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -167.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -73.1 123.71 24.13 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.16 105.3 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -148.25 -166.47 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.35 -21.59 13.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.359 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -82.96 145.74 29.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.81 1.186 . . . . 0.0 110.868 176.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.31 -81.85 0.31 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.984 1.313 . . . . 0.0 109.809 172.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 tptm 46.33 110.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 130.078 3.351 . . . . 0.0 112.551 -164.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -47.57 -45.08 26.75 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 111.825 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -60.81 -31.45 70.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.964 1.256 . . . . 0.0 113.185 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -70.26 -37.39 74.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.747 1.158 . . . . 0.0 110.617 170.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.11 -47.8 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.409 1.004 . . . . 0.0 108.454 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.1 -58.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.88 -51.03 55.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.912 1.233 . . . . 0.0 111.336 -176.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.298 0.499 . . . . 0.0 110.295 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.31 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.441 0.564 . . . . 0.0 111.785 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -63.85 -47.19 81.71 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.615 1.966 . . . . 0.0 111.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.86 66.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.777 0.431 . . . . 0.0 112.002 172.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.48 47.15 9.15 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 125.9 1.714 . . . . 0.0 110.691 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.03 144.7 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -65.61 -21.23 66.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.664 0.269 . . . . 0.0 111.569 -178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 175.49 44.4 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -135.05 142.98 46.46 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.02 133.89 44.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 129.461 3.105 . . . . 0.0 104.302 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.02 147.55 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -50.29 134.97 23.89 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.098 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.22 147.39 85.41 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 120.557 1.235 . . . . 0.0 110.902 -6.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.86 145.12 32.09 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.841 -0.537 . . . . 0.0 112.06 176.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -141.36 174.58 10.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.244 1.818 . . . . 0.0 110.23 -170.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.29 67.62 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 175.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.89 66.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.181 1.392 . . . . 0.0 113.997 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 t -93.23 -40.77 10.26 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.569 1.077 . . . . 0.0 109.182 168.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -53.84 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.04 0.936 . . . . 0.0 109.483 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -28.6 70.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.71 1.204 . . . . 0.0 112.653 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.57 -46.58 31.08 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.031 0.933 . . . . 0.0 109.064 178.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -69.83 -32.94 71.62 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 109.823 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.5 -56.91 15.75 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.111 0.964 . . . . 0.0 109.424 167.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -57.17 -29.94 64.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -68.48 0.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 117.511 -1.233 . . . . 0.0 109.148 166.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.5 pt -62.13 -28.12 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 119.831 1.196 . . . . 0.0 112.726 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -59.46 -54.33 47.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.111 0.564 . . . . 0.0 109.797 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.14 -47.03 38.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.985 0.811 . . . . 0.0 110.942 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -68.16 -73.27 0.15 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.774 1.629 . . . . 0.0 110.093 -172.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.03 -21.2 66.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.541 0.61 . . . . 0.0 111.444 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.26 33.62 28.36 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.5 mmm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.057 179.513 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 119.179 -0.438 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.57 67.22 0.81 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.746 2.018 . . . . 0.0 110.496 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 5' ' ' GLU . 44.2 m-20 -54.24 109.96 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.569 1.948 . . . . 0.0 111.043 -163.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -76.9 36.98 0.18 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.718 1.145 . . . . 0.0 110.477 171.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 3' ' ' ASP . 26.4 tt0 -140.47 33.29 1.86 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.479 2.311 . . . . 0.0 106.925 -171.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tp -41.25 123.16 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 128.017 2.527 . . . . 0.0 110.573 -177.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -70.03 130.54 42.42 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.83 160.51 17.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 162.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.72 137.5 51.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.12 103.59 6.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 125.683 1.593 . . . . 0.0 106.947 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.14 53.84 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.629 1.204 . . . . 0.0 107.872 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.51 126.36 30.65 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.87 -45.1 93.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.989 0.516 . . . . 0.0 112.035 -174.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -75.61 106.18 7.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 t -58.05 -33.22 68.78 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.583 1.538 . . . . 0.0 112.885 -171.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.6 m -57.67 -36.84 72.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.406 -1.434 . . . . 0.0 110.851 174.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.1 tpp -55.29 -43.15 74.53 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.346 1.059 . . . . 0.0 109.539 173.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -66.6 -41.88 87.75 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.574 0.625 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -57.2 -47.06 82.24 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.028 173.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.85 -58.14 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.036 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.8 t -54.64 -50.6 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 125.34 1.456 . . . . 0.0 110.699 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -59.99 -41.73 92.69 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.826 0.739 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -64.39 -45.68 86.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.434 0.561 . . . . 0.0 111.346 176.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.29 -43.78 92.56 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.752 0.821 . . . . 0.0 110.269 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.34 -58.74 6.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.009 1.324 . . . . 0.0 110.558 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HE2' ' OD1' ' A' ' 31' ' ' ASN . 11.5 ptmm? -66.27 -22.65 66.31 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 117.37 -1.3 . . . . 0.0 112.087 -177.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.45 90.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.391 1.451 . . . . 0.0 109.197 175.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.33 -42.4 23.04 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.436 1.094 . . . . 0.0 110.089 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.18 -25.13 0.19 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.258 -1.301 . . . . 0.0 115.757 169.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.93 101.59 5.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.425 2.113 . . . . 0.0 111.093 -174.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.483 ' OD1' ' HE2' ' A' ' 26' ' ' LYS . 45.8 m-80 -85.82 -27.4 25.15 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.235 -0.915 . . . . 0.0 112.985 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.54 76.38 2.24 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.297 1.522 . . . . 0.0 108.505 -159.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.23 108.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.813 2.045 . . . . 0.0 105.826 -162.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -86.4 -168.49 2.25 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.332 1.853 . . . . 0.0 109.894 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.92 172.35 1.67 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 130.589 3.555 . . . . 0.0 105.081 -167.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.96 175.75 9.99 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -168.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.78 -39.08 87.68 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.375 -0.828 . . . . 0.0 110.973 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.87 166.57 4.39 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -158.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.59 49.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.296 0.953 . . . . 0.0 112.554 171.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 t -57.81 -45.12 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.435 1.094 . . . . 0.0 110.536 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.93 -30.39 61.23 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.64 0.776 . . . . 0.0 109.633 176.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.91 -50.14 74.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.565 -0.71 . . . . 0.0 109.508 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.26 -45.61 76.08 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.144 0.578 . . . . 0.0 110.362 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.24 -38.0 87.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.051 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.26 -48.02 81.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.422 1.01 . . . . 0.0 109.512 171.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -60.82 -47.99 83.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 35.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.04 -49.28 4.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.64 153.91 20.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.047 1.784 . . . . 0.0 110.246 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -8.2 74.86 Favored Glycine 0 N--CA 1.466 0.685 0 O-C-N 121.047 -1.266 . . . . 0.0 114.03 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -72.7 161.8 30.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 159.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.21 3.79 4.46 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 117.758 -1.579 . . . . 0.0 113.544 164.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.38 141.89 31.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.855 1.828 . . . . 0.0 111.043 -174.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.77 72.07 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -75.81 140.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 t -154.49 147.34 24.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.215 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -72.47 165.11 25.26 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 158.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -77.37 -52.53 8.99 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.467 1.507 . . . . 0.0 110.113 163.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.68 84.52 5.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.527 -158.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.71 162.95 51.96 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.391 1.476 . . . . 0.0 109.73 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.53 176.75 9.69 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.238 1.958 . . . . 0.0 111.166 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 58.41 -98.54 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.1 2.56 . . . . 0.0 110.796 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 9.6 ttm -91.21 104.84 17.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 172.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.08 158.12 14.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.605 0.717 . . . . 0.0 110.685 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.82 -26.04 73.09 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.939 -168.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.438 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -72.58 -38.2 67.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.861 1.33 . . . . 0.0 108.932 175.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -66.44 -40.08 89.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.545 0.611 . . . . 0.0 111.294 174.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.78 -49.61 74.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.07 0.85 . . . . 0.0 109.493 172.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 tp -53.85 -58.2 8.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.073 174.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 29.6 mttt -61.99 -32.37 72.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.922 1.692 . . . . 0.0 112.414 -172.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.6 m -59.27 -49.1 79.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.186 0.995 . . . . 0.0 109.118 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.3 mt -64.92 -46.87 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -20.6 62.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.485 1.114 . . . . 0.0 112.736 -174.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.57 60.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.564 1.074 . . . . 0.0 110.739 172.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.12 154.09 35.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.744 0.702 . . . . 0.0 110.031 -173.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.95 -13.22 79.88 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.702 -178.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.25 -41.87 1.38 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.786 1.293 . . . . 0.0 111.967 -175.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.6 mmt -64.44 -12.92 48.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.194 0.906 . . . . 0.0 111.705 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 p -55.52 -22.45 21.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.769 1.628 . . . . 0.0 113.317 171.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.53 63.02 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.25 0.932 . . . . 0.0 112.576 175.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.1 mt -61.72 139.38 95.38 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 118.94 0.791 . . . . 0.0 111.65 -171.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.32 77.46 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.704 2.936 . . . . 0.0 109.008 159.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -60.99 114.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.285 1.834 . . . . 0.0 107.546 159.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 ' CD2' ' HZ1' ' A' ' 119' ' ' LYS . 61.8 tp -132.81 114.22 13.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 109.483 -166.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mtp -91.25 119.45 31.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.45 101.5 8.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.911 1.685 . . . . 0.0 106.643 -174.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.28 172.12 13.6 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.455 -0.778 . . . . 0.0 111.127 -165.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.6 -13.88 36.22 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.142 -0.974 . . . . 0.0 113.027 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -91.1 123.35 34.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.07 0.948 . . . . 0.0 111.154 -174.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 20.74 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.784 0.833 . . . . 0.0 110.497 163.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -51.27 115.24 1.48 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.635 1.574 . . . . 0.0 108.825 -175.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -58.14 -41.95 84.8 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 119.139 -0.457 . . . . 0.0 109.976 -175.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.42 -32.35 70.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.876 173.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -68.67 -39.31 80.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.939 1.245 . . . . 0.0 109.422 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.81 -44.83 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 118.237 -0.887 . . . . 0.0 108.652 172.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.95 -58.7 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.239 0.927 . . . . 0.0 108.717 175.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.57 83.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.109 0.868 . . . . 0.0 111.055 -173.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.95 74.83 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.096 0.558 . . . . 0.0 110.348 172.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.82 87.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.317 0.508 . . . . 0.0 111.863 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -54.08 -55.54 26.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.608 1.963 . . . . 0.0 108.685 171.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.04 -13.46 61.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.89 1.276 . . . . 0.0 112.734 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.81 36.95 40.62 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.261 -1.299 . . . . 0.0 112.397 178.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.47 43.69 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.204 1.502 . . . . 0.0 109.564 176.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.5 p -71.05 -24.73 62.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 117.716 0.235 . . . . 0.0 111.528 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.8 163.71 36.84 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 118.109 0.413 . . . . 0.0 112.199 174.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -134.21 110.93 9.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.623 1.569 . . . . 0.0 107.988 -176.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.59 99.95 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 106.596 -163.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.59 144.47 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -56.78 162.25 3.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 0.0 111.281 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.09 108.8 0.92 Allowed 'Cis proline' 0 N--CA 1.457 -0.669 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 -21.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.68 76.3 7.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.686 0.794 . . . . 0.0 109.357 -169.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -64.67 172.47 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.257 1.423 . . . . 0.0 112.393 -173.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.75 70.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.09 -18.53 61.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.53 -31.4 9.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.091 1.314 . . . . 0.0 109.553 172.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.74 -47.36 80.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 108.382 175.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -42.56 73.3 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.073 0.949 . . . . 0.0 111.583 -176.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.03 -64.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.605 1.962 . . . . 0.0 109.177 168.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.433 ' HZ1' ' CD2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.181 -173.403 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.35 -53.83 46.48 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.284 0.947 . . . . 0.0 109.445 174.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -35.47 77.38 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.866 0.757 . . . . 0.0 110.044 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -51.75 -57.07 10.31 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.899 0.879 . . . . 0.0 110.652 171.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -17.52 11.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -57.28 -67.31 0.34 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 159.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.37 -36.72 79.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.785 -0.572 . . . . 0.0 112.434 -167.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -67.28 0.73 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -176.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.35 -29.61 67.45 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.8 -171.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.77 25.1 13.83 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 117.762 -1.577 . . . . 0.0 111.4 -166.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 C--O 1.249 1.072 0 CA-C-N 120.266 2.033 . . . . 0.0 111.291 179.213 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.576 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.71 157.07 47.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 58.52 -172.85 0.1 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.089 1.356 . . . . 0.0 109.803 -165.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -85.04 -3.71 58.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.498 -1.376 . . . . 0.0 110.932 158.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 45.92 42.66 9.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.246 1.018 . . . . 0.0 109.984 -158.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.27 119.47 7.45 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.35 1.06 . . . . 0.0 109.313 -173.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -91.07 152.9 20.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.721 0.772 . . . . 0.0 111.814 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.72 156.48 19.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 158.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 tp -119.33 143.19 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.454 ' HB ' HH11 ' A' ' 18' ' ' ARG . 19.4 t -137.34 93.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -171.003 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.07 57.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -174.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.9 131.4 37.47 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.61 -56.64 17.62 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.661 1.185 . . . . 0.0 111.76 177.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.4 t80 -69.6 114.37 7.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -48.89 76.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.377 0.99 . . . . 0.0 111.093 -170.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.49 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.7 m -58.53 -28.42 65.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.551 0.741 . . . . 0.0 111.574 176.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.0 ttp -63.89 -36.27 83.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.568 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.454 HH11 ' HB ' ' A' ' 10' ' ' VAL . 5.6 ttt85 -64.64 -42.17 95.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.729 1.604 . . . . 0.0 109.52 172.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -58.92 -37.91 77.73 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.871 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.41 -65.31 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.574 169.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.8 t -48.21 -52.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.686 2.039 . . . . 0.0 111.189 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -56.57 -47.5 79.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.941 177.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.35 -49.38 77.42 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.777 0.717 . . . . 0.0 111.533 176.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.77 -39.1 83.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 110.988 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -48.58 72.08 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.65 -0.656 . . . . 0.0 110.386 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.99 -28.39 68.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.831 178.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.16 -45.23 95.49 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 119.942 1.246 . . . . 0.0 109.488 173.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.54 -27.74 64.39 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 0.0 111.062 177.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 1.92 6.41 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.412 1.482 . . . . 0.0 113.959 169.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -70.14 170.13 12.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.359 1.08 . . . . 0.0 110.645 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -143.01 -178.79 6.0 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.062 1.345 . . . . 0.0 109.801 -172.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 75.5 -64.22 0.38 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.63 2.372 . . . . 0.0 113.92 170.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.3 m 33.87 65.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.658 1.983 . . . . 0.0 113.984 162.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.28 -174.8 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.015 1.726 . . . . 0.0 110.614 175.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.59 169.55 21.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.386 1.874 . . . . 0.0 108.232 -172.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.94 166.43 26.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 170.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.26 -35.95 80.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.14 0.976 . . . . 0.0 111.33 176.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.17 176.16 3.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.927 2.091 . . . . 0.0 107.615 -169.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.62 -36.22 58.57 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.9 -51.72 69.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 120.396 2.098 . . . . 0.0 107.718 177.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.84 -35.28 77.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.963 0.505 . . . . 0.0 111.02 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.66 -47.68 79.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -42.9 80.25 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.777 0.673 . . . . 0.0 111.453 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.56 -46.86 85.98 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.453 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -55.84 -45.72 78.35 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.226 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -57.34 -38.55 74.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.846 1.203 . . . . 0.0 110.262 178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -72.34 27.21 0.05 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.867 1.267 . . . . 0.0 113.951 173.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.65 -8.61 16.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.901 1.28 . . . . 0.0 111.313 158.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.22 169.68 4.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.075 1.321 . . . . 0.0 112.808 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.4 -1.92 17.81 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.633 -0.922 . . . . 0.0 113.21 -177.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.53 112.06 3.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 166.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.58 -9.56 71.86 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.334 171.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.8 145.09 21.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.815 1.308 . . . . 0.0 111.238 -166.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.86 111.42 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -114.35 136.22 51.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -146.48 162.52 38.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.109 0.413 . . . . 0.0 111.183 171.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 21.8 t70 -75.96 -167.73 0.78 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 158.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.498 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 10.2 t-105 -114.06 -52.84 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.405 2.282 . . . . 0.0 110.857 -175.197 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 86.58 0.15 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.531 2.332 . . . . 0.0 110.33 -167.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -142.99 153.12 60.13 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 124.916 1.287 . . . . 0.0 109.183 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -78.0 -179.22 5.24 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.481 2.12 . . . . 0.0 108.301 165.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 54.9 -94.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.29 1.836 . . . . 0.0 109.983 176.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.0 tpp -91.38 80.7 5.48 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.85 149.72 4.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 159.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.64 -27.62 61.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.284 -0.885 . . . . 0.0 113.34 -169.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -34.39 68.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.644 1.222 . . . . 0.0 110.513 176.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -66.06 -42.49 89.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.546 172.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.84 -50.04 75.47 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -61.97 1.92 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.611 1.164 . . . . 0.0 109.199 173.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.54 -34.24 77.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.677 1.126 . . . . 0.0 112.522 -172.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.4 m -59.04 -48.38 81.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.5 mt -64.09 -48.7 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.412 1.085 . . . . 0.0 109.112 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -29.0 67.64 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.55 -171.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.49 -68.87 0.14 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.463 1.105 . . . . 0.0 112.214 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -173.33 -144.07 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.893 1.277 . . . . 0.0 109.657 -166.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.28 12.89 61.6 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.606 -1.309 . . . . 0.0 112.68 -176.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.21 8.75 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.585 2.354 . . . . 0.0 113.894 -159.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.88 -16.68 62.71 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 121.348 -0.845 . . . . 0.0 110.325 170.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.1 p -60.64 -22.04 63.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.786 0.834 . . . . 0.0 112.728 -174.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.68 -3.38 59.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.159 1.384 . . . . 0.0 113.553 174.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.6 mt -68.33 130.47 92.28 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 119.911 1.232 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.44 98.0 0.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 108.67 164.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.87 107.1 10.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.591 1.557 . . . . 0.0 107.742 164.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.15 116.45 31.95 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.092 1.357 . . . . 0.0 107.873 -176.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.0 mtp -88.11 120.19 29.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -130.42 105.19 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -171.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -146.67 173.72 12.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.805 0.812 . . . . 0.0 110.923 -167.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.71 -19.72 20.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.484 0.713 . . . . 0.0 112.107 175.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -90.11 139.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.939 0.79 . . . . 0.0 109.737 -177.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.09 -59.71 2.66 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 tptt 45.99 80.92 0.04 OUTLIER 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.775 1.63 . . . . 0.0 109.558 173.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -54.91 -35.04 63.72 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.845 -167.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.64 -29.98 70.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.742 1.61 . . . . 0.0 113.385 174.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -65.47 -42.51 92.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 120.044 1.293 . . . . 0.0 109.412 167.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.1 mt -62.98 -52.25 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.868 0.758 . . . . 0.0 109.584 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.252 1.7 mt -54.6 -46.85 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 117.273 -1.346 . . . . 0.0 113.489 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.1 82.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.003 1.274 . . . . 0.0 110.472 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.6 -48.48 77.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.73 0.812 . . . . 0.0 110.918 175.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -22.86 63.09 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.84 -0.538 . . . . 0.0 112.394 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -77.15 -53.76 7.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.924 2.09 . . . . 0.0 108.772 171.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.35 -26.79 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.154 1.382 . . . . 0.0 112.659 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.56 34.3 5.05 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 124.677 1.132 . . . . 0.0 113.291 173.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.83 151.62 29.36 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.662 1.231 . . . . 0.0 110.576 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.7 p -77.08 -14.22 59.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.83 171.69 37.1 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 172.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -134.23 127.87 32.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.12 96.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 175.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.19 149.15 8.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 160.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -55.52 163.2 1.97 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 122.654 0.382 . . . . 0.0 110.45 160.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.08 137.06 47.44 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 -14.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -133.86 154.7 50.86 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.287 0.635 . . . . 0.0 110.567 -175.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 p -145.23 176.69 9.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.189 1.795 . . . . 0.0 109.367 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.68 -29.82 68.34 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.039 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.46 80.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.143 0.977 . . . . 0.0 112.475 175.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.08 -29.92 26.43 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.962 0.801 . . . . 0.0 110.291 175.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -55.92 25.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -27.33 69.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.216 0.606 . . . . 0.0 112.184 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.87 -43.8 87.27 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.607 -0.683 . . . . 0.0 110.255 172.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -66.66 -35.12 79.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.781 173.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.33 -53.09 61.74 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.556 1.071 . . . . 0.0 109.182 177.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.61 -34.44 72.77 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.204 0.457 . . . . 0.0 111.119 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -69.77 0.11 Allowed 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.112 0.965 . . . . 0.0 109.64 168.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 pt -74.12 -26.9 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 118.729 0.695 . . . . 0.0 112.444 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -58.75 -56.76 18.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -81.69 -38.01 26.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.585 -174.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -67.49 -74.51 0.11 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.59 1.156 . . . . 0.0 109.12 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.46 -31.34 72.37 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.218 0.463 . . . . 0.0 110.152 -175.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.84 37.64 8.44 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -165.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 C--O 1.248 1.006 0 CA-C-N 118.592 1.196 . . . . 0.0 109.104 164.888 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.24 168.71 19.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.051 1.34 . . . . 0.0 108.44 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.81 178.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.821 1.249 . . . . 0.0 108.978 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -54.8 -23.11 16.66 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.302 -0.874 . . . . 0.0 111.723 165.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.03 30.9 4.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.326 1.85 . . . . 0.0 111.968 -175.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 tt -54.68 118.58 4.33 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 175.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 134.06 34.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -95.53 98.75 10.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -76.74 140.06 40.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.52 115.52 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.33 1.052 . . . . 0.0 108.984 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.43 55.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.743 1.156 . . . . 0.0 109.928 -173.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.84 152.74 45.02 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.954 -1.092 . . . . 0.0 109.598 170.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.38 -47.63 17.23 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.413 1.085 . . . . 0.0 110.973 -173.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 6.3 t80 -77.84 117.28 19.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -56.07 -44.17 78.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.971 0.805 . . . . 0.0 110.637 -173.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 28.2 m -59.38 -38.32 80.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.028 -1.045 . . . . 0.0 111.283 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.14 -39.46 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.309 1.413 . . . . 0.0 110.121 171.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -65.67 -41.27 92.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.879 0.763 . . . . 0.0 109.872 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -46.26 88.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.504 174.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.58 -59.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 117.137 -1.411 . . . . 0.0 109.5 177.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.16 -52.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.87 1.668 . . . . 0.0 110.142 -177.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -61.63 -35.8 78.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.713 -0.617 . . . . 0.0 111.341 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -64.78 -44.47 89.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.709 1.141 . . . . 0.0 110.954 173.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.03 -38.7 92.24 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.503 1.121 . . . . 0.0 110.334 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.6 -45.22 94.82 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.021 0.928 . . . . 0.0 110.691 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -64.06 -28.01 69.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.77 -0.581 . . . . 0.0 111.417 174.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.33 -8.44 53.74 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.16 -1.587 . . . . 0.0 111.894 172.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.74 7.67 10.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.151 1.781 . . . . 0.0 112.025 -175.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 47.7 7.8 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 174.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.61 109.21 10.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.99 -7.8 8.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -78.52 49.2 0.84 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 166.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 m -80.54 159.59 4.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.738 -1.226 . . . . 0.0 109.115 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.59 169.01 19.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.598 1.959 . . . . 0.0 107.401 167.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -132.71 166.27 22.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.85 168.82 18.82 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.527 0.731 . . . . 0.0 109.147 173.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.83 -33.13 57.96 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.91 178.09 1.0 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.916 2.486 . . . . 0.0 108.565 -177.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -50.68 -38.22 35.84 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.56 176.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 120.047 1.924 . . . . 0.0 108.433 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 32.7 t0 -65.56 -37.51 86.9 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.222 -0.299 . . . . 0.0 110.448 174.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.71 72.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.24 -43.2 74.38 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.672 0.789 . . . . 0.0 110.195 175.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.47 -24.31 65.59 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 3.4 mptp? -66.17 -54.57 23.71 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.595 1.089 . . . . 0.0 108.43 165.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 mt -55.23 -48.0 74.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.623 0.647 . . . . 0.0 110.089 -169.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.63 0.82 28.56 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.07 -20.84 31.96 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.883 1.22 . . . . 0.0 111.71 163.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.07 154.49 24.58 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.059 1.314 . . . . 0.0 113.778 166.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.47 -13.77 65.66 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.283 2.373 . . . . 0.0 113.729 175.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.49 124.48 27.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.585 1.193 . . . . 0.0 107.975 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.77 -2.14 9.58 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.25 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.69 137.85 35.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.857 1.328 . . . . 0.0 108.438 173.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.91 80.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -171.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.19 125.96 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 p -145.87 165.15 29.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.507 0.594 . . . . 0.0 110.973 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.83 179.7 0.83 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.231 1.015 . . . . 0.0 110.284 161.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -89.68 -49.96 6.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.948 157.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.08 137.53 47.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.107 0.867 . . . . 0.0 109.735 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.476 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -147.21 167.45 13.55 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 124.112 0.965 . . . . 0.0 109.064 168.862 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.25 -23.01 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.226 1.95 . . . . 0.0 112.951 172.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -139.14 -83.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.421 1.464 . . . . 0.0 111.121 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.7 ttm -78.08 96.23 5.08 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.11 161.15 9.01 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.328 1.018 . . . . 0.0 110.32 170.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.44 -30.03 73.25 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.599 0.619 . . . . 0.0 112.842 -172.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -39.56 67.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.355 1.077 . . . . 0.0 109.799 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.6 -37.29 84.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.405 173.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.42 -54.08 50.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.896 1.225 . . . . 0.0 109.678 174.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.48 -51.8 52.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.401 1.08 . . . . 0.0 110.677 173.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -68.43 -25.07 64.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.174 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m -71.36 -50.3 33.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.4 -32.1 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.444 1.498 . . . . 0.0 108.596 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -58.88 -20.2 49.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.761 1.624 . . . . 0.0 112.78 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.41 45.49 0.72 Allowed 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.262 2.225 . . . . 0.0 110.968 -161.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -127.15 -152.37 0.52 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.706 1.203 . . . . 0.0 111.742 -176.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.92 51.79 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 129.104 3.24 . . . . 0.0 112.699 174.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 60.99 20.6 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.305 2.642 . . . . 0.0 112.873 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mmt -71.79 -2.64 18.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 117.69 -1.147 . . . . 0.0 113.208 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -56.94 -26.14 58.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.799 1.636 . . . . 0.0 113.797 -165.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.79 65.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.954 0.902 . . . . 0.0 113.348 177.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.46 138.59 75.5 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.523 1.129 . . . . 0.0 111.022 -172.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.8 100.25 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.829 2.353 . . . . 0.0 108.379 169.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 m -92.72 111.86 25.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 125.898 1.679 . . . . 0.0 106.586 174.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.4 tp -120.5 112.1 18.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.066 0.946 . . . . 0.0 108.836 -168.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.87 117.54 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.86 104.19 9.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -149.05 174.08 12.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.819 0.819 . . . . 0.0 109.74 -164.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.63 -14.04 41.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.121 -0.987 . . . . 0.0 112.19 162.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.75 96.51 6.29 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.203 1.401 . . . . 0.0 108.215 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.38 -92.07 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 162.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 51.15 101.41 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.692 1.997 . . . . 0.0 111.108 -174.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -41.14 -47.06 3.18 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.338 -0.851 . . . . 0.0 111.745 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -61.79 -34.98 76.86 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.67 -43.32 93.95 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 172.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.63 -45.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.755 174.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 mt -58.85 -56.78 14.54 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.249 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.76 -41.24 70.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.321 1.419 . . . . 0.0 110.822 -174.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.76 -53.77 54.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.738 0.815 . . . . 0.0 110.249 173.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.58 83.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.26 0.624 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -56.0 -56.37 21.51 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.824 1.65 . . . . 0.0 109.71 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.72 -21.45 64.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.684 0.794 . . . . 0.0 112.2 178.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.68 33.61 6.65 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-O 118.628 -1.096 . . . . 0.0 111.785 175.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.93 148.98 41.86 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.468 1.134 . . . . 0.0 108.904 -179.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -83.61 -6.69 59.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -172.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.17 175.22 35.64 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 119.082 0.855 . . . . 0.0 111.842 173.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.16 150.26 46.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.038 1.335 . . . . 0.0 108.847 -177.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.87 138.77 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 128.396 2.678 . . . . 0.0 104.846 166.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -118.59 143.39 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 156.92 14.45 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.803 170.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.82 154.32 97.75 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 N-CA-C 109.772 -0.895 . . . . 0.0 109.772 -16.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -158.75 160.54 36.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.561 0.744 . . . . 0.0 109.345 -169.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -147.49 -179.56 6.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.955 0.502 . . . . 0.0 110.429 -171.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.85 67.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.348 0.659 . . . . 0.0 109.438 176.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.28 -17.92 64.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 174.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 t -95.64 -37.83 10.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 121.407 1.912 . . . . 0.0 109.752 164.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -51.78 60.63 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -34.3 77.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.237 1.415 . . . . 0.0 112.455 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -71.43 -40.86 70.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 17.6 mmtp -65.3 -39.74 92.91 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 174.314 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.6 mt -54.96 -57.48 11.5 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -56.97 -33.77 67.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.455 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 24.9 mttm -56.71 -68.72 0.19 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 117.86 -1.067 . . . . 0.0 108.834 170.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -24.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 120.683 1.583 . . . . 0.0 113.339 -171.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -59.37 -49.19 78.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.98 1.312 . . . . 0.0 111.098 171.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.59 -54.84 5.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.611 0.642 . . . . 0.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.21 5.34 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.616 1.566 . . . . 0.0 108.561 -164.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -72.28 -54.14 10.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.35 15.87 2.96 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.682 -1.066 . . . . 0.0 112.347 -171.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.9 mmm . . . . . 0 C--O 1.247 0.921 0 CA-C-N 118.617 1.208 . . . . 0.0 111.495 -163.683 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.15 162.16 21.82 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.178 1.391 . . . . 0.0 108.139 165.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 9.8 m-20 -77.95 163.72 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.317 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -59.81 -13.01 8.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.388 159.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 20.9 tt0 40.92 51.43 3.2 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 129.952 3.301 . . . . 0.0 110.524 176.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.63 111.43 2.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.961 -171.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -90.6 143.64 26.54 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.169 0.918 . . . . 0.0 110.387 -162.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -111.39 100.66 9.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.584 1.154 . . . . 0.0 109.087 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -74.08 142.83 45.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.981 0.81 . . . . 0.0 109.383 175.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.44 99.61 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.761 1.625 . . . . 0.0 107.219 170.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.74 87.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -91.62 109.2 20.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.656 1.182 . . . . 0.0 112.174 -162.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.91 -24.06 59.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -120.33 -7.09 9.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -158.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 m 68.46 -58.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 128.042 2.537 . . . . 0.0 110.263 -173.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.0 m -55.56 -24.9 35.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.47 1.508 . . . . 0.0 111.16 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.4 tpp -64.82 -37.56 88.01 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.929 1.695 . . . . 0.0 109.934 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.438 HH11 ' CD ' ' A' ' 35' ' ' GLU . 23.3 ttp180 -77.34 -33.07 55.5 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 121.126 1.785 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -52.17 -58.06 7.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.842 1.201 . . . . 0.0 108.579 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.66 -67.75 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.509 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.32 -41.71 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 120.444 1.474 . . . . 0.0 110.392 -169.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -48.19 82.76 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 119.651 1.114 . . . . 0.0 109.445 174.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.59 -48.53 74.69 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.385 175.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.37 -43.14 96.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.024 0.829 . . . . 0.0 110.67 -176.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.76 -44.99 95.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.298 1.039 . . . . 0.0 110.104 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -63.87 -29.4 70.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.152 -1.404 . . . . 0.0 112.546 177.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.9 -62.36 1.93 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.061 1.3 . . . . 0.0 108.373 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.07 2.34 1.51 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.65 -108.62 3.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -151.38 175.95 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.314 2.246 . . . . 0.0 107.255 -164.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -138.09 -178.57 5.33 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.06 0.846 . . . . 0.0 112.085 -169.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 m120 59.72 75.91 0.38 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.953 2.901 . . . . 0.0 109.717 -167.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.18 166.17 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.041 168.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -135.5 174.24 10.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.438 ' CD ' HH11 ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.0 156.05 42.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.257 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.77 151.38 40.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 163.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.36 -30.49 66.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.634 0.584 . . . . 0.0 111.211 176.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.28 156.91 14.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -161.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.97 -42.46 30.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.23 0.919 . . . . 0.0 114.381 171.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.96 -37.6 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 120.2 2.0 . . . . 0.0 109.438 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.22 -43.95 96.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.526 0.731 . . . . 0.0 109.47 171.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.48 80.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.693 1.597 . . . . 0.0 110.324 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.71 -43.24 72.39 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.717 0.636 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.17 -37.18 86.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.315 0.646 . . . . 0.0 110.985 176.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -57.42 -45.06 85.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.028 1.286 . . . . 0.0 110.043 170.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -58.69 -51.45 69.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -78.8 16.76 0.81 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.66 62.13 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.521 -1.362 . . . . 0.0 110.048 159.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.73 -88.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -175.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.74 86.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -173.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -64.81 166.68 8.61 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.008 1.323 . . . . 0.0 110.736 172.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.47 -20.0 10.71 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.561 -1.133 . . . . 0.0 113.37 172.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -146.49 142.4 28.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.72 1.208 . . . . 0.0 109.702 -174.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.47 70.02 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -177.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -78.59 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 155.65 44.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.252 0.933 . . . . 0.0 110.19 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.9 176.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 158.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -96.18 -60.57 1.6 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.215 1.006 . . . . 0.0 108.78 170.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.26 74.92 9.99 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.458 0.703 . . . . 0.0 109.868 -159.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.1 mmt -107.4 162.31 20.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.245 1.818 . . . . 0.0 109.942 175.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -69.94 177.77 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.375 2.717 . . . . 0.0 112.062 173.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 44.8 -110.8 0.21 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.062 2.145 . . . . 0.0 110.944 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.51 85.73 6.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -54.5 173.68 0.07 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.518 1.927 . . . . 0.0 112.498 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -27.91 60.58 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.143 -0.973 . . . . 0.0 113.423 -173.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -82.17 -35.77 28.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.186 0.993 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -67.15 -42.08 84.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.852 169.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.1 tp -50.82 -52.65 39.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.532 1.533 . . . . 0.0 109.301 172.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.6 tp -53.0 -58.72 6.04 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.239 0.616 . . . . 0.0 109.794 173.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.33 -35.62 77.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.479 1.036 . . . . 0.0 111.552 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.1 m -58.04 -48.44 80.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.29 1.036 . . . . 0.0 108.843 175.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.92 -51.42 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.44 66.85 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.226 1.81 . . . . 0.0 112.535 -176.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -6.8 57.94 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.311 1.444 . . . . 0.0 112.415 178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.86 138.51 37.8 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.639 1.109 . . . . 0.0 110.945 -174.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.15 -13.73 43.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.531 -1.15 . . . . 0.0 114.829 -175.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.37 -50.21 2.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.119 1.459 . . . . 0.0 111.635 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 70.0 mtm -60.51 -25.85 66.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.091 0.859 . . . . 0.0 111.959 -172.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -10.06 2.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.738 1.615 . . . . 0.0 114.273 -177.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.017 1.281 . . . . 0.0 112.757 170.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.6 mt -70.41 129.94 89.75 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 123.447 0.699 . . . . 0.0 110.978 -170.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.77 107.8 2.13 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.81 2.34 . . . . 0.0 108.859 163.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.96 140.08 16.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.28 111.14 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 -171.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 126.64 31.14 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.06 93.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -138.63 -174.28 3.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.869 0.868 . . . . 0.0 109.902 -166.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.8 -16.77 14.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.699 1.2 . . . . 0.0 112.851 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.25 117.27 28.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.339 1.056 . . . . 0.0 109.276 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.29 -81.73 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 tptt 54.11 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.236 1.814 . . . . 0.0 111.317 -176.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -50.28 -43.34 53.33 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.405 -1.434 . . . . 0.0 112.03 178.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -52.11 -35.43 48.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.953 0.901 . . . . 0.0 112.125 176.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -78.62 -37.86 41.24 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.838 1.255 . . . . 0.0 110.536 176.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.22 -50.75 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.966 1.257 . . . . 0.0 109.138 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.327 1.9 mt -51.3 -54.47 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.916 166.035 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.41 -44.11 72.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 121.086 1.766 . . . . 0.0 112.112 -178.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.05 -55.48 34.53 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 118.935 0.789 . . . . 0.0 110.448 174.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -27.89 69.25 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -71.78 -53.63 12.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.333 1.853 . . . . 0.0 109.665 174.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.27 -24.53 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.179 0.992 . . . . 0.0 112.18 176.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.82 34.79 6.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.756 1.17 . . . . 0.0 111.851 176.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.05 145.02 56.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 118.43 1.115 . . . . 0.0 108.092 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 p -76.01 -12.98 60.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.306 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.6 171.86 40.69 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.273 0.939 . . . . 0.0 111.075 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.26 134.71 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.53 1.532 . . . . 0.0 107.723 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.55 140.26 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 127.734 2.414 . . . . 0.0 106.96 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.99 145.31 28.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 145.59 89.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.963 0.801 . . . . 0.0 110.318 168.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 136.58 43.38 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 119.68 0.922 . . . . 0.0 111.139 -6.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -141.4 155.56 45.88 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 110.781 175.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -151.39 -178.29 6.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.494 1.118 . . . . 0.0 111.527 -171.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.06 -28.75 64.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.789 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.51 64.16 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 174.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 t -97.38 -30.58 12.85 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.208 0.913 . . . . 0.0 110.289 171.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -52.85 -53.19 52.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.459 1.027 . . . . 0.0 108.869 177.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.69 -35.23 74.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.754 1.222 . . . . 0.0 111.675 178.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 37.3 tt0 -74.58 -41.61 60.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.477 -0.765 . . . . 0.0 109.672 -176.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -64.2 -39.34 93.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.805 176.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.5 mt -55.08 -58.34 8.05 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -55.68 -38.33 69.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.366 0.667 . . . . 0.0 112.331 -178.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.402 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -55.83 -64.28 0.9 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.711 172.626 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.05 -29.59 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.184 1.356 . . . . 0.0 113.282 -173.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -56.88 -52.65 64.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.632 0.773 . . . . 0.0 109.026 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -73.39 -46.09 50.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.935 0.334 . . . . 0.0 111.287 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -69.27 -73.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.62 -23.64 64.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.02 0.528 . . . . 0.0 110.969 -175.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.33 31.42 19.48 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -166.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 116.491 -1.719 . . . . 0.0 110.457 -175.7 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.86 164.75 0.08 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 128.371 2.668 . . . . 0.0 114.482 -175.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.49 167.32 10.68 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.298 1.839 . . . . 0.0 107.937 -177.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -53.6 -29.01 35.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.862 0.865 . . . . 0.0 112.407 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 39.0 44.12 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.571 1.948 . . . . 0.0 112.242 -171.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.31 119.52 8.1 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -90.69 132.96 35.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.87 138.53 38.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 163.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.12 140.04 37.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.65 103.19 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.13 60.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.37 1.068 . . . . 0.0 108.816 -178.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.76 146.23 29.1 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.357 -1.465 . . . . 0.0 110.746 169.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -67.15 -58.66 4.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.064 1.346 . . . . 0.0 110.03 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -83.87 83.23 8.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.231 -174.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 t -40.08 -27.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.49 2.316 . . . . 0.0 115.847 -166.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 m -43.52 -47.66 7.28 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 119.887 -1.758 . . . . 0.0 111.804 164.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -37.61 46.4 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 0.0 111.016 172.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -66.26 -44.02 84.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.4 1.454 . . . . 0.0 109.549 -178.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -58.08 9.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.497 1.119 . . . . 0.0 108.364 172.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.11 -61.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 124.509 1.124 . . . . 0.0 108.978 -176.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.5 t -54.82 -43.72 68.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 119.758 1.163 . . . . 0.0 110.452 -175.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -60.34 -48.2 82.76 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.204 1.365 . . . . 0.0 109.689 175.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.27 -42.72 91.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.205 1.002 . . . . 0.0 111.047 -178.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.76 -41.22 98.03 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.999 0.92 . . . . 0.0 110.067 175.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.04 -29.6 70.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.045 0.839 . . . . 0.0 111.405 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -73.53 -28.77 62.06 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.857 -1.152 . . . . 0.0 111.636 173.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.58 -48.98 67.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.28 0.946 . . . . 0.0 109.735 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.02 95.12 1.37 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 123.288 1.518 . . . . 0.0 108.375 -174.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -132.18 3.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.244 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -131.77 165.75 23.08 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.832 0.853 . . . . 0.0 111.883 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.34 -174.49 2.54 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.921 1.688 . . . . 0.0 110.195 173.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.46 81.63 0.15 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.464 2.306 . . . . 0.0 109.59 -175.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 146.33 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.64 176.15 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.576 1.551 . . . . 0.0 109.754 -177.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -131.47 166.36 21.51 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.143 0.977 . . . . 0.0 108.888 173.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.94 172.2 9.59 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 160.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.07 -41.09 82.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 174.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -170.94 177.17 3.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.793 2.037 . . . . 0.0 108.19 -169.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.39 -37.09 72.43 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.944 0.783 . . . . 0.0 113.111 -178.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -63.42 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 O-C-N 121.724 -0.868 . . . . 0.0 108.91 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.53 -29.31 64.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.523 174.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.57 85.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.726 1.21 . . . . 0.0 109.83 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 tp -58.26 -41.24 83.83 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.255 0.479 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -40.61 96.03 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.364 175.589 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -53.64 -54.94 30.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.996 172.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.4 mt -57.76 -40.54 79.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.777 1.171 . . . . 0.0 110.89 -174.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -65.17 -19.56 66.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.55 6.03 34.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.265 1.826 . . . . 0.0 113.907 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.69 175.06 45.45 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 119.167 -1.492 . . . . 0.0 116.736 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.84 4.99 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.473 1.511 . . . . 0.0 109.968 177.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -75.96 72.27 2.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.462 1.505 . . . . 0.0 107.099 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.47 -4.29 37.37 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.405 1.002 . . . . 0.0 113.454 -172.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.79 136.5 48.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.089 1.355 . . . . 0.0 108.263 170.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.21 64.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.03 139.16 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.4 p -152.01 167.58 27.95 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.956 -0.465 . . . . 0.0 110.722 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.89 169.46 9.8 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 158.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -55.72 -64.45 0.85 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.824 -1.173 . . . . 0.0 107.87 163.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.86 165.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.79 2.436 . . . . 0.0 112.431 -166.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.1 75.73 12.7 Favored Pre-proline 0 N--CA 1.45 -0.455 0 O-C-N 119.63 -1.919 . . . . 0.0 107.497 167.322 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.07 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.895 2.397 . . . . 0.0 110.419 176.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -165.17 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 129.986 3.314 . . . . 0.0 104.102 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.2 ttp -72.98 89.19 1.41 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 160.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.78 168.8 4.62 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.11 0.964 . . . . 0.0 110.666 164.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.6 -19.76 60.77 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.677 -176.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.434 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -77.37 -49.0 15.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.256 1.528 . . . . 0.0 108.722 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.94 0.496 . . . . 0.0 110.551 174.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -56.14 -53.05 61.77 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.087 0.955 . . . . 0.0 109.306 175.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 tp -54.03 -55.79 24.0 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 110.574 175.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 72.4 mttt -63.96 -36.99 85.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.636 1.562 . . . . 0.0 112.301 -174.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.7 m -61.44 -39.25 90.13 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 109.718 175.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.2 mt -71.17 -47.84 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.21 68.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.752 1.621 . . . . 0.0 111.449 -178.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.62 -8.33 59.61 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.36 -0.837 . . . . 0.0 112.77 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -83.45 152.71 24.84 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.308 0.958 . . . . 0.0 110.701 -171.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.49 -22.54 77.22 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.458 -0.776 . . . . 0.0 113.476 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 -55.98 2.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.822 1.249 . . . . 0.0 109.21 173.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.3 mtt -71.44 -9.17 57.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -59.03 -20.42 52.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.769 1.168 . . . . 0.0 112.227 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.76 60.01 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.7 mt -68.6 138.46 91.04 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.914 1.234 . . . . 0.0 110.5 -170.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 82.71 1.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.564 2.176 . . . . 0.0 108.726 166.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 m -65.54 108.83 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 159.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 tp -130.83 105.97 8.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -160.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.6 mmt -78.69 120.9 24.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -174.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.63 87.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.8 t -129.19 170.52 13.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.601 0.715 . . . . 0.0 112.924 -159.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.11 57.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.789 0.835 . . . . 0.0 112.822 161.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.54 98.34 2.28 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.851 1.26 . . . . 0.0 111.424 -167.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.18 23.16 0.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.968 -1.083 . . . . 0.0 111.306 163.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -70.93 104.25 2.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.437 -1.414 . . . . 0.0 107.792 -174.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -31.93 -65.49 0.14 Allowed 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 125.716 1.606 . . . . 0.0 111.974 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.74 -29.17 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.743 -172.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -62.42 -46.29 89.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.392 0.996 . . . . 0.0 109.436 171.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.33 -46.4 95.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.55 -57.23 9.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.56 -40.05 74.51 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.908 0.777 . . . . 0.0 111.215 -172.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.73 -52.16 53.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.572 1.149 . . . . 0.0 110.436 176.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 177.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -62.38 -50.92 69.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 111.345 177.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.39 61.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.482 1.113 . . . . 0.0 112.892 178.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.33 30.76 9.6 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.356 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.67 146.79 44.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.93 1.365 . . . . 0.0 108.135 175.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.1 p -70.39 -8.37 50.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.32 165.84 20.03 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -140.22 85.53 2.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.078 0.951 . . . . 0.0 109.755 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -85.21 141.29 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 169.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.19 157.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 171.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -56.22 137.32 74.64 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.657 159.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.3 159.47 97.64 Favored 'Cis proline' 0 C--N 1.348 0.503 0 CA-C-N 121.166 1.452 . . . . 0.0 112.327 -6.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -177.75 155.09 0.99 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.264 1.025 . . . . 0.0 109.909 -174.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -150.35 -174.02 4.62 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.6 1.16 . . . . 0.0 112.076 -168.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.04 -35.83 62.4 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -47.22 -30.79 3.21 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.006 2.122 . . . . 0.0 115.074 174.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.411 HG23 ' HE2' ' A' ' 119' ' ' LYS . 1.2 t -111.21 -19.79 12.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.968 0.507 . . . . 0.0 110.939 176.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.33 -55.94 25.71 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.738 -1.226 . . . . 0.0 108.226 167.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -44.84 79.07 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.909 1.283 . . . . 0.0 111.684 178.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -38.64 76.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.443 -0.785 . . . . 0.0 110.807 -177.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' HE2' HG23 ' A' ' 115' ' ' THR . 46.2 mtmt -61.99 -39.25 91.56 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.151 -0.968 . . . . 0.0 110.3 173.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.12 -51.25 70.85 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.419 172.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.7 -36.53 72.1 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.097 1.317 . . . . 0.0 112.36 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -69.8 0.11 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.32 1.448 . . . . 0.0 108.382 169.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -22.29 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -171.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.49 -45.59 86.66 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.152 0.981 . . . . 0.0 109.679 174.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.19 -39.26 25.74 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.333 0.969 . . . . 0.0 110.979 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -74.59 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -171.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.84 -37.83 88.37 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.23 44.42 4.08 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -163.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.728 -1.129 . . . . 0.0 111.372 -175.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.59 177.08 9.34 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 159.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -132.82 155.0 49.76 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.637 0.732 . . . . 0.0 110.34 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -49.7 -33.67 16.58 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 126.283 1.833 . . . . 0.0 111.238 167.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 41.73 55.67 3.56 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.944 1.697 . . . . 0.0 108.648 -170.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.27 107.89 0.21 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.341 2.257 . . . . 0.0 108.308 -176.547 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.54 143.18 30.35 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.139 -163.111 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.58 95.5 5.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.83 135.89 50.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.887 1.221 . . . . 0.0 108.464 174.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.32 114.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.194 1.398 . . . . 0.0 108.331 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.44 64.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 124.912 1.285 . . . . 0.0 108.032 -173.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.44 156.74 29.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.62 -51.92 66.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 108.766 170.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.44 108.64 19.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -51.33 -42.68 61.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.213 178.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -50.97 -45.77 61.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.181 1.355 . . . . 0.0 111.625 172.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.2 ttm -62.59 -25.19 67.95 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.701 0.801 . . . . 0.0 111.572 -178.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -68.8 -39.03 80.33 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.44 -1.413 . . . . 0.0 110.56 170.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -66.48 -36.59 83.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.16 178.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -47.06 -49.32 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.294 1.406 . . . . 0.0 110.883 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -57.0 -46.96 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.444 0.698 . . . . 0.0 110.74 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.4 -40.36 94.12 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.394 0.678 . . . . 0.0 111.131 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.55 -38.67 87.61 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.854 -0.529 . . . . 0.0 110.375 177.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.2 -26.71 67.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.366 0.53 . . . . 0.0 111.613 172.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -73.05 -38.28 66.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.736 1.153 . . . . 0.0 110.839 169.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.45 -36.7 85.01 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.339 0.972 . . . . 0.0 111.244 176.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.62 99.71 0.58 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.214 2.205 . . . . 0.0 108.81 177.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.2 -113.37 0.54 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.71 171.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -145.08 -176.97 5.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.101 1.76 . . . . 0.0 109.484 -162.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -133.92 -176.12 4.07 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.386 1.474 . . . . 0.0 109.932 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 54.5 63.65 2.08 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.836 1.654 . . . . 0.0 110.548 -171.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.11 160.29 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.485 165.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -133.03 173.08 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.63 2.372 . . . . 0.0 106.106 175.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -139.2 166.88 23.38 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.95 169.39 17.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.97 1.308 . . . . 0.0 109.133 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.24 -40.63 77.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.549 0.74 . . . . 0.0 109.745 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -178.44 179.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.506 2.322 . . . . 0.0 108.426 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.65 -41.99 10.13 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.85 1.69 . . . . 0.0 115.432 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.85 -47.25 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.147 1.473 . . . . 0.0 108.642 179.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -67.98 -32.34 72.67 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 175.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.1 -43.21 91.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.792 -1.193 . . . . 0.0 110.071 177.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.702 0.683 . . . . 0.0 111.076 173.566 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.07 -43.37 77.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.919 0.887 . . . . 0.0 111.471 178.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -63.36 -52.77 60.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -53.06 60.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.594 1.158 . . . . 0.0 112.565 -172.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.32 -1.69 3.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 112.257 -177.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.3 25.32 7.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.176 2.19 . . . . 0.0 111.412 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.64 168.43 38.23 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 121.107 1.776 . . . . 0.0 114.023 169.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.95 53.66 1.39 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 124.773 1.178 . . . . 0.0 110.355 -178.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -62.01 142.49 57.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.443 1.097 . . . . 0.0 110.117 -177.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.05 -29.76 9.44 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 119.491 -0.616 . . . . 0.0 111.689 173.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -138.19 149.07 45.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.384 1.074 . . . . 0.0 109.431 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.5 t -137.17 108.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -178.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.65 136.38 58.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.52 153.5 38.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.724 0.238 . . . . 0.0 110.931 -159.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -64.86 170.82 3.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.926 0.87 . . . . 0.0 111.194 163.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -83.47 -76.46 0.28 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 160.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.97 -170.42 0.08 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.01 1.324 . . . . 0.0 110.999 176.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.3 ttp -162.89 75.67 1.96 Allowed Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 158.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.48 -71.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.117 2.545 . . . . 0.0 107.935 175.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -131.96 -67.97 0.65 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.231 1.412 . . . . 0.0 107.737 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 ttm -91.09 104.75 17.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.403 2.281 . . . . 0.0 107.614 161.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.73 171.44 5.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.513 0.597 . . . . 0.0 110.73 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.67 69.19 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.749 -0.594 . . . . 0.0 112.364 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -40.94 74.12 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.998 0.899 . . . . 0.0 109.782 178.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.79 -32.3 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.886 1.274 . . . . 0.0 111.005 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -58.48 -55.54 33.78 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -53.42 -57.16 11.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.41 1.084 . . . . 0.0 109.491 174.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.8 -21.38 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.973 1.26 . . . . 0.0 113.83 -173.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -61.37 -64.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 163.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.0 mt -56.48 -36.6 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.917 1.287 . . . . 0.0 110.6 -174.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -22.54 61.86 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.446 1.899 . . . . 0.0 113.519 -177.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.87 -1.94 17.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.104 0.866 . . . . 0.0 111.385 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.39 150.56 46.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 159.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.83 -3.44 89.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.362 -1.244 . . . . 0.0 113.719 -174.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.57 -40.8 0.71 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.343 1.572 . . . . 0.0 111.035 -177.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.4 mtm -71.14 -8.87 56.46 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.305 -0.872 . . . . 0.0 113.147 -175.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.3 p -63.53 -18.28 63.67 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.42 1.009 . . . . 0.0 113.314 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.17 52.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.404 1.482 . . . . 0.0 113.277 172.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -73.79 147.22 86.37 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 111.345 -175.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.55 56.36 1.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.605 2.87 . . . . 0.0 111.085 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.1 m -53.28 113.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 119.081 0.855 . . . . 0.0 110.242 176.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.7 122.97 48.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.589 1.156 . . . . 0.0 108.674 -169.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mmt -80.99 128.29 33.53 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 174.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.26 108.44 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -152.06 165.6 34.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.969 0.89 . . . . 0.0 112.017 -166.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.82 60.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.45 -0.781 . . . . 0.0 111.433 161.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.97 96.87 10.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.249 1.419 . . . . 0.0 109.414 -163.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -73.92 0.07 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.265 1.026 . . . . 0.0 110.781 177.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.5 tttt 39.25 93.37 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 127.151 2.18 . . . . 0.0 112.537 -175.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -44.29 -40.85 5.54 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.711 176.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.31 -45.28 76.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.3 0.955 . . . . 0.0 112.992 176.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.17 -37.71 81.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.329 1.452 . . . . 0.0 109.557 176.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.4 mt -64.52 -41.84 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.332 176.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -59.71 -48.38 87.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-N 120.61 1.55 . . . . 0.0 108.076 171.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.19 -43.8 74.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.089 1.313 . . . . 0.0 111.443 -177.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.87 85.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.859 0.464 . . . . 0.0 110.38 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.51 83.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.295 0.638 . . . . 0.0 112.105 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -64.51 -45.12 88.6 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.131 1.772 . . . . 0.0 110.721 174.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.78 -6.16 39.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.444 0.697 . . . . 0.0 112.298 170.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.03 64.84 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.351 -1.468 . . . . 0.0 113.049 172.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.88 160.21 0.73 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.465 1.106 . . . . 0.0 110.214 176.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -63.36 -30.7 71.79 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.361 -0.837 . . . . 0.0 111.575 176.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.46 -174.98 46.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 178.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -139.65 94.94 2.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 107.748 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.2 t -77.76 133.22 30.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 150.05 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -55.52 168.38 0.62 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 173.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.61 94.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.545 0 N-CA-C 107.442 -1.791 . . . . 0.0 107.442 -20.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -81.77 158.74 24.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.909 0.861 . . . . 0.0 111.613 -165.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.7 p -146.89 -179.05 6.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.589 1.556 . . . . 0.0 109.623 -172.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -34.14 65.67 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 110.046 176.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.18 58.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.819 0.848 . . . . 0.0 113.229 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -34.88 7.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.249 0.932 . . . . 0.0 110.506 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.04 -47.54 68.33 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.962 1.305 . . . . 0.0 108.995 176.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.01 74.57 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.411 1.084 . . . . 0.0 112.207 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.11 -44.11 89.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.862 1.21 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -67.62 -42.62 82.06 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.947 -176.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.72 -52.4 64.02 Favored 'General case' 0 C--O 1.221 -0.403 0 O-C-N 123.861 0.726 . . . . 0.0 110.216 172.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.99 -47.45 71.42 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.532 1.06 . . . . 0.0 111.251 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -56.23 -62.95 1.37 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.75 178.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -27.08 36.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 120.375 1.443 . . . . 0.0 113.633 -175.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.32 -50.57 73.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.31 -48.74 39.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -65.43 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.413 1.485 . . . . 0.0 108.509 -160.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.61 -41.23 96.35 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.287 0.949 . . . . 0.0 108.609 175.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.77 18.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.269 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-O 116.813 -1.565 . . . . 0.0 112.181 -163.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -89.71 132.01 35.39 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 34.9 m-85 -85.13 139.18 31.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.13 140.16 38.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 161.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -135.53 100.38 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.88 84.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 21.0 t70 -91.45 171.83 8.93 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.993 0.902 . . . . 0.0 111.516 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.91 -28.56 68.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.237 1.815 . . . . 0.0 112.259 165.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -131.95 113.82 13.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.904 1.681 . . . . 0.0 107.802 -163.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -50.37 -40.46 49.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.149 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 m -52.73 -37.63 59.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.184 0.994 . . . . 0.0 111.22 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -58.83 -41.34 86.62 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.663 1.12 . . . . 0.0 110.243 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.603 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.03 -48.39 80.47 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.338 0.972 . . . . 0.0 109.959 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.28 -58.19 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.69 1.196 . . . . 0.0 108.893 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.23 -50.64 70.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.323 1.049 . . . . 0.0 109.975 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -53.97 -48.57 70.19 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.852 0.751 . . . . 0.0 110.412 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.45 -46.01 84.96 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.682 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.99 -40.27 95.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.383 0.992 . . . . 0.0 110.525 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -60.78 -37.75 82.94 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.72 0.808 . . . . 0.0 110.838 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -70.74 -35.45 72.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 117.735 -1.126 . . . . 0.0 111.927 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -60.07 -42.26 94.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.654 1.115 . . . . 0.0 108.892 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.61 -56.34 14.53 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.281 0.632 . . . . 0.0 109.867 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.24 4.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.186 -1.341 . . . . 0.0 116.291 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.97 171.98 12.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.897 1.848 . . . . 0.0 112.382 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.21 -179.95 6.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.206 1.802 . . . . 0.0 108.267 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.2 t30 65.15 82.34 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.073 2.549 . . . . 0.0 112.353 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.41 162.08 13.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -140.91 170.73 15.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.223 1.809 . . . . 0.0 110.362 167.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -122.17 168.27 12.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.941 2.496 . . . . 0.0 107.582 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.21 171.0 14.67 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.616 1.166 . . . . 0.0 109.308 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.64 -35.64 65.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.938 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.26 178.38 0.71 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.473 1.909 . . . . 0.0 107.881 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.23 -43.37 4.59 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.31 1.91 . . . . 0.0 116.076 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.43 -47.29 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.865 1.833 . . . . 0.0 109.259 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -68.55 -37.23 79.77 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.1 -0.375 . . . . 0.0 110.85 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.9 -51.93 67.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.712 1.605 . . . . 0.0 109.818 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.62 -43.42 80.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.77 0.795 . . . . 0.0 110.54 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -71.74 -24.7 61.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -65.97 -42.07 90.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.376 166.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 72' ' ' ILE . 6.4 mt -56.03 -46.82 78.71 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.305 1.412 . . . . 0.0 108.249 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.37 10.81 0.9 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.733 1.213 . . . . 0.0 114.067 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.0 38.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.051 1.296 . . . . 0.0 110.988 160.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.49 -82.86 0.11 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.43 94.28 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.34 170.9 14.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.292 1.037 . . . . 0.0 110.484 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.09 -30.02 5.87 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.993 -0.893 . . . . 0.0 113.953 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 87.2 m-85 -146.55 148.58 32.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.258 1.023 . . . . 0.0 108.689 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -125.19 80.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 5.9 mt -91.73 130.84 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -171.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 p -144.5 161.36 39.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.513 1.506 . . . . 0.0 114.957 -173.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 1.6 p-10 -73.46 -158.25 0.06 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.258 1.023 . . . . 0.0 110.278 159.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -134.08 -30.27 1.21 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.329 2.252 . . . . 0.0 112.528 -167.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.43 32.02 6.36 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.889 2.076 . . . . 0.0 112.094 -158.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.539 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 2.4 mpt? -44.69 154.33 0.43 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 113.329 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.35 -25.74 35.81 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.127 2.551 . . . . 0.0 112.943 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -119.98 -99.57 0.44 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.2 ttt -78.35 106.17 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 161.03 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.469 1.108 . . . . 0.0 111.867 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.33 73.83 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 119.48 -0.622 . . . . 0.0 112.483 -166.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.28 -34.59 48.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.896 0.879 . . . . 0.0 109.942 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.36 -37.56 71.65 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 111.05 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.48 -50.71 72.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.757 0.708 . . . . 0.0 109.354 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -52.58 -61.09 2.5 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.041 0.936 . . . . 0.0 108.717 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.33 -26.13 67.6 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.879 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.8 m -66.82 -48.36 69.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.582 1.083 . . . . 0.0 110.864 170.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 46' ' ' LEU . 13.7 mt -60.89 -40.83 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 4.16 1.6 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.604 2.362 . . . . 0.0 113.572 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 120.238 1.381 . . . . 0.0 111.161 170.092 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.82 -54.1 0.46 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.485 2.714 . . . . 0.0 113.827 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -15.99 62.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.611 1.564 . . . . 0.0 114.383 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD13 HG21 ' A' ' 54' ' ' VAL . 19.1 mt -68.2 121.71 81.31 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 119.148 0.886 . . . . 0.0 109.452 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.51 106.81 1.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.871 1.714 . . . . 0.0 108.739 166.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.05 134.09 28.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 9.4 tp -131.65 106.28 8.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.9 mtp -82.14 117.75 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.94 105.05 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -145.49 172.61 12.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.932 0.872 . . . . 0.0 111.007 -164.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -11.45 59.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.44 -0.788 . . . . 0.0 112.918 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -88.24 107.98 19.07 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.203 2.201 . . . . 0.0 112.356 -165.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -91.4 3.91 53.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.52 120.32 6.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.243 1.383 . . . . 0.0 109.922 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -55.64 -44.31 77.03 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.324 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -63.68 -33.43 75.62 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.927 1.239 . . . . 0.0 111.023 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.02 -47.07 84.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.287 0.949 . . . . 0.0 109.373 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.58 -45.18 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.17 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.75 -56.82 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.83 -46.55 60.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.768 1.227 . . . . 0.0 110.146 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.82 71.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.523 0.729 . . . . 0.0 112.029 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.52 97.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -61.85 -46.47 89.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.818 1.647 . . . . 0.0 111.408 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.02 -16.21 59.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.788 0.835 . . . . 0.0 112.458 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.65 33.57 18.68 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.446 1.021 . . . . 0.0 111.722 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.06 142.74 53.53 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.0 p -72.91 -14.13 61.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.515 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.21 169.58 38.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -136.78 144.61 43.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.927 1.291 . . . . 0.0 107.922 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.98 140.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.978 2.111 . . . . 0.0 105.712 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 90' ' ' ALA . 10.8 t -123.24 144.64 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 149.4 21.17 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.053 169.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 140.67 67.19 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 109.691 -0.927 . . . . 0.0 109.691 -16.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -134.73 167.14 21.39 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.997 -1.064 . . . . 0.0 111.041 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 p -137.2 172.78 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.644 1.178 . . . . 0.0 110.991 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.83 -33.47 64.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.817 1.247 . . . . 0.0 109.511 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.03 -54.52 38.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.718 1.207 . . . . 0.0 111.246 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -31.82 58.3 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.564 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -56.49 19.53 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -66.5 -21.1 66.17 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.758 -0.588 . . . . 0.0 112.464 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -68.49 -47.98 65.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.244 0.929 . . . . 0.0 109.526 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -68.92 -38.36 79.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.651 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 mt -57.6 -54.51 46.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.254 0.934 . . . . 0.0 110.146 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -65.51 -30.2 70.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.754 0.706 . . . . 0.0 110.725 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -55.53 -58.24 8.58 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.933 165.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.82 -22.7 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 120.691 1.587 . . . . 0.0 113.619 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -57.83 -65.24 0.67 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -76.11 -30.6 58.3 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.18 -169.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -71.43 -68.17 0.47 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.319 1.048 . . . . 0.0 109.462 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.8 -31.59 45.99 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.354 1.062 . . . . 0.0 111.756 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.21 29.88 8.16 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.382 -1.232 . . . . 0.0 111.709 -165.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.7 mmt . . . . . 0 C--O 1.247 0.971 0 CA-C-N 119.868 1.834 . . . . 0.0 111.756 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 155.1 19.0 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 110.371 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -104.33 101.64 11.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 164.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.47 133.9 46.19 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 117.361 -1.736 . . . . 0.0 106.727 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.4 t -132.06 105.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.41 58.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.055 1.342 . . . . 0.0 107.782 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.55 157.21 17.76 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.883 -0.511 . . . . 0.0 110.445 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.13 -28.21 68.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.879 1.271 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -132.41 123.21 26.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.524 1.53 . . . . 0.0 107.488 -167.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -52.15 -52.77 49.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.715 0.689 . . . . 0.0 111.514 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.2 m -59.33 -29.8 67.91 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.546 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 ttt -61.94 -44.48 96.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.26 0.936 . . . . 0.0 109.957 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -39.88 94.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.329 0.968 . . . . 0.0 109.111 174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -44.82 93.0 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.44 -62.22 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.342 172.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.01 -49.23 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 121.423 1.92 . . . . 0.0 111.13 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -48.61 76.74 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.443 1.097 . . . . 0.0 110.379 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -56.22 -51.22 68.87 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.927 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.31 -36.31 79.74 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.496 1.518 . . . . 0.0 112.033 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.65 -52.4 60.91 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.712 -0.617 . . . . 0.0 109.659 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -64.74 -20.6 66.44 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.1 -52.32 56.19 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.261 1.424 . . . . 0.0 109.879 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.37 2.43 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -166.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.86 -84.66 1.08 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 124.542 1.068 . . . . 0.0 110.997 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -151.28 175.44 12.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.205 1.402 . . . . 0.0 109.559 -169.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -139.09 -179.15 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.376 1.07 . . . . 0.0 109.944 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 64.39 77.17 0.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.996 2.519 . . . . 0.0 110.335 -165.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.97 172.36 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.069 160.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.39 174.29 10.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.723 2.009 . . . . 0.0 106.192 158.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.7 164.66 23.49 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.39 170.72 13.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.166 1.786 . . . . 0.0 106.817 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.1 -37.75 84.45 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.948 0.794 . . . . 0.0 110.389 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -172.64 166.92 5.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.985 1.314 . . . . 0.0 108.578 -160.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.548 ' H ' ' HG3' ' A' ' 60' ' ' MET . . . -49.35 -40.86 31.15 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.9 1.714 . . . . 0.0 113.966 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.02 -52.99 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.82 0.848 . . . . 0.0 108.77 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.63 -23.91 56.41 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.349 1.46 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.97 51.42 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.71 -46.2 70.69 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.895 0.747 . . . . 0.0 111.045 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.82 -46.58 74.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.475 1.51 . . . . 0.0 111.764 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.63 -48.36 82.14 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.741 -1.123 . . . . 0.0 109.736 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 72' ' ' ILE . 17.0 mt -53.83 -46.31 71.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.347 1.431 . . . . 0.0 110.81 -173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.91 7.55 2.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.39 -4.92 18.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.933 1.242 . . . . 0.0 113.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.88 32.06 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 120.418 1.463 . . . . 0.0 113.247 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.46 43.66 2.35 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.586 1.565 . . . . 0.0 113.614 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.08 82.0 2.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.47 -1.12 78.57 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.928 1.251 . . . . 0.0 113.065 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.77 134.87 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 81' ' ' LEU . 33.1 t -128.68 96.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.76 134.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.12 168.96 18.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.036 0.922 . . . . 0.0 110.012 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -46.93 -176.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 130.986 3.714 . . . . 0.0 113.304 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -115.98 -42.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.39 158.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.63 47.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.217 1.007 . . . . 0.0 111.691 -159.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.548 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -61.07 138.69 94.3 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.862 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 60' ' ' MET . 21.1 Cg_endo -61.12 26.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 125.265 3.976 . . . . 0.0 118.017 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.33 -71.89 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 122.058 2.208 . . . . 0.0 110.03 159.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.8 ttt -91.34 85.07 5.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.929 2.091 . . . . 0.0 107.164 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -47.07 153.55 0.43 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.006 1.322 . . . . 0.0 110.32 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.04 -27.53 62.53 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.429 -0.795 . . . . 0.0 112.167 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.81 -36.57 78.4 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.965 0.882 . . . . 0.0 110.29 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.18 -31.41 55.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.866 0.867 . . . . 0.0 110.795 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -57.86 -53.22 60.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.674 0.67 . . . . 0.0 109.272 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -52.56 -56.47 15.05 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.289 1.036 . . . . 0.0 108.701 174.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -63.44 -30.92 71.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.726 1.148 . . . . 0.0 112.703 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -69.22 -42.22 76.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.103 0.961 . . . . 0.0 110.053 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 46' ' ' LEU . 31.6 mt -61.57 -50.62 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -60.09 -24.68 64.81 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.377 1.871 . . . . 0.0 112.334 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 124.52 1.128 . . . . 0.0 112.627 176.488 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 -36.55 67.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.941 1.297 . . . . 0.0 112.616 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.99 60.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.336 0.971 . . . . 0.0 113.146 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 54' ' ' VAL . 34.2 mt -57.95 135.01 83.68 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-N 119.693 1.133 . . . . 0.0 111.49 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.67 109.84 2.74 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.764 2.309 . . . . 0.0 107.589 161.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -102.68 113.57 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.103 1.761 . . . . 0.0 107.364 177.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.73 111.9 19.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.219 1.008 . . . . 0.0 108.836 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.03 132.03 34.38 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.43 127.54 59.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -161.55 169.61 21.42 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.59 -12.98 47.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.254 -0.904 . . . . 0.0 111.409 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.32 119.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.973 1.261 . . . . 0.0 111.796 -165.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.06 11.04 14.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.537 0.735 . . . . 0.0 112.018 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -52.21 117.97 3.18 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.302 1.841 . . . . 0.0 110.62 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -52.83 -47.73 67.5 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.807 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -46.7 -46.12 19.96 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.17 0.988 . . . . 0.0 111.56 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -65.36 -43.82 89.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.03 -48.57 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.08 -54.44 34.36 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.26 -48.41 45.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.357 1.463 . . . . 0.0 110.84 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.06 27.01 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.219 0.607 . . . . 0.0 109.701 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.75 66.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -73.39 -56.85 4.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.699 2.0 . . . . 0.0 109.641 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.41 -35.61 60.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.573 0.749 . . . . 0.0 110.18 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.6 27.85 3.69 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 125.166 1.365 . . . . 0.0 111.545 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.72 138.59 55.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.112 0.956 . . . . 0.0 110.322 -172.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -72.89 -5.53 38.97 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.59 1.556 . . . . 0.0 112.003 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.32 165.46 34.79 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 158.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -137.79 110.78 7.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.66 104.35 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.442 1.897 . . . . 0.0 106.23 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.62 147.83 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -66.91 147.14 99.15 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 162.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.65 139.7 58.79 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.195 1.105 . . . . 0.0 110.498 -3.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.81 148.09 40.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -144.97 -176.25 5.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 109.811 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.43 -33.23 43.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.936 1.294 . . . . 0.0 110.166 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.54 76.23 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.69 0.796 . . . . 0.0 112.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.01 -27.98 19.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.949 . . . . 0.0 110.003 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.92 -53.39 58.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.365 1.066 . . . . 0.0 109.374 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -37.48 85.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.63 1.172 . . . . 0.0 111.462 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.42 -45.38 69.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.677 1.591 . . . . 0.0 108.896 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.63 87.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.392 -1.766 . . . . 0.0 111.245 170.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.23 -56.51 17.92 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.354 1.034 . . . . 0.0 109.281 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -59.54 -35.02 73.4 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.45 1.023 . . . . 0.0 111.109 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -54.93 -50.82 67.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.689 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.18 -24.42 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.704 1.138 . . . . 0.0 113.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -56.68 -55.56 32.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -74.83 -46.52 36.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -68.49 -70.41 0.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.02 -26.64 66.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.127 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.03 12.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -164.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.5 mmt . . . . . 0 C--O 1.252 1.228 0 CA-C-N 118.998 1.399 . . . . 0.0 109.09 176.258 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.627 0.727 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -89.38 117.65 28.47 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.728 -162.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.13 152.56 41.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.6 tp -123.29 134.8 54.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.73 119.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.678 1.191 . . . . 0.0 108.306 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.09 61.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.35 156.85 36.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -62.05 -44.4 96.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.654 1.181 . . . . 0.0 110.485 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 12.2 t80 -116.08 132.59 56.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 109.029 -159.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -51.28 -60.65 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.128 0.971 . . . . 0.0 111.97 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 64.4 m -51.22 -37.25 45.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.997 0.519 . . . . 0.0 110.936 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.59 -47.17 82.86 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.018 0.826 . . . . 0.0 111.045 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.3 ptt85 -72.92 -27.43 61.86 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 120.997 1.726 . . . . 0.0 111.545 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -62.59 -40.95 98.55 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.467 -0.771 . . . . 0.0 109.431 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.23 -63.43 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.49 -42.63 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.804 1.184 . . . . 0.0 110.671 -171.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -60.56 -49.21 78.44 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 117.709 -1.138 . . . . 0.0 111.07 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -50.86 -54.68 21.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.377 0.989 . . . . 0.0 109.66 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.82 -42.62 75.95 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.099 0.96 . . . . 0.0 111.535 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.86 -47.63 79.94 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.52 -19.29 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.441 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.76 -33.08 74.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.178 1.354 . . . . 0.0 110.156 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.05 -50.28 6.75 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.461 1.504 . . . . 0.0 108.738 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.94 -97.14 0.13 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 35.92 64.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 128.363 2.665 . . . . 0.0 112.316 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -68.41 1.48 2.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.83 100.47 4.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.894 1.679 . . . . 0.0 110.694 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.63 91.56 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 125.799 1.639 . . . . 0.0 107.64 -172.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 164.4 17.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.429 0.691 . . . . 0.0 109.56 169.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.82 166.31 22.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 158.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -113.54 178.58 4.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.368 1.067 . . . . 0.0 108.668 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.65 -43.1 23.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -167.24 164.03 15.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.264 1.826 . . . . 0.0 108.121 -161.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.88 -39.42 11.2 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.191 1.377 . . . . 0.0 114.034 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.018 0.909 . . . . 0.0 109.314 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.16 -26.15 66.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.171 0.589 . . . . 0.0 111.038 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.46 -54.6 43.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.802 1.183 . . . . 0.0 108.433 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.89 -39.87 82.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.337 0.589 . . . . 0.0 111.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -56.1 -47.11 78.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.435 1.094 . . . . 0.0 110.353 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -59.38 -48.83 80.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.941 1.297 . . . . 0.0 109.911 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 72' ' ' ILE . 3.2 mt -57.91 -39.32 77.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.837 1.199 . . . . 0.0 109.755 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -76.25 10.07 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.15 -37.15 84.96 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.501 -1.375 . . . . 0.0 109.835 159.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.24 -19.68 0.73 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 118.112 -1.382 . . . . 0.0 116.136 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.01 86.42 0.06 OUTLIER Glycine 0 C--N 1.338 0.691 0 CA-C-N 120.389 2.095 . . . . 0.0 113.541 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.26 163.5 14.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.588 0.694 . . . . 0.0 109.925 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.42 -38.84 4.63 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.419 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -142.5 151.17 41.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.463 1.131 . . . . 0.0 109.113 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -129.27 79.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -97.31 120.62 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -169.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -151.65 156.54 40.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.114 1.324 . . . . 0.0 113.216 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.12 168.44 20.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.631 1.173 . . . . 0.0 110.051 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -82.28 -56.21 4.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.075 0.95 . . . . 0.0 113.409 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.19 67.23 4.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.699 0.799 . . . . 0.0 112.41 -158.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -66.89 147.63 99.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.712 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.45 -6.32 14.83 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 114.096 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -139.88 -89.95 0.18 Allowed 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.196 1.362 . . . . 0.0 111.746 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.7 ttm -82.0 95.85 7.54 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.77 155.66 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.89 -24.18 48.54 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.359 -0.838 . . . . 0.0 112.022 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.69 -35.45 57.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.609 1.204 . . . . 0.0 111.515 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.04 -40.24 75.26 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.098 0.959 . . . . 0.0 109.705 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.82 -54.08 48.93 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.211 1.404 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tp -53.07 -58.36 7.26 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.719 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 26.7 mttm -60.9 -31.76 71.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.389 0.995 . . . . 0.0 111.844 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.5 m -65.28 -48.71 72.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.566 0.746 . . . . 0.0 110.608 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 HD11 HD11 ' A' ' 46' ' ' LEU . 28.0 mt -59.16 -45.03 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -7.08 13.16 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.896 1.678 . . . . 0.0 113.57 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 119.741 1.155 . . . . 0.0 111.689 173.705 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.7 mtt . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.0 -57.13 3.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.09 2.556 . . . . 0.0 112.966 -159.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.83 -9.97 59.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.254 -1.355 . . . . 0.0 113.874 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 54' ' ' VAL . 12.7 mt -56.8 117.78 19.38 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.181 1.355 . . . . 0.0 110.571 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.54 100.88 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.07 2.513 . . . . 0.0 109.098 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.01 130.86 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 166.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.5 tp -131.17 112.22 12.64 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.735 1.214 . . . . 0.0 108.444 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.6 mmm -83.01 96.88 8.48 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -100.34 107.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -154.41 167.27 30.56 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.161 -0.962 . . . . 0.0 111.153 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.75 47.43 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.543 -0.723 . . . . 0.0 111.872 165.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -76.05 94.4 3.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.866 1.266 . . . . 0.0 110.737 -164.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -83.54 14.93 3.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.978 1.311 . . . . 0.0 112.974 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 118.98 4.62 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.579 1.152 . . . . 0.0 108.19 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -57.26 -43.38 82.96 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.431 1.014 . . . . 0.0 110.02 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.71 -29.48 69.37 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.766 1.166 . . . . 0.0 112.11 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -67.7 -45.24 75.71 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.715 0.689 . . . . 0.0 109.719 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.62 -48.12 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.251 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.87 -55.17 19.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.82 69.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.227 1.011 . . . . 0.0 110.38 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.31 -53.42 58.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.712 0.805 . . . . 0.0 110.763 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.66 93.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.312 0.505 . . . . 0.0 110.484 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -59.89 -49.67 76.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.951 2.1 . . . . 0.0 111.272 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -61.6 -31.24 71.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.471 1.108 . . . . 0.0 111.56 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.03 16.01 7.53 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.699 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.81 136.8 58.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 119.712 1.756 . . . . 0.0 108.553 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -66.63 -19.57 65.8 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 123.313 0.383 . . . . 0.0 110.954 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.59 176.88 48.25 Favored Glycine 0 N--CA 1.439 -1.101 0 O-C-N 121.187 -0.946 . . . . 0.0 113.186 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.89 137.74 51.61 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.483 1.513 . . . . 0.0 107.34 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.0 85.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.513 2.325 . . . . 0.0 104.943 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 90' ' ' ALA . 23.5 t -70.73 144.82 13.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 167.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 155.03 6.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.192 0.997 . . . . 0.0 110.506 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.01 145.44 83.93 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 N-CA-C 109.464 -1.014 . . . . 0.0 109.464 -10.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -132.24 150.79 52.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.346 1.058 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -147.28 169.46 19.35 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.182 2.193 . . . . 0.0 108.334 -164.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.19 74.12 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.76 17.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.016 1.326 . . . . 0.0 114.313 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.63 -25.49 8.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.757 1.162 . . . . 0.0 110.892 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -57.7 11.67 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 170.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -32.07 71.56 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.22 -49.25 67.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 109.425 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 3.8 mmpt? -68.53 -37.31 79.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 116.724 -1.607 . . . . 0.0 110.278 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.94 -57.36 12.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.307 0.958 . . . . 0.0 109.077 171.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -50.42 -45.27 55.64 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.058 0.943 . . . . 0.0 110.866 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 11.5 mtmm -59.43 -48.03 83.2 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.559 -1.21 . . . . 0.0 112.596 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 pt -75.05 -31.91 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.896 2.134 . . . . 0.0 113.283 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -55.4 -50.53 69.53 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.879 1.272 . . . . 0.0 108.82 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.04 -57.78 4.2 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.935 0.494 . . . . 0.0 109.916 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -58.65 3.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -159.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 129' ' ' MET . 6.6 mt -71.43 -26.33 62.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.45 40.69 8.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -169.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 127' ' ' LEU . 14.7 mmt . . . . . 0 C--O 1.253 1.243 0 CA-C-N 118.897 1.349 . . . . 0.0 108.135 171.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -75.0 135.09 41.32 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 53' ' ' PHE . 8.3 m-85 -92.78 149.44 21.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 166.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -121.78 138.29 54.43 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 166.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.26 108.09 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -124.51 57.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.37 162.69 5.87 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 159.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -47.83 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.376 -0.827 . . . . 0.0 110.167 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -64.17 -19.94 65.66 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -158.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 t 70.64 -47.27 0.64 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.926 2.491 . . . . 0.0 111.55 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.8 m -52.69 -36.95 58.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.467 -1.396 . . . . 0.0 109.29 160.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.2 ttp -67.92 -17.66 64.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.213 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.486 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.24 -48.03 81.75 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 120.663 1.574 . . . . 0.0 108.327 168.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -56.85 -52.88 63.38 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 107.893 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.36 -68.47 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 124.059 0.849 . . . . 0.0 108.811 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.49 -46.66 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.995 0.816 . . . . 0.0 110.746 -170.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -63.89 -35.52 80.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.156 0.889 . . . . 0.0 111.018 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -72.3 -32.98 67.04 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.52 1.055 . . . . 0.0 111.751 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.92 -36.8 80.78 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.978 -1.076 . . . . 0.0 109.868 172.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.54 -36.47 81.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.865 -0.522 . . . . 0.0 110.517 172.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -64.66 -34.49 78.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.728 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -56.66 -64.93 0.71 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.931 1.241 . . . . 0.0 110.925 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.67 28.53 1.05 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -165.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.03 -116.34 2.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.463 1.506 . . . . 0.0 110.226 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -141.54 176.4 8.92 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.461 1.105 . . . . 0.0 111.708 -159.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.42 -177.64 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.066 1.746 . . . . 0.0 110.391 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 60.05 74.29 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.118 2.167 . . . . 0.0 109.781 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.28 125.06 73.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 172.87 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.697 1.199 . . . . 0.0 107.952 165.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -134.43 173.91 11.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.729 1.212 . . . . 0.0 107.992 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.38 177.19 8.06 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.111 0.964 . . . . 0.0 109.601 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.04 -38.59 52.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.883 0.473 . . . . 0.0 111.461 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.05 162.88 1.67 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.784 2.033 . . . . 0.0 107.131 -158.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -47.89 -42.31 22.09 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.077 1.322 . . . . 0.0 114.663 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.8 -36.56 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.067 1.933 . . . . 0.0 109.533 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.5 t70 -78.95 -36.3 41.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.556 1.542 . . . . 0.0 110.261 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.62 -46.96 83.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.262 1.425 . . . . 0.0 109.081 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -52.62 -47.91 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.22 1.408 . . . . 0.0 110.383 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.2 -19.8 63.98 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.114 0.965 . . . . 0.0 112.926 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HE2' ' OD1' ' A' ' 41' ' ' ASP . 4.2 mptp? -69.25 -49.03 59.97 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.388 -1.445 . . . . 0.0 110.094 162.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.61 HD11 HD11 ' A' ' 72' ' ' ILE . 5.5 mt -54.71 -54.69 38.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.113 1.324 . . . . 0.0 109.581 -174.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.51 -0.96 9.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.5 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.308 1.413 . . . . 0.0 110.52 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.39 -82.59 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.11 91.7 0.11 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -84.21 155.7 22.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.55 -66.99 0.5 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 7.2 m-85 -87.38 136.57 32.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.947 0.873 . . . . 0.0 108.821 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 81' ' ' LEU . 42.3 t -129.75 113.84 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.4 125.78 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.3 p -156.57 168.71 26.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.376 0.989 . . . . 0.0 112.907 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.78 167.54 21.62 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.768 0.827 . . . . 0.0 110.362 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 4.0 t-105 -78.93 -42.58 26.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 158.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -78.53 56.27 1.77 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.311 2.244 . . . . 0.0 112.327 -159.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.471 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -76.81 165.82 49.5 Favored Pre-proline 0 C--O 1.238 0.456 0 O-C-N 120.869 -1.144 . . . . 0.0 110.792 -177.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.82 -39.52 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.45 2.1 . . . . 0.0 110.84 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.82 -69.07 0.87 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.839 1.2 . . . . 0.0 112.295 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.2 ttm -91.14 83.48 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.93 140.6 1.02 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.918 2.087 . . . . 0.0 108.671 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.5 -20.81 66.14 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.052 -1.03 . . . . 0.0 114.77 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.43 -38.38 74.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.104 0.952 . . . . 0.0 109.708 172.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.83 -41.14 83.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 109.911 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.88 -51.08 71.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.496 1.044 . . . . 0.0 110.045 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.23 -56.35 17.22 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.821 173.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.56 -24.86 65.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.812 1.642 . . . . 0.0 113.666 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 m -64.01 -52.16 60.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.61 HD11 HD11 ' A' ' 46' ' ' LEU . 30.9 mt -64.29 -28.66 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 12.39 19.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.433 1.893 . . . . 0.0 111.22 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.535 0 CA-C-N 120.512 1.505 . . . . 0.0 112.412 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -57.66 -18.27 19.51 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.435 -1.415 . . . . 0.0 113.743 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.89 4.34 50.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.0 113.386 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 54' ' ' VAL . 10.4 mt -73.27 127.9 88.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 120.334 -1.479 . . . . 0.0 108.988 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.86 62.82 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.339 4.026 . . . . 0.0 111.716 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.84 112.08 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.349 1.86 . . . . 0.0 111.675 177.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 114.52 27.17 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 125.367 1.467 . . . . 0.0 109.201 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 mmt -76.17 131.03 39.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 105.14 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.246 1.819 . . . . 0.0 106.401 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 t -139.99 178.84 6.98 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.008 0.909 . . . . 0.0 110.696 -171.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.05 -26.2 19.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.124 0.97 . . . . 0.0 111.788 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -91.17 134.95 34.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.201 0.91 . . . . 0.0 111.646 -168.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 -95.8 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.408 -0.806 . . . . 0.0 108.915 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 1.9 tpmt? 59.15 112.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.326 2.25 . . . . 0.0 111.789 -171.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -51.8 -47.42 64.28 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.76 -28.33 69.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.599 1.545 . . . . 0.0 113.423 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -65.02 -47.35 77.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.606 1.094 . . . . 0.0 108.927 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.2 -51.64 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.71 -58.01 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.027 0.931 . . . . 0.0 110.56 -172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.79 88.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.33 -39.28 92.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.591 0.632 . . . . 0.0 112.519 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -60.23 -54.75 42.04 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.929 1.691 . . . . 0.0 109.594 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.46 -12.18 29.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.035 1.334 . . . . 0.0 112.27 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.47 29.65 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 119.099 -0.834 . . . . 0.0 112.531 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.692 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.52 152.16 26.66 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.9 m -55.52 -34.94 65.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.145 0.978 . . . . 0.0 112.23 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.25 179.78 44.15 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.11 92.29 3.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.474 1.51 . . . . 0.0 107.874 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -81.93 137.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.42 144.14 38.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 156.92 43.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.426 0.557 . . . . 0.0 110.801 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.72 137.17 46.21 Favored 'Cis proline' 0 N--CA 1.453 -0.891 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 -12.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -139.07 155.02 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.986 0.422 . . . . 0.0 110.194 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 p -151.72 -172.3 4.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.73 1.612 . . . . 0.0 111.022 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.2 18.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.558 1.143 . . . . 0.0 110.475 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.1 87.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.705 0.802 . . . . 0.0 112.889 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 -34.55 22.22 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.767 1.167 . . . . 0.0 109.269 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.95 -55.96 19.5 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -41.28 99.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.688 1.195 . . . . 0.0 112.518 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.41 -45.11 73.5 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.829 -0.545 . . . . 0.0 110.04 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.36 -38.38 89.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.0 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.29 -60.39 3.47 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.7 -34.83 73.4 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.393 0.542 . . . . 0.0 111.766 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -68.73 0.16 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.966 0.906 . . . . 0.0 109.349 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -24.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -57.56 -64.03 1.03 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.55 0.74 . . . . 0.0 109.219 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.83 -54.73 12.2 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -59.39 -52.6 64.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.537 0.735 . . . . 0.0 111.97 -164.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.74 -47.44 11.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.398 0.679 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.52 19.51 3.1 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.257 1.408 . . . . 0.0 112.704 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.1 mmm . . . . . 0 C--O 1.253 1.254 0 CA-C-N 120.152 1.976 . . . . 0.0 112.837 -172.507 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--O 1.234 0.242 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -90.62 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -86.74 159.48 19.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -125.67 142.2 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.77 110.11 16.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.6 t -125.0 70.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 123.223 1.487 . . . . 0.0 107.346 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.54 173.23 10.67 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.34 1.856 . . . . 0.0 110.996 168.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.18 -18.38 24.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.361 2.264 . . . . 0.0 114.069 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.31 112.62 8.69 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.057 -1.652 . . . . 0.0 109.029 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.85 -46.31 1.96 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.272 1.396 . . . . 0.0 114.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.0 m -51.76 -45.81 63.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.607 1.094 . . . . 0.0 111.673 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.6 ttm -52.39 -41.16 62.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 109.359 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -71.2 -40.56 71.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.88 1.218 . . . . 0.0 111.479 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -54.7 -54.9 35.69 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.41 -65.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.926 1.291 . . . . 0.0 107.923 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.41 -45.41 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.603 1.547 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -64.75 -39.42 93.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.251 1.387 . . . . 0.0 110.698 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -58.56 -51.57 69.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.204 1.366 . . . . 0.0 110.601 171.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.39 -26.35 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.181 0.592 . . . . 0.0 111.994 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -77.91 -45.95 22.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.344 1.057 . . . . 0.0 110.426 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -73.55 -9.63 58.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.16 -36.91 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.397 0.999 . . . . 0.0 109.925 158.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.93 -4.37 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.868 1.667 . . . . 0.0 111.597 -165.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.53 -110.2 1.54 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.999 1.761 . . . . 0.0 108.888 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 40.51 49.86 2.72 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.898 2.479 . . . . 0.0 112.972 165.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -70.67 -4.96 26.13 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.777 0.831 . . . . 0.0 113.241 -160.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -131.09 77.01 1.76 Allowed 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.354 1.461 . . . . 0.0 107.81 -169.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.69 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 164.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.87 171.9 12.64 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.78 2.032 . . . . 0.0 108.04 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.66 148.25 42.15 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.735 1.214 . . . . 0.0 107.733 -164.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -129.82 167.78 17.6 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.127 0.571 . . . . 0.0 109.891 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -74.3 -31.43 62.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.657 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.62 172.72 2.53 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.598 1.559 . . . . 0.0 107.873 -172.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.05 -39.63 26.77 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.796 1.188 . . . . 0.0 113.789 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.38 -45.27 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.6 -0.941 . . . . 0.0 109.892 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.02 -25.66 64.6 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.655 -0.653 . . . . 0.0 110.181 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.58 -55.07 34.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.517 1.053 . . . . 0.0 108.51 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.97 -42.36 76.15 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.682 0.753 . . . . 0.0 110.751 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.94 -40.49 84.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.541 0.737 . . . . 0.0 112.023 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.2 mmtm -62.15 -44.06 97.46 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.232 0.924 . . . . 0.0 109.285 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.459 HD11 HD11 ' A' ' 72' ' ' ILE . 10.5 mt -58.0 -43.94 86.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.11 0.868 . . . . 0.0 110.71 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -69.84 -13.54 62.31 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.52 48.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.774 1.23 . . . . 0.0 112.906 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.93 34.87 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 119.706 1.139 . . . . 0.0 110.882 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.7 76.19 1.09 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -70.91 159.0 35.47 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.2 -1.66 3.92 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.784 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.55 136.96 17.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.141 1.47 . . . . 0.0 108.839 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -134.88 80.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.07 139.94 16.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.3 p -148.96 167.44 25.75 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.511 0.596 . . . . 0.0 111.935 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.9 t70 -78.98 -157.6 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 158.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 16.3 t-105 -122.59 -42.01 2.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.33 2.252 . . . . 0.0 110.293 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.63 43.74 1.0 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 112.203 -159.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -91.79 144.1 28.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 121.25 -0.906 . . . . 0.0 108.567 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.23 159.06 50.62 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.28 1.987 . . . . 0.0 111.379 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.82 -78.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 127.356 2.262 . . . . 0.0 111.862 -171.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.5 86.37 6.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -55.93 165.86 0.86 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 167.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.0 -30.32 53.86 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.809 -1.182 . . . . 0.0 112.416 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -79.54 -29.09 41.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.669 1.235 . . . . 0.0 111.645 -179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.45 -44.52 57.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.86 -51.07 62.43 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.281 1.432 . . . . 0.0 109.178 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.7 tp -57.12 -58.75 6.85 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.417 1.087 . . . . 0.0 110.216 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 67.5 mttt -66.63 -28.88 68.84 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.472 1.487 . . . . 0.0 111.939 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.1 m -62.27 -55.41 28.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.467 1.03 . . . . 0.0 108.699 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.459 HD11 HD11 ' A' ' 46' ' ' LEU . 32.8 mt -50.66 -55.4 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.693 1.597 . . . . 0.0 108.564 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -30.72 65.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.264 1.426 . . . . 0.0 112.266 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 C-N-CA 124.207 1.003 . . . . 0.0 111.745 -169.673 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -34.12 1.96 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.117 2.167 . . . . 0.0 112.159 169.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.38 4.95 19.38 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.68 1.592 . . . . 0.0 113.705 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 54' ' ' VAL . 12.8 mt -66.13 125.63 90.5 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.89 124.64 11.66 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 108.697 -1.309 . . . . 0.0 108.697 170.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 69' ' ' LEU . 2.2 m -104.79 142.1 18.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.9 tp -137.86 111.76 8.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -73.91 122.53 22.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.45 102.43 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -144.3 171.93 13.64 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.688 0.756 . . . . 0.0 112.565 -161.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.56 -24.36 39.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.312 1.045 . . . . 0.0 110.482 163.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.08 94.8 1.95 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.355 1.462 . . . . 0.0 110.514 -168.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 3.62 7.32 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.344 -0.848 . . . . 0.0 111.85 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -49.52 115.91 1.54 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 109.598 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -49.09 -53.07 22.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.418 0.687 . . . . 0.0 111.326 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.99 -25.8 67.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -72.78 -40.21 66.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.326 0.966 . . . . 0.0 109.658 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.58 -49.64 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.7 -57.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.21 76.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.816 0.735 . . . . 0.0 111.105 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.907 0.483 . . . . 0.0 110.149 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -27.48 67.27 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -68.93 -54.55 14.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.756 1.623 . . . . 0.0 109.404 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.83 80.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.881 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.24 35.08 2.78 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 124.691 1.138 . . . . 0.0 112.458 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.39 141.67 46.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -78.46 -4.84 50.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.978 0.174 . . . . 0.0 111.215 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.44 172.76 41.44 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 161.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -139.08 132.0 29.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.29 1.036 . . . . 0.0 108.519 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -132.97 130.67 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 127.065 2.146 . . . . 0.0 106.32 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.32 152.23 10.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -50.72 143.48 14.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.457 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.56 132.79 27.98 Favored 'Cis proline' 0 CA--C 1.534 0.484 0 CA-C-N 120.707 1.288 . . . . 0.0 111.012 -8.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -134.32 157.92 45.11 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.411 0.684 . . . . 0.0 111.243 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -155.51 171.91 19.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.516 1.927 . . . . 0.0 110.765 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.31 75.6 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.46 -50.5 31.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.937 1.295 . . . . 0.0 111.981 169.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.29 -35.3 48.13 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.808 -0.557 . . . . 0.0 109.749 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -57.65 11.01 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.257 1.023 . . . . 0.0 108.841 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.27 -29.69 70.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.042 0.937 . . . . 0.0 111.868 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.59 -45.45 65.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.564 0.346 . . . . 0.0 110.617 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.06 -35.33 80.81 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.954 -1.091 . . . . 0.0 110.306 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.3 mt -58.33 -56.71 18.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 109.729 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -50.71 -43.82 57.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.874 0.761 . . . . 0.0 110.916 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -51.68 -61.4 2.27 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.307 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 pt -70.96 -26.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.715 1.598 . . . . 0.0 114.531 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.67 -58.62 7.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.31 -41.74 66.25 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.876 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -68.38 -67.73 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.554 1.542 . . . . 0.0 108.77 -173.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.423 HD23 ' HD2' ' A' ' 126' ' ' LYS . 8.5 mt -72.9 -29.13 62.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.74 0.416 . . . . 0.0 110.374 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.84 26.13 25.36 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 117.737 -1.59 . . . . 0.0 110.361 -161.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--O 1.242 0.692 0 CA-C-N 120.174 1.987 . . . . 0.0 109.801 175.347 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -91.11 138.5 31.55 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.087 0.555 . . . . 0.0 110.726 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.3 102.36 14.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.349 1.86 . . . . 0.0 107.747 165.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.89 136.75 54.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.3 106.16 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 42' ' ' ALA . 6.7 t -109.03 89.26 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.24 158.81 16.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.65 0.738 . . . . 0.0 110.734 170.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.79 -4.34 58.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.384 1.074 . . . . 0.0 112.685 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 10.0 t80 -131.52 -3.92 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.844 1.258 . . . . 0.0 112.309 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 62.31 -60.18 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.214 2.205 . . . . 0.0 110.76 -159.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.422 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 68.8 m -62.63 -29.07 70.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 111.189 -171.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.02 64.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.648 1.567 . . . . 0.0 110.904 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.7 ttp85 -67.95 -43.86 78.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 121.288 1.858 . . . . 0.0 107.309 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.85 -45.63 67.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.239 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.08 -65.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.887 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.14 -47.53 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.204 1.365 . . . . 0.0 111.148 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.624 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.3 ttt180 -55.15 -49.5 71.65 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 109.755 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -60.17 -39.74 87.51 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.847 0.748 . . . . 0.0 110.744 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 113' ' ' ALA . 60.8 mt -66.45 -34.07 77.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.045 0.839 . . . . 0.0 110.989 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -67.27 -37.01 82.76 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.354 -0.841 . . . . 0.0 110.706 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -70.06 -29.2 66.15 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.538 -1.351 . . . . 0.0 111.084 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.34 -51.75 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.35 1.06 . . . . 0.0 110.582 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 47.37 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.613 0.721 . . . . 0.0 112.264 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.0 -111.72 0.83 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.6 158.27 44.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.178 0.989 . . . . 0.0 111.156 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -82.65 177.81 8.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.196 0.999 . . . . 0.0 109.357 159.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 60.78 79.25 0.25 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.745 2.018 . . . . 0.0 111.631 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.624 HG21 ' HG3' ' A' ' 22' ' ' ARG . 5.2 m -97.56 169.17 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.352 163.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -141.8 -179.6 6.29 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.97 1.708 . . . . 0.0 108.514 163.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -134.12 158.11 44.47 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.464 1.506 . . . . 0.0 107.775 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.59 159.14 40.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.598 1.559 . . . . 0.0 107.262 162.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.26 -24.13 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -171.5 168.68 6.37 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.468 1.507 . . . . 0.0 107.21 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.72 -37.89 21.57 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.291 0.948 . . . . 0.0 113.526 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.98 -51.22 47.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.261 1.024 . . . . 0.0 109.997 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -74.14 -28.23 61.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.143 1.377 . . . . 0.0 110.073 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.98 -50.84 71.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.492 1.117 . . . . 0.0 108.942 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.18 -37.76 75.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.353 0.261 . . . . 0.0 110.492 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -67.77 -36.11 79.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.277 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 mmtt -63.45 -40.1 96.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.874 1.215 . . . . 0.0 109.605 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -62.55 -39.1 92.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.763 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -71.26 5.96 1.94 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.28 59.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.54 -1.35 . . . . 0.0 112.943 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -105.31 0.29 Allowed Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.379 0.991 . . . . 0.0 110.698 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.31 87.37 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.364 0.983 . . . . 0.0 110.98 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -67.69 164.82 18.47 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.365 1.066 . . . . 0.0 110.993 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.97 -43.71 3.76 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 119.044 -0.865 . . . . 0.0 111.221 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.05 145.59 44.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 117.894 0.847 . . . . 0.0 112.307 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' LEU . 14.1 t -136.09 81.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.135 1.374 . . . . 0.0 107.894 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.88 127.1 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -136.81 144.39 43.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -171.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.15 166.66 19.44 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 158.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -71.92 -45.58 60.69 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.578 0.751 . . . . 0.0 109.317 162.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -73.97 98.75 3.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.054 0.942 . . . . 0.0 112.17 -160.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 mmt -131.4 155.51 81.38 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.96 -45.11 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.469 2.113 . . . . 0.0 111.273 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.65 -99.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.428 1.091 . . . . 0.0 108.657 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.9 ttm -79.18 96.12 5.8 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.4 166.75 4.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.057 0.943 . . . . 0.0 111.291 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.95 -24.28 71.5 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.259 -171.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -43.88 34.9 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.118 1.459 . . . . 0.0 107.758 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.43 -41.13 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.576 0.75 . . . . 0.0 110.977 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.55 -49.54 77.39 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.066 0.946 . . . . 0.0 109.638 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -53.58 -56.01 20.8 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.719 -1.134 . . . . 0.0 109.448 175.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 45.2 mttt -64.13 -37.97 89.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.677 1.581 . . . . 0.0 111.192 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.9 m -56.89 -49.17 76.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.451 0.569 . . . . 0.0 109.798 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -65.89 -42.82 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.41 0.684 . . . . 0.0 109.432 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.83 84.53 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 111.993 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.03 1.332 . . . . 0.0 111.479 -179.027 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.9 p -57.99 -21.13 43.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.404 1.081 . . . . 0.0 112.825 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.29 -16.19 62.45 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 54' ' ' VAL . 45.2 mt -64.86 149.01 96.97 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 119.892 1.223 . . . . 0.0 112.299 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.14 86.7 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.535 2.823 . . . . 0.0 108.777 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -77.25 99.51 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -107.97 110.6 22.37 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.382 1.073 . . . . 0.0 108.267 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -72.53 123.24 22.75 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.94 96.65 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.3 t -134.46 -170.31 2.51 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.243 1.017 . . . . 0.0 109.88 -169.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.12 -12.13 14.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.844 1.258 . . . . 0.0 112.348 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.81 105.47 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.438 1.017 . . . . 0.0 110.761 -172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.93 4.44 8.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.812 0.845 . . . . 0.0 113.271 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -53.64 115.28 1.89 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.959 1.704 . . . . 0.0 109.724 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -55.25 -45.03 76.07 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.011 0.924 . . . . 0.0 110.119 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -41.91 39.87 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.56 1.144 . . . . 0.0 112.392 172.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.28 -34.38 63.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.583 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.75 -48.93 85.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.248 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mt -57.25 -50.31 77.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 CA-C-N 120.952 1.705 . . . . 0.0 109.336 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.26 -46.29 72.61 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 119.158 0.89 . . . . 0.0 110.304 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.69 76.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 110.867 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.41 99.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.388 0.995 . . . . 0.0 111.803 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.23 -48.36 81.85 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.51 1.924 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -62.56 -38.49 90.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.04 0.936 . . . . 0.0 110.923 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 33.51 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.851 1.215 . . . . 0.0 112.343 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.632 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.53 145.39 44.35 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.11 1.455 . . . . 0.0 109.217 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -73.41 -16.09 61.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.302 0.641 . . . . 0.0 111.736 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.76 173.55 39.34 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.62 136.42 35.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.37 144.82 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.84 138.84 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -52.14 139.51 34.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 165.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.96 137.75 51.43 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 CA-C-N 119.963 1.022 . . . . 0.0 110.5 -8.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.07 150.92 46.3 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.481 0.712 . . . . 0.0 110.077 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -147.98 -173.3 4.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.298 0.639 . . . . 0.0 111.057 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -50.54 -35.41 29.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.479 1.112 . . . . 0.0 109.669 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.81 -19.46 28.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -114.46 -23.36 9.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.24 0.927 . . . . 0.0 112.039 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.09 -50.59 72.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -47.34 74.68 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.287 1.035 . . . . 0.0 111.244 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.25 -52.8 63.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 122.991 0.516 . . . . 0.0 109.851 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.99 -33.17 74.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.222 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.34 -58.02 10.32 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.715 1.143 . . . . 0.0 109.69 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -56.94 -40.01 75.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.867 0.758 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -55.31 -56.46 19.76 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.031 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 -26.11 18.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 120.39 1.45 . . . . 0.0 112.812 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -53.96 -53.53 51.54 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.084 0.856 . . . . 0.0 108.912 169.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.3 -43.83 26.95 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.552 0.341 . . . . 0.0 110.737 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -73.88 -62.01 1.65 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.074 0.549 . . . . 0.0 110.045 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mt -71.93 -43.22 65.62 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.972 0.509 . . . . 0.0 109.776 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.55 32.47 3.39 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.491 -163.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--O 1.253 1.282 0 CA-C-N 118.631 1.215 . . . . 0.0 111.239 172.293 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 111.097 0.036 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 169.89 17.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 111.779 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -136.95 101.9 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.988 1.715 . . . . 0.0 108.258 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.9 tp -71.01 131.08 43.13 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.3 99.74 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.37 70.12 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.492 1.917 . . . . 0.0 108.576 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.44 151.67 41.04 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.948 -1.095 . . . . 0.0 108.102 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.5 -42.13 65.18 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.138 -0.976 . . . . 0.0 110.793 169.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -90.96 115.97 28.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.618 1.567 . . . . 0.0 107.02 -173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -57.75 -47.61 81.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.262 0.483 . . . . 0.0 110.078 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -53.57 -40.88 65.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.75 0.705 . . . . 0.0 111.177 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 ttt -58.3 -39.96 80.71 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.546 0.738 . . . . 0.0 110.143 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HG2' ' HE ' ' A' ' 22' ' ' ARG . 14.1 ttp180 -62.13 -46.79 87.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.004 1.322 . . . . 0.0 109.797 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -55.81 -51.93 65.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.744 0.818 . . . . 0.0 108.887 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.51 -62.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.254 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -48.64 -44.23 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 120.828 1.649 . . . . 0.0 110.671 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HE ' ' HG2' ' A' ' 18' ' ' ARG . 59.5 mtt-85 -60.85 -45.44 94.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.669 1.122 . . . . 0.0 111.664 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -63.88 -42.5 97.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.758 0.708 . . . . 0.0 111.748 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.76 -32.41 73.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.922 0.889 . . . . 0.0 111.478 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.16 -56.76 11.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -64.79 -19.47 65.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -51.73 -33.44 34.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.898 1.226 . . . . 0.0 110.804 164.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.9 -41.4 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.975 2.11 . . . . 0.0 110.129 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.86 -139.27 6.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 64.86 60.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 123.173 1.464 . . . . 0.0 110.32 166.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.24 176.18 4.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.539 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 56.41 48.34 17.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 127.483 2.313 . . . . 0.0 113.477 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -55.51 161.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 121.13 -0.981 . . . . 0.0 111.369 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.04 157.5 44.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.279 1.832 . . . . 0.0 107.617 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.17 116.86 19.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.24 163.77 13.49 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 158.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.3 -37.04 58.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.006 0.821 . . . . 0.0 110.432 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.86 174.71 14.57 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.156 1.383 . . . . 0.0 109.237 -169.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.47 -35.31 71.78 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.5 t -66.38 -48.87 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 120.822 2.311 . . . . 0.0 107.152 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.73 -28.86 70.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.816 0.847 . . . . 0.0 111.287 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.68 -56.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.947 1.699 . . . . 0.0 109.43 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.73 -45.62 74.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.105 0.562 . . . . 0.0 109.77 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -65.75 -28.92 69.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.15 0.58 . . . . 0.0 112.161 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -62.93 -52.56 62.58 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.074 0.95 . . . . 0.0 108.804 166.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 HG13 ' A' ' 54' ' ' VAL . 14.1 mt -53.86 -41.45 67.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.704 1.138 . . . . 0.0 111.131 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -72.12 -7.09 47.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -17.6 58.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.463 1.029 . . . . 0.0 111.653 167.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.08 169.96 16.85 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.546 1.067 . . . . 0.0 111.548 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.22 108.2 2.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.244 0.926 . . . . 0.0 113.279 -171.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.49 163.4 27.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.444 1.098 . . . . 0.0 108.749 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.53 -45.06 19.35 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 166.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -135.91 150.59 49.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.599 0.76 . . . . 0.0 112.437 -166.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.682 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -131.63 70.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.082 1.353 . . . . 0.0 108.687 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.18 130.97 34.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.5 m -150.39 158.77 44.53 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.614 -0.679 . . . . 0.0 110.979 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.91 169.08 18.97 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.458 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -83.28 -48.92 9.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.719 1.608 . . . . 0.0 112.372 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.86 79.32 6.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.71 1.604 . . . . 0.0 109.582 -159.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.34 125.29 28.28 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.63 -40.57 29.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.125 2.55 . . . . 0.0 113.7 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -83.54 -101.91 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttp -79.78 106.97 12.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.79 160.61 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.19 -29.72 56.71 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.082 -1.011 . . . . 0.0 112.117 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.01 -43.01 83.97 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.764 0.782 . . . . 0.0 110.842 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.54 -37.55 71.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.611 0.765 . . . . 0.0 110.304 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.3 tp -53.06 -58.62 6.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.211 1.004 . . . . 0.0 108.701 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -48.09 -56.96 6.51 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.089 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -67.41 -24.68 65.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.035 1.289 . . . . 0.0 114.02 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -65.98 -48.27 71.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.257 6.3 mt -55.57 -57.83 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 167.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -23.86 67.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.163 1.385 . . . . 0.0 113.038 -165.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.314 0 CA-C-N 119.507 1.049 . . . . 0.0 110.264 -178.067 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 119.72 -0.181 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.8 p -59.52 -25.03 64.14 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.092 0.957 . . . . 0.0 113.285 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -9.43 59.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 113.618 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 54' ' ' VAL . 14.2 mt -56.59 144.22 65.15 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 119.199 0.909 . . . . 0.0 109.821 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.98 79.96 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.261 2.641 . . . . 0.0 109.042 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.91 110.37 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 128.627 2.771 . . . . 0.0 107.746 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.578 HD21 ' HD3' ' A' ' 119' ' ' LYS . 26.7 tp -135.94 113.21 10.6 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.263 -0.898 . . . . 0.0 111.935 -158.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -80.97 129.73 34.68 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.36 105.18 5.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -152.26 166.79 30.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.302 0.501 . . . . 0.0 110.831 -166.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.56 57.05 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.282 -0.886 . . . . 0.0 112.178 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -72.82 96.6 2.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.338 1.455 . . . . 0.0 110.084 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.59 -0.81 52.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.861 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 94' ' ' ASN . 31.6 ttmt -50.71 118.03 2.85 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.559 1.072 . . . . 0.0 109.812 -174.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -50.71 -52.98 35.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.103 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.24 -29.85 69.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.422 1.01 . . . . 0.0 112.625 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.413 ' H ' ' HG2' ' A' ' 91' ' ' LYS . 69.6 m-20 -72.13 -36.33 69.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.203 0.91 . . . . 0.0 110.039 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.3 -44.5 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.66 -48.92 84.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.25 -44.55 83.99 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.427 1.012 . . . . 0.0 110.152 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.95 88.18 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 119.225 0.921 . . . . 0.0 111.236 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.73 92.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.272 0.487 . . . . 0.0 109.874 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -62.15 -49.91 73.97 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.926 2.491 . . . . 0.0 111.283 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.39 -22.1 62.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.608 1.163 . . . . 0.0 111.89 174.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.22 6.11 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.7 1.143 . . . . 0.0 110.327 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -65.52 142.46 58.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.6 p -66.4 -24.36 66.46 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.105 0.562 . . . . 0.0 111.093 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 169.45 38.3 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.92 126.18 28.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.224 1.41 . . . . 0.0 108.563 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -121.08 107.31 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.04 153.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 166.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.43 150.37 34.1 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.548 1.539 . . . . 0.0 109.105 160.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.51 147.75 79.22 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 CA-C-N 121.105 1.43 . . . . 0.0 109.903 -12.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -146.92 138.41 24.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -140.94 -174.75 4.08 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.559 1.544 . . . . 0.0 109.613 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.19 -25.64 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.304 -0.872 . . . . 0.0 110.153 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.12 53.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.202 1.001 . . . . 0.0 112.723 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.6 t -98.6 -27.0 14.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.839 0.745 . . . . 0.0 110.754 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.72 86.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.302 0.956 . . . . 0.0 108.797 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -38.53 91.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.717 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.62 -54.1 22.52 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.747 0.703 . . . . 0.0 110.355 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HD3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -58.72 -38.08 77.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.829 1.195 . . . . 0.0 111.042 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.98 -54.67 44.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.01 0.823 . . . . 0.0 110.629 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.82 -39.64 68.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.85 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -64.99 -45.49 85.4 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.332 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -19.63 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 121.041 1.746 . . . . 0.0 113.414 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -56.54 -62.9 1.41 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 159.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -72.54 -30.37 64.4 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.259 -0.9 . . . . 0.0 112.609 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -68.66 0.65 Allowed 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.95 -23.57 61.47 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 122.954 0.159 . . . . 0.0 110.89 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.53 23.26 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.532 -1.704 . . . . 0.0 110.056 -165.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-N 119.866 1.833 . . . . 0.0 110.476 172.356 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.234 0.238 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.271 2.4 ptpt -91.86 164.01 13.83 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.31 108.53 12.31 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.371 1.468 . . . . 0.0 108.77 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -82.43 139.33 34.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.79 1.632 . . . . 0.0 109.963 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -135.72 112.45 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.361 1.465 . . . . 0.0 108.448 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.27 41.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.081 1.352 . . . . 0.0 110.324 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.32 154.67 7.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.955 -1.09 . . . . 0.0 108.959 164.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.08 -45.31 11.52 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.22 -1.55 . . . . 0.0 110.744 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -70.6 115.22 9.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.645 1.978 . . . . 0.0 107.636 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -59.64 -39.53 84.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.192 1.36 . . . . 0.0 111.884 -172.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.4 m -55.13 -32.41 62.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.74 0.7 . . . . 0.0 111.45 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 tpp -60.5 -42.46 96.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.231 -0.918 . . . . 0.0 109.947 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -66.18 -34.44 78.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.719 1.145 . . . . 0.0 111.124 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -59.79 -58.77 7.12 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.74 -63.26 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 C-N-CA 125.978 1.711 . . . . 0.0 109.05 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.78 -46.04 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 121.071 1.759 . . . . 0.0 111.267 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -65.51 -41.24 93.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 120.179 1.354 . . . . 0.0 111.518 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -58.15 -54.57 45.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.421 1.088 . . . . 0.0 109.437 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -52.26 -48.53 65.18 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.861 2.064 . . . . 0.0 110.829 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.03 -44.15 82.6 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.318 0.647 . . . . 0.0 110.811 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -77.62 -17.24 57.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.51 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.81 -43.89 94.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.34 1.427 . . . . 0.0 109.287 166.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.07 -37.24 78.39 Favored 'General case' 0 N--CA 1.46 0.038 0 O-C-N 122.179 -0.325 . . . . 0.0 110.596 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.98 6.1 10.32 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.92 1.248 . . . . 0.0 113.885 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.24 155.82 39.77 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.7 1.75 . . . . 0.0 108.942 163.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -149.88 -167.53 2.85 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.322 1.049 . . . . 0.0 108.394 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 55.15 37.93 29.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.108 1.363 . . . . 0.0 111.16 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.29 158.11 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -140.76 166.68 24.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.624 2.37 . . . . 0.0 107.478 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -128.78 155.11 45.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.91 167.75 10.38 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 161.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -42.97 89.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.68 0.792 . . . . 0.0 111.435 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.3 173.87 5.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.038 1.335 . . . . 0.0 108.835 -169.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.33 -42.01 72.98 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 119.923 1.238 . . . . 0.0 113.389 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.11 -51.42 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.86 1.264 . . . . 0.0 109.659 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -70.33 -35.65 73.75 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.754 0.821 . . . . 0.0 111.076 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.31 65.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.568 1.147 . . . . 0.0 109.409 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -54.61 -48.92 71.59 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.721 0.638 . . . . 0.0 111.6 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -66.3 -28.5 68.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -64.19 -46.56 83.39 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.372 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 54' ' ' VAL . 8.2 mt -57.55 -41.69 81.51 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 110.665 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 3.06 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 158.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.82 164.32 11.22 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.969 1.271 . . . . 0.0 111.395 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.17 14.53 78.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.035 0.826 . . . . 0.0 113.167 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -81.46 117.32 21.79 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.44 -25.11 26.78 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.225 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -148.94 149.7 31.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.17 0.988 . . . . 0.0 110.803 -169.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -133.99 85.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.27 127.22 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -152.03 163.64 38.89 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.082 -1.011 . . . . 0.0 110.308 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.35 173.58 5.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.795 0.807 . . . . 0.0 110.278 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 -71.58 -60.69 2.1 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.664 158.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.258 23.7 p30 29.21 -157.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 130.392 3.477 . . . . 0.0 116.215 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 65.15 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.034 1.334 . . . . 0.0 112.504 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 58.3 Cg_endo -65.36 -66.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 121.796 1.664 . . . . 0.0 108.78 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 5.7 m120 -155.61 -69.69 0.12 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.661 2.385 . . . . 0.0 104.953 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.0 ttm -70.01 88.36 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 160.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -65.61 172.01 3.72 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.793 0.837 . . . . 0.0 110.428 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.53 -32.75 53.43 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.988 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -70.46 -49.87 44.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.537 1.169 . . . . 0.0 110.579 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.61 -38.06 89.67 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.472 0.709 . . . . 0.0 110.874 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.0 tp -55.94 -61.31 2.46 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.115 1.366 . . . . 0.0 108.722 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -46.42 -53.52 10.91 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.843 1.257 . . . . 0.0 109.511 174.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 66.6 mttt -66.62 -26.25 66.99 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.126 0.875 . . . . 0.0 113.12 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.2 m -72.87 -43.36 62.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.361 1.064 . . . . 0.0 109.612 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.37 -45.79 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.969 1.308 . . . . 0.0 113.593 166.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -49.3 77.16 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.311 1.044 . . . . 0.0 109.529 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.585 0 C-N-CA 124.088 0.955 . . . . 0.0 113.303 178.646 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mtm . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 p -65.34 -17.29 64.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.492 1.042 . . . . 0.0 113.167 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.7 59.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.526 1.13 . . . . 0.0 113.471 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 54' ' ' VAL . 19.5 mt -61.01 133.24 92.48 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.314 0.961 . . . . 0.0 110.271 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.01 125.3 12.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.011 1.807 . . . . 0.0 108.682 166.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.624 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -119.07 107.71 22.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.205 2.202 . . . . 0.0 106.804 -173.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 tp -125.12 115.2 20.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.341 1.057 . . . . 0.0 109.712 -164.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.38 122.35 26.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.92 113.59 24.87 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -156.0 168.9 25.8 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.259 -0.9 . . . . 0.0 110.626 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.32 -21.23 46.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.379 -0.825 . . . . 0.0 111.684 163.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.53 107.35 19.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.231 1.012 . . . . 0.0 111.227 -167.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -73.56 0.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.989 171.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.1 tttt 32.73 98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.828 2.451 . . . . 0.0 113.381 -167.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -52.45 -41.51 63.36 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.287 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.73 -36.27 69.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.151 1.342 . . . . 0.0 112.752 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.81 -36.41 70.24 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 121.536 -0.727 . . . . 0.0 110.085 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.1 mt -63.46 -39.17 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.642 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.3 -53.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.51 -46.45 70.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.987 0.812 . . . . 0.0 110.654 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.47 73.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.916 0.886 . . . . 0.0 110.741 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.88 99.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.43 0.692 . . . . 0.0 110.147 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -60.84 -50.89 71.63 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.312 1.845 . . . . 0.0 111.17 175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.46 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -59.62 -22.65 62.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.918 0.887 . . . . 0.0 112.267 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.78 11.73 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.544 -1.142 . . . . 0.0 112.281 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.04 134.96 57.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.415 1.107 . . . . 0.0 108.805 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 m -67.64 -10.08 49.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.201 1.001 . . . . 0.0 112.255 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.06 170.54 38.2 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.332 0.969 . . . . 0.0 111.345 166.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.14 132.32 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.276 1.43 . . . . 0.0 107.681 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.39 104.79 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 156.68 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -58.21 151.08 49.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 158.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.27 148.36 91.04 Favored 'Cis proline' 0 N--CA 1.457 -0.632 0 CA-C-N 119.653 0.912 . . . . 0.0 110.633 -9.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -149.44 154.47 38.89 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.322 0.649 . . . . 0.0 110.088 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 p -143.81 -175.19 4.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.363 1.065 . . . . 0.0 109.46 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -29.62 60.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.599 0.76 . . . . 0.0 110.3 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.77 67.98 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 t -99.57 -27.61 13.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.85 1.204 . . . . 0.0 110.224 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -50.63 70.21 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -37.21 84.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.863 1.265 . . . . 0.0 112.249 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.98 -57.19 13.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.865 1.266 . . . . 0.0 109.14 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -66.01 -34.16 77.45 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.489 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 mt -59.54 -55.1 38.85 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.187 175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.465 ' HA ' ' CD2' ' A' ' 124' ' ' PHE . 18.7 t-20 -64.37 -30.56 71.6 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 118.283 0.492 . . . . 0.0 110.412 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -60.2 3.51 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.029 167.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.4 pt -71.15 -26.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.426 1.466 . . . . 0.0 113.86 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 121' ' ' ASN . 21.6 m-30 -59.47 -39.07 82.5 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.092 0.86 . . . . 0.0 109.918 170.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.58 -40.22 17.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.008 0.523 . . . . 0.0 110.71 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HG3' HD23 ' A' ' 127' ' ' LEU . 32.1 tptt -77.14 -71.7 0.39 Allowed 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.564 1.145 . . . . 0.0 108.125 -168.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.429 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.3 mt -68.28 -20.41 64.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.269 0.486 . . . . 0.0 111.105 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 38.47 30.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -167.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.7 mmm . . . . . 0 C--O 1.25 1.093 0 CA-C-N 117.882 0.841 . . . . 0.0 109.377 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 177.14 6.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.987 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.76 124.39 43.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.168 2.187 . . . . 0.0 106.091 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.13 134.52 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 158.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.66 92.54 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.5 t -95.84 51.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.24 105.24 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -47.99 -43.12 29.42 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.784 1.634 . . . . 0.0 112.103 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.75 116.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.304 1.041 . . . . 0.0 108.521 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -52.35 -51.45 58.76 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.164 0.986 . . . . 0.0 110.77 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -52.17 -39.35 59.95 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.417 -0.802 . . . . 0.0 111.346 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 ttp -61.43 -42.06 98.16 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.11 98.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.854 1.207 . . . . 0.0 109.944 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -57.46 -57.44 12.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -49.07 -60.81 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.772 1.629 . . . . 0.0 108.866 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.38 -51.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 120.388 1.449 . . . . 0.0 111.055 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -41.17 91.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.07 0.85 . . . . 0.0 111.052 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.27 -53.94 47.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.91 -34.28 69.67 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.586 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -60.09 -62.71 1.67 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.873 0.869 . . . . 0.0 109.314 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -65.24 -14.33 60.43 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.08 -7.98 34.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.425 1.49 . . . . 0.0 113.152 166.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.5 mt -126.01 7.79 7.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.485 3.114 . . . . 0.0 112.086 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 -144.13 22.67 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.33 40.39 18.28 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.189 1.495 . . . . 0.0 113.3 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.08 171.08 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.498 -0.751 . . . . 0.0 110.936 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 98.57 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.29 3.036 . . . . 0.0 107.139 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.754 -0.591 . . . . 0.0 110.156 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -132.14 175.43 9.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.81 2.044 . . . . 0.0 107.615 167.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -127.3 166.33 18.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.54 1.536 . . . . 0.0 107.379 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.68 168.36 9.84 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 159.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.75 -26.33 62.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.731 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.32 174.76 0.45 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.031 1.732 . . . . 0.0 107.674 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.25 -39.41 42.83 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.005 1.288 . . . . 0.0 115.428 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.57 -43.95 92.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.048 1.424 . . . . 0.0 109.918 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.07 -28.05 60.2 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.561 1.144 . . . . 0.0 110.652 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -62.11 -46.25 89.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.009 0.924 . . . . 0.0 110.102 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.11 -45.16 95.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.768 -0.635 . . . . 0.0 109.324 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -57.75 -44.55 86.16 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.646 0.657 . . . . 0.0 111.661 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -53.51 -50.87 64.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.751 0.82 . . . . 0.0 109.778 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -35.62 80.28 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.209 0.604 . . . . 0.0 112.017 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.02 -1.34 7.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.816 0.846 . . . . 0.0 112.19 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.6 12.93 7.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.572 1.949 . . . . 0.0 112.495 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.33 163.97 23.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.214 1.37 . . . . 0.0 113.857 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.97 78.96 1.85 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -70.76 119.62 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.61 -19.89 79.73 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.523 -168.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -132.09 150.46 52.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 127.046 2.138 . . . . 0.0 106.416 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 81' ' ' LEU . 13.4 t -137.56 72.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -77.33 143.73 12.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 p -149.71 163.13 38.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.659 0.663 . . . . 0.0 111.011 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.45 179.97 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.461 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 29.0 t-105 -71.04 -78.13 0.08 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 162.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.2 t30 43.1 178.16 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.956 2.902 . . . . 0.0 112.606 -164.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.2 mtm -140.33 68.26 32.63 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 119.053 -2.28 . . . . 0.0 110.553 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.49 49.0 2.32 Favored 'Trans proline' 0 CA--C 1.543 0.964 1 C-N-CA 125.467 4.111 . . . . 0.0 110.791 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 72.88 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.439 1.495 . . . . 0.0 108.709 -159.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.2 ttm -79.52 81.73 5.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.16 159.78 2.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.543 1.137 . . . . 0.0 110.675 167.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.96 59.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.369 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -74.39 -46.86 37.61 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.584 1.154 . . . . 0.0 109.313 174.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.27 -38.3 90.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.559 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.02 -53.81 54.07 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.301 0.955 . . . . 0.0 109.21 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -48.85 -56.1 9.72 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -66.17 -28.69 68.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 120.384 1.447 . . . . 0.0 114.078 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.5 m -71.98 -33.75 68.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.262 0.937 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.4 mt -73.36 -48.37 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.962 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.66 24.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.508 3.123 . . . . 0.0 111.475 171.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 108.146 172.097 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 120.489 0.185 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -61.53 -25.08 67.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.424 1.089 . . . . 0.0 113.341 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -16.5 61.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 54' ' ' VAL . 32.8 mt -60.5 141.7 91.55 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 118.472 0.578 . . . . 0.0 111.465 -169.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 72.69 5.78 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.707 2.271 . . . . 0.0 108.423 166.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -60.53 137.77 22.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 160.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' CD1' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp -147.97 111.6 5.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -160.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.93 123.14 24.55 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.7 102.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -142.35 174.74 10.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.179 0.99 . . . . 0.0 110.281 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.78 -23.5 19.7 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.814 0.846 . . . . 0.0 111.617 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -86.5 111.32 20.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.756 0.707 . . . . 0.0 109.141 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.96 -73.52 0.07 Allowed 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 166.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 tptp 43.78 91.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.538 1.637 . . . . 0.0 112.432 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -52.16 -34.65 45.89 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.2 -0.938 . . . . 0.0 112.889 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.34 -36.03 80.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.293 1.406 . . . . 0.0 111.692 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -63.31 -38.91 93.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.236 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.54 -49.99 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.565 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.46 -55.53 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 119.542 1.065 . . . . 0.0 108.341 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.12 79.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.924 0.489 . . . . 0.0 110.769 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.16 90.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.919 -0.488 . . . . 0.0 110.543 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.45 77.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -61.4 -49.99 74.65 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.718 1.607 . . . . 0.0 109.672 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -28.19 69.07 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.927 0.491 . . . . 0.0 111.233 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.5 42.03 6.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 124.74 1.162 . . . . 0.0 111.338 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.18 156.87 11.44 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 72.8 p -64.93 -22.77 67.05 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.301 -0.874 . . . . 0.0 111.948 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.12 -175.95 37.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.69 1.614 . . . . 0.0 109.426 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -136.74 91.03 2.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.673 1.189 . . . . 0.0 108.046 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -75.3 125.97 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.88 144.15 16.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -75.8 162.34 72.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -64.12 145.75 60.93 Favored 'Cis proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.714 0.934 . . . . 0.0 109.782 -12.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -139.2 162.16 35.66 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.086 0.955 . . . . 0.0 109.235 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -142.88 171.98 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.354 1.061 . . . . 0.0 110.109 -164.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.83 69.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.642 0.777 . . . . 0.0 112.401 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t -81.76 -33.27 31.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.981 1.264 . . . . 0.0 110.119 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -50.99 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.552 1.069 . . . . 0.0 109.017 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -41.57 92.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.125 1.77 . . . . 0.0 111.073 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.95 -42.44 98.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.303 1.041 . . . . 0.0 109.156 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HE3' ' CD1' ' A' ' 84' ' ' LEU . 3.2 mmmp? -68.95 -29.72 68.02 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.712 -1.613 . . . . 0.0 112.384 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -54.48 24.41 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -55.32 -42.92 74.41 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 118.225 0.466 . . . . 0.0 111.258 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -51.23 -60.04 3.55 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.39 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 104' ' ' SER . 15.4 pt -67.57 -32.66 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 121.343 1.883 . . . . 0.0 113.757 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -58.63 -45.09 90.01 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.701 0.682 . . . . 0.0 109.632 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.47 -34.17 15.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -76.1 -72.43 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -37.0 79.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.266 0.627 . . . . 0.0 109.333 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.01 41.58 4.58 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -164.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.246 0.9 0 CA-C-N 118.501 1.151 . . . . 0.0 110.883 175.479 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.411 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.93 161.71 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.574 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.8 95.28 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -69.31 138.91 54.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.0 1.273 . . . . 0.0 109.492 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -131.67 115.5 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.7 t -130.69 76.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.23 159.84 18.68 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.853 0.835 . . . . 0.0 111.342 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.55 97.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.199 1.4 . . . . 0.0 111.212 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD2' ' HB ' ' A' ' 16' ' ' THR . 1.2 t80 -90.0 -63.85 1.22 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.683 0.393 . . . . 0.0 110.528 -159.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 m 127.28 -59.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 1 C-N-CA 133.273 4.629 . . . . 0.0 106.875 -161.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 91.8 m -65.59 -33.75 76.63 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.771 -174.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -61.5 -27.25 68.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.23 1.377 . . . . 0.0 110.207 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD3' ' HG3' ' A' ' 35' ' ' GLU . 13.3 ttm180 -63.47 -47.73 80.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.477 1.035 . . . . 0.0 109.589 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -48.43 80.94 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.762 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.36 -47.01 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.0 1.32 . . . . 0.0 111.228 -172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -54.03 -50.75 65.98 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.35 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.28 -43.44 91.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.235 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 mt -55.12 -43.14 73.83 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.244 0.929 . . . . 0.0 109.848 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.7 -48.81 70.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.548 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -64.85 -33.63 76.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.118 -0.944 . . . . 0.0 112.473 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -58.41 -30.76 67.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.491 1.041 . . . . 0.0 110.908 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.96 12.25 37.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.24 1.816 . . . . 0.0 111.699 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -33.67 5.04 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.641 1.591 . . . . 0.0 113.317 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -61.38 140.01 58.09 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.929 1.365 . . . . 0.0 110.633 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 177.47 7.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.075 0.94 . . . . 0.0 111.403 -168.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.251 21.4 t30 67.96 34.0 4.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.77 2.828 . . . . 0.0 113.503 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 154.97 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.474 0.654 . . . . 0.0 109.723 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.33 179.41 6.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.454 2.701 . . . . 0.0 108.019 -163.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 31.0 tt0 -145.88 152.27 39.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.848 -0.532 . . . . 0.0 111.614 -164.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.21 172.5 12.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.793 1.237 . . . . 0.0 108.93 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -68.46 -47.69 66.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.746 0.818 . . . . 0.0 112.726 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.84 168.01 10.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.85 2.06 . . . . 0.0 107.335 -158.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.6 -38.02 27.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.723 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.0 t -63.41 -51.01 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.706 2.253 . . . . 0.0 107.555 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.97 -28.69 69.99 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 0.0 110.829 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -69.57 -42.9 73.92 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.947 1.699 . . . . 0.0 111.37 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -65.62 -43.54 89.26 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -56.52 -39.71 73.8 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.155 0.982 . . . . 0.0 111.058 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.31 -61.46 2.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.365 0.984 . . . . 0.0 109.252 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.37 -49.8 60.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -168.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.72 -2.87 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.4 -11.5 59.25 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.822 1.192 . . . . 0.0 112.969 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.71 5.82 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 119.199 2.44 . . . . 0.0 119.199 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.42 73.71 0.64 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 120.603 2.202 . . . . 0.0 110.377 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.17 109.21 2.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.39 -10.75 24.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.338 -0.701 . . . . 0.0 114.398 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.4 144.68 42.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.143 1.377 . . . . 0.0 109.159 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -132.13 91.24 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -108.49 125.69 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -143.03 168.05 20.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.852 0.834 . . . . 0.0 110.896 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.83 170.18 10.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 158.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -84.91 -51.68 6.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.455 1.502 . . . . 0.0 108.307 162.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -87.24 72.49 9.88 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.61 1.564 . . . . 0.0 110.192 -159.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 tpt -124.77 125.51 25.45 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 -0.31 9.73 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.748 2.299 . . . . 0.0 115.067 -161.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -107.25 -96.24 0.37 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.3 ttm -91.07 89.9 7.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.28 155.11 5.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.089 172.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.78 -31.79 58.34 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.03 -0.872 . . . . 0.0 112.203 -172.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -36.5 72.4 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.871 1.335 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -68.09 -41.5 81.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.011 175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.63 -49.11 79.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.784 0.72 . . . . 0.0 109.575 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -50.59 -63.11 1.23 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.836 1.254 . . . . 0.0 108.106 172.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -63.22 -27.48 69.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.94 1.246 . . . . 0.0 113.398 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.1 m -61.74 -53.87 50.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.394 0.997 . . . . 0.0 108.884 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -62.51 -46.05 97.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.671 1.188 . . . . 0.0 110.21 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.58 7.91 0.56 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.698 1.999 . . . . 0.0 113.215 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.148 0 CA-C-N 120.961 1.709 . . . . 0.0 111.862 -177.304 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.571 ' HB3' HD12 ' A' ' 81' ' ' LEU . 37.1 mtm . . . . . 0 C--O 1.223 -0.301 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -55.06 -23.99 22.96 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 121.743 2.065 . . . . 0.0 114.451 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -9.57 53.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.596 1.089 . . . . 0.0 113.255 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 54' ' ' VAL . 16.9 mt -78.02 128.93 77.36 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 121.129 -0.982 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 91.02 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.387 2.058 . . . . 0.0 109.749 170.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 69' ' ' LEU . 2.7 m -75.76 107.85 7.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 167.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 tp -112.6 113.97 26.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.269 1.427 . . . . 0.0 108.562 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.9 mmt -85.67 125.93 33.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.03 88.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -122.62 174.21 7.22 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 113.657 -161.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.58 -21.69 26.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 111.662 164.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -86.18 106.74 17.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.781 1.232 . . . . 0.0 110.972 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.23 8.62 15.23 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.476 -0.765 . . . . 0.0 112.587 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -51.96 121.35 6.54 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.242 1.017 . . . . 0.0 108.927 -171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -38.71 76.89 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.275 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.36 -32.32 64.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.489 1.04 . . . . 0.0 112.329 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.72 -39.56 61.82 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.732 0.696 . . . . 0.0 109.495 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.43 -46.96 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.36 -57.44 4.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.34 -45.44 80.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.335 1.054 . . . . 0.0 110.71 -172.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.78 96.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.22 -15.25 61.0 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -75.05 -51.73 12.82 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.266 1.426 . . . . 0.0 108.011 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.53 78.04 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.501 0.72 . . . . 0.0 111.905 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.79 58.84 2.07 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.106 1.336 . . . . 0.0 110.502 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.61 162.35 5.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.398 0.599 . . . . 0.0 110.834 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -62.42 -43.06 99.73 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.41 173.18 46.1 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 125.472 1.51 . . . . 0.0 110.152 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 135.23 46.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.327 1.851 . . . . 0.0 107.288 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.0 t -134.47 145.86 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 128.327 2.651 . . . . 0.0 104.763 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t -127.63 164.48 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -49.85 141.18 14.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.284 160.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -78.35 173.49 56.27 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 120.702 1.287 . . . . 0.0 109.337 -20.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -177.28 151.5 0.79 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.596 -1.315 . . . . 0.0 108.619 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -153.77 -179.33 7.72 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 127.285 2.234 . . . . 0.0 108.275 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.5 -29.7 62.13 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.321 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.59 33.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.857 1.263 . . . . 0.0 113.076 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.26 -30.8 13.25 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.808 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -48.74 79.08 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.751 1.16 . . . . 0.0 108.331 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -40.7 97.03 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.617 1.167 . . . . 0.0 111.51 -176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.3 -40.4 77.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.9 0.88 . . . . 0.0 109.042 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HE2' ' HE3' ' A' ' 122' ' ' LYS . 50.4 mmtt -65.7 -40.82 92.69 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.648 -1.282 . . . . 0.0 110.527 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.0 mt -55.44 -49.7 71.77 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.776 0.831 . . . . 0.0 108.968 170.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.81 -38.58 88.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.065 0.848 . . . . 0.0 112.612 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE3' ' HE2' ' A' ' 119' ' ' LYS . 9.2 mtmm -55.5 -52.49 63.49 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.027 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.7 pt -73.68 -24.78 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 120.192 1.36 . . . . 0.0 113.473 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -56.95 -59.55 4.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.24 -43.72 73.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.085 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -69.82 0.33 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.61 -29.38 65.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.7 30.53 13.11 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 117.907 -1.496 . . . . 0.0 109.756 -160.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mmm . . . . . 0 C--O 1.247 0.95 0 CA-C-N 120.135 1.967 . . . . 0.0 109.417 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.46 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.01 0.433 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.61 29.9 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.97 152.84 19.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.14 134.65 54.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 162.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.84 108.33 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.3 t -125.33 69.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.02 156.85 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -67.11 -55.46 14.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.06 1.3 . . . . 0.0 109.258 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.2 t80 -70.9 115.82 10.49 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.95 -48.43 70.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.739 1.216 . . . . 0.0 111.326 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 25.1 m -62.66 -26.03 68.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.006 0.922 . . . . 0.0 111.82 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.3 ttm -58.42 -29.32 66.01 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.713 1.142 . . . . 0.0 109.893 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -70.39 -30.76 67.74 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.032 0.833 . . . . 0.0 110.26 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -61.49 -51.22 69.54 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.447 1.021 . . . . 0.0 108.354 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.63 -60.38 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.34 0.656 . . . . 0.0 109.798 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.92 -52.81 12.53 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 126.057 1.743 . . . . 0.0 109.774 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -56.47 -47.76 78.5 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.089 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -59.12 -44.75 92.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 119.933 1.242 . . . . 0.0 110.143 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.55 -36.87 83.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 110.68 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -66.36 0.51 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.391 1.076 . . . . 0.0 109.996 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -25.59 68.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.502 1.121 . . . . 0.0 112.092 -167.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -15.11 51.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.684 1.129 . . . . 0.0 112.57 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -147.03 19.05 1.25 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 112.103 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.1 28.64 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.349 -0.844 . . . . 0.0 111.804 -161.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -57.37 123.35 15.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.981 1.712 . . . . 0.0 110.918 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -72.12 -3.06 20.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.916 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -118.74 128.48 54.53 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.019 1.327 . . . . 0.0 107.766 -158.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.79 165.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 125.77 1.628 . . . . 0.0 107.304 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -127.04 161.18 29.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -125.63 127.13 45.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -83.6 173.92 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 170.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.48 -46.46 66.58 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.4 -0.812 . . . . 0.0 110.568 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.24 175.25 6.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.024 1.73 . . . . 0.0 108.187 -163.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.75 -43.23 29.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.376 0.989 . . . . 0.0 114.111 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.78 -52.07 64.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 119.022 1.411 . . . . 0.0 108.694 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.67 -21.95 66.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.361 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.02 -47.42 68.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.347 1.431 . . . . 0.0 109.543 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.62 -46.02 87.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.319 0.581 . . . . 0.0 109.668 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -60.35 -44.78 95.24 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.719 0.807 . . . . 0.0 111.536 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.9 mmtm -59.41 -41.38 89.35 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.001 1.32 . . . . 0.0 110.219 172.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -59.09 -43.9 91.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.344 0.975 . . . . 0.0 111.347 178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.66 -0.21 29.1 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.66 4.38 40.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.735 1.152 . . . . 0.0 112.958 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.14 -172.39 34.63 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 120.496 -1.377 . . . . 0.0 112.035 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.85 79.41 1.58 Allowed Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -75.53 165.48 25.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 159.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -139.52 -7.59 1.04 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.852 173.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -144.33 135.22 25.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.598 1.199 . . . . 0.0 108.423 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.72 117.96 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -165.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.83 134.04 67.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.727 1.611 . . . . 0.0 106.902 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 m -150.81 159.69 44.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.978 0.354 . . . . 0.0 111.432 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.98 157.92 32.54 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 166.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -67.99 -47.14 69.33 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 110.408 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.439 HD21 ' HG2' ' A' ' 89' ' ' GLU . 86.7 m-20 -80.81 59.04 3.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.674 1.19 . . . . 0.0 110.998 -159.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mmt -93.46 160.05 33.84 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 122.791 0.437 . . . . 0.0 110.661 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 162.39 36.32 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.803 2.335 . . . . 0.0 108.916 165.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 50.99 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.298 1.839 . . . . 0.0 113.143 170.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.8 ttm -82.01 86.5 6.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.447 1.099 . . . . 0.0 108.313 168.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.12 154.81 1.46 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.192 1.397 . . . . 0.0 110.143 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.43 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.501 -1.374 . . . . 0.0 113.161 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.51 -33.61 71.38 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.313 1.057 . . . . 0.0 110.263 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -72.12 -35.11 69.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.894 . . . . 0.0 110.57 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -53.46 57.3 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.707 0.685 . . . . 0.0 109.582 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -50.17 -56.53 10.62 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 34.6 mttm -66.29 -27.97 68.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.742 1.156 . . . . 0.0 114.038 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -70.77 -46.89 62.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.423 1.01 . . . . 0.0 108.742 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.41 -43.88 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.342 0.657 . . . . 0.0 109.356 172.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -24.03 60.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.218 1.407 . . . . 0.0 112.228 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 C-N-CA 124.765 1.226 . . . . 0.0 112.042 173.844 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.7 mmt . . . . . 0 C--O 1.226 -0.167 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -48.13 -29.76 3.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.419 1.009 . . . . 0.0 112.098 165.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.05 -11.85 61.18 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -66.98 134.05 93.9 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 119.959 1.254 . . . . 0.0 109.077 -174.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 94.1 Cg_endo -78.78 56.6 6.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 0.0 111.587 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HD13 ' A' ' 69' ' ' LEU 0.254 2.4 m -47.58 107.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.213 1.005 . . . . 0.0 112.233 170.432 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -106.42 117.46 34.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.711 1.604 . . . . 0.0 107.839 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.44 123.08 31.99 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.98 107.06 11.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -144.78 178.42 8.01 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.016 0.912 . . . . 0.0 111.466 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.9 -29.39 32.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.084 0.953 . . . . 0.0 111.893 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.439 ' HG2' HD21 ' A' ' 59' ' ' ASN . 48.5 mm-40 -74.88 107.86 7.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.946 0.498 . . . . 0.0 110.237 -170.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -72.63 18.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.048 -1.033 . . . . 0.0 111.708 162.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.37 110.31 0.84 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 125.267 1.427 . . . . 0.0 109.001 -168.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -40.34 -59.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 112.621 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.05 -31.18 62.92 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.841 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.1 -38.67 61.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.709 1.14 . . . . 0.0 109.619 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.35 -55.87 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.97 -47.12 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.84 -41.26 77.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.098 1.317 . . . . 0.0 109.789 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.74 -53.28 59.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.801 0.728 . . . . 0.0 110.902 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.99 -27.15 67.92 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.325 0.65 . . . . 0.0 112.534 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -73.65 -52.89 11.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.704 2.002 . . . . 0.0 109.407 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -55.58 -40.36 71.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.684 0.794 . . . . 0.0 111.134 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.0 2.47 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.412 1.482 . . . . 0.0 113.217 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.98 156.6 6.63 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.536 1.168 . . . . 0.0 111.195 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 5.2 p -70.83 -28.11 64.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.654 0.382 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.71 171.7 38.42 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -130.78 139.22 50.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.009 1.324 . . . . 0.0 108.037 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.86 137.73 42.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 126.44 1.896 . . . . 0.0 106.004 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 90' ' ' ALA . 48.3 t -130.22 144.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -52.46 145.85 18.88 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.105 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.61 10.09 60.82 Favored 'Cis proline' 0 C--N 1.348 0.508 0 N-CA-C 116.992 1.882 . . . . 0.0 116.992 8.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.8 p90 15.79 114.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 130.768 3.627 . . . . 0.0 116.564 -175.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -89.73 166.5 13.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.821 -1.174 . . . . 0.0 112.553 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.02 -33.83 73.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 166.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.36 -13.39 5.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.684 1.594 . . . . 0.0 115.013 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -28.67 7.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.497 1.499 . . . . 0.0 111.225 171.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.38 -51.13 71.1 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.292 1.037 . . . . 0.0 111.181 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -66.83 -44.18 81.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -66.92 -35.55 80.26 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.223 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.08 -57.9 11.01 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.039 0.935 . . . . 0.0 109.029 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -47.74 -45.26 28.78 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.288 1.035 . . . . 0.0 111.049 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -68.8 0.14 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.657 174.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.7 pt -66.94 -26.75 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 120.212 1.369 . . . . 0.0 113.704 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -56.22 -57.33 12.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -84.39 -34.02 23.66 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.788 -0.57 . . . . 0.0 111.326 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -64.23 -72.81 0.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.381 1.472 . . . . 0.0 109.739 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.51 -38.49 62.82 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.023 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.2 22.14 6.65 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.609 -1.106 . . . . 0.0 112.366 -166.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.3 mmt . . . . . 0 C--O 1.251 1.182 0 CA-C-N 119.587 1.694 . . . . 0.0 112.275 -175.182 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.67 165.2 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.856 0.463 . . . . 0.0 110.993 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.95 91.79 3.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 163.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.31 131.0 44.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -135.89 125.28 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.36 67.66 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -84.92 166.71 16.58 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.896 -1.128 . . . . 0.0 111.241 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -19.74 65.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.969 0.908 . . . . 0.0 113.355 -169.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.84 131.64 21.42 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.624 1.97 . . . . 0.0 105.894 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -52.55 -41.23 63.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.678 0.672 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.6 m -51.33 -47.11 62.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.647 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.1 mtm -59.7 -35.36 74.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.446 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -68.03 -31.11 70.56 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 120.055 1.298 . . . . 0.0 110.482 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -69.39 -50.21 48.15 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.93 -61.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.165 1.386 . . . . 0.0 109.643 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.6 t -51.9 -49.38 37.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.33 1.452 . . . . 0.0 109.793 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.4 ttt85 -54.95 -48.51 73.09 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 119.385 0.993 . . . . 0.0 110.635 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -52.7 63.72 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.479 0.712 . . . . 0.0 109.688 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 113' ' ' ALA . 75.1 mt -58.27 -42.41 86.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.373 1.069 . . . . 0.0 110.435 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.96 -48.49 81.33 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 110.722 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -65.73 -33.48 75.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.599 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -45.87 92.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.081 1.309 . . . . 0.0 109.224 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.4 mt -66.21 -43.26 87.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.757 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.38 -5.44 1.39 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.398 0.999 . . . . 0.0 114.226 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -73.85 152.52 40.2 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.765 1.226 . . . . 0.0 109.789 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -145.5 179.04 7.68 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.397 -0.814 . . . . 0.0 110.518 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 53.98 58.85 4.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.656 1.982 . . . . 0.0 111.463 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 22' ' ' ARG . 30.7 m -66.45 160.08 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.322 162.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.51 169.69 16.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.126 1.77 . . . . 0.0 108.367 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -130.05 142.15 50.65 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.547 1.939 . . . . 0.0 106.939 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.53 170.22 8.59 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 159.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -24.87 30.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.987 0.358 . . . . 0.0 111.228 170.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.69 175.57 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.307 1.443 . . . . 0.0 108.697 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -62.89 -35.16 91.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.332 1.92 . . . . 0.0 114.606 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.02 -49.53 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 120.309 2.055 . . . . 0.0 107.934 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -58.57 -39.28 79.87 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.858 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.1 99.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.269 1.395 . . . . 0.0 111.547 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.41 -43.39 90.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -65.11 -42.55 93.85 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.388 -0.195 . . . . 0.0 111.469 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -52.94 -50.35 64.18 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 127.533 2.333 . . . . 0.0 108.854 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.97 -48.0 83.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.433 0.56 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.46 -11.04 56.91 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.87 24.23 12.92 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.763 2.425 . . . . 0.0 110.858 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.43 161.08 28.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 31.05 8.44 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 162.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -70.16 89.05 0.62 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.02 1.328 . . . . 0.0 109.069 -161.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -3.44 50.22 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.555 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -138.98 129.87 26.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.601 1.2 . . . . 0.0 109.083 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 81' ' ' LEU . 11.4 t -133.98 124.42 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -168.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.76 134.32 60.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 127.379 2.272 . . . . 0.0 106.25 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.9 p -152.03 163.54 39.09 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.385 0.538 . . . . 0.0 111.069 173.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.4 159.98 28.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.032 160.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CH2' ' HG ' ' A' ' 66' ' ' LEU . 23.6 t-105 -72.64 -58.53 3.29 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.587 1.955 . . . . 0.0 111.422 169.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.5 19.39 0.13 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.998 2.119 . . . . 0.0 112.822 -160.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.558 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -61.68 129.21 91.24 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 126.113 1.765 . . . . 0.0 107.553 -170.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.8 157.85 54.02 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 N-CA-C 109.402 -1.038 . . . . 0.0 109.402 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.77 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.249 1.42 . . . . 0.0 109.992 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.2 ttp -91.33 91.32 8.1 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.159 0.984 . . . . 0.0 108.878 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.88 153.47 1.29 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 109.027 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.54 -31.54 63.53 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 120.885 -1.134 . . . . 0.0 112.456 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -68.78 -36.84 78.8 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.633 0.717 . . . . 0.0 110.644 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.19 -41.65 70.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.047 0.939 . . . . 0.0 109.546 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp -56.39 -50.12 72.49 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.578 1.151 . . . . 0.0 109.469 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -52.69 -61.47 2.27 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 124.957 1.303 . . . . 0.0 108.866 173.623 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 66' ' ' LEU . 90.7 mttt -62.66 -27.66 69.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.903 1.229 . . . . 0.0 112.382 -173.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.3 m -64.46 -55.73 18.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.117 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.76 -36.45 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.323 1.449 . . . . 0.0 111.448 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -21.92 61.9 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 120.883 -1.135 . . . . 0.0 111.258 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 119.493 1.042 . . . . 0.0 110.108 171.974 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.1 mtt . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 t -61.11 -21.17 63.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.119 1.327 . . . . 0.0 112.214 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.96 -2.01 25.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.849 1.26 . . . . 0.0 113.817 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 54' ' ' VAL . 83.7 mt -79.77 129.76 69.81 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 119.783 1.174 . . . . 0.0 109.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.47 58.02 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.128 2.552 . . . . 0.0 111.925 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -47.24 108.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.979 1.712 . . . . 0.0 111.028 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 tp -112.97 119.6 38.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.852 1.661 . . . . 0.0 108.901 -165.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -82.92 118.73 23.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.16 110.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.219 1.408 . . . . 0.0 108.47 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -157.62 169.76 23.92 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.555 0.693 . . . . 0.0 110.401 -167.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.76 -23.0 62.33 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.239 -0.913 . . . . 0.0 112.179 160.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -81.26 112.03 18.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.007 0.821 . . . . 0.0 112.001 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.51 -88.25 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 160.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? 49.81 99.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.126 1.371 . . . . 0.0 111.2 -169.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -41.32 -48.83 3.71 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.4 -0.812 . . . . 0.0 111.765 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -58.87 -37.69 77.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -60.18 -43.99 95.43 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.031 0.832 . . . . 0.0 109.487 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.21 -43.69 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.18 -58.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.33 70.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 111.059 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.82 80.08 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.047 0.939 . . . . 0.0 110.059 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.93 79.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.879 0.472 . . . . 0.0 111.162 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -61.16 -51.16 70.22 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.709 1.604 . . . . 0.0 110.495 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.18 -29.94 71.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.206 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.25 34.97 4.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.552 1.072 . . . . 0.0 112.804 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.78 159.41 11.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.109 1.454 . . . . 0.0 110.68 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 p -63.93 -35.68 81.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.45 0.568 . . . . 0.0 110.595 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.59 -177.57 45.1 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.23 132.32 33.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.07 102.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.99 154.54 4.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.26 155.39 79.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 120.93 -1.106 . . . . 0.0 110.452 159.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.13 151.28 96.79 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 N-CA-C 110.346 -0.675 . . . . 0.0 110.346 -7.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -151.94 157.55 41.94 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.428 0.691 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -144.51 -173.02 3.92 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.891 0.876 . . . . 0.0 110.384 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -56.45 -29.24 61.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.397 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.8 -25.25 64.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 t -95.87 -39.19 9.94 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.043 1.292 . . . . 0.0 109.246 170.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -50.14 53.57 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 109.765 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.22 72.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.918 1.687 . . . . 0.0 112.772 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.83 -48.53 21.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -61.6 -37.66 84.72 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.687 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.14 -52.21 59.47 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.451 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.28 -42.47 86.64 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.291 0.95 . . . . 0.0 112.414 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -54.38 -53.09 58.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.374 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 pt -74.63 -20.89 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 117.568 -1.206 . . . . 0.0 114.0 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.83 -50.79 71.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.525 1.511 . . . . 0.0 108.097 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -77.29 -42.84 35.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -73.61 -62.07 1.62 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.959 0.504 . . . . 0.0 110.634 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -20.57 39.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.715 0.806 . . . . 0.0 110.446 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.17 36.75 12.2 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -170.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 118.192 0.996 . . . . 0.0 111.014 175.555 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -91.1 133.67 35.14 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.172 1.789 . . . . 0.0 110.239 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.66 106.9 18.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.286 1.834 . . . . 0.0 107.484 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -74.34 138.07 43.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.568 1.076 . . . . 0.0 108.175 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.15 105.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ALA . 10.0 t -113.78 59.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 122.619 1.2 . . . . 0.0 107.768 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -85.96 108.97 18.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -174.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' H ' ' CB ' ' A' ' 57' ' ' ASP . 33.9 t70 -53.95 -45.27 71.23 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.422 1.089 . . . . 0.0 112.377 -170.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.24 101.39 1.88 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 164.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -42.66 70.11 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.21 0.604 . . . . 0.0 111.378 -168.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 m -59.83 -33.77 72.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.583 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mtm -59.12 -32.22 69.64 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 120.111 1.323 . . . . 0.0 110.476 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 HH21 ' NH1' ' A' ' 19' ' ' ARG . 24.9 ttp85 -62.63 -43.5 98.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.889 1.222 . . . . 0.0 110.717 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH1' HH21 ' A' ' 18' ' ' ARG . 8.9 mpt_? -59.69 -41.56 91.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.716 176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.21 -63.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.21 -43.48 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.899 1.68 . . . . 0.0 110.945 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -56.89 -48.36 78.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 0.0 110.392 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.97 -44.13 97.8 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.956 0.798 . . . . 0.0 110.841 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.66 -38.39 90.92 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.196 1.398 . . . . 0.0 111.689 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.83 -57.94 10.73 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -56.64 -36.09 69.09 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.162 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.67 -22.06 65.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.109 1.322 . . . . 0.0 112.464 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.35 -75.45 0.24 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 164.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.75 -168.41 33.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 65.33 164.43 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.264 1.826 . . . . 0.0 111.925 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -151.16 -3.05 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.371 1.469 . . . . 0.0 112.063 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.69 98.96 10.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.59 158.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.92 -155.47 0.61 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.43 1.092 . . . . 0.0 109.088 167.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 43.1 tt0 -178.37 159.16 1.19 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -158.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.86 33.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.142 1.777 . . . . 0.0 106.362 170.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.33 -31.59 72.47 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.795 -0.565 . . . . 0.0 112.352 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.58 171.26 10.43 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.872 2.469 . . . . 0.0 105.955 -174.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' ' CE ' ' A' ' 60' ' ' MET . . . -57.52 -37.12 80.87 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.587 -1.119 . . . . 0.0 114.565 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.66 -42.99 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.969 2.385 . . . . 0.0 108.714 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.1 -28.22 69.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.333 -0.855 . . . . 0.0 111.725 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.7 -47.68 77.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.195 -1.566 . . . . 0.0 109.655 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.72 -41.25 73.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.409 1.084 . . . . 0.0 109.496 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.67 -44.1 97.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.694 1.197 . . . . 0.0 111.742 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.311 -0.868 . . . . 0.0 110.67 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -51.27 70.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -68.48 3.14 1.92 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.18 1.48 56.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.06 1.3 . . . . 0.0 112.947 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.04 -81.79 0.07 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 121.353 1.888 . . . . 0.0 115.249 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.07 82.38 0.05 OUTLIER Glycine 0 C--N 1.331 0.261 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -164.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -90.32 153.8 20.18 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.23 1.015 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.78 -20.98 15.11 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.757 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -145.27 148.96 34.04 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.051 1.34 . . . . 0.0 109.277 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 81' ' ' LEU . 13.5 t -137.26 67.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -75.93 144.25 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 153.32 31.6 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.665 -0.647 . . . . 0.0 110.462 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CB ' ' H ' ' A' ' 13' ' ' ASP . 45.5 t0 -74.13 149.97 40.74 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 164.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.771 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 33.5 t-105 -61.21 -58.75 7.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.837 0.855 . . . . 0.0 109.498 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 25.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.188 1.395 . . . . 0.0 113.366 -159.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.574 ' CE ' ' H ' ' A' ' 39' ' ' GLY . 8.4 ptm -60.12 159.41 21.59 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.159 -0.963 . . . . 0.0 110.97 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -167.8 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.764 3.642 . . . . 0.0 111.192 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.49 -146.71 0.46 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.419 1.488 . . . . 0.0 110.09 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.98 96.41 0.43 Allowed 'General case' 0 C--N 1.34 0.175 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.71 174.1 0.07 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.17 1.788 . . . . 0.0 113.561 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.11 -29.76 59.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.386 -0.821 . . . . 0.0 113.57 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.771 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -71.03 -42.78 69.08 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 117.957 0.879 . . . . 0.0 110.034 176.617 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.93 -40.1 83.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.148 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.14 -55.03 27.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.656 1.116 . . . . 0.0 110.024 169.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -50.31 -56.27 11.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.601 0.761 . . . . 0.0 109.085 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.09 -41.56 96.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.748 0.704 . . . . 0.0 111.126 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.7 m -57.57 -51.44 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.061 0.944 . . . . 0.0 109.293 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 mt -58.53 -45.22 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.646 0.778 . . . . 0.0 109.659 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.5 -27.37 69.09 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 125.629 1.572 . . . . 0.0 112.148 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 C-N-CA 125.325 1.45 . . . . 0.0 114.565 -171.312 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.334 0.112 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 p -52.29 -37.69 56.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.981 1.712 . . . . 0.0 111.953 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.73 62.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 54' ' ' VAL . 8.1 mt -52.52 141.18 34.85 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.517 1.053 . . . . 0.0 112.177 -162.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.03 74.0 3.02 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.489 2.126 . . . . 0.0 110.425 163.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -70.42 116.26 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 158.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.63 111.72 15.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mmt -75.12 128.35 35.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 101.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -141.45 169.86 16.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.65 -169.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.06 -17.19 41.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.258 163.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -80.67 104.21 11.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.212 0.915 . . . . 0.0 111.615 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -82.88 16.03 2.45 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -57.84 110.13 0.85 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.348 0.977 . . . . 0.0 108.881 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.6 -47.76 66.71 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.677 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -53.25 -33.08 51.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.33 -30.55 25.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.794 -0.566 . . . . 0.0 110.996 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.22 -44.23 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 118.362 -0.828 . . . . 0.0 108.989 161.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.51 -54.4 35.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.375 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.2 63.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 120.176 1.353 . . . . 0.0 110.774 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.56 -51.96 65.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 110.21 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.32 85.22 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.257 0.623 . . . . 0.0 111.269 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -57.35 -50.65 72.28 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.723 2.009 . . . . 0.0 110.513 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.03 -18.58 65.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.614 0.766 . . . . 0.0 112.68 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.02 27.66 13.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.236 0.922 . . . . 0.0 112.527 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.81 140.44 56.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.847 1.324 . . . . 0.0 108.191 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.6 p -68.46 -18.76 64.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.145 -174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.57 173.87 40.13 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.6 104.83 4.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.73 144.88 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 90' ' ' ALA . 64.2 t -127.9 143.21 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.6 151.22 71.92 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.46 1.504 . . . . 0.0 111.463 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.92 173.3 37.89 Favored 'Cis proline' 0 C--N 1.345 0.378 0 N-CA-C 109.421 -1.031 . . . . 0.0 109.421 -16.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -177.91 146.72 0.43 Allowed 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.162 -1.586 . . . . 0.0 108.267 -164.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -149.52 -176.51 5.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.184 1.793 . . . . 0.0 109.232 -170.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.49 68.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.781 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.18 62.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.222 1.009 . . . . 0.0 113.189 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.72 -28.99 12.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.876 0.762 . . . . 0.0 110.286 177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.45 -54.84 38.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -29.85 71.06 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.885 1.274 . . . . 0.0 112.396 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.38 -55.25 12.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.606 1.162 . . . . 0.0 109.351 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.6 -31.44 72.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.743 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.2 mt -58.49 -58.06 10.2 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 123.835 0.854 . . . . 0.0 109.484 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -61.29 -29.19 69.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.043 1.292 . . . . 0.0 112.257 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.01 -60.56 3.3 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.148 -0.97 . . . . 0.0 110.333 168.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -23.3 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.319 0.963 . . . . 0.0 113.081 -171.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -57.21 -58.03 9.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.82 -30.0 56.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.525 -0.734 . . . . 0.0 112.354 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -65.35 1.02 Allowed 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.57 -25.55 64.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.984 0.514 . . . . 0.0 111.051 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.23 23.21 35.26 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-O 117.805 -1.553 . . . . 0.0 110.703 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 28.7 mmt . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.704 1.752 . . . . 0.0 110.47 -176.511 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -79.51 132.47 36.33 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.45 93.81 6.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.67 131.75 45.1 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.316 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 18' ' ' ARG . 64.6 t -132.52 119.36 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -130.95 63.53 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.699 1.599 . . . . 0.0 108.6 -174.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.29 159.1 33.72 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.792 -1.193 . . . . 0.0 108.5 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.47 -64.77 1.03 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.62 112.77 3.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -53.17 -41.61 65.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.857 1.208 . . . . 0.0 112.055 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -59.82 -31.8 70.06 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.757 -1.214 . . . . 0.0 111.773 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.0 92.62 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.562 1.074 . . . . 0.0 110.159 171.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD3' HG12 ' A' ' 10' ' ' VAL . 32.8 tpt85 -65.83 -36.69 84.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.299 1.04 . . . . 0.0 110.049 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -48.02 83.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.503 -0.761 . . . . 0.0 109.524 171.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.09 -58.36 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.32 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.9 t -52.29 -46.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.127 1.33 . . . . 0.0 110.206 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -60.75 -43.9 97.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.238 0.472 . . . . 0.0 111.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.27 -45.11 95.86 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.265 0.626 . . . . 0.0 111.133 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 113' ' ' ALA . 78.2 mt -65.41 -36.37 83.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.43 0.692 . . . . 0.0 111.062 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.91 -44.7 96.25 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.411 0.684 . . . . 0.0 110.09 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -41.65 98.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 116.994 -1.479 . . . . 0.0 111.462 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -57.07 -44.64 83.25 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 119.439 1.018 . . . . 0.0 110.51 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.14 -34.35 63.83 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.255 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.63 57.34 0.37 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.01 153.02 47.23 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.895 1.278 . . . . 0.0 107.824 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.81 178.9 7.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.785 1.634 . . . . 0.0 108.559 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 53.87 54.2 10.14 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.584 1.553 . . . . 0.0 111.683 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 m -68.68 164.36 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.122 159.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.46 174.81 10.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -136.71 147.81 46.97 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.11 167.44 12.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 164.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -68.37 -47.29 67.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 110.117 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.33 169.01 22.88 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 125.797 1.639 . . . . 0.0 109.171 -159.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.7 -41.05 49.69 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.953 1.263 . . . . 0.0 115.546 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -67.95 -44.66 84.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.97 1.885 . . . . 0.0 107.854 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.78 -26.17 68.51 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.173 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.81 -49.03 67.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.99 1.268 . . . . 0.0 110.14 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.02 -42.77 95.05 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.208 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.85 -47.37 85.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.479 1.112 . . . . 0.0 110.893 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.95 -46.43 78.56 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.802 0.841 . . . . 0.0 109.799 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 54' ' ' VAL . 2.1 mm? -57.33 -37.87 73.2 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.001 0.819 . . . . 0.0 111.342 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 4.6 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.16 82.0 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 119.715 -1.865 . . . . 0.0 110.399 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.49 104.4 1.24 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.773 1.177 . . . . 0.0 111.66 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.65 13.68 1.08 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.438 1.018 . . . . 0.0 115.134 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -69.43 167.28 16.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.214 1.507 . . . . 0.0 110.988 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.31 -19.21 0.88 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.561 167.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -131.84 144.0 50.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.536 1.668 . . . . 0.0 107.727 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HD13 ' A' ' 81' ' ' LEU . 15.3 t -134.37 62.41 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.74 135.36 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -144.92 168.91 19.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.019 0.827 . . . . 0.0 110.434 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.44 169.46 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.555 0.693 . . . . 0.0 109.359 159.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -74.08 -53.68 9.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.878 158.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.25 86.99 6.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.487 1.115 . . . . 0.0 111.54 -158.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.2 mmt -127.17 149.71 70.27 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.289 0.636 . . . . 0.0 111.2 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.96 147.1 60.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.492 2.128 . . . . 0.0 109.822 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 54.92 -84.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.283 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 41.4 ttm -88.19 97.64 11.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.941 1.296 . . . . 0.0 107.65 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.39 161.97 2.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.31 -33.68 53.04 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.558 -0.714 . . . . 0.0 111.847 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.57 -42.21 99.41 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.715 0.757 . . . . 0.0 109.942 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -81.19 -30.36 34.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.774 -0.579 . . . . 0.0 111.264 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.51 -52.1 67.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.16 0.984 . . . . 0.0 108.556 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.8 tp -51.13 -60.04 3.53 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.01 1.324 . . . . 0.0 109.463 173.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 24.3 mmtt -59.72 -40.34 87.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.523 1.056 . . . . 0.0 112.363 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.5 m -59.62 -49.05 79.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.631 0.772 . . . . 0.0 109.364 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.16 -39.37 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.15 -25.91 68.29 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.448 1.899 . . . . 0.0 112.234 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.556 175.22 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.8 mtm . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 p -50.97 -31.66 18.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.732 1.213 . . . . 0.0 112.422 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.7 65.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.983 1.313 . . . . 0.0 114.029 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 54' ' ' VAL . 17.5 mt -56.55 138.01 76.51 Favored Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.317 -171.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.03 84.21 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.616 2.211 . . . . 0.0 108.951 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -76.69 126.76 37.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tp -142.28 110.56 6.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -159.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -79.32 126.34 30.67 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.372 1.045 . . . . 0.0 108.423 -171.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.2 t -136.1 101.34 2.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.254 1.822 . . . . 0.0 106.646 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -149.26 164.6 34.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.363 0.601 . . . . 0.0 111.391 -159.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.11 -20.91 57.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.582 1.153 . . . . 0.0 111.689 161.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -76.38 87.76 3.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.967 1.307 . . . . 0.0 111.031 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.98 5.3 4.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.094 0.958 . . . . 0.0 113.287 172.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -48.4 112.81 0.64 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.144 1.777 . . . . 0.0 108.307 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.81 -43.28 80.83 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -56.21 -37.79 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.374 1.07 . . . . 0.0 112.287 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -66.99 -40.5 87.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.393 0.542 . . . . 0.0 109.541 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.91 -49.43 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.156 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.0 -58.52 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.07 -49.3 63.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.587 1.155 . . . . 0.0 111.011 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.96 95.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.181 0.901 . . . . 0.0 110.883 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.15 91.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.902 0.319 . . . . 0.0 111.166 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -60.51 -55.81 28.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.19 1.396 . . . . 0.0 110.052 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.636 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -59.33 -28.87 67.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 111.51 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.66 38.76 4.6 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.278 0.942 . . . . 0.0 111.933 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.44 153.3 27.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.818 0.809 . . . . 0.0 109.306 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -69.98 -14.88 62.91 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.01 171.46 37.01 Favored Glycine 0 N--CA 1.443 -0.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.673 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -137.06 135.23 37.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.357 1.463 . . . . 0.0 107.343 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.45 103.43 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 90' ' ' ALA . 3.0 t -74.13 144.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -60.67 154.17 58.37 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.826 1.251 . . . . 0.0 109.619 163.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.92 174.54 46.7 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.373 0.812 . . . . 0.0 111.329 -14.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -178.43 151.33 0.6 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -167.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 p -144.79 -171.69 3.68 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.441 1.096 . . . . 0.0 109.825 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.402 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.99 -30.99 72.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.446 -0.784 . . . . 0.0 109.583 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.97 -19.68 45.43 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.47 -27.4 9.03 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.493 1.042 . . . . 0.0 110.999 171.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.46 -50.61 62.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.225 1.375 . . . . 0.0 107.939 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -31.56 72.47 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.631 1.172 . . . . 0.0 112.151 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -77.27 -36.1 54.67 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.712 0.687 . . . . 0.0 110.591 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -64.96 -43.46 92.62 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.122 -0.986 . . . . 0.0 109.211 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -58.66 -56.76 18.02 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.715 1.206 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -52.1 -42.31 63.16 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.937 1.295 . . . . 0.0 111.329 176.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -52.82 -63.18 1.23 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.366 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 pt -68.48 -30.14 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 120.487 1.494 . . . . 0.0 114.402 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.88 -53.92 52.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -83.09 -34.46 26.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 121.282 -0.167 . . . . 0.0 110.577 -171.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -74.0 -74.1 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.831 1.253 . . . . 0.0 108.862 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.92 -20.93 62.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.697 0.799 . . . . 0.0 110.967 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.34 26.98 26.54 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.499 -172.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 C--O 1.249 1.079 0 CA-C-N 119.639 1.72 . . . . 0.0 111.678 -175.166 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.06 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 34' ' ' GLU . 12.3 tttt -82.47 135.45 35.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.336 -164.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.23 85.14 2.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -169.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.67 139.58 53.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.11 120.74 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -129.17 65.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.679 1.228 . . . . 0.0 107.949 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.24 111.32 22.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 7.0 t70 -47.74 -46.16 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.36 1.464 . . . . 0.0 112.59 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.5 -13.31 13.09 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t 76.34 -68.1 0.2 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.128 1.771 . . . . 0.0 108.42 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -55.87 -28.08 54.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.964 -1.085 . . . . 0.0 111.674 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.5 mtp -56.86 -46.57 81.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 116.854 -1.546 . . . . 0.0 111.011 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -22.88 63.13 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 121.645 2.021 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -65.7 -52.44 51.4 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.43 -60.51 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.736 1.214 . . . . 0.0 108.666 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.91 -49.19 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.239 1.016 . . . . 0.0 111.063 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -60.43 -42.97 97.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.768 1.167 . . . . 0.0 110.891 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -57.96 -53.12 61.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.09 -38.85 77.2 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.006 0.923 . . . . 0.0 111.902 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.24 -47.24 86.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.506 0.722 . . . . 0.0 110.087 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -64.89 -36.61 84.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.55 -41.24 89.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.652 1.569 . . . . 0.0 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.44 -54.04 10.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.76 62.86 0.07 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -137.52 156.96 47.53 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.347 1.059 . . . . 0.0 109.325 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 -175.33 4.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.378 1.071 . . . . 0.0 111.271 -168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 50.82 46.82 25.57 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.781 2.032 . . . . 0.0 111.45 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.31 161.9 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.0 -1.063 . . . . 0.0 109.474 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 3.4 mm-40 -145.52 171.72 14.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.713 2.005 . . . . 0.0 108.68 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.51 145.6 37.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -120.7 160.26 23.67 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.59 -39.45 93.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.711 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.99 165.77 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.558 1.143 . . . . 0.0 107.921 -161.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.48 68.67 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.828 1.649 . . . . 0.0 113.835 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.56 -44.87 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.964 -1.315 . . . . 0.0 109.63 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.93 -27.55 64.86 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.574 0.625 . . . . 0.0 110.737 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -59.99 -50.09 75.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.728 -1.232 . . . . 0.0 108.322 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -43.5 72.05 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.769 0.795 . . . . 0.0 111.375 175.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -65.79 -25.48 67.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 112.683 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 30.3 mmtm -74.88 -47.4 30.29 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.229 -1.545 . . . . 0.0 108.805 168.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 72' ' ' ILE . 17.3 mt -56.96 -35.98 69.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.176 1.353 . . . . 0.0 111.969 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -74.72 9.61 1.75 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.56 42.47 2.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.493 1.517 . . . . 0.0 111.171 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.17 -171.14 22.62 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 121.49 -0.756 . . . . 0.0 111.861 163.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.2 70.23 1.87 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -65.43 145.38 56.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.23 3.09 2.99 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.844 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.74 142.14 23.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.692 1.246 . . . . 0.0 108.854 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -138.4 78.68 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -173.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.7 141.52 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -152.35 158.22 42.41 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.735 -0.603 . . . . 0.0 111.041 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 23.1 t0 -77.26 169.81 17.67 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 164.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 66' ' ' LEU . 2.8 t-105 -79.34 -51.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.413 -0.804 . . . . 0.0 111.806 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -74.85 79.6 2.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.16 1.384 . . . . 0.0 110.232 -159.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.8 ptp -135.01 153.32 78.44 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 121.13 -0.981 . . . . 0.0 111.174 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.2 -172.1 1.07 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.04 2.493 . . . . 0.0 109.394 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 57.61 -104.26 0.21 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.917 1.687 . . . . 0.0 109.674 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.32 95.07 9.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.55 153.14 3.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.425 1.09 . . . . 0.0 109.779 170.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.39 -30.15 64.35 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.42 -0.8 . . . . 0.0 113.723 -167.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 2.1 tm? -72.26 -39.77 68.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.286 1.043 . . . . 0.0 110.02 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.81 -39.35 90.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.787 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.9 tp -57.79 -51.07 71.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.83 0.741 . . . . 0.0 109.917 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -50.08 -57.88 6.71 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 109.038 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 27.3 mttm -65.44 -27.39 68.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 m -59.96 -59.59 5.18 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 46' ' ' LEU . 24.3 mt -58.62 -40.99 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.23 1.412 . . . . 0.0 109.722 -174.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -13.35 26.68 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.623 1.569 . . . . 0.0 113.43 -170.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 119.656 1.116 . . . . 0.0 110.951 -177.835 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.3 mtt . . . . . 0 C--O 1.226 -0.167 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -55.54 -28.76 56.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.413 1.085 . . . . 0.0 111.579 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.26 -2.02 43.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.364 1.466 . . . . 0.0 113.398 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.703 HD13 HG21 ' A' ' 54' ' ' VAL . 40.8 mt -74.38 136.08 75.42 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 119.859 1.209 . . . . 0.0 110.18 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.13 89.0 0.8 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 108.614 164.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -71.17 111.01 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 164.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -115.35 113.38 23.72 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mmt -79.46 117.29 20.29 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.89 96.49 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -132.64 -166.47 1.75 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.761 0.824 . . . . 0.0 110.089 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.24 -3.08 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.833 2.053 . . . . 0.0 111.016 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -86.91 81.57 8.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.533 0.682 . . . . 0.0 109.554 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -65.83 -4.49 6.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.523 1.529 . . . . 0.0 113.776 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -46.78 123.9 5.6 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.617 1.567 . . . . 0.0 110.354 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -53.17 54.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.228 0.537 . . . . 0.0 110.869 -173.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.84 -26.92 66.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.91 -46.42 78.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.792 1.237 . . . . 0.0 109.547 171.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.87 -46.8 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.45 -53.79 36.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.82 -44.23 73.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.493 0.717 . . . . 0.0 110.619 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.47 88.2 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.846 0.748 . . . . 0.0 111.865 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.32 -41.11 81.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.386 0.539 . . . . 0.0 111.049 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -57.29 -46.49 83.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.542 1.937 . . . . 0.0 109.778 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.78 -34.09 76.11 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.899 0.48 . . . . 0.0 111.472 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.87 39.27 4.4 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.924 1.25 . . . . 0.0 111.544 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.71 143.45 50.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.539 1.17 . . . . 0.0 109.201 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -66.69 -19.73 65.82 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 170.04 41.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.97 130.83 27.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.315 1.446 . . . . 0.0 107.396 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.08 137.63 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 t -127.76 124.15 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -51.18 146.01 12.11 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.831 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.91 168.19 72.37 Favored 'Cis proline' 0 CA--C 1.534 0.509 0 CA-C-N 119.273 0.776 . . . . 0.0 111.913 -3.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -177.97 152.41 0.74 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.665 1.186 . . . . 0.0 109.104 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -148.37 -177.51 5.81 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.62 1.968 . . . . 0.0 109.751 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.13 -26.63 39.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.77 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.51 -53.02 51.54 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.743 1.217 . . . . 0.0 112.135 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.24 -33.77 61.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.059 0.845 . . . . 0.0 109.654 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -52.11 66.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.377 0.989 . . . . 0.0 109.318 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.57 -28.42 69.63 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.6 0.76 . . . . 0.0 111.867 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.67 -43.96 24.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.077 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -65.91 -30.49 71.09 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.429 -1.419 . . . . 0.0 110.015 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -58.75 -52.88 63.81 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.118 168.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -51.68 -48.51 63.45 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.768 1.167 . . . . 0.0 111.178 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -54.71 -51.01 66.93 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.494 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.88 -30.26 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.931 1.696 . . . . 0.0 113.043 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -58.04 -48.05 81.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.77 -23.99 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -170.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -68.68 0.77 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 mt -67.2 -26.64 66.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.709 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.54 39.47 18.08 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -165.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.245 0.851 0 CA-C-N 117.912 0.856 . . . . 0.0 109.558 175.597 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -69.31 123.24 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.28 159.35 16.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -121.62 137.04 54.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 164.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 t -134.34 114.1 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.68 72.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB2' ' H ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -80.1 165.84 22.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.643 1.177 . . . . 0.0 109.065 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.48 -9.69 59.76 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.819 -1.175 . . . . 0.0 111.047 166.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 16.3 t80 -132.95 107.75 8.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.34 -1.475 . . . . 0.0 108.807 -170.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -49.77 -45.62 49.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.879 0.763 . . . . 0.0 112.758 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 57.3 m -52.43 -36.77 55.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.811 0.844 . . . . 0.0 111.502 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 ttm -57.16 -34.63 68.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 116.791 -1.576 . . . . 0.0 110.386 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.79 -42.82 99.87 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.129 1.786 . . . . 0.0 110.954 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -63.53 -54.15 40.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.58 -63.37 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.613 1.565 . . . . 0.0 109.143 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.47 -51.9 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 119.704 1.138 . . . . 0.0 110.768 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.58 -40.93 84.52 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 118.676 0.671 . . . . 0.0 111.231 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.08 -53.5 37.42 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 118.732 0.696 . . . . 0.0 109.146 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.45 -36.25 68.83 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 124.143 0.977 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.45 -67.15 0.35 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.258 169.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -57.38 -27.93 62.74 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.521 1.055 . . . . 0.0 113.089 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -58.02 -20.58 39.85 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.741 1.155 . . . . 0.0 112.563 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.1 mt -108.83 -35.7 6.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.223 3.009 . . . . 0.0 111.612 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.8 177.62 28.31 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.428 1.489 . . . . 0.0 110.985 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 62.22 -177.8 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.914 1.286 . . . . 0.0 112.392 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 170.29 -167.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 130.581 3.552 . . . . 0.0 105.568 -164.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 56.12 46.65 21.15 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.751 1.62 . . . . 0.0 111.977 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -71.77 149.21 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.36 173.13 8.6 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.493 2.317 . . . . 0.0 106.523 166.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.75 176.7 8.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.986 1.314 . . . . 0.0 109.111 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.4 169.66 16.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.725 2.01 . . . . 0.0 106.696 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.93 -32.12 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.539 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -170.94 174.83 4.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.936 1.695 . . . . 0.0 107.558 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.65 -36.06 69.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.32 1.438 . . . . 0.0 114.75 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.08 -40.76 90.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -71.33 -34.81 70.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 110.713 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.19 66.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.408 1.083 . . . . 0.0 109.232 -175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.44 -42.65 64.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.542 0.737 . . . . 0.0 111.527 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.67 -28.57 65.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.055 0.542 . . . . 0.0 111.713 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.61 -53.21 59.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.801 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.44 -54.72 32.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.941 0.792 . . . . 0.0 110.616 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.45 11.89 0.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.93 86.6 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 158.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.33 88.73 0.34 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.498 1.523 . . . . 0.0 109.827 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.68 0.24 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.715 1.626 . . . . 0.0 111.014 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -54.32 141.14 31.08 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.128 0.971 . . . . 0.0 109.344 166.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.2 -18.14 5.11 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.769 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.21 147.53 27.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.718 1.259 . . . . 0.0 107.878 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 ' CG2' HD13 ' A' ' 81' ' ' LEU . 2.9 t -131.9 128.2 59.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -169.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.7 132.48 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 p -151.78 161.16 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.294 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.74 169.98 13.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 110.076 169.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -80.23 -57.7 3.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 159.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -77.51 111.37 13.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.417 0.687 . . . . 0.0 109.2 -159.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 16.9 mmm -119.42 170.55 6.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.808 0.843 . . . . 0.0 110.726 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.82 -3.63 10.52 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.59 2.86 . . . . 0.0 113.015 166.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.84 -91.83 0.06 Allowed 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -160.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.7 ttm -91.07 95.12 9.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.202 1.801 . . . . 0.0 107.613 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 11.4 m-20 -51.63 154.28 2.01 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 108.449 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.78 -24.5 26.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.031 0.824 . . . . 0.0 112.922 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.88 -52.23 31.83 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.564 1.182 . . . . 0.0 110.801 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -68.78 -32.37 72.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.179 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.31 -59.55 5.28 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 118.129 -0.938 . . . . 0.0 109.108 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.706 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -45.06 -55.51 5.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.761 1.224 . . . . 0.0 109.108 173.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -64.66 -27.55 69.0 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 117.868 -1.063 . . . . 0.0 113.286 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.9 m -69.19 -50.97 42.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 119.383 0.992 . . . . 0.0 109.04 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.2 mt -45.89 -57.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.384 1.088 . . . . 0.0 112.279 165.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.6 8.03 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.594 2.357 . . . . 0.0 112.839 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.255 0 CA-C-N 120.629 1.559 . . . . 0.0 110.868 177.997 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . 0.284 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.083 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.2 p -52.49 -31.97 37.71 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.33 -13.87 60.45 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.916 1.235 . . . . 0.0 112.745 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD13 ' CG2' ' A' ' 54' ' ' VAL . 11.5 mt -58.05 129.79 82.75 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 109.244 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.24 109.74 2.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.958 1.772 . . . . 0.0 108.938 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -90.12 94.66 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.182 0.993 . . . . 0.0 109.043 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tp -87.18 113.97 23.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.804 -1.185 . . . . 0.0 108.222 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mtt -84.8 124.61 31.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.5 114.91 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -147.25 -179.41 6.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.513 1.149 . . . . 0.0 109.904 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.05 -24.95 16.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 112.014 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -91.24 151.83 20.76 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 119.08 0.855 . . . . 0.0 111.152 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.61 -80.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.424 171.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? 52.55 100.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.422 1.489 . . . . 0.0 110.432 -167.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -54.46 -37.79 65.61 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.471 -1.393 . . . . 0.0 110.2 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -33.81 74.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 0.627 . . . . 0.0 112.553 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -65.14 -44.52 88.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.28 0.632 . . . . 0.0 109.442 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.73 -50.48 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.766 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.16 -56.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.62 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.14 95.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.415 0.552 . . . . 0.0 109.964 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.15 77.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.927 0.491 . . . . 0.0 112.129 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -69.7 -52.3 26.83 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.699 1.999 . . . . 0.0 111.086 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.15 77.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.35 41.94 1.01 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.432 1.491 . . . . 0.0 111.782 169.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.74 165.27 4.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.7 1.2 . . . . 0.0 110.695 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.0 t -51.41 -44.6 62.3 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.524 1.13 . . . . 0.0 108.712 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.35 172.7 39.08 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 169.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -100.86 141.36 33.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -131.19 128.27 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.17 139.2 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -58.29 139.96 83.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.526 168.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.51 131.31 23.49 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.4 1.179 . . . . 0.0 111.267 -1.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -131.5 159.15 38.96 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.164 0.985 . . . . 0.0 109.511 169.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 p -152.16 171.12 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.836 2.454 . . . . 0.0 108.364 -168.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.87 75.02 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.03 -15.27 12.56 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.31 -33.09 6.74 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.193 1.36 . . . . 0.0 110.869 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.94 -49.09 66.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.544 1.538 . . . . 0.0 108.65 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -57.07 -33.11 66.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 125.954 1.702 . . . . 0.0 112.689 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 32.9 tt0 -78.07 -33.62 50.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.412 0.285 . . . . 0.0 110.246 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -63.15 -43.4 98.41 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.823 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.9 mt -55.71 -52.91 62.26 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.94 -35.43 73.12 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 23.8 mtmt -61.77 -59.39 5.23 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.09 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 pt -65.25 -30.16 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.547 1.521 . . . . 0.0 112.869 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -55.3 -62.89 1.37 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.46 -35.45 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -81.51 -61.4 1.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.875 1.27 . . . . 0.0 109.193 -172.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.47 HD23 ' HD2' ' A' ' 126' ' ' LYS . 4.1 mt -79.66 -20.88 45.61 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.436 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.72 38.06 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.818 -169.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.7 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.059 -1.448 . . . . 0.0 109.966 -178.049 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp . . . . . 0 C--O 1.233 0.218 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -90.74 132.37 35.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.616 -165.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -107.68 104.44 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.6 134.15 38.28 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.36 118.7 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -133.85 56.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.312 1.445 . . . . 0.0 108.222 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.68 146.17 55.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -69.01 -58.24 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.782 0.833 . . . . 0.0 109.073 172.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.4 t80 -72.81 114.22 10.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 m -50.43 -51.45 46.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 112.337 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.497 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 24.8 m -61.6 -26.59 68.08 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.564 -1.208 . . . . 0.0 112.176 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 ttm -59.77 -44.55 93.82 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.629 1.559 . . . . 0.0 109.903 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -65.42 -36.94 85.44 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 119.267 0.939 . . . . 0.0 111.054 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.3 -42.79 99.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.189 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.84 -66.19 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 116.688 -1.625 . . . . 0.0 107.798 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.36 -49.55 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.309 1.868 . . . . 0.0 110.993 -172.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -57.92 -42.91 85.8 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.728 0.811 . . . . 0.0 110.607 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.93 -45.74 91.06 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.388 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 mt -59.49 -44.37 93.08 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.721 0.692 . . . . 0.0 109.296 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.49 -47.45 78.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.644 0.778 . . . . 0.0 111.131 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 3.0 mmpt? -60.99 -42.44 98.41 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.038 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.56 -44.5 85.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.78 1.232 . . . . 0.0 110.02 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.91 4.64 16.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.266 1.027 . . . . 0.0 112.234 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.01 -18.08 47.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.617 1.58 . . . . 0.0 114.53 166.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -67.74 156.95 35.8 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.015 1.408 . . . . 0.0 111.234 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -136.09 -172.72 3.19 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.352 1.861 . . . . 0.0 109.9 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.8 t30 55.17 58.68 4.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 127.177 2.191 . . . . 0.0 112.559 165.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.7 148.14 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.897 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -121.26 160.06 24.69 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.152 1.781 . . . . 0.0 108.187 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 28.2 tt0 -121.59 151.9 39.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.56 164.81 21.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -72.56 -35.82 68.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.516 0.327 . . . . 0.0 111.234 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.81 176.89 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.719 1.208 . . . . 0.0 109.797 -170.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.63 43.64 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.259 1.885 . . . . 0.0 115.866 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.5 -51.45 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.666 2.233 . . . . 0.0 107.981 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.29 -34.36 76.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.645 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.68 -47.97 82.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.665 -1.272 . . . . 0.0 110.197 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.32 -41.52 89.28 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.69 -30.0 69.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.353 0.661 . . . . 0.0 112.666 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 35' ' ' GLU . 4.3 mptp? -67.69 -42.34 82.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.357 -0.839 . . . . 0.0 110.167 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 46' ' ' LEU . 3.7 mm? -62.9 -39.02 93.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.732 1.151 . . . . 0.0 110.225 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -70.25 12.33 0.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.796 0.839 . . . . 0.0 112.673 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.03 16.54 7.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.122 2.169 . . . . 0.0 111.836 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.47 -178.68 38.16 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.525 1.511 . . . . 0.0 115.57 162.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.01 73.5 0.97 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -69.44 154.66 41.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.614 0.766 . . . . 0.0 109.659 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.87 -32.28 11.24 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.612 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -142.86 149.85 39.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 81' ' ' LEU . 21.2 t -139.42 64.57 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.32 132.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 153.98 37.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.787 0.435 . . . . 0.0 110.394 -169.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 13' ' ' ASP . 7.9 t0 -84.84 167.47 15.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 161.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.76 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 2.7 t-105 -73.08 -44.43 60.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.871 0.868 . . . . 0.0 110.325 164.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -68.61 29.38 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 131.403 3.881 . . . . 0.0 115.909 -158.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 38.0 mtt -65.94 170.54 4.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 127.891 2.476 . . . . 0.0 109.826 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.1 -39.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.825 2.35 . . . . 0.0 112.915 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -124.56 -76.94 0.59 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 123.924 0.889 . . . . 0.0 109.436 -167.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 tpt -72.75 103.78 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.36 164.14 19.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.332 0.587 . . . . 0.0 109.745 173.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.59 -25.54 67.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 121.069 -0.586 . . . . 0.0 114.111 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.76 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -73.63 -43.08 60.51 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.054 1.342 . . . . 0.0 108.919 177.568 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.55 -42.64 98.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.57 0.748 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -54.63 -52.4 62.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.856 0.753 . . . . 0.0 109.259 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.2 tp -51.7 -58.96 4.9 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 123.411 0.684 . . . . 0.0 110.179 174.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -63.26 -30.57 71.69 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.994 0.815 . . . . 0.0 112.39 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 68.9 m -69.07 -51.23 41.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.11 0.964 . . . . 0.0 108.426 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.4 mt -56.13 -47.51 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.533 0.733 . . . . 0.0 109.982 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -58.88 -23.62 61.21 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.428 1.491 . . . . 0.0 112.839 -175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 123.925 0.89 . . . . 0.0 111.568 -169.133 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.5 p -54.03 -47.33 71.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.414 0.686 . . . . 0.0 112.153 -166.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.04 7.32 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 54' ' ' VAL . 11.5 mt -54.35 142.78 48.6 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-N 119.839 1.2 . . . . 0.0 111.381 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 72.18 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.696 2.264 . . . . 0.0 109.803 160.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -64.46 137.45 24.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 158.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 tp -141.69 113.53 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.72 128.92 36.73 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 124.269 0.981 . . . . 0.0 108.444 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.63 110.49 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -153.13 167.96 27.51 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.578 -0.701 . . . . 0.0 110.3 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.72 -23.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.343 -0.848 . . . . 0.0 112.474 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.67 116.3 22.58 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.444 1.02 . . . . 0.0 109.329 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.53 -81.42 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.438 166.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.5 tptt 45.94 95.04 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.3 1.44 . . . . 0.0 111.213 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.71 -33.78 35.95 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 120.225 -1.547 . . . . 0.0 112.138 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -42.98 85.73 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.701 1.137 . . . . 0.0 112.491 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -59.56 -44.88 93.14 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.701 0.8 . . . . 0.0 109.098 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.41 -46.07 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.954 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -61.36 -52.51 60.47 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.576 1.08 . . . . 0.0 108.52 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.28 -45.93 69.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.521 1.055 . . . . 0.0 110.962 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.439 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -64.16 -46.85 82.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.332 0.653 . . . . 0.0 109.951 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.05 86.76 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.89 0.768 . . . . 0.0 110.609 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -55.31 -51.49 66.55 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 126.742 2.017 . . . . 0.0 110.857 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -21.01 66.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.09 25.18 8.51 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.849 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.8 136.39 57.97 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 p -74.55 -1.75 22.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . 172.75 169.05 34.89 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 121.182 -0.949 . . . . 0.0 111.619 172.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -139.72 92.7 2.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.026 1.331 . . . . 0.0 108.699 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.04 112.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.75 157.85 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -64.12 159.58 55.43 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.037 158.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.1 166.81 81.46 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.826 0.974 . . . . 0.0 110.097 -11.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -178.09 158.73 1.24 Allowed 'General case' 0 C--N 1.333 -0.135 0 O-C-N 121.266 -0.897 . . . . 0.0 111.285 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -154.86 -177.34 6.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.766 2.026 . . . . 0.0 109.026 -173.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.83 -23.55 53.24 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.753 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.32 -53.51 49.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.877 0.871 . . . . 0.0 112.075 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -30.5 60.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 0.0 109.935 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -53.84 53.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.407 1.003 . . . . 0.0 108.94 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.98 -39.77 87.25 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.533 0.606 . . . . 0.0 111.469 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.0 -47.83 74.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.171 0.989 . . . . 0.0 109.87 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 1.8 mmmp? -68.15 -37.48 81.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.15 -1.881 . . . . 0.0 112.336 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.45 -58.32 9.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.521 1.055 . . . . 0.0 108.207 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -58.19 -36.05 72.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.15 0.98 . . . . 0.0 109.937 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -56.94 -56.0 27.35 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 117.589 -1.196 . . . . 0.0 112.901 168.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.0 pt -68.95 -25.67 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 121.398 1.908 . . . . 0.0 112.934 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -57.87 -55.73 31.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.85 -47.13 79.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 122.547 0.339 . . . . 0.0 111.676 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HG3' HD23 ' A' ' 127' ' ' LEU . 11.3 tptt -78.23 -71.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.202 1.001 . . . . 0.0 109.727 -168.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 126' ' ' LYS . 13.1 mt -64.9 -20.67 66.56 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.211 -178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.88 42.36 16.73 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 -166.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.249 1.072 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.234 169.306 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 119.574 -0.251 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -81.57 149.96 28.39 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.884 0.874 . . . . 0.0 109.549 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.401 ' CZ ' ' CE1' ' A' ' 53' ' ' PHE . 12.0 m-85 -120.97 106.62 11.77 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.415 1.086 . . . . 0.0 109.528 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.77 136.15 43.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.611 1.55 . . . . 0.0 108.84 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -136.15 105.5 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.343 1.457 . . . . 0.0 107.3 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.29 70.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.239 1.016 . . . . 0.0 108.378 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.38 138.75 35.58 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 1.3 t70 -53.07 -33.08 50.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.939 2.095 . . . . 0.0 112.656 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -115.24 120.49 39.86 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 107.156 -168.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -53.07 -47.69 68.29 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.62 -175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.3 m -51.85 -44.64 63.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.625 1.102 . . . . 0.0 111.539 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.83 94.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -69.56 -44.16 71.42 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.913 1.285 . . . . 0.0 109.314 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -52.45 -52.34 54.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.13 2.172 . . . . 0.0 109.723 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.89 -62.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.218 -1.372 . . . . 0.0 108.261 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -52.03 -48.1 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 120.822 1.647 . . . . 0.0 110.761 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' HH11 ' A' ' 22' ' ' ARG . 0.2 OUTLIER -56.37 -49.86 73.23 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.674 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -60.39 -42.67 96.37 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 118.521 0.601 . . . . 0.0 110.713 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 113' ' ' ALA . 94.6 mt -63.69 -39.4 94.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.765 0.826 . . . . 0.0 111.013 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -64.84 -48.43 74.38 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 121.913 -0.492 . . . . 0.0 110.378 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -58.84 -39.76 82.22 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.07 0.948 . . . . 0.0 110.951 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.5 -51.04 68.33 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.36 1.064 . . . . 0.0 109.338 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.25 -48.21 80.95 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.06 3.14 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.4 1.953 . . . . 0.0 111.977 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.07 133.47 51.7 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 109.63 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 -176.38 5.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -167.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.7 t30 62.06 80.39 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 128.622 2.769 . . . . 0.0 108.76 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.06 160.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.354 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -114.31 147.08 39.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 158.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.37 164.31 12.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 158.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.75 167.86 14.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 158.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.44 -27.41 46.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.865 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -176.17 156.93 1.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.779 1.232 . . . . 0.0 108.084 -158.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.52 -45.33 5.47 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.107 1.337 . . . . 0.0 114.807 170.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.47 -36.87 78.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 119.608 1.704 . . . . 0.0 110.417 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -70.87 -31.97 68.82 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 122.763 0.425 . . . . 0.0 110.23 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.16 61.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -58.43 -40.12 81.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.779 0.432 . . . . 0.0 111.605 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -56.12 -51.35 68.26 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.971 0.508 . . . . 0.0 109.877 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -55.74 -46.68 77.74 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.184 0.994 . . . . 0.0 110.297 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 72' ' ' ILE . 11.5 mt -58.07 -46.99 84.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.958 0.799 . . . . 0.0 110.286 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -81.47 5.18 18.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.652 0.781 . . . . 0.0 112.423 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -57.22 12.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 159.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.26 88.89 0.07 OUTLIER Glycine 0 C--N 1.339 0.701 0 O-C-N 121.142 -0.974 . . . . 0.0 113.825 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.3 84.08 0.03 OUTLIER Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.946 1.736 . . . . 0.0 114.993 158.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -81.91 175.8 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.569 0.699 . . . . 0.0 112.649 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.45 -72.61 1.15 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 165.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE1' ' CZ ' ' A' ' 8' ' ' PHE . 27.1 m-85 -110.91 154.24 24.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.855 -171.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.28 91.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.37 129.39 52.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.3 p -151.38 162.2 41.34 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.655 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 18.0 t70 -72.89 -177.0 2.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 9.1 t-105 -116.11 -33.13 5.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.334 2.654 . . . . 0.0 112.366 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -76.2 21.48 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.306 2.242 . . . . 0.0 114.133 -159.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.406 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.27 147.06 79.01 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.342 1.057 . . . . 0.0 110.214 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.57 -172.21 1.24 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.014 2.476 . . . . 0.0 110.14 159.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 55.78 -105.86 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.613 1.965 . . . . 0.0 109.981 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.8 ttm -87.88 85.89 7.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.8 156.9 22.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.014 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.62 64.18 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.685 -169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.74 -35.59 44.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.32 1.56 . . . . 0.0 110.951 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -26.03 39.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.164 0.893 . . . . 0.0 111.254 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.14 -54.38 47.57 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.23 1.412 . . . . 0.0 108.622 164.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 8.1 tp -52.46 -58.51 6.51 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.088 0.955 . . . . 0.0 108.578 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 87.1 mttt -64.25 -28.15 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.352 1.433 . . . . 0.0 112.774 -174.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.3 m -62.22 -53.96 47.75 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.917 1.235 . . . . 0.0 108.354 168.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 46' ' ' LEU . 33.4 mt -56.29 -47.47 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.688 1.195 . . . . 0.0 107.853 -177.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -5.98 12.12 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.389 1.876 . . . . 0.0 113.652 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.304 0 CA-C-N 120.234 1.379 . . . . 0.0 109.858 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtm . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -42.72 -39.04 2.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.631 1.973 . . . . 0.0 112.421 159.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.53 -15.56 54.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 HG21 ' A' ' 54' ' ' VAL . 26.7 mt -64.39 131.91 95.2 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 120.116 1.325 . . . . 0.0 110.703 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.83 87.65 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.974 3.116 . . . . 0.0 109.779 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -67.24 104.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 128.516 2.726 . . . . 0.0 108.762 163.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.43 109.9 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.922 1.289 . . . . 0.0 108.198 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 59.6 mmm -87.78 129.84 35.05 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.25 94.51 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.16 1.784 . . . . 0.0 106.189 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -130.93 174.49 9.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.848 0.832 . . . . 0.0 111.09 -167.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.78 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.394 -0.816 . . . . 0.0 111.726 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.0 113.86 23.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.558 0.743 . . . . 0.0 111.73 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 8.48 1.63 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.495 1.518 . . . . 0.0 111.973 161.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -54.32 116.88 2.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.183 0.993 . . . . 0.0 108.452 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -60.87 -36.45 79.22 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.581 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -44.71 85.57 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.455 1.025 . . . . 0.0 109.531 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.64 -40.99 96.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 mt -64.89 -48.79 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.267 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.16 -51.65 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 120.009 1.277 . . . . 0.0 108.11 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.04 -42.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 110.904 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.605 0.762 . . . . 0.0 110.32 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.46 98.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.28 0.632 . . . . 0.0 110.722 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -57.07 -55.01 40.28 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 127.549 2.34 . . . . 0.0 108.83 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.73 -7.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.722 1.209 . . . . 0.0 113.234 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.41 30.81 56.16 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.302 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.87 143.55 36.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.899 1.349 . . . . 0.0 109.309 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 p -73.42 -14.85 61.34 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 122.15 -0.344 . . . . 0.0 111.908 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.34 167.55 38.75 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.84 137.88 40.19 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.24 125.68 51.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 170.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -96.2 150.35 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 166.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.65 69.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.538 -0.726 . . . . 0.0 109.79 166.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.84 175.43 44.8 Favored 'Cis proline' 0 CA--C 1.538 0.7 0 CA-C-N 119.846 0.981 . . . . 0.0 110.266 -15.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -178.07 159.01 1.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.528 1.531 . . . . 0.0 108.399 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.486 ' H ' HG22 ' A' ' 115' ' ' THR . 2.5 p -149.33 174.76 12.08 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.695 1.998 . . . . 0.0 109.297 -165.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -60.99 -34.34 74.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -6.15 2.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.287 1.835 . . . . 0.0 115.686 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 112' ' ' THR . 2.8 t -115.33 -34.56 4.92 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 121.395 1.907 . . . . 0.0 110.15 161.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.05 -56.92 5.64 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.643 1.577 . . . . 0.0 108.19 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -60.42 -31.61 70.57 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.03 1.332 . . . . 0.0 113.002 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 30.1 tt0 -72.54 -43.31 63.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.557 -0.715 . . . . 0.0 109.409 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 13.2 mmtp -68.81 -34.75 76.03 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.067 -1.02 . . . . 0.0 110.015 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.3 mt -55.04 -58.06 9.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.78 -35.36 68.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.711 0.687 . . . . 0.0 112.038 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 22.7 mttm -59.97 -47.49 85.61 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.369 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.06 -28.02 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.496 1.953 . . . . 0.0 114.033 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -60.47 -54.01 50.72 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.834 0.854 . . . . 0.0 109.101 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -67.63 -51.65 47.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.97 -0.456 . . . . 0.0 110.426 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -64.31 1.0 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -162.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.31 -22.01 66.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 119.429 -0.319 . . . . 0.0 110.903 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 26.81 50.25 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.931 -167.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.3 mmt . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.768 1.784 . . . . 0.0 110.411 177.328 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.695 HD11 ' HA3' ' A' ' 52' ' ' GLY . 5.9 tt . . . . . 0 CA--C 1.508 -0.639 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -83.89 131.37 34.87 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -83.8 138.46 33.23 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 158.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 42' ' ' ALA . 22.0 tp -111.07 135.75 51.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 169.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.11 122.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.77 48.0 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.99 157.49 21.77 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.493 -1.379 . . . . 0.0 108.727 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -33.32 71.18 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 121.493 -0.755 . . . . 0.0 111.182 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.1 t80 -102.43 127.84 49.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.058 1.343 . . . . 0.0 107.622 -171.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -49.04 79.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.362 0.601 . . . . 0.0 110.057 -172.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 8.8 m -63.04 -24.15 67.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.62 -0.705 . . . . 0.0 111.743 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 18.7 ttm -64.95 -34.09 77.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.362 1.437 . . . . 0.0 109.938 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -36.8 80.77 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 120.352 1.433 . . . . 0.0 110.565 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -52.01 -53.06 46.2 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 168.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.22 -63.71 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-O 117.439 -1.267 . . . . 0.0 108.673 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.5 t -52.71 -46.34 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.664 1.574 . . . . 0.0 110.65 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.78 91.12 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.82 1.191 . . . . 0.0 110.318 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.73 -39.54 91.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.309 0.959 . . . . 0.0 111.922 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.57 -41.33 96.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.036 0.934 . . . . 0.0 110.079 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.84 -45.75 92.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.075 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -63.43 -39.39 94.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.799 0.727 . . . . 0.0 110.802 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.61 -12.98 61.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.598 -171.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.84 13.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.35 -90.61 0.43 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.558 1.075 . . . . 0.0 111.197 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -147.69 175.47 10.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.198 0.999 . . . . 0.0 112.824 -159.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -118.74 171.61 8.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 128.43 2.692 . . . . 0.0 109.194 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 77.29 99.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 128.388 2.675 . . . . 0.0 113.228 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -121.1 154.87 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.566 0.698 . . . . 0.0 112.449 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -122.3 145.42 48.25 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 158.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -119.71 93.89 4.22 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -76.29 163.45 27.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.67 0.748 . . . . 0.0 111.079 -172.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.65 -33.05 60.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.308 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.36 160.97 1.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.343 1.457 . . . . 0.0 107.535 -163.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.4 -40.36 10.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.755 1.161 . . . . 0.0 115.156 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.1 t -65.77 -39.41 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.237 2.018 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.22 -29.77 65.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.142 0.977 . . . . 0.0 111.028 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HA ' HD21 ' A' ' 9' ' ' LEU . . . -61.24 -51.44 68.92 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.949 -1.095 . . . . 0.0 109.401 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.38 -41.06 83.98 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.317 1.047 . . . . 0.0 111.144 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -56.51 -50.8 70.76 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.297 1.039 . . . . 0.0 110.282 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -54.78 -49.67 70.35 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.126 175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 72' ' ' ILE . 15.4 mt -53.45 -43.84 68.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.074 1.306 . . . . 0.0 109.935 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.59 10.56 0.35 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -4.9 47.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.987 1.267 . . . . 0.0 112.764 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.92 163.16 8.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.229 1.395 . . . . 0.0 113.438 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.2 22.74 76.26 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.466 -1.02 . . . . 0.0 112.281 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -90.96 156.57 17.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.536 1.168 . . . . 0.0 107.974 170.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.695 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -159.81 9.54 0.15 Allowed Glycine 0 C--O 1.225 -0.445 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.23 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.06 132.26 17.4 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 81' ' ' LEU . 5.9 t -133.29 86.11 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 CA-C-O 122.436 1.112 . . . . 0.0 108.0 -171.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -97.76 131.61 44.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.194 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -151.86 145.6 25.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.854 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.91 162.17 27.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.91 0.862 . . . . 0.0 109.485 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -70.27 -52.75 20.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.78 1.232 . . . . 0.0 109.478 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.45 82.25 6.52 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.742 1.617 . . . . 0.0 108.656 -169.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.5 mmt -86.95 168.64 17.26 Favored Pre-proline 0 C--O 1.234 0.263 0 O-C-N 121.806 -0.558 . . . . 0.0 111.013 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.37 0.94 9.28 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.217 2.611 . . . . 0.0 113.023 165.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -150.73 -80.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 121.008 1.731 . . . . 0.0 112.05 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.5 ttm -90.73 94.28 9.61 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.43 148.82 0.86 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.855 2.062 . . . . 0.0 111.434 176.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.98 -36.04 41.91 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.521 1.058 . . . . 0.0 113.754 -172.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.36 -34.14 55.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.775 0.83 . . . . 0.0 110.417 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.82 -42.95 85.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.56 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.11 -49.02 79.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.476 1.035 . . . . 0.0 110.013 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 83' ' ' VAL . 2.1 tp -52.43 -56.72 13.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.95 -26.25 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 120.241 1.382 . . . . 0.0 113.243 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 m -65.3 -49.06 70.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.34 0.973 . . . . 0.0 108.609 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 46' ' ' LEU . 18.8 mt -61.35 -44.42 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.519 1.127 . . . . 0.0 109.261 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 10.21 2.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.249 1.819 . . . . 0.0 111.712 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.346 0 CA-C-N 119.602 1.092 . . . . 0.0 111.735 177.572 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 C--O 1.232 0.163 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -59.76 -23.95 63.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -15.3 60.84 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.389 1.45 . . . . 0.0 113.538 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 54' ' ' VAL . 13.0 mt -55.52 135.38 70.67 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.961 0.904 . . . . 0.0 111.559 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.87 87.18 0.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.692 2.261 . . . . 0.0 108.942 162.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.573 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -77.0 140.88 16.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 162.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.17 118.56 14.71 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -172.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.3 mmt -78.28 127.01 31.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.63 110.44 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.7 t -155.71 172.15 18.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.932 0.787 . . . . 0.0 111.232 -168.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.71 -28.18 62.52 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.235 -0.916 . . . . 0.0 111.539 159.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.75 93.29 0.94 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -164.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.9 4.53 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.987 170.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -45.16 105.25 0.05 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.999 1.72 . . . . 0.0 108.524 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -50.7 -43.15 57.62 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 122.462 0.305 . . . . 0.0 110.218 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -49.32 -43.0 43.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.715 1.206 . . . . 0.0 113.317 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -69.59 -40.94 76.4 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.372 1.069 . . . . 0.0 109.802 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.91 -46.45 76.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.683 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.91 -55.99 17.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.73 76.75 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.735 0.698 . . . . 0.0 111.313 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.61 64.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.514 0.726 . . . . 0.0 110.536 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.67 97.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.041 0.536 . . . . 0.0 110.037 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -58.16 -53.84 53.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 126.787 2.035 . . . . 0.0 111.527 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.75 -38.27 78.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.112 0.565 . . . . 0.0 110.254 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.69 30.2 3.11 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.713 1.149 . . . . 0.0 112.298 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.3 150.16 22.65 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.678 1.239 . . . . 0.0 109.699 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -72.79 -18.51 61.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.964 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.2 43.15 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.77 139.52 47.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 77.3 t -133.25 137.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.921 2.088 . . . . 0.0 105.368 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 90' ' ' ALA . 2.5 t -121.5 152.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -62.22 149.64 86.52 Favored Pre-proline 0 CA--C 1.542 0.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.233 164.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.61 127.63 14.13 Favored 'Cis proline' 0 N--CA 1.456 -0.723 0 N-CA-C 109.538 -0.985 . . . . 0.0 109.538 -15.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -117.75 156.24 28.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -146.26 178.76 8.0 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 108.872 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.7 -25.49 67.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.215 -0.897 . . . . 0.0 109.216 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.69 -38.83 64.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.186 0.994 . . . . 0.0 112.575 170.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -31.9 20.79 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.828 1.195 . . . . 0.0 109.712 173.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.07 -48.77 75.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.713 1.142 . . . . 0.0 109.404 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.51 -36.14 81.6 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.349 0.66 . . . . 0.0 111.675 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 10.0 tt0 -66.38 -46.99 74.79 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.81 0.732 . . . . 0.0 109.189 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -44.94 89.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.203 -0.903 . . . . 0.0 108.769 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.05 -53.51 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.701 0.8 . . . . 0.0 110.183 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.93 -45.97 82.35 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.568 0.747 . . . . 0.0 110.997 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -53.27 -55.99 20.16 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.878 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -27.77 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.935 1.243 . . . . 0.0 112.574 -169.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -54.73 -60.36 3.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 165.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.8 -52.55 42.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 109.725 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.294 1.437 . . . . 0.0 110.983 -164.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.07 -32.13 71.36 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.05 44.45 5.98 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -162.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.1 mmt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 119.115 1.457 . . . . 0.0 109.996 169.268 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.8 tp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -81.55 129.01 34.51 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -111.31 109.76 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.654 1.182 . . . . 0.0 107.847 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.31 138.53 47.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.732 1.606 . . . . 0.0 109.012 171.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.93 109.22 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.291 1.036 . . . . 0.0 109.308 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -120.06 52.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -66.55 158.39 29.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.293 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.19 -43.03 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.797 -0.565 . . . . 0.0 111.486 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -92.0 114.66 27.26 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 116.739 -1.6 . . . . 0.0 108.958 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -53.14 -37.55 61.92 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 122.703 2.502 . . . . 0.0 114.622 -167.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 m -48.52 -38.42 20.25 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.578 -1.326 . . . . 0.0 111.708 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.0 ttm -65.36 -25.31 67.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.711 2.004 . . . . 0.0 111.572 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -56.42 22.1 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.452 1.933 . . . . 0.0 107.912 167.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -53.34 54.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.548 1.139 . . . . 0.0 108.584 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.9 -67.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 117.088 -1.434 . . . . 0.0 108.417 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.22 -48.27 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 120.673 1.579 . . . . 0.0 111.0 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -56.33 -48.79 76.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 109.837 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -63.04 -44.58 95.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 113' ' ' ALA . 85.2 mt -56.64 -44.17 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.17 0.988 . . . . 0.0 110.186 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.43 -42.84 96.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.639 0.776 . . . . 0.0 111.174 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -62.89 -35.13 79.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.57 -5.08 22.06 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.27 0.941 . . . . 0.0 111.464 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.67 15.58 8.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.258 2.623 . . . . 0.0 111.375 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.91 85.14 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.807 169.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -97.91 163.56 12.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.355 1.577 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -159.39 -160.28 0.82 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 110.197 -173.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.42 37.29 23.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.519 1.527 . . . . 0.0 113.085 165.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.44 146.51 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.582 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -110.26 167.17 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 158.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.65 168.86 11.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 163.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -126.28 164.5 20.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.73 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.997 0.519 . . . . 0.0 110.556 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.66 173.31 8.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.836 1.654 . . . . 0.0 108.54 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.93 -29.11 54.64 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.53 -49.77 56.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.537 2.168 . . . . 0.0 107.321 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -60.63 -32.37 71.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.29 0.636 . . . . 0.0 110.879 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.71 -52.65 59.6 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.728 -1.232 . . . . 0.0 109.042 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.42 -35.38 71.98 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.56 -44.62 93.58 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.34 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -62.58 -38.64 90.9 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.113 0.869 . . . . 0.0 111.528 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.48 HD21 HG13 ' A' ' 54' ' ' VAL . 11.0 mt -59.99 -46.68 88.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.3 1.409 . . . . 0.0 108.991 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -77.66 29.18 0.16 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.037 1.335 . . . . 0.0 111.486 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.77 32.8 4.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.559 1.944 . . . . 0.0 109.724 159.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.61 19.69 8.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.913 164.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.59 83.02 0.62 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.125 1.463 . . . . 0.0 109.528 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -69.56 170.33 10.88 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.158 0.583 . . . . 0.0 109.858 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 -40.62 26.34 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.668 -0.645 . . . . 0.0 112.565 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -139.73 155.84 47.12 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.328 0.564 . . . . 0.0 111.547 -166.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -134.3 71.08 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.56 129.37 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -150.42 157.67 43.3 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.262 -1.524 . . . . 0.0 110.525 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -73.76 171.96 12.36 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.668 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 5.1 t-105 -66.7 -59.15 3.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 159.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.55 71.36 5.01 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -158.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.82 154.35 47.79 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.3 160.04 45.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.8 1.666 . . . . 0.0 109.257 162.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.24 -79.07 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 C-N-CA 129.104 2.962 . . . . 0.0 114.227 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 ttp -88.45 79.79 7.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.86 150.17 2.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.026 1.73 . . . . 0.0 109.517 167.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.98 -27.93 71.2 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.205 -0.934 . . . . 0.0 113.785 -161.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.668 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -75.81 -31.42 59.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.974 0.887 . . . . 0.0 111.36 175.603 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.65 -40.54 84.53 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.792 0.723 . . . . 0.0 109.119 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.8 tp -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.521 0.6 . . . . 0.0 109.73 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tp -53.19 -56.98 12.15 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.946 0.898 . . . . 0.0 109.526 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.482 ' HE3' HD12 ' A' ' 66' ' ' LEU . 80.7 mttt -63.48 -30.17 71.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.026 0.83 . . . . 0.0 112.25 -174.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 m -62.18 -55.77 25.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 109.126 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 46' ' ' LEU . 25.2 mt -59.81 -44.04 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.125 1.37 . . . . 0.0 108.183 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -57.7 -26.24 61.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.999 1.719 . . . . 0.0 112.756 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 119.181 0.901 . . . . 0.0 112.311 179.486 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.49 ' HB3' HD12 ' A' ' 81' ' ' LEU . 43.9 mtt . . . . . 0 C--O 1.221 -0.441 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -57.23 -26.86 61.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.837 1.199 . . . . 0.0 111.264 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.62 -10.09 59.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.002 1.321 . . . . 0.0 113.975 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 54' ' ' VAL . 18.0 mt -68.58 143.5 95.25 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 119.625 1.102 . . . . 0.0 110.125 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.78 87.94 0.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.996 2.464 . . . . 0.0 110.099 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -76.85 88.77 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 126.321 1.848 . . . . 0.0 107.083 163.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.5 tp -96.26 118.33 32.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.62 122.76 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.2 t -132.55 99.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.412 1.885 . . . . 0.0 107.405 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -139.61 -173.54 3.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.132 0.968 . . . . 0.0 110.382 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.09 -15.02 15.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.116 1.367 . . . . 0.0 111.666 163.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.54 103.75 7.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.61 -73.58 0.11 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 39.98 92.7 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 126.433 1.893 . . . . 0.0 110.782 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -28.43 -57.75 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.071 1.348 . . . . 0.0 114.276 173.368 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 22.1 tt0 -54.73 -40.26 69.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.656 2.382 . . . . 0.0 113.654 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -71.04 -39.47 72.27 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.856 1.263 . . . . 0.0 110.474 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.97 -50.41 79.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.276 2.1 mt -53.9 -46.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 116.857 -1.544 . . . . 0.0 114.93 168.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.69 82.55 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 121.325 1.875 . . . . 0.0 110.488 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.66 -42.6 99.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.009 0.924 . . . . 0.0 110.729 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.58 78.79 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.565 -0.709 . . . . 0.0 112.394 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.44 -44.07 75.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.487 1.515 . . . . 0.0 110.091 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.13 58.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.548 0.739 . . . . 0.0 112.739 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.41 39.79 34.85 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.26 0.936 . . . . 0.0 112.453 173.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.62 150.4 31.97 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.428 0.614 . . . . 0.0 109.972 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -77.15 -14.33 59.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.96 0.904 . . . . 0.0 111.466 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.67 171.37 43.0 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 160.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -132.07 133.12 44.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.2 t -134.99 134.92 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.0 141.84 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -53.84 142.22 44.95 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.308 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.32 135.87 40.69 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.497 1.213 . . . . 0.0 110.77 -10.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.96 152.24 51.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 109.275 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 p -149.74 -176.71 5.52 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.66 1.584 . . . . 0.0 108.943 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -61.92 -32.89 73.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.402 -0.809 . . . . 0.0 108.901 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.46 -19.89 17.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.751 1.22 . . . . 0.0 114.218 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.58 -25.46 9.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.783 1.174 . . . . 0.0 111.668 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -47.59 81.21 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.17 -30.32 71.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 112.162 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -78.8 -43.36 25.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.465 0.706 . . . . 0.0 110.114 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -25.63 60.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.224 -1.369 . . . . 0.0 110.133 175.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 mt -57.52 -53.24 60.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.457 1.026 . . . . 0.0 108.677 166.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -50.09 -45.47 52.64 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.801 0.728 . . . . 0.0 111.302 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -62.67 1.5 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.316 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 pt -67.47 -27.03 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 120.319 1.418 . . . . 0.0 113.089 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -53.78 -62.51 1.61 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 167.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.02 -29.6 58.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -168.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -69.49 0.67 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.553 1.541 . . . . 0.0 107.829 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.97 -28.14 66.35 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.465 0.575 . . . . 0.0 111.546 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 43.16 6.52 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -162.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 38.2 mmt . . . . . 0 C--O 1.253 1.257 0 CA-C-N 118.66 1.23 . . . . 0.0 109.296 169.573 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 166.1 12.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.453 1.12 . . . . 0.0 111.263 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 33' ' ' VAL . 1.4 m-85 -124.17 161.67 25.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.25 139.38 43.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 158.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -127.87 104.24 11.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 42' ' ' ALA . 3.2 t -109.04 78.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.21 157.83 35.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 165.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -80.79 -23.21 39.43 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.48 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -83.41 -151.75 0.11 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.127 1.371 . . . . 0.0 109.575 178.563 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -139.78 -43.81 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.097 -1.002 . . . . 0.0 108.539 159.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.2 m -50.12 -31.93 14.68 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 169.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 ttm -64.72 -39.69 94.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.289 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -33.35 71.16 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 122.122 2.237 . . . . 0.0 110.937 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -56.43 -54.0 50.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.1 -60.25 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.51 1.124 . . . . 0.0 108.548 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.63 -46.92 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.597 1.089 . . . . 0.0 111.064 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.564 HH11 ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.24 -42.88 96.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.835 1.198 . . . . 0.0 109.914 -179.405 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.49 -53.96 51.34 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.195 0.907 . . . . 0.0 110.69 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.77 -37.46 71.12 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.157 0.983 . . . . 0.0 111.325 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -52.04 40.91 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.843 171.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' HH11 ' A' ' 22' ' ' ARG . 26.1 mttt -62.47 -23.84 67.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.324 1.42 . . . . 0.0 111.997 -172.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -52.22 -48.98 64.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.22 0.918 . . . . 0.0 110.324 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.1 mt -75.84 -50.09 16.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.554 1.542 . . . . 0.0 109.465 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.17 -163.43 31.02 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.622 1.105 . . . . 0.0 111.274 -174.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.533 ' HB2' HH22 ' A' ' 22' ' ' ARG . 61.4 m-85 59.2 174.48 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.209 1.803 . . . . 0.0 111.894 -171.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -170.89 -162.7 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.674 1.19 . . . . 0.0 108.378 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.69 27.57 17.3 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.876 2.071 . . . . 0.0 114.439 159.268 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 8' ' ' PHE . 7.5 m -70.08 174.14 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.104 0.562 . . . . 0.0 111.35 -175.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -136.98 177.05 8.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 108.064 164.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -132.09 177.19 7.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.777 1.231 . . . . 0.0 107.962 167.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 172.27 13.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.952 1.301 . . . . 0.0 108.005 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.69 -40.39 88.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.552 0.341 . . . . 0.0 111.181 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -174.74 172.04 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.517 1.927 . . . . 0.0 107.702 -163.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.53 -42.43 26.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.828 1.204 . . . . 0.0 115.539 178.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.47 -47.64 88.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 119.857 1.829 . . . . 0.0 108.517 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.35 -24.74 66.56 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.763 -0.585 . . . . 0.0 111.659 175.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.69 -53.63 44.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tp -51.75 -47.21 64.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.743 1.617 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -56.35 -42.08 77.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.496 1.518 . . . . 0.0 111.388 176.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.0 -45.46 88.89 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.645 -1.284 . . . . 0.0 111.246 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 72' ' ' ILE . 13.2 mt -55.12 -51.52 66.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.421 1.464 . . . . 0.0 109.521 -175.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.01 29.56 0.11 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.968 0.907 . . . . 0.0 113.172 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.34 18.03 12.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.735 1.614 . . . . 0.0 111.631 170.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.23 -6.53 0.7 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-O 117.984 -1.453 . . . . 0.0 114.904 166.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.83 107.57 0.73 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.381 1.591 . . . . 0.0 109.709 -174.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.91 164.41 14.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.036 1.335 . . . . 0.0 108.646 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.91 -28.87 27.56 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.479 -0.763 . . . . 0.0 112.625 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -145.98 159.46 43.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.192 1.797 . . . . 0.0 108.476 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.735 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -135.37 62.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.4 mt -69.52 131.76 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.62 141.43 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.599 0.359 . . . . 0.0 110.13 -163.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -62.89 165.19 7.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 164.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -80.96 -59.63 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 159.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.97 37.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.341 1.056 . . . . 0.0 112.55 -170.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.7 ptp -63.56 149.68 91.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 158.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.74 175.04 11.7 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.586 2.19 . . . . 0.0 110.607 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 m120 53.56 -92.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.992 2.117 . . . . 0.0 111.437 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -90.8 97.3 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.61 164.04 6.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.577 0.626 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.24 -38.38 56.63 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.641 0.639 . . . . 0.0 113.63 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.53 -38.92 92.7 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.976 0.888 . . . . 0.0 110.42 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.67 -35.58 52.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.13 0.572 . . . . 0.0 110.269 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.23 -49.93 74.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.568 0.747 . . . . 0.0 109.152 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -50.87 -56.57 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.597 1.159 . . . . 0.0 109.643 172.194 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -64.48 -31.34 72.51 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.109 1.322 . . . . 0.0 113.454 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.2 m -62.44 -51.5 67.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.37 1.068 . . . . 0.0 109.005 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 46' ' ' LEU . 28.3 mt -58.63 -43.54 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 126.217 1.807 . . . . 0.0 110.157 176.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -8.95 41.66 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.486 -172.072 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 124.293 1.037 . . . . 0.0 111.561 -172.425 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.3 mtt . . . . . 0 C--O 1.22 -0.493 0 N-CA-C 111.112 0.042 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -35.28 11.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.356 2.262 . . . . 0.0 112.579 173.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.11 -7.17 58.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.656 1.582 . . . . 0.0 114.002 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 54' ' ' VAL . 17.2 mt -65.07 131.52 95.19 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 119.735 1.152 . . . . 0.0 108.674 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.98 83.65 0.9 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.452 1.434 . . . . 0.0 110.375 167.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -68.5 115.55 7.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 159.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tp -130.53 107.63 9.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -167.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -73.1 123.71 24.13 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.16 105.3 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -148.25 -166.47 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.35 -21.59 13.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.359 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -82.96 145.74 29.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.81 1.186 . . . . 0.0 110.868 176.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.31 -81.85 0.31 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.984 1.313 . . . . 0.0 109.809 172.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 tptm 46.33 110.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 130.078 3.351 . . . . 0.0 112.551 -164.041 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -47.57 -45.08 26.75 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 111.825 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -60.81 -31.45 70.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.964 1.256 . . . . 0.0 113.185 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -70.26 -37.39 74.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.747 1.158 . . . . 0.0 110.617 170.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.11 -47.8 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.409 1.004 . . . . 0.0 108.454 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.1 -58.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.88 -51.03 55.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.912 1.233 . . . . 0.0 111.336 -176.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.298 0.499 . . . . 0.0 110.295 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.31 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.441 0.564 . . . . 0.0 111.785 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -63.85 -47.19 81.71 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.615 1.966 . . . . 0.0 111.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.86 66.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.777 0.431 . . . . 0.0 112.002 172.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.48 47.15 9.15 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 125.9 1.714 . . . . 0.0 110.691 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.03 144.7 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -65.61 -21.23 66.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.664 0.269 . . . . 0.0 111.569 -178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 175.49 44.4 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -135.05 142.98 46.46 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.02 133.89 44.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 129.461 3.105 . . . . 0.0 104.302 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.02 147.55 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -50.29 134.97 23.89 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.098 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.22 147.39 85.41 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 120.557 1.235 . . . . 0.0 110.902 -6.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.86 145.12 32.09 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.841 -0.537 . . . . 0.0 112.06 176.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 115' ' ' THR . 2.3 p -141.36 174.58 10.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.244 1.818 . . . . 0.0 110.23 -170.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.29 67.62 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 175.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.89 66.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.181 1.392 . . . . 0.0 113.997 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 112' ' ' THR . 6.6 t -93.23 -40.77 10.26 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.569 1.077 . . . . 0.0 109.182 168.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -53.84 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.04 0.936 . . . . 0.0 109.483 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -28.6 70.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.71 1.204 . . . . 0.0 112.653 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.57 -46.58 31.08 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.031 0.933 . . . . 0.0 109.064 178.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -69.83 -32.94 71.62 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 109.823 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.5 -56.91 15.75 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.111 0.964 . . . . 0.0 109.424 167.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -57.17 -29.94 64.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -68.48 0.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 117.511 -1.233 . . . . 0.0 109.148 166.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.5 pt -62.13 -28.12 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 119.831 1.196 . . . . 0.0 112.726 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -59.46 -54.33 47.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.111 0.564 . . . . 0.0 109.797 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.14 -47.03 38.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.985 0.811 . . . . 0.0 110.942 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HG3' HD23 ' A' ' 127' ' ' LEU . 31.6 tptt -68.16 -73.27 0.15 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.774 1.629 . . . . 0.0 110.093 -172.162 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.462 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.9 mt -65.03 -21.2 66.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.541 0.61 . . . . 0.0 111.444 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.26 33.62 28.36 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.5 mmm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.057 179.513 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.462 HD11 ' HA3' ' A' ' 52' ' ' GLY . 1.1 tp . . . . . 0 C--O 1.235 0.337 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -70.03 130.54 42.42 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.83 160.51 17.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 162.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.72 137.5 51.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.12 103.59 6.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 125.683 1.593 . . . . 0.0 106.947 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.9 t -112.14 53.84 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.629 1.204 . . . . 0.0 107.872 -175.4 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.51 126.36 30.65 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.87 -45.1 93.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.989 0.516 . . . . 0.0 112.035 -174.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 29.0 t80 -75.61 106.18 7.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 t -58.05 -33.22 68.78 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.583 1.538 . . . . 0.0 112.885 -171.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 61.6 m -57.67 -36.84 72.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.406 -1.434 . . . . 0.0 110.851 174.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.1 tpp -55.29 -43.15 74.53 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.346 1.059 . . . . 0.0 109.539 173.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -66.6 -41.88 87.75 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.574 0.625 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -57.2 -47.06 82.24 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.028 173.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.85 -58.14 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.036 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.8 t -54.64 -50.6 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 125.34 1.456 . . . . 0.0 110.699 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -59.99 -41.73 92.69 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.826 0.739 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -64.39 -45.68 86.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.434 0.561 . . . . 0.0 111.346 176.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.29 -43.78 92.56 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.752 0.821 . . . . 0.0 110.269 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.34 -58.74 6.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.009 1.324 . . . . 0.0 110.558 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.492 ' HE2' ' OD1' ' A' ' 31' ' ' ASN . 11.5 ptmm? -66.27 -22.65 66.31 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 117.37 -1.3 . . . . 0.0 112.087 -177.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.45 90.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.391 1.451 . . . . 0.0 109.197 175.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.33 -42.4 23.04 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.436 1.094 . . . . 0.0 110.089 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.18 -25.13 0.19 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.258 -1.301 . . . . 0.0 115.757 169.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.93 101.59 5.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.425 2.113 . . . . 0.0 111.093 -174.194 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.492 ' OD1' ' HE2' ' A' ' 26' ' ' LYS . 45.8 m-80 -85.82 -27.4 25.15 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.235 -0.915 . . . . 0.0 112.985 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.54 76.38 2.24 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.297 1.522 . . . . 0.0 108.505 -159.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.23 108.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.813 2.045 . . . . 0.0 105.826 -162.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -86.4 -168.49 2.25 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.332 1.853 . . . . 0.0 109.894 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.92 172.35 1.67 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 130.589 3.555 . . . . 0.0 105.081 -167.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.96 175.75 9.99 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -168.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.78 -39.08 87.68 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.375 -0.828 . . . . 0.0 110.973 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.87 166.57 4.39 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -158.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.59 49.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.296 0.953 . . . . 0.0 112.554 171.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 t -57.81 -45.12 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.435 1.094 . . . . 0.0 110.536 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.93 -30.39 61.23 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.64 0.776 . . . . 0.0 109.633 176.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.91 -50.14 74.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.565 -0.71 . . . . 0.0 109.508 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.26 -45.61 76.08 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.144 0.578 . . . . 0.0 110.362 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.24 -38.0 87.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.051 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.26 -48.02 81.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.422 1.01 . . . . 0.0 109.512 171.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 72' ' ' ILE . 3.4 mt -60.82 -47.99 83.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 35.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.04 -49.28 4.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.64 153.91 20.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.047 1.784 . . . . 0.0 110.246 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -8.2 74.86 Favored Glycine 0 N--CA 1.466 0.685 0 O-C-N 121.047 -1.266 . . . . 0.0 114.03 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -72.7 161.8 30.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 159.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -134.21 3.79 4.46 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 117.758 -1.579 . . . . 0.0 113.544 164.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.38 141.89 31.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.855 1.828 . . . . 0.0 111.043 -174.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 81' ' ' LEU . 4.0 t -132.77 72.07 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -75.81 140.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 t -154.49 147.34 24.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.215 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -72.47 165.11 25.26 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 158.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 97' ' ' ALA . 7.3 t-105 -77.37 -52.53 8.99 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.467 1.507 . . . . 0.0 110.113 163.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.68 84.52 5.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.527 -158.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.71 162.95 51.96 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.391 1.476 . . . . 0.0 109.73 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.53 176.75 9.69 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.238 1.958 . . . . 0.0 111.166 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 58.41 -98.54 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.1 2.56 . . . . 0.0 110.796 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 9.6 ttm -91.21 104.84 17.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 172.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.08 158.12 14.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.605 0.717 . . . . 0.0 110.685 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.82 -26.04 73.09 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.939 -168.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -72.58 -38.2 67.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.861 1.33 . . . . 0.0 108.932 175.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -66.44 -40.08 89.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.545 0.611 . . . . 0.0 111.294 174.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.78 -49.61 74.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.07 0.85 . . . . 0.0 109.493 172.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.567 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.85 -58.2 8.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.073 174.202 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 29.6 mttt -61.99 -32.37 72.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.922 1.692 . . . . 0.0 112.414 -172.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.6 m -59.27 -49.1 79.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.186 0.995 . . . . 0.0 109.118 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 46' ' ' LEU . 21.3 mt -64.92 -46.87 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -20.6 62.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.485 1.114 . . . . 0.0 112.736 -174.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-N 119.564 1.074 . . . . 0.0 110.739 172.884 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 p -55.52 -22.45 21.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.769 1.628 . . . . 0.0 113.317 171.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.53 63.02 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.25 0.932 . . . . 0.0 112.576 175.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 54' ' ' VAL . 26.1 mt -61.72 139.38 95.38 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 118.94 0.791 . . . . 0.0 111.65 -171.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.32 77.46 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.704 2.936 . . . . 0.0 109.008 159.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 69' ' ' LEU . 1.4 m -60.99 114.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.285 1.834 . . . . 0.0 107.546 159.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -132.81 114.22 13.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 109.483 -166.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mtp -91.25 119.45 31.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.45 101.5 8.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.911 1.685 . . . . 0.0 106.643 -174.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.28 172.12 13.6 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.455 -0.778 . . . . 0.0 111.127 -165.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.6 -13.88 36.22 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.142 -0.974 . . . . 0.0 113.027 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -91.1 123.35 34.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.07 0.948 . . . . 0.0 111.154 -174.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 20.74 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.784 0.833 . . . . 0.0 110.497 163.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -51.27 115.24 1.48 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.635 1.574 . . . . 0.0 108.825 -175.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -58.14 -41.95 84.8 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 119.139 -0.457 . . . . 0.0 109.976 -175.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.42 -32.35 70.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.876 173.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -68.67 -39.31 80.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.939 1.245 . . . . 0.0 109.422 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.81 -44.83 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 118.237 -0.887 . . . . 0.0 108.652 172.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.95 -58.7 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.239 0.927 . . . . 0.0 108.717 175.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HH2' ' A' ' 58' ' ' TRP . . . -58.57 -40.57 83.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.109 0.868 . . . . 0.0 111.055 -173.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.95 74.83 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.096 0.558 . . . . 0.0 110.348 172.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.82 87.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.317 0.508 . . . . 0.0 111.863 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -54.08 -55.54 26.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.608 1.963 . . . . 0.0 108.685 171.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.04 -13.46 61.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.89 1.276 . . . . 0.0 112.734 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.81 36.95 40.62 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.261 -1.299 . . . . 0.0 112.397 178.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.45 145.47 43.69 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.204 1.502 . . . . 0.0 109.564 176.037 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.5 p -71.05 -24.73 62.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 117.716 0.235 . . . . 0.0 111.528 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.8 163.71 36.84 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 118.109 0.413 . . . . 0.0 112.199 174.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -134.21 110.93 9.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.623 1.569 . . . . 0.0 107.988 -176.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.59 99.95 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 106.596 -163.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.59 144.47 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -56.78 162.25 3.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 0.0 111.281 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.09 108.8 0.92 Allowed 'Cis proline' 0 N--CA 1.457 -0.669 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 -21.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.68 76.3 7.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.686 0.794 . . . . 0.0 109.357 -169.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -64.67 172.47 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.257 1.423 . . . . 0.0 112.393 -173.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.75 70.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.09 -18.53 61.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.53 -31.4 9.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.091 1.314 . . . . 0.0 109.553 172.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -56.74 -47.36 80.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 108.382 175.372 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -42.56 73.3 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.073 0.949 . . . . 0.0 111.583 -176.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.03 -64.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.605 1.962 . . . . 0.0 109.177 168.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.181 -173.403 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.35 -53.83 46.48 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.284 0.947 . . . . 0.0 109.445 174.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -35.47 77.38 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.866 0.757 . . . . 0.0 110.044 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -51.75 -57.07 10.31 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.899 0.879 . . . . 0.0 110.652 171.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -17.52 11.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -57.28 -67.31 0.34 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 159.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.37 -36.72 79.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.785 -0.572 . . . . 0.0 112.434 -167.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -67.28 0.73 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -176.349 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.35 -29.61 67.45 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.8 -171.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.77 25.1 13.83 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 117.762 -1.577 . . . . 0.0 111.4 -166.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 C--O 1.249 1.072 0 CA-C-N 120.266 2.033 . . . . 0.0 111.291 179.213 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -91.07 152.9 20.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.721 0.772 . . . . 0.0 111.814 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.72 156.48 19.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 158.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 tp -119.33 143.19 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.084 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 t -137.34 93.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -171.003 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.07 57.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -174.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.9 131.4 37.47 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.61 -56.64 17.62 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.661 1.185 . . . . 0.0 111.76 177.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.4 t80 -69.6 114.37 7.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -48.89 76.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.377 0.99 . . . . 0.0 111.093 -170.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.523 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.7 m -58.53 -28.42 65.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.551 0.741 . . . . 0.0 111.574 176.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.0 ttp -63.89 -36.27 83.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.568 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -64.64 -42.17 95.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.729 1.604 . . . . 0.0 109.52 172.304 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -58.92 -37.91 77.73 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.871 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.41 -65.31 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.574 169.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.8 t -48.21 -52.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.686 2.039 . . . . 0.0 111.189 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG2' HG21 ' A' ' 33' ' ' VAL . 3.9 tmm_? -56.57 -47.5 79.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.941 177.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.35 -49.38 77.42 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.777 0.717 . . . . 0.0 111.533 176.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.77 -39.1 83.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 110.988 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -48.58 72.08 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.65 -0.656 . . . . 0.0 110.386 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.99 -28.39 68.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.831 178.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.16 -45.23 95.49 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 119.942 1.246 . . . . 0.0 109.488 173.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.54 -27.74 64.39 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 0.0 111.062 177.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 1.92 6.41 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.412 1.482 . . . . 0.0 113.959 169.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -70.14 170.13 12.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.359 1.08 . . . . 0.0 110.645 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -143.01 -178.79 6.0 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.062 1.345 . . . . 0.0 109.801 -172.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 75.5 -64.22 0.38 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.63 2.372 . . . . 0.0 113.92 170.438 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 22' ' ' ARG . 2.3 m 33.87 65.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.658 1.983 . . . . 0.0 113.984 162.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.28 -174.8 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.015 1.726 . . . . 0.0 110.614 175.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.59 169.55 21.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.386 1.874 . . . . 0.0 108.232 -172.039 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.94 166.43 26.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 170.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.26 -35.95 80.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.14 0.976 . . . . 0.0 111.33 176.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.17 176.16 3.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.927 2.091 . . . . 0.0 107.615 -169.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.62 -36.22 58.57 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.9 -51.72 69.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 120.396 2.098 . . . . 0.0 107.718 177.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.84 -35.28 77.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.963 0.505 . . . . 0.0 111.02 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.66 -47.68 79.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -42.9 80.25 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.777 0.673 . . . . 0.0 111.453 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.56 -46.86 85.98 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.453 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -55.84 -45.72 78.35 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.226 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 72' ' ' ILE . 8.9 mt -57.34 -38.55 74.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.846 1.203 . . . . 0.0 110.262 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -72.34 27.21 0.05 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.867 1.267 . . . . 0.0 113.951 173.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.65 -8.61 16.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.901 1.28 . . . . 0.0 111.313 158.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.22 169.68 4.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.075 1.321 . . . . 0.0 112.808 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.4 -1.92 17.81 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.633 -0.922 . . . . 0.0 113.21 -177.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.53 112.06 3.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 166.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.58 -9.56 71.86 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.334 171.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.8 145.09 21.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.815 1.308 . . . . 0.0 111.238 -166.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.687 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -136.86 111.42 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.42 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -114.35 136.22 51.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -146.48 162.52 38.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.109 0.413 . . . . 0.0 111.183 171.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 21.8 t70 -75.96 -167.73 0.78 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 158.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.457 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 10.2 t-105 -114.06 -52.84 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.405 2.282 . . . . 0.0 110.857 -175.197 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 86.58 0.15 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.531 2.332 . . . . 0.0 110.33 -167.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -142.99 153.12 60.13 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 124.916 1.287 . . . . 0.0 109.183 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -78.0 -179.22 5.24 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.481 2.12 . . . . 0.0 108.301 165.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 54.9 -94.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.29 1.836 . . . . 0.0 109.983 176.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.0 tpp -91.38 80.7 5.48 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.85 149.72 4.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 159.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.64 -27.62 61.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.284 -0.885 . . . . 0.0 113.34 -169.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -34.39 68.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.644 1.222 . . . . 0.0 110.513 176.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -66.06 -42.49 89.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.546 172.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.84 -50.04 75.47 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -51.71 -61.97 1.92 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.611 1.164 . . . . 0.0 109.199 173.848 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.54 -34.24 77.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.677 1.126 . . . . 0.0 112.522 -172.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.4 m -59.04 -48.38 81.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD11 HD11 ' A' ' 46' ' ' LEU . 30.5 mt -64.09 -48.7 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.412 1.085 . . . . 0.0 109.112 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -29.0 67.64 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.55 -171.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 124.463 1.105 . . . . 0.0 112.214 -175.865 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.1 p -60.64 -22.04 63.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.786 0.834 . . . . 0.0 112.728 -174.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.68 -3.38 59.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.159 1.384 . . . . 0.0 113.553 174.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 54' ' ' VAL . 30.6 mt -68.33 130.47 92.28 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 119.911 1.232 . . . . 0.0 109.1 178.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.44 98.0 0.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 108.67 164.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -78.87 107.1 10.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.591 1.557 . . . . 0.0 107.742 164.85 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.15 116.45 31.95 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.092 1.357 . . . . 0.0 107.873 -176.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.0 mtp -88.11 120.19 29.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -130.42 105.19 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -171.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -146.67 173.72 12.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.805 0.812 . . . . 0.0 110.923 -167.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.71 -19.72 20.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.484 0.713 . . . . 0.0 112.107 175.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -90.11 139.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.939 0.79 . . . . 0.0 109.737 -177.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.09 -59.71 2.66 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 tptt 45.99 80.92 0.04 OUTLIER 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.775 1.63 . . . . 0.0 109.558 173.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -54.91 -35.04 63.72 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.845 -167.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 96' ' ' ILE . 6.2 mt-10 -65.64 -29.98 70.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.742 1.61 . . . . 0.0 113.385 174.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -65.47 -42.51 92.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 120.044 1.293 . . . . 0.0 109.412 167.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.1 mt -62.98 -52.25 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.868 0.758 . . . . 0.0 109.584 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' GLU 0.252 1.7 mt -54.6 -46.85 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 117.273 -1.346 . . . . 0.0 113.489 169.733 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.1 82.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.003 1.274 . . . . 0.0 110.472 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.6 -48.48 77.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.73 0.812 . . . . 0.0 110.918 175.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -22.86 63.09 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.84 -0.538 . . . . 0.0 112.394 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -77.15 -53.76 7.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.924 2.09 . . . . 0.0 108.772 171.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.35 -26.79 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.154 1.382 . . . . 0.0 112.659 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.56 34.3 5.05 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 124.677 1.132 . . . . 0.0 113.291 173.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.83 151.62 29.36 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.662 1.231 . . . . 0.0 110.576 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.7 p -77.08 -14.22 59.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.83 171.69 37.1 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 172.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -134.23 127.87 32.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.12 96.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 175.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.19 149.15 8.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 160.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -55.52 163.2 1.97 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 122.654 0.382 . . . . 0.0 110.45 160.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.08 137.06 47.44 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 -14.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -133.86 154.7 50.86 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.287 0.635 . . . . 0.0 110.567 -175.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 p -145.23 176.69 9.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.189 1.795 . . . . 0.0 109.367 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.68 -29.82 68.34 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.039 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.46 80.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.143 0.977 . . . . 0.0 112.475 175.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.08 -29.92 26.43 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.962 0.801 . . . . 0.0 110.291 175.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -55.92 25.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -27.33 69.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.216 0.606 . . . . 0.0 112.184 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.87 -43.8 87.27 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.607 -0.683 . . . . 0.0 110.255 172.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -66.66 -35.12 79.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.781 173.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.33 -53.09 61.74 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.556 1.071 . . . . 0.0 109.182 177.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.61 -34.44 72.77 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.204 0.457 . . . . 0.0 111.119 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -69.77 0.11 Allowed 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.112 0.965 . . . . 0.0 109.64 168.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 pt -74.12 -26.9 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 118.729 0.695 . . . . 0.0 112.444 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -58.75 -56.76 18.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -81.69 -38.01 26.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.585 -174.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -67.49 -74.51 0.11 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.59 1.156 . . . . 0.0 109.12 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.46 -31.34 72.37 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.218 0.463 . . . . 0.0 110.152 -175.069 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.84 37.64 8.44 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -165.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 C--O 1.248 1.006 0 CA-C-N 118.592 1.196 . . . . 0.0 109.104 164.888 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 134.06 34.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -95.53 98.75 10.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -76.74 140.06 40.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.52 115.52 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.33 1.052 . . . . 0.0 108.984 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.43 55.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.743 1.156 . . . . 0.0 109.928 -173.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.84 152.74 45.02 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.954 -1.092 . . . . 0.0 109.598 170.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.38 -47.63 17.23 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.413 1.085 . . . . 0.0 110.973 -173.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 6.3 t80 -77.84 117.28 19.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -56.07 -44.17 78.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.971 0.805 . . . . 0.0 110.637 -173.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 28.2 m -59.38 -38.32 80.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.028 -1.045 . . . . 0.0 111.283 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.14 -39.46 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.309 1.413 . . . . 0.0 110.121 171.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -65.67 -41.27 92.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.879 0.763 . . . . 0.0 109.872 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -46.26 88.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.504 174.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.58 -59.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 117.137 -1.411 . . . . 0.0 109.5 177.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.16 -52.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.87 1.668 . . . . 0.0 110.142 -177.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -61.63 -35.8 78.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.713 -0.617 . . . . 0.0 111.341 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -64.78 -44.47 89.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.709 1.141 . . . . 0.0 110.954 173.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.03 -38.7 92.24 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.503 1.121 . . . . 0.0 110.334 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.6 -45.22 94.82 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.021 0.928 . . . . 0.0 110.691 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -64.06 -28.01 69.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.77 -0.581 . . . . 0.0 111.417 174.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.33 -8.44 53.74 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.16 -1.587 . . . . 0.0 111.894 172.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.74 7.67 10.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.151 1.781 . . . . 0.0 112.025 -175.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 47.7 7.8 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 174.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.61 109.21 10.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.99 -7.8 8.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -78.52 49.2 0.84 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 166.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 33' ' ' VAL . 3.2 m -80.54 159.59 4.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.738 -1.226 . . . . 0.0 109.115 176.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.59 169.01 19.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.598 1.959 . . . . 0.0 107.401 167.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -132.71 166.27 22.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.85 168.82 18.82 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.527 0.731 . . . . 0.0 109.147 173.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.83 -33.13 57.96 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.91 178.09 1.0 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.916 2.486 . . . . 0.0 108.565 -177.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -50.68 -38.22 35.84 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.56 176.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 120.047 1.924 . . . . 0.0 108.433 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 32.7 t0 -65.56 -37.51 86.9 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.222 -0.299 . . . . 0.0 110.448 174.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.71 72.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.24 -43.2 74.38 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.672 0.789 . . . . 0.0 110.195 175.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.47 -24.31 65.59 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 3.4 mptp? -66.17 -54.57 23.71 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.595 1.089 . . . . 0.0 108.43 165.057 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 72' ' ' ILE . 2.7 mt -55.23 -48.0 74.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.623 0.647 . . . . 0.0 110.089 -169.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.63 0.82 28.56 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.07 -20.84 31.96 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.883 1.22 . . . . 0.0 111.71 163.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.07 154.49 24.58 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.059 1.314 . . . . 0.0 113.778 166.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.47 -13.77 65.66 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.283 2.373 . . . . 0.0 113.729 175.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.49 124.48 27.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.585 1.193 . . . . 0.0 107.975 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.77 -2.14 9.58 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.25 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.69 137.85 35.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.857 1.328 . . . . 0.0 108.438 173.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -130.91 80.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -171.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.19 125.96 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 p -145.87 165.15 29.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.507 0.594 . . . . 0.0 110.973 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.83 179.7 0.83 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.231 1.015 . . . . 0.0 110.284 161.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.622 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 3.5 t-105 -89.68 -49.96 6.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.948 157.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.08 137.53 47.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.107 0.867 . . . . 0.0 109.735 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.439 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -147.21 167.45 13.55 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 124.112 0.965 . . . . 0.0 109.064 168.862 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.25 -23.01 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.226 1.95 . . . . 0.0 112.951 172.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -139.14 -83.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.421 1.464 . . . . 0.0 111.121 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.7 ttm -78.08 96.23 5.08 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.11 161.15 9.01 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.328 1.018 . . . . 0.0 110.32 170.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.44 -30.03 73.25 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.599 0.619 . . . . 0.0 112.842 -172.529 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.622 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -72.37 -39.56 67.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.355 1.077 . . . . 0.0 109.799 177.482 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.6 -37.29 84.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.405 173.405 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.42 -54.08 50.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.896 1.225 . . . . 0.0 109.678 174.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 83' ' ' VAL . 3.4 tp -51.48 -51.8 52.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.401 1.08 . . . . 0.0 110.677 173.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -68.43 -25.07 64.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.174 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m -71.36 -50.3 33.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 46' ' ' LEU . 30.7 mt -58.4 -32.1 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.444 1.498 . . . . 0.0 108.596 -177.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -58.88 -20.2 49.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.761 1.624 . . . . 0.0 112.78 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.738 0 C-N-CA 127.262 2.225 . . . . 0.0 110.968 -161.902 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.625 ' HB3' HD12 ' A' ' 81' ' ' LEU . 23.2 mmt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 117.69 -1.147 . . . . 0.0 113.208 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -56.94 -26.14 58.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.799 1.636 . . . . 0.0 113.797 -165.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.79 65.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.954 0.902 . . . . 0.0 113.348 177.555 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 54' ' ' VAL . 13.2 mt -56.46 138.59 75.5 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.523 1.129 . . . . 0.0 111.022 -172.248 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.8 100.25 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.829 2.353 . . . . 0.0 108.379 169.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -92.72 111.86 25.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 125.898 1.679 . . . . 0.0 106.586 174.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.4 tp -120.5 112.1 18.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.066 0.946 . . . . 0.0 108.836 -168.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.87 117.54 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.86 104.19 9.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -149.05 174.08 12.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.819 0.819 . . . . 0.0 109.74 -164.154 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.63 -14.04 41.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.121 -0.987 . . . . 0.0 112.19 162.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.75 96.51 6.29 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.203 1.401 . . . . 0.0 108.215 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.38 -92.07 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 162.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 51.15 101.41 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.692 1.997 . . . . 0.0 111.108 -174.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -41.14 -47.06 3.18 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.338 -0.851 . . . . 0.0 111.745 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -61.79 -34.98 76.86 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.67 -43.32 93.95 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 172.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.63 -45.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.755 174.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 mt -58.85 -56.78 14.54 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.249 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.76 -41.24 70.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.321 1.419 . . . . 0.0 110.822 -174.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -57.76 -53.77 54.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.738 0.815 . . . . 0.0 110.249 173.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.58 83.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.26 0.624 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -56.37 21.51 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.824 1.65 . . . . 0.0 109.71 178.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.72 -21.45 64.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.684 0.794 . . . . 0.0 112.2 178.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.68 33.61 6.65 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-O 118.628 -1.096 . . . . 0.0 111.785 175.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.93 148.98 41.86 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.468 1.134 . . . . 0.0 108.904 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -83.61 -6.69 59.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -172.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.17 175.22 35.64 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 119.082 0.855 . . . . 0.0 111.842 173.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.16 150.26 46.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.038 1.335 . . . . 0.0 108.847 -177.046 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.87 138.77 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 128.396 2.678 . . . . 0.0 104.846 166.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -118.59 143.39 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 156.92 14.45 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.803 170.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.82 154.32 97.75 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 N-CA-C 109.772 -0.895 . . . . 0.0 109.772 -16.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -158.75 160.54 36.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.561 0.744 . . . . 0.0 109.345 -169.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -147.49 -179.56 6.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.955 0.502 . . . . 0.0 110.429 -171.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.85 67.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.348 0.659 . . . . 0.0 109.438 176.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.28 -17.92 64.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 174.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 t -95.64 -37.83 10.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 121.407 1.912 . . . . 0.0 109.752 164.104 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -51.78 60.63 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -34.3 77.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.237 1.415 . . . . 0.0 112.455 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -71.43 -40.86 70.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 17.6 mmtp -65.3 -39.74 92.91 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 174.314 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.6 mt -54.96 -57.48 11.5 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -56.97 -33.77 67.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 24.9 mttm -56.71 -68.72 0.19 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 117.86 -1.067 . . . . 0.0 108.834 170.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -24.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 120.683 1.583 . . . . 0.0 113.339 -171.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -59.37 -49.19 78.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.98 1.312 . . . . 0.0 111.098 171.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.59 -54.84 5.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.611 0.642 . . . . 0.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.21 5.34 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.616 1.566 . . . . 0.0 108.561 -164.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -72.28 -54.14 10.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.35 15.87 2.96 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.682 -1.066 . . . . 0.0 112.347 -171.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.9 mmm . . . . . 0 C--O 1.247 0.921 0 CA-C-N 118.617 1.208 . . . . 0.0 111.495 -163.683 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -90.6 143.64 26.54 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.169 0.918 . . . . 0.0 110.387 -162.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -111.39 100.66 9.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.584 1.154 . . . . 0.0 109.087 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -74.08 142.83 45.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.981 0.81 . . . . 0.0 109.383 175.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.44 99.61 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.761 1.625 . . . . 0.0 107.219 170.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.74 87.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -91.62 109.2 20.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.656 1.182 . . . . 0.0 112.174 -162.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.91 -24.06 59.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -120.33 -7.09 9.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -158.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 m 68.46 -58.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 128.042 2.537 . . . . 0.0 110.263 -173.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.0 m -55.56 -24.9 35.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.47 1.508 . . . . 0.0 111.16 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.4 tpp -64.82 -37.56 88.01 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.929 1.695 . . . . 0.0 109.934 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -77.34 -33.07 55.5 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 121.126 1.785 . . . . 0.0 109.538 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -52.17 -58.06 7.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.842 1.201 . . . . 0.0 108.579 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.66 -67.75 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.509 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.32 -41.71 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 120.444 1.474 . . . . 0.0 110.392 -169.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -48.19 82.76 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 119.651 1.114 . . . . 0.0 109.445 174.642 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.59 -48.53 74.69 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.385 175.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.37 -43.14 96.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.024 0.829 . . . . 0.0 110.67 -176.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.76 -44.99 95.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.298 1.039 . . . . 0.0 110.104 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -63.87 -29.4 70.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.152 -1.404 . . . . 0.0 112.546 177.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.9 -62.36 1.93 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.061 1.3 . . . . 0.0 108.373 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.07 2.34 1.51 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.65 -108.62 3.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -151.38 175.95 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.314 2.246 . . . . 0.0 107.255 -164.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -138.09 -178.57 5.33 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.06 0.846 . . . . 0.0 112.085 -169.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 m120 59.72 75.91 0.38 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.953 2.901 . . . . 0.0 109.717 -167.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.18 166.17 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.041 168.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -135.5 174.24 10.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 156.05 42.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.257 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.77 151.38 40.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 163.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.36 -30.49 66.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.634 0.584 . . . . 0.0 111.211 176.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.28 156.91 14.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -161.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.97 -42.46 30.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.23 0.919 . . . . 0.0 114.381 171.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.96 -37.6 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 120.2 2.0 . . . . 0.0 109.438 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.22 -43.95 96.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.526 0.731 . . . . 0.0 109.47 171.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.48 80.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.693 1.597 . . . . 0.0 110.324 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.71 -43.24 72.39 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.717 0.636 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.17 -37.18 86.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.315 0.646 . . . . 0.0 110.985 176.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -57.42 -45.06 85.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.028 1.286 . . . . 0.0 110.043 170.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 72' ' ' ILE . 5.7 mt -58.69 -51.45 69.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -78.8 16.76 0.81 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.66 62.13 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.521 -1.362 . . . . 0.0 110.048 159.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.73 -88.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -175.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.74 86.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -173.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -64.81 166.68 8.61 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.008 1.323 . . . . 0.0 110.736 172.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.47 -20.0 10.71 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.561 -1.133 . . . . 0.0 113.37 172.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -146.49 142.4 28.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.72 1.208 . . . . 0.0 109.702 -174.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.47 70.02 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -177.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -78.59 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 155.65 44.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.252 0.933 . . . . 0.0 110.19 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.9 176.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 158.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 98' ' ' ALA . 4.4 t-105 -96.18 -60.57 1.6 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.215 1.006 . . . . 0.0 108.78 170.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.26 74.92 9.99 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.458 0.703 . . . . 0.0 109.868 -159.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.1 mmt -107.4 162.31 20.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.245 1.818 . . . . 0.0 109.942 175.136 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -69.94 177.77 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.375 2.717 . . . . 0.0 112.062 173.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 44.8 -110.8 0.21 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.062 2.145 . . . . 0.0 110.944 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.51 85.73 6.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.024 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -54.5 173.68 0.07 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.518 1.927 . . . . 0.0 112.498 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -27.91 60.58 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.143 -0.973 . . . . 0.0 113.423 -173.033 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -82.17 -35.77 28.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.186 0.993 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -67.15 -42.08 84.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.852 169.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.1 tp -50.82 -52.65 39.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.532 1.533 . . . . 0.0 109.301 172.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.0 -58.72 6.04 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.239 0.616 . . . . 0.0 109.794 173.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.33 -35.62 77.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.479 1.036 . . . . 0.0 111.552 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.1 m -58.04 -48.44 80.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.29 1.036 . . . . 0.0 108.843 175.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.479 HD11 HD11 ' A' ' 46' ' ' LEU . 29.6 mt -63.92 -51.42 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.44 66.85 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.226 1.81 . . . . 0.0 112.535 -176.239 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.358 0 C-N-CA 125.311 1.444 . . . . 0.0 112.415 178.475 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -10.06 2.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.738 1.615 . . . . 0.0 114.273 -177.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.017 1.281 . . . . 0.0 112.757 170.015 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 54' ' ' VAL . 33.6 mt -70.41 129.94 89.75 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 123.447 0.699 . . . . 0.0 110.978 -170.088 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.77 107.8 2.13 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.81 2.34 . . . . 0.0 108.859 163.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.96 140.08 16.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.28 111.14 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 -171.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 126.64 31.14 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.06 93.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -138.63 -174.28 3.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.869 0.868 . . . . 0.0 109.902 -166.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.8 -16.77 14.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.699 1.2 . . . . 0.0 112.851 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.25 117.27 28.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.339 1.056 . . . . 0.0 109.276 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.29 -81.73 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 tptt 54.11 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.236 1.814 . . . . 0.0 111.317 -176.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -50.28 -43.34 53.33 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.405 -1.434 . . . . 0.0 112.03 178.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -52.11 -35.43 48.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.953 0.901 . . . . 0.0 112.125 176.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -78.62 -37.86 41.24 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.838 1.255 . . . . 0.0 110.536 176.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.22 -50.75 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.966 1.257 . . . . 0.0 109.138 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.327 1.9 mt -51.3 -54.47 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.916 166.035 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.41 -44.11 72.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 121.086 1.766 . . . . 0.0 112.112 -178.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -59.05 -55.48 34.53 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 118.935 0.789 . . . . 0.0 110.448 174.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -27.89 69.25 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -71.78 -53.63 12.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.333 1.853 . . . . 0.0 109.665 174.383 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.27 -24.53 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.179 0.992 . . . . 0.0 112.18 176.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.82 34.79 6.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.756 1.17 . . . . 0.0 111.851 176.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -63.05 145.02 56.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 118.43 1.115 . . . . 0.0 108.092 177.409 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 p -76.01 -12.98 60.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.306 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.6 171.86 40.69 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.273 0.939 . . . . 0.0 111.075 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.26 134.71 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.53 1.532 . . . . 0.0 107.723 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.55 140.26 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 127.734 2.414 . . . . 0.0 106.96 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.99 145.31 28.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 145.59 89.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.963 0.801 . . . . 0.0 110.318 168.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 136.58 43.38 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 119.68 0.922 . . . . 0.0 111.139 -6.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -141.4 155.56 45.88 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 110.781 175.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -151.39 -178.29 6.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.494 1.118 . . . . 0.0 111.527 -171.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.06 -28.75 64.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.789 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.51 64.16 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 174.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 t -97.38 -30.58 12.85 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.208 0.913 . . . . 0.0 110.289 171.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -52.85 -53.19 52.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.459 1.027 . . . . 0.0 108.869 177.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.69 -35.23 74.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.754 1.222 . . . . 0.0 111.675 178.511 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -74.58 -41.61 60.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.477 -0.765 . . . . 0.0 109.672 -176.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -64.2 -39.34 93.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.805 176.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.5 mt -55.08 -58.34 8.05 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -55.68 -38.33 69.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.366 0.667 . . . . 0.0 112.331 -178.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -64.28 0.9 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.711 172.626 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.05 -29.59 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.184 1.356 . . . . 0.0 113.282 -173.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -56.88 -52.65 64.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.632 0.773 . . . . 0.0 109.026 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -73.39 -46.09 50.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.935 0.334 . . . . 0.0 111.287 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -69.27 -73.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.62 -23.64 64.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.02 0.528 . . . . 0.0 110.969 -175.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.33 31.42 19.48 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -166.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 116.491 -1.719 . . . . 0.0 110.457 -175.7 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--O 1.231 0.117 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -90.69 132.96 35.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.87 138.53 38.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 163.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.12 140.04 37.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.214 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.65 103.19 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.032 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.13 60.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.37 1.068 . . . . 0.0 108.816 -178.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 7.3 p-10 -82.76 146.23 29.1 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.357 -1.465 . . . . 0.0 110.746 169.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -67.15 -58.66 4.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.064 1.346 . . . . 0.0 110.03 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -83.87 83.23 8.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.231 -174.621 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 t -40.08 -27.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.49 2.316 . . . . 0.0 115.847 -166.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 m -43.52 -47.66 7.28 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 119.887 -1.758 . . . . 0.0 111.804 164.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -37.61 46.4 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 0.0 111.016 172.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -66.26 -44.02 84.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.4 1.454 . . . . 0.0 109.549 -178.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -58.08 9.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.497 1.119 . . . . 0.0 108.364 172.135 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.11 -61.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 124.509 1.124 . . . . 0.0 108.978 -176.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.5 t -54.82 -43.72 68.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 119.758 1.163 . . . . 0.0 110.452 -175.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -60.34 -48.2 82.76 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.204 1.365 . . . . 0.0 109.689 175.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.27 -42.72 91.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.205 1.002 . . . . 0.0 111.047 -178.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 113' ' ' ALA . 84.8 mt -63.76 -41.22 98.03 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.999 0.92 . . . . 0.0 110.067 175.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.04 -29.6 70.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.045 0.839 . . . . 0.0 111.405 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -73.53 -28.77 62.06 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.857 -1.152 . . . . 0.0 111.636 173.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.58 -48.98 67.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.28 0.946 . . . . 0.0 109.735 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.02 95.12 1.37 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 123.288 1.518 . . . . 0.0 108.375 -174.742 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -132.18 3.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.244 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -131.77 165.75 23.08 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.832 0.853 . . . . 0.0 111.883 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.34 -174.49 2.54 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.921 1.688 . . . . 0.0 110.195 173.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.46 81.63 0.15 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.464 2.306 . . . . 0.0 109.59 -175.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 146.33 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.64 176.15 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.576 1.551 . . . . 0.0 109.754 -177.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -131.47 166.36 21.51 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.143 0.977 . . . . 0.0 108.888 173.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.94 172.2 9.59 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 160.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.07 -41.09 82.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 174.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -170.94 177.17 3.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.793 2.037 . . . . 0.0 108.19 -169.321 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.39 -37.09 72.43 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.944 0.783 . . . . 0.0 113.111 -178.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -63.42 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 O-C-N 121.724 -0.868 . . . . 0.0 108.91 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.53 -29.31 64.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.523 174.471 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.57 85.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.726 1.21 . . . . 0.0 109.83 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 tp -58.26 -41.24 83.83 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.255 0.479 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -40.61 96.03 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.364 175.589 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -53.64 -54.94 30.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.996 172.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 72' ' ' ILE . 7.4 mt -57.76 -40.54 79.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.777 1.171 . . . . 0.0 110.89 -174.594 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -65.17 -19.56 66.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.55 6.03 34.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.265 1.826 . . . . 0.0 113.907 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.69 175.06 45.45 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 119.167 -1.492 . . . . 0.0 116.736 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.84 4.99 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.473 1.511 . . . . 0.0 109.968 177.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -75.96 72.27 2.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.462 1.505 . . . . 0.0 107.099 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.47 -4.29 37.37 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.405 1.002 . . . . 0.0 113.454 -172.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.79 136.5 48.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.089 1.355 . . . . 0.0 108.263 170.079 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.752 HG21 HD13 ' A' ' 81' ' ' LEU . 5.0 t -127.21 64.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.495 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.03 139.16 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.4 p -152.01 167.58 27.95 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.956 -0.465 . . . . 0.0 110.722 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 10.6 t70 -67.89 169.46 9.8 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 158.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CH2' HD23 ' A' ' 66' ' ' LEU . 68.1 t-105 -55.72 -64.45 0.85 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.824 -1.173 . . . . 0.0 107.87 163.324 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.86 165.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.79 2.436 . . . . 0.0 112.431 -166.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.1 75.73 12.7 Favored Pre-proline 0 N--CA 1.45 -0.455 0 O-C-N 119.63 -1.919 . . . . 0.0 107.497 167.322 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.07 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.895 2.397 . . . . 0.0 110.419 176.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -165.17 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 129.986 3.314 . . . . 0.0 104.102 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.2 ttp -72.98 89.19 1.41 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 160.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.78 168.8 4.62 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.11 0.964 . . . . 0.0 110.666 164.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.6 -19.76 60.77 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.677 -176.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -77.37 -49.0 15.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.256 1.528 . . . . 0.0 108.722 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.94 0.496 . . . . 0.0 110.551 174.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -56.14 -53.05 61.77 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.087 0.955 . . . . 0.0 109.306 175.263 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.4 tp -54.03 -55.79 24.0 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 110.574 175.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 72.4 mttt -63.96 -36.99 85.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.636 1.562 . . . . 0.0 112.301 -174.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.7 m -61.44 -39.25 90.13 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 109.718 175.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 46' ' ' LEU . 32.2 mt -71.17 -47.84 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.21 68.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.752 1.621 . . . . 0.0 111.449 -178.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.302 0 O-C-N 121.36 -0.837 . . . . 0.0 112.77 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HD12 ' A' ' 81' ' ' LEU . 56.3 mtt . . . . . 0 C--O 1.226 -0.175 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -59.03 -20.42 52.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.769 1.168 . . . . 0.0 112.227 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.76 60.01 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 54' ' ' VAL . 48.7 mt -68.6 138.46 91.04 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.914 1.234 . . . . 0.0 110.5 -170.695 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 82.71 1.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.564 2.176 . . . . 0.0 108.726 166.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 69' ' ' LEU . 1.8 m -65.54 108.83 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 159.552 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 tp -130.83 105.97 8.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -160.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.6 mmt -78.69 120.9 24.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -174.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.63 87.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.475 ' HB ' ' H ' ' A' ' 58' ' ' TRP . 3.8 t -129.19 170.52 13.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.601 0.715 . . . . 0.0 112.924 -159.092 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.11 57.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.789 0.835 . . . . 0.0 112.822 161.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.54 98.34 2.28 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.851 1.26 . . . . 0.0 111.424 -167.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.18 23.16 0.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.968 -1.083 . . . . 0.0 111.306 163.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -70.93 104.25 2.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.437 -1.414 . . . . 0.0 107.792 -174.73 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -31.93 -65.49 0.14 Allowed 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 125.716 1.606 . . . . 0.0 111.974 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.74 -29.17 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.743 -172.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -62.42 -46.29 89.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.392 0.996 . . . . 0.0 109.436 171.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.33 -46.4 95.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.55 -57.23 9.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' C ' HD21 ' A' ' 66' ' ' LEU . . . -56.56 -40.05 74.51 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.908 0.777 . . . . 0.0 111.215 -172.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.73 -52.16 53.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.572 1.149 . . . . 0.0 110.436 176.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 177.251 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -62.38 -50.92 69.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 111.345 177.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.39 61.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.482 1.113 . . . . 0.0 112.892 178.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.33 30.76 9.6 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.356 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.727 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.67 146.79 44.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.93 1.365 . . . . 0.0 108.135 175.598 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.1 p -70.39 -8.37 50.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.004 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.32 165.84 20.03 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -140.22 85.53 2.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.078 0.951 . . . . 0.0 109.755 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -85.21 141.29 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 169.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.19 157.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 171.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -56.22 137.32 74.64 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.657 159.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.3 159.47 97.64 Favored 'Cis proline' 0 C--N 1.348 0.503 0 CA-C-N 121.166 1.452 . . . . 0.0 112.327 -6.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -177.75 155.09 0.99 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.264 1.025 . . . . 0.0 109.909 -174.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -150.35 -174.02 4.62 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.6 1.16 . . . . 0.0 112.076 -168.253 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.484 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -54.04 -35.83 62.4 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.525 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -47.22 -30.79 3.21 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.006 2.122 . . . . 0.0 115.074 174.048 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.428 HG23 ' HE2' ' A' ' 119' ' ' LYS . 1.2 t -111.21 -19.79 12.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.968 0.507 . . . . 0.0 110.939 176.417 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.33 -55.94 25.71 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.738 -1.226 . . . . 0.0 108.226 167.521 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -44.84 79.07 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.909 1.283 . . . . 0.0 111.684 178.341 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -38.64 76.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.443 -0.785 . . . . 0.0 110.807 -177.481 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HE2' HG23 ' A' ' 115' ' ' THR . 46.2 mtmt -61.99 -39.25 91.56 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.151 -0.968 . . . . 0.0 110.3 173.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.12 -51.25 70.85 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.419 172.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.7 -36.53 72.1 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.097 1.317 . . . . 0.0 112.36 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -69.8 0.11 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.32 1.448 . . . . 0.0 108.382 169.438 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -22.29 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -171.05 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.49 -45.59 86.66 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.152 0.981 . . . . 0.0 109.679 174.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.19 -39.26 25.74 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.333 0.969 . . . . 0.0 110.979 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -74.59 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -171.079 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.84 -37.83 88.37 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.23 44.42 4.08 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -163.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.728 -1.129 . . . . 0.0 111.372 -175.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.54 143.18 30.35 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.139 -163.111 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.58 95.5 5.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 34' ' ' GLU . 21.5 tp -69.83 135.89 50.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.887 1.221 . . . . 0.0 108.464 174.51 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.32 114.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.194 1.398 . . . . 0.0 108.331 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.44 64.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 124.912 1.285 . . . . 0.0 108.032 -173.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.44 156.74 29.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.62 -51.92 66.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 108.766 170.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.44 108.64 19.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -51.33 -42.68 61.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.213 178.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -50.97 -45.77 61.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.181 1.355 . . . . 0.0 111.625 172.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.2 ttm -62.59 -25.19 67.95 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.701 0.801 . . . . 0.0 111.572 -178.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -68.8 -39.03 80.33 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.44 -1.413 . . . . 0.0 110.56 170.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -66.48 -36.59 83.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.16 178.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -47.06 -49.32 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.294 1.406 . . . . 0.0 110.883 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -57.0 -46.96 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.444 0.698 . . . . 0.0 110.74 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.4 -40.36 94.12 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.394 0.678 . . . . 0.0 111.131 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.55 -38.67 87.61 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.854 -0.529 . . . . 0.0 110.375 177.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.2 -26.71 67.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.366 0.53 . . . . 0.0 111.613 172.395 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -73.05 -38.28 66.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.736 1.153 . . . . 0.0 110.839 169.061 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.45 -36.7 85.01 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.339 0.972 . . . . 0.0 111.244 176.643 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -166.62 99.71 0.58 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.214 2.205 . . . . 0.0 108.81 177.268 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.2 -113.37 0.54 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.71 171.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -145.08 -176.97 5.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.101 1.76 . . . . 0.0 109.484 -162.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -133.92 -176.12 4.07 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.386 1.474 . . . . 0.0 109.932 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 54.5 63.65 2.08 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.836 1.654 . . . . 0.0 110.548 -171.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.11 160.29 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.485 165.506 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' HB3' HD12 ' A' ' 9' ' ' LEU . 2.9 tp10 -133.03 173.08 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.63 2.372 . . . . 0.0 106.106 175.449 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -139.2 166.88 23.38 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.95 169.39 17.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.97 1.308 . . . . 0.0 109.133 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.24 -40.63 77.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.549 0.74 . . . . 0.0 109.745 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -178.44 179.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.506 2.322 . . . . 0.0 108.426 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.65 -41.99 10.13 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.85 1.69 . . . . 0.0 115.432 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.85 -47.25 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.147 1.473 . . . . 0.0 108.642 179.172 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -67.98 -32.34 72.67 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 175.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.1 -43.21 91.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.792 -1.193 . . . . 0.0 110.071 177.126 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.702 0.683 . . . . 0.0 111.076 173.566 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.07 -43.37 77.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.919 0.887 . . . . 0.0 111.471 178.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -63.36 -52.77 60.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -55.2 -53.06 60.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.594 1.158 . . . . 0.0 112.565 -172.723 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.32 -1.69 3.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 112.257 -177.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.3 25.32 7.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.176 2.19 . . . . 0.0 111.412 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.64 168.43 38.23 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 121.107 1.776 . . . . 0.0 114.023 169.125 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.95 53.66 1.39 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 124.773 1.178 . . . . 0.0 110.355 -178.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -62.01 142.49 57.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.443 1.097 . . . . 0.0 110.117 -177.056 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.05 -29.76 9.44 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 119.491 -0.616 . . . . 0.0 111.689 173.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -138.19 149.07 45.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.384 1.074 . . . . 0.0 109.431 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG21 HD13 ' A' ' 81' ' ' LEU . 16.5 t -137.17 108.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.65 136.38 58.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.52 153.5 38.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.724 0.238 . . . . 0.0 110.931 -159.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -64.86 170.82 3.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.926 0.87 . . . . 0.0 111.194 163.131 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 42.0 t-105 -83.47 -76.46 0.28 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 160.145 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.97 -170.42 0.08 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.01 1.324 . . . . 0.0 110.999 176.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.3 ttp -162.89 75.67 1.96 Allowed Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 158.573 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.48 -71.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.117 2.545 . . . . 0.0 107.935 175.36 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -131.96 -67.97 0.65 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.231 1.412 . . . . 0.0 107.737 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 ttm -91.09 104.75 17.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.403 2.281 . . . . 0.0 107.614 161.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.73 171.44 5.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.513 0.597 . . . . 0.0 110.73 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.67 69.19 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.749 -0.594 . . . . 0.0 112.364 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.598 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.25 -40.94 74.12 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.998 0.899 . . . . 0.0 109.782 178.437 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.79 -32.3 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.886 1.274 . . . . 0.0 111.005 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -58.48 -55.54 33.78 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.42 -57.16 11.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.41 1.084 . . . . 0.0 109.491 174.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.8 -21.38 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.973 1.26 . . . . 0.0 113.83 -173.151 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -61.37 -64.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 163.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.0 mt -56.48 -36.6 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.917 1.287 . . . . 0.0 110.6 -174.512 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -22.54 61.86 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.446 1.899 . . . . 0.0 113.519 -177.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.339 0 CA-C-N 119.104 0.866 . . . . 0.0 111.385 -178.756 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.3 p -63.53 -18.28 63.67 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.42 1.009 . . . . 0.0 113.314 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.17 52.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.404 1.482 . . . . 0.0 113.277 172.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.591 HD13 HG21 ' A' ' 54' ' ' VAL . 24.9 mt -73.79 147.22 86.37 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 111.345 -175.126 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.55 56.36 1.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.605 2.87 . . . . 0.0 111.085 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG2' HD13 ' A' ' 69' ' ' LEU . 1.1 m -53.28 113.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 119.081 0.855 . . . . 0.0 110.242 176.58 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.7 122.97 48.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.589 1.156 . . . . 0.0 108.674 -169.482 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mmt -80.99 128.29 33.53 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 174.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.26 108.44 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -152.06 165.6 34.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.969 0.89 . . . . 0.0 112.017 -166.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.82 60.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.45 -0.781 . . . . 0.0 111.433 161.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.97 96.87 10.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.249 1.419 . . . . 0.0 109.414 -163.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -73.92 0.07 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.265 1.026 . . . . 0.0 110.781 177.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.5 tttt 39.25 93.37 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 127.151 2.18 . . . . 0.0 112.537 -175.08 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -44.29 -40.85 5.54 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.711 176.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.31 -45.28 76.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.3 0.955 . . . . 0.0 112.992 176.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.17 -37.71 81.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.329 1.452 . . . . 0.0 109.557 176.316 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.4 mt -64.52 -41.84 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.332 176.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -59.71 -48.38 87.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-N 120.61 1.55 . . . . 0.0 108.076 171.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.19 -43.8 74.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.089 1.313 . . . . 0.0 111.443 -177.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.87 85.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.859 0.464 . . . . 0.0 110.38 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.51 83.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.295 0.638 . . . . 0.0 112.105 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -64.51 -45.12 88.6 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.131 1.772 . . . . 0.0 110.721 174.16 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.78 -6.16 39.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.444 0.697 . . . . 0.0 112.298 170.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.03 64.84 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.351 -1.468 . . . . 0.0 113.049 172.426 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -51.88 160.21 0.73 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.465 1.106 . . . . 0.0 110.214 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -63.36 -30.7 71.79 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.361 -0.837 . . . . 0.0 111.575 176.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.46 -174.98 46.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 178.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -139.65 94.94 2.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 107.748 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.414 HG22 ' HE3' ' A' ' 119' ' ' LYS . 75.2 t -77.76 133.22 30.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.291 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 150.05 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -55.52 168.38 0.62 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 173.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.61 94.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.545 0 N-CA-C 107.442 -1.791 . . . . 0.0 107.442 -20.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -81.77 158.74 24.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.909 0.861 . . . . 0.0 111.613 -165.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.7 p -146.89 -179.05 6.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.589 1.556 . . . . 0.0 109.623 -172.63 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -34.14 65.67 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 110.046 176.834 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.18 58.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.819 0.848 . . . . 0.0 113.229 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -34.88 7.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.249 0.932 . . . . 0.0 110.506 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.04 -47.54 68.33 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.962 1.305 . . . . 0.0 108.995 176.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.01 74.57 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.411 1.084 . . . . 0.0 112.207 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.11 -44.11 89.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.862 1.21 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 107' ' ' VAL . 15.6 mmtt -67.62 -42.62 82.06 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.947 -176.116 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.72 -52.4 64.02 Favored 'General case' 0 C--O 1.221 -0.403 0 O-C-N 123.861 0.726 . . . . 0.0 110.216 172.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.99 -47.45 71.42 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.532 1.06 . . . . 0.0 111.251 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -56.23 -62.95 1.37 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.75 178.365 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -27.08 36.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 120.375 1.443 . . . . 0.0 113.633 -175.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.32 -50.57 73.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.31 -48.74 39.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -65.43 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.413 1.485 . . . . 0.0 108.509 -160.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.61 -41.23 96.35 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.287 0.949 . . . . 0.0 108.609 175.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.77 18.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.269 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-O 116.813 -1.565 . . . . 0.0 112.181 -163.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 mtt . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.24 50.95 1.69 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.561 1.528 . . . . 0.0 110.629 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.24 177.78 7.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.303 1.841 . . . . 0.0 109.527 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -11.92 61.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.966 -1.084 . . . . 0.0 111.405 159.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 44.78 33.98 1.09 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.637 2.375 . . . . 0.0 111.331 -173.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.6 108.56 0.65 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.341 1.057 . . . . 0.0 112.582 -159.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -89.71 132.01 35.39 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 34.9 m-85 -85.13 139.18 31.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.13 140.16 38.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 161.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -135.53 100.38 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.88 84.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 21.0 t70 -91.45 171.83 8.93 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.993 0.902 . . . . 0.0 111.516 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.91 -28.56 68.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.237 1.815 . . . . 0.0 112.259 165.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -131.95 113.82 13.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.904 1.681 . . . . 0.0 107.802 -163.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -50.37 -40.46 49.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.149 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 m -52.73 -37.63 59.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.184 0.994 . . . . 0.0 111.22 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -58.83 -41.34 86.62 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.663 1.12 . . . . 0.0 110.243 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.603 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.03 -48.39 80.47 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.338 0.972 . . . . 0.0 109.959 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.28 -58.19 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.69 1.196 . . . . 0.0 108.893 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.23 -50.64 70.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.323 1.049 . . . . 0.0 109.975 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -53.97 -48.57 70.19 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.852 0.751 . . . . 0.0 110.412 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.45 -46.01 84.96 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.682 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.99 -40.27 95.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.383 0.992 . . . . 0.0 110.525 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -60.78 -37.75 82.94 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.72 0.808 . . . . 0.0 110.838 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -70.74 -35.45 72.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 117.735 -1.126 . . . . 0.0 111.927 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -60.07 -42.26 94.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.654 1.115 . . . . 0.0 108.892 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.61 -56.34 14.53 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.281 0.632 . . . . 0.0 109.867 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.24 4.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.186 -1.341 . . . . 0.0 116.291 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.97 171.98 12.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.897 1.848 . . . . 0.0 112.382 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.21 -179.95 6.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.206 1.802 . . . . 0.0 108.267 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.2 t30 65.15 82.34 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.073 2.549 . . . . 0.0 112.353 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.41 162.08 13.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -140.91 170.73 15.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.223 1.809 . . . . 0.0 110.362 167.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -122.17 168.27 12.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.941 2.496 . . . . 0.0 107.582 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.21 171.0 14.67 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.616 1.166 . . . . 0.0 109.308 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.64 -35.64 65.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.938 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.26 178.38 0.71 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.473 1.909 . . . . 0.0 107.881 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.23 -43.37 4.59 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.31 1.91 . . . . 0.0 116.076 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.43 -47.29 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.865 1.833 . . . . 0.0 109.259 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -68.55 -37.23 79.77 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.1 -0.375 . . . . 0.0 110.85 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.9 -51.93 67.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.712 1.605 . . . . 0.0 109.818 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.62 -43.42 80.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.77 0.795 . . . . 0.0 110.54 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -71.74 -24.7 61.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -65.97 -42.07 90.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.376 166.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 72' ' ' ILE . 6.4 mt -56.03 -46.82 78.71 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.305 1.412 . . . . 0.0 108.249 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.37 10.81 0.9 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.733 1.213 . . . . 0.0 114.067 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.0 38.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.051 1.296 . . . . 0.0 110.988 160.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.49 -82.86 0.11 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.43 94.28 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.34 170.9 14.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.292 1.037 . . . . 0.0 110.484 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.09 -30.02 5.87 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.993 -0.893 . . . . 0.0 113.953 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 87.2 m-85 -146.55 148.58 32.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.258 1.023 . . . . 0.0 108.689 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -125.19 80.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 5.9 mt -91.73 130.84 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -171.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 p -144.5 161.36 39.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.513 1.506 . . . . 0.0 114.957 -173.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 1.6 p-10 -73.46 -158.25 0.06 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.258 1.023 . . . . 0.0 110.278 159.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -134.08 -30.27 1.21 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.329 2.252 . . . . 0.0 112.528 -167.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.43 32.02 6.36 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.889 2.076 . . . . 0.0 112.094 -158.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.539 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 2.4 mpt? -44.69 154.33 0.43 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 113.329 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.35 -25.74 35.81 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.127 2.551 . . . . 0.0 112.943 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -119.98 -99.57 0.44 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.2 ttt -78.35 106.17 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 161.03 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.469 1.108 . . . . 0.0 111.867 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.33 73.83 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 119.48 -0.622 . . . . 0.0 112.483 -166.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.28 -34.59 48.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.896 0.879 . . . . 0.0 109.942 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.36 -37.56 71.65 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 111.05 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.48 -50.71 72.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.757 0.708 . . . . 0.0 109.354 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -52.58 -61.09 2.5 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.041 0.936 . . . . 0.0 108.717 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.33 -26.13 67.6 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.879 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.8 m -66.82 -48.36 69.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.582 1.083 . . . . 0.0 110.864 170.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 46' ' ' LEU . 13.7 mt -60.89 -40.83 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 4.16 1.6 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.604 2.362 . . . . 0.0 113.572 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.4 57.32 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.238 1.381 . . . . 0.0 111.161 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 64.34 -176.35 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.952 2.501 . . . . 0.0 111.419 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.1 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.291 1.424 . . . . 0.0 113.796 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.41 -72.02 0.68 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.786 1.634 . . . . 0.0 109.149 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 mtt -89.68 -6.51 56.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.82 -54.1 0.46 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.485 2.714 . . . . 0.0 113.827 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -15.99 62.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.611 1.564 . . . . 0.0 114.383 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD13 HG21 ' A' ' 54' ' ' VAL . 19.1 mt -68.2 121.71 81.31 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 119.148 0.886 . . . . 0.0 109.452 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.51 106.81 1.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.871 1.714 . . . . 0.0 108.739 166.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.05 134.09 28.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 9.4 tp -131.65 106.28 8.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.9 mtp -82.14 117.75 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.94 105.05 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -145.49 172.61 12.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.932 0.872 . . . . 0.0 111.007 -164.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -11.45 59.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.44 -0.788 . . . . 0.0 112.918 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -88.24 107.98 19.07 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.203 2.201 . . . . 0.0 112.356 -165.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -91.4 3.91 53.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.52 120.32 6.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.243 1.383 . . . . 0.0 109.922 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -55.64 -44.31 77.03 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.324 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -63.68 -33.43 75.62 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.927 1.239 . . . . 0.0 111.023 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.02 -47.07 84.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.287 0.949 . . . . 0.0 109.373 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.58 -45.18 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.17 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.75 -56.82 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.83 -46.55 60.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.768 1.227 . . . . 0.0 110.146 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.82 71.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.523 0.729 . . . . 0.0 112.029 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.52 97.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -61.85 -46.47 89.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.818 1.647 . . . . 0.0 111.408 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.02 -16.21 59.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.788 0.835 . . . . 0.0 112.458 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.65 33.57 18.68 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.446 1.021 . . . . 0.0 111.722 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.06 142.74 53.53 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.0 p -72.91 -14.13 61.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.515 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.21 169.58 38.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -136.78 144.61 43.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.927 1.291 . . . . 0.0 107.922 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.98 140.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.978 2.111 . . . . 0.0 105.712 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 90' ' ' ALA . 10.8 t -123.24 144.64 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 149.4 21.17 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.053 169.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 140.67 67.19 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 109.691 -0.927 . . . . 0.0 109.691 -16.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -134.73 167.14 21.39 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.997 -1.064 . . . . 0.0 111.041 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 p -137.2 172.78 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.644 1.178 . . . . 0.0 110.991 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.83 -33.47 64.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.817 1.247 . . . . 0.0 109.511 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.03 -54.52 38.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.718 1.207 . . . . 0.0 111.246 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -31.82 58.3 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.564 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -56.49 19.53 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -66.5 -21.1 66.17 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.758 -0.588 . . . . 0.0 112.464 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -68.49 -47.98 65.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.244 0.929 . . . . 0.0 109.526 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -68.92 -38.36 79.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.651 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 mt -57.6 -54.51 46.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.254 0.934 . . . . 0.0 110.146 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -65.51 -30.2 70.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.754 0.706 . . . . 0.0 110.725 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -55.53 -58.24 8.58 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.933 165.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.82 -22.7 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 120.691 1.587 . . . . 0.0 113.619 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -57.83 -65.24 0.67 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -76.11 -30.6 58.3 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.18 -169.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -71.43 -68.17 0.47 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.319 1.048 . . . . 0.0 109.462 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.8 -31.59 45.99 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.354 1.062 . . . . 0.0 111.756 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.21 29.88 8.16 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.382 -1.232 . . . . 0.0 111.709 -165.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.7 mmt . . . . . 0 C--O 1.247 0.971 0 CA-C-N 119.868 1.834 . . . . 0.0 111.756 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.23 15.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.136 1.374 . . . . 0.0 108.497 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 2.5 m-20 -108.28 168.3 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -20.34 66.02 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.852 -0.53 . . . . 0.0 111.682 165.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 8.6 tt0 37.92 47.48 0.9 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.167 2.587 . . . . 0.0 111.551 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.43 126.37 26.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 155.1 19.0 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 110.371 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -104.33 101.64 11.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 164.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.47 133.9 46.19 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 117.361 -1.736 . . . . 0.0 106.727 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.4 t -132.06 105.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.41 58.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.055 1.342 . . . . 0.0 107.782 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.55 157.21 17.76 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.883 -0.511 . . . . 0.0 110.445 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.13 -28.21 68.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.879 1.271 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -132.41 123.21 26.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.524 1.53 . . . . 0.0 107.488 -167.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -52.15 -52.77 49.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.715 0.689 . . . . 0.0 111.514 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.2 m -59.33 -29.8 67.91 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.546 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 ttt -61.94 -44.48 96.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.26 0.936 . . . . 0.0 109.957 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -39.88 94.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.329 0.968 . . . . 0.0 109.111 174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -44.82 93.0 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.44 -62.22 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.342 172.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.01 -49.23 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 121.423 1.92 . . . . 0.0 111.13 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -48.61 76.74 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.443 1.097 . . . . 0.0 110.379 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -56.22 -51.22 68.87 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.927 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.31 -36.31 79.74 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.496 1.518 . . . . 0.0 112.033 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.65 -52.4 60.91 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.712 -0.617 . . . . 0.0 109.659 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -64.74 -20.6 66.44 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.1 -52.32 56.19 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.261 1.424 . . . . 0.0 109.879 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.37 2.43 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -166.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.86 -84.66 1.08 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 124.542 1.068 . . . . 0.0 110.997 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -151.28 175.44 12.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.205 1.402 . . . . 0.0 109.559 -169.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -139.09 -179.15 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.376 1.07 . . . . 0.0 109.944 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 64.39 77.17 0.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.996 2.519 . . . . 0.0 110.335 -165.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.97 172.36 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.069 160.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.39 174.29 10.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.723 2.009 . . . . 0.0 106.192 158.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.7 164.66 23.49 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.39 170.72 13.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.166 1.786 . . . . 0.0 106.817 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.1 -37.75 84.45 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.948 0.794 . . . . 0.0 110.389 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -172.64 166.92 5.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.985 1.314 . . . . 0.0 108.578 -160.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' H ' ' HG3' ' A' ' 60' ' ' MET . . . -49.35 -40.86 31.15 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.9 1.714 . . . . 0.0 113.966 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.02 -52.99 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.82 0.848 . . . . 0.0 108.77 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.63 -23.91 56.41 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.349 1.46 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.97 51.42 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.71 -46.2 70.69 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.895 0.747 . . . . 0.0 111.045 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.82 -46.58 74.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.475 1.51 . . . . 0.0 111.764 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.63 -48.36 82.14 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.741 -1.123 . . . . 0.0 109.736 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 72' ' ' ILE . 17.0 mt -53.83 -46.31 71.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.347 1.431 . . . . 0.0 110.81 -173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.91 7.55 2.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.39 -4.92 18.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.933 1.242 . . . . 0.0 113.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.88 32.06 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 120.418 1.463 . . . . 0.0 113.247 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.46 43.66 2.35 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.586 1.565 . . . . 0.0 113.614 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.08 82.0 2.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.47 -1.12 78.57 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.928 1.251 . . . . 0.0 113.065 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.77 134.87 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 81' ' ' LEU . 33.1 t -128.68 96.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.76 134.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.12 168.96 18.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.036 0.922 . . . . 0.0 110.012 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -46.93 -176.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 130.986 3.714 . . . . 0.0 113.304 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -115.98 -42.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.39 158.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.63 47.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.217 1.007 . . . . 0.0 111.691 -159.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.548 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -61.07 138.69 94.3 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.862 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 60' ' ' MET . 21.1 Cg_endo -61.12 26.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 125.265 3.976 . . . . 0.0 118.017 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.33 -71.89 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 122.058 2.208 . . . . 0.0 110.03 159.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.8 ttt -91.34 85.07 5.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.929 2.091 . . . . 0.0 107.164 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -47.07 153.55 0.43 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.006 1.322 . . . . 0.0 110.32 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.04 -27.53 62.53 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.429 -0.795 . . . . 0.0 112.167 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.81 -36.57 78.4 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.965 0.882 . . . . 0.0 110.29 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.18 -31.41 55.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.866 0.867 . . . . 0.0 110.795 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -57.86 -53.22 60.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.674 0.67 . . . . 0.0 109.272 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -52.56 -56.47 15.05 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.289 1.036 . . . . 0.0 108.701 174.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -63.44 -30.92 71.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.726 1.148 . . . . 0.0 112.703 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -69.22 -42.22 76.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.103 0.961 . . . . 0.0 110.053 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 46' ' ' LEU . 31.6 mt -61.57 -50.62 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -60.09 -24.68 64.81 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.377 1.871 . . . . 0.0 112.334 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.88 -3.38 3.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.52 1.128 . . . . 0.0 112.627 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 t0 89.54 30.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.547 1.539 . . . . 0.0 112.525 158.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.72 43.32 1.37 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.34 1.924 . . . . 0.0 112.741 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 75.33 8.22 3.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 130.044 3.338 . . . . 0.0 112.419 -170.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.9 mtt -119.29 2.9 11.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.715 1.206 . . . . 0.0 112.363 -163.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 -36.55 67.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.941 1.297 . . . . 0.0 112.616 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.99 60.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.336 0.971 . . . . 0.0 113.146 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 54' ' ' VAL . 34.2 mt -57.95 135.01 83.68 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-N 119.693 1.133 . . . . 0.0 111.49 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.67 109.84 2.74 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.764 2.309 . . . . 0.0 107.589 161.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -102.68 113.57 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.103 1.761 . . . . 0.0 107.364 177.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.73 111.9 19.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.219 1.008 . . . . 0.0 108.836 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.03 132.03 34.38 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.43 127.54 59.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -161.55 169.61 21.42 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.59 -12.98 47.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.254 -0.904 . . . . 0.0 111.409 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.32 119.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.973 1.261 . . . . 0.0 111.796 -165.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.06 11.04 14.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.537 0.735 . . . . 0.0 112.018 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -52.21 117.97 3.18 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.302 1.841 . . . . 0.0 110.62 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -52.83 -47.73 67.5 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.807 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -46.7 -46.12 19.96 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.17 0.988 . . . . 0.0 111.56 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -65.36 -43.82 89.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.03 -48.57 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.08 -54.44 34.36 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.26 -48.41 45.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.357 1.463 . . . . 0.0 110.84 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.06 27.01 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.219 0.607 . . . . 0.0 109.701 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.75 66.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -73.39 -56.85 4.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.699 2.0 . . . . 0.0 109.641 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.41 -35.61 60.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.573 0.749 . . . . 0.0 110.18 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.6 27.85 3.69 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 125.166 1.365 . . . . 0.0 111.545 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.72 138.59 55.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.112 0.956 . . . . 0.0 110.322 -172.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -72.89 -5.53 38.97 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.59 1.556 . . . . 0.0 112.003 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.32 165.46 34.79 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 158.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -137.79 110.78 7.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.66 104.35 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.442 1.897 . . . . 0.0 106.23 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.62 147.83 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -66.91 147.14 99.15 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 162.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.65 139.7 58.79 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.195 1.105 . . . . 0.0 110.498 -3.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.81 148.09 40.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -144.97 -176.25 5.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 109.811 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.43 -33.23 43.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.936 1.294 . . . . 0.0 110.166 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.54 76.23 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.69 0.796 . . . . 0.0 112.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.01 -27.98 19.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.949 . . . . 0.0 110.003 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.92 -53.39 58.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.365 1.066 . . . . 0.0 109.374 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -37.48 85.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.63 1.172 . . . . 0.0 111.462 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.42 -45.38 69.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.677 1.591 . . . . 0.0 108.896 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.63 87.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.392 -1.766 . . . . 0.0 111.245 170.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.23 -56.51 17.92 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.354 1.034 . . . . 0.0 109.281 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -59.54 -35.02 73.4 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.45 1.023 . . . . 0.0 111.109 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -54.93 -50.82 67.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.689 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.18 -24.42 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.704 1.138 . . . . 0.0 113.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -56.68 -55.56 32.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -74.83 -46.52 36.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -68.49 -70.41 0.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.02 -26.64 66.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.127 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.03 12.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -164.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.5 mmt . . . . . 0 C--O 1.252 1.228 0 CA-C-N 118.998 1.399 . . . . 0.0 109.09 176.258 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.43 179.83 6.86 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.997 1.719 . . . . 0.0 107.277 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -66.7 172.52 4.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 159.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.02 -12.74 20.39 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.551 -1.343 . . . . 0.0 111.495 159.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.459 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 27.8 mt-10 46.87 49.19 14.68 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.6 1.96 . . . . 0.0 109.151 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.98 106.37 0.22 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.806 0.842 . . . . 0.0 109.458 -169.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -89.38 117.65 28.47 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.728 -162.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.13 152.56 41.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.6 tp -123.29 134.8 54.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.73 119.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.678 1.191 . . . . 0.0 108.306 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.09 61.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.35 156.85 36.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -62.05 -44.4 96.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.654 1.181 . . . . 0.0 110.485 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 12.2 t80 -116.08 132.59 56.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 109.029 -159.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -51.28 -60.65 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.128 0.971 . . . . 0.0 111.97 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 64.4 m -51.22 -37.25 45.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.997 0.519 . . . . 0.0 110.936 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.59 -47.17 82.86 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.018 0.826 . . . . 0.0 111.045 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.3 ptt85 -72.92 -27.43 61.86 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 120.997 1.726 . . . . 0.0 111.545 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -62.59 -40.95 98.55 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.467 -0.771 . . . . 0.0 109.431 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.23 -63.43 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.49 -42.63 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.804 1.184 . . . . 0.0 110.671 -171.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -60.56 -49.21 78.44 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 117.709 -1.138 . . . . 0.0 111.07 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -50.86 -54.68 21.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.377 0.989 . . . . 0.0 109.66 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.82 -42.62 75.95 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.099 0.96 . . . . 0.0 111.535 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.86 -47.63 79.94 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.52 -19.29 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.441 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.76 -33.08 74.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.178 1.354 . . . . 0.0 110.156 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.05 -50.28 6.75 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.461 1.504 . . . . 0.0 108.738 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.94 -97.14 0.13 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 35.92 64.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 128.363 2.665 . . . . 0.0 112.316 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -68.41 1.48 2.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.83 100.47 4.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.894 1.679 . . . . 0.0 110.694 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.63 91.56 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 125.799 1.639 . . . . 0.0 107.64 -172.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 164.4 17.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.429 0.691 . . . . 0.0 109.56 169.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.82 166.31 22.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 158.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -113.54 178.58 4.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.368 1.067 . . . . 0.0 108.668 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.65 -43.1 23.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -167.24 164.03 15.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.264 1.826 . . . . 0.0 108.121 -161.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.88 -39.42 11.2 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.191 1.377 . . . . 0.0 114.034 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.018 0.909 . . . . 0.0 109.314 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.16 -26.15 66.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.171 0.589 . . . . 0.0 111.038 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.46 -54.6 43.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.802 1.183 . . . . 0.0 108.433 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.89 -39.87 82.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.337 0.589 . . . . 0.0 111.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -56.1 -47.11 78.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.435 1.094 . . . . 0.0 110.353 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -59.38 -48.83 80.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.941 1.297 . . . . 0.0 109.911 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 72' ' ' ILE . 3.2 mt -57.91 -39.32 77.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.837 1.199 . . . . 0.0 109.755 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -76.25 10.07 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.15 -37.15 84.96 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.501 -1.375 . . . . 0.0 109.835 159.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.24 -19.68 0.73 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 118.112 -1.382 . . . . 0.0 116.136 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.01 86.42 0.06 OUTLIER Glycine 0 C--N 1.338 0.691 0 CA-C-N 120.389 2.095 . . . . 0.0 113.541 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.26 163.5 14.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.588 0.694 . . . . 0.0 109.925 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.42 -38.84 4.63 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.419 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -142.5 151.17 41.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.463 1.131 . . . . 0.0 109.113 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -129.27 79.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -97.31 120.62 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -169.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -151.65 156.54 40.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.114 1.324 . . . . 0.0 113.216 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.12 168.44 20.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.631 1.173 . . . . 0.0 110.051 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -82.28 -56.21 4.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.075 0.95 . . . . 0.0 113.409 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.19 67.23 4.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.699 0.799 . . . . 0.0 112.41 -158.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -66.89 147.63 99.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.712 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.45 -6.32 14.83 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 114.096 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -139.88 -89.95 0.18 Allowed 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.196 1.362 . . . . 0.0 111.746 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.7 ttm -82.0 95.85 7.54 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.77 155.66 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.89 -24.18 48.54 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.359 -0.838 . . . . 0.0 112.022 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.69 -35.45 57.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.609 1.204 . . . . 0.0 111.515 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.04 -40.24 75.26 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.098 0.959 . . . . 0.0 109.705 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.82 -54.08 48.93 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.211 1.404 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tp -53.07 -58.36 7.26 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.719 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 26.7 mttm -60.9 -31.76 71.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.389 0.995 . . . . 0.0 111.844 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.5 m -65.28 -48.71 72.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.566 0.746 . . . . 0.0 110.608 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 HD11 HD11 ' A' ' 46' ' ' LEU . 28.0 mt -59.16 -45.03 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -7.08 13.16 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.896 1.678 . . . . 0.0 113.57 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.96 -16.78 46.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.741 1.155 . . . . 0.0 111.689 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.4 175.08 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.692 1.597 . . . . 0.0 111.635 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.47 -9.13 29.94 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 120.797 -1.19 . . . . 0.0 112.949 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.1 -28.01 0.33 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.7 mtt -145.25 6.31 1.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.194 0.998 . . . . 0.0 111.361 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.0 -57.13 3.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.09 2.556 . . . . 0.0 112.966 -159.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.83 -9.97 59.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.254 -1.355 . . . . 0.0 113.874 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 54' ' ' VAL . 12.7 mt -56.8 117.78 19.38 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.181 1.355 . . . . 0.0 110.571 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.54 100.88 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.07 2.513 . . . . 0.0 109.098 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.01 130.86 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 166.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.5 tp -131.17 112.22 12.64 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.735 1.214 . . . . 0.0 108.444 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.6 mmm -83.01 96.88 8.48 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -100.34 107.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -154.41 167.27 30.56 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.161 -0.962 . . . . 0.0 111.153 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.75 47.43 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.543 -0.723 . . . . 0.0 111.872 165.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -76.05 94.4 3.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.866 1.266 . . . . 0.0 110.737 -164.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -83.54 14.93 3.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.978 1.311 . . . . 0.0 112.974 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 118.98 4.62 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.579 1.152 . . . . 0.0 108.19 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -57.26 -43.38 82.96 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.431 1.014 . . . . 0.0 110.02 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.71 -29.48 69.37 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.766 1.166 . . . . 0.0 112.11 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -67.7 -45.24 75.71 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.715 0.689 . . . . 0.0 109.719 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.62 -48.12 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.251 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.87 -55.17 19.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.82 69.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.227 1.011 . . . . 0.0 110.38 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.31 -53.42 58.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.712 0.805 . . . . 0.0 110.763 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.66 93.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.312 0.505 . . . . 0.0 110.484 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -59.89 -49.67 76.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.951 2.1 . . . . 0.0 111.272 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -61.6 -31.24 71.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.471 1.108 . . . . 0.0 111.56 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.03 16.01 7.53 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.699 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.81 136.8 58.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 119.712 1.756 . . . . 0.0 108.553 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -66.63 -19.57 65.8 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 123.313 0.383 . . . . 0.0 110.954 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.59 176.88 48.25 Favored Glycine 0 N--CA 1.439 -1.101 0 O-C-N 121.187 -0.946 . . . . 0.0 113.186 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.89 137.74 51.61 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.483 1.513 . . . . 0.0 107.34 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.0 85.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.513 2.325 . . . . 0.0 104.943 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 90' ' ' ALA . 23.5 t -70.73 144.82 13.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 167.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 155.03 6.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.192 0.997 . . . . 0.0 110.506 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.01 145.44 83.93 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 N-CA-C 109.464 -1.014 . . . . 0.0 109.464 -10.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -132.24 150.79 52.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.346 1.058 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -147.28 169.46 19.35 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.182 2.193 . . . . 0.0 108.334 -164.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.19 74.12 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.76 17.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.016 1.326 . . . . 0.0 114.313 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.63 -25.49 8.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.757 1.162 . . . . 0.0 110.892 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -57.7 11.67 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 170.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -32.07 71.56 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.22 -49.25 67.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 109.425 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 3.8 mmpt? -68.53 -37.31 79.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 116.724 -1.607 . . . . 0.0 110.278 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.94 -57.36 12.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.307 0.958 . . . . 0.0 109.077 171.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -50.42 -45.27 55.64 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.058 0.943 . . . . 0.0 110.866 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 11.5 mtmm -59.43 -48.03 83.2 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.559 -1.21 . . . . 0.0 112.596 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 pt -75.05 -31.91 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.896 2.134 . . . . 0.0 113.283 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -55.4 -50.53 69.53 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.879 1.272 . . . . 0.0 108.82 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.04 -57.78 4.2 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.935 0.494 . . . . 0.0 109.916 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -58.65 3.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -159.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 129' ' ' MET . 6.6 mt -71.43 -26.33 62.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.45 40.69 8.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -169.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 127' ' ' LEU . 14.7 mmt . . . . . 0 C--O 1.253 1.243 0 CA-C-N 118.897 1.349 . . . . 0.0 108.135 171.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tmm? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 122.369 1.081 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.07 165.41 35.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.986 2.514 . . . . 0.0 107.916 -171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -61.54 173.47 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.757 1.223 . . . . 0.0 109.491 170.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HE2' HD12 ' A' ' 6' ' ' LEU . 80.8 tttt -62.11 -29.79 70.57 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 120.348 -1.47 . . . . 0.0 110.109 159.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 46.99 47.11 15.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.904 1.282 . . . . 0.0 110.642 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD12 ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -53.22 109.43 0.43 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.34 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -75.0 135.09 41.32 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 53' ' ' PHE . 8.3 m-85 -92.78 149.44 21.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 166.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -121.78 138.29 54.43 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 166.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.26 108.09 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -124.51 57.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.37 162.69 5.87 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 159.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -47.83 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.376 -0.827 . . . . 0.0 110.167 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -64.17 -19.94 65.66 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -158.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 t 70.64 -47.27 0.64 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.926 2.491 . . . . 0.0 111.55 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.8 m -52.69 -36.95 58.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.467 -1.396 . . . . 0.0 109.29 160.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.2 ttp -67.92 -17.66 64.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.213 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.486 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.24 -48.03 81.75 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 120.663 1.574 . . . . 0.0 108.327 168.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -56.85 -52.88 63.38 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 107.893 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.36 -68.47 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 124.059 0.849 . . . . 0.0 108.811 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.49 -46.66 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.995 0.816 . . . . 0.0 110.746 -170.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -63.89 -35.52 80.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.156 0.889 . . . . 0.0 111.018 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -72.3 -32.98 67.04 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.52 1.055 . . . . 0.0 111.751 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.92 -36.8 80.78 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.978 -1.076 . . . . 0.0 109.868 172.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.54 -36.47 81.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.865 -0.522 . . . . 0.0 110.517 172.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -64.66 -34.49 78.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.728 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -56.66 -64.93 0.71 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.931 1.241 . . . . 0.0 110.925 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.67 28.53 1.05 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -165.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.03 -116.34 2.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.463 1.506 . . . . 0.0 110.226 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -141.54 176.4 8.92 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.461 1.105 . . . . 0.0 111.708 -159.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.42 -177.64 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.066 1.746 . . . . 0.0 110.391 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 60.05 74.29 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.118 2.167 . . . . 0.0 109.781 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.28 125.06 73.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 172.87 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.697 1.199 . . . . 0.0 107.952 165.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -134.43 173.91 11.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.729 1.212 . . . . 0.0 107.992 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.38 177.19 8.06 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.111 0.964 . . . . 0.0 109.601 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.04 -38.59 52.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.883 0.473 . . . . 0.0 111.461 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.05 162.88 1.67 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.784 2.033 . . . . 0.0 107.131 -158.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -47.89 -42.31 22.09 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.077 1.322 . . . . 0.0 114.663 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.8 -36.56 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.067 1.933 . . . . 0.0 109.533 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.5 t70 -78.95 -36.3 41.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.556 1.542 . . . . 0.0 110.261 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.62 -46.96 83.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.262 1.425 . . . . 0.0 109.081 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -52.62 -47.91 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.22 1.408 . . . . 0.0 110.383 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.2 -19.8 63.98 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.114 0.965 . . . . 0.0 112.926 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HE2' ' OD1' ' A' ' 41' ' ' ASP . 4.2 mptp? -69.25 -49.03 59.97 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.388 -1.445 . . . . 0.0 110.094 162.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.61 HD11 HD11 ' A' ' 72' ' ' ILE . 5.5 mt -54.71 -54.69 38.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.113 1.324 . . . . 0.0 109.581 -174.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.51 -0.96 9.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.5 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.308 1.413 . . . . 0.0 110.52 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.39 -82.59 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.11 91.7 0.11 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -84.21 155.7 22.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.55 -66.99 0.5 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 7.2 m-85 -87.38 136.57 32.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.947 0.873 . . . . 0.0 108.821 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 81' ' ' LEU . 42.3 t -129.75 113.84 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.4 125.78 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.3 p -156.57 168.71 26.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.376 0.989 . . . . 0.0 112.907 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.78 167.54 21.62 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.768 0.827 . . . . 0.0 110.362 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 4.0 t-105 -78.93 -42.58 26.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 158.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -78.53 56.27 1.77 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.311 2.244 . . . . 0.0 112.327 -159.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.471 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -76.81 165.82 49.5 Favored Pre-proline 0 C--O 1.238 0.456 0 O-C-N 120.869 -1.144 . . . . 0.0 110.792 -177.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.82 -39.52 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.45 2.1 . . . . 0.0 110.84 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.82 -69.07 0.87 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.839 1.2 . . . . 0.0 112.295 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.2 ttm -91.14 83.48 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.93 140.6 1.02 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.918 2.087 . . . . 0.0 108.671 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.5 -20.81 66.14 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.052 -1.03 . . . . 0.0 114.77 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.43 -38.38 74.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.104 0.952 . . . . 0.0 109.708 172.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.83 -41.14 83.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 109.911 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.88 -51.08 71.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.496 1.044 . . . . 0.0 110.045 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.23 -56.35 17.22 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.821 173.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.56 -24.86 65.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.812 1.642 . . . . 0.0 113.666 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 m -64.01 -52.16 60.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.61 HD11 HD11 ' A' ' 46' ' ' LEU . 30.9 mt -64.29 -28.66 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 12.39 19.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.433 1.893 . . . . 0.0 111.22 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.49 -16.48 60.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.512 1.505 . . . . 0.0 112.412 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.6 t0 68.59 163.15 0.22 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 129.842 3.257 . . . . 0.0 111.803 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.29 2.97 22.43 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.001 -1.444 . . . . 0.0 113.756 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -165.85 82.02 0.31 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.916 1.858 . . . . 0.0 106.741 167.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.2 mtt 103.81 17.31 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.743 2.417 . . . . 0.0 114.657 164.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -57.66 -18.27 19.51 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.435 -1.415 . . . . 0.0 113.743 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.89 4.34 50.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.0 113.386 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 54' ' ' VAL . 10.4 mt -73.27 127.9 88.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 120.334 -1.479 . . . . 0.0 108.988 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.86 62.82 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.339 4.026 . . . . 0.0 111.716 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.84 112.08 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.349 1.86 . . . . 0.0 111.675 177.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 114.52 27.17 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 125.367 1.467 . . . . 0.0 109.201 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 mmt -76.17 131.03 39.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 105.14 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.246 1.819 . . . . 0.0 106.401 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 t -139.99 178.84 6.98 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.008 0.909 . . . . 0.0 110.696 -171.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.05 -26.2 19.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.124 0.97 . . . . 0.0 111.788 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -91.17 134.95 34.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.201 0.91 . . . . 0.0 111.646 -168.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 -95.8 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.408 -0.806 . . . . 0.0 108.915 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 1.9 tpmt? 59.15 112.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.326 2.25 . . . . 0.0 111.789 -171.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -51.8 -47.42 64.28 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.76 -28.33 69.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.599 1.545 . . . . 0.0 113.423 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -65.02 -47.35 77.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.606 1.094 . . . . 0.0 108.927 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.2 -51.64 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.71 -58.01 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.027 0.931 . . . . 0.0 110.56 -172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.79 88.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.33 -39.28 92.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.591 0.632 . . . . 0.0 112.519 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -60.23 -54.75 42.04 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.929 1.691 . . . . 0.0 109.594 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.46 -12.18 29.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.035 1.334 . . . . 0.0 112.27 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.47 29.65 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 119.099 -0.834 . . . . 0.0 112.531 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.692 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.52 152.16 26.66 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.9 m -55.52 -34.94 65.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.145 0.978 . . . . 0.0 112.23 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.25 179.78 44.15 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.11 92.29 3.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.474 1.51 . . . . 0.0 107.874 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -81.93 137.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.42 144.14 38.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 156.92 43.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.426 0.557 . . . . 0.0 110.801 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.72 137.17 46.21 Favored 'Cis proline' 0 N--CA 1.453 -0.891 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 -12.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -139.07 155.02 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.986 0.422 . . . . 0.0 110.194 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 p -151.72 -172.3 4.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.73 1.612 . . . . 0.0 111.022 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.2 18.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.558 1.143 . . . . 0.0 110.475 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.1 87.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.705 0.802 . . . . 0.0 112.889 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 -34.55 22.22 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.767 1.167 . . . . 0.0 109.269 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.95 -55.96 19.5 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -41.28 99.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.688 1.195 . . . . 0.0 112.518 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.41 -45.11 73.5 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.829 -0.545 . . . . 0.0 110.04 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.36 -38.38 89.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.0 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.29 -60.39 3.47 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.7 -34.83 73.4 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.393 0.542 . . . . 0.0 111.766 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -68.73 0.16 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.966 0.906 . . . . 0.0 109.349 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -24.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -57.56 -64.03 1.03 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.55 0.74 . . . . 0.0 109.219 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.83 -54.73 12.2 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -59.39 -52.6 64.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.537 0.735 . . . . 0.0 111.97 -164.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.74 -47.44 11.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.398 0.679 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.52 19.51 3.1 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.257 1.408 . . . . 0.0 112.704 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.1 mmm . . . . . 0 C--O 1.253 1.254 0 CA-C-N 120.152 1.976 . . . . 0.0 112.837 -172.507 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 -163.54 0.43 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.265 1.426 . . . . 0.0 108.623 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.91 175.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.348 -0.845 . . . . 0.0 109.293 166.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -63.35 -16.7 61.22 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.877 -1.139 . . . . 0.0 112.999 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 49.4 57.6 6.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.576 1.15 . . . . 0.0 110.107 -172.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.23 111.56 1.4 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -90.62 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -86.74 159.48 19.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -125.67 142.2 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.77 110.11 16.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.6 t -125.0 70.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 123.223 1.487 . . . . 0.0 107.346 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.54 173.23 10.67 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.34 1.856 . . . . 0.0 110.996 168.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.18 -18.38 24.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.361 2.264 . . . . 0.0 114.069 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.31 112.62 8.69 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.057 -1.652 . . . . 0.0 109.029 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.85 -46.31 1.96 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.272 1.396 . . . . 0.0 114.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.0 m -51.76 -45.81 63.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.607 1.094 . . . . 0.0 111.673 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.6 ttm -52.39 -41.16 62.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 109.359 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -71.2 -40.56 71.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.88 1.218 . . . . 0.0 111.479 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -54.7 -54.9 35.69 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.41 -65.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.926 1.291 . . . . 0.0 107.923 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.41 -45.41 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.603 1.547 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -64.75 -39.42 93.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.251 1.387 . . . . 0.0 110.698 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -58.56 -51.57 69.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.204 1.366 . . . . 0.0 110.601 171.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.39 -26.35 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.181 0.592 . . . . 0.0 111.994 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -77.91 -45.95 22.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.344 1.057 . . . . 0.0 110.426 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -73.55 -9.63 58.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.16 -36.91 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.397 0.999 . . . . 0.0 109.925 158.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.93 -4.37 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.868 1.667 . . . . 0.0 111.597 -165.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.53 -110.2 1.54 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.999 1.761 . . . . 0.0 108.888 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 40.51 49.86 2.72 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.898 2.479 . . . . 0.0 112.972 165.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -70.67 -4.96 26.13 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.777 0.831 . . . . 0.0 113.241 -160.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -131.09 77.01 1.76 Allowed 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.354 1.461 . . . . 0.0 107.81 -169.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.69 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 164.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.87 171.9 12.64 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.78 2.032 . . . . 0.0 108.04 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.66 148.25 42.15 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.735 1.214 . . . . 0.0 107.733 -164.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -129.82 167.78 17.6 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.127 0.571 . . . . 0.0 109.891 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -74.3 -31.43 62.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.657 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.62 172.72 2.53 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.598 1.559 . . . . 0.0 107.873 -172.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.05 -39.63 26.77 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.796 1.188 . . . . 0.0 113.789 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.38 -45.27 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.6 -0.941 . . . . 0.0 109.892 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.02 -25.66 64.6 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.655 -0.653 . . . . 0.0 110.181 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.58 -55.07 34.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.517 1.053 . . . . 0.0 108.51 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.97 -42.36 76.15 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.682 0.753 . . . . 0.0 110.751 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.94 -40.49 84.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.541 0.737 . . . . 0.0 112.023 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.2 mmtm -62.15 -44.06 97.46 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.232 0.924 . . . . 0.0 109.285 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.459 HD11 HD11 ' A' ' 72' ' ' ILE . 10.5 mt -58.0 -43.94 86.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.11 0.868 . . . . 0.0 110.71 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -69.84 -13.54 62.31 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.52 48.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.774 1.23 . . . . 0.0 112.906 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.93 34.87 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 119.706 1.139 . . . . 0.0 110.882 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.7 76.19 1.09 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -70.91 159.0 35.47 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.2 -1.66 3.92 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.784 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.55 136.96 17.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.141 1.47 . . . . 0.0 108.839 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -134.88 80.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.07 139.94 16.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.3 p -148.96 167.44 25.75 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.511 0.596 . . . . 0.0 111.935 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.9 t70 -78.98 -157.6 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 158.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 16.3 t-105 -122.59 -42.01 2.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.33 2.252 . . . . 0.0 110.293 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.63 43.74 1.0 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 112.203 -159.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -91.79 144.1 28.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 121.25 -0.906 . . . . 0.0 108.567 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.23 159.06 50.62 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.28 1.987 . . . . 0.0 111.379 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.82 -78.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 127.356 2.262 . . . . 0.0 111.862 -171.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.5 86.37 6.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -55.93 165.86 0.86 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 167.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.0 -30.32 53.86 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.809 -1.182 . . . . 0.0 112.416 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -79.54 -29.09 41.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.669 1.235 . . . . 0.0 111.645 -179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.45 -44.52 57.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.86 -51.07 62.43 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.281 1.432 . . . . 0.0 109.178 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.7 tp -57.12 -58.75 6.85 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.417 1.087 . . . . 0.0 110.216 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 67.5 mttt -66.63 -28.88 68.84 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.472 1.487 . . . . 0.0 111.939 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.1 m -62.27 -55.41 28.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.467 1.03 . . . . 0.0 108.699 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.459 HD11 HD11 ' A' ' 46' ' ' LEU . 32.8 mt -50.66 -55.4 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.693 1.597 . . . . 0.0 108.564 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -30.72 65.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.264 1.426 . . . . 0.0 112.266 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.24 8.2 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.207 1.003 . . . . 0.0 111.745 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -175.16 -161.92 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.335 1.854 . . . . 0.0 109.347 165.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.3 33.41 4.56 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 123.87 0.748 . . . . 0.0 111.414 163.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 69.74 -37.33 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 129.38 3.072 . . . . 0.0 111.492 -160.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.48 -16.61 48.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.52 1.528 . . . . 0.0 112.281 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -34.12 1.96 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.117 2.167 . . . . 0.0 112.159 169.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.38 4.95 19.38 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.68 1.592 . . . . 0.0 113.705 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 54' ' ' VAL . 12.8 mt -66.13 125.63 90.5 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.89 124.64 11.66 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 108.697 -1.309 . . . . 0.0 108.697 170.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 69' ' ' LEU . 2.2 m -104.79 142.1 18.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.9 tp -137.86 111.76 8.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -73.91 122.53 22.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.45 102.43 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -144.3 171.93 13.64 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.688 0.756 . . . . 0.0 112.565 -161.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.56 -24.36 39.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.312 1.045 . . . . 0.0 110.482 163.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.08 94.8 1.95 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.355 1.462 . . . . 0.0 110.514 -168.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 3.62 7.32 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.344 -0.848 . . . . 0.0 111.85 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -49.52 115.91 1.54 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 109.598 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -49.09 -53.07 22.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.418 0.687 . . . . 0.0 111.326 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.99 -25.8 67.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -72.78 -40.21 66.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.326 0.966 . . . . 0.0 109.658 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.58 -49.64 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.7 -57.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.21 76.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.816 0.735 . . . . 0.0 111.105 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.907 0.483 . . . . 0.0 110.149 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -27.48 67.27 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -68.93 -54.55 14.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.756 1.623 . . . . 0.0 109.404 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.83 80.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.881 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.24 35.08 2.78 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 124.691 1.138 . . . . 0.0 112.458 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.39 141.67 46.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -78.46 -4.84 50.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.978 0.174 . . . . 0.0 111.215 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.44 172.76 41.44 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 161.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -139.08 132.0 29.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.29 1.036 . . . . 0.0 108.519 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -132.97 130.67 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 127.065 2.146 . . . . 0.0 106.32 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.32 152.23 10.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -50.72 143.48 14.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.457 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.56 132.79 27.98 Favored 'Cis proline' 0 CA--C 1.534 0.484 0 CA-C-N 120.707 1.288 . . . . 0.0 111.012 -8.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -134.32 157.92 45.11 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.411 0.684 . . . . 0.0 111.243 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -155.51 171.91 19.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.516 1.927 . . . . 0.0 110.765 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.31 75.6 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.46 -50.5 31.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.937 1.295 . . . . 0.0 111.981 169.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.29 -35.3 48.13 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.808 -0.557 . . . . 0.0 109.749 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -57.65 11.01 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.257 1.023 . . . . 0.0 108.841 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.27 -29.69 70.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.042 0.937 . . . . 0.0 111.868 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.59 -45.45 65.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.564 0.346 . . . . 0.0 110.617 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.06 -35.33 80.81 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.954 -1.091 . . . . 0.0 110.306 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.3 mt -58.33 -56.71 18.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 109.729 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -50.71 -43.82 57.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.874 0.761 . . . . 0.0 110.916 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -51.68 -61.4 2.27 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.307 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 pt -70.96 -26.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.715 1.598 . . . . 0.0 114.531 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.67 -58.62 7.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.31 -41.74 66.25 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.876 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -68.38 -67.73 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.554 1.542 . . . . 0.0 108.77 -173.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.423 HD23 ' HD2' ' A' ' 126' ' ' LYS . 8.5 mt -72.9 -29.13 62.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.74 0.416 . . . . 0.0 110.374 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.84 26.13 25.36 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 117.737 -1.59 . . . . 0.0 110.361 -161.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--O 1.242 0.692 0 CA-C-N 120.174 1.987 . . . . 0.0 109.801 175.347 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.73 38.98 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 147.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -109.07 170.23 8.18 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 158.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -63.91 -19.22 64.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 45.88 37.24 3.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.275 1.83 . . . . 0.0 110.632 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.56 110.91 2.89 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.351 1.86 . . . . 0.0 108.878 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -91.11 138.5 31.55 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.087 0.555 . . . . 0.0 110.726 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.3 102.36 14.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.349 1.86 . . . . 0.0 107.747 165.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.89 136.75 54.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.3 106.16 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 42' ' ' ALA . 6.7 t -109.03 89.26 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.24 158.81 16.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.65 0.738 . . . . 0.0 110.734 170.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.79 -4.34 58.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.384 1.074 . . . . 0.0 112.685 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 10.0 t80 -131.52 -3.92 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.844 1.258 . . . . 0.0 112.309 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 62.31 -60.18 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.214 2.205 . . . . 0.0 110.76 -159.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.422 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 68.8 m -62.63 -29.07 70.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 111.189 -171.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.02 64.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.648 1.567 . . . . 0.0 110.904 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.7 ttp85 -67.95 -43.86 78.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 121.288 1.858 . . . . 0.0 107.309 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.85 -45.63 67.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.239 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.08 -65.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.887 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.14 -47.53 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.204 1.365 . . . . 0.0 111.148 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.624 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.3 ttt180 -55.15 -49.5 71.65 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 109.755 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -60.17 -39.74 87.51 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.847 0.748 . . . . 0.0 110.744 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 113' ' ' ALA . 60.8 mt -66.45 -34.07 77.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.045 0.839 . . . . 0.0 110.989 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -67.27 -37.01 82.76 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.354 -0.841 . . . . 0.0 110.706 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -70.06 -29.2 66.15 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.538 -1.351 . . . . 0.0 111.084 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.34 -51.75 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.35 1.06 . . . . 0.0 110.582 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 47.37 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.613 0.721 . . . . 0.0 112.264 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.0 -111.72 0.83 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.6 158.27 44.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.178 0.989 . . . . 0.0 111.156 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -82.65 177.81 8.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.196 0.999 . . . . 0.0 109.357 159.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 60.78 79.25 0.25 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.745 2.018 . . . . 0.0 111.631 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.624 HG21 ' HG3' ' A' ' 22' ' ' ARG . 5.2 m -97.56 169.17 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.352 163.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -141.8 -179.6 6.29 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.97 1.708 . . . . 0.0 108.514 163.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -134.12 158.11 44.47 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.464 1.506 . . . . 0.0 107.775 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.59 159.14 40.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.598 1.559 . . . . 0.0 107.262 162.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.26 -24.13 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -171.5 168.68 6.37 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.468 1.507 . . . . 0.0 107.21 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.72 -37.89 21.57 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.291 0.948 . . . . 0.0 113.526 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.98 -51.22 47.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.261 1.024 . . . . 0.0 109.997 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -74.14 -28.23 61.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.143 1.377 . . . . 0.0 110.073 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.98 -50.84 71.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.492 1.117 . . . . 0.0 108.942 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.18 -37.76 75.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.353 0.261 . . . . 0.0 110.492 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -67.77 -36.11 79.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.277 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 mmtt -63.45 -40.1 96.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.874 1.215 . . . . 0.0 109.605 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -62.55 -39.1 92.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.763 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -71.26 5.96 1.94 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.28 59.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.54 -1.35 . . . . 0.0 112.943 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -105.31 0.29 Allowed Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.379 0.991 . . . . 0.0 110.698 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.31 87.37 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.364 0.983 . . . . 0.0 110.98 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -67.69 164.82 18.47 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.365 1.066 . . . . 0.0 110.993 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.97 -43.71 3.76 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 119.044 -0.865 . . . . 0.0 111.221 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.05 145.59 44.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 117.894 0.847 . . . . 0.0 112.307 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' LEU . 14.1 t -136.09 81.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.135 1.374 . . . . 0.0 107.894 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.88 127.1 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -136.81 144.39 43.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -171.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.15 166.66 19.44 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 158.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -71.92 -45.58 60.69 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.578 0.751 . . . . 0.0 109.317 162.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -73.97 98.75 3.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.054 0.942 . . . . 0.0 112.17 -160.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 mmt -131.4 155.51 81.38 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.96 -45.11 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.469 2.113 . . . . 0.0 111.273 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.65 -99.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.428 1.091 . . . . 0.0 108.657 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.9 ttm -79.18 96.12 5.8 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.4 166.75 4.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.057 0.943 . . . . 0.0 111.291 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.95 -24.28 71.5 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.259 -171.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -43.88 34.9 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.118 1.459 . . . . 0.0 107.758 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.43 -41.13 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.576 0.75 . . . . 0.0 110.977 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.55 -49.54 77.39 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.066 0.946 . . . . 0.0 109.638 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -53.58 -56.01 20.8 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.719 -1.134 . . . . 0.0 109.448 175.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 45.2 mttt -64.13 -37.97 89.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.677 1.581 . . . . 0.0 111.192 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.9 m -56.89 -49.17 76.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.451 0.569 . . . . 0.0 109.798 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -65.89 -42.82 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.41 0.684 . . . . 0.0 109.432 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.83 84.53 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 111.993 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.15 1.82 56.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.03 1.332 . . . . 0.0 111.479 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.64 155.79 39.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 162.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.89 -25.3 58.32 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.487 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.15 -47.44 2.94 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.975 1.31 . . . . 0.0 110.795 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 mtt -66.5 -14.21 61.95 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.9 p -57.99 -21.13 43.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.404 1.081 . . . . 0.0 112.825 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.29 -16.19 62.45 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 54' ' ' VAL . 45.2 mt -64.86 149.01 96.97 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 119.892 1.223 . . . . 0.0 112.299 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.14 86.7 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.535 2.823 . . . . 0.0 108.777 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -77.25 99.51 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -107.97 110.6 22.37 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.382 1.073 . . . . 0.0 108.267 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -72.53 123.24 22.75 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.94 96.65 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.3 t -134.46 -170.31 2.51 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.243 1.017 . . . . 0.0 109.88 -169.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.12 -12.13 14.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.844 1.258 . . . . 0.0 112.348 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.81 105.47 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.438 1.017 . . . . 0.0 110.761 -172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.93 4.44 8.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.812 0.845 . . . . 0.0 113.271 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -53.64 115.28 1.89 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.959 1.704 . . . . 0.0 109.724 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -55.25 -45.03 76.07 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.011 0.924 . . . . 0.0 110.119 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -41.91 39.87 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.56 1.144 . . . . 0.0 112.392 172.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.28 -34.38 63.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.583 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.75 -48.93 85.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.248 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mt -57.25 -50.31 77.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 CA-C-N 120.952 1.705 . . . . 0.0 109.336 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.26 -46.29 72.61 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 119.158 0.89 . . . . 0.0 110.304 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.69 76.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 110.867 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.41 99.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.388 0.995 . . . . 0.0 111.803 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.23 -48.36 81.85 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.51 1.924 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -62.56 -38.49 90.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.04 0.936 . . . . 0.0 110.923 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 33.51 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.851 1.215 . . . . 0.0 112.343 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.632 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.53 145.39 44.35 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.11 1.455 . . . . 0.0 109.217 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -73.41 -16.09 61.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.302 0.641 . . . . 0.0 111.736 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.76 173.55 39.34 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.62 136.42 35.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.37 144.82 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.84 138.84 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -52.14 139.51 34.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 165.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.96 137.75 51.43 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 CA-C-N 119.963 1.022 . . . . 0.0 110.5 -8.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.07 150.92 46.3 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.481 0.712 . . . . 0.0 110.077 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -147.98 -173.3 4.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.298 0.639 . . . . 0.0 111.057 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -50.54 -35.41 29.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.479 1.112 . . . . 0.0 109.669 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.81 -19.46 28.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -114.46 -23.36 9.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.24 0.927 . . . . 0.0 112.039 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.09 -50.59 72.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -47.34 74.68 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.287 1.035 . . . . 0.0 111.244 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.25 -52.8 63.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 122.991 0.516 . . . . 0.0 109.851 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.99 -33.17 74.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.222 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.34 -58.02 10.32 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.715 1.143 . . . . 0.0 109.69 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -56.94 -40.01 75.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.867 0.758 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -55.31 -56.46 19.76 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.031 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 -26.11 18.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 120.39 1.45 . . . . 0.0 112.812 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -53.96 -53.53 51.54 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.084 0.856 . . . . 0.0 108.912 169.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.3 -43.83 26.95 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.552 0.341 . . . . 0.0 110.737 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -73.88 -62.01 1.65 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.074 0.549 . . . . 0.0 110.045 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mt -71.93 -43.22 65.62 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.972 0.509 . . . . 0.0 109.776 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.55 32.47 3.39 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.491 -163.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--O 1.253 1.282 0 CA-C-N 118.631 1.215 . . . . 0.0 111.239 172.293 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtp . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.62 163.13 24.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.432 0.693 . . . . 0.0 109.65 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 58.91 86.68 0.08 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 128.329 2.652 . . . . 0.0 108.532 -159.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -76.94 32.53 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.843 1.257 . . . . 0.0 111.937 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 42.86 59.01 3.0 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 128.604 2.762 . . . . 0.0 109.312 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.07 108.22 0.38 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.097 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 169.89 17.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 111.779 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -136.95 101.9 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.988 1.715 . . . . 0.0 108.258 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.9 tp -71.01 131.08 43.13 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.3 99.74 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.37 70.12 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.492 1.917 . . . . 0.0 108.576 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.44 151.67 41.04 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.948 -1.095 . . . . 0.0 108.102 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.5 -42.13 65.18 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.138 -0.976 . . . . 0.0 110.793 169.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -90.96 115.97 28.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.618 1.567 . . . . 0.0 107.02 -173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -57.75 -47.61 81.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.262 0.483 . . . . 0.0 110.078 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -53.57 -40.88 65.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.75 0.705 . . . . 0.0 111.177 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 ttt -58.3 -39.96 80.71 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.546 0.738 . . . . 0.0 110.143 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HG2' ' HE ' ' A' ' 22' ' ' ARG . 14.1 ttp180 -62.13 -46.79 87.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.004 1.322 . . . . 0.0 109.797 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -55.81 -51.93 65.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.744 0.818 . . . . 0.0 108.887 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.51 -62.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.254 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -48.64 -44.23 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 120.828 1.649 . . . . 0.0 110.671 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HE ' ' HG2' ' A' ' 18' ' ' ARG . 59.5 mtt-85 -60.85 -45.44 94.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.669 1.122 . . . . 0.0 111.664 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -63.88 -42.5 97.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.758 0.708 . . . . 0.0 111.748 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.76 -32.41 73.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.922 0.889 . . . . 0.0 111.478 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.16 -56.76 11.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -64.79 -19.47 65.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -51.73 -33.44 34.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.898 1.226 . . . . 0.0 110.804 164.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.9 -41.4 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.975 2.11 . . . . 0.0 110.129 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.86 -139.27 6.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 64.86 60.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 123.173 1.464 . . . . 0.0 110.32 166.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.24 176.18 4.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.539 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 56.41 48.34 17.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 127.483 2.313 . . . . 0.0 113.477 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -55.51 161.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 121.13 -0.981 . . . . 0.0 111.369 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.04 157.5 44.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.279 1.832 . . . . 0.0 107.617 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.17 116.86 19.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.24 163.77 13.49 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 158.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.3 -37.04 58.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.006 0.821 . . . . 0.0 110.432 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.86 174.71 14.57 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.156 1.383 . . . . 0.0 109.237 -169.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.47 -35.31 71.78 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.5 t -66.38 -48.87 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 120.822 2.311 . . . . 0.0 107.152 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.73 -28.86 70.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.816 0.847 . . . . 0.0 111.287 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.68 -56.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.947 1.699 . . . . 0.0 109.43 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.73 -45.62 74.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.105 0.562 . . . . 0.0 109.77 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -65.75 -28.92 69.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.15 0.58 . . . . 0.0 112.161 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -62.93 -52.56 62.58 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.074 0.95 . . . . 0.0 108.804 166.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 HG13 ' A' ' 54' ' ' VAL . 14.1 mt -53.86 -41.45 67.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.704 1.138 . . . . 0.0 111.131 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -72.12 -7.09 47.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -17.6 58.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.463 1.029 . . . . 0.0 111.653 167.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.08 169.96 16.85 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.546 1.067 . . . . 0.0 111.548 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.22 108.2 2.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.244 0.926 . . . . 0.0 113.279 -171.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.49 163.4 27.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.444 1.098 . . . . 0.0 108.749 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.53 -45.06 19.35 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 166.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -135.91 150.59 49.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.599 0.76 . . . . 0.0 112.437 -166.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.682 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -131.63 70.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.082 1.353 . . . . 0.0 108.687 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.18 130.97 34.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.5 m -150.39 158.77 44.53 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.614 -0.679 . . . . 0.0 110.979 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.91 169.08 18.97 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.458 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -83.28 -48.92 9.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.719 1.608 . . . . 0.0 112.372 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.86 79.32 6.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.71 1.604 . . . . 0.0 109.582 -159.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.34 125.29 28.28 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.63 -40.57 29.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.125 2.55 . . . . 0.0 113.7 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -83.54 -101.91 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttp -79.78 106.97 12.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.79 160.61 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.19 -29.72 56.71 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.082 -1.011 . . . . 0.0 112.117 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.01 -43.01 83.97 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.764 0.782 . . . . 0.0 110.842 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.54 -37.55 71.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.611 0.765 . . . . 0.0 110.304 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.3 tp -53.06 -58.62 6.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.211 1.004 . . . . 0.0 108.701 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -48.09 -56.96 6.51 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.089 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -67.41 -24.68 65.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.035 1.289 . . . . 0.0 114.02 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -65.98 -48.27 71.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.257 6.3 mt -55.57 -57.83 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 167.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -23.86 67.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.163 1.385 . . . . 0.0 113.038 -165.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.25 -79.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.507 1.049 . . . . 0.0 110.264 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -168.79 8.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -161.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.73 23.73 1.03 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.99 1.281 . . . . 0.0 115.163 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 65.58 14.7 9.65 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 128.088 2.555 . . . . 0.0 112.251 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.0 mtm -126.71 3.52 6.74 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.9 1.68 . . . . 0.0 110.835 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.8 p -59.52 -25.03 64.14 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.092 0.957 . . . . 0.0 113.285 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -9.43 59.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 113.618 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 54' ' ' VAL . 14.2 mt -56.59 144.22 65.15 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 119.199 0.909 . . . . 0.0 109.821 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.98 79.96 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.261 2.641 . . . . 0.0 109.042 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.91 110.37 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 128.627 2.771 . . . . 0.0 107.746 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.578 HD21 ' HD3' ' A' ' 119' ' ' LYS . 26.7 tp -135.94 113.21 10.6 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.263 -0.898 . . . . 0.0 111.935 -158.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -80.97 129.73 34.68 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.36 105.18 5.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -152.26 166.79 30.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.302 0.501 . . . . 0.0 110.831 -166.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.56 57.05 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.282 -0.886 . . . . 0.0 112.178 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -72.82 96.6 2.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.338 1.455 . . . . 0.0 110.084 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.59 -0.81 52.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.861 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 94' ' ' ASN . 31.6 ttmt -50.71 118.03 2.85 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.559 1.072 . . . . 0.0 109.812 -174.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -50.71 -52.98 35.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.103 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.24 -29.85 69.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.422 1.01 . . . . 0.0 112.625 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.413 ' H ' ' HG2' ' A' ' 91' ' ' LYS . 69.6 m-20 -72.13 -36.33 69.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.203 0.91 . . . . 0.0 110.039 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.3 -44.5 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.66 -48.92 84.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.25 -44.55 83.99 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.427 1.012 . . . . 0.0 110.152 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.95 88.18 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 119.225 0.921 . . . . 0.0 111.236 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.73 92.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.272 0.487 . . . . 0.0 109.874 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -62.15 -49.91 73.97 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.926 2.491 . . . . 0.0 111.283 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.39 -22.1 62.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.608 1.163 . . . . 0.0 111.89 174.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.22 6.11 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.7 1.143 . . . . 0.0 110.327 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -65.52 142.46 58.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.6 p -66.4 -24.36 66.46 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.105 0.562 . . . . 0.0 111.093 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 169.45 38.3 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.92 126.18 28.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.224 1.41 . . . . 0.0 108.563 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -121.08 107.31 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.04 153.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 166.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.43 150.37 34.1 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.548 1.539 . . . . 0.0 109.105 160.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.51 147.75 79.22 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 CA-C-N 121.105 1.43 . . . . 0.0 109.903 -12.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -146.92 138.41 24.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -140.94 -174.75 4.08 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.559 1.544 . . . . 0.0 109.613 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.19 -25.64 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.304 -0.872 . . . . 0.0 110.153 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.12 53.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.202 1.001 . . . . 0.0 112.723 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.6 t -98.6 -27.0 14.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.839 0.745 . . . . 0.0 110.754 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.72 86.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.302 0.956 . . . . 0.0 108.797 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -38.53 91.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.717 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.62 -54.1 22.52 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.747 0.703 . . . . 0.0 110.355 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HD3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -58.72 -38.08 77.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.829 1.195 . . . . 0.0 111.042 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.98 -54.67 44.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.01 0.823 . . . . 0.0 110.629 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.82 -39.64 68.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.85 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -64.99 -45.49 85.4 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.332 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -19.63 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 121.041 1.746 . . . . 0.0 113.414 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -56.54 -62.9 1.41 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 159.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -72.54 -30.37 64.4 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.259 -0.9 . . . . 0.0 112.609 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -68.66 0.65 Allowed 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.95 -23.57 61.47 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 122.954 0.159 . . . . 0.0 110.89 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.53 23.26 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.532 -1.704 . . . . 0.0 110.056 -165.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-N 119.866 1.833 . . . . 0.0 110.476 172.356 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.078 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.73 36.65 0.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 121.533 1.969 . . . . 0.0 110.629 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.58 161.86 33.92 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.29 -159.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -91.36 -1.7 57.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.276 0.63 . . . . 0.0 110.683 159.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 51.97 33.98 12.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.209 1.404 . . . . 0.0 111.325 -161.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.93 123.07 11.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.153 1.781 . . . . 0.0 110.415 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.271 2.4 ptpt -91.86 164.01 13.83 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.31 108.53 12.31 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.371 1.468 . . . . 0.0 108.77 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -82.43 139.33 34.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.79 1.632 . . . . 0.0 109.963 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -135.72 112.45 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.361 1.465 . . . . 0.0 108.448 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.27 41.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.081 1.352 . . . . 0.0 110.324 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.32 154.67 7.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.955 -1.09 . . . . 0.0 108.959 164.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.08 -45.31 11.52 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.22 -1.55 . . . . 0.0 110.744 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -70.6 115.22 9.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.645 1.978 . . . . 0.0 107.636 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -59.64 -39.53 84.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.192 1.36 . . . . 0.0 111.884 -172.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.4 m -55.13 -32.41 62.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.74 0.7 . . . . 0.0 111.45 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 tpp -60.5 -42.46 96.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.231 -0.918 . . . . 0.0 109.947 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -66.18 -34.44 78.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.719 1.145 . . . . 0.0 111.124 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -59.79 -58.77 7.12 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.74 -63.26 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 C-N-CA 125.978 1.711 . . . . 0.0 109.05 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.78 -46.04 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 121.071 1.759 . . . . 0.0 111.267 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -65.51 -41.24 93.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 120.179 1.354 . . . . 0.0 111.518 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -58.15 -54.57 45.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.421 1.088 . . . . 0.0 109.437 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -52.26 -48.53 65.18 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.861 2.064 . . . . 0.0 110.829 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.03 -44.15 82.6 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.318 0.647 . . . . 0.0 110.811 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -77.62 -17.24 57.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.51 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.81 -43.89 94.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.34 1.427 . . . . 0.0 109.287 166.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.07 -37.24 78.39 Favored 'General case' 0 N--CA 1.46 0.038 0 O-C-N 122.179 -0.325 . . . . 0.0 110.596 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.98 6.1 10.32 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.92 1.248 . . . . 0.0 113.885 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.24 155.82 39.77 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.7 1.75 . . . . 0.0 108.942 163.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -149.88 -167.53 2.85 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.322 1.049 . . . . 0.0 108.394 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 55.15 37.93 29.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.108 1.363 . . . . 0.0 111.16 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.29 158.11 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -140.76 166.68 24.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.624 2.37 . . . . 0.0 107.478 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -128.78 155.11 45.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.91 167.75 10.38 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 161.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -42.97 89.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.68 0.792 . . . . 0.0 111.435 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.3 173.87 5.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.038 1.335 . . . . 0.0 108.835 -169.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.33 -42.01 72.98 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 119.923 1.238 . . . . 0.0 113.389 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.11 -51.42 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.86 1.264 . . . . 0.0 109.659 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -70.33 -35.65 73.75 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.754 0.821 . . . . 0.0 111.076 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.31 65.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.568 1.147 . . . . 0.0 109.409 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -54.61 -48.92 71.59 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.721 0.638 . . . . 0.0 111.6 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -66.3 -28.5 68.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -64.19 -46.56 83.39 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.372 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 54' ' ' VAL . 8.2 mt -57.55 -41.69 81.51 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 110.665 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 3.06 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 158.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.82 164.32 11.22 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.969 1.271 . . . . 0.0 111.395 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.17 14.53 78.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.035 0.826 . . . . 0.0 113.167 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -81.46 117.32 21.79 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.44 -25.11 26.78 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.225 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -148.94 149.7 31.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.17 0.988 . . . . 0.0 110.803 -169.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -133.99 85.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.27 127.22 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -152.03 163.64 38.89 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.082 -1.011 . . . . 0.0 110.308 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.35 173.58 5.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.795 0.807 . . . . 0.0 110.278 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 -71.58 -60.69 2.1 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.664 158.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.258 23.7 p30 29.21 -157.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 130.392 3.477 . . . . 0.0 116.215 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 65.15 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.034 1.334 . . . . 0.0 112.504 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 58.3 Cg_endo -65.36 -66.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 121.796 1.664 . . . . 0.0 108.78 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 5.7 m120 -155.61 -69.69 0.12 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.661 2.385 . . . . 0.0 104.953 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.0 ttm -70.01 88.36 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 160.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -65.61 172.01 3.72 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.793 0.837 . . . . 0.0 110.428 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.53 -32.75 53.43 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.988 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -70.46 -49.87 44.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.537 1.169 . . . . 0.0 110.579 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.61 -38.06 89.67 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.472 0.709 . . . . 0.0 110.874 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.0 tp -55.94 -61.31 2.46 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.115 1.366 . . . . 0.0 108.722 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -46.42 -53.52 10.91 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.843 1.257 . . . . 0.0 109.511 174.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 66.6 mttt -66.62 -26.25 66.99 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.126 0.875 . . . . 0.0 113.12 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.2 m -72.87 -43.36 62.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.361 1.064 . . . . 0.0 109.612 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.37 -45.79 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.969 1.308 . . . . 0.0 113.593 166.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -49.3 77.16 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.311 1.044 . . . . 0.0 109.529 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.3 1.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.088 0.955 . . . . 0.0 113.303 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -81.84 -165.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.474 1.033 . . . . 0.0 109.287 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.6 -41.84 0.08 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.989 1.757 . . . . 0.0 110.865 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.88 -8.74 59.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.836 1.255 . . . . 0.0 112.642 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mtm -126.33 -8.39 6.39 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 p -65.34 -17.29 64.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.492 1.042 . . . . 0.0 113.167 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.7 59.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.526 1.13 . . . . 0.0 113.471 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 54' ' ' VAL . 19.5 mt -61.01 133.24 92.48 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.314 0.961 . . . . 0.0 110.271 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.01 125.3 12.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.011 1.807 . . . . 0.0 108.682 166.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.624 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -119.07 107.71 22.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.205 2.202 . . . . 0.0 106.804 -173.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 tp -125.12 115.2 20.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.341 1.057 . . . . 0.0 109.712 -164.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.38 122.35 26.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.92 113.59 24.87 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -156.0 168.9 25.8 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.259 -0.9 . . . . 0.0 110.626 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.32 -21.23 46.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.379 -0.825 . . . . 0.0 111.684 163.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.53 107.35 19.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.231 1.012 . . . . 0.0 111.227 -167.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -73.56 0.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.989 171.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.1 tttt 32.73 98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.828 2.451 . . . . 0.0 113.381 -167.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -52.45 -41.51 63.36 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.287 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.73 -36.27 69.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.151 1.342 . . . . 0.0 112.752 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.81 -36.41 70.24 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 121.536 -0.727 . . . . 0.0 110.085 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.1 mt -63.46 -39.17 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.642 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.3 -53.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.51 -46.45 70.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.987 0.812 . . . . 0.0 110.654 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.47 73.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.916 0.886 . . . . 0.0 110.741 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.88 99.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.43 0.692 . . . . 0.0 110.147 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -60.84 -50.89 71.63 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.312 1.845 . . . . 0.0 111.17 175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.46 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -59.62 -22.65 62.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.918 0.887 . . . . 0.0 112.267 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.78 11.73 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.544 -1.142 . . . . 0.0 112.281 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.04 134.96 57.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.415 1.107 . . . . 0.0 108.805 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 m -67.64 -10.08 49.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.201 1.001 . . . . 0.0 112.255 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.06 170.54 38.2 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.332 0.969 . . . . 0.0 111.345 166.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.14 132.32 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.276 1.43 . . . . 0.0 107.681 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.39 104.79 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 156.68 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -58.21 151.08 49.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 158.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.27 148.36 91.04 Favored 'Cis proline' 0 N--CA 1.457 -0.632 0 CA-C-N 119.653 0.912 . . . . 0.0 110.633 -9.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -149.44 154.47 38.89 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.322 0.649 . . . . 0.0 110.088 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 p -143.81 -175.19 4.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.363 1.065 . . . . 0.0 109.46 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -29.62 60.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.599 0.76 . . . . 0.0 110.3 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.77 67.98 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 t -99.57 -27.61 13.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.85 1.204 . . . . 0.0 110.224 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -50.63 70.21 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -37.21 84.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.863 1.265 . . . . 0.0 112.249 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.98 -57.19 13.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.865 1.266 . . . . 0.0 109.14 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -66.01 -34.16 77.45 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.489 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 mt -59.54 -55.1 38.85 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.187 175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.465 ' HA ' ' CD2' ' A' ' 124' ' ' PHE . 18.7 t-20 -64.37 -30.56 71.6 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 118.283 0.492 . . . . 0.0 110.412 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -60.2 3.51 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.029 167.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.4 pt -71.15 -26.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.426 1.466 . . . . 0.0 113.86 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 121' ' ' ASN . 21.6 m-30 -59.47 -39.07 82.5 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.092 0.86 . . . . 0.0 109.918 170.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.58 -40.22 17.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.008 0.523 . . . . 0.0 110.71 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HG3' HD23 ' A' ' 127' ' ' LEU . 32.1 tptt -77.14 -71.7 0.39 Allowed 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.564 1.145 . . . . 0.0 108.125 -168.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.429 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.3 mt -68.28 -20.41 64.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.269 0.486 . . . . 0.0 111.105 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 38.47 30.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -167.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.7 mmm . . . . . 0 C--O 1.25 1.093 0 CA-C-N 117.882 0.841 . . . . 0.0 109.377 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.62 -157.82 0.71 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.586 1.554 . . . . 0.0 108.676 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -84.53 -178.22 6.83 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.381 1.072 . . . . 0.0 108.747 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -14.85 61.77 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.909 158.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 50.01 61.19 3.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.676 1.991 . . . . 0.0 107.546 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt -49.12 104.14 0.06 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.145 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 177.14 6.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.987 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.76 124.39 43.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.168 2.187 . . . . 0.0 106.091 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.13 134.52 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 158.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.66 92.54 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.5 t -95.84 51.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.24 105.24 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -47.99 -43.12 29.42 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.784 1.634 . . . . 0.0 112.103 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.75 116.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.304 1.041 . . . . 0.0 108.521 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -52.35 -51.45 58.76 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.164 0.986 . . . . 0.0 110.77 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -52.17 -39.35 59.95 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.417 -0.802 . . . . 0.0 111.346 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 ttp -61.43 -42.06 98.16 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.11 98.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.854 1.207 . . . . 0.0 109.944 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -57.46 -57.44 12.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -49.07 -60.81 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.772 1.629 . . . . 0.0 108.866 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.38 -51.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 120.388 1.449 . . . . 0.0 111.055 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -41.17 91.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.07 0.85 . . . . 0.0 111.052 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.27 -53.94 47.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.91 -34.28 69.67 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.586 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -60.09 -62.71 1.67 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.873 0.869 . . . . 0.0 109.314 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -65.24 -14.33 60.43 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.08 -7.98 34.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.425 1.49 . . . . 0.0 113.152 166.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.5 mt -126.01 7.79 7.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.485 3.114 . . . . 0.0 112.086 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 -144.13 22.67 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.33 40.39 18.28 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.189 1.495 . . . . 0.0 113.3 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.08 171.08 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.498 -0.751 . . . . 0.0 110.936 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 98.57 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.29 3.036 . . . . 0.0 107.139 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.754 -0.591 . . . . 0.0 110.156 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -132.14 175.43 9.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.81 2.044 . . . . 0.0 107.615 167.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -127.3 166.33 18.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.54 1.536 . . . . 0.0 107.379 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.68 168.36 9.84 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 159.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.75 -26.33 62.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.731 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.32 174.76 0.45 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.031 1.732 . . . . 0.0 107.674 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.25 -39.41 42.83 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.005 1.288 . . . . 0.0 115.428 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.57 -43.95 92.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.048 1.424 . . . . 0.0 109.918 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.07 -28.05 60.2 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.561 1.144 . . . . 0.0 110.652 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -62.11 -46.25 89.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.009 0.924 . . . . 0.0 110.102 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.11 -45.16 95.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.768 -0.635 . . . . 0.0 109.324 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -57.75 -44.55 86.16 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.646 0.657 . . . . 0.0 111.661 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -53.51 -50.87 64.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.751 0.82 . . . . 0.0 109.778 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -35.62 80.28 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.209 0.604 . . . . 0.0 112.017 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.02 -1.34 7.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.816 0.846 . . . . 0.0 112.19 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.6 12.93 7.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.572 1.949 . . . . 0.0 112.495 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.33 163.97 23.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.214 1.37 . . . . 0.0 113.857 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.97 78.96 1.85 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -70.76 119.62 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.61 -19.89 79.73 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.523 -168.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -132.09 150.46 52.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 127.046 2.138 . . . . 0.0 106.416 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 81' ' ' LEU . 13.4 t -137.56 72.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -77.33 143.73 12.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 p -149.71 163.13 38.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.659 0.663 . . . . 0.0 111.011 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.45 179.97 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.461 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 29.0 t-105 -71.04 -78.13 0.08 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 162.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.2 t30 43.1 178.16 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.956 2.902 . . . . 0.0 112.606 -164.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.2 mtm -140.33 68.26 32.63 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 119.053 -2.28 . . . . 0.0 110.553 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.49 49.0 2.32 Favored 'Trans proline' 0 CA--C 1.543 0.964 1 C-N-CA 125.467 4.111 . . . . 0.0 110.791 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 72.88 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.439 1.495 . . . . 0.0 108.709 -159.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.2 ttm -79.52 81.73 5.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.16 159.78 2.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.543 1.137 . . . . 0.0 110.675 167.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.96 59.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.369 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -74.39 -46.86 37.61 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.584 1.154 . . . . 0.0 109.313 174.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.27 -38.3 90.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.559 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.02 -53.81 54.07 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.301 0.955 . . . . 0.0 109.21 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -48.85 -56.1 9.72 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -66.17 -28.69 68.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 120.384 1.447 . . . . 0.0 114.078 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.5 m -71.98 -33.75 68.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.262 0.937 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.4 mt -73.36 -48.37 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.962 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.66 24.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.508 3.123 . . . . 0.0 111.475 171.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.8 -72.42 0.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 108.146 172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 157.21 -11.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 129.398 3.079 . . . . 0.0 112.455 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 20.43 0.18 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 126.946 2.212 . . . . 0.0 116.569 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 92.86 -12.31 0.17 Allowed 'General case' 0 N--CA 1.461 0.099 1 C-N-CA 133.37 4.668 . . . . 0.0 110.961 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.1 mtt -76.48 -18.87 58.54 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.649 -0.657 . . . . 0.0 110.815 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -61.53 -25.08 67.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.424 1.089 . . . . 0.0 113.341 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -16.5 61.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 54' ' ' VAL . 32.8 mt -60.5 141.7 91.55 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 118.472 0.578 . . . . 0.0 111.465 -169.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 72.69 5.78 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.707 2.271 . . . . 0.0 108.423 166.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -60.53 137.77 22.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 160.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' CD1' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp -147.97 111.6 5.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -160.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.93 123.14 24.55 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.7 102.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -142.35 174.74 10.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.179 0.99 . . . . 0.0 110.281 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.78 -23.5 19.7 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.814 0.846 . . . . 0.0 111.617 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -86.5 111.32 20.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.756 0.707 . . . . 0.0 109.141 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.96 -73.52 0.07 Allowed 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 166.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 tptp 43.78 91.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.538 1.637 . . . . 0.0 112.432 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -52.16 -34.65 45.89 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.2 -0.938 . . . . 0.0 112.889 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.34 -36.03 80.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.293 1.406 . . . . 0.0 111.692 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -63.31 -38.91 93.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.236 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.54 -49.99 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.565 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.46 -55.53 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 119.542 1.065 . . . . 0.0 108.341 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.12 79.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.924 0.489 . . . . 0.0 110.769 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.16 90.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.919 -0.488 . . . . 0.0 110.543 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.45 77.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -61.4 -49.99 74.65 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.718 1.607 . . . . 0.0 109.672 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -28.19 69.07 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.927 0.491 . . . . 0.0 111.233 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.5 42.03 6.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 124.74 1.162 . . . . 0.0 111.338 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.18 156.87 11.44 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 72.8 p -64.93 -22.77 67.05 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.301 -0.874 . . . . 0.0 111.948 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.12 -175.95 37.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.69 1.614 . . . . 0.0 109.426 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -136.74 91.03 2.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.673 1.189 . . . . 0.0 108.046 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -75.3 125.97 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.88 144.15 16.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -75.8 162.34 72.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -64.12 145.75 60.93 Favored 'Cis proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.714 0.934 . . . . 0.0 109.782 -12.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -139.2 162.16 35.66 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.086 0.955 . . . . 0.0 109.235 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -142.88 171.98 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.354 1.061 . . . . 0.0 110.109 -164.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.83 69.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.642 0.777 . . . . 0.0 112.401 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t -81.76 -33.27 31.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.981 1.264 . . . . 0.0 110.119 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -50.99 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.552 1.069 . . . . 0.0 109.017 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -41.57 92.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.125 1.77 . . . . 0.0 111.073 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.95 -42.44 98.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.303 1.041 . . . . 0.0 109.156 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HE3' ' CD1' ' A' ' 84' ' ' LEU . 3.2 mmmp? -68.95 -29.72 68.02 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.712 -1.613 . . . . 0.0 112.384 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -54.48 24.41 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -55.32 -42.92 74.41 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 118.225 0.466 . . . . 0.0 111.258 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -51.23 -60.04 3.55 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.39 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 104' ' ' SER . 15.4 pt -67.57 -32.66 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 121.343 1.883 . . . . 0.0 113.757 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -58.63 -45.09 90.01 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.701 0.682 . . . . 0.0 109.632 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.47 -34.17 15.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -76.1 -72.43 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -37.0 79.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.266 0.627 . . . . 0.0 109.333 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.01 41.58 4.58 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -164.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.246 0.9 0 CA-C-N 118.501 1.151 . . . . 0.0 110.883 175.479 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.44 111.33 22.09 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.563 1.545 . . . . 0.0 109.367 -166.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -72.14 -9.29 58.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.25 0.62 . . . . 0.0 112.482 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.19 6.59 0.72 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.091 2.156 . . . . 0.0 114.468 -164.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -71.22 -21.96 62.07 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.641 1.11 . . . . 0.0 112.904 168.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -52.13 123.27 10.19 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.595 1.158 . . . . 0.0 107.938 -174.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.93 161.71 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.574 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.8 95.28 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -69.31 138.91 54.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.0 1.273 . . . . 0.0 109.492 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -131.67 115.5 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.7 t -130.69 76.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.23 159.84 18.68 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.853 0.835 . . . . 0.0 111.342 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.55 97.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.199 1.4 . . . . 0.0 111.212 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD2' ' HB ' ' A' ' 16' ' ' THR . 1.2 t80 -90.0 -63.85 1.22 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.683 0.393 . . . . 0.0 110.528 -159.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 m 127.28 -59.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 1 C-N-CA 133.273 4.629 . . . . 0.0 106.875 -161.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 91.8 m -65.59 -33.75 76.63 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.771 -174.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -61.5 -27.25 68.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.23 1.377 . . . . 0.0 110.207 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD3' ' HG3' ' A' ' 35' ' ' GLU . 13.3 ttm180 -63.47 -47.73 80.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.477 1.035 . . . . 0.0 109.589 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -48.43 80.94 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.762 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.36 -47.01 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.0 1.32 . . . . 0.0 111.228 -172.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -54.03 -50.75 65.98 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.35 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.28 -43.44 91.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.235 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 mt -55.12 -43.14 73.83 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.244 0.929 . . . . 0.0 109.848 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.7 -48.81 70.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.548 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -64.85 -33.63 76.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.118 -0.944 . . . . 0.0 112.473 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -58.41 -30.76 67.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.491 1.041 . . . . 0.0 110.908 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.96 12.25 37.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.24 1.816 . . . . 0.0 111.699 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -33.67 5.04 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.641 1.591 . . . . 0.0 113.317 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -61.38 140.01 58.09 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.929 1.365 . . . . 0.0 110.633 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 177.47 7.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.075 0.94 . . . . 0.0 111.403 -168.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.251 21.4 t30 67.96 34.0 4.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.77 2.828 . . . . 0.0 113.503 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 154.97 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.474 0.654 . . . . 0.0 109.723 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.33 179.41 6.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.454 2.701 . . . . 0.0 108.019 -163.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 31.0 tt0 -145.88 152.27 39.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.848 -0.532 . . . . 0.0 111.614 -164.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.21 172.5 12.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.793 1.237 . . . . 0.0 108.93 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -68.46 -47.69 66.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.746 0.818 . . . . 0.0 112.726 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.84 168.01 10.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.85 2.06 . . . . 0.0 107.335 -158.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.6 -38.02 27.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.723 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.0 t -63.41 -51.01 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.706 2.253 . . . . 0.0 107.555 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.97 -28.69 69.99 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 0.0 110.829 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -69.57 -42.9 73.92 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.947 1.699 . . . . 0.0 111.37 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -65.62 -43.54 89.26 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -56.52 -39.71 73.8 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.155 0.982 . . . . 0.0 111.058 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.31 -61.46 2.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.365 0.984 . . . . 0.0 109.252 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.37 -49.8 60.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -168.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.72 -2.87 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.4 -11.5 59.25 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.822 1.192 . . . . 0.0 112.969 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.71 5.82 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 119.199 2.44 . . . . 0.0 119.199 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.42 73.71 0.64 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 120.603 2.202 . . . . 0.0 110.377 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.17 109.21 2.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.39 -10.75 24.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.338 -0.701 . . . . 0.0 114.398 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.4 144.68 42.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.143 1.377 . . . . 0.0 109.159 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -132.13 91.24 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -108.49 125.69 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -143.03 168.05 20.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.852 0.834 . . . . 0.0 110.896 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.83 170.18 10.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 158.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -84.91 -51.68 6.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.455 1.502 . . . . 0.0 108.307 162.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -87.24 72.49 9.88 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.61 1.564 . . . . 0.0 110.192 -159.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 tpt -124.77 125.51 25.45 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 -0.31 9.73 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.748 2.299 . . . . 0.0 115.067 -161.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -107.25 -96.24 0.37 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.3 ttm -91.07 89.9 7.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.28 155.11 5.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.089 172.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.78 -31.79 58.34 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.03 -0.872 . . . . 0.0 112.203 -172.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -36.5 72.4 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.871 1.335 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -68.09 -41.5 81.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.011 175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.63 -49.11 79.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.784 0.72 . . . . 0.0 109.575 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -50.59 -63.11 1.23 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.836 1.254 . . . . 0.0 108.106 172.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -63.22 -27.48 69.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.94 1.246 . . . . 0.0 113.398 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.1 m -61.74 -53.87 50.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.394 0.997 . . . . 0.0 108.884 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -62.51 -46.05 97.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.671 1.188 . . . . 0.0 110.21 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.58 7.91 0.56 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.698 1.999 . . . . 0.0 113.215 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.54 65.09 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 120.961 1.709 . . . . 0.0 111.862 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 130.35 -79.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.21 3.404 . . . . 0.0 107.998 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.95 39.85 2.06 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 126.502 2.001 . . . . 0.0 112.098 -170.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.89 -76.86 0.3 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.983 1.313 . . . . 0.0 108.055 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.571 ' HB3' HD12 ' A' ' 81' ' ' LEU . 37.1 mtm -142.6 15.03 1.97 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -55.06 -23.99 22.96 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 121.743 2.065 . . . . 0.0 114.451 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -9.57 53.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.596 1.089 . . . . 0.0 113.255 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 54' ' ' VAL . 16.9 mt -78.02 128.93 77.36 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 121.129 -0.982 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 91.02 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.387 2.058 . . . . 0.0 109.749 170.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 69' ' ' LEU . 2.7 m -75.76 107.85 7.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 167.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 tp -112.6 113.97 26.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.269 1.427 . . . . 0.0 108.562 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.9 mmt -85.67 125.93 33.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.03 88.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -122.62 174.21 7.22 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 113.657 -161.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.58 -21.69 26.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 111.662 164.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -86.18 106.74 17.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.781 1.232 . . . . 0.0 110.972 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.23 8.62 15.23 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.476 -0.765 . . . . 0.0 112.587 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -51.96 121.35 6.54 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.242 1.017 . . . . 0.0 108.927 -171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -38.71 76.89 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.275 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.36 -32.32 64.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.489 1.04 . . . . 0.0 112.329 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.72 -39.56 61.82 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.732 0.696 . . . . 0.0 109.495 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.43 -46.96 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.36 -57.44 4.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.34 -45.44 80.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.335 1.054 . . . . 0.0 110.71 -172.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.78 96.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.22 -15.25 61.0 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -75.05 -51.73 12.82 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.266 1.426 . . . . 0.0 108.011 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.53 78.04 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.501 0.72 . . . . 0.0 111.905 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.79 58.84 2.07 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.106 1.336 . . . . 0.0 110.502 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.61 162.35 5.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.398 0.599 . . . . 0.0 110.834 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -62.42 -43.06 99.73 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.41 173.18 46.1 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 125.472 1.51 . . . . 0.0 110.152 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 135.23 46.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.327 1.851 . . . . 0.0 107.288 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.0 t -134.47 145.86 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 128.327 2.651 . . . . 0.0 104.763 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t -127.63 164.48 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -49.85 141.18 14.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.284 160.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -78.35 173.49 56.27 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 120.702 1.287 . . . . 0.0 109.337 -20.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -177.28 151.5 0.79 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.596 -1.315 . . . . 0.0 108.619 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -153.77 -179.33 7.72 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 127.285 2.234 . . . . 0.0 108.275 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.5 -29.7 62.13 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.321 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.59 33.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.857 1.263 . . . . 0.0 113.076 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.26 -30.8 13.25 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.808 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -48.74 79.08 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.751 1.16 . . . . 0.0 108.331 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -40.7 97.03 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.617 1.167 . . . . 0.0 111.51 -176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.3 -40.4 77.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.9 0.88 . . . . 0.0 109.042 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HE2' ' HE3' ' A' ' 122' ' ' LYS . 50.4 mmtt -65.7 -40.82 92.69 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.648 -1.282 . . . . 0.0 110.527 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.0 mt -55.44 -49.7 71.77 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.776 0.831 . . . . 0.0 108.968 170.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.81 -38.58 88.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.065 0.848 . . . . 0.0 112.612 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE3' ' HE2' ' A' ' 119' ' ' LYS . 9.2 mtmm -55.5 -52.49 63.49 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.027 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.7 pt -73.68 -24.78 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 120.192 1.36 . . . . 0.0 113.473 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -56.95 -59.55 4.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.24 -43.72 73.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.085 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -69.82 0.33 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.61 -29.38 65.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.7 30.53 13.11 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 117.907 -1.496 . . . . 0.0 109.756 -160.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mmm . . . . . 0 C--O 1.247 0.95 0 CA-C-N 120.135 1.967 . . . . 0.0 109.417 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.12 -172.7 4.12 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -123.4 157.4 33.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.33 -23.32 66.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.199 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 47.66 60.34 3.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.496 1.918 . . . . 0.0 109.157 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.6 OUTLIER -41.53 108.82 0.1 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.563 1.545 . . . . 0.0 110.209 173.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.61 29.9 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.97 152.84 19.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.14 134.65 54.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 162.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.84 108.33 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.3 t -125.33 69.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.02 156.85 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -67.11 -55.46 14.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.06 1.3 . . . . 0.0 109.258 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.2 t80 -70.9 115.82 10.49 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.95 -48.43 70.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.739 1.216 . . . . 0.0 111.326 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 25.1 m -62.66 -26.03 68.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.006 0.922 . . . . 0.0 111.82 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.3 ttm -58.42 -29.32 66.01 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.713 1.142 . . . . 0.0 109.893 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -70.39 -30.76 67.74 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.032 0.833 . . . . 0.0 110.26 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -61.49 -51.22 69.54 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.447 1.021 . . . . 0.0 108.354 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.63 -60.38 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.34 0.656 . . . . 0.0 109.798 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.92 -52.81 12.53 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 126.057 1.743 . . . . 0.0 109.774 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -56.47 -47.76 78.5 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.089 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -59.12 -44.75 92.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 119.933 1.242 . . . . 0.0 110.143 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.55 -36.87 83.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 110.68 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -66.36 0.51 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.391 1.076 . . . . 0.0 109.996 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -25.59 68.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.502 1.121 . . . . 0.0 112.092 -167.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -15.11 51.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.684 1.129 . . . . 0.0 112.57 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -147.03 19.05 1.25 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 112.103 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.1 28.64 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.349 -0.844 . . . . 0.0 111.804 -161.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -57.37 123.35 15.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.981 1.712 . . . . 0.0 110.918 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -72.12 -3.06 20.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.916 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -118.74 128.48 54.53 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.019 1.327 . . . . 0.0 107.766 -158.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.79 165.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 125.77 1.628 . . . . 0.0 107.304 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -127.04 161.18 29.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -125.63 127.13 45.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -83.6 173.92 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 170.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.48 -46.46 66.58 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.4 -0.812 . . . . 0.0 110.568 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.24 175.25 6.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.024 1.73 . . . . 0.0 108.187 -163.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.75 -43.23 29.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.376 0.989 . . . . 0.0 114.111 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.78 -52.07 64.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 119.022 1.411 . . . . 0.0 108.694 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.67 -21.95 66.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.361 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.02 -47.42 68.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.347 1.431 . . . . 0.0 109.543 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.62 -46.02 87.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.319 0.581 . . . . 0.0 109.668 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -60.35 -44.78 95.24 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.719 0.807 . . . . 0.0 111.536 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.9 mmtm -59.41 -41.38 89.35 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.001 1.32 . . . . 0.0 110.219 172.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -59.09 -43.9 91.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.344 0.975 . . . . 0.0 111.347 178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.66 -0.21 29.1 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.66 4.38 40.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.735 1.152 . . . . 0.0 112.958 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.14 -172.39 34.63 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 120.496 -1.377 . . . . 0.0 112.035 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.85 79.41 1.58 Allowed Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -75.53 165.48 25.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 159.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -139.52 -7.59 1.04 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.852 173.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -144.33 135.22 25.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.598 1.199 . . . . 0.0 108.423 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.72 117.96 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -165.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.83 134.04 67.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.727 1.611 . . . . 0.0 106.902 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 m -150.81 159.69 44.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.978 0.354 . . . . 0.0 111.432 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.98 157.92 32.54 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 166.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -67.99 -47.14 69.33 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 110.408 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.439 HD21 ' HG2' ' A' ' 89' ' ' GLU . 86.7 m-20 -80.81 59.04 3.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.674 1.19 . . . . 0.0 110.998 -159.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mmt -93.46 160.05 33.84 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 122.791 0.437 . . . . 0.0 110.661 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 162.39 36.32 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.803 2.335 . . . . 0.0 108.916 165.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 50.99 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.298 1.839 . . . . 0.0 113.143 170.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.8 ttm -82.01 86.5 6.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.447 1.099 . . . . 0.0 108.313 168.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.12 154.81 1.46 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.192 1.397 . . . . 0.0 110.143 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.43 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.501 -1.374 . . . . 0.0 113.161 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.51 -33.61 71.38 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.313 1.057 . . . . 0.0 110.263 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -72.12 -35.11 69.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.894 . . . . 0.0 110.57 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -53.46 57.3 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.707 0.685 . . . . 0.0 109.582 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -50.17 -56.53 10.62 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 34.6 mttm -66.29 -27.97 68.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.742 1.156 . . . . 0.0 114.038 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -70.77 -46.89 62.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.423 1.01 . . . . 0.0 108.742 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.41 -43.88 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.342 0.657 . . . . 0.0 109.356 172.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -24.03 60.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.218 1.407 . . . . 0.0 112.228 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.64 -1.1 23.05 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.765 1.226 . . . . 0.0 112.042 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.3 135.65 40.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.124 0.875 . . . . 0.0 108.721 174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.19 -23.69 74.74 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.038 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.32 -60.53 1.92 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.294 1.047 . . . . 0.0 108.89 168.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.7 mmt -68.24 -8.67 41.22 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -160.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -48.13 -29.76 3.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.419 1.009 . . . . 0.0 112.098 165.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.05 -11.85 61.18 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -66.98 134.05 93.9 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 119.959 1.254 . . . . 0.0 109.077 -174.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 94.1 Cg_endo -78.78 56.6 6.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 0.0 111.587 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HD13 ' A' ' 69' ' ' LEU 0.254 2.4 m -47.58 107.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.213 1.005 . . . . 0.0 112.233 170.432 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -106.42 117.46 34.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.711 1.604 . . . . 0.0 107.839 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.44 123.08 31.99 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.98 107.06 11.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -144.78 178.42 8.01 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.016 0.912 . . . . 0.0 111.466 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.9 -29.39 32.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.084 0.953 . . . . 0.0 111.893 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' HG2' HD21 ' A' ' 59' ' ' ASN . 48.5 mm-40 -74.88 107.86 7.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.946 0.498 . . . . 0.0 110.237 -170.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -72.63 18.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.048 -1.033 . . . . 0.0 111.708 162.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.37 110.31 0.84 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 125.267 1.427 . . . . 0.0 109.001 -168.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -40.34 -59.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 112.621 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.05 -31.18 62.92 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.841 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.1 -38.67 61.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.709 1.14 . . . . 0.0 109.619 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.35 -55.87 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.97 -47.12 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.84 -41.26 77.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.098 1.317 . . . . 0.0 109.789 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.74 -53.28 59.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.801 0.728 . . . . 0.0 110.902 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.99 -27.15 67.92 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.325 0.65 . . . . 0.0 112.534 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -73.65 -52.89 11.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.704 2.002 . . . . 0.0 109.407 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -55.58 -40.36 71.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.684 0.794 . . . . 0.0 111.134 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.0 2.47 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.412 1.482 . . . . 0.0 113.217 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.98 156.6 6.63 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.536 1.168 . . . . 0.0 111.195 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 5.2 p -70.83 -28.11 64.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.654 0.382 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.71 171.7 38.42 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -130.78 139.22 50.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.009 1.324 . . . . 0.0 108.037 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.86 137.73 42.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 126.44 1.896 . . . . 0.0 106.004 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 90' ' ' ALA . 48.3 t -130.22 144.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -52.46 145.85 18.88 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.105 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.61 10.09 60.82 Favored 'Cis proline' 0 C--N 1.348 0.508 0 N-CA-C 116.992 1.882 . . . . 0.0 116.992 8.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.8 p90 15.79 114.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 130.768 3.627 . . . . 0.0 116.564 -175.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -89.73 166.5 13.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.821 -1.174 . . . . 0.0 112.553 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.02 -33.83 73.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 166.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.36 -13.39 5.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.684 1.594 . . . . 0.0 115.013 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -28.67 7.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.497 1.499 . . . . 0.0 111.225 171.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.38 -51.13 71.1 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.292 1.037 . . . . 0.0 111.181 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -66.83 -44.18 81.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -66.92 -35.55 80.26 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.223 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.08 -57.9 11.01 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.039 0.935 . . . . 0.0 109.029 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -47.74 -45.26 28.78 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.288 1.035 . . . . 0.0 111.049 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -68.8 0.14 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.657 174.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.7 pt -66.94 -26.75 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 120.212 1.369 . . . . 0.0 113.704 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -56.22 -57.33 12.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -84.39 -34.02 23.66 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.788 -0.57 . . . . 0.0 111.326 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -64.23 -72.81 0.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.381 1.472 . . . . 0.0 109.739 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.51 -38.49 62.82 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.023 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.2 22.14 6.65 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.609 -1.106 . . . . 0.0 112.366 -166.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.3 mmt . . . . . 0 C--O 1.251 1.182 0 CA-C-N 119.587 1.694 . . . . 0.0 112.275 -175.182 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.07 147.88 6.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.388 1.475 . . . . 0.0 107.547 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.22 162.68 24.86 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.894 0.877 . . . . 0.0 112.034 -161.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -56.25 -9.84 0.75 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.395 1.878 . . . . 0.0 113.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.35 26.25 15.08 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.703 1.601 . . . . 0.0 111.663 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.66 116.22 2.79 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 108.99 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.67 165.2 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.856 0.463 . . . . 0.0 110.993 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.95 91.79 3.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 163.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.31 131.0 44.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -135.89 125.28 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.36 67.66 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -84.92 166.71 16.58 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.896 -1.128 . . . . 0.0 111.241 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -19.74 65.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.969 0.908 . . . . 0.0 113.355 -169.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.84 131.64 21.42 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.624 1.97 . . . . 0.0 105.894 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -52.55 -41.23 63.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.678 0.672 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.6 m -51.33 -47.11 62.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.647 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.1 mtm -59.7 -35.36 74.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.446 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -68.03 -31.11 70.56 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 120.055 1.298 . . . . 0.0 110.482 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -69.39 -50.21 48.15 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.93 -61.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.165 1.386 . . . . 0.0 109.643 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.6 t -51.9 -49.38 37.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.33 1.452 . . . . 0.0 109.793 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.4 ttt85 -54.95 -48.51 73.09 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 119.385 0.993 . . . . 0.0 110.635 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -52.7 63.72 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.479 0.712 . . . . 0.0 109.688 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 113' ' ' ALA . 75.1 mt -58.27 -42.41 86.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.373 1.069 . . . . 0.0 110.435 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.96 -48.49 81.33 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 110.722 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -65.73 -33.48 75.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.599 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -45.87 92.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.081 1.309 . . . . 0.0 109.224 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.4 mt -66.21 -43.26 87.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.757 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.38 -5.44 1.39 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.398 0.999 . . . . 0.0 114.226 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -73.85 152.52 40.2 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.765 1.226 . . . . 0.0 109.789 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -145.5 179.04 7.68 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.397 -0.814 . . . . 0.0 110.518 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 53.98 58.85 4.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.656 1.982 . . . . 0.0 111.463 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 22' ' ' ARG . 30.7 m -66.45 160.08 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.322 162.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.51 169.69 16.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.126 1.77 . . . . 0.0 108.367 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -130.05 142.15 50.65 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.547 1.939 . . . . 0.0 106.939 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.53 170.22 8.59 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 159.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -24.87 30.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.987 0.358 . . . . 0.0 111.228 170.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.69 175.57 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.307 1.443 . . . . 0.0 108.697 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -62.89 -35.16 91.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.332 1.92 . . . . 0.0 114.606 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.02 -49.53 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 120.309 2.055 . . . . 0.0 107.934 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -58.57 -39.28 79.87 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.858 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.1 99.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.269 1.395 . . . . 0.0 111.547 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.41 -43.39 90.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -65.11 -42.55 93.85 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.388 -0.195 . . . . 0.0 111.469 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -52.94 -50.35 64.18 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 127.533 2.333 . . . . 0.0 108.854 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.97 -48.0 83.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.433 0.56 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.46 -11.04 56.91 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.87 24.23 12.92 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.763 2.425 . . . . 0.0 110.858 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.43 161.08 28.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 31.05 8.44 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 162.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -70.16 89.05 0.62 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.02 1.328 . . . . 0.0 109.069 -161.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -3.44 50.22 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.555 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -138.98 129.87 26.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.601 1.2 . . . . 0.0 109.083 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 81' ' ' LEU . 11.4 t -133.98 124.42 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -168.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.76 134.32 60.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 127.379 2.272 . . . . 0.0 106.25 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.9 p -152.03 163.54 39.09 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.385 0.538 . . . . 0.0 111.069 173.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.4 159.98 28.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.032 160.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CH2' ' HG ' ' A' ' 66' ' ' LEU . 23.6 t-105 -72.64 -58.53 3.29 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.587 1.955 . . . . 0.0 111.422 169.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.5 19.39 0.13 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.998 2.119 . . . . 0.0 112.822 -160.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.558 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -61.68 129.21 91.24 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 126.113 1.765 . . . . 0.0 107.553 -170.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.8 157.85 54.02 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 N-CA-C 109.402 -1.038 . . . . 0.0 109.402 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.77 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.249 1.42 . . . . 0.0 109.992 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.2 ttp -91.33 91.32 8.1 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.159 0.984 . . . . 0.0 108.878 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.88 153.47 1.29 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 109.027 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.54 -31.54 63.53 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 120.885 -1.134 . . . . 0.0 112.456 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -68.78 -36.84 78.8 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.633 0.717 . . . . 0.0 110.644 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.19 -41.65 70.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.047 0.939 . . . . 0.0 109.546 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp -56.39 -50.12 72.49 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.578 1.151 . . . . 0.0 109.469 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -52.69 -61.47 2.27 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 124.957 1.303 . . . . 0.0 108.866 173.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 66' ' ' LEU . 90.7 mttt -62.66 -27.66 69.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.903 1.229 . . . . 0.0 112.382 -173.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.3 m -64.46 -55.73 18.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.117 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.76 -36.45 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.323 1.449 . . . . 0.0 111.448 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -21.92 61.9 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 120.883 -1.135 . . . . 0.0 111.258 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.76 2.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.493 1.042 . . . . 0.0 110.108 171.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 61.53 -121.32 0.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.842 2.057 . . . . 0.0 112.066 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.65 17.9 55.07 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.605 1.093 . . . . 0.0 111.056 -158.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.74 2.87 3.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 129.001 2.92 . . . . 0.0 113.844 -164.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.1 mtt -93.04 -3.12 54.88 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.418 1.087 . . . . 0.0 113.442 -168.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 t -61.11 -21.17 63.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.119 1.327 . . . . 0.0 112.214 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.96 -2.01 25.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.849 1.26 . . . . 0.0 113.817 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 54' ' ' VAL . 83.7 mt -79.77 129.76 69.81 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 119.783 1.174 . . . . 0.0 109.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.47 58.02 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.128 2.552 . . . . 0.0 111.925 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -47.24 108.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.979 1.712 . . . . 0.0 111.028 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 tp -112.97 119.6 38.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.852 1.661 . . . . 0.0 108.901 -165.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -82.92 118.73 23.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.16 110.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.219 1.408 . . . . 0.0 108.47 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -157.62 169.76 23.92 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.555 0.693 . . . . 0.0 110.401 -167.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.76 -23.0 62.33 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.239 -0.913 . . . . 0.0 112.179 160.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -81.26 112.03 18.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.007 0.821 . . . . 0.0 112.001 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.51 -88.25 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 160.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? 49.81 99.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.126 1.371 . . . . 0.0 111.2 -169.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -41.32 -48.83 3.71 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.4 -0.812 . . . . 0.0 111.765 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -58.87 -37.69 77.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -60.18 -43.99 95.43 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.031 0.832 . . . . 0.0 109.487 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.21 -43.69 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.18 -58.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.33 70.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 111.059 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.82 80.08 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.047 0.939 . . . . 0.0 110.059 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.93 79.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.879 0.472 . . . . 0.0 111.162 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -61.16 -51.16 70.22 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.709 1.604 . . . . 0.0 110.495 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.18 -29.94 71.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.206 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.25 34.97 4.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.552 1.072 . . . . 0.0 112.804 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.78 159.41 11.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.109 1.454 . . . . 0.0 110.68 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 p -63.93 -35.68 81.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.45 0.568 . . . . 0.0 110.595 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.59 -177.57 45.1 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.23 132.32 33.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.07 102.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.99 154.54 4.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.26 155.39 79.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 120.93 -1.106 . . . . 0.0 110.452 159.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.13 151.28 96.79 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 N-CA-C 110.346 -0.675 . . . . 0.0 110.346 -7.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -151.94 157.55 41.94 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.428 0.691 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -144.51 -173.02 3.92 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.891 0.876 . . . . 0.0 110.384 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -56.45 -29.24 61.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.397 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.8 -25.25 64.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 t -95.87 -39.19 9.94 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.043 1.292 . . . . 0.0 109.246 170.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -50.14 53.57 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 109.765 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.22 72.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.918 1.687 . . . . 0.0 112.772 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.83 -48.53 21.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -61.6 -37.66 84.72 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.687 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.14 -52.21 59.47 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.451 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.28 -42.47 86.64 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.291 0.95 . . . . 0.0 112.414 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -54.38 -53.09 58.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.374 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 pt -74.63 -20.89 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 117.568 -1.206 . . . . 0.0 114.0 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.83 -50.79 71.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.525 1.511 . . . . 0.0 108.097 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -77.29 -42.84 35.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -73.61 -62.07 1.62 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.959 0.504 . . . . 0.0 110.634 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -20.57 39.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.715 0.806 . . . . 0.0 110.446 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.17 36.75 12.2 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -170.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 118.192 0.996 . . . . 0.0 111.014 175.555 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.69 65.66 0.26 Allowed 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.206 -0.934 . . . . 0.0 109.253 165.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.04 160.06 17.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -75.33 -15.37 60.49 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.033 1.333 . . . . 0.0 112.357 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 49.14 31.82 3.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.779 1.632 . . . . 0.0 111.834 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.62 104.63 4.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.104 0.562 . . . . 0.0 109.894 -170.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -91.1 133.67 35.14 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.172 1.789 . . . . 0.0 110.239 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.66 106.9 18.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.286 1.834 . . . . 0.0 107.484 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -74.34 138.07 43.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.568 1.076 . . . . 0.0 108.175 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.15 105.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ALA . 10.0 t -113.78 59.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 122.619 1.2 . . . . 0.0 107.768 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -85.96 108.97 18.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -174.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' H ' ' CB ' ' A' ' 57' ' ' ASP . 33.9 t70 -53.95 -45.27 71.23 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.422 1.089 . . . . 0.0 112.377 -170.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.24 101.39 1.88 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 164.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -42.66 70.11 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.21 0.604 . . . . 0.0 111.378 -168.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 m -59.83 -33.77 72.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.583 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mtm -59.12 -32.22 69.64 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 120.111 1.323 . . . . 0.0 110.476 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 HH21 ' NH1' ' A' ' 19' ' ' ARG . 24.9 ttp85 -62.63 -43.5 98.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.889 1.222 . . . . 0.0 110.717 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH1' HH21 ' A' ' 18' ' ' ARG . 8.9 mpt_? -59.69 -41.56 91.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.716 176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.21 -63.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.21 -43.48 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.899 1.68 . . . . 0.0 110.945 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -56.89 -48.36 78.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 0.0 110.392 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.97 -44.13 97.8 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.956 0.798 . . . . 0.0 110.841 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.66 -38.39 90.92 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.196 1.398 . . . . 0.0 111.689 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.83 -57.94 10.73 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -56.64 -36.09 69.09 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.162 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.67 -22.06 65.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.109 1.322 . . . . 0.0 112.464 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.35 -75.45 0.24 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 164.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.75 -168.41 33.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 65.33 164.43 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.264 1.826 . . . . 0.0 111.925 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -151.16 -3.05 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.371 1.469 . . . . 0.0 112.063 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.69 98.96 10.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.59 158.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.92 -155.47 0.61 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.43 1.092 . . . . 0.0 109.088 167.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 43.1 tt0 -178.37 159.16 1.19 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -158.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.86 33.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.142 1.777 . . . . 0.0 106.362 170.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.33 -31.59 72.47 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.795 -0.565 . . . . 0.0 112.352 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.58 171.26 10.43 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.872 2.469 . . . . 0.0 105.955 -174.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' ' CE ' ' A' ' 60' ' ' MET . . . -57.52 -37.12 80.87 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.587 -1.119 . . . . 0.0 114.565 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.66 -42.99 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.969 2.385 . . . . 0.0 108.714 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.1 -28.22 69.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.333 -0.855 . . . . 0.0 111.725 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.7 -47.68 77.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.195 -1.566 . . . . 0.0 109.655 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.72 -41.25 73.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.409 1.084 . . . . 0.0 109.496 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.67 -44.1 97.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.694 1.197 . . . . 0.0 111.742 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.311 -0.868 . . . . 0.0 110.67 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -51.27 70.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -68.48 3.14 1.92 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.18 1.48 56.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.06 1.3 . . . . 0.0 112.947 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.04 -81.79 0.07 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 121.353 1.888 . . . . 0.0 115.249 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.07 82.38 0.05 OUTLIER Glycine 0 C--N 1.331 0.261 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -164.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -90.32 153.8 20.18 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.23 1.015 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.78 -20.98 15.11 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.757 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -145.27 148.96 34.04 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.051 1.34 . . . . 0.0 109.277 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 81' ' ' LEU . 13.5 t -137.26 67.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -75.93 144.25 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 153.32 31.6 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.665 -0.647 . . . . 0.0 110.462 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CB ' ' H ' ' A' ' 13' ' ' ASP . 45.5 t0 -74.13 149.97 40.74 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 164.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.771 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 33.5 t-105 -61.21 -58.75 7.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.837 0.855 . . . . 0.0 109.498 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 25.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.188 1.395 . . . . 0.0 113.366 -159.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.574 ' CE ' ' H ' ' A' ' 39' ' ' GLY . 8.4 ptm -60.12 159.41 21.59 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.159 -0.963 . . . . 0.0 110.97 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -167.8 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.764 3.642 . . . . 0.0 111.192 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.49 -146.71 0.46 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.419 1.488 . . . . 0.0 110.09 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.98 96.41 0.43 Allowed 'General case' 0 C--N 1.34 0.175 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.71 174.1 0.07 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.17 1.788 . . . . 0.0 113.561 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.11 -29.76 59.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.386 -0.821 . . . . 0.0 113.57 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.771 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -71.03 -42.78 69.08 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 117.957 0.879 . . . . 0.0 110.034 176.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.93 -40.1 83.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.148 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.14 -55.03 27.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.656 1.116 . . . . 0.0 110.024 169.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -50.31 -56.27 11.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.601 0.761 . . . . 0.0 109.085 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.09 -41.56 96.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.748 0.704 . . . . 0.0 111.126 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.7 m -57.57 -51.44 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.061 0.944 . . . . 0.0 109.293 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 mt -58.53 -45.22 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.646 0.778 . . . . 0.0 109.659 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.5 -27.37 69.09 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 125.629 1.572 . . . . 0.0 112.148 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.16 14.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.325 1.45 . . . . 0.0 114.565 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 132.83 -107.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 131.033 3.733 . . . . 0.0 107.613 159.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.47 4.33 9.05 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.775 1.179 . . . . 0.0 114.905 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.41 25.01 5.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.18 1.49 . . . . 0.0 111.516 -158.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.3 mmt -113.48 -9.17 13.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.215 2.606 . . . . 0.0 111.053 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 p -52.29 -37.69 56.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.981 1.712 . . . . 0.0 111.953 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.73 62.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 54' ' ' VAL . 8.1 mt -52.52 141.18 34.85 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.517 1.053 . . . . 0.0 112.177 -162.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.03 74.0 3.02 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.489 2.126 . . . . 0.0 110.425 163.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -70.42 116.26 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 158.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.63 111.72 15.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mmt -75.12 128.35 35.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 101.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -141.45 169.86 16.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.65 -169.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.06 -17.19 41.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.258 163.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -80.67 104.21 11.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.212 0.915 . . . . 0.0 111.615 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -82.88 16.03 2.45 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -57.84 110.13 0.85 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.348 0.977 . . . . 0.0 108.881 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.6 -47.76 66.71 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.677 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -53.25 -33.08 51.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.33 -30.55 25.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.794 -0.566 . . . . 0.0 110.996 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.22 -44.23 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 118.362 -0.828 . . . . 0.0 108.989 161.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.51 -54.4 35.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.375 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.2 63.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 120.176 1.353 . . . . 0.0 110.774 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.56 -51.96 65.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 110.21 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.32 85.22 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.257 0.623 . . . . 0.0 111.269 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -57.35 -50.65 72.28 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.723 2.009 . . . . 0.0 110.513 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.03 -18.58 65.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.614 0.766 . . . . 0.0 112.68 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.02 27.66 13.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.236 0.922 . . . . 0.0 112.527 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.81 140.44 56.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.847 1.324 . . . . 0.0 108.191 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.6 p -68.46 -18.76 64.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.145 -174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.57 173.87 40.13 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.6 104.83 4.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.73 144.88 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 90' ' ' ALA . 64.2 t -127.9 143.21 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.6 151.22 71.92 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.46 1.504 . . . . 0.0 111.463 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.92 173.3 37.89 Favored 'Cis proline' 0 C--N 1.345 0.378 0 N-CA-C 109.421 -1.031 . . . . 0.0 109.421 -16.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -177.91 146.72 0.43 Allowed 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.162 -1.586 . . . . 0.0 108.267 -164.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -149.52 -176.51 5.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.184 1.793 . . . . 0.0 109.232 -170.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.49 68.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.781 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.18 62.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.222 1.009 . . . . 0.0 113.189 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.72 -28.99 12.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.876 0.762 . . . . 0.0 110.286 177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.45 -54.84 38.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -29.85 71.06 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.885 1.274 . . . . 0.0 112.396 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.38 -55.25 12.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.606 1.162 . . . . 0.0 109.351 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.6 -31.44 72.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.743 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.2 mt -58.49 -58.06 10.2 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 123.835 0.854 . . . . 0.0 109.484 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -61.29 -29.19 69.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.043 1.292 . . . . 0.0 112.257 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.01 -60.56 3.3 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.148 -0.97 . . . . 0.0 110.333 168.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -23.3 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.319 0.963 . . . . 0.0 113.081 -171.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -57.21 -58.03 9.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.82 -30.0 56.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.525 -0.734 . . . . 0.0 112.354 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -65.35 1.02 Allowed 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.57 -25.55 64.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.984 0.514 . . . . 0.0 111.051 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.23 23.21 35.26 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-O 117.805 -1.553 . . . . 0.0 110.703 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 28.7 mmt . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.704 1.752 . . . . 0.0 110.47 -176.511 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 ttm . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.7 72.61 8.64 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.607 1.549 . . . . 0.0 107.738 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.23 158.58 23.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.399 0.619 . . . . 0.0 112.257 -160.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -51.51 -25.5 6.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 39.15 53.54 2.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.726 2.41 . . . . 0.0 109.406 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.62 104.13 0.77 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.169 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -79.51 132.47 36.33 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.45 93.81 6.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.67 131.75 45.1 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.316 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 18' ' ' ARG . 64.6 t -132.52 119.36 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -130.95 63.53 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.699 1.599 . . . . 0.0 108.6 -174.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.29 159.1 33.72 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.792 -1.193 . . . . 0.0 108.5 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.47 -64.77 1.03 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.62 112.77 3.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -53.17 -41.61 65.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.857 1.208 . . . . 0.0 112.055 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -59.82 -31.8 70.06 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.757 -1.214 . . . . 0.0 111.773 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.0 92.62 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.562 1.074 . . . . 0.0 110.159 171.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD3' HG12 ' A' ' 10' ' ' VAL . 32.8 tpt85 -65.83 -36.69 84.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.299 1.04 . . . . 0.0 110.049 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -48.02 83.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.503 -0.761 . . . . 0.0 109.524 171.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.09 -58.36 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.32 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.9 t -52.29 -46.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.127 1.33 . . . . 0.0 110.206 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -60.75 -43.9 97.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.238 0.472 . . . . 0.0 111.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.27 -45.11 95.86 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.265 0.626 . . . . 0.0 111.133 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 113' ' ' ALA . 78.2 mt -65.41 -36.37 83.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.43 0.692 . . . . 0.0 111.062 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.91 -44.7 96.25 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.411 0.684 . . . . 0.0 110.09 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -41.65 98.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 116.994 -1.479 . . . . 0.0 111.462 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -57.07 -44.64 83.25 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 119.439 1.018 . . . . 0.0 110.51 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.14 -34.35 63.83 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.255 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.63 57.34 0.37 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.01 153.02 47.23 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.895 1.278 . . . . 0.0 107.824 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.81 178.9 7.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.785 1.634 . . . . 0.0 108.559 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 53.87 54.2 10.14 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.584 1.553 . . . . 0.0 111.683 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 m -68.68 164.36 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.122 159.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.46 174.81 10.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -136.71 147.81 46.97 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.11 167.44 12.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 164.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -68.37 -47.29 67.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 110.117 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.33 169.01 22.88 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 125.797 1.639 . . . . 0.0 109.171 -159.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.7 -41.05 49.69 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.953 1.263 . . . . 0.0 115.546 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -67.95 -44.66 84.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.97 1.885 . . . . 0.0 107.854 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.78 -26.17 68.51 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.173 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.81 -49.03 67.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.99 1.268 . . . . 0.0 110.14 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.02 -42.77 95.05 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.208 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.85 -47.37 85.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.479 1.112 . . . . 0.0 110.893 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.95 -46.43 78.56 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.802 0.841 . . . . 0.0 109.799 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 54' ' ' VAL . 2.1 mm? -57.33 -37.87 73.2 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.001 0.819 . . . . 0.0 111.342 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 4.6 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.16 82.0 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 119.715 -1.865 . . . . 0.0 110.399 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.49 104.4 1.24 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.773 1.177 . . . . 0.0 111.66 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.65 13.68 1.08 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.438 1.018 . . . . 0.0 115.134 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -69.43 167.28 16.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.214 1.507 . . . . 0.0 110.988 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.31 -19.21 0.88 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.561 167.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -131.84 144.0 50.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.536 1.668 . . . . 0.0 107.727 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HD13 ' A' ' 81' ' ' LEU . 15.3 t -134.37 62.41 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.74 135.36 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -144.92 168.91 19.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.019 0.827 . . . . 0.0 110.434 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.44 169.46 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.555 0.693 . . . . 0.0 109.359 159.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -74.08 -53.68 9.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.878 158.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.25 86.99 6.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.487 1.115 . . . . 0.0 111.54 -158.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.2 mmt -127.17 149.71 70.27 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.289 0.636 . . . . 0.0 111.2 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.96 147.1 60.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.492 2.128 . . . . 0.0 109.822 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 54.92 -84.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.283 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 41.4 ttm -88.19 97.64 11.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.941 1.296 . . . . 0.0 107.65 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.39 161.97 2.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.31 -33.68 53.04 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.558 -0.714 . . . . 0.0 111.847 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.57 -42.21 99.41 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.715 0.757 . . . . 0.0 109.942 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -81.19 -30.36 34.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.774 -0.579 . . . . 0.0 111.264 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.51 -52.1 67.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.16 0.984 . . . . 0.0 108.556 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.8 tp -51.13 -60.04 3.53 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.01 1.324 . . . . 0.0 109.463 173.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 24.3 mmtt -59.72 -40.34 87.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.523 1.056 . . . . 0.0 112.363 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.5 m -59.62 -49.05 79.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.631 0.772 . . . . 0.0 109.364 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.16 -39.37 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.15 -25.91 68.29 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.448 1.899 . . . . 0.0 112.234 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.03 60.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.556 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -71.46 148.14 47.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.804 0.842 . . . . 0.0 110.917 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.26 -17.96 70.79 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.027 -0.874 . . . . 0.0 113.203 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.07 -50.81 1.03 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.122 1.369 . . . . 0.0 111.285 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.8 mtm -67.0 -13.69 62.15 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 p -50.97 -31.66 18.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.732 1.213 . . . . 0.0 112.422 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.7 65.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.983 1.313 . . . . 0.0 114.029 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 54' ' ' VAL . 17.5 mt -56.55 138.01 76.51 Favored Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.317 -171.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.03 84.21 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.616 2.211 . . . . 0.0 108.951 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -76.69 126.76 37.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tp -142.28 110.56 6.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -159.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -79.32 126.34 30.67 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.372 1.045 . . . . 0.0 108.423 -171.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.2 t -136.1 101.34 2.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.254 1.822 . . . . 0.0 106.646 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -149.26 164.6 34.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.363 0.601 . . . . 0.0 111.391 -159.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.11 -20.91 57.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.582 1.153 . . . . 0.0 111.689 161.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -76.38 87.76 3.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.967 1.307 . . . . 0.0 111.031 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.98 5.3 4.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.094 0.958 . . . . 0.0 113.287 172.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -48.4 112.81 0.64 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.144 1.777 . . . . 0.0 108.307 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.81 -43.28 80.83 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -56.21 -37.79 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.374 1.07 . . . . 0.0 112.287 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -66.99 -40.5 87.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.393 0.542 . . . . 0.0 109.541 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.91 -49.43 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.156 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.0 -58.52 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.07 -49.3 63.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.587 1.155 . . . . 0.0 111.011 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.96 95.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.181 0.901 . . . . 0.0 110.883 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.15 91.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.902 0.319 . . . . 0.0 111.166 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -60.51 -55.81 28.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.19 1.396 . . . . 0.0 110.052 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.636 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -59.33 -28.87 67.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 111.51 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.66 38.76 4.6 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.278 0.942 . . . . 0.0 111.933 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.44 153.3 27.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.818 0.809 . . . . 0.0 109.306 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -69.98 -14.88 62.91 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.01 171.46 37.01 Favored Glycine 0 N--CA 1.443 -0.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.673 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -137.06 135.23 37.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.357 1.463 . . . . 0.0 107.343 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.45 103.43 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 90' ' ' ALA . 3.0 t -74.13 144.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -60.67 154.17 58.37 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.826 1.251 . . . . 0.0 109.619 163.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.92 174.54 46.7 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.373 0.812 . . . . 0.0 111.329 -14.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -178.43 151.33 0.6 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -167.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 p -144.79 -171.69 3.68 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.441 1.096 . . . . 0.0 109.825 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.402 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.99 -30.99 72.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.446 -0.784 . . . . 0.0 109.583 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.97 -19.68 45.43 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.47 -27.4 9.03 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.493 1.042 . . . . 0.0 110.999 171.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.46 -50.61 62.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.225 1.375 . . . . 0.0 107.939 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -31.56 72.47 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.631 1.172 . . . . 0.0 112.151 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -77.27 -36.1 54.67 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.712 0.687 . . . . 0.0 110.591 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -64.96 -43.46 92.62 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.122 -0.986 . . . . 0.0 109.211 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -58.66 -56.76 18.02 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.715 1.206 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -52.1 -42.31 63.16 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.937 1.295 . . . . 0.0 111.329 176.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -52.82 -63.18 1.23 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.366 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 pt -68.48 -30.14 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 120.487 1.494 . . . . 0.0 114.402 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.88 -53.92 52.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -83.09 -34.46 26.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 121.282 -0.167 . . . . 0.0 110.577 -171.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -74.0 -74.1 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.831 1.253 . . . . 0.0 108.862 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.92 -20.93 62.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.697 0.799 . . . . 0.0 110.967 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.34 26.98 26.54 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.499 -172.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 C--O 1.249 1.079 0 CA-C-N 119.639 1.72 . . . . 0.0 111.678 -175.166 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.38 -156.8 0.75 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.762 1.225 . . . . 0.0 108.472 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -115.46 -177.6 3.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.879 2.071 . . . . 0.0 106.99 173.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -61.9 -38.37 88.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.551 1.069 . . . . 0.0 109.042 159.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 48.23 63.78 1.92 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.314 1.446 . . . . 0.0 107.123 -160.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.5 106.56 0.21 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.019 0.928 . . . . 0.0 109.116 -175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 34' ' ' GLU . 12.3 tttt -82.47 135.45 35.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.336 -164.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.23 85.14 2.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -169.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.67 139.58 53.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.11 120.74 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -129.17 65.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.679 1.228 . . . . 0.0 107.949 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.24 111.32 22.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 7.0 t70 -47.74 -46.16 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.36 1.464 . . . . 0.0 112.59 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.5 -13.31 13.09 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t 76.34 -68.1 0.2 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.128 1.771 . . . . 0.0 108.42 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -55.87 -28.08 54.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.964 -1.085 . . . . 0.0 111.674 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.5 mtp -56.86 -46.57 81.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 116.854 -1.546 . . . . 0.0 111.011 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -22.88 63.13 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 121.645 2.021 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -65.7 -52.44 51.4 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.43 -60.51 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.736 1.214 . . . . 0.0 108.666 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.91 -49.19 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.239 1.016 . . . . 0.0 111.063 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -60.43 -42.97 97.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.768 1.167 . . . . 0.0 110.891 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -57.96 -53.12 61.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.09 -38.85 77.2 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.006 0.923 . . . . 0.0 111.902 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.24 -47.24 86.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.506 0.722 . . . . 0.0 110.087 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -64.89 -36.61 84.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.55 -41.24 89.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.652 1.569 . . . . 0.0 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.44 -54.04 10.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.76 62.86 0.07 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -137.52 156.96 47.53 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.347 1.059 . . . . 0.0 109.325 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 -175.33 4.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.378 1.071 . . . . 0.0 111.271 -168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 50.82 46.82 25.57 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.781 2.032 . . . . 0.0 111.45 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.31 161.9 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.0 -1.063 . . . . 0.0 109.474 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 3.4 mm-40 -145.52 171.72 14.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.713 2.005 . . . . 0.0 108.68 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.51 145.6 37.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -120.7 160.26 23.67 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.59 -39.45 93.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.711 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.99 165.77 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.558 1.143 . . . . 0.0 107.921 -161.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.48 68.67 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.828 1.649 . . . . 0.0 113.835 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.56 -44.87 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.964 -1.315 . . . . 0.0 109.63 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.93 -27.55 64.86 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.574 0.625 . . . . 0.0 110.737 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -59.99 -50.09 75.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.728 -1.232 . . . . 0.0 108.322 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -43.5 72.05 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.769 0.795 . . . . 0.0 111.375 175.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -65.79 -25.48 67.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 112.683 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 30.3 mmtm -74.88 -47.4 30.29 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.229 -1.545 . . . . 0.0 108.805 168.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 72' ' ' ILE . 17.3 mt -56.96 -35.98 69.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.176 1.353 . . . . 0.0 111.969 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -74.72 9.61 1.75 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.56 42.47 2.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.493 1.517 . . . . 0.0 111.171 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.17 -171.14 22.62 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 121.49 -0.756 . . . . 0.0 111.861 163.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.2 70.23 1.87 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -65.43 145.38 56.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.23 3.09 2.99 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.844 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.74 142.14 23.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.692 1.246 . . . . 0.0 108.854 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -138.4 78.68 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -173.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.7 141.52 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -152.35 158.22 42.41 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.735 -0.603 . . . . 0.0 111.041 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 23.1 t0 -77.26 169.81 17.67 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 164.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 66' ' ' LEU . 2.8 t-105 -79.34 -51.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.413 -0.804 . . . . 0.0 111.806 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -74.85 79.6 2.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.16 1.384 . . . . 0.0 110.232 -159.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.8 ptp -135.01 153.32 78.44 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 121.13 -0.981 . . . . 0.0 111.174 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.2 -172.1 1.07 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.04 2.493 . . . . 0.0 109.394 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 57.61 -104.26 0.21 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.917 1.687 . . . . 0.0 109.674 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.32 95.07 9.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.55 153.14 3.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.425 1.09 . . . . 0.0 109.779 170.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.39 -30.15 64.35 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.42 -0.8 . . . . 0.0 113.723 -167.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 2.1 tm? -72.26 -39.77 68.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.286 1.043 . . . . 0.0 110.02 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.81 -39.35 90.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.787 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.9 tp -57.79 -51.07 71.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.83 0.741 . . . . 0.0 109.917 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -50.08 -57.88 6.71 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 109.038 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 27.3 mttm -65.44 -27.39 68.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 m -59.96 -59.59 5.18 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 46' ' ' LEU . 24.3 mt -58.62 -40.99 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.23 1.412 . . . . 0.0 109.722 -174.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -13.35 26.68 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.623 1.569 . . . . 0.0 113.43 -170.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -81.85 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.656 1.116 . . . . 0.0 110.951 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -172.6 -163.63 0.23 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.811 1.645 . . . . 0.0 108.839 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.79 29.62 46.8 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -162.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.73 -18.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 129.936 3.294 . . . . 0.0 114.523 -166.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.3 mtt -62.41 -19.21 63.22 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.328 0.967 . . . . 0.0 112.276 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -55.54 -28.76 56.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.413 1.085 . . . . 0.0 111.579 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.26 -2.02 43.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.364 1.466 . . . . 0.0 113.398 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.703 HD13 HG21 ' A' ' 54' ' ' VAL . 40.8 mt -74.38 136.08 75.42 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 119.859 1.209 . . . . 0.0 110.18 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.13 89.0 0.8 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 108.614 164.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -71.17 111.01 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 164.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -115.35 113.38 23.72 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mmt -79.46 117.29 20.29 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.89 96.49 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -132.64 -166.47 1.75 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.761 0.824 . . . . 0.0 110.089 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.24 -3.08 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.833 2.053 . . . . 0.0 111.016 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -86.91 81.57 8.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.533 0.682 . . . . 0.0 109.554 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -65.83 -4.49 6.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.523 1.529 . . . . 0.0 113.776 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -46.78 123.9 5.6 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.617 1.567 . . . . 0.0 110.354 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -53.17 54.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.228 0.537 . . . . 0.0 110.869 -173.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.84 -26.92 66.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.91 -46.42 78.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.792 1.237 . . . . 0.0 109.547 171.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.87 -46.8 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.45 -53.79 36.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.82 -44.23 73.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.493 0.717 . . . . 0.0 110.619 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.47 88.2 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.846 0.748 . . . . 0.0 111.865 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.32 -41.11 81.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.386 0.539 . . . . 0.0 111.049 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -57.29 -46.49 83.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.542 1.937 . . . . 0.0 109.778 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.78 -34.09 76.11 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.899 0.48 . . . . 0.0 111.472 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.87 39.27 4.4 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.924 1.25 . . . . 0.0 111.544 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.71 143.45 50.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.539 1.17 . . . . 0.0 109.201 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -66.69 -19.73 65.82 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 170.04 41.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.97 130.83 27.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.315 1.446 . . . . 0.0 107.396 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.08 137.63 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 t -127.76 124.15 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -51.18 146.01 12.11 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.831 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.91 168.19 72.37 Favored 'Cis proline' 0 CA--C 1.534 0.509 0 CA-C-N 119.273 0.776 . . . . 0.0 111.913 -3.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -177.97 152.41 0.74 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.665 1.186 . . . . 0.0 109.104 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -148.37 -177.51 5.81 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.62 1.968 . . . . 0.0 109.751 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.13 -26.63 39.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.77 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.51 -53.02 51.54 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.743 1.217 . . . . 0.0 112.135 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.24 -33.77 61.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.059 0.845 . . . . 0.0 109.654 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -52.11 66.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.377 0.989 . . . . 0.0 109.318 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.57 -28.42 69.63 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.6 0.76 . . . . 0.0 111.867 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.67 -43.96 24.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.077 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -65.91 -30.49 71.09 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.429 -1.419 . . . . 0.0 110.015 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -58.75 -52.88 63.81 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.118 168.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -51.68 -48.51 63.45 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.768 1.167 . . . . 0.0 111.178 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -54.71 -51.01 66.93 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.494 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.88 -30.26 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.931 1.696 . . . . 0.0 113.043 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -58.04 -48.05 81.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.77 -23.99 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -170.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -68.68 0.77 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 mt -67.2 -26.64 66.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.709 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.54 39.47 18.08 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -165.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.245 0.851 0 CA-C-N 117.912 0.856 . . . . 0.0 109.558 175.597 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 119.707 -0.187 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.26 98.19 6.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -125.23 28.57 6.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.248 1.019 . . . . 0.0 109.915 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' H ' ' CD ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -70.26 61.62 0.21 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.477 1.911 . . . . 0.0 109.933 168.386 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -178.93 24.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.776 3.23 . . . . 0.0 109.308 -162.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.42 115.04 0.71 Allowed 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.959 1.303 . . . . 0.0 109.327 164.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -69.31 123.24 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.28 159.35 16.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -121.62 137.04 54.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 164.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 t -134.34 114.1 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.68 72.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB2' ' H ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -80.1 165.84 22.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.643 1.177 . . . . 0.0 109.065 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.48 -9.69 59.76 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.819 -1.175 . . . . 0.0 111.047 166.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 16.3 t80 -132.95 107.75 8.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.34 -1.475 . . . . 0.0 108.807 -170.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -49.77 -45.62 49.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.879 0.763 . . . . 0.0 112.758 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 57.3 m -52.43 -36.77 55.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.811 0.844 . . . . 0.0 111.502 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 ttm -57.16 -34.63 68.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 116.791 -1.576 . . . . 0.0 110.386 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.79 -42.82 99.87 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.129 1.786 . . . . 0.0 110.954 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -63.53 -54.15 40.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.58 -63.37 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.613 1.565 . . . . 0.0 109.143 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.47 -51.9 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 119.704 1.138 . . . . 0.0 110.768 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.58 -40.93 84.52 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 118.676 0.671 . . . . 0.0 111.231 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.08 -53.5 37.42 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 118.732 0.696 . . . . 0.0 109.146 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.45 -36.25 68.83 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 124.143 0.977 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.45 -67.15 0.35 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.258 169.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -57.38 -27.93 62.74 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.521 1.055 . . . . 0.0 113.089 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -58.02 -20.58 39.85 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.741 1.155 . . . . 0.0 112.563 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.1 mt -108.83 -35.7 6.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.223 3.009 . . . . 0.0 111.612 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.8 177.62 28.31 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.428 1.489 . . . . 0.0 110.985 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 62.22 -177.8 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.914 1.286 . . . . 0.0 112.392 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 170.29 -167.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 130.581 3.552 . . . . 0.0 105.568 -164.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 56.12 46.65 21.15 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.751 1.62 . . . . 0.0 111.977 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -71.77 149.21 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.36 173.13 8.6 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.493 2.317 . . . . 0.0 106.523 166.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.75 176.7 8.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.986 1.314 . . . . 0.0 109.111 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.4 169.66 16.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.725 2.01 . . . . 0.0 106.696 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.93 -32.12 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.539 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -170.94 174.83 4.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.936 1.695 . . . . 0.0 107.558 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.65 -36.06 69.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.32 1.438 . . . . 0.0 114.75 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.08 -40.76 90.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -71.33 -34.81 70.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 110.713 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.19 66.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.408 1.083 . . . . 0.0 109.232 -175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.44 -42.65 64.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.542 0.737 . . . . 0.0 111.527 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.67 -28.57 65.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.055 0.542 . . . . 0.0 111.713 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.61 -53.21 59.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.801 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.44 -54.72 32.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.941 0.792 . . . . 0.0 110.616 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.45 11.89 0.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.93 86.6 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 158.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.33 88.73 0.34 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.498 1.523 . . . . 0.0 109.827 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.68 0.24 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.715 1.626 . . . . 0.0 111.014 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -54.32 141.14 31.08 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.128 0.971 . . . . 0.0 109.344 166.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.2 -18.14 5.11 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.769 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.21 147.53 27.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.718 1.259 . . . . 0.0 107.878 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 ' CG2' HD13 ' A' ' 81' ' ' LEU . 2.9 t -131.9 128.2 59.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -169.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.7 132.48 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 p -151.78 161.16 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.294 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.74 169.98 13.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 110.076 169.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -80.23 -57.7 3.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 159.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -77.51 111.37 13.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.417 0.687 . . . . 0.0 109.2 -159.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 16.9 mmm -119.42 170.55 6.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.808 0.843 . . . . 0.0 110.726 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.82 -3.63 10.52 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.59 2.86 . . . . 0.0 113.015 166.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.84 -91.83 0.06 Allowed 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -160.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.7 ttm -91.07 95.12 9.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.202 1.801 . . . . 0.0 107.613 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 11.4 m-20 -51.63 154.28 2.01 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 108.449 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.78 -24.5 26.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.031 0.824 . . . . 0.0 112.922 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.88 -52.23 31.83 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.564 1.182 . . . . 0.0 110.801 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -68.78 -32.37 72.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.179 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.31 -59.55 5.28 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 118.129 -0.938 . . . . 0.0 109.108 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.706 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -45.06 -55.51 5.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.761 1.224 . . . . 0.0 109.108 173.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -64.66 -27.55 69.0 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 117.868 -1.063 . . . . 0.0 113.286 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.9 m -69.19 -50.97 42.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 119.383 0.992 . . . . 0.0 109.04 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.2 mt -45.89 -57.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.384 1.088 . . . . 0.0 112.279 165.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.6 8.03 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.594 2.357 . . . . 0.0 112.839 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.64 -28.39 67.68 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.629 1.559 . . . . 0.0 110.868 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 127.98 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 1 C-N-CA 134.278 5.031 . . . . 0.0 107.044 175.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.43 25.41 1.1 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.667 1.127 . . . . 0.0 114.896 -172.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.22 34.17 2.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.273 1.829 . . . . 0.0 110.604 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . 0.284 0.5 OUTLIER 95.0 30.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.533 1.533 . . . . 0.0 111.083 168.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.2 p -52.49 -31.97 37.71 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.33 -13.87 60.45 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.916 1.235 . . . . 0.0 112.745 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD13 ' CG2' ' A' ' 54' ' ' VAL . 11.5 mt -58.05 129.79 82.75 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 109.244 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.24 109.74 2.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.958 1.772 . . . . 0.0 108.938 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -90.12 94.66 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.182 0.993 . . . . 0.0 109.043 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tp -87.18 113.97 23.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.804 -1.185 . . . . 0.0 108.222 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mtt -84.8 124.61 31.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.5 114.91 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -147.25 -179.41 6.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.513 1.149 . . . . 0.0 109.904 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.05 -24.95 16.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 112.014 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -91.24 151.83 20.76 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 119.08 0.855 . . . . 0.0 111.152 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.61 -80.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.424 171.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? 52.55 100.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.422 1.489 . . . . 0.0 110.432 -167.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -54.46 -37.79 65.61 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.471 -1.393 . . . . 0.0 110.2 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -33.81 74.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 0.627 . . . . 0.0 112.553 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -65.14 -44.52 88.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.28 0.632 . . . . 0.0 109.442 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.73 -50.48 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.766 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.16 -56.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.62 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.14 95.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.415 0.552 . . . . 0.0 109.964 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.15 77.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.927 0.491 . . . . 0.0 112.129 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -69.7 -52.3 26.83 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.699 1.999 . . . . 0.0 111.086 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.15 77.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.35 41.94 1.01 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.432 1.491 . . . . 0.0 111.782 169.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.74 165.27 4.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.7 1.2 . . . . 0.0 110.695 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.0 t -51.41 -44.6 62.3 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.524 1.13 . . . . 0.0 108.712 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.35 172.7 39.08 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 169.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -100.86 141.36 33.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -131.19 128.27 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.17 139.2 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -58.29 139.96 83.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.526 168.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.51 131.31 23.49 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.4 1.179 . . . . 0.0 111.267 -1.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -131.5 159.15 38.96 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.164 0.985 . . . . 0.0 109.511 169.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 p -152.16 171.12 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.836 2.454 . . . . 0.0 108.364 -168.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.87 75.02 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.03 -15.27 12.56 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.31 -33.09 6.74 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.193 1.36 . . . . 0.0 110.869 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.94 -49.09 66.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.544 1.538 . . . . 0.0 108.65 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -57.07 -33.11 66.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 125.954 1.702 . . . . 0.0 112.689 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 32.9 tt0 -78.07 -33.62 50.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.412 0.285 . . . . 0.0 110.246 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -63.15 -43.4 98.41 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.823 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.9 mt -55.71 -52.91 62.26 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.94 -35.43 73.12 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 23.8 mtmt -61.77 -59.39 5.23 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.09 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 pt -65.25 -30.16 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.547 1.521 . . . . 0.0 112.869 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -55.3 -62.89 1.37 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.46 -35.45 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -81.51 -61.4 1.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.875 1.27 . . . . 0.0 109.193 -172.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.47 HD23 ' HD2' ' A' ' 126' ' ' LYS . 4.1 mt -79.66 -20.88 45.61 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.436 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.72 38.06 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.818 -169.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.7 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.059 -1.448 . . . . 0.0 109.966 -178.049 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.57 92.67 1.41 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -151.46 158.88 44.24 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.077 0.951 . . . . 0.0 109.063 -159.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.64 -10.04 59.6 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.492 0.717 . . . . 0.0 110.75 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 48.87 48.08 20.76 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 126.592 1.957 . . . . 0.0 109.281 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp -29.08 104.88 0.03 OUTLIER 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.571 1.548 . . . . 0.0 113.952 -158.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -90.74 132.37 35.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.616 -165.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -107.68 104.44 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.6 134.15 38.28 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.36 118.7 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -133.85 56.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.312 1.445 . . . . 0.0 108.222 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.68 146.17 55.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -69.01 -58.24 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.782 0.833 . . . . 0.0 109.073 172.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.4 t80 -72.81 114.22 10.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 m -50.43 -51.45 46.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 112.337 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.497 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 24.8 m -61.6 -26.59 68.08 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.564 -1.208 . . . . 0.0 112.176 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 ttm -59.77 -44.55 93.82 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.629 1.559 . . . . 0.0 109.903 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -65.42 -36.94 85.44 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 119.267 0.939 . . . . 0.0 111.054 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.3 -42.79 99.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.189 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.84 -66.19 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 116.688 -1.625 . . . . 0.0 107.798 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.36 -49.55 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.309 1.868 . . . . 0.0 110.993 -172.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -57.92 -42.91 85.8 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.728 0.811 . . . . 0.0 110.607 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.93 -45.74 91.06 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.388 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 mt -59.49 -44.37 93.08 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.721 0.692 . . . . 0.0 109.296 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.49 -47.45 78.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.644 0.778 . . . . 0.0 111.131 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 3.0 mmpt? -60.99 -42.44 98.41 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.038 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.56 -44.5 85.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.78 1.232 . . . . 0.0 110.02 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.91 4.64 16.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.266 1.027 . . . . 0.0 112.234 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.01 -18.08 47.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.617 1.58 . . . . 0.0 114.53 166.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -67.74 156.95 35.8 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.015 1.408 . . . . 0.0 111.234 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -136.09 -172.72 3.19 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.352 1.861 . . . . 0.0 109.9 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.8 t30 55.17 58.68 4.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 127.177 2.191 . . . . 0.0 112.559 165.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.7 148.14 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.897 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -121.26 160.06 24.69 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.152 1.781 . . . . 0.0 108.187 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 28.2 tt0 -121.59 151.9 39.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.56 164.81 21.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -72.56 -35.82 68.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.516 0.327 . . . . 0.0 111.234 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.81 176.89 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.719 1.208 . . . . 0.0 109.797 -170.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.63 43.64 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.259 1.885 . . . . 0.0 115.866 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.5 -51.45 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.666 2.233 . . . . 0.0 107.981 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.29 -34.36 76.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.645 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.68 -47.97 82.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.665 -1.272 . . . . 0.0 110.197 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.32 -41.52 89.28 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.69 -30.0 69.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.353 0.661 . . . . 0.0 112.666 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 35' ' ' GLU . 4.3 mptp? -67.69 -42.34 82.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.357 -0.839 . . . . 0.0 110.167 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 46' ' ' LEU . 3.7 mm? -62.9 -39.02 93.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.732 1.151 . . . . 0.0 110.225 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -70.25 12.33 0.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.796 0.839 . . . . 0.0 112.673 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.03 16.54 7.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.122 2.169 . . . . 0.0 111.836 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.47 -178.68 38.16 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.525 1.511 . . . . 0.0 115.57 162.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.01 73.5 0.97 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -69.44 154.66 41.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.614 0.766 . . . . 0.0 109.659 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.87 -32.28 11.24 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.612 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -142.86 149.85 39.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 81' ' ' LEU . 21.2 t -139.42 64.57 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.32 132.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 153.98 37.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.787 0.435 . . . . 0.0 110.394 -169.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 13' ' ' ASP . 7.9 t0 -84.84 167.47 15.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 161.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.76 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 2.7 t-105 -73.08 -44.43 60.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.871 0.868 . . . . 0.0 110.325 164.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -68.61 29.38 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 131.403 3.881 . . . . 0.0 115.909 -158.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 38.0 mtt -65.94 170.54 4.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 127.891 2.476 . . . . 0.0 109.826 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.1 -39.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.825 2.35 . . . . 0.0 112.915 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -124.56 -76.94 0.59 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 123.924 0.889 . . . . 0.0 109.436 -167.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 tpt -72.75 103.78 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.36 164.14 19.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.332 0.587 . . . . 0.0 109.745 173.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.59 -25.54 67.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 121.069 -0.586 . . . . 0.0 114.111 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.76 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -73.63 -43.08 60.51 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.054 1.342 . . . . 0.0 108.919 177.568 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.55 -42.64 98.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.57 0.748 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -54.63 -52.4 62.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.856 0.753 . . . . 0.0 109.259 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.2 tp -51.7 -58.96 4.9 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 123.411 0.684 . . . . 0.0 110.179 174.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -63.26 -30.57 71.69 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.994 0.815 . . . . 0.0 112.39 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 68.9 m -69.07 -51.23 41.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.11 0.964 . . . . 0.0 108.426 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.4 mt -56.13 -47.51 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.533 0.733 . . . . 0.0 109.982 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -58.88 -23.62 61.21 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.428 1.491 . . . . 0.0 112.839 -175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.07 -62.04 2.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.925 0.89 . . . . 0.0 111.568 -169.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -161.66 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.108 1.363 . . . . 0.0 108.604 166.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.56 1.92 5.24 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.627 2.06 . . . . 0.0 115.068 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.08 9.16 2.26 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.781 2.433 . . . . 0.0 112.329 -159.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt -96.8 -10.4 26.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.027 1.731 . . . . 0.0 111.092 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.5 p -54.03 -47.33 71.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.414 0.686 . . . . 0.0 112.153 -166.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.04 7.32 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 54' ' ' VAL . 11.5 mt -54.35 142.78 48.6 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-N 119.839 1.2 . . . . 0.0 111.381 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 72.18 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.696 2.264 . . . . 0.0 109.803 160.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -64.46 137.45 24.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 158.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 tp -141.69 113.53 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.72 128.92 36.73 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 124.269 0.981 . . . . 0.0 108.444 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.63 110.49 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -153.13 167.96 27.51 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.578 -0.701 . . . . 0.0 110.3 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.72 -23.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.343 -0.848 . . . . 0.0 112.474 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.67 116.3 22.58 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.444 1.02 . . . . 0.0 109.329 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.53 -81.42 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.438 166.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.5 tptt 45.94 95.04 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.3 1.44 . . . . 0.0 111.213 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.71 -33.78 35.95 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 120.225 -1.547 . . . . 0.0 112.138 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -42.98 85.73 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.701 1.137 . . . . 0.0 112.491 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -59.56 -44.88 93.14 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.701 0.8 . . . . 0.0 109.098 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.41 -46.07 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.954 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -61.36 -52.51 60.47 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.576 1.08 . . . . 0.0 108.52 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.28 -45.93 69.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.521 1.055 . . . . 0.0 110.962 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.439 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -64.16 -46.85 82.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.332 0.653 . . . . 0.0 109.951 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.05 86.76 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.89 0.768 . . . . 0.0 110.609 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -55.31 -51.49 66.55 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 126.742 2.017 . . . . 0.0 110.857 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -21.01 66.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.09 25.18 8.51 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.849 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.8 136.39 57.97 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 p -74.55 -1.75 22.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . 172.75 169.05 34.89 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 121.182 -0.949 . . . . 0.0 111.619 172.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -139.72 92.7 2.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.026 1.331 . . . . 0.0 108.699 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.04 112.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.75 157.85 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -64.12 159.58 55.43 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.037 158.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.1 166.81 81.46 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.826 0.974 . . . . 0.0 110.097 -11.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -178.09 158.73 1.24 Allowed 'General case' 0 C--N 1.333 -0.135 0 O-C-N 121.266 -0.897 . . . . 0.0 111.285 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -154.86 -177.34 6.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.766 2.026 . . . . 0.0 109.026 -173.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.83 -23.55 53.24 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.753 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.32 -53.51 49.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.877 0.871 . . . . 0.0 112.075 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -30.5 60.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 0.0 109.935 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -53.84 53.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.407 1.003 . . . . 0.0 108.94 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.98 -39.77 87.25 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.533 0.606 . . . . 0.0 111.469 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.0 -47.83 74.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.171 0.989 . . . . 0.0 109.87 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 1.8 mmmp? -68.15 -37.48 81.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.15 -1.881 . . . . 0.0 112.336 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.45 -58.32 9.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.521 1.055 . . . . 0.0 108.207 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -58.19 -36.05 72.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.15 0.98 . . . . 0.0 109.937 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -56.94 -56.0 27.35 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 117.589 -1.196 . . . . 0.0 112.901 168.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.0 pt -68.95 -25.67 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 121.398 1.908 . . . . 0.0 112.934 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -57.87 -55.73 31.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.85 -47.13 79.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 122.547 0.339 . . . . 0.0 111.676 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HG3' HD23 ' A' ' 127' ' ' LEU . 11.3 tptt -78.23 -71.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.202 1.001 . . . . 0.0 109.727 -168.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 126' ' ' LYS . 13.1 mt -64.9 -20.67 66.56 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.211 -178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.88 42.36 16.73 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 -166.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.249 1.072 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.234 169.306 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.68 -142.77 0.17 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 152.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -71.52 -178.06 2.05 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 162.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -53.24 -23.84 9.79 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.076 -1.015 . . . . 0.0 111.115 165.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 58.63 49.13 10.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.645 1.978 . . . . 0.0 107.643 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 112.1 2.33 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 110.511 -167.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -81.57 149.96 28.39 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.884 0.874 . . . . 0.0 109.549 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.401 ' CZ ' ' CE1' ' A' ' 53' ' ' PHE . 12.0 m-85 -120.97 106.62 11.77 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.415 1.086 . . . . 0.0 109.528 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.77 136.15 43.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.611 1.55 . . . . 0.0 108.84 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -136.15 105.5 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.343 1.457 . . . . 0.0 107.3 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.29 70.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.239 1.016 . . . . 0.0 108.378 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.38 138.75 35.58 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 1.3 t70 -53.07 -33.08 50.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.939 2.095 . . . . 0.0 112.656 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -115.24 120.49 39.86 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 107.156 -168.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -53.07 -47.69 68.29 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.62 -175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.3 m -51.85 -44.64 63.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.625 1.102 . . . . 0.0 111.539 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.83 94.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -69.56 -44.16 71.42 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.913 1.285 . . . . 0.0 109.314 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -52.45 -52.34 54.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.13 2.172 . . . . 0.0 109.723 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.89 -62.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.218 -1.372 . . . . 0.0 108.261 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -52.03 -48.1 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 120.822 1.647 . . . . 0.0 110.761 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' HH11 ' A' ' 22' ' ' ARG . 0.2 OUTLIER -56.37 -49.86 73.23 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.674 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -60.39 -42.67 96.37 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 118.521 0.601 . . . . 0.0 110.713 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 113' ' ' ALA . 94.6 mt -63.69 -39.4 94.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.765 0.826 . . . . 0.0 111.013 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -64.84 -48.43 74.38 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 121.913 -0.492 . . . . 0.0 110.378 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -58.84 -39.76 82.22 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.07 0.948 . . . . 0.0 110.951 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.5 -51.04 68.33 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.36 1.064 . . . . 0.0 109.338 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.25 -48.21 80.95 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.06 3.14 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.4 1.953 . . . . 0.0 111.977 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.07 133.47 51.7 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 109.63 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 -176.38 5.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -167.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.7 t30 62.06 80.39 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 128.622 2.769 . . . . 0.0 108.76 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.06 160.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.354 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -114.31 147.08 39.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 158.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.37 164.31 12.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 158.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.75 167.86 14.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 158.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.44 -27.41 46.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.865 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -176.17 156.93 1.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.779 1.232 . . . . 0.0 108.084 -158.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.52 -45.33 5.47 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.107 1.337 . . . . 0.0 114.807 170.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.47 -36.87 78.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 119.608 1.704 . . . . 0.0 110.417 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -70.87 -31.97 68.82 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 122.763 0.425 . . . . 0.0 110.23 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.16 61.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -58.43 -40.12 81.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.779 0.432 . . . . 0.0 111.605 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -56.12 -51.35 68.26 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.971 0.508 . . . . 0.0 109.877 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -55.74 -46.68 77.74 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.184 0.994 . . . . 0.0 110.297 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 72' ' ' ILE . 11.5 mt -58.07 -46.99 84.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.958 0.799 . . . . 0.0 110.286 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -81.47 5.18 18.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.652 0.781 . . . . 0.0 112.423 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -57.22 12.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 159.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.26 88.89 0.07 OUTLIER Glycine 0 C--N 1.339 0.701 0 O-C-N 121.142 -0.974 . . . . 0.0 113.825 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.3 84.08 0.03 OUTLIER Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.946 1.736 . . . . 0.0 114.993 158.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -81.91 175.8 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.569 0.699 . . . . 0.0 112.649 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.45 -72.61 1.15 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 165.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE1' ' CZ ' ' A' ' 8' ' ' PHE . 27.1 m-85 -110.91 154.24 24.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.855 -171.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.28 91.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.37 129.39 52.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.3 p -151.38 162.2 41.34 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.655 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 18.0 t70 -72.89 -177.0 2.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 9.1 t-105 -116.11 -33.13 5.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.334 2.654 . . . . 0.0 112.366 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -76.2 21.48 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.306 2.242 . . . . 0.0 114.133 -159.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.406 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.27 147.06 79.01 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.342 1.057 . . . . 0.0 110.214 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.57 -172.21 1.24 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.014 2.476 . . . . 0.0 110.14 159.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 55.78 -105.86 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.613 1.965 . . . . 0.0 109.981 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.8 ttm -87.88 85.89 7.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.8 156.9 22.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.014 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.62 64.18 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.685 -169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.74 -35.59 44.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.32 1.56 . . . . 0.0 110.951 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -26.03 39.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.164 0.893 . . . . 0.0 111.254 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.14 -54.38 47.57 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.23 1.412 . . . . 0.0 108.622 164.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 8.1 tp -52.46 -58.51 6.51 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.088 0.955 . . . . 0.0 108.578 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 87.1 mttt -64.25 -28.15 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.352 1.433 . . . . 0.0 112.774 -174.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.3 m -62.22 -53.96 47.75 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.917 1.235 . . . . 0.0 108.354 168.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 46' ' ' LEU . 33.4 mt -56.29 -47.47 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.688 1.195 . . . . 0.0 107.853 -177.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -5.98 12.12 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.389 1.876 . . . . 0.0 113.652 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -75.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.234 1.379 . . . . 0.0 109.858 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.22 -112.74 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.826 1.651 . . . . 0.0 108.167 161.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.59 22.29 52.09 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 120.052 1.296 . . . . 0.0 112.922 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.58 -6.97 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 127.874 2.47 . . . . 0.0 113.976 -165.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtm -71.71 -16.82 62.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.851 -1.156 . . . . 0.0 110.148 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -42.72 -39.04 2.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.631 1.973 . . . . 0.0 112.421 159.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.53 -15.56 54.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 HG21 ' A' ' 54' ' ' VAL . 26.7 mt -64.39 131.91 95.2 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 120.116 1.325 . . . . 0.0 110.703 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.83 87.65 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.974 3.116 . . . . 0.0 109.779 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -67.24 104.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 128.516 2.726 . . . . 0.0 108.762 163.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.43 109.9 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.922 1.289 . . . . 0.0 108.198 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 59.6 mmm -87.78 129.84 35.05 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.25 94.51 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.16 1.784 . . . . 0.0 106.189 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -130.93 174.49 9.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.848 0.832 . . . . 0.0 111.09 -167.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.78 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.394 -0.816 . . . . 0.0 111.726 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.0 113.86 23.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.558 0.743 . . . . 0.0 111.73 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 8.48 1.63 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.495 1.518 . . . . 0.0 111.973 161.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -54.32 116.88 2.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.183 0.993 . . . . 0.0 108.452 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -60.87 -36.45 79.22 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.581 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -44.71 85.57 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.455 1.025 . . . . 0.0 109.531 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.64 -40.99 96.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 mt -64.89 -48.79 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.267 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.16 -51.65 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 120.009 1.277 . . . . 0.0 108.11 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.04 -42.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 110.904 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.605 0.762 . . . . 0.0 110.32 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.46 98.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.28 0.632 . . . . 0.0 110.722 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -57.07 -55.01 40.28 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 127.549 2.34 . . . . 0.0 108.83 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.73 -7.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.722 1.209 . . . . 0.0 113.234 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.41 30.81 56.16 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.302 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.87 143.55 36.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.899 1.349 . . . . 0.0 109.309 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 p -73.42 -14.85 61.34 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 122.15 -0.344 . . . . 0.0 111.908 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.34 167.55 38.75 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.84 137.88 40.19 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.24 125.68 51.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 170.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -96.2 150.35 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 166.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.65 69.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.538 -0.726 . . . . 0.0 109.79 166.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.84 175.43 44.8 Favored 'Cis proline' 0 CA--C 1.538 0.7 0 CA-C-N 119.846 0.981 . . . . 0.0 110.266 -15.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -178.07 159.01 1.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.528 1.531 . . . . 0.0 108.399 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.486 ' H ' HG22 ' A' ' 115' ' ' THR . 2.5 p -149.33 174.76 12.08 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.695 1.998 . . . . 0.0 109.297 -165.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -60.99 -34.34 74.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -6.15 2.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.287 1.835 . . . . 0.0 115.686 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 112' ' ' THR . 2.8 t -115.33 -34.56 4.92 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 121.395 1.907 . . . . 0.0 110.15 161.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.05 -56.92 5.64 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.643 1.577 . . . . 0.0 108.19 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -60.42 -31.61 70.57 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.03 1.332 . . . . 0.0 113.002 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 30.1 tt0 -72.54 -43.31 63.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.557 -0.715 . . . . 0.0 109.409 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 13.2 mmtp -68.81 -34.75 76.03 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.067 -1.02 . . . . 0.0 110.015 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.3 mt -55.04 -58.06 9.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.78 -35.36 68.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.711 0.687 . . . . 0.0 112.038 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 22.7 mttm -59.97 -47.49 85.61 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.369 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.06 -28.02 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.496 1.953 . . . . 0.0 114.033 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -60.47 -54.01 50.72 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.834 0.854 . . . . 0.0 109.101 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -67.63 -51.65 47.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.97 -0.456 . . . . 0.0 110.426 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -64.31 1.0 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -162.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.31 -22.01 66.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 119.429 -0.319 . . . . 0.0 110.903 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 26.81 50.25 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.931 -167.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.3 mmt . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.768 1.784 . . . . 0.0 110.411 177.328 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.314 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.59 -70.86 0.23 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.03 0.932 . . . . 0.0 110.544 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -140.9 -171.36 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.349 1.86 . . . . 0.0 108.209 -163.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -55.39 -32.09 62.35 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.156 -0.965 . . . . 0.0 110.623 159.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 51.66 46.13 27.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.286 1.434 . . . . 0.0 108.421 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.695 HD11 ' HA3' ' A' ' 52' ' ' GLY . 5.9 tt -44.67 127.27 6.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.909 1.683 . . . . 0.0 109.757 -176.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -83.89 131.37 34.87 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -83.8 138.46 33.23 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 158.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 42' ' ' ALA . 22.0 tp -111.07 135.75 51.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 169.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.11 122.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.77 48.0 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.99 157.49 21.77 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.493 -1.379 . . . . 0.0 108.727 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -33.32 71.18 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 121.493 -0.755 . . . . 0.0 111.182 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.1 t80 -102.43 127.84 49.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.058 1.343 . . . . 0.0 107.622 -171.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -49.04 79.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.362 0.601 . . . . 0.0 110.057 -172.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 8.8 m -63.04 -24.15 67.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.62 -0.705 . . . . 0.0 111.743 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 18.7 ttm -64.95 -34.09 77.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.362 1.437 . . . . 0.0 109.938 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -36.8 80.77 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 120.352 1.433 . . . . 0.0 110.565 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -52.01 -53.06 46.2 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 168.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.22 -63.71 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-O 117.439 -1.267 . . . . 0.0 108.673 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.5 t -52.71 -46.34 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.664 1.574 . . . . 0.0 110.65 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.78 91.12 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.82 1.191 . . . . 0.0 110.318 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.73 -39.54 91.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.309 0.959 . . . . 0.0 111.922 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.57 -41.33 96.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.036 0.934 . . . . 0.0 110.079 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.84 -45.75 92.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.075 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -63.43 -39.39 94.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.799 0.727 . . . . 0.0 110.802 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.61 -12.98 61.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.598 -171.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.84 13.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.35 -90.61 0.43 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.558 1.075 . . . . 0.0 111.197 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -147.69 175.47 10.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.198 0.999 . . . . 0.0 112.824 -159.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -118.74 171.61 8.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 128.43 2.692 . . . . 0.0 109.194 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 77.29 99.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 128.388 2.675 . . . . 0.0 113.228 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -121.1 154.87 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.566 0.698 . . . . 0.0 112.449 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -122.3 145.42 48.25 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 158.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -119.71 93.89 4.22 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -76.29 163.45 27.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.67 0.748 . . . . 0.0 111.079 -172.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.65 -33.05 60.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.308 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.36 160.97 1.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.343 1.457 . . . . 0.0 107.535 -163.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.4 -40.36 10.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.755 1.161 . . . . 0.0 115.156 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.1 t -65.77 -39.41 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.237 2.018 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.22 -29.77 65.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.142 0.977 . . . . 0.0 111.028 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HA ' HD21 ' A' ' 9' ' ' LEU . . . -61.24 -51.44 68.92 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.949 -1.095 . . . . 0.0 109.401 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.38 -41.06 83.98 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.317 1.047 . . . . 0.0 111.144 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -56.51 -50.8 70.76 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.297 1.039 . . . . 0.0 110.282 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -54.78 -49.67 70.35 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.126 175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 72' ' ' ILE . 15.4 mt -53.45 -43.84 68.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.074 1.306 . . . . 0.0 109.935 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.59 10.56 0.35 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -4.9 47.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.987 1.267 . . . . 0.0 112.764 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.92 163.16 8.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.229 1.395 . . . . 0.0 113.438 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.2 22.74 76.26 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.466 -1.02 . . . . 0.0 112.281 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -90.96 156.57 17.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.536 1.168 . . . . 0.0 107.974 170.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.695 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -159.81 9.54 0.15 Allowed Glycine 0 C--O 1.225 -0.445 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.23 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.06 132.26 17.4 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 81' ' ' LEU . 5.9 t -133.29 86.11 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 CA-C-O 122.436 1.112 . . . . 0.0 108.0 -171.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -97.76 131.61 44.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.194 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -151.86 145.6 25.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.854 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.91 162.17 27.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.91 0.862 . . . . 0.0 109.485 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -70.27 -52.75 20.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.78 1.232 . . . . 0.0 109.478 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.45 82.25 6.52 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.742 1.617 . . . . 0.0 108.656 -169.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.5 mmt -86.95 168.64 17.26 Favored Pre-proline 0 C--O 1.234 0.263 0 O-C-N 121.806 -0.558 . . . . 0.0 111.013 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.37 0.94 9.28 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.217 2.611 . . . . 0.0 113.023 165.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -150.73 -80.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 121.008 1.731 . . . . 0.0 112.05 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.5 ttm -90.73 94.28 9.61 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.43 148.82 0.86 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.855 2.062 . . . . 0.0 111.434 176.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.98 -36.04 41.91 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.521 1.058 . . . . 0.0 113.754 -172.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.36 -34.14 55.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.775 0.83 . . . . 0.0 110.417 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.82 -42.95 85.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.56 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.11 -49.02 79.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.476 1.035 . . . . 0.0 110.013 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 83' ' ' VAL . 2.1 tp -52.43 -56.72 13.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.95 -26.25 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 120.241 1.382 . . . . 0.0 113.243 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 m -65.3 -49.06 70.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.34 0.973 . . . . 0.0 108.609 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 46' ' ' LEU . 18.8 mt -61.35 -44.42 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.519 1.127 . . . . 0.0 109.261 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 10.21 2.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.249 1.819 . . . . 0.0 111.712 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.81 -15.28 63.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.602 1.092 . . . . 0.0 111.735 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 59.86 -176.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.959 2.104 . . . . 0.0 110.574 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.24 -33.82 1.32 Allowed Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.26 -1.525 . . . . 0.0 110.797 -159.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.08 166.55 32.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.267 1.827 . . . . 0.0 108.113 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.6 mtt 72.45 -8.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 130.178 3.391 . . . . 0.0 116.209 158.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -59.76 -23.95 63.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -15.3 60.84 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.389 1.45 . . . . 0.0 113.538 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 54' ' ' VAL . 13.0 mt -55.52 135.38 70.67 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.961 0.904 . . . . 0.0 111.559 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.87 87.18 0.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.692 2.261 . . . . 0.0 108.942 162.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.573 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -77.0 140.88 16.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 162.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.17 118.56 14.71 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -172.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.3 mmt -78.28 127.01 31.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.63 110.44 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.7 t -155.71 172.15 18.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.932 0.787 . . . . 0.0 111.232 -168.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.71 -28.18 62.52 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.235 -0.916 . . . . 0.0 111.539 159.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.75 93.29 0.94 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -164.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.9 4.53 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.987 170.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -45.16 105.25 0.05 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.999 1.72 . . . . 0.0 108.524 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -50.7 -43.15 57.62 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 122.462 0.305 . . . . 0.0 110.218 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -49.32 -43.0 43.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.715 1.206 . . . . 0.0 113.317 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -69.59 -40.94 76.4 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.372 1.069 . . . . 0.0 109.802 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.91 -46.45 76.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.683 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.91 -55.99 17.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.73 76.75 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.735 0.698 . . . . 0.0 111.313 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.61 64.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.514 0.726 . . . . 0.0 110.536 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.67 97.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.041 0.536 . . . . 0.0 110.037 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -58.16 -53.84 53.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 126.787 2.035 . . . . 0.0 111.527 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.75 -38.27 78.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.112 0.565 . . . . 0.0 110.254 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.69 30.2 3.11 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.713 1.149 . . . . 0.0 112.298 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.3 150.16 22.65 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.678 1.239 . . . . 0.0 109.699 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -72.79 -18.51 61.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.964 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.2 43.15 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.77 139.52 47.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 77.3 t -133.25 137.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.921 2.088 . . . . 0.0 105.368 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 90' ' ' ALA . 2.5 t -121.5 152.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -62.22 149.64 86.52 Favored Pre-proline 0 CA--C 1.542 0.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.233 164.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.61 127.63 14.13 Favored 'Cis proline' 0 N--CA 1.456 -0.723 0 N-CA-C 109.538 -0.985 . . . . 0.0 109.538 -15.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -117.75 156.24 28.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -146.26 178.76 8.0 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 108.872 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.7 -25.49 67.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.215 -0.897 . . . . 0.0 109.216 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.69 -38.83 64.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.186 0.994 . . . . 0.0 112.575 170.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -31.9 20.79 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.828 1.195 . . . . 0.0 109.712 173.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.07 -48.77 75.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.713 1.142 . . . . 0.0 109.404 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.51 -36.14 81.6 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.349 0.66 . . . . 0.0 111.675 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 10.0 tt0 -66.38 -46.99 74.79 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.81 0.732 . . . . 0.0 109.189 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -44.94 89.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.203 -0.903 . . . . 0.0 108.769 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.05 -53.51 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.701 0.8 . . . . 0.0 110.183 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.93 -45.97 82.35 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.568 0.747 . . . . 0.0 110.997 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -53.27 -55.99 20.16 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.878 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -27.77 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.935 1.243 . . . . 0.0 112.574 -169.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -54.73 -60.36 3.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 165.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.8 -52.55 42.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 109.725 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.294 1.437 . . . . 0.0 110.983 -164.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.07 -32.13 71.36 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.05 44.45 5.98 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -162.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.1 mmt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 119.115 1.457 . . . . 0.0 109.996 169.268 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.84 174.78 6.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 162.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.43 39.88 0.85 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.167 -0.958 . . . . 0.0 110.962 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -69.9 8.28 0.75 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.388 -1.445 . . . . 0.0 113.714 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.4 71.37 1.38 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.32 135.7 4.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.725 2.01 . . . . 0.0 111.696 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -81.55 129.01 34.51 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -111.31 109.76 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.654 1.182 . . . . 0.0 107.847 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.31 138.53 47.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.732 1.606 . . . . 0.0 109.012 171.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.93 109.22 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.291 1.036 . . . . 0.0 109.308 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -120.06 52.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -66.55 158.39 29.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.293 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.19 -43.03 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.797 -0.565 . . . . 0.0 111.486 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -92.0 114.66 27.26 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 116.739 -1.6 . . . . 0.0 108.958 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -53.14 -37.55 61.92 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 122.703 2.502 . . . . 0.0 114.622 -167.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 m -48.52 -38.42 20.25 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.578 -1.326 . . . . 0.0 111.708 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.0 ttm -65.36 -25.31 67.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.711 2.004 . . . . 0.0 111.572 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -56.42 22.1 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.452 1.933 . . . . 0.0 107.912 167.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -53.34 54.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.548 1.139 . . . . 0.0 108.584 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.9 -67.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 117.088 -1.434 . . . . 0.0 108.417 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.22 -48.27 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 120.673 1.579 . . . . 0.0 111.0 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -56.33 -48.79 76.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 109.837 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -63.04 -44.58 95.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 113' ' ' ALA . 85.2 mt -56.64 -44.17 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.17 0.988 . . . . 0.0 110.186 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.43 -42.84 96.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.639 0.776 . . . . 0.0 111.174 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -62.89 -35.13 79.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.57 -5.08 22.06 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.27 0.941 . . . . 0.0 111.464 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.67 15.58 8.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.258 2.623 . . . . 0.0 111.375 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.91 85.14 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.807 169.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -97.91 163.56 12.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.355 1.577 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -159.39 -160.28 0.82 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 110.197 -173.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.42 37.29 23.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.519 1.527 . . . . 0.0 113.085 165.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.44 146.51 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.582 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -110.26 167.17 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 158.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.65 168.86 11.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 163.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -126.28 164.5 20.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.73 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.997 0.519 . . . . 0.0 110.556 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.66 173.31 8.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.836 1.654 . . . . 0.0 108.54 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.93 -29.11 54.64 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.53 -49.77 56.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.537 2.168 . . . . 0.0 107.321 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -60.63 -32.37 71.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.29 0.636 . . . . 0.0 110.879 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.71 -52.65 59.6 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.728 -1.232 . . . . 0.0 109.042 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.42 -35.38 71.98 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.56 -44.62 93.58 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.34 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -62.58 -38.64 90.9 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.113 0.869 . . . . 0.0 111.528 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.48 HD21 HG13 ' A' ' 54' ' ' VAL . 11.0 mt -59.99 -46.68 88.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.3 1.409 . . . . 0.0 108.991 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -77.66 29.18 0.16 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.037 1.335 . . . . 0.0 111.486 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.77 32.8 4.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.559 1.944 . . . . 0.0 109.724 159.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.61 19.69 8.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.913 164.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.59 83.02 0.62 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.125 1.463 . . . . 0.0 109.528 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -69.56 170.33 10.88 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.158 0.583 . . . . 0.0 109.858 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 -40.62 26.34 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.668 -0.645 . . . . 0.0 112.565 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -139.73 155.84 47.12 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.328 0.564 . . . . 0.0 111.547 -166.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -134.3 71.08 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.56 129.37 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -150.42 157.67 43.3 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.262 -1.524 . . . . 0.0 110.525 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -73.76 171.96 12.36 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.668 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 5.1 t-105 -66.7 -59.15 3.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 159.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.55 71.36 5.01 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -158.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.82 154.35 47.79 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.3 160.04 45.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.8 1.666 . . . . 0.0 109.257 162.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.24 -79.07 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 C-N-CA 129.104 2.962 . . . . 0.0 114.227 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 ttp -88.45 79.79 7.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.86 150.17 2.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.026 1.73 . . . . 0.0 109.517 167.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.98 -27.93 71.2 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.205 -0.934 . . . . 0.0 113.785 -161.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.668 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -75.81 -31.42 59.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.974 0.887 . . . . 0.0 111.36 175.603 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.65 -40.54 84.53 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.792 0.723 . . . . 0.0 109.119 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.8 tp -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.521 0.6 . . . . 0.0 109.73 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tp -53.19 -56.98 12.15 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.946 0.898 . . . . 0.0 109.526 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.482 ' HE3' HD12 ' A' ' 66' ' ' LEU . 80.7 mttt -63.48 -30.17 71.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.026 0.83 . . . . 0.0 112.25 -174.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 m -62.18 -55.77 25.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 109.126 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 46' ' ' LEU . 25.2 mt -59.81 -44.04 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.125 1.37 . . . . 0.0 108.183 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -57.7 -26.24 61.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.999 1.719 . . . . 0.0 112.756 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.63 -21.7 28.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.181 0.901 . . . . 0.0 112.311 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.36 133.89 43.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.999 1.272 . . . . 0.0 110.488 -173.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.67 58.99 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.668 -0.645 . . . . 0.0 114.308 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.32 -58.71 1.86 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.696 1.248 . . . . 0.0 108.254 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.49 ' HB3' HD12 ' A' ' 81' ' ' LEU . 43.9 mtt -69.42 -12.75 61.91 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -164.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -57.23 -26.86 61.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.837 1.199 . . . . 0.0 111.264 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.62 -10.09 59.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.002 1.321 . . . . 0.0 113.975 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 54' ' ' VAL . 18.0 mt -68.58 143.5 95.25 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 119.625 1.102 . . . . 0.0 110.125 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.78 87.94 0.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.996 2.464 . . . . 0.0 110.099 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -76.85 88.77 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 126.321 1.848 . . . . 0.0 107.083 163.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.5 tp -96.26 118.33 32.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.62 122.76 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.2 t -132.55 99.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.412 1.885 . . . . 0.0 107.405 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -139.61 -173.54 3.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.132 0.968 . . . . 0.0 110.382 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.09 -15.02 15.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.116 1.367 . . . . 0.0 111.666 163.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.54 103.75 7.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.61 -73.58 0.11 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 39.98 92.7 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 126.433 1.893 . . . . 0.0 110.782 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -28.43 -57.75 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.071 1.348 . . . . 0.0 114.276 173.368 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 22.1 tt0 -54.73 -40.26 69.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.656 2.382 . . . . 0.0 113.654 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -71.04 -39.47 72.27 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.856 1.263 . . . . 0.0 110.474 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.97 -50.41 79.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.276 2.1 mt -53.9 -46.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 116.857 -1.544 . . . . 0.0 114.93 168.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.69 82.55 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 121.325 1.875 . . . . 0.0 110.488 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.66 -42.6 99.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.009 0.924 . . . . 0.0 110.729 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.58 78.79 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.565 -0.709 . . . . 0.0 112.394 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.44 -44.07 75.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.487 1.515 . . . . 0.0 110.091 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.13 58.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.548 0.739 . . . . 0.0 112.739 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.41 39.79 34.85 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.26 0.936 . . . . 0.0 112.453 173.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.62 150.4 31.97 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.428 0.614 . . . . 0.0 109.972 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -77.15 -14.33 59.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.96 0.904 . . . . 0.0 111.466 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.67 171.37 43.0 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 160.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -132.07 133.12 44.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.2 t -134.99 134.92 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.0 141.84 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -53.84 142.22 44.95 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.308 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.32 135.87 40.69 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.497 1.213 . . . . 0.0 110.77 -10.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.96 152.24 51.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 109.275 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 p -149.74 -176.71 5.52 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.66 1.584 . . . . 0.0 108.943 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -61.92 -32.89 73.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.402 -0.809 . . . . 0.0 108.901 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.46 -19.89 17.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.751 1.22 . . . . 0.0 114.218 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.58 -25.46 9.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.783 1.174 . . . . 0.0 111.668 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -47.59 81.21 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.17 -30.32 71.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 112.162 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -78.8 -43.36 25.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.465 0.706 . . . . 0.0 110.114 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -25.63 60.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.224 -1.369 . . . . 0.0 110.133 175.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 mt -57.52 -53.24 60.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.457 1.026 . . . . 0.0 108.677 166.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -50.09 -45.47 52.64 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.801 0.728 . . . . 0.0 111.302 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -62.67 1.5 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.316 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 pt -67.47 -27.03 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 120.319 1.418 . . . . 0.0 113.089 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -53.78 -62.51 1.61 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 167.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.02 -29.6 58.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -168.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -69.49 0.67 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.553 1.541 . . . . 0.0 107.829 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.97 -28.14 66.35 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.465 0.575 . . . . 0.0 111.546 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 43.16 6.52 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -162.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 38.2 mmt . . . . . 0 C--O 1.253 1.257 0 CA-C-N 118.66 1.23 . . . . 0.0 109.296 169.573 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtt . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.37 19.58 3.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.661 1.573 . . . . 0.0 112.19 -172.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.29 61.81 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.066 1.747 . . . . 0.0 109.929 -159.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.53 -12.15 50.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.161 -0.962 . . . . 0.0 112.135 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.99 56.71 0.85 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.921 2.488 . . . . 0.0 106.347 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.46 120.54 7.31 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.605 2.362 . . . . 0.0 110.173 176.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 166.1 12.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.453 1.12 . . . . 0.0 111.263 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 33' ' ' VAL . 1.4 m-85 -124.17 161.67 25.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.25 139.38 43.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 158.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -127.87 104.24 11.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 42' ' ' ALA . 3.2 t -109.04 78.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.21 157.83 35.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 165.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -80.79 -23.21 39.43 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.48 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -83.41 -151.75 0.11 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.127 1.371 . . . . 0.0 109.575 178.563 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -139.78 -43.81 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.097 -1.002 . . . . 0.0 108.539 159.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.2 m -50.12 -31.93 14.68 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 169.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 ttm -64.72 -39.69 94.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.289 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -33.35 71.16 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 122.122 2.237 . . . . 0.0 110.937 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -56.43 -54.0 50.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.1 -60.25 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.51 1.124 . . . . 0.0 108.548 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.63 -46.92 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.597 1.089 . . . . 0.0 111.064 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.564 HH11 ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.24 -42.88 96.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.835 1.198 . . . . 0.0 109.914 -179.405 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.49 -53.96 51.34 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.195 0.907 . . . . 0.0 110.69 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.77 -37.46 71.12 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.157 0.983 . . . . 0.0 111.325 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -52.04 40.91 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.843 171.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' HH11 ' A' ' 22' ' ' ARG . 26.1 mttt -62.47 -23.84 67.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.324 1.42 . . . . 0.0 111.997 -172.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -52.22 -48.98 64.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.22 0.918 . . . . 0.0 110.324 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.1 mt -75.84 -50.09 16.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.554 1.542 . . . . 0.0 109.465 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.17 -163.43 31.02 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.622 1.105 . . . . 0.0 111.274 -174.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.533 ' HB2' HH22 ' A' ' 22' ' ' ARG . 61.4 m-85 59.2 174.48 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.209 1.803 . . . . 0.0 111.894 -171.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -170.89 -162.7 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.674 1.19 . . . . 0.0 108.378 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.69 27.57 17.3 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.876 2.071 . . . . 0.0 114.439 159.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 8' ' ' PHE . 7.5 m -70.08 174.14 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.104 0.562 . . . . 0.0 111.35 -175.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -136.98 177.05 8.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 108.064 164.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -132.09 177.19 7.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.777 1.231 . . . . 0.0 107.962 167.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 172.27 13.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.952 1.301 . . . . 0.0 108.005 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.69 -40.39 88.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.552 0.341 . . . . 0.0 111.181 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -174.74 172.04 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.517 1.927 . . . . 0.0 107.702 -163.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.53 -42.43 26.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.828 1.204 . . . . 0.0 115.539 178.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.47 -47.64 88.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 119.857 1.829 . . . . 0.0 108.517 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.35 -24.74 66.56 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.763 -0.585 . . . . 0.0 111.659 175.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.69 -53.63 44.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tp -51.75 -47.21 64.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.743 1.617 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -56.35 -42.08 77.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.496 1.518 . . . . 0.0 111.388 176.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.0 -45.46 88.89 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.645 -1.284 . . . . 0.0 111.246 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 72' ' ' ILE . 13.2 mt -55.12 -51.52 66.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.421 1.464 . . . . 0.0 109.521 -175.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.01 29.56 0.11 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.968 0.907 . . . . 0.0 113.172 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.34 18.03 12.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.735 1.614 . . . . 0.0 111.631 170.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.23 -6.53 0.7 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-O 117.984 -1.453 . . . . 0.0 114.904 166.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.83 107.57 0.73 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.381 1.591 . . . . 0.0 109.709 -174.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.91 164.41 14.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.036 1.335 . . . . 0.0 108.646 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.91 -28.87 27.56 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.479 -0.763 . . . . 0.0 112.625 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -145.98 159.46 43.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.192 1.797 . . . . 0.0 108.476 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.735 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -135.37 62.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.4 mt -69.52 131.76 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.62 141.43 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.599 0.359 . . . . 0.0 110.13 -163.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -62.89 165.19 7.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 164.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -80.96 -59.63 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 159.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.97 37.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.341 1.056 . . . . 0.0 112.55 -170.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.7 ptp -63.56 149.68 91.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 158.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.74 175.04 11.7 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.586 2.19 . . . . 0.0 110.607 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 m120 53.56 -92.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.992 2.117 . . . . 0.0 111.437 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -90.8 97.3 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.61 164.04 6.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.577 0.626 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.24 -38.38 56.63 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.641 0.639 . . . . 0.0 113.63 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.53 -38.92 92.7 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.976 0.888 . . . . 0.0 110.42 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.67 -35.58 52.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.13 0.572 . . . . 0.0 110.269 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.23 -49.93 74.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.568 0.747 . . . . 0.0 109.152 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -50.87 -56.57 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.597 1.159 . . . . 0.0 109.643 172.194 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -64.48 -31.34 72.51 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.109 1.322 . . . . 0.0 113.454 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.2 m -62.44 -51.5 67.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.37 1.068 . . . . 0.0 109.005 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 46' ' ' LEU . 28.3 mt -58.63 -43.54 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 126.217 1.807 . . . . 0.0 110.157 176.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -8.95 41.66 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.486 -172.072 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.36 -68.61 0.16 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.293 1.037 . . . . 0.0 111.561 -172.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 p30 170.98 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.281 1.432 . . . . 0.0 114.554 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -67.86 22.21 0.26 Allowed Glycine 0 CA--C 1.539 1.567 0 CA-C-N 120.821 1.646 . . . . 0.0 116.081 -173.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 75.3 -16.97 0.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 131.066 3.746 . . . . 0.0 111.484 -162.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.3 mtt -70.98 -11.95 61.26 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 111.112 -177.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -35.28 11.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.356 2.262 . . . . 0.0 112.579 173.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.11 -7.17 58.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.656 1.582 . . . . 0.0 114.002 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 54' ' ' VAL . 17.2 mt -65.07 131.52 95.19 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 119.735 1.152 . . . . 0.0 108.674 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.98 83.65 0.9 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.452 1.434 . . . . 0.0 110.375 167.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -68.5 115.55 7.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 159.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tp -130.53 107.63 9.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -167.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -73.1 123.71 24.13 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.16 105.3 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -148.25 -166.47 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.35 -21.59 13.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.359 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -82.96 145.74 29.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.81 1.186 . . . . 0.0 110.868 176.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.31 -81.85 0.31 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.984 1.313 . . . . 0.0 109.809 172.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 tptm 46.33 110.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 130.078 3.351 . . . . 0.0 112.551 -164.041 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -47.57 -45.08 26.75 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 111.825 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -60.81 -31.45 70.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.964 1.256 . . . . 0.0 113.185 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -70.26 -37.39 74.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.747 1.158 . . . . 0.0 110.617 170.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.11 -47.8 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.409 1.004 . . . . 0.0 108.454 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.1 -58.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.88 -51.03 55.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.912 1.233 . . . . 0.0 111.336 -176.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.298 0.499 . . . . 0.0 110.295 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.31 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.441 0.564 . . . . 0.0 111.785 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -63.85 -47.19 81.71 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.615 1.966 . . . . 0.0 111.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.86 66.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.777 0.431 . . . . 0.0 112.002 172.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.48 47.15 9.15 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 125.9 1.714 . . . . 0.0 110.691 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.03 144.7 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -65.61 -21.23 66.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.664 0.269 . . . . 0.0 111.569 -178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 175.49 44.4 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -135.05 142.98 46.46 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.02 133.89 44.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 129.461 3.105 . . . . 0.0 104.302 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.02 147.55 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -50.29 134.97 23.89 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.098 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.22 147.39 85.41 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 120.557 1.235 . . . . 0.0 110.902 -6.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.86 145.12 32.09 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.841 -0.537 . . . . 0.0 112.06 176.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 115' ' ' THR . 2.3 p -141.36 174.58 10.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.244 1.818 . . . . 0.0 110.23 -170.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.29 67.62 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 175.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.89 66.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.181 1.392 . . . . 0.0 113.997 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 112' ' ' THR . 6.6 t -93.23 -40.77 10.26 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.569 1.077 . . . . 0.0 109.182 168.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -53.84 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.04 0.936 . . . . 0.0 109.483 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -28.6 70.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.71 1.204 . . . . 0.0 112.653 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.57 -46.58 31.08 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.031 0.933 . . . . 0.0 109.064 178.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -69.83 -32.94 71.62 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 109.823 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.5 -56.91 15.75 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.111 0.964 . . . . 0.0 109.424 167.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -57.17 -29.94 64.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -68.48 0.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 117.511 -1.233 . . . . 0.0 109.148 166.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.5 pt -62.13 -28.12 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 119.831 1.196 . . . . 0.0 112.726 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -59.46 -54.33 47.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.111 0.564 . . . . 0.0 109.797 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.14 -47.03 38.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.985 0.811 . . . . 0.0 110.942 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HG3' HD23 ' A' ' 127' ' ' LEU . 31.6 tptt -68.16 -73.27 0.15 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.774 1.629 . . . . 0.0 110.093 -172.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.462 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.9 mt -65.03 -21.2 66.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.541 0.61 . . . . 0.0 111.444 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.26 33.62 28.36 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.5 mmm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.057 179.513 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 119.179 -0.438 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.57 67.22 0.81 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.746 2.018 . . . . 0.0 110.496 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -54.24 109.96 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.569 1.948 . . . . 0.0 111.043 -163.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -76.9 36.98 0.18 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.718 1.145 . . . . 0.0 110.477 171.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -140.47 33.29 1.86 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.479 2.311 . . . . 0.0 106.925 -171.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.462 HD11 ' HA3' ' A' ' 52' ' ' GLY . 1.1 tp -41.25 123.16 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 128.017 2.527 . . . . 0.0 110.573 -177.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -70.03 130.54 42.42 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.83 160.51 17.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 162.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.72 137.5 51.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.12 103.59 6.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 125.683 1.593 . . . . 0.0 106.947 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.9 t -112.14 53.84 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.629 1.204 . . . . 0.0 107.872 -175.4 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.51 126.36 30.65 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.87 -45.1 93.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.989 0.516 . . . . 0.0 112.035 -174.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 29.0 t80 -75.61 106.18 7.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 t -58.05 -33.22 68.78 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.583 1.538 . . . . 0.0 112.885 -171.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 61.6 m -57.67 -36.84 72.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.406 -1.434 . . . . 0.0 110.851 174.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.1 tpp -55.29 -43.15 74.53 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.346 1.059 . . . . 0.0 109.539 173.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -66.6 -41.88 87.75 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.574 0.625 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -57.2 -47.06 82.24 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.028 173.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.85 -58.14 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.036 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.8 t -54.64 -50.6 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 125.34 1.456 . . . . 0.0 110.699 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -59.99 -41.73 92.69 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.826 0.739 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -64.39 -45.68 86.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.434 0.561 . . . . 0.0 111.346 176.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.29 -43.78 92.56 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.752 0.821 . . . . 0.0 110.269 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.34 -58.74 6.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.009 1.324 . . . . 0.0 110.558 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.492 ' HE2' ' OD1' ' A' ' 31' ' ' ASN . 11.5 ptmm? -66.27 -22.65 66.31 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 117.37 -1.3 . . . . 0.0 112.087 -177.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.45 90.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.391 1.451 . . . . 0.0 109.197 175.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.33 -42.4 23.04 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.436 1.094 . . . . 0.0 110.089 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.18 -25.13 0.19 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.258 -1.301 . . . . 0.0 115.757 169.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.93 101.59 5.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.425 2.113 . . . . 0.0 111.093 -174.194 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.492 ' OD1' ' HE2' ' A' ' 26' ' ' LYS . 45.8 m-80 -85.82 -27.4 25.15 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.235 -0.915 . . . . 0.0 112.985 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.54 76.38 2.24 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.297 1.522 . . . . 0.0 108.505 -159.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.23 108.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.813 2.045 . . . . 0.0 105.826 -162.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -86.4 -168.49 2.25 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.332 1.853 . . . . 0.0 109.894 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.92 172.35 1.67 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 130.589 3.555 . . . . 0.0 105.081 -167.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.96 175.75 9.99 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -168.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.78 -39.08 87.68 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.375 -0.828 . . . . 0.0 110.973 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.87 166.57 4.39 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -158.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.59 49.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.296 0.953 . . . . 0.0 112.554 171.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 t -57.81 -45.12 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.435 1.094 . . . . 0.0 110.536 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.93 -30.39 61.23 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.64 0.776 . . . . 0.0 109.633 176.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.91 -50.14 74.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.565 -0.71 . . . . 0.0 109.508 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.26 -45.61 76.08 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.144 0.578 . . . . 0.0 110.362 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.24 -38.0 87.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.051 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.26 -48.02 81.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.422 1.01 . . . . 0.0 109.512 171.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 72' ' ' ILE . 3.4 mt -60.82 -47.99 83.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 35.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.04 -49.28 4.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.64 153.91 20.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.047 1.784 . . . . 0.0 110.246 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -8.2 74.86 Favored Glycine 0 N--CA 1.466 0.685 0 O-C-N 121.047 -1.266 . . . . 0.0 114.03 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -72.7 161.8 30.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 159.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -134.21 3.79 4.46 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 117.758 -1.579 . . . . 0.0 113.544 164.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.38 141.89 31.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.855 1.828 . . . . 0.0 111.043 -174.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 81' ' ' LEU . 4.0 t -132.77 72.07 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -75.81 140.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 t -154.49 147.34 24.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.215 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -72.47 165.11 25.26 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 158.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 97' ' ' ALA . 7.3 t-105 -77.37 -52.53 8.99 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.467 1.507 . . . . 0.0 110.113 163.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.68 84.52 5.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.527 -158.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.71 162.95 51.96 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.391 1.476 . . . . 0.0 109.73 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.53 176.75 9.69 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.238 1.958 . . . . 0.0 111.166 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 58.41 -98.54 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.1 2.56 . . . . 0.0 110.796 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 9.6 ttm -91.21 104.84 17.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 172.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.08 158.12 14.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.605 0.717 . . . . 0.0 110.685 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.82 -26.04 73.09 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.939 -168.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -72.58 -38.2 67.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.861 1.33 . . . . 0.0 108.932 175.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -66.44 -40.08 89.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.545 0.611 . . . . 0.0 111.294 174.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.78 -49.61 74.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.07 0.85 . . . . 0.0 109.493 172.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.567 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.85 -58.2 8.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.073 174.202 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 29.6 mttt -61.99 -32.37 72.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.922 1.692 . . . . 0.0 112.414 -172.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.6 m -59.27 -49.1 79.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.186 0.995 . . . . 0.0 109.118 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 46' ' ' LEU . 21.3 mt -64.92 -46.87 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -20.6 62.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.485 1.114 . . . . 0.0 112.736 -174.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.57 60.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.564 1.074 . . . . 0.0 110.739 172.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.12 154.09 35.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.744 0.702 . . . . 0.0 110.031 -173.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.95 -13.22 79.88 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.702 -178.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.25 -41.87 1.38 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.786 1.293 . . . . 0.0 111.967 -175.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.6 mmt -64.44 -12.92 48.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.194 0.906 . . . . 0.0 111.705 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 p -55.52 -22.45 21.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.769 1.628 . . . . 0.0 113.317 171.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.53 63.02 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.25 0.932 . . . . 0.0 112.576 175.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 54' ' ' VAL . 26.1 mt -61.72 139.38 95.38 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 118.94 0.791 . . . . 0.0 111.65 -171.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.32 77.46 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.704 2.936 . . . . 0.0 109.008 159.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 69' ' ' LEU . 1.4 m -60.99 114.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.285 1.834 . . . . 0.0 107.546 159.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -132.81 114.22 13.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 109.483 -166.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mtp -91.25 119.45 31.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.45 101.5 8.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.911 1.685 . . . . 0.0 106.643 -174.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.28 172.12 13.6 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.455 -0.778 . . . . 0.0 111.127 -165.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.6 -13.88 36.22 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.142 -0.974 . . . . 0.0 113.027 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -91.1 123.35 34.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.07 0.948 . . . . 0.0 111.154 -174.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 20.74 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.784 0.833 . . . . 0.0 110.497 163.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -51.27 115.24 1.48 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.635 1.574 . . . . 0.0 108.825 -175.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -58.14 -41.95 84.8 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 119.139 -0.457 . . . . 0.0 109.976 -175.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.42 -32.35 70.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.876 173.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -68.67 -39.31 80.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.939 1.245 . . . . 0.0 109.422 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.81 -44.83 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 118.237 -0.887 . . . . 0.0 108.652 172.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.95 -58.7 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.239 0.927 . . . . 0.0 108.717 175.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HH2' ' A' ' 58' ' ' TRP . . . -58.57 -40.57 83.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.109 0.868 . . . . 0.0 111.055 -173.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.95 74.83 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.096 0.558 . . . . 0.0 110.348 172.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.82 87.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.317 0.508 . . . . 0.0 111.863 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -54.08 -55.54 26.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.608 1.963 . . . . 0.0 108.685 171.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.04 -13.46 61.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.89 1.276 . . . . 0.0 112.734 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.81 36.95 40.62 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.261 -1.299 . . . . 0.0 112.397 178.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.45 145.47 43.69 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.204 1.502 . . . . 0.0 109.564 176.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.5 p -71.05 -24.73 62.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 117.716 0.235 . . . . 0.0 111.528 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.8 163.71 36.84 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 118.109 0.413 . . . . 0.0 112.199 174.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -134.21 110.93 9.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.623 1.569 . . . . 0.0 107.988 -176.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.59 99.95 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 106.596 -163.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.59 144.47 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -56.78 162.25 3.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 0.0 111.281 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.09 108.8 0.92 Allowed 'Cis proline' 0 N--CA 1.457 -0.669 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 -21.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.68 76.3 7.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.686 0.794 . . . . 0.0 109.357 -169.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -64.67 172.47 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.257 1.423 . . . . 0.0 112.393 -173.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.75 70.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.09 -18.53 61.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.53 -31.4 9.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.091 1.314 . . . . 0.0 109.553 172.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -56.74 -47.36 80.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 108.382 175.372 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -42.56 73.3 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.073 0.949 . . . . 0.0 111.583 -176.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.03 -64.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.605 1.962 . . . . 0.0 109.177 168.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.181 -173.403 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.35 -53.83 46.48 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.284 0.947 . . . . 0.0 109.445 174.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -35.47 77.38 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.866 0.757 . . . . 0.0 110.044 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -51.75 -57.07 10.31 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.899 0.879 . . . . 0.0 110.652 171.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -17.52 11.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -57.28 -67.31 0.34 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 159.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.37 -36.72 79.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.785 -0.572 . . . . 0.0 112.434 -167.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -67.28 0.73 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -176.349 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.35 -29.61 67.45 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.8 -171.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.77 25.1 13.83 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 117.762 -1.577 . . . . 0.0 111.4 -166.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 C--O 1.249 1.072 0 CA-C-N 120.266 2.033 . . . . 0.0 111.291 179.213 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.576 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -135.71 157.07 47.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 58.52 -172.85 0.1 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.089 1.356 . . . . 0.0 109.803 -165.108 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -85.04 -3.71 58.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.498 -1.376 . . . . 0.0 110.932 158.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 45.92 42.66 9.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.246 1.018 . . . . 0.0 109.984 -158.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.27 119.47 7.45 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.35 1.06 . . . . 0.0 109.313 -173.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -91.07 152.9 20.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.721 0.772 . . . . 0.0 111.814 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.72 156.48 19.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 158.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 tp -119.33 143.19 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 t -137.34 93.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -171.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.07 57.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -174.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.9 131.4 37.47 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.61 -56.64 17.62 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.661 1.185 . . . . 0.0 111.76 177.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.4 t80 -69.6 114.37 7.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -48.89 76.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.377 0.99 . . . . 0.0 111.093 -170.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.523 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.7 m -58.53 -28.42 65.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.551 0.741 . . . . 0.0 111.574 176.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.0 ttp -63.89 -36.27 83.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.568 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -64.64 -42.17 95.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.729 1.604 . . . . 0.0 109.52 172.304 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -58.92 -37.91 77.73 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.871 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.41 -65.31 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.574 169.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.8 t -48.21 -52.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.686 2.039 . . . . 0.0 111.189 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG2' HG21 ' A' ' 33' ' ' VAL . 3.9 tmm_? -56.57 -47.5 79.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.941 177.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.35 -49.38 77.42 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.777 0.717 . . . . 0.0 111.533 176.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.77 -39.1 83.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 110.988 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -48.58 72.08 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.65 -0.656 . . . . 0.0 110.386 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.99 -28.39 68.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.831 178.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.16 -45.23 95.49 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 119.942 1.246 . . . . 0.0 109.488 173.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.54 -27.74 64.39 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 0.0 111.062 177.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 1.92 6.41 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.412 1.482 . . . . 0.0 113.959 169.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -70.14 170.13 12.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.359 1.08 . . . . 0.0 110.645 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -143.01 -178.79 6.0 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.062 1.345 . . . . 0.0 109.801 -172.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 75.5 -64.22 0.38 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.63 2.372 . . . . 0.0 113.92 170.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 22' ' ' ARG . 2.3 m 33.87 65.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.658 1.983 . . . . 0.0 113.984 162.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.28 -174.8 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.015 1.726 . . . . 0.0 110.614 175.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.59 169.55 21.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.386 1.874 . . . . 0.0 108.232 -172.039 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.94 166.43 26.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 170.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.26 -35.95 80.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.14 0.976 . . . . 0.0 111.33 176.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.17 176.16 3.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.927 2.091 . . . . 0.0 107.615 -169.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.62 -36.22 58.57 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.9 -51.72 69.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 120.396 2.098 . . . . 0.0 107.718 177.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.84 -35.28 77.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.963 0.505 . . . . 0.0 111.02 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.66 -47.68 79.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -42.9 80.25 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.777 0.673 . . . . 0.0 111.453 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.56 -46.86 85.98 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.453 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -55.84 -45.72 78.35 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.226 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 72' ' ' ILE . 8.9 mt -57.34 -38.55 74.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.846 1.203 . . . . 0.0 110.262 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -72.34 27.21 0.05 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.867 1.267 . . . . 0.0 113.951 173.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.65 -8.61 16.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.901 1.28 . . . . 0.0 111.313 158.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.22 169.68 4.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.075 1.321 . . . . 0.0 112.808 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.4 -1.92 17.81 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.633 -0.922 . . . . 0.0 113.21 -177.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.53 112.06 3.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 166.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.58 -9.56 71.86 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.334 171.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.8 145.09 21.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.815 1.308 . . . . 0.0 111.238 -166.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.687 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -136.86 111.42 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.42 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -114.35 136.22 51.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -146.48 162.52 38.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.109 0.413 . . . . 0.0 111.183 171.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 21.8 t70 -75.96 -167.73 0.78 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 158.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.457 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 10.2 t-105 -114.06 -52.84 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.405 2.282 . . . . 0.0 110.857 -175.197 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 86.58 0.15 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.531 2.332 . . . . 0.0 110.33 -167.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -142.99 153.12 60.13 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 124.916 1.287 . . . . 0.0 109.183 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -78.0 -179.22 5.24 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.481 2.12 . . . . 0.0 108.301 165.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 54.9 -94.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.29 1.836 . . . . 0.0 109.983 176.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.0 tpp -91.38 80.7 5.48 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.85 149.72 4.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 159.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.64 -27.62 61.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.284 -0.885 . . . . 0.0 113.34 -169.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -34.39 68.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.644 1.222 . . . . 0.0 110.513 176.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -66.06 -42.49 89.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.546 172.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.84 -50.04 75.47 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -51.71 -61.97 1.92 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.611 1.164 . . . . 0.0 109.199 173.848 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.54 -34.24 77.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.677 1.126 . . . . 0.0 112.522 -172.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.4 m -59.04 -48.38 81.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD11 HD11 ' A' ' 46' ' ' LEU . 30.5 mt -64.09 -48.7 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.412 1.085 . . . . 0.0 109.112 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -29.0 67.64 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.55 -171.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.49 -68.87 0.14 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.463 1.105 . . . . 0.0 112.214 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -173.33 -144.07 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.893 1.277 . . . . 0.0 109.657 -166.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.28 12.89 61.6 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.606 -1.309 . . . . 0.0 112.68 -176.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.21 8.75 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.585 2.354 . . . . 0.0 113.894 -159.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.88 -16.68 62.71 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 121.348 -0.845 . . . . 0.0 110.325 170.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.1 p -60.64 -22.04 63.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.786 0.834 . . . . 0.0 112.728 -174.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.68 -3.38 59.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.159 1.384 . . . . 0.0 113.553 174.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 54' ' ' VAL . 30.6 mt -68.33 130.47 92.28 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 119.911 1.232 . . . . 0.0 109.1 178.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.44 98.0 0.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 108.67 164.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -78.87 107.1 10.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.591 1.557 . . . . 0.0 107.742 164.85 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.15 116.45 31.95 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.092 1.357 . . . . 0.0 107.873 -176.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.0 mtp -88.11 120.19 29.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -130.42 105.19 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -171.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -146.67 173.72 12.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.805 0.812 . . . . 0.0 110.923 -167.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.71 -19.72 20.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.484 0.713 . . . . 0.0 112.107 175.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -90.11 139.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.939 0.79 . . . . 0.0 109.737 -177.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.09 -59.71 2.66 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 tptt 45.99 80.92 0.04 OUTLIER 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.775 1.63 . . . . 0.0 109.558 173.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -54.91 -35.04 63.72 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.845 -167.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 96' ' ' ILE . 6.2 mt-10 -65.64 -29.98 70.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.742 1.61 . . . . 0.0 113.385 174.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -65.47 -42.51 92.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 120.044 1.293 . . . . 0.0 109.412 167.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.1 mt -62.98 -52.25 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.868 0.758 . . . . 0.0 109.584 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' GLU 0.252 1.7 mt -54.6 -46.85 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 117.273 -1.346 . . . . 0.0 113.489 169.733 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.1 82.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.003 1.274 . . . . 0.0 110.472 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.6 -48.48 77.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.73 0.812 . . . . 0.0 110.918 175.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -22.86 63.09 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.84 -0.538 . . . . 0.0 112.394 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -77.15 -53.76 7.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.924 2.09 . . . . 0.0 108.772 171.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.35 -26.79 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.154 1.382 . . . . 0.0 112.659 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.56 34.3 5.05 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 124.677 1.132 . . . . 0.0 113.291 173.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.83 151.62 29.36 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.662 1.231 . . . . 0.0 110.576 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.7 p -77.08 -14.22 59.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.83 171.69 37.1 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 172.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -134.23 127.87 32.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.12 96.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 175.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.19 149.15 8.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 160.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -55.52 163.2 1.97 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 122.654 0.382 . . . . 0.0 110.45 160.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.08 137.06 47.44 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 -14.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -133.86 154.7 50.86 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.287 0.635 . . . . 0.0 110.567 -175.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 p -145.23 176.69 9.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.189 1.795 . . . . 0.0 109.367 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.68 -29.82 68.34 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.039 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.46 80.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.143 0.977 . . . . 0.0 112.475 175.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.08 -29.92 26.43 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.962 0.801 . . . . 0.0 110.291 175.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -55.92 25.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -27.33 69.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.216 0.606 . . . . 0.0 112.184 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.87 -43.8 87.27 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.607 -0.683 . . . . 0.0 110.255 172.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -66.66 -35.12 79.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.781 173.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.33 -53.09 61.74 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.556 1.071 . . . . 0.0 109.182 177.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.61 -34.44 72.77 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.204 0.457 . . . . 0.0 111.119 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -69.77 0.11 Allowed 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.112 0.965 . . . . 0.0 109.64 168.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 pt -74.12 -26.9 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 118.729 0.695 . . . . 0.0 112.444 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -58.75 -56.76 18.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -81.69 -38.01 26.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.585 -174.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -67.49 -74.51 0.11 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.59 1.156 . . . . 0.0 109.12 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.46 -31.34 72.37 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.218 0.463 . . . . 0.0 110.152 -175.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.84 37.64 8.44 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -165.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 C--O 1.248 1.006 0 CA-C-N 118.592 1.196 . . . . 0.0 109.104 164.888 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.24 168.71 19.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.051 1.34 . . . . 0.0 108.44 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.81 178.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.821 1.249 . . . . 0.0 108.978 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -54.8 -23.11 16.66 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.302 -0.874 . . . . 0.0 111.723 165.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.03 30.9 4.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.326 1.85 . . . . 0.0 111.968 -175.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 tt -54.68 118.58 4.33 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 175.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 134.06 34.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -95.53 98.75 10.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -76.74 140.06 40.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.52 115.52 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.33 1.052 . . . . 0.0 108.984 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.43 55.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.743 1.156 . . . . 0.0 109.928 -173.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.84 152.74 45.02 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.954 -1.092 . . . . 0.0 109.598 170.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.38 -47.63 17.23 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.413 1.085 . . . . 0.0 110.973 -173.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 6.3 t80 -77.84 117.28 19.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -56.07 -44.17 78.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.971 0.805 . . . . 0.0 110.637 -173.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 28.2 m -59.38 -38.32 80.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.028 -1.045 . . . . 0.0 111.283 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.14 -39.46 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.309 1.413 . . . . 0.0 110.121 171.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -65.67 -41.27 92.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.879 0.763 . . . . 0.0 109.872 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -46.26 88.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.504 174.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.58 -59.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 117.137 -1.411 . . . . 0.0 109.5 177.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.16 -52.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.87 1.668 . . . . 0.0 110.142 -177.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -61.63 -35.8 78.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.713 -0.617 . . . . 0.0 111.341 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -64.78 -44.47 89.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.709 1.141 . . . . 0.0 110.954 173.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.03 -38.7 92.24 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.503 1.121 . . . . 0.0 110.334 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.6 -45.22 94.82 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.021 0.928 . . . . 0.0 110.691 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -64.06 -28.01 69.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.77 -0.581 . . . . 0.0 111.417 174.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.33 -8.44 53.74 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.16 -1.587 . . . . 0.0 111.894 172.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.74 7.67 10.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.151 1.781 . . . . 0.0 112.025 -175.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 47.7 7.8 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 174.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.61 109.21 10.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.99 -7.8 8.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -78.52 49.2 0.84 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 166.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 33' ' ' VAL . 3.2 m -80.54 159.59 4.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.738 -1.226 . . . . 0.0 109.115 176.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.59 169.01 19.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.598 1.959 . . . . 0.0 107.401 167.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -132.71 166.27 22.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.85 168.82 18.82 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.527 0.731 . . . . 0.0 109.147 173.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.83 -33.13 57.96 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.91 178.09 1.0 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.916 2.486 . . . . 0.0 108.565 -177.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -50.68 -38.22 35.84 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.56 176.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 120.047 1.924 . . . . 0.0 108.433 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 32.7 t0 -65.56 -37.51 86.9 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.222 -0.299 . . . . 0.0 110.448 174.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.71 72.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.24 -43.2 74.38 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.672 0.789 . . . . 0.0 110.195 175.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.47 -24.31 65.59 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 3.4 mptp? -66.17 -54.57 23.71 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.595 1.089 . . . . 0.0 108.43 165.057 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 72' ' ' ILE . 2.7 mt -55.23 -48.0 74.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.623 0.647 . . . . 0.0 110.089 -169.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.63 0.82 28.56 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.07 -20.84 31.96 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.883 1.22 . . . . 0.0 111.71 163.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.07 154.49 24.58 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.059 1.314 . . . . 0.0 113.778 166.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.47 -13.77 65.66 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.283 2.373 . . . . 0.0 113.729 175.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.49 124.48 27.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.585 1.193 . . . . 0.0 107.975 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.77 -2.14 9.58 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.25 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.69 137.85 35.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.857 1.328 . . . . 0.0 108.438 173.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -130.91 80.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -171.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.19 125.96 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 p -145.87 165.15 29.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.507 0.594 . . . . 0.0 110.973 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.83 179.7 0.83 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.231 1.015 . . . . 0.0 110.284 161.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.622 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 3.5 t-105 -89.68 -49.96 6.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.948 157.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.08 137.53 47.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.107 0.867 . . . . 0.0 109.735 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.439 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -147.21 167.45 13.55 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 124.112 0.965 . . . . 0.0 109.064 168.862 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.25 -23.01 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.226 1.95 . . . . 0.0 112.951 172.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -139.14 -83.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.421 1.464 . . . . 0.0 111.121 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.7 ttm -78.08 96.23 5.08 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.11 161.15 9.01 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.328 1.018 . . . . 0.0 110.32 170.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.44 -30.03 73.25 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.599 0.619 . . . . 0.0 112.842 -172.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.622 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -72.37 -39.56 67.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.355 1.077 . . . . 0.0 109.799 177.482 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.6 -37.29 84.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.405 173.405 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.42 -54.08 50.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.896 1.225 . . . . 0.0 109.678 174.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 83' ' ' VAL . 3.4 tp -51.48 -51.8 52.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.401 1.08 . . . . 0.0 110.677 173.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -68.43 -25.07 64.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.174 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m -71.36 -50.3 33.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 46' ' ' LEU . 30.7 mt -58.4 -32.1 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.444 1.498 . . . . 0.0 108.596 -177.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -58.88 -20.2 49.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.761 1.624 . . . . 0.0 112.78 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.41 45.49 0.72 Allowed 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.262 2.225 . . . . 0.0 110.968 -161.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -127.15 -152.37 0.52 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.706 1.203 . . . . 0.0 111.742 -176.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.92 51.79 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 129.104 3.24 . . . . 0.0 112.699 174.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 60.99 20.6 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.305 2.642 . . . . 0.0 112.873 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.625 ' HB3' HD12 ' A' ' 81' ' ' LEU . 23.2 mmt -71.79 -2.64 18.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 117.69 -1.147 . . . . 0.0 113.208 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -56.94 -26.14 58.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.799 1.636 . . . . 0.0 113.797 -165.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.79 65.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.954 0.902 . . . . 0.0 113.348 177.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 54' ' ' VAL . 13.2 mt -56.46 138.59 75.5 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.523 1.129 . . . . 0.0 111.022 -172.248 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.8 100.25 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.829 2.353 . . . . 0.0 108.379 169.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -92.72 111.86 25.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 125.898 1.679 . . . . 0.0 106.586 174.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.4 tp -120.5 112.1 18.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.066 0.946 . . . . 0.0 108.836 -168.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.87 117.54 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.86 104.19 9.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -149.05 174.08 12.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.819 0.819 . . . . 0.0 109.74 -164.154 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.63 -14.04 41.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.121 -0.987 . . . . 0.0 112.19 162.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.75 96.51 6.29 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.203 1.401 . . . . 0.0 108.215 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.38 -92.07 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 162.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 51.15 101.41 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.692 1.997 . . . . 0.0 111.108 -174.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -41.14 -47.06 3.18 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.338 -0.851 . . . . 0.0 111.745 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -61.79 -34.98 76.86 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.67 -43.32 93.95 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 172.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.63 -45.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.755 174.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 mt -58.85 -56.78 14.54 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.249 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.76 -41.24 70.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.321 1.419 . . . . 0.0 110.822 -174.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -57.76 -53.77 54.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.738 0.815 . . . . 0.0 110.249 173.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.58 83.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.26 0.624 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -56.37 21.51 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.824 1.65 . . . . 0.0 109.71 178.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.72 -21.45 64.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.684 0.794 . . . . 0.0 112.2 178.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.68 33.61 6.65 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-O 118.628 -1.096 . . . . 0.0 111.785 175.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.93 148.98 41.86 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.468 1.134 . . . . 0.0 108.904 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -83.61 -6.69 59.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -172.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.17 175.22 35.64 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 119.082 0.855 . . . . 0.0 111.842 173.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.16 150.26 46.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.038 1.335 . . . . 0.0 108.847 -177.046 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.87 138.77 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 128.396 2.678 . . . . 0.0 104.846 166.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -118.59 143.39 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 156.92 14.45 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.803 170.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.82 154.32 97.75 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 N-CA-C 109.772 -0.895 . . . . 0.0 109.772 -16.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -158.75 160.54 36.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.561 0.744 . . . . 0.0 109.345 -169.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -147.49 -179.56 6.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.955 0.502 . . . . 0.0 110.429 -171.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.85 67.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.348 0.659 . . . . 0.0 109.438 176.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.28 -17.92 64.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 174.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 t -95.64 -37.83 10.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 121.407 1.912 . . . . 0.0 109.752 164.104 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -51.78 60.63 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -34.3 77.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.237 1.415 . . . . 0.0 112.455 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -71.43 -40.86 70.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 17.6 mmtp -65.3 -39.74 92.91 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 174.314 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.6 mt -54.96 -57.48 11.5 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -56.97 -33.77 67.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 24.9 mttm -56.71 -68.72 0.19 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 117.86 -1.067 . . . . 0.0 108.834 170.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -24.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 120.683 1.583 . . . . 0.0 113.339 -171.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -59.37 -49.19 78.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.98 1.312 . . . . 0.0 111.098 171.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.59 -54.84 5.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.611 0.642 . . . . 0.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.21 5.34 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.616 1.566 . . . . 0.0 108.561 -164.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -72.28 -54.14 10.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.35 15.87 2.96 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.682 -1.066 . . . . 0.0 112.347 -171.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.9 mmm . . . . . 0 C--O 1.247 0.921 0 CA-C-N 118.617 1.208 . . . . 0.0 111.495 -163.683 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.15 162.16 21.82 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.178 1.391 . . . . 0.0 108.139 165.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 9.8 m-20 -77.95 163.72 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.317 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -59.81 -13.01 8.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.388 159.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 20.9 tt0 40.92 51.43 3.2 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 129.952 3.301 . . . . 0.0 110.524 176.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.63 111.43 2.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.961 -171.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -90.6 143.64 26.54 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.169 0.918 . . . . 0.0 110.387 -162.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -111.39 100.66 9.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.584 1.154 . . . . 0.0 109.087 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -74.08 142.83 45.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.981 0.81 . . . . 0.0 109.383 175.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.44 99.61 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.761 1.625 . . . . 0.0 107.219 170.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.74 87.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -91.62 109.2 20.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.656 1.182 . . . . 0.0 112.174 -162.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.91 -24.06 59.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -120.33 -7.09 9.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -158.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 m 68.46 -58.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 128.042 2.537 . . . . 0.0 110.263 -173.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.0 m -55.56 -24.9 35.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.47 1.508 . . . . 0.0 111.16 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.4 tpp -64.82 -37.56 88.01 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.929 1.695 . . . . 0.0 109.934 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -77.34 -33.07 55.5 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 121.126 1.785 . . . . 0.0 109.538 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -52.17 -58.06 7.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.842 1.201 . . . . 0.0 108.579 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.66 -67.75 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.509 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.32 -41.71 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 120.444 1.474 . . . . 0.0 110.392 -169.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -48.19 82.76 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 119.651 1.114 . . . . 0.0 109.445 174.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.59 -48.53 74.69 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.385 175.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.37 -43.14 96.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.024 0.829 . . . . 0.0 110.67 -176.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.76 -44.99 95.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.298 1.039 . . . . 0.0 110.104 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -63.87 -29.4 70.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.152 -1.404 . . . . 0.0 112.546 177.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.9 -62.36 1.93 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.061 1.3 . . . . 0.0 108.373 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.07 2.34 1.51 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.65 -108.62 3.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -151.38 175.95 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.314 2.246 . . . . 0.0 107.255 -164.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -138.09 -178.57 5.33 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.06 0.846 . . . . 0.0 112.085 -169.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 m120 59.72 75.91 0.38 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.953 2.901 . . . . 0.0 109.717 -167.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.18 166.17 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.041 168.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -135.5 174.24 10.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 156.05 42.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.257 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.77 151.38 40.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 163.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.36 -30.49 66.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.634 0.584 . . . . 0.0 111.211 176.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.28 156.91 14.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -161.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.97 -42.46 30.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.23 0.919 . . . . 0.0 114.381 171.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.96 -37.6 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 120.2 2.0 . . . . 0.0 109.438 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.22 -43.95 96.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.526 0.731 . . . . 0.0 109.47 171.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.48 80.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.693 1.597 . . . . 0.0 110.324 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.71 -43.24 72.39 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.717 0.636 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.17 -37.18 86.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.315 0.646 . . . . 0.0 110.985 176.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -57.42 -45.06 85.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.028 1.286 . . . . 0.0 110.043 170.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 72' ' ' ILE . 5.7 mt -58.69 -51.45 69.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -78.8 16.76 0.81 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.66 62.13 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.521 -1.362 . . . . 0.0 110.048 159.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.73 -88.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -175.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.74 86.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -173.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -64.81 166.68 8.61 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.008 1.323 . . . . 0.0 110.736 172.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.47 -20.0 10.71 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.561 -1.133 . . . . 0.0 113.37 172.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -146.49 142.4 28.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.72 1.208 . . . . 0.0 109.702 -174.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.47 70.02 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -177.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -78.59 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 155.65 44.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.252 0.933 . . . . 0.0 110.19 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.9 176.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 158.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 98' ' ' ALA . 4.4 t-105 -96.18 -60.57 1.6 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.215 1.006 . . . . 0.0 108.78 170.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.26 74.92 9.99 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.458 0.703 . . . . 0.0 109.868 -159.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.1 mmt -107.4 162.31 20.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.245 1.818 . . . . 0.0 109.942 175.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -69.94 177.77 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.375 2.717 . . . . 0.0 112.062 173.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 44.8 -110.8 0.21 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.062 2.145 . . . . 0.0 110.944 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.51 85.73 6.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.024 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -54.5 173.68 0.07 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.518 1.927 . . . . 0.0 112.498 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -27.91 60.58 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.143 -0.973 . . . . 0.0 113.423 -173.033 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -82.17 -35.77 28.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.186 0.993 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -67.15 -42.08 84.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.852 169.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.1 tp -50.82 -52.65 39.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.532 1.533 . . . . 0.0 109.301 172.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.0 -58.72 6.04 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.239 0.616 . . . . 0.0 109.794 173.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.33 -35.62 77.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.479 1.036 . . . . 0.0 111.552 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.1 m -58.04 -48.44 80.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.29 1.036 . . . . 0.0 108.843 175.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.479 HD11 HD11 ' A' ' 46' ' ' LEU . 29.6 mt -63.92 -51.42 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.44 66.85 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.226 1.81 . . . . 0.0 112.535 -176.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -6.8 57.94 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.311 1.444 . . . . 0.0 112.415 178.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.86 138.51 37.8 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.639 1.109 . . . . 0.0 110.945 -174.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.15 -13.73 43.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.531 -1.15 . . . . 0.0 114.829 -175.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.37 -50.21 2.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.119 1.459 . . . . 0.0 111.635 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 70.0 mtm -60.51 -25.85 66.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.091 0.859 . . . . 0.0 111.959 -172.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -10.06 2.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.738 1.615 . . . . 0.0 114.273 -177.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.017 1.281 . . . . 0.0 112.757 170.015 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 54' ' ' VAL . 33.6 mt -70.41 129.94 89.75 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 123.447 0.699 . . . . 0.0 110.978 -170.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.77 107.8 2.13 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.81 2.34 . . . . 0.0 108.859 163.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.96 140.08 16.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.28 111.14 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 -171.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 126.64 31.14 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.06 93.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -138.63 -174.28 3.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.869 0.868 . . . . 0.0 109.902 -166.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.8 -16.77 14.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.699 1.2 . . . . 0.0 112.851 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.25 117.27 28.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.339 1.056 . . . . 0.0 109.276 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.29 -81.73 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 tptt 54.11 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.236 1.814 . . . . 0.0 111.317 -176.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -50.28 -43.34 53.33 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.405 -1.434 . . . . 0.0 112.03 178.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -52.11 -35.43 48.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.953 0.901 . . . . 0.0 112.125 176.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -78.62 -37.86 41.24 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.838 1.255 . . . . 0.0 110.536 176.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.22 -50.75 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.966 1.257 . . . . 0.0 109.138 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.327 1.9 mt -51.3 -54.47 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.916 166.035 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.41 -44.11 72.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 121.086 1.766 . . . . 0.0 112.112 -178.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -59.05 -55.48 34.53 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 118.935 0.789 . . . . 0.0 110.448 174.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -27.89 69.25 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -71.78 -53.63 12.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.333 1.853 . . . . 0.0 109.665 174.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.27 -24.53 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.179 0.992 . . . . 0.0 112.18 176.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.82 34.79 6.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.756 1.17 . . . . 0.0 111.851 176.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -63.05 145.02 56.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 118.43 1.115 . . . . 0.0 108.092 177.409 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 p -76.01 -12.98 60.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.306 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.6 171.86 40.69 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.273 0.939 . . . . 0.0 111.075 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.26 134.71 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.53 1.532 . . . . 0.0 107.723 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.55 140.26 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 127.734 2.414 . . . . 0.0 106.96 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.99 145.31 28.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 145.59 89.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.963 0.801 . . . . 0.0 110.318 168.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 136.58 43.38 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 119.68 0.922 . . . . 0.0 111.139 -6.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -141.4 155.56 45.88 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 110.781 175.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -151.39 -178.29 6.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.494 1.118 . . . . 0.0 111.527 -171.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.06 -28.75 64.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.789 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.51 64.16 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 174.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 t -97.38 -30.58 12.85 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.208 0.913 . . . . 0.0 110.289 171.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -52.85 -53.19 52.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.459 1.027 . . . . 0.0 108.869 177.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.69 -35.23 74.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.754 1.222 . . . . 0.0 111.675 178.511 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -74.58 -41.61 60.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.477 -0.765 . . . . 0.0 109.672 -176.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -64.2 -39.34 93.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.805 176.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.5 mt -55.08 -58.34 8.05 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -55.68 -38.33 69.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.366 0.667 . . . . 0.0 112.331 -178.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -64.28 0.9 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.711 172.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.05 -29.59 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.184 1.356 . . . . 0.0 113.282 -173.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -56.88 -52.65 64.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.632 0.773 . . . . 0.0 109.026 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -73.39 -46.09 50.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.935 0.334 . . . . 0.0 111.287 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -69.27 -73.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.62 -23.64 64.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.02 0.528 . . . . 0.0 110.969 -175.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.33 31.42 19.48 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -166.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 116.491 -1.719 . . . . 0.0 110.457 -175.7 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.86 164.75 0.08 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 128.371 2.668 . . . . 0.0 114.482 -175.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.49 167.32 10.68 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.298 1.839 . . . . 0.0 107.937 -177.49 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -53.6 -29.01 35.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.862 0.865 . . . . 0.0 112.407 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 39.0 44.12 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.571 1.948 . . . . 0.0 112.242 -171.313 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.31 119.52 8.1 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -90.69 132.96 35.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.87 138.53 38.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 163.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.12 140.04 37.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.214 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.65 103.19 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.032 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.13 60.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.37 1.068 . . . . 0.0 108.816 -178.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 7.3 p-10 -82.76 146.23 29.1 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.357 -1.465 . . . . 0.0 110.746 169.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -67.15 -58.66 4.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.064 1.346 . . . . 0.0 110.03 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -83.87 83.23 8.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.231 -174.621 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 t -40.08 -27.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.49 2.316 . . . . 0.0 115.847 -166.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 m -43.52 -47.66 7.28 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 119.887 -1.758 . . . . 0.0 111.804 164.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -37.61 46.4 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 0.0 111.016 172.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -66.26 -44.02 84.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.4 1.454 . . . . 0.0 109.549 -178.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -58.08 9.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.497 1.119 . . . . 0.0 108.364 172.135 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.11 -61.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 124.509 1.124 . . . . 0.0 108.978 -176.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.5 t -54.82 -43.72 68.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 119.758 1.163 . . . . 0.0 110.452 -175.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -60.34 -48.2 82.76 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.204 1.365 . . . . 0.0 109.689 175.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.27 -42.72 91.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.205 1.002 . . . . 0.0 111.047 -178.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 113' ' ' ALA . 84.8 mt -63.76 -41.22 98.03 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.999 0.92 . . . . 0.0 110.067 175.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.04 -29.6 70.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.045 0.839 . . . . 0.0 111.405 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -73.53 -28.77 62.06 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.857 -1.152 . . . . 0.0 111.636 173.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.58 -48.98 67.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.28 0.946 . . . . 0.0 109.735 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.02 95.12 1.37 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 123.288 1.518 . . . . 0.0 108.375 -174.742 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -132.18 3.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.244 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -131.77 165.75 23.08 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.832 0.853 . . . . 0.0 111.883 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.34 -174.49 2.54 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.921 1.688 . . . . 0.0 110.195 173.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.46 81.63 0.15 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.464 2.306 . . . . 0.0 109.59 -175.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 146.33 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.64 176.15 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.576 1.551 . . . . 0.0 109.754 -177.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -131.47 166.36 21.51 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.143 0.977 . . . . 0.0 108.888 173.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.94 172.2 9.59 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 160.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.07 -41.09 82.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 174.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -170.94 177.17 3.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.793 2.037 . . . . 0.0 108.19 -169.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.39 -37.09 72.43 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.944 0.783 . . . . 0.0 113.111 -178.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -63.42 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 O-C-N 121.724 -0.868 . . . . 0.0 108.91 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.53 -29.31 64.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.523 174.471 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.57 85.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.726 1.21 . . . . 0.0 109.83 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 tp -58.26 -41.24 83.83 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.255 0.479 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -40.61 96.03 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.364 175.589 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -53.64 -54.94 30.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.996 172.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 72' ' ' ILE . 7.4 mt -57.76 -40.54 79.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.777 1.171 . . . . 0.0 110.89 -174.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -65.17 -19.56 66.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.55 6.03 34.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.265 1.826 . . . . 0.0 113.907 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.69 175.06 45.45 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 119.167 -1.492 . . . . 0.0 116.736 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.84 4.99 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.473 1.511 . . . . 0.0 109.968 177.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -75.96 72.27 2.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.462 1.505 . . . . 0.0 107.099 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.47 -4.29 37.37 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.405 1.002 . . . . 0.0 113.454 -172.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.79 136.5 48.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.089 1.355 . . . . 0.0 108.263 170.079 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.752 HG21 HD13 ' A' ' 81' ' ' LEU . 5.0 t -127.21 64.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.03 139.16 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.4 p -152.01 167.58 27.95 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.956 -0.465 . . . . 0.0 110.722 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 10.6 t70 -67.89 169.46 9.8 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 158.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CH2' HD23 ' A' ' 66' ' ' LEU . 68.1 t-105 -55.72 -64.45 0.85 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.824 -1.173 . . . . 0.0 107.87 163.324 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.86 165.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.79 2.436 . . . . 0.0 112.431 -166.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.1 75.73 12.7 Favored Pre-proline 0 N--CA 1.45 -0.455 0 O-C-N 119.63 -1.919 . . . . 0.0 107.497 167.322 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.07 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.895 2.397 . . . . 0.0 110.419 176.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -165.17 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 129.986 3.314 . . . . 0.0 104.102 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.2 ttp -72.98 89.19 1.41 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 160.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.78 168.8 4.62 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.11 0.964 . . . . 0.0 110.666 164.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.6 -19.76 60.77 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.677 -176.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -77.37 -49.0 15.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.256 1.528 . . . . 0.0 108.722 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.94 0.496 . . . . 0.0 110.551 174.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -56.14 -53.05 61.77 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.087 0.955 . . . . 0.0 109.306 175.263 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.4 tp -54.03 -55.79 24.0 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 110.574 175.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 72.4 mttt -63.96 -36.99 85.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.636 1.562 . . . . 0.0 112.301 -174.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.7 m -61.44 -39.25 90.13 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 109.718 175.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 46' ' ' LEU . 32.2 mt -71.17 -47.84 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.21 68.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.752 1.621 . . . . 0.0 111.449 -178.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.62 -8.33 59.61 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.36 -0.837 . . . . 0.0 112.77 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -83.45 152.71 24.84 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.308 0.958 . . . . 0.0 110.701 -171.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.49 -22.54 77.22 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.458 -0.776 . . . . 0.0 113.476 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 -55.98 2.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.822 1.249 . . . . 0.0 109.21 173.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HD12 ' A' ' 81' ' ' LEU . 56.3 mtt -71.44 -9.17 57.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -59.03 -20.42 52.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.769 1.168 . . . . 0.0 112.227 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.76 60.01 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 54' ' ' VAL . 48.7 mt -68.6 138.46 91.04 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.914 1.234 . . . . 0.0 110.5 -170.695 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 82.71 1.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.564 2.176 . . . . 0.0 108.726 166.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 69' ' ' LEU . 1.8 m -65.54 108.83 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 159.552 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 tp -130.83 105.97 8.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -160.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.6 mmt -78.69 120.9 24.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -174.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.63 87.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.475 ' HB ' ' H ' ' A' ' 58' ' ' TRP . 3.8 t -129.19 170.52 13.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.601 0.715 . . . . 0.0 112.924 -159.092 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.11 57.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.789 0.835 . . . . 0.0 112.822 161.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.54 98.34 2.28 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.851 1.26 . . . . 0.0 111.424 -167.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.18 23.16 0.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.968 -1.083 . . . . 0.0 111.306 163.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -70.93 104.25 2.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.437 -1.414 . . . . 0.0 107.792 -174.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -31.93 -65.49 0.14 Allowed 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 125.716 1.606 . . . . 0.0 111.974 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.74 -29.17 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.743 -172.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -62.42 -46.29 89.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.392 0.996 . . . . 0.0 109.436 171.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.33 -46.4 95.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.55 -57.23 9.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' C ' HD21 ' A' ' 66' ' ' LEU . . . -56.56 -40.05 74.51 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.908 0.777 . . . . 0.0 111.215 -172.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.73 -52.16 53.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.572 1.149 . . . . 0.0 110.436 176.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 177.251 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -62.38 -50.92 69.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 111.345 177.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.39 61.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.482 1.113 . . . . 0.0 112.892 178.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.33 30.76 9.6 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.356 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.727 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.67 146.79 44.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.93 1.365 . . . . 0.0 108.135 175.598 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.1 p -70.39 -8.37 50.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.32 165.84 20.03 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -140.22 85.53 2.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.078 0.951 . . . . 0.0 109.755 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -85.21 141.29 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 169.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.19 157.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 171.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -56.22 137.32 74.64 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.657 159.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.3 159.47 97.64 Favored 'Cis proline' 0 C--N 1.348 0.503 0 CA-C-N 121.166 1.452 . . . . 0.0 112.327 -6.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -177.75 155.09 0.99 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.264 1.025 . . . . 0.0 109.909 -174.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -150.35 -174.02 4.62 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.6 1.16 . . . . 0.0 112.076 -168.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.484 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -54.04 -35.83 62.4 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -47.22 -30.79 3.21 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.006 2.122 . . . . 0.0 115.074 174.048 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.428 HG23 ' HE2' ' A' ' 119' ' ' LYS . 1.2 t -111.21 -19.79 12.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.968 0.507 . . . . 0.0 110.939 176.417 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.33 -55.94 25.71 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.738 -1.226 . . . . 0.0 108.226 167.521 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -44.84 79.07 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.909 1.283 . . . . 0.0 111.684 178.341 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -38.64 76.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.443 -0.785 . . . . 0.0 110.807 -177.481 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HE2' HG23 ' A' ' 115' ' ' THR . 46.2 mtmt -61.99 -39.25 91.56 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.151 -0.968 . . . . 0.0 110.3 173.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.12 -51.25 70.85 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.419 172.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.7 -36.53 72.1 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.097 1.317 . . . . 0.0 112.36 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -69.8 0.11 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.32 1.448 . . . . 0.0 108.382 169.438 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -22.29 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -171.05 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.49 -45.59 86.66 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.152 0.981 . . . . 0.0 109.679 174.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.19 -39.26 25.74 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.333 0.969 . . . . 0.0 110.979 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -74.59 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -171.079 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.84 -37.83 88.37 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.23 44.42 4.08 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -163.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.728 -1.129 . . . . 0.0 111.372 -175.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.59 177.08 9.34 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 159.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -132.82 155.0 49.76 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.637 0.732 . . . . 0.0 110.34 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -49.7 -33.67 16.58 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 126.283 1.833 . . . . 0.0 111.238 167.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 41.73 55.67 3.56 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.944 1.697 . . . . 0.0 108.648 -170.142 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.27 107.89 0.21 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.341 2.257 . . . . 0.0 108.308 -176.547 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.54 143.18 30.35 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.139 -163.111 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.58 95.5 5.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 34' ' ' GLU . 21.5 tp -69.83 135.89 50.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.887 1.221 . . . . 0.0 108.464 174.51 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.32 114.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.194 1.398 . . . . 0.0 108.331 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.44 64.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 124.912 1.285 . . . . 0.0 108.032 -173.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.44 156.74 29.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.62 -51.92 66.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 108.766 170.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.44 108.64 19.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -51.33 -42.68 61.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.213 178.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -50.97 -45.77 61.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.181 1.355 . . . . 0.0 111.625 172.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.2 ttm -62.59 -25.19 67.95 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.701 0.801 . . . . 0.0 111.572 -178.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -68.8 -39.03 80.33 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.44 -1.413 . . . . 0.0 110.56 170.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -66.48 -36.59 83.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.16 178.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -47.06 -49.32 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.294 1.406 . . . . 0.0 110.883 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -57.0 -46.96 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.444 0.698 . . . . 0.0 110.74 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.4 -40.36 94.12 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.394 0.678 . . . . 0.0 111.131 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.55 -38.67 87.61 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.854 -0.529 . . . . 0.0 110.375 177.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.2 -26.71 67.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.366 0.53 . . . . 0.0 111.613 172.395 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -73.05 -38.28 66.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.736 1.153 . . . . 0.0 110.839 169.061 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.45 -36.7 85.01 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.339 0.972 . . . . 0.0 111.244 176.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -166.62 99.71 0.58 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.214 2.205 . . . . 0.0 108.81 177.268 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.2 -113.37 0.54 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.71 171.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -145.08 -176.97 5.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.101 1.76 . . . . 0.0 109.484 -162.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -133.92 -176.12 4.07 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.386 1.474 . . . . 0.0 109.932 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 54.5 63.65 2.08 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.836 1.654 . . . . 0.0 110.548 -171.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.11 160.29 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.485 165.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' HB3' HD12 ' A' ' 9' ' ' LEU . 2.9 tp10 -133.03 173.08 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.63 2.372 . . . . 0.0 106.106 175.449 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -139.2 166.88 23.38 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.95 169.39 17.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.97 1.308 . . . . 0.0 109.133 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.24 -40.63 77.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.549 0.74 . . . . 0.0 109.745 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -178.44 179.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.506 2.322 . . . . 0.0 108.426 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.65 -41.99 10.13 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.85 1.69 . . . . 0.0 115.432 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.85 -47.25 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.147 1.473 . . . . 0.0 108.642 179.172 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -67.98 -32.34 72.67 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 175.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.1 -43.21 91.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.792 -1.193 . . . . 0.0 110.071 177.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.702 0.683 . . . . 0.0 111.076 173.566 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.07 -43.37 77.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.919 0.887 . . . . 0.0 111.471 178.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -63.36 -52.77 60.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -55.2 -53.06 60.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.594 1.158 . . . . 0.0 112.565 -172.723 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.32 -1.69 3.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 112.257 -177.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.3 25.32 7.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.176 2.19 . . . . 0.0 111.412 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.64 168.43 38.23 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 121.107 1.776 . . . . 0.0 114.023 169.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.95 53.66 1.39 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 124.773 1.178 . . . . 0.0 110.355 -178.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -62.01 142.49 57.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.443 1.097 . . . . 0.0 110.117 -177.056 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.05 -29.76 9.44 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 119.491 -0.616 . . . . 0.0 111.689 173.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -138.19 149.07 45.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.384 1.074 . . . . 0.0 109.431 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG21 HD13 ' A' ' 81' ' ' LEU . 16.5 t -137.17 108.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.65 136.38 58.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.52 153.5 38.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.724 0.238 . . . . 0.0 110.931 -159.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -64.86 170.82 3.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.926 0.87 . . . . 0.0 111.194 163.131 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 42.0 t-105 -83.47 -76.46 0.28 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 160.145 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.97 -170.42 0.08 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.01 1.324 . . . . 0.0 110.999 176.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.3 ttp -162.89 75.67 1.96 Allowed Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 158.573 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.48 -71.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.117 2.545 . . . . 0.0 107.935 175.36 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -131.96 -67.97 0.65 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.231 1.412 . . . . 0.0 107.737 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 ttm -91.09 104.75 17.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.403 2.281 . . . . 0.0 107.614 161.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.73 171.44 5.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.513 0.597 . . . . 0.0 110.73 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.67 69.19 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.749 -0.594 . . . . 0.0 112.364 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.598 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.25 -40.94 74.12 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.998 0.899 . . . . 0.0 109.782 178.437 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.79 -32.3 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.886 1.274 . . . . 0.0 111.005 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -58.48 -55.54 33.78 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.42 -57.16 11.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.41 1.084 . . . . 0.0 109.491 174.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.8 -21.38 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.973 1.26 . . . . 0.0 113.83 -173.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -61.37 -64.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 163.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.0 mt -56.48 -36.6 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.917 1.287 . . . . 0.0 110.6 -174.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -22.54 61.86 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.446 1.899 . . . . 0.0 113.519 -177.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.87 -1.94 17.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.104 0.866 . . . . 0.0 111.385 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.39 150.56 46.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 159.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.83 -3.44 89.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.362 -1.244 . . . . 0.0 113.719 -174.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.57 -40.8 0.71 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.343 1.572 . . . . 0.0 111.035 -177.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.4 mtm -71.14 -8.87 56.46 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.305 -0.872 . . . . 0.0 113.147 -175.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.3 p -63.53 -18.28 63.67 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.42 1.009 . . . . 0.0 113.314 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.17 52.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.404 1.482 . . . . 0.0 113.277 172.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.591 HD13 HG21 ' A' ' 54' ' ' VAL . 24.9 mt -73.79 147.22 86.37 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 111.345 -175.126 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.55 56.36 1.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.605 2.87 . . . . 0.0 111.085 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG2' HD13 ' A' ' 69' ' ' LEU . 1.1 m -53.28 113.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 119.081 0.855 . . . . 0.0 110.242 176.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.7 122.97 48.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.589 1.156 . . . . 0.0 108.674 -169.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mmt -80.99 128.29 33.53 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 174.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.26 108.44 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -152.06 165.6 34.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.969 0.89 . . . . 0.0 112.017 -166.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.82 60.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.45 -0.781 . . . . 0.0 111.433 161.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.97 96.87 10.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.249 1.419 . . . . 0.0 109.414 -163.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -73.92 0.07 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.265 1.026 . . . . 0.0 110.781 177.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.5 tttt 39.25 93.37 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 127.151 2.18 . . . . 0.0 112.537 -175.08 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -44.29 -40.85 5.54 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.711 176.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.31 -45.28 76.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.3 0.955 . . . . 0.0 112.992 176.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.17 -37.71 81.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.329 1.452 . . . . 0.0 109.557 176.316 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.4 mt -64.52 -41.84 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.332 176.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -59.71 -48.38 87.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-N 120.61 1.55 . . . . 0.0 108.076 171.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.19 -43.8 74.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.089 1.313 . . . . 0.0 111.443 -177.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.87 85.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.859 0.464 . . . . 0.0 110.38 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.51 83.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.295 0.638 . . . . 0.0 112.105 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -64.51 -45.12 88.6 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.131 1.772 . . . . 0.0 110.721 174.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.78 -6.16 39.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.444 0.697 . . . . 0.0 112.298 170.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.03 64.84 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.351 -1.468 . . . . 0.0 113.049 172.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -51.88 160.21 0.73 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.465 1.106 . . . . 0.0 110.214 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -63.36 -30.7 71.79 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.361 -0.837 . . . . 0.0 111.575 176.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.46 -174.98 46.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 178.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -139.65 94.94 2.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 107.748 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.414 HG22 ' HE3' ' A' ' 119' ' ' LYS . 75.2 t -77.76 133.22 30.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.291 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 150.05 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -55.52 168.38 0.62 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 173.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.61 94.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.545 0 N-CA-C 107.442 -1.791 . . . . 0.0 107.442 -20.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -81.77 158.74 24.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.909 0.861 . . . . 0.0 111.613 -165.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.7 p -146.89 -179.05 6.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.589 1.556 . . . . 0.0 109.623 -172.63 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -34.14 65.67 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 110.046 176.834 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.18 58.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.819 0.848 . . . . 0.0 113.229 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -34.88 7.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.249 0.932 . . . . 0.0 110.506 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.04 -47.54 68.33 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.962 1.305 . . . . 0.0 108.995 176.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.01 74.57 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.411 1.084 . . . . 0.0 112.207 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.11 -44.11 89.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.862 1.21 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 107' ' ' VAL . 15.6 mmtt -67.62 -42.62 82.06 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.947 -176.116 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.72 -52.4 64.02 Favored 'General case' 0 C--O 1.221 -0.403 0 O-C-N 123.861 0.726 . . . . 0.0 110.216 172.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.99 -47.45 71.42 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.532 1.06 . . . . 0.0 111.251 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -56.23 -62.95 1.37 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.75 178.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -27.08 36.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 120.375 1.443 . . . . 0.0 113.633 -175.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.32 -50.57 73.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.31 -48.74 39.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -65.43 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.413 1.485 . . . . 0.0 108.509 -160.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.61 -41.23 96.35 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.287 0.949 . . . . 0.0 108.609 175.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.77 18.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.269 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-O 116.813 -1.565 . . . . 0.0 112.181 -163.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -89.71 132.01 35.39 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 34.9 m-85 -85.13 139.18 31.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.13 140.16 38.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 161.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -135.53 100.38 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.88 84.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 21.0 t70 -91.45 171.83 8.93 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.993 0.902 . . . . 0.0 111.516 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.91 -28.56 68.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.237 1.815 . . . . 0.0 112.259 165.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -131.95 113.82 13.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.904 1.681 . . . . 0.0 107.802 -163.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -50.37 -40.46 49.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.149 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 m -52.73 -37.63 59.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.184 0.994 . . . . 0.0 111.22 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -58.83 -41.34 86.62 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.663 1.12 . . . . 0.0 110.243 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.603 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.03 -48.39 80.47 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.338 0.972 . . . . 0.0 109.959 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.28 -58.19 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.69 1.196 . . . . 0.0 108.893 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.23 -50.64 70.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.323 1.049 . . . . 0.0 109.975 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -53.97 -48.57 70.19 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.852 0.751 . . . . 0.0 110.412 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.45 -46.01 84.96 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.682 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.99 -40.27 95.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.383 0.992 . . . . 0.0 110.525 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -60.78 -37.75 82.94 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.72 0.808 . . . . 0.0 110.838 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -70.74 -35.45 72.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 117.735 -1.126 . . . . 0.0 111.927 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -60.07 -42.26 94.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.654 1.115 . . . . 0.0 108.892 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.61 -56.34 14.53 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.281 0.632 . . . . 0.0 109.867 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.24 4.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.186 -1.341 . . . . 0.0 116.291 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.97 171.98 12.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.897 1.848 . . . . 0.0 112.382 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.21 -179.95 6.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.206 1.802 . . . . 0.0 108.267 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.2 t30 65.15 82.34 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.073 2.549 . . . . 0.0 112.353 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.41 162.08 13.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -140.91 170.73 15.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.223 1.809 . . . . 0.0 110.362 167.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -122.17 168.27 12.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.941 2.496 . . . . 0.0 107.582 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.21 171.0 14.67 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.616 1.166 . . . . 0.0 109.308 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.64 -35.64 65.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.938 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.26 178.38 0.71 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.473 1.909 . . . . 0.0 107.881 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.23 -43.37 4.59 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.31 1.91 . . . . 0.0 116.076 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.43 -47.29 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.865 1.833 . . . . 0.0 109.259 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -68.55 -37.23 79.77 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.1 -0.375 . . . . 0.0 110.85 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.9 -51.93 67.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.712 1.605 . . . . 0.0 109.818 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.62 -43.42 80.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.77 0.795 . . . . 0.0 110.54 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -71.74 -24.7 61.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -65.97 -42.07 90.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.376 166.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 72' ' ' ILE . 6.4 mt -56.03 -46.82 78.71 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.305 1.412 . . . . 0.0 108.249 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.37 10.81 0.9 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.733 1.213 . . . . 0.0 114.067 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.0 38.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.051 1.296 . . . . 0.0 110.988 160.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.49 -82.86 0.11 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.43 94.28 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.34 170.9 14.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.292 1.037 . . . . 0.0 110.484 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.09 -30.02 5.87 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.993 -0.893 . . . . 0.0 113.953 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 87.2 m-85 -146.55 148.58 32.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.258 1.023 . . . . 0.0 108.689 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -125.19 80.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 5.9 mt -91.73 130.84 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -171.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 p -144.5 161.36 39.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.513 1.506 . . . . 0.0 114.957 -173.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 1.6 p-10 -73.46 -158.25 0.06 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.258 1.023 . . . . 0.0 110.278 159.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -134.08 -30.27 1.21 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.329 2.252 . . . . 0.0 112.528 -167.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.43 32.02 6.36 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.889 2.076 . . . . 0.0 112.094 -158.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.539 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 2.4 mpt? -44.69 154.33 0.43 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 113.329 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.35 -25.74 35.81 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.127 2.551 . . . . 0.0 112.943 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -119.98 -99.57 0.44 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.2 ttt -78.35 106.17 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 161.03 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.469 1.108 . . . . 0.0 111.867 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.33 73.83 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 119.48 -0.622 . . . . 0.0 112.483 -166.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.28 -34.59 48.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.896 0.879 . . . . 0.0 109.942 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.36 -37.56 71.65 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 111.05 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.48 -50.71 72.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.757 0.708 . . . . 0.0 109.354 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -52.58 -61.09 2.5 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.041 0.936 . . . . 0.0 108.717 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.33 -26.13 67.6 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.879 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.8 m -66.82 -48.36 69.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.582 1.083 . . . . 0.0 110.864 170.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 46' ' ' LEU . 13.7 mt -60.89 -40.83 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 4.16 1.6 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.604 2.362 . . . . 0.0 113.572 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 120.238 1.381 . . . . 0.0 111.161 170.092 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.82 -54.1 0.46 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.485 2.714 . . . . 0.0 113.827 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -15.99 62.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.611 1.564 . . . . 0.0 114.383 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD13 HG21 ' A' ' 54' ' ' VAL . 19.1 mt -68.2 121.71 81.31 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 119.148 0.886 . . . . 0.0 109.452 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.51 106.81 1.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.871 1.714 . . . . 0.0 108.739 166.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.05 134.09 28.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 9.4 tp -131.65 106.28 8.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.9 mtp -82.14 117.75 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.94 105.05 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -145.49 172.61 12.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.932 0.872 . . . . 0.0 111.007 -164.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -11.45 59.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.44 -0.788 . . . . 0.0 112.918 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -88.24 107.98 19.07 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.203 2.201 . . . . 0.0 112.356 -165.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -91.4 3.91 53.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.52 120.32 6.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.243 1.383 . . . . 0.0 109.922 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -55.64 -44.31 77.03 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.324 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -63.68 -33.43 75.62 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.927 1.239 . . . . 0.0 111.023 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.02 -47.07 84.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.287 0.949 . . . . 0.0 109.373 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.58 -45.18 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.17 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.75 -56.82 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.83 -46.55 60.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.768 1.227 . . . . 0.0 110.146 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.82 71.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.523 0.729 . . . . 0.0 112.029 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.52 97.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -61.85 -46.47 89.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.818 1.647 . . . . 0.0 111.408 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.02 -16.21 59.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.788 0.835 . . . . 0.0 112.458 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.65 33.57 18.68 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.446 1.021 . . . . 0.0 111.722 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.06 142.74 53.53 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.0 p -72.91 -14.13 61.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.515 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.21 169.58 38.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -136.78 144.61 43.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.927 1.291 . . . . 0.0 107.922 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.98 140.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.978 2.111 . . . . 0.0 105.712 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 90' ' ' ALA . 10.8 t -123.24 144.64 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 149.4 21.17 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.053 169.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 140.67 67.19 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 109.691 -0.927 . . . . 0.0 109.691 -16.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -134.73 167.14 21.39 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.997 -1.064 . . . . 0.0 111.041 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 p -137.2 172.78 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.644 1.178 . . . . 0.0 110.991 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.83 -33.47 64.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.817 1.247 . . . . 0.0 109.511 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.03 -54.52 38.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.718 1.207 . . . . 0.0 111.246 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -31.82 58.3 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.564 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -56.49 19.53 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -66.5 -21.1 66.17 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.758 -0.588 . . . . 0.0 112.464 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -68.49 -47.98 65.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.244 0.929 . . . . 0.0 109.526 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -68.92 -38.36 79.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.651 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 mt -57.6 -54.51 46.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.254 0.934 . . . . 0.0 110.146 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -65.51 -30.2 70.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.754 0.706 . . . . 0.0 110.725 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -55.53 -58.24 8.58 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.933 165.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.82 -22.7 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 120.691 1.587 . . . . 0.0 113.619 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -57.83 -65.24 0.67 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -76.11 -30.6 58.3 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.18 -169.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -71.43 -68.17 0.47 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.319 1.048 . . . . 0.0 109.462 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.8 -31.59 45.99 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.354 1.062 . . . . 0.0 111.756 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.21 29.88 8.16 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.382 -1.232 . . . . 0.0 111.709 -165.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.7 mmt . . . . . 0 C--O 1.247 0.971 0 CA-C-N 119.868 1.834 . . . . 0.0 111.756 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 155.1 19.0 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 110.371 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -104.33 101.64 11.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 164.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.47 133.9 46.19 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 117.361 -1.736 . . . . 0.0 106.727 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.4 t -132.06 105.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.41 58.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.055 1.342 . . . . 0.0 107.782 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.55 157.21 17.76 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.883 -0.511 . . . . 0.0 110.445 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.13 -28.21 68.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.879 1.271 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -132.41 123.21 26.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.524 1.53 . . . . 0.0 107.488 -167.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -52.15 -52.77 49.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.715 0.689 . . . . 0.0 111.514 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.2 m -59.33 -29.8 67.91 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.546 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 ttt -61.94 -44.48 96.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.26 0.936 . . . . 0.0 109.957 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -39.88 94.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.329 0.968 . . . . 0.0 109.111 174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -44.82 93.0 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.44 -62.22 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.342 172.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.01 -49.23 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 121.423 1.92 . . . . 0.0 111.13 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -48.61 76.74 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.443 1.097 . . . . 0.0 110.379 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -56.22 -51.22 68.87 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.927 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.31 -36.31 79.74 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.496 1.518 . . . . 0.0 112.033 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.65 -52.4 60.91 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.712 -0.617 . . . . 0.0 109.659 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -64.74 -20.6 66.44 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.1 -52.32 56.19 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.261 1.424 . . . . 0.0 109.879 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.37 2.43 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -166.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.86 -84.66 1.08 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 124.542 1.068 . . . . 0.0 110.997 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -151.28 175.44 12.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.205 1.402 . . . . 0.0 109.559 -169.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -139.09 -179.15 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.376 1.07 . . . . 0.0 109.944 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 64.39 77.17 0.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.996 2.519 . . . . 0.0 110.335 -165.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.97 172.36 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.069 160.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.39 174.29 10.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.723 2.009 . . . . 0.0 106.192 158.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.7 164.66 23.49 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.39 170.72 13.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.166 1.786 . . . . 0.0 106.817 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.1 -37.75 84.45 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.948 0.794 . . . . 0.0 110.389 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -172.64 166.92 5.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.985 1.314 . . . . 0.0 108.578 -160.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.548 ' H ' ' HG3' ' A' ' 60' ' ' MET . . . -49.35 -40.86 31.15 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.9 1.714 . . . . 0.0 113.966 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.02 -52.99 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.82 0.848 . . . . 0.0 108.77 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.63 -23.91 56.41 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.349 1.46 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.97 51.42 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.71 -46.2 70.69 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.895 0.747 . . . . 0.0 111.045 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.82 -46.58 74.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.475 1.51 . . . . 0.0 111.764 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.63 -48.36 82.14 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.741 -1.123 . . . . 0.0 109.736 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 72' ' ' ILE . 17.0 mt -53.83 -46.31 71.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.347 1.431 . . . . 0.0 110.81 -173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.91 7.55 2.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.39 -4.92 18.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.933 1.242 . . . . 0.0 113.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.88 32.06 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 120.418 1.463 . . . . 0.0 113.247 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.46 43.66 2.35 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.586 1.565 . . . . 0.0 113.614 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.08 82.0 2.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.47 -1.12 78.57 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.928 1.251 . . . . 0.0 113.065 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.77 134.87 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 81' ' ' LEU . 33.1 t -128.68 96.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.76 134.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.12 168.96 18.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.036 0.922 . . . . 0.0 110.012 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -46.93 -176.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 130.986 3.714 . . . . 0.0 113.304 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -115.98 -42.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.39 158.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.63 47.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.217 1.007 . . . . 0.0 111.691 -159.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.548 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -61.07 138.69 94.3 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.862 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 60' ' ' MET . 21.1 Cg_endo -61.12 26.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 125.265 3.976 . . . . 0.0 118.017 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.33 -71.89 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 122.058 2.208 . . . . 0.0 110.03 159.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.8 ttt -91.34 85.07 5.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.929 2.091 . . . . 0.0 107.164 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -47.07 153.55 0.43 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.006 1.322 . . . . 0.0 110.32 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.04 -27.53 62.53 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.429 -0.795 . . . . 0.0 112.167 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.81 -36.57 78.4 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.965 0.882 . . . . 0.0 110.29 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.18 -31.41 55.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.866 0.867 . . . . 0.0 110.795 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -57.86 -53.22 60.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.674 0.67 . . . . 0.0 109.272 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -52.56 -56.47 15.05 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.289 1.036 . . . . 0.0 108.701 174.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -63.44 -30.92 71.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.726 1.148 . . . . 0.0 112.703 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -69.22 -42.22 76.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.103 0.961 . . . . 0.0 110.053 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 46' ' ' LEU . 31.6 mt -61.57 -50.62 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -60.09 -24.68 64.81 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.377 1.871 . . . . 0.0 112.334 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 124.52 1.128 . . . . 0.0 112.627 176.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 -36.55 67.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.941 1.297 . . . . 0.0 112.616 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.99 60.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.336 0.971 . . . . 0.0 113.146 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 54' ' ' VAL . 34.2 mt -57.95 135.01 83.68 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-N 119.693 1.133 . . . . 0.0 111.49 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.67 109.84 2.74 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.764 2.309 . . . . 0.0 107.589 161.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -102.68 113.57 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.103 1.761 . . . . 0.0 107.364 177.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.73 111.9 19.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.219 1.008 . . . . 0.0 108.836 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.03 132.03 34.38 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.43 127.54 59.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -161.55 169.61 21.42 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.59 -12.98 47.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.254 -0.904 . . . . 0.0 111.409 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.32 119.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.973 1.261 . . . . 0.0 111.796 -165.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.06 11.04 14.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.537 0.735 . . . . 0.0 112.018 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -52.21 117.97 3.18 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.302 1.841 . . . . 0.0 110.62 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -52.83 -47.73 67.5 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.807 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -46.7 -46.12 19.96 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.17 0.988 . . . . 0.0 111.56 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -65.36 -43.82 89.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.03 -48.57 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.08 -54.44 34.36 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.26 -48.41 45.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.357 1.463 . . . . 0.0 110.84 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.06 27.01 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.219 0.607 . . . . 0.0 109.701 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.75 66.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -73.39 -56.85 4.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.699 2.0 . . . . 0.0 109.641 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.41 -35.61 60.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.573 0.749 . . . . 0.0 110.18 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.6 27.85 3.69 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 125.166 1.365 . . . . 0.0 111.545 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.72 138.59 55.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.112 0.956 . . . . 0.0 110.322 -172.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -72.89 -5.53 38.97 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.59 1.556 . . . . 0.0 112.003 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.32 165.46 34.79 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 158.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -137.79 110.78 7.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.66 104.35 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.442 1.897 . . . . 0.0 106.23 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.62 147.83 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -66.91 147.14 99.15 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 162.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.65 139.7 58.79 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.195 1.105 . . . . 0.0 110.498 -3.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.81 148.09 40.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -144.97 -176.25 5.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 109.811 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.43 -33.23 43.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.936 1.294 . . . . 0.0 110.166 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.54 76.23 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.69 0.796 . . . . 0.0 112.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.01 -27.98 19.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.949 . . . . 0.0 110.003 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.92 -53.39 58.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.365 1.066 . . . . 0.0 109.374 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -37.48 85.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.63 1.172 . . . . 0.0 111.462 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.42 -45.38 69.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.677 1.591 . . . . 0.0 108.896 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.63 87.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.392 -1.766 . . . . 0.0 111.245 170.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.23 -56.51 17.92 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.354 1.034 . . . . 0.0 109.281 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -59.54 -35.02 73.4 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.45 1.023 . . . . 0.0 111.109 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -54.93 -50.82 67.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.689 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.18 -24.42 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.704 1.138 . . . . 0.0 113.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -56.68 -55.56 32.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -74.83 -46.52 36.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -68.49 -70.41 0.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.02 -26.64 66.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.127 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.03 12.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -164.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.5 mmt . . . . . 0 C--O 1.252 1.228 0 CA-C-N 118.998 1.399 . . . . 0.0 109.09 176.258 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.627 0.727 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -89.38 117.65 28.47 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.728 -162.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.13 152.56 41.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.6 tp -123.29 134.8 54.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.73 119.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.678 1.191 . . . . 0.0 108.306 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.09 61.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.35 156.85 36.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -62.05 -44.4 96.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.654 1.181 . . . . 0.0 110.485 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 12.2 t80 -116.08 132.59 56.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 109.029 -159.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -51.28 -60.65 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.128 0.971 . . . . 0.0 111.97 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 64.4 m -51.22 -37.25 45.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.997 0.519 . . . . 0.0 110.936 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.59 -47.17 82.86 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.018 0.826 . . . . 0.0 111.045 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.3 ptt85 -72.92 -27.43 61.86 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 120.997 1.726 . . . . 0.0 111.545 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -62.59 -40.95 98.55 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.467 -0.771 . . . . 0.0 109.431 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.23 -63.43 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.49 -42.63 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.804 1.184 . . . . 0.0 110.671 -171.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -60.56 -49.21 78.44 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 117.709 -1.138 . . . . 0.0 111.07 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -50.86 -54.68 21.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.377 0.989 . . . . 0.0 109.66 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.82 -42.62 75.95 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.099 0.96 . . . . 0.0 111.535 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.86 -47.63 79.94 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.52 -19.29 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.441 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.76 -33.08 74.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.178 1.354 . . . . 0.0 110.156 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.05 -50.28 6.75 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.461 1.504 . . . . 0.0 108.738 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.94 -97.14 0.13 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 35.92 64.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 128.363 2.665 . . . . 0.0 112.316 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -68.41 1.48 2.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.83 100.47 4.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.894 1.679 . . . . 0.0 110.694 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.63 91.56 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 125.799 1.639 . . . . 0.0 107.64 -172.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 164.4 17.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.429 0.691 . . . . 0.0 109.56 169.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.82 166.31 22.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 158.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -113.54 178.58 4.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.368 1.067 . . . . 0.0 108.668 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.65 -43.1 23.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -167.24 164.03 15.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.264 1.826 . . . . 0.0 108.121 -161.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.88 -39.42 11.2 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.191 1.377 . . . . 0.0 114.034 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.018 0.909 . . . . 0.0 109.314 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.16 -26.15 66.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.171 0.589 . . . . 0.0 111.038 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.46 -54.6 43.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.802 1.183 . . . . 0.0 108.433 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.89 -39.87 82.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.337 0.589 . . . . 0.0 111.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -56.1 -47.11 78.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.435 1.094 . . . . 0.0 110.353 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -59.38 -48.83 80.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.941 1.297 . . . . 0.0 109.911 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 72' ' ' ILE . 3.2 mt -57.91 -39.32 77.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.837 1.199 . . . . 0.0 109.755 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -76.25 10.07 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.15 -37.15 84.96 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.501 -1.375 . . . . 0.0 109.835 159.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.24 -19.68 0.73 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 118.112 -1.382 . . . . 0.0 116.136 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.01 86.42 0.06 OUTLIER Glycine 0 C--N 1.338 0.691 0 CA-C-N 120.389 2.095 . . . . 0.0 113.541 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.26 163.5 14.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.588 0.694 . . . . 0.0 109.925 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.42 -38.84 4.63 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.419 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -142.5 151.17 41.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.463 1.131 . . . . 0.0 109.113 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -129.27 79.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -97.31 120.62 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -169.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -151.65 156.54 40.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.114 1.324 . . . . 0.0 113.216 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.12 168.44 20.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.631 1.173 . . . . 0.0 110.051 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -82.28 -56.21 4.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.075 0.95 . . . . 0.0 113.409 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.19 67.23 4.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.699 0.799 . . . . 0.0 112.41 -158.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -66.89 147.63 99.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.712 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.45 -6.32 14.83 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 114.096 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -139.88 -89.95 0.18 Allowed 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.196 1.362 . . . . 0.0 111.746 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.7 ttm -82.0 95.85 7.54 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.77 155.66 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.89 -24.18 48.54 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.359 -0.838 . . . . 0.0 112.022 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.69 -35.45 57.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.609 1.204 . . . . 0.0 111.515 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.04 -40.24 75.26 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.098 0.959 . . . . 0.0 109.705 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.82 -54.08 48.93 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.211 1.404 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tp -53.07 -58.36 7.26 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.719 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 26.7 mttm -60.9 -31.76 71.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.389 0.995 . . . . 0.0 111.844 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.5 m -65.28 -48.71 72.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.566 0.746 . . . . 0.0 110.608 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 HD11 HD11 ' A' ' 46' ' ' LEU . 28.0 mt -59.16 -45.03 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -7.08 13.16 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.896 1.678 . . . . 0.0 113.57 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 119.741 1.155 . . . . 0.0 111.689 173.705 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.7 mtt . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.0 -57.13 3.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.09 2.556 . . . . 0.0 112.966 -159.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.83 -9.97 59.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.254 -1.355 . . . . 0.0 113.874 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 54' ' ' VAL . 12.7 mt -56.8 117.78 19.38 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.181 1.355 . . . . 0.0 110.571 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.54 100.88 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.07 2.513 . . . . 0.0 109.098 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.01 130.86 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 166.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.5 tp -131.17 112.22 12.64 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.735 1.214 . . . . 0.0 108.444 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.6 mmm -83.01 96.88 8.48 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -100.34 107.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -154.41 167.27 30.56 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.161 -0.962 . . . . 0.0 111.153 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.75 47.43 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.543 -0.723 . . . . 0.0 111.872 165.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -76.05 94.4 3.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.866 1.266 . . . . 0.0 110.737 -164.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -83.54 14.93 3.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.978 1.311 . . . . 0.0 112.974 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 118.98 4.62 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.579 1.152 . . . . 0.0 108.19 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -57.26 -43.38 82.96 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.431 1.014 . . . . 0.0 110.02 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.71 -29.48 69.37 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.766 1.166 . . . . 0.0 112.11 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -67.7 -45.24 75.71 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.715 0.689 . . . . 0.0 109.719 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.62 -48.12 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.251 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.87 -55.17 19.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.82 69.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.227 1.011 . . . . 0.0 110.38 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.31 -53.42 58.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.712 0.805 . . . . 0.0 110.763 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.66 93.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.312 0.505 . . . . 0.0 110.484 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -59.89 -49.67 76.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.951 2.1 . . . . 0.0 111.272 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -61.6 -31.24 71.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.471 1.108 . . . . 0.0 111.56 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.03 16.01 7.53 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.699 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.81 136.8 58.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 119.712 1.756 . . . . 0.0 108.553 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -66.63 -19.57 65.8 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 123.313 0.383 . . . . 0.0 110.954 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.59 176.88 48.25 Favored Glycine 0 N--CA 1.439 -1.101 0 O-C-N 121.187 -0.946 . . . . 0.0 113.186 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.89 137.74 51.61 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.483 1.513 . . . . 0.0 107.34 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.0 85.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.513 2.325 . . . . 0.0 104.943 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 90' ' ' ALA . 23.5 t -70.73 144.82 13.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 167.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 155.03 6.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.192 0.997 . . . . 0.0 110.506 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.01 145.44 83.93 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 N-CA-C 109.464 -1.014 . . . . 0.0 109.464 -10.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -132.24 150.79 52.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.346 1.058 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -147.28 169.46 19.35 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.182 2.193 . . . . 0.0 108.334 -164.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.19 74.12 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.76 17.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.016 1.326 . . . . 0.0 114.313 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.63 -25.49 8.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.757 1.162 . . . . 0.0 110.892 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -57.7 11.67 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 170.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -32.07 71.56 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.22 -49.25 67.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 109.425 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 3.8 mmpt? -68.53 -37.31 79.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 116.724 -1.607 . . . . 0.0 110.278 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.94 -57.36 12.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.307 0.958 . . . . 0.0 109.077 171.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -50.42 -45.27 55.64 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.058 0.943 . . . . 0.0 110.866 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 11.5 mtmm -59.43 -48.03 83.2 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.559 -1.21 . . . . 0.0 112.596 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 pt -75.05 -31.91 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.896 2.134 . . . . 0.0 113.283 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -55.4 -50.53 69.53 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.879 1.272 . . . . 0.0 108.82 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.04 -57.78 4.2 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.935 0.494 . . . . 0.0 109.916 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -58.65 3.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -159.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 129' ' ' MET . 6.6 mt -71.43 -26.33 62.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.45 40.69 8.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -169.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 127' ' ' LEU . 14.7 mmt . . . . . 0 C--O 1.253 1.243 0 CA-C-N 118.897 1.349 . . . . 0.0 108.135 171.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -75.0 135.09 41.32 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 53' ' ' PHE . 8.3 m-85 -92.78 149.44 21.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 166.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -121.78 138.29 54.43 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 166.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.26 108.09 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -124.51 57.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.37 162.69 5.87 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 159.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -47.83 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.376 -0.827 . . . . 0.0 110.167 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -64.17 -19.94 65.66 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -158.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 t 70.64 -47.27 0.64 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.926 2.491 . . . . 0.0 111.55 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.8 m -52.69 -36.95 58.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.467 -1.396 . . . . 0.0 109.29 160.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.2 ttp -67.92 -17.66 64.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.213 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.486 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.24 -48.03 81.75 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 120.663 1.574 . . . . 0.0 108.327 168.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -56.85 -52.88 63.38 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 107.893 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.36 -68.47 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 124.059 0.849 . . . . 0.0 108.811 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.49 -46.66 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.995 0.816 . . . . 0.0 110.746 -170.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -63.89 -35.52 80.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.156 0.889 . . . . 0.0 111.018 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -72.3 -32.98 67.04 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.52 1.055 . . . . 0.0 111.751 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.92 -36.8 80.78 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.978 -1.076 . . . . 0.0 109.868 172.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.54 -36.47 81.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.865 -0.522 . . . . 0.0 110.517 172.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -64.66 -34.49 78.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.728 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -56.66 -64.93 0.71 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.931 1.241 . . . . 0.0 110.925 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.67 28.53 1.05 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -165.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.03 -116.34 2.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.463 1.506 . . . . 0.0 110.226 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -141.54 176.4 8.92 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.461 1.105 . . . . 0.0 111.708 -159.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.42 -177.64 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.066 1.746 . . . . 0.0 110.391 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 60.05 74.29 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.118 2.167 . . . . 0.0 109.781 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.28 125.06 73.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 172.87 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.697 1.199 . . . . 0.0 107.952 165.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -134.43 173.91 11.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.729 1.212 . . . . 0.0 107.992 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.38 177.19 8.06 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.111 0.964 . . . . 0.0 109.601 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.04 -38.59 52.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.883 0.473 . . . . 0.0 111.461 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.05 162.88 1.67 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.784 2.033 . . . . 0.0 107.131 -158.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -47.89 -42.31 22.09 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.077 1.322 . . . . 0.0 114.663 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.8 -36.56 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.067 1.933 . . . . 0.0 109.533 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.5 t70 -78.95 -36.3 41.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.556 1.542 . . . . 0.0 110.261 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.62 -46.96 83.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.262 1.425 . . . . 0.0 109.081 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -52.62 -47.91 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.22 1.408 . . . . 0.0 110.383 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.2 -19.8 63.98 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.114 0.965 . . . . 0.0 112.926 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HE2' ' OD1' ' A' ' 41' ' ' ASP . 4.2 mptp? -69.25 -49.03 59.97 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.388 -1.445 . . . . 0.0 110.094 162.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.61 HD11 HD11 ' A' ' 72' ' ' ILE . 5.5 mt -54.71 -54.69 38.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.113 1.324 . . . . 0.0 109.581 -174.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.51 -0.96 9.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.5 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.308 1.413 . . . . 0.0 110.52 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.39 -82.59 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.11 91.7 0.11 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -84.21 155.7 22.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.55 -66.99 0.5 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 7.2 m-85 -87.38 136.57 32.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.947 0.873 . . . . 0.0 108.821 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 81' ' ' LEU . 42.3 t -129.75 113.84 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.4 125.78 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.3 p -156.57 168.71 26.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.376 0.989 . . . . 0.0 112.907 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.78 167.54 21.62 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.768 0.827 . . . . 0.0 110.362 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 4.0 t-105 -78.93 -42.58 26.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 158.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -78.53 56.27 1.77 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.311 2.244 . . . . 0.0 112.327 -159.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.471 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -76.81 165.82 49.5 Favored Pre-proline 0 C--O 1.238 0.456 0 O-C-N 120.869 -1.144 . . . . 0.0 110.792 -177.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.82 -39.52 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.45 2.1 . . . . 0.0 110.84 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.82 -69.07 0.87 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.839 1.2 . . . . 0.0 112.295 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.2 ttm -91.14 83.48 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.93 140.6 1.02 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.918 2.087 . . . . 0.0 108.671 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.5 -20.81 66.14 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.052 -1.03 . . . . 0.0 114.77 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.43 -38.38 74.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.104 0.952 . . . . 0.0 109.708 172.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.83 -41.14 83.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 109.911 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.88 -51.08 71.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.496 1.044 . . . . 0.0 110.045 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.23 -56.35 17.22 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.821 173.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.56 -24.86 65.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.812 1.642 . . . . 0.0 113.666 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 m -64.01 -52.16 60.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.61 HD11 HD11 ' A' ' 46' ' ' LEU . 30.9 mt -64.29 -28.66 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 12.39 19.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.433 1.893 . . . . 0.0 111.22 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.535 0 CA-C-N 120.512 1.505 . . . . 0.0 112.412 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -57.66 -18.27 19.51 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.435 -1.415 . . . . 0.0 113.743 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.89 4.34 50.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.0 113.386 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 54' ' ' VAL . 10.4 mt -73.27 127.9 88.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 120.334 -1.479 . . . . 0.0 108.988 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.86 62.82 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.339 4.026 . . . . 0.0 111.716 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.84 112.08 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.349 1.86 . . . . 0.0 111.675 177.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 114.52 27.17 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 125.367 1.467 . . . . 0.0 109.201 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 mmt -76.17 131.03 39.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 105.14 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.246 1.819 . . . . 0.0 106.401 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 t -139.99 178.84 6.98 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.008 0.909 . . . . 0.0 110.696 -171.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.05 -26.2 19.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.124 0.97 . . . . 0.0 111.788 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -91.17 134.95 34.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.201 0.91 . . . . 0.0 111.646 -168.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 -95.8 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.408 -0.806 . . . . 0.0 108.915 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 1.9 tpmt? 59.15 112.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.326 2.25 . . . . 0.0 111.789 -171.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -51.8 -47.42 64.28 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.76 -28.33 69.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.599 1.545 . . . . 0.0 113.423 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -65.02 -47.35 77.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.606 1.094 . . . . 0.0 108.927 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.2 -51.64 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.71 -58.01 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.027 0.931 . . . . 0.0 110.56 -172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.79 88.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.33 -39.28 92.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.591 0.632 . . . . 0.0 112.519 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -60.23 -54.75 42.04 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.929 1.691 . . . . 0.0 109.594 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.46 -12.18 29.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.035 1.334 . . . . 0.0 112.27 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.47 29.65 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 119.099 -0.834 . . . . 0.0 112.531 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.692 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.52 152.16 26.66 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.9 m -55.52 -34.94 65.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.145 0.978 . . . . 0.0 112.23 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.25 179.78 44.15 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.11 92.29 3.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.474 1.51 . . . . 0.0 107.874 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -81.93 137.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.42 144.14 38.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 156.92 43.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.426 0.557 . . . . 0.0 110.801 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.72 137.17 46.21 Favored 'Cis proline' 0 N--CA 1.453 -0.891 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 -12.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -139.07 155.02 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.986 0.422 . . . . 0.0 110.194 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 p -151.72 -172.3 4.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.73 1.612 . . . . 0.0 111.022 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.2 18.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.558 1.143 . . . . 0.0 110.475 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.1 87.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.705 0.802 . . . . 0.0 112.889 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 -34.55 22.22 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.767 1.167 . . . . 0.0 109.269 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.95 -55.96 19.5 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -41.28 99.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.688 1.195 . . . . 0.0 112.518 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.41 -45.11 73.5 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.829 -0.545 . . . . 0.0 110.04 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.36 -38.38 89.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.0 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.29 -60.39 3.47 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.7 -34.83 73.4 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.393 0.542 . . . . 0.0 111.766 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -68.73 0.16 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.966 0.906 . . . . 0.0 109.349 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -24.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -57.56 -64.03 1.03 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.55 0.74 . . . . 0.0 109.219 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.83 -54.73 12.2 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -59.39 -52.6 64.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.537 0.735 . . . . 0.0 111.97 -164.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.74 -47.44 11.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.398 0.679 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.52 19.51 3.1 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.257 1.408 . . . . 0.0 112.704 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.1 mmm . . . . . 0 C--O 1.253 1.254 0 CA-C-N 120.152 1.976 . . . . 0.0 112.837 -172.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--O 1.234 0.242 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -90.62 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -86.74 159.48 19.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -125.67 142.2 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.77 110.11 16.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.6 t -125.0 70.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 123.223 1.487 . . . . 0.0 107.346 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.54 173.23 10.67 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.34 1.856 . . . . 0.0 110.996 168.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.18 -18.38 24.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.361 2.264 . . . . 0.0 114.069 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.31 112.62 8.69 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.057 -1.652 . . . . 0.0 109.029 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.85 -46.31 1.96 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.272 1.396 . . . . 0.0 114.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.0 m -51.76 -45.81 63.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.607 1.094 . . . . 0.0 111.673 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.6 ttm -52.39 -41.16 62.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 109.359 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -71.2 -40.56 71.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.88 1.218 . . . . 0.0 111.479 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -54.7 -54.9 35.69 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.41 -65.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.926 1.291 . . . . 0.0 107.923 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.41 -45.41 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.603 1.547 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -64.75 -39.42 93.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.251 1.387 . . . . 0.0 110.698 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -58.56 -51.57 69.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.204 1.366 . . . . 0.0 110.601 171.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.39 -26.35 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.181 0.592 . . . . 0.0 111.994 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -77.91 -45.95 22.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.344 1.057 . . . . 0.0 110.426 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -73.55 -9.63 58.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.16 -36.91 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.397 0.999 . . . . 0.0 109.925 158.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.93 -4.37 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.868 1.667 . . . . 0.0 111.597 -165.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.53 -110.2 1.54 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.999 1.761 . . . . 0.0 108.888 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 40.51 49.86 2.72 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.898 2.479 . . . . 0.0 112.972 165.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -70.67 -4.96 26.13 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.777 0.831 . . . . 0.0 113.241 -160.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -131.09 77.01 1.76 Allowed 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.354 1.461 . . . . 0.0 107.81 -169.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.69 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 164.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.87 171.9 12.64 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.78 2.032 . . . . 0.0 108.04 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.66 148.25 42.15 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.735 1.214 . . . . 0.0 107.733 -164.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -129.82 167.78 17.6 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.127 0.571 . . . . 0.0 109.891 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -74.3 -31.43 62.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.657 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.62 172.72 2.53 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.598 1.559 . . . . 0.0 107.873 -172.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.05 -39.63 26.77 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.796 1.188 . . . . 0.0 113.789 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.38 -45.27 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.6 -0.941 . . . . 0.0 109.892 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.02 -25.66 64.6 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.655 -0.653 . . . . 0.0 110.181 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.58 -55.07 34.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.517 1.053 . . . . 0.0 108.51 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.97 -42.36 76.15 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.682 0.753 . . . . 0.0 110.751 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.94 -40.49 84.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.541 0.737 . . . . 0.0 112.023 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.2 mmtm -62.15 -44.06 97.46 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.232 0.924 . . . . 0.0 109.285 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.459 HD11 HD11 ' A' ' 72' ' ' ILE . 10.5 mt -58.0 -43.94 86.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.11 0.868 . . . . 0.0 110.71 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -69.84 -13.54 62.31 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.52 48.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.774 1.23 . . . . 0.0 112.906 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.93 34.87 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 119.706 1.139 . . . . 0.0 110.882 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.7 76.19 1.09 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -70.91 159.0 35.47 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.2 -1.66 3.92 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.784 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.55 136.96 17.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.141 1.47 . . . . 0.0 108.839 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -134.88 80.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.07 139.94 16.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.3 p -148.96 167.44 25.75 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.511 0.596 . . . . 0.0 111.935 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.9 t70 -78.98 -157.6 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 158.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 16.3 t-105 -122.59 -42.01 2.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.33 2.252 . . . . 0.0 110.293 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.63 43.74 1.0 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 112.203 -159.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -91.79 144.1 28.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 121.25 -0.906 . . . . 0.0 108.567 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.23 159.06 50.62 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.28 1.987 . . . . 0.0 111.379 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.82 -78.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 127.356 2.262 . . . . 0.0 111.862 -171.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.5 86.37 6.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -55.93 165.86 0.86 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 167.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.0 -30.32 53.86 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.809 -1.182 . . . . 0.0 112.416 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -79.54 -29.09 41.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.669 1.235 . . . . 0.0 111.645 -179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.45 -44.52 57.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.86 -51.07 62.43 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.281 1.432 . . . . 0.0 109.178 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.7 tp -57.12 -58.75 6.85 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.417 1.087 . . . . 0.0 110.216 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 67.5 mttt -66.63 -28.88 68.84 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.472 1.487 . . . . 0.0 111.939 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.1 m -62.27 -55.41 28.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.467 1.03 . . . . 0.0 108.699 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.459 HD11 HD11 ' A' ' 46' ' ' LEU . 32.8 mt -50.66 -55.4 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.693 1.597 . . . . 0.0 108.564 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -30.72 65.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.264 1.426 . . . . 0.0 112.266 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 C-N-CA 124.207 1.003 . . . . 0.0 111.745 -169.673 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -34.12 1.96 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.117 2.167 . . . . 0.0 112.159 169.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.38 4.95 19.38 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.68 1.592 . . . . 0.0 113.705 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 54' ' ' VAL . 12.8 mt -66.13 125.63 90.5 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.89 124.64 11.66 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 108.697 -1.309 . . . . 0.0 108.697 170.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 69' ' ' LEU . 2.2 m -104.79 142.1 18.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.9 tp -137.86 111.76 8.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -73.91 122.53 22.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.45 102.43 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -144.3 171.93 13.64 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.688 0.756 . . . . 0.0 112.565 -161.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.56 -24.36 39.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.312 1.045 . . . . 0.0 110.482 163.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.08 94.8 1.95 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.355 1.462 . . . . 0.0 110.514 -168.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 3.62 7.32 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.344 -0.848 . . . . 0.0 111.85 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -49.52 115.91 1.54 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 109.598 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -49.09 -53.07 22.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.418 0.687 . . . . 0.0 111.326 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.99 -25.8 67.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -72.78 -40.21 66.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.326 0.966 . . . . 0.0 109.658 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.58 -49.64 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.7 -57.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.21 76.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.816 0.735 . . . . 0.0 111.105 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.907 0.483 . . . . 0.0 110.149 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -27.48 67.27 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -68.93 -54.55 14.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.756 1.623 . . . . 0.0 109.404 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.83 80.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.881 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.24 35.08 2.78 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 124.691 1.138 . . . . 0.0 112.458 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.39 141.67 46.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -78.46 -4.84 50.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.978 0.174 . . . . 0.0 111.215 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.44 172.76 41.44 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 161.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -139.08 132.0 29.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.29 1.036 . . . . 0.0 108.519 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -132.97 130.67 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 127.065 2.146 . . . . 0.0 106.32 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.32 152.23 10.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -50.72 143.48 14.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.457 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.56 132.79 27.98 Favored 'Cis proline' 0 CA--C 1.534 0.484 0 CA-C-N 120.707 1.288 . . . . 0.0 111.012 -8.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -134.32 157.92 45.11 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.411 0.684 . . . . 0.0 111.243 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -155.51 171.91 19.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.516 1.927 . . . . 0.0 110.765 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.31 75.6 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.46 -50.5 31.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.937 1.295 . . . . 0.0 111.981 169.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.29 -35.3 48.13 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.808 -0.557 . . . . 0.0 109.749 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -57.65 11.01 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.257 1.023 . . . . 0.0 108.841 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.27 -29.69 70.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.042 0.937 . . . . 0.0 111.868 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.59 -45.45 65.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.564 0.346 . . . . 0.0 110.617 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.06 -35.33 80.81 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.954 -1.091 . . . . 0.0 110.306 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.3 mt -58.33 -56.71 18.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 109.729 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -50.71 -43.82 57.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.874 0.761 . . . . 0.0 110.916 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -51.68 -61.4 2.27 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.307 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 pt -70.96 -26.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.715 1.598 . . . . 0.0 114.531 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.67 -58.62 7.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.31 -41.74 66.25 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.876 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -68.38 -67.73 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.554 1.542 . . . . 0.0 108.77 -173.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.423 HD23 ' HD2' ' A' ' 126' ' ' LYS . 8.5 mt -72.9 -29.13 62.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.74 0.416 . . . . 0.0 110.374 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.84 26.13 25.36 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 117.737 -1.59 . . . . 0.0 110.361 -161.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--O 1.242 0.692 0 CA-C-N 120.174 1.987 . . . . 0.0 109.801 175.347 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -91.11 138.5 31.55 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.087 0.555 . . . . 0.0 110.726 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.3 102.36 14.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.349 1.86 . . . . 0.0 107.747 165.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.89 136.75 54.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.3 106.16 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 42' ' ' ALA . 6.7 t -109.03 89.26 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.24 158.81 16.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.65 0.738 . . . . 0.0 110.734 170.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.79 -4.34 58.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.384 1.074 . . . . 0.0 112.685 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 10.0 t80 -131.52 -3.92 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.844 1.258 . . . . 0.0 112.309 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 62.31 -60.18 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.214 2.205 . . . . 0.0 110.76 -159.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.422 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 68.8 m -62.63 -29.07 70.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 111.189 -171.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.02 64.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.648 1.567 . . . . 0.0 110.904 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.7 ttp85 -67.95 -43.86 78.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 121.288 1.858 . . . . 0.0 107.309 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.85 -45.63 67.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.239 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.08 -65.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.887 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.14 -47.53 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.204 1.365 . . . . 0.0 111.148 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.624 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.3 ttt180 -55.15 -49.5 71.65 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 109.755 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -60.17 -39.74 87.51 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.847 0.748 . . . . 0.0 110.744 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 113' ' ' ALA . 60.8 mt -66.45 -34.07 77.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.045 0.839 . . . . 0.0 110.989 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -67.27 -37.01 82.76 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.354 -0.841 . . . . 0.0 110.706 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -70.06 -29.2 66.15 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.538 -1.351 . . . . 0.0 111.084 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.34 -51.75 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.35 1.06 . . . . 0.0 110.582 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 47.37 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.613 0.721 . . . . 0.0 112.264 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.0 -111.72 0.83 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.6 158.27 44.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.178 0.989 . . . . 0.0 111.156 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -82.65 177.81 8.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.196 0.999 . . . . 0.0 109.357 159.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 60.78 79.25 0.25 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.745 2.018 . . . . 0.0 111.631 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.624 HG21 ' HG3' ' A' ' 22' ' ' ARG . 5.2 m -97.56 169.17 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.352 163.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -141.8 -179.6 6.29 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.97 1.708 . . . . 0.0 108.514 163.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -134.12 158.11 44.47 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.464 1.506 . . . . 0.0 107.775 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.59 159.14 40.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.598 1.559 . . . . 0.0 107.262 162.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.26 -24.13 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -171.5 168.68 6.37 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.468 1.507 . . . . 0.0 107.21 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.72 -37.89 21.57 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.291 0.948 . . . . 0.0 113.526 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.98 -51.22 47.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.261 1.024 . . . . 0.0 109.997 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -74.14 -28.23 61.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.143 1.377 . . . . 0.0 110.073 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.98 -50.84 71.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.492 1.117 . . . . 0.0 108.942 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.18 -37.76 75.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.353 0.261 . . . . 0.0 110.492 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -67.77 -36.11 79.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.277 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 mmtt -63.45 -40.1 96.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.874 1.215 . . . . 0.0 109.605 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -62.55 -39.1 92.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.763 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -71.26 5.96 1.94 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.28 59.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.54 -1.35 . . . . 0.0 112.943 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -105.31 0.29 Allowed Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.379 0.991 . . . . 0.0 110.698 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.31 87.37 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.364 0.983 . . . . 0.0 110.98 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -67.69 164.82 18.47 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.365 1.066 . . . . 0.0 110.993 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.97 -43.71 3.76 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 119.044 -0.865 . . . . 0.0 111.221 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.05 145.59 44.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 117.894 0.847 . . . . 0.0 112.307 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' LEU . 14.1 t -136.09 81.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.135 1.374 . . . . 0.0 107.894 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.88 127.1 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -136.81 144.39 43.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -171.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.15 166.66 19.44 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 158.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -71.92 -45.58 60.69 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.578 0.751 . . . . 0.0 109.317 162.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -73.97 98.75 3.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.054 0.942 . . . . 0.0 112.17 -160.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 mmt -131.4 155.51 81.38 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.96 -45.11 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.469 2.113 . . . . 0.0 111.273 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.65 -99.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.428 1.091 . . . . 0.0 108.657 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.9 ttm -79.18 96.12 5.8 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.4 166.75 4.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.057 0.943 . . . . 0.0 111.291 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.95 -24.28 71.5 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.259 -171.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -43.88 34.9 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.118 1.459 . . . . 0.0 107.758 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.43 -41.13 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.576 0.75 . . . . 0.0 110.977 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.55 -49.54 77.39 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.066 0.946 . . . . 0.0 109.638 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -53.58 -56.01 20.8 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.719 -1.134 . . . . 0.0 109.448 175.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 45.2 mttt -64.13 -37.97 89.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.677 1.581 . . . . 0.0 111.192 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.9 m -56.89 -49.17 76.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.451 0.569 . . . . 0.0 109.798 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -65.89 -42.82 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.41 0.684 . . . . 0.0 109.432 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.83 84.53 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 111.993 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.03 1.332 . . . . 0.0 111.479 -179.027 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.9 p -57.99 -21.13 43.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.404 1.081 . . . . 0.0 112.825 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.29 -16.19 62.45 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 54' ' ' VAL . 45.2 mt -64.86 149.01 96.97 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 119.892 1.223 . . . . 0.0 112.299 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.14 86.7 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.535 2.823 . . . . 0.0 108.777 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -77.25 99.51 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -107.97 110.6 22.37 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.382 1.073 . . . . 0.0 108.267 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -72.53 123.24 22.75 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.94 96.65 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.3 t -134.46 -170.31 2.51 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.243 1.017 . . . . 0.0 109.88 -169.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.12 -12.13 14.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.844 1.258 . . . . 0.0 112.348 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.81 105.47 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.438 1.017 . . . . 0.0 110.761 -172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.93 4.44 8.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.812 0.845 . . . . 0.0 113.271 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -53.64 115.28 1.89 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.959 1.704 . . . . 0.0 109.724 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -55.25 -45.03 76.07 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.011 0.924 . . . . 0.0 110.119 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -41.91 39.87 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.56 1.144 . . . . 0.0 112.392 172.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.28 -34.38 63.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.583 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.75 -48.93 85.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.248 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mt -57.25 -50.31 77.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 CA-C-N 120.952 1.705 . . . . 0.0 109.336 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.26 -46.29 72.61 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 119.158 0.89 . . . . 0.0 110.304 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.69 76.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 110.867 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.41 99.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.388 0.995 . . . . 0.0 111.803 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.23 -48.36 81.85 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.51 1.924 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -62.56 -38.49 90.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.04 0.936 . . . . 0.0 110.923 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 33.51 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.851 1.215 . . . . 0.0 112.343 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.632 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.53 145.39 44.35 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.11 1.455 . . . . 0.0 109.217 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -73.41 -16.09 61.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.302 0.641 . . . . 0.0 111.736 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.76 173.55 39.34 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.62 136.42 35.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.37 144.82 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.84 138.84 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -52.14 139.51 34.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 165.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.96 137.75 51.43 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 CA-C-N 119.963 1.022 . . . . 0.0 110.5 -8.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.07 150.92 46.3 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.481 0.712 . . . . 0.0 110.077 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -147.98 -173.3 4.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.298 0.639 . . . . 0.0 111.057 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -50.54 -35.41 29.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.479 1.112 . . . . 0.0 109.669 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.81 -19.46 28.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -114.46 -23.36 9.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.24 0.927 . . . . 0.0 112.039 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.09 -50.59 72.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -47.34 74.68 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.287 1.035 . . . . 0.0 111.244 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.25 -52.8 63.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 122.991 0.516 . . . . 0.0 109.851 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.99 -33.17 74.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.222 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.34 -58.02 10.32 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.715 1.143 . . . . 0.0 109.69 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -56.94 -40.01 75.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.867 0.758 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -55.31 -56.46 19.76 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.031 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 -26.11 18.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 120.39 1.45 . . . . 0.0 112.812 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -53.96 -53.53 51.54 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.084 0.856 . . . . 0.0 108.912 169.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.3 -43.83 26.95 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.552 0.341 . . . . 0.0 110.737 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -73.88 -62.01 1.65 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.074 0.549 . . . . 0.0 110.045 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mt -71.93 -43.22 65.62 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.972 0.509 . . . . 0.0 109.776 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.55 32.47 3.39 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.491 -163.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--O 1.253 1.282 0 CA-C-N 118.631 1.215 . . . . 0.0 111.239 172.293 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 111.097 0.036 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 169.89 17.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 111.779 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -136.95 101.9 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.988 1.715 . . . . 0.0 108.258 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.9 tp -71.01 131.08 43.13 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.3 99.74 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.37 70.12 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.492 1.917 . . . . 0.0 108.576 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.44 151.67 41.04 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.948 -1.095 . . . . 0.0 108.102 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.5 -42.13 65.18 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.138 -0.976 . . . . 0.0 110.793 169.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -90.96 115.97 28.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.618 1.567 . . . . 0.0 107.02 -173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -57.75 -47.61 81.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.262 0.483 . . . . 0.0 110.078 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -53.57 -40.88 65.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.75 0.705 . . . . 0.0 111.177 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 ttt -58.3 -39.96 80.71 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.546 0.738 . . . . 0.0 110.143 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HG2' ' HE ' ' A' ' 22' ' ' ARG . 14.1 ttp180 -62.13 -46.79 87.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.004 1.322 . . . . 0.0 109.797 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -55.81 -51.93 65.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.744 0.818 . . . . 0.0 108.887 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.51 -62.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.254 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -48.64 -44.23 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 120.828 1.649 . . . . 0.0 110.671 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HE ' ' HG2' ' A' ' 18' ' ' ARG . 59.5 mtt-85 -60.85 -45.44 94.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.669 1.122 . . . . 0.0 111.664 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -63.88 -42.5 97.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.758 0.708 . . . . 0.0 111.748 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.76 -32.41 73.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.922 0.889 . . . . 0.0 111.478 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.16 -56.76 11.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -64.79 -19.47 65.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -51.73 -33.44 34.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.898 1.226 . . . . 0.0 110.804 164.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.9 -41.4 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.975 2.11 . . . . 0.0 110.129 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.86 -139.27 6.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 64.86 60.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 123.173 1.464 . . . . 0.0 110.32 166.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.24 176.18 4.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.539 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 56.41 48.34 17.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 127.483 2.313 . . . . 0.0 113.477 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -55.51 161.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 121.13 -0.981 . . . . 0.0 111.369 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.04 157.5 44.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.279 1.832 . . . . 0.0 107.617 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.17 116.86 19.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.24 163.77 13.49 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 158.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.3 -37.04 58.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.006 0.821 . . . . 0.0 110.432 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.86 174.71 14.57 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.156 1.383 . . . . 0.0 109.237 -169.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.47 -35.31 71.78 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.5 t -66.38 -48.87 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 120.822 2.311 . . . . 0.0 107.152 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.73 -28.86 70.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.816 0.847 . . . . 0.0 111.287 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.68 -56.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.947 1.699 . . . . 0.0 109.43 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.73 -45.62 74.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.105 0.562 . . . . 0.0 109.77 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -65.75 -28.92 69.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.15 0.58 . . . . 0.0 112.161 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -62.93 -52.56 62.58 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.074 0.95 . . . . 0.0 108.804 166.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 HG13 ' A' ' 54' ' ' VAL . 14.1 mt -53.86 -41.45 67.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.704 1.138 . . . . 0.0 111.131 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -72.12 -7.09 47.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -17.6 58.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.463 1.029 . . . . 0.0 111.653 167.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.08 169.96 16.85 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.546 1.067 . . . . 0.0 111.548 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.22 108.2 2.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.244 0.926 . . . . 0.0 113.279 -171.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.49 163.4 27.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.444 1.098 . . . . 0.0 108.749 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.53 -45.06 19.35 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 166.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -135.91 150.59 49.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.599 0.76 . . . . 0.0 112.437 -166.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.682 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -131.63 70.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.082 1.353 . . . . 0.0 108.687 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.18 130.97 34.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.5 m -150.39 158.77 44.53 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.614 -0.679 . . . . 0.0 110.979 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.91 169.08 18.97 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.458 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -83.28 -48.92 9.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.719 1.608 . . . . 0.0 112.372 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.86 79.32 6.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.71 1.604 . . . . 0.0 109.582 -159.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.34 125.29 28.28 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.63 -40.57 29.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.125 2.55 . . . . 0.0 113.7 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -83.54 -101.91 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttp -79.78 106.97 12.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.79 160.61 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.19 -29.72 56.71 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.082 -1.011 . . . . 0.0 112.117 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.01 -43.01 83.97 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.764 0.782 . . . . 0.0 110.842 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.54 -37.55 71.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.611 0.765 . . . . 0.0 110.304 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.3 tp -53.06 -58.62 6.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.211 1.004 . . . . 0.0 108.701 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -48.09 -56.96 6.51 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.089 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -67.41 -24.68 65.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.035 1.289 . . . . 0.0 114.02 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -65.98 -48.27 71.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.257 6.3 mt -55.57 -57.83 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 167.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -23.86 67.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.163 1.385 . . . . 0.0 113.038 -165.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.314 0 CA-C-N 119.507 1.049 . . . . 0.0 110.264 -178.067 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 119.72 -0.181 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.8 p -59.52 -25.03 64.14 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.092 0.957 . . . . 0.0 113.285 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -9.43 59.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 113.618 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 54' ' ' VAL . 14.2 mt -56.59 144.22 65.15 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 119.199 0.909 . . . . 0.0 109.821 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.98 79.96 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.261 2.641 . . . . 0.0 109.042 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.91 110.37 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 128.627 2.771 . . . . 0.0 107.746 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.578 HD21 ' HD3' ' A' ' 119' ' ' LYS . 26.7 tp -135.94 113.21 10.6 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.263 -0.898 . . . . 0.0 111.935 -158.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -80.97 129.73 34.68 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.36 105.18 5.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -152.26 166.79 30.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.302 0.501 . . . . 0.0 110.831 -166.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.56 57.05 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.282 -0.886 . . . . 0.0 112.178 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -72.82 96.6 2.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.338 1.455 . . . . 0.0 110.084 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.59 -0.81 52.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.861 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 94' ' ' ASN . 31.6 ttmt -50.71 118.03 2.85 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.559 1.072 . . . . 0.0 109.812 -174.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -50.71 -52.98 35.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.103 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.24 -29.85 69.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.422 1.01 . . . . 0.0 112.625 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.413 ' H ' ' HG2' ' A' ' 91' ' ' LYS . 69.6 m-20 -72.13 -36.33 69.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.203 0.91 . . . . 0.0 110.039 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.3 -44.5 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.66 -48.92 84.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.25 -44.55 83.99 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.427 1.012 . . . . 0.0 110.152 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.95 88.18 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 119.225 0.921 . . . . 0.0 111.236 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.73 92.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.272 0.487 . . . . 0.0 109.874 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -62.15 -49.91 73.97 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.926 2.491 . . . . 0.0 111.283 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.39 -22.1 62.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.608 1.163 . . . . 0.0 111.89 174.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.22 6.11 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.7 1.143 . . . . 0.0 110.327 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -65.52 142.46 58.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.6 p -66.4 -24.36 66.46 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.105 0.562 . . . . 0.0 111.093 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 169.45 38.3 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.92 126.18 28.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.224 1.41 . . . . 0.0 108.563 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -121.08 107.31 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.04 153.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 166.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.43 150.37 34.1 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.548 1.539 . . . . 0.0 109.105 160.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.51 147.75 79.22 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 CA-C-N 121.105 1.43 . . . . 0.0 109.903 -12.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -146.92 138.41 24.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -140.94 -174.75 4.08 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.559 1.544 . . . . 0.0 109.613 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.19 -25.64 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.304 -0.872 . . . . 0.0 110.153 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.12 53.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.202 1.001 . . . . 0.0 112.723 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.6 t -98.6 -27.0 14.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.839 0.745 . . . . 0.0 110.754 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.72 86.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.302 0.956 . . . . 0.0 108.797 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -38.53 91.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.717 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.62 -54.1 22.52 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.747 0.703 . . . . 0.0 110.355 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HD3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -58.72 -38.08 77.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.829 1.195 . . . . 0.0 111.042 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.98 -54.67 44.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.01 0.823 . . . . 0.0 110.629 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.82 -39.64 68.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.85 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -64.99 -45.49 85.4 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.332 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -19.63 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 121.041 1.746 . . . . 0.0 113.414 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -56.54 -62.9 1.41 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 159.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -72.54 -30.37 64.4 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.259 -0.9 . . . . 0.0 112.609 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -68.66 0.65 Allowed 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.95 -23.57 61.47 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 122.954 0.159 . . . . 0.0 110.89 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.53 23.26 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.532 -1.704 . . . . 0.0 110.056 -165.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-N 119.866 1.833 . . . . 0.0 110.476 172.356 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.234 0.238 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.271 2.4 ptpt -91.86 164.01 13.83 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.31 108.53 12.31 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.371 1.468 . . . . 0.0 108.77 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -82.43 139.33 34.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.79 1.632 . . . . 0.0 109.963 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -135.72 112.45 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.361 1.465 . . . . 0.0 108.448 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.27 41.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.081 1.352 . . . . 0.0 110.324 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.32 154.67 7.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.955 -1.09 . . . . 0.0 108.959 164.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.08 -45.31 11.52 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.22 -1.55 . . . . 0.0 110.744 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -70.6 115.22 9.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.645 1.978 . . . . 0.0 107.636 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -59.64 -39.53 84.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.192 1.36 . . . . 0.0 111.884 -172.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.4 m -55.13 -32.41 62.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.74 0.7 . . . . 0.0 111.45 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 tpp -60.5 -42.46 96.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.231 -0.918 . . . . 0.0 109.947 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -66.18 -34.44 78.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.719 1.145 . . . . 0.0 111.124 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -59.79 -58.77 7.12 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.74 -63.26 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 C-N-CA 125.978 1.711 . . . . 0.0 109.05 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.78 -46.04 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 121.071 1.759 . . . . 0.0 111.267 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -65.51 -41.24 93.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 120.179 1.354 . . . . 0.0 111.518 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -58.15 -54.57 45.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.421 1.088 . . . . 0.0 109.437 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -52.26 -48.53 65.18 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.861 2.064 . . . . 0.0 110.829 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.03 -44.15 82.6 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.318 0.647 . . . . 0.0 110.811 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -77.62 -17.24 57.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.51 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.81 -43.89 94.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.34 1.427 . . . . 0.0 109.287 166.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.07 -37.24 78.39 Favored 'General case' 0 N--CA 1.46 0.038 0 O-C-N 122.179 -0.325 . . . . 0.0 110.596 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.98 6.1 10.32 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.92 1.248 . . . . 0.0 113.885 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.24 155.82 39.77 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.7 1.75 . . . . 0.0 108.942 163.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -149.88 -167.53 2.85 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.322 1.049 . . . . 0.0 108.394 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 55.15 37.93 29.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.108 1.363 . . . . 0.0 111.16 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.29 158.11 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -140.76 166.68 24.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.624 2.37 . . . . 0.0 107.478 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -128.78 155.11 45.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.91 167.75 10.38 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 161.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -42.97 89.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.68 0.792 . . . . 0.0 111.435 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.3 173.87 5.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.038 1.335 . . . . 0.0 108.835 -169.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.33 -42.01 72.98 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 119.923 1.238 . . . . 0.0 113.389 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.11 -51.42 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.86 1.264 . . . . 0.0 109.659 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -70.33 -35.65 73.75 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.754 0.821 . . . . 0.0 111.076 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.31 65.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.568 1.147 . . . . 0.0 109.409 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -54.61 -48.92 71.59 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.721 0.638 . . . . 0.0 111.6 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -66.3 -28.5 68.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -64.19 -46.56 83.39 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.372 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 54' ' ' VAL . 8.2 mt -57.55 -41.69 81.51 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 110.665 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 3.06 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 158.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.82 164.32 11.22 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.969 1.271 . . . . 0.0 111.395 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.17 14.53 78.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.035 0.826 . . . . 0.0 113.167 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -81.46 117.32 21.79 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.44 -25.11 26.78 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.225 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -148.94 149.7 31.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.17 0.988 . . . . 0.0 110.803 -169.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -133.99 85.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.27 127.22 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -152.03 163.64 38.89 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.082 -1.011 . . . . 0.0 110.308 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.35 173.58 5.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.795 0.807 . . . . 0.0 110.278 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 -71.58 -60.69 2.1 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.664 158.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.258 23.7 p30 29.21 -157.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 130.392 3.477 . . . . 0.0 116.215 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 65.15 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.034 1.334 . . . . 0.0 112.504 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 58.3 Cg_endo -65.36 -66.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 121.796 1.664 . . . . 0.0 108.78 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 5.7 m120 -155.61 -69.69 0.12 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.661 2.385 . . . . 0.0 104.953 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.0 ttm -70.01 88.36 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 160.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -65.61 172.01 3.72 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.793 0.837 . . . . 0.0 110.428 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.53 -32.75 53.43 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.988 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -70.46 -49.87 44.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.537 1.169 . . . . 0.0 110.579 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.61 -38.06 89.67 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.472 0.709 . . . . 0.0 110.874 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.0 tp -55.94 -61.31 2.46 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.115 1.366 . . . . 0.0 108.722 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -46.42 -53.52 10.91 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.843 1.257 . . . . 0.0 109.511 174.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 66.6 mttt -66.62 -26.25 66.99 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.126 0.875 . . . . 0.0 113.12 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.2 m -72.87 -43.36 62.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.361 1.064 . . . . 0.0 109.612 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.37 -45.79 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.969 1.308 . . . . 0.0 113.593 166.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -49.3 77.16 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.311 1.044 . . . . 0.0 109.529 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.585 0 C-N-CA 124.088 0.955 . . . . 0.0 113.303 178.646 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mtm . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 p -65.34 -17.29 64.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.492 1.042 . . . . 0.0 113.167 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.7 59.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.526 1.13 . . . . 0.0 113.471 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 54' ' ' VAL . 19.5 mt -61.01 133.24 92.48 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.314 0.961 . . . . 0.0 110.271 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.01 125.3 12.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.011 1.807 . . . . 0.0 108.682 166.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.624 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -119.07 107.71 22.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.205 2.202 . . . . 0.0 106.804 -173.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 tp -125.12 115.2 20.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.341 1.057 . . . . 0.0 109.712 -164.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.38 122.35 26.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.92 113.59 24.87 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -156.0 168.9 25.8 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.259 -0.9 . . . . 0.0 110.626 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.32 -21.23 46.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.379 -0.825 . . . . 0.0 111.684 163.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.53 107.35 19.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.231 1.012 . . . . 0.0 111.227 -167.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -73.56 0.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.989 171.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.1 tttt 32.73 98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.828 2.451 . . . . 0.0 113.381 -167.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -52.45 -41.51 63.36 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.287 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.73 -36.27 69.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.151 1.342 . . . . 0.0 112.752 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.81 -36.41 70.24 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 121.536 -0.727 . . . . 0.0 110.085 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.1 mt -63.46 -39.17 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.642 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.3 -53.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.51 -46.45 70.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.987 0.812 . . . . 0.0 110.654 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.47 73.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.916 0.886 . . . . 0.0 110.741 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.88 99.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.43 0.692 . . . . 0.0 110.147 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -60.84 -50.89 71.63 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.312 1.845 . . . . 0.0 111.17 175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.46 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -59.62 -22.65 62.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.918 0.887 . . . . 0.0 112.267 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.78 11.73 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.544 -1.142 . . . . 0.0 112.281 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.04 134.96 57.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.415 1.107 . . . . 0.0 108.805 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 m -67.64 -10.08 49.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.201 1.001 . . . . 0.0 112.255 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.06 170.54 38.2 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.332 0.969 . . . . 0.0 111.345 166.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.14 132.32 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.276 1.43 . . . . 0.0 107.681 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.39 104.79 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 156.68 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -58.21 151.08 49.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 158.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.27 148.36 91.04 Favored 'Cis proline' 0 N--CA 1.457 -0.632 0 CA-C-N 119.653 0.912 . . . . 0.0 110.633 -9.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -149.44 154.47 38.89 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.322 0.649 . . . . 0.0 110.088 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 p -143.81 -175.19 4.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.363 1.065 . . . . 0.0 109.46 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -29.62 60.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.599 0.76 . . . . 0.0 110.3 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.77 67.98 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 t -99.57 -27.61 13.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.85 1.204 . . . . 0.0 110.224 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -50.63 70.21 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -37.21 84.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.863 1.265 . . . . 0.0 112.249 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.98 -57.19 13.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.865 1.266 . . . . 0.0 109.14 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -66.01 -34.16 77.45 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.489 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 mt -59.54 -55.1 38.85 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.187 175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.465 ' HA ' ' CD2' ' A' ' 124' ' ' PHE . 18.7 t-20 -64.37 -30.56 71.6 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 118.283 0.492 . . . . 0.0 110.412 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -60.2 3.51 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.029 167.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.4 pt -71.15 -26.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.426 1.466 . . . . 0.0 113.86 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 121' ' ' ASN . 21.6 m-30 -59.47 -39.07 82.5 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.092 0.86 . . . . 0.0 109.918 170.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.58 -40.22 17.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.008 0.523 . . . . 0.0 110.71 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HG3' HD23 ' A' ' 127' ' ' LEU . 32.1 tptt -77.14 -71.7 0.39 Allowed 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.564 1.145 . . . . 0.0 108.125 -168.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.429 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.3 mt -68.28 -20.41 64.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.269 0.486 . . . . 0.0 111.105 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 38.47 30.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -167.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.7 mmm . . . . . 0 C--O 1.25 1.093 0 CA-C-N 117.882 0.841 . . . . 0.0 109.377 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 177.14 6.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.987 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.76 124.39 43.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.168 2.187 . . . . 0.0 106.091 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.13 134.52 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 158.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.66 92.54 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.5 t -95.84 51.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.24 105.24 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -47.99 -43.12 29.42 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.784 1.634 . . . . 0.0 112.103 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.75 116.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.304 1.041 . . . . 0.0 108.521 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -52.35 -51.45 58.76 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.164 0.986 . . . . 0.0 110.77 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -52.17 -39.35 59.95 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.417 -0.802 . . . . 0.0 111.346 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 ttp -61.43 -42.06 98.16 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.11 98.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.854 1.207 . . . . 0.0 109.944 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -57.46 -57.44 12.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -49.07 -60.81 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.772 1.629 . . . . 0.0 108.866 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.38 -51.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 120.388 1.449 . . . . 0.0 111.055 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -41.17 91.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.07 0.85 . . . . 0.0 111.052 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.27 -53.94 47.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.91 -34.28 69.67 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.586 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -60.09 -62.71 1.67 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.873 0.869 . . . . 0.0 109.314 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -65.24 -14.33 60.43 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.08 -7.98 34.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.425 1.49 . . . . 0.0 113.152 166.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.5 mt -126.01 7.79 7.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.485 3.114 . . . . 0.0 112.086 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 -144.13 22.67 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.33 40.39 18.28 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.189 1.495 . . . . 0.0 113.3 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.08 171.08 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.498 -0.751 . . . . 0.0 110.936 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 98.57 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.29 3.036 . . . . 0.0 107.139 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.754 -0.591 . . . . 0.0 110.156 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -132.14 175.43 9.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.81 2.044 . . . . 0.0 107.615 167.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -127.3 166.33 18.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.54 1.536 . . . . 0.0 107.379 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.68 168.36 9.84 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 159.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.75 -26.33 62.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.731 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.32 174.76 0.45 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.031 1.732 . . . . 0.0 107.674 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.25 -39.41 42.83 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.005 1.288 . . . . 0.0 115.428 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.57 -43.95 92.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.048 1.424 . . . . 0.0 109.918 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.07 -28.05 60.2 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.561 1.144 . . . . 0.0 110.652 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -62.11 -46.25 89.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.009 0.924 . . . . 0.0 110.102 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.11 -45.16 95.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.768 -0.635 . . . . 0.0 109.324 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -57.75 -44.55 86.16 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.646 0.657 . . . . 0.0 111.661 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -53.51 -50.87 64.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.751 0.82 . . . . 0.0 109.778 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -35.62 80.28 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.209 0.604 . . . . 0.0 112.017 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.02 -1.34 7.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.816 0.846 . . . . 0.0 112.19 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.6 12.93 7.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.572 1.949 . . . . 0.0 112.495 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.33 163.97 23.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.214 1.37 . . . . 0.0 113.857 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.97 78.96 1.85 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -70.76 119.62 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.61 -19.89 79.73 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.523 -168.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -132.09 150.46 52.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 127.046 2.138 . . . . 0.0 106.416 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 81' ' ' LEU . 13.4 t -137.56 72.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -77.33 143.73 12.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 p -149.71 163.13 38.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.659 0.663 . . . . 0.0 111.011 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.45 179.97 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.461 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 29.0 t-105 -71.04 -78.13 0.08 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 162.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.2 t30 43.1 178.16 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.956 2.902 . . . . 0.0 112.606 -164.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.2 mtm -140.33 68.26 32.63 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 119.053 -2.28 . . . . 0.0 110.553 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.49 49.0 2.32 Favored 'Trans proline' 0 CA--C 1.543 0.964 1 C-N-CA 125.467 4.111 . . . . 0.0 110.791 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.88 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.439 1.495 . . . . 0.0 108.709 -159.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.2 ttm -79.52 81.73 5.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.16 159.78 2.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.543 1.137 . . . . 0.0 110.675 167.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.96 59.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.369 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -74.39 -46.86 37.61 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.584 1.154 . . . . 0.0 109.313 174.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.27 -38.3 90.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.559 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.02 -53.81 54.07 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.301 0.955 . . . . 0.0 109.21 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -48.85 -56.1 9.72 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -66.17 -28.69 68.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 120.384 1.447 . . . . 0.0 114.078 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.5 m -71.98 -33.75 68.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.262 0.937 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.4 mt -73.36 -48.37 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.962 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.66 24.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.508 3.123 . . . . 0.0 111.475 171.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 108.146 172.097 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 120.489 0.185 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -61.53 -25.08 67.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.424 1.089 . . . . 0.0 113.341 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -16.5 61.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 54' ' ' VAL . 32.8 mt -60.5 141.7 91.55 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 118.472 0.578 . . . . 0.0 111.465 -169.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 72.69 5.78 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.707 2.271 . . . . 0.0 108.423 166.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -60.53 137.77 22.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 160.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' CD1' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp -147.97 111.6 5.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -160.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.93 123.14 24.55 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.7 102.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -142.35 174.74 10.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.179 0.99 . . . . 0.0 110.281 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.78 -23.5 19.7 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.814 0.846 . . . . 0.0 111.617 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -86.5 111.32 20.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.756 0.707 . . . . 0.0 109.141 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.96 -73.52 0.07 Allowed 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 166.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 tptp 43.78 91.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.538 1.637 . . . . 0.0 112.432 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -52.16 -34.65 45.89 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.2 -0.938 . . . . 0.0 112.889 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.34 -36.03 80.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.293 1.406 . . . . 0.0 111.692 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -63.31 -38.91 93.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.236 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.54 -49.99 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.565 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.46 -55.53 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 119.542 1.065 . . . . 0.0 108.341 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.12 79.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.924 0.489 . . . . 0.0 110.769 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.16 90.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.919 -0.488 . . . . 0.0 110.543 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.45 77.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -61.4 -49.99 74.65 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.718 1.607 . . . . 0.0 109.672 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -28.19 69.07 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.927 0.491 . . . . 0.0 111.233 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.5 42.03 6.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 124.74 1.162 . . . . 0.0 111.338 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.18 156.87 11.44 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 72.8 p -64.93 -22.77 67.05 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.301 -0.874 . . . . 0.0 111.948 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.12 -175.95 37.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.69 1.614 . . . . 0.0 109.426 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -136.74 91.03 2.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.673 1.189 . . . . 0.0 108.046 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -75.3 125.97 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.88 144.15 16.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -75.8 162.34 72.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -64.12 145.75 60.93 Favored 'Cis proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.714 0.934 . . . . 0.0 109.782 -12.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -139.2 162.16 35.66 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.086 0.955 . . . . 0.0 109.235 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -142.88 171.98 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.354 1.061 . . . . 0.0 110.109 -164.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.83 69.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.642 0.777 . . . . 0.0 112.401 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t -81.76 -33.27 31.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.981 1.264 . . . . 0.0 110.119 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -50.99 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.552 1.069 . . . . 0.0 109.017 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -41.57 92.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.125 1.77 . . . . 0.0 111.073 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.95 -42.44 98.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.303 1.041 . . . . 0.0 109.156 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HE3' ' CD1' ' A' ' 84' ' ' LEU . 3.2 mmmp? -68.95 -29.72 68.02 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.712 -1.613 . . . . 0.0 112.384 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -54.48 24.41 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -55.32 -42.92 74.41 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 118.225 0.466 . . . . 0.0 111.258 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -51.23 -60.04 3.55 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.39 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 104' ' ' SER . 15.4 pt -67.57 -32.66 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 121.343 1.883 . . . . 0.0 113.757 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -58.63 -45.09 90.01 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.701 0.682 . . . . 0.0 109.632 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.47 -34.17 15.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -76.1 -72.43 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -37.0 79.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.266 0.627 . . . . 0.0 109.333 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.01 41.58 4.58 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -164.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.246 0.9 0 CA-C-N 118.501 1.151 . . . . 0.0 110.883 175.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.411 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.93 161.71 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.574 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.8 95.28 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -69.31 138.91 54.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.0 1.273 . . . . 0.0 109.492 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -131.67 115.5 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.7 t -130.69 76.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.23 159.84 18.68 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.853 0.835 . . . . 0.0 111.342 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.55 97.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.199 1.4 . . . . 0.0 111.212 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD2' ' HB ' ' A' ' 16' ' ' THR . 1.2 t80 -90.0 -63.85 1.22 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.683 0.393 . . . . 0.0 110.528 -159.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 m 127.28 -59.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 1 C-N-CA 133.273 4.629 . . . . 0.0 106.875 -161.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 91.8 m -65.59 -33.75 76.63 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.771 -174.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -61.5 -27.25 68.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.23 1.377 . . . . 0.0 110.207 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD3' ' HG3' ' A' ' 35' ' ' GLU . 13.3 ttm180 -63.47 -47.73 80.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.477 1.035 . . . . 0.0 109.589 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -48.43 80.94 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.762 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.36 -47.01 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.0 1.32 . . . . 0.0 111.228 -172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -54.03 -50.75 65.98 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.35 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.28 -43.44 91.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.235 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 mt -55.12 -43.14 73.83 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.244 0.929 . . . . 0.0 109.848 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.7 -48.81 70.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.548 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -64.85 -33.63 76.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.118 -0.944 . . . . 0.0 112.473 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -58.41 -30.76 67.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.491 1.041 . . . . 0.0 110.908 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.96 12.25 37.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.24 1.816 . . . . 0.0 111.699 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -33.67 5.04 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.641 1.591 . . . . 0.0 113.317 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -61.38 140.01 58.09 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.929 1.365 . . . . 0.0 110.633 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 177.47 7.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.075 0.94 . . . . 0.0 111.403 -168.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.251 21.4 t30 67.96 34.0 4.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.77 2.828 . . . . 0.0 113.503 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 154.97 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.474 0.654 . . . . 0.0 109.723 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.33 179.41 6.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.454 2.701 . . . . 0.0 108.019 -163.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 31.0 tt0 -145.88 152.27 39.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.848 -0.532 . . . . 0.0 111.614 -164.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.21 172.5 12.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.793 1.237 . . . . 0.0 108.93 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -68.46 -47.69 66.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.746 0.818 . . . . 0.0 112.726 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.84 168.01 10.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.85 2.06 . . . . 0.0 107.335 -158.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.6 -38.02 27.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.723 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.0 t -63.41 -51.01 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.706 2.253 . . . . 0.0 107.555 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.97 -28.69 69.99 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 0.0 110.829 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -69.57 -42.9 73.92 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.947 1.699 . . . . 0.0 111.37 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -65.62 -43.54 89.26 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -56.52 -39.71 73.8 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.155 0.982 . . . . 0.0 111.058 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.31 -61.46 2.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.365 0.984 . . . . 0.0 109.252 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.37 -49.8 60.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -168.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.72 -2.87 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.4 -11.5 59.25 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.822 1.192 . . . . 0.0 112.969 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.71 5.82 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 119.199 2.44 . . . . 0.0 119.199 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.42 73.71 0.64 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 120.603 2.202 . . . . 0.0 110.377 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.17 109.21 2.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.39 -10.75 24.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.338 -0.701 . . . . 0.0 114.398 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.4 144.68 42.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.143 1.377 . . . . 0.0 109.159 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -132.13 91.24 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -108.49 125.69 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -143.03 168.05 20.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.852 0.834 . . . . 0.0 110.896 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.83 170.18 10.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 158.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -84.91 -51.68 6.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.455 1.502 . . . . 0.0 108.307 162.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -87.24 72.49 9.88 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.61 1.564 . . . . 0.0 110.192 -159.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 tpt -124.77 125.51 25.45 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 -0.31 9.73 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.748 2.299 . . . . 0.0 115.067 -161.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -107.25 -96.24 0.37 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.3 ttm -91.07 89.9 7.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.28 155.11 5.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.089 172.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.78 -31.79 58.34 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.03 -0.872 . . . . 0.0 112.203 -172.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -36.5 72.4 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.871 1.335 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -68.09 -41.5 81.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.011 175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.63 -49.11 79.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.784 0.72 . . . . 0.0 109.575 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -50.59 -63.11 1.23 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.836 1.254 . . . . 0.0 108.106 172.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -63.22 -27.48 69.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.94 1.246 . . . . 0.0 113.398 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.1 m -61.74 -53.87 50.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.394 0.997 . . . . 0.0 108.884 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -62.51 -46.05 97.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.671 1.188 . . . . 0.0 110.21 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.58 7.91 0.56 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.698 1.999 . . . . 0.0 113.215 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.148 0 CA-C-N 120.961 1.709 . . . . 0.0 111.862 -177.304 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.571 ' HB3' HD12 ' A' ' 81' ' ' LEU . 37.1 mtm . . . . . 0 C--O 1.223 -0.301 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -55.06 -23.99 22.96 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 121.743 2.065 . . . . 0.0 114.451 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -9.57 53.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.596 1.089 . . . . 0.0 113.255 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 54' ' ' VAL . 16.9 mt -78.02 128.93 77.36 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 121.129 -0.982 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 91.02 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.387 2.058 . . . . 0.0 109.749 170.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 69' ' ' LEU . 2.7 m -75.76 107.85 7.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 167.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 tp -112.6 113.97 26.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.269 1.427 . . . . 0.0 108.562 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.9 mmt -85.67 125.93 33.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.03 88.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -122.62 174.21 7.22 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 113.657 -161.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.58 -21.69 26.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 111.662 164.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -86.18 106.74 17.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.781 1.232 . . . . 0.0 110.972 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.23 8.62 15.23 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.476 -0.765 . . . . 0.0 112.587 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -51.96 121.35 6.54 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.242 1.017 . . . . 0.0 108.927 -171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -38.71 76.89 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.275 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.36 -32.32 64.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.489 1.04 . . . . 0.0 112.329 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.72 -39.56 61.82 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.732 0.696 . . . . 0.0 109.495 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.43 -46.96 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.36 -57.44 4.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.34 -45.44 80.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.335 1.054 . . . . 0.0 110.71 -172.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.78 96.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.22 -15.25 61.0 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -75.05 -51.73 12.82 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.266 1.426 . . . . 0.0 108.011 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.53 78.04 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.501 0.72 . . . . 0.0 111.905 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.79 58.84 2.07 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.106 1.336 . . . . 0.0 110.502 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.61 162.35 5.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.398 0.599 . . . . 0.0 110.834 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -62.42 -43.06 99.73 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.41 173.18 46.1 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 125.472 1.51 . . . . 0.0 110.152 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 135.23 46.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.327 1.851 . . . . 0.0 107.288 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.0 t -134.47 145.86 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 128.327 2.651 . . . . 0.0 104.763 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t -127.63 164.48 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -49.85 141.18 14.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.284 160.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -78.35 173.49 56.27 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 120.702 1.287 . . . . 0.0 109.337 -20.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -177.28 151.5 0.79 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.596 -1.315 . . . . 0.0 108.619 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -153.77 -179.33 7.72 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 127.285 2.234 . . . . 0.0 108.275 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.5 -29.7 62.13 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.321 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.59 33.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.857 1.263 . . . . 0.0 113.076 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.26 -30.8 13.25 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.808 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -48.74 79.08 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.751 1.16 . . . . 0.0 108.331 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -40.7 97.03 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.617 1.167 . . . . 0.0 111.51 -176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.3 -40.4 77.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.9 0.88 . . . . 0.0 109.042 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HE2' ' HE3' ' A' ' 122' ' ' LYS . 50.4 mmtt -65.7 -40.82 92.69 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.648 -1.282 . . . . 0.0 110.527 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.0 mt -55.44 -49.7 71.77 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.776 0.831 . . . . 0.0 108.968 170.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.81 -38.58 88.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.065 0.848 . . . . 0.0 112.612 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE3' ' HE2' ' A' ' 119' ' ' LYS . 9.2 mtmm -55.5 -52.49 63.49 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.027 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.7 pt -73.68 -24.78 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 120.192 1.36 . . . . 0.0 113.473 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -56.95 -59.55 4.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.24 -43.72 73.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.085 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -69.82 0.33 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.61 -29.38 65.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.7 30.53 13.11 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 117.907 -1.496 . . . . 0.0 109.756 -160.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mmm . . . . . 0 C--O 1.247 0.95 0 CA-C-N 120.135 1.967 . . . . 0.0 109.417 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.46 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.01 0.433 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.61 29.9 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.97 152.84 19.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.14 134.65 54.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 162.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.84 108.33 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.3 t -125.33 69.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.02 156.85 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -67.11 -55.46 14.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.06 1.3 . . . . 0.0 109.258 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.2 t80 -70.9 115.82 10.49 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.95 -48.43 70.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.739 1.216 . . . . 0.0 111.326 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 25.1 m -62.66 -26.03 68.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.006 0.922 . . . . 0.0 111.82 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.3 ttm -58.42 -29.32 66.01 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.713 1.142 . . . . 0.0 109.893 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -70.39 -30.76 67.74 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.032 0.833 . . . . 0.0 110.26 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -61.49 -51.22 69.54 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.447 1.021 . . . . 0.0 108.354 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.63 -60.38 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.34 0.656 . . . . 0.0 109.798 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.92 -52.81 12.53 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 126.057 1.743 . . . . 0.0 109.774 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -56.47 -47.76 78.5 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.089 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -59.12 -44.75 92.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 119.933 1.242 . . . . 0.0 110.143 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.55 -36.87 83.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 110.68 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -66.36 0.51 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.391 1.076 . . . . 0.0 109.996 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -25.59 68.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.502 1.121 . . . . 0.0 112.092 -167.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -15.11 51.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.684 1.129 . . . . 0.0 112.57 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -147.03 19.05 1.25 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 112.103 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.1 28.64 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.349 -0.844 . . . . 0.0 111.804 -161.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -57.37 123.35 15.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.981 1.712 . . . . 0.0 110.918 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -72.12 -3.06 20.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.916 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -118.74 128.48 54.53 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.019 1.327 . . . . 0.0 107.766 -158.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.79 165.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 125.77 1.628 . . . . 0.0 107.304 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -127.04 161.18 29.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -125.63 127.13 45.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -83.6 173.92 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 170.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.48 -46.46 66.58 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.4 -0.812 . . . . 0.0 110.568 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.24 175.25 6.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.024 1.73 . . . . 0.0 108.187 -163.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.75 -43.23 29.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.376 0.989 . . . . 0.0 114.111 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.78 -52.07 64.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 119.022 1.411 . . . . 0.0 108.694 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.67 -21.95 66.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.361 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.02 -47.42 68.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.347 1.431 . . . . 0.0 109.543 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.62 -46.02 87.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.319 0.581 . . . . 0.0 109.668 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -60.35 -44.78 95.24 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.719 0.807 . . . . 0.0 111.536 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.9 mmtm -59.41 -41.38 89.35 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.001 1.32 . . . . 0.0 110.219 172.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -59.09 -43.9 91.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.344 0.975 . . . . 0.0 111.347 178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.66 -0.21 29.1 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.66 4.38 40.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.735 1.152 . . . . 0.0 112.958 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.14 -172.39 34.63 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 120.496 -1.377 . . . . 0.0 112.035 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.85 79.41 1.58 Allowed Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -75.53 165.48 25.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 159.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -139.52 -7.59 1.04 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.852 173.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -144.33 135.22 25.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.598 1.199 . . . . 0.0 108.423 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.72 117.96 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -165.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.83 134.04 67.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.727 1.611 . . . . 0.0 106.902 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 m -150.81 159.69 44.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.978 0.354 . . . . 0.0 111.432 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.98 157.92 32.54 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 166.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -67.99 -47.14 69.33 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 110.408 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.439 HD21 ' HG2' ' A' ' 89' ' ' GLU . 86.7 m-20 -80.81 59.04 3.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.674 1.19 . . . . 0.0 110.998 -159.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mmt -93.46 160.05 33.84 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 122.791 0.437 . . . . 0.0 110.661 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 162.39 36.32 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.803 2.335 . . . . 0.0 108.916 165.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 50.99 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.298 1.839 . . . . 0.0 113.143 170.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.8 ttm -82.01 86.5 6.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.447 1.099 . . . . 0.0 108.313 168.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.12 154.81 1.46 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.192 1.397 . . . . 0.0 110.143 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.43 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.501 -1.374 . . . . 0.0 113.161 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.51 -33.61 71.38 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.313 1.057 . . . . 0.0 110.263 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -72.12 -35.11 69.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.894 . . . . 0.0 110.57 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -53.46 57.3 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.707 0.685 . . . . 0.0 109.582 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -50.17 -56.53 10.62 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 34.6 mttm -66.29 -27.97 68.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.742 1.156 . . . . 0.0 114.038 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -70.77 -46.89 62.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.423 1.01 . . . . 0.0 108.742 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.41 -43.88 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.342 0.657 . . . . 0.0 109.356 172.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -24.03 60.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.218 1.407 . . . . 0.0 112.228 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 C-N-CA 124.765 1.226 . . . . 0.0 112.042 173.844 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.7 mmt . . . . . 0 C--O 1.226 -0.167 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -48.13 -29.76 3.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.419 1.009 . . . . 0.0 112.098 165.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.05 -11.85 61.18 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -66.98 134.05 93.9 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 119.959 1.254 . . . . 0.0 109.077 -174.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 94.1 Cg_endo -78.78 56.6 6.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 0.0 111.587 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HD13 ' A' ' 69' ' ' LEU 0.254 2.4 m -47.58 107.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.213 1.005 . . . . 0.0 112.233 170.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -106.42 117.46 34.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.711 1.604 . . . . 0.0 107.839 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.44 123.08 31.99 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.98 107.06 11.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -144.78 178.42 8.01 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.016 0.912 . . . . 0.0 111.466 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.9 -29.39 32.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.084 0.953 . . . . 0.0 111.893 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.439 ' HG2' HD21 ' A' ' 59' ' ' ASN . 48.5 mm-40 -74.88 107.86 7.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.946 0.498 . . . . 0.0 110.237 -170.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -72.63 18.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.048 -1.033 . . . . 0.0 111.708 162.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.37 110.31 0.84 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 125.267 1.427 . . . . 0.0 109.001 -168.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -40.34 -59.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 112.621 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.05 -31.18 62.92 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.841 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.1 -38.67 61.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.709 1.14 . . . . 0.0 109.619 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.35 -55.87 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.97 -47.12 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.84 -41.26 77.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.098 1.317 . . . . 0.0 109.789 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.74 -53.28 59.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.801 0.728 . . . . 0.0 110.902 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.99 -27.15 67.92 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.325 0.65 . . . . 0.0 112.534 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -73.65 -52.89 11.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.704 2.002 . . . . 0.0 109.407 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -55.58 -40.36 71.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.684 0.794 . . . . 0.0 111.134 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.0 2.47 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.412 1.482 . . . . 0.0 113.217 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.98 156.6 6.63 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.536 1.168 . . . . 0.0 111.195 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 5.2 p -70.83 -28.11 64.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.654 0.382 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.71 171.7 38.42 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -130.78 139.22 50.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.009 1.324 . . . . 0.0 108.037 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.86 137.73 42.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 126.44 1.896 . . . . 0.0 106.004 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 90' ' ' ALA . 48.3 t -130.22 144.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -52.46 145.85 18.88 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.105 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.61 10.09 60.82 Favored 'Cis proline' 0 C--N 1.348 0.508 0 N-CA-C 116.992 1.882 . . . . 0.0 116.992 8.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.8 p90 15.79 114.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 130.768 3.627 . . . . 0.0 116.564 -175.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -89.73 166.5 13.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.821 -1.174 . . . . 0.0 112.553 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.02 -33.83 73.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 166.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.36 -13.39 5.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.684 1.594 . . . . 0.0 115.013 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -28.67 7.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.497 1.499 . . . . 0.0 111.225 171.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.38 -51.13 71.1 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.292 1.037 . . . . 0.0 111.181 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -66.83 -44.18 81.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -66.92 -35.55 80.26 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.223 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.08 -57.9 11.01 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.039 0.935 . . . . 0.0 109.029 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -47.74 -45.26 28.78 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.288 1.035 . . . . 0.0 111.049 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -68.8 0.14 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.657 174.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.7 pt -66.94 -26.75 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 120.212 1.369 . . . . 0.0 113.704 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -56.22 -57.33 12.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -84.39 -34.02 23.66 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.788 -0.57 . . . . 0.0 111.326 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -64.23 -72.81 0.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.381 1.472 . . . . 0.0 109.739 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.51 -38.49 62.82 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.023 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.2 22.14 6.65 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.609 -1.106 . . . . 0.0 112.366 -166.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.3 mmt . . . . . 0 C--O 1.251 1.182 0 CA-C-N 119.587 1.694 . . . . 0.0 112.275 -175.182 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.166 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.67 165.2 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.856 0.463 . . . . 0.0 110.993 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.95 91.79 3.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 163.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.31 131.0 44.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -135.89 125.28 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.36 67.66 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -84.92 166.71 16.58 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.896 -1.128 . . . . 0.0 111.241 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -19.74 65.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.969 0.908 . . . . 0.0 113.355 -169.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.84 131.64 21.42 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.624 1.97 . . . . 0.0 105.894 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -52.55 -41.23 63.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.678 0.672 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.6 m -51.33 -47.11 62.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.647 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.1 mtm -59.7 -35.36 74.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.446 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -68.03 -31.11 70.56 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 120.055 1.298 . . . . 0.0 110.482 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -69.39 -50.21 48.15 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.93 -61.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.165 1.386 . . . . 0.0 109.643 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.6 t -51.9 -49.38 37.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.33 1.452 . . . . 0.0 109.793 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.4 ttt85 -54.95 -48.51 73.09 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 119.385 0.993 . . . . 0.0 110.635 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -52.7 63.72 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.479 0.712 . . . . 0.0 109.688 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 113' ' ' ALA . 75.1 mt -58.27 -42.41 86.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.373 1.069 . . . . 0.0 110.435 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.96 -48.49 81.33 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 110.722 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -65.73 -33.48 75.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.599 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -45.87 92.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.081 1.309 . . . . 0.0 109.224 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.4 mt -66.21 -43.26 87.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.757 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.38 -5.44 1.39 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.398 0.999 . . . . 0.0 114.226 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -73.85 152.52 40.2 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.765 1.226 . . . . 0.0 109.789 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -145.5 179.04 7.68 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.397 -0.814 . . . . 0.0 110.518 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 53.98 58.85 4.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.656 1.982 . . . . 0.0 111.463 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 22' ' ' ARG . 30.7 m -66.45 160.08 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.322 162.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.51 169.69 16.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.126 1.77 . . . . 0.0 108.367 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -130.05 142.15 50.65 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.547 1.939 . . . . 0.0 106.939 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.53 170.22 8.59 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 159.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -24.87 30.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.987 0.358 . . . . 0.0 111.228 170.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.69 175.57 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.307 1.443 . . . . 0.0 108.697 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -62.89 -35.16 91.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.332 1.92 . . . . 0.0 114.606 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.02 -49.53 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 120.309 2.055 . . . . 0.0 107.934 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -58.57 -39.28 79.87 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.858 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.1 99.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.269 1.395 . . . . 0.0 111.547 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.41 -43.39 90.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -65.11 -42.55 93.85 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.388 -0.195 . . . . 0.0 111.469 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -52.94 -50.35 64.18 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 127.533 2.333 . . . . 0.0 108.854 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.97 -48.0 83.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.433 0.56 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.46 -11.04 56.91 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.87 24.23 12.92 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.763 2.425 . . . . 0.0 110.858 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.43 161.08 28.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 31.05 8.44 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 162.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -70.16 89.05 0.62 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.02 1.328 . . . . 0.0 109.069 -161.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -3.44 50.22 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.555 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -138.98 129.87 26.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.601 1.2 . . . . 0.0 109.083 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 81' ' ' LEU . 11.4 t -133.98 124.42 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -168.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.76 134.32 60.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 127.379 2.272 . . . . 0.0 106.25 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.9 p -152.03 163.54 39.09 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.385 0.538 . . . . 0.0 111.069 173.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.4 159.98 28.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.032 160.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CH2' ' HG ' ' A' ' 66' ' ' LEU . 23.6 t-105 -72.64 -58.53 3.29 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.587 1.955 . . . . 0.0 111.422 169.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.5 19.39 0.13 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.998 2.119 . . . . 0.0 112.822 -160.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.558 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -61.68 129.21 91.24 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 126.113 1.765 . . . . 0.0 107.553 -170.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.8 157.85 54.02 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 N-CA-C 109.402 -1.038 . . . . 0.0 109.402 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.77 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.249 1.42 . . . . 0.0 109.992 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.2 ttp -91.33 91.32 8.1 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.159 0.984 . . . . 0.0 108.878 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.88 153.47 1.29 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 109.027 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.54 -31.54 63.53 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 120.885 -1.134 . . . . 0.0 112.456 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -68.78 -36.84 78.8 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.633 0.717 . . . . 0.0 110.644 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.19 -41.65 70.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.047 0.939 . . . . 0.0 109.546 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp -56.39 -50.12 72.49 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.578 1.151 . . . . 0.0 109.469 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -52.69 -61.47 2.27 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 124.957 1.303 . . . . 0.0 108.866 173.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 66' ' ' LEU . 90.7 mttt -62.66 -27.66 69.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.903 1.229 . . . . 0.0 112.382 -173.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.3 m -64.46 -55.73 18.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.117 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.76 -36.45 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.323 1.449 . . . . 0.0 111.448 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -21.92 61.9 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 120.883 -1.135 . . . . 0.0 111.258 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 119.493 1.042 . . . . 0.0 110.108 171.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.1 mtt . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 t -61.11 -21.17 63.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.119 1.327 . . . . 0.0 112.214 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.96 -2.01 25.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.849 1.26 . . . . 0.0 113.817 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 54' ' ' VAL . 83.7 mt -79.77 129.76 69.81 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 119.783 1.174 . . . . 0.0 109.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.47 58.02 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.128 2.552 . . . . 0.0 111.925 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -47.24 108.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.979 1.712 . . . . 0.0 111.028 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 tp -112.97 119.6 38.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.852 1.661 . . . . 0.0 108.901 -165.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -82.92 118.73 23.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.16 110.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.219 1.408 . . . . 0.0 108.47 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -157.62 169.76 23.92 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.555 0.693 . . . . 0.0 110.401 -167.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.76 -23.0 62.33 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.239 -0.913 . . . . 0.0 112.179 160.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -81.26 112.03 18.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.007 0.821 . . . . 0.0 112.001 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.51 -88.25 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 160.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? 49.81 99.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.126 1.371 . . . . 0.0 111.2 -169.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -41.32 -48.83 3.71 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.4 -0.812 . . . . 0.0 111.765 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -58.87 -37.69 77.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -60.18 -43.99 95.43 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.031 0.832 . . . . 0.0 109.487 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.21 -43.69 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.18 -58.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.33 70.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 111.059 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.82 80.08 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.047 0.939 . . . . 0.0 110.059 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.93 79.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.879 0.472 . . . . 0.0 111.162 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -61.16 -51.16 70.22 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.709 1.604 . . . . 0.0 110.495 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.18 -29.94 71.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.206 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.25 34.97 4.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.552 1.072 . . . . 0.0 112.804 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.78 159.41 11.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.109 1.454 . . . . 0.0 110.68 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 p -63.93 -35.68 81.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.45 0.568 . . . . 0.0 110.595 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.59 -177.57 45.1 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.23 132.32 33.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.07 102.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.99 154.54 4.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.26 155.39 79.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 120.93 -1.106 . . . . 0.0 110.452 159.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.13 151.28 96.79 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 N-CA-C 110.346 -0.675 . . . . 0.0 110.346 -7.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -151.94 157.55 41.94 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.428 0.691 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -144.51 -173.02 3.92 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.891 0.876 . . . . 0.0 110.384 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -56.45 -29.24 61.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.397 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.8 -25.25 64.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 t -95.87 -39.19 9.94 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.043 1.292 . . . . 0.0 109.246 170.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -50.14 53.57 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 109.765 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.22 72.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.918 1.687 . . . . 0.0 112.772 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.83 -48.53 21.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -61.6 -37.66 84.72 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.687 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.14 -52.21 59.47 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.451 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.28 -42.47 86.64 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.291 0.95 . . . . 0.0 112.414 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -54.38 -53.09 58.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.374 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 pt -74.63 -20.89 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 117.568 -1.206 . . . . 0.0 114.0 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.83 -50.79 71.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.525 1.511 . . . . 0.0 108.097 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -77.29 -42.84 35.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -73.61 -62.07 1.62 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.959 0.504 . . . . 0.0 110.634 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -20.57 39.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.715 0.806 . . . . 0.0 110.446 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.17 36.75 12.2 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -170.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 118.192 0.996 . . . . 0.0 111.014 175.555 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -91.1 133.67 35.14 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.172 1.789 . . . . 0.0 110.239 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.66 106.9 18.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.286 1.834 . . . . 0.0 107.484 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -74.34 138.07 43.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.568 1.076 . . . . 0.0 108.175 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.15 105.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ALA . 10.0 t -113.78 59.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 122.619 1.2 . . . . 0.0 107.768 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -85.96 108.97 18.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -174.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' H ' ' CB ' ' A' ' 57' ' ' ASP . 33.9 t70 -53.95 -45.27 71.23 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.422 1.089 . . . . 0.0 112.377 -170.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.24 101.39 1.88 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 164.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -42.66 70.11 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.21 0.604 . . . . 0.0 111.378 -168.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 m -59.83 -33.77 72.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.583 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mtm -59.12 -32.22 69.64 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 120.111 1.323 . . . . 0.0 110.476 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 HH21 ' NH1' ' A' ' 19' ' ' ARG . 24.9 ttp85 -62.63 -43.5 98.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.889 1.222 . . . . 0.0 110.717 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH1' HH21 ' A' ' 18' ' ' ARG . 8.9 mpt_? -59.69 -41.56 91.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.716 176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.21 -63.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.21 -43.48 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.899 1.68 . . . . 0.0 110.945 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -56.89 -48.36 78.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 0.0 110.392 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.97 -44.13 97.8 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.956 0.798 . . . . 0.0 110.841 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.66 -38.39 90.92 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.196 1.398 . . . . 0.0 111.689 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.83 -57.94 10.73 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -56.64 -36.09 69.09 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.162 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.67 -22.06 65.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.109 1.322 . . . . 0.0 112.464 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.35 -75.45 0.24 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 164.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.75 -168.41 33.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 65.33 164.43 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.264 1.826 . . . . 0.0 111.925 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -151.16 -3.05 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.371 1.469 . . . . 0.0 112.063 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.69 98.96 10.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.59 158.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.92 -155.47 0.61 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.43 1.092 . . . . 0.0 109.088 167.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 43.1 tt0 -178.37 159.16 1.19 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -158.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.86 33.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.142 1.777 . . . . 0.0 106.362 170.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.33 -31.59 72.47 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.795 -0.565 . . . . 0.0 112.352 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.58 171.26 10.43 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.872 2.469 . . . . 0.0 105.955 -174.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' ' CE ' ' A' ' 60' ' ' MET . . . -57.52 -37.12 80.87 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.587 -1.119 . . . . 0.0 114.565 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.66 -42.99 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.969 2.385 . . . . 0.0 108.714 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.1 -28.22 69.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.333 -0.855 . . . . 0.0 111.725 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.7 -47.68 77.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.195 -1.566 . . . . 0.0 109.655 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.72 -41.25 73.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.409 1.084 . . . . 0.0 109.496 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.67 -44.1 97.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.694 1.197 . . . . 0.0 111.742 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.311 -0.868 . . . . 0.0 110.67 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -51.27 70.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -68.48 3.14 1.92 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.18 1.48 56.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.06 1.3 . . . . 0.0 112.947 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.04 -81.79 0.07 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 121.353 1.888 . . . . 0.0 115.249 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.07 82.38 0.05 OUTLIER Glycine 0 C--N 1.331 0.261 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -164.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -90.32 153.8 20.18 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.23 1.015 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.78 -20.98 15.11 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.757 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -145.27 148.96 34.04 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.051 1.34 . . . . 0.0 109.277 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 81' ' ' LEU . 13.5 t -137.26 67.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -75.93 144.25 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 153.32 31.6 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.665 -0.647 . . . . 0.0 110.462 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CB ' ' H ' ' A' ' 13' ' ' ASP . 45.5 t0 -74.13 149.97 40.74 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 164.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.771 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 33.5 t-105 -61.21 -58.75 7.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.837 0.855 . . . . 0.0 109.498 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 25.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.188 1.395 . . . . 0.0 113.366 -159.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.574 ' CE ' ' H ' ' A' ' 39' ' ' GLY . 8.4 ptm -60.12 159.41 21.59 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.159 -0.963 . . . . 0.0 110.97 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -167.8 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.764 3.642 . . . . 0.0 111.192 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.49 -146.71 0.46 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.419 1.488 . . . . 0.0 110.09 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.98 96.41 0.43 Allowed 'General case' 0 C--N 1.34 0.175 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.71 174.1 0.07 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.17 1.788 . . . . 0.0 113.561 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.11 -29.76 59.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.386 -0.821 . . . . 0.0 113.57 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.771 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -71.03 -42.78 69.08 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 117.957 0.879 . . . . 0.0 110.034 176.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.93 -40.1 83.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.148 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.14 -55.03 27.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.656 1.116 . . . . 0.0 110.024 169.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -50.31 -56.27 11.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.601 0.761 . . . . 0.0 109.085 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.09 -41.56 96.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.748 0.704 . . . . 0.0 111.126 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.7 m -57.57 -51.44 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.061 0.944 . . . . 0.0 109.293 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 mt -58.53 -45.22 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.646 0.778 . . . . 0.0 109.659 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.5 -27.37 69.09 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 125.629 1.572 . . . . 0.0 112.148 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 C-N-CA 125.325 1.45 . . . . 0.0 114.565 -171.312 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.334 0.112 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 p -52.29 -37.69 56.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.981 1.712 . . . . 0.0 111.953 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.73 62.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 54' ' ' VAL . 8.1 mt -52.52 141.18 34.85 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.517 1.053 . . . . 0.0 112.177 -162.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.03 74.0 3.02 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.489 2.126 . . . . 0.0 110.425 163.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -70.42 116.26 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 158.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.63 111.72 15.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mmt -75.12 128.35 35.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 101.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -141.45 169.86 16.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.65 -169.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.06 -17.19 41.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.258 163.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -80.67 104.21 11.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.212 0.915 . . . . 0.0 111.615 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -82.88 16.03 2.45 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -57.84 110.13 0.85 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.348 0.977 . . . . 0.0 108.881 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.6 -47.76 66.71 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.677 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -53.25 -33.08 51.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.33 -30.55 25.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.794 -0.566 . . . . 0.0 110.996 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.22 -44.23 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 118.362 -0.828 . . . . 0.0 108.989 161.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.51 -54.4 35.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.375 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.2 63.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 120.176 1.353 . . . . 0.0 110.774 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.56 -51.96 65.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 110.21 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.32 85.22 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.257 0.623 . . . . 0.0 111.269 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -57.35 -50.65 72.28 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.723 2.009 . . . . 0.0 110.513 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.03 -18.58 65.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.614 0.766 . . . . 0.0 112.68 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.02 27.66 13.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.236 0.922 . . . . 0.0 112.527 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.81 140.44 56.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.847 1.324 . . . . 0.0 108.191 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.6 p -68.46 -18.76 64.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.145 -174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.57 173.87 40.13 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.6 104.83 4.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.73 144.88 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 90' ' ' ALA . 64.2 t -127.9 143.21 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.6 151.22 71.92 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.46 1.504 . . . . 0.0 111.463 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.92 173.3 37.89 Favored 'Cis proline' 0 C--N 1.345 0.378 0 N-CA-C 109.421 -1.031 . . . . 0.0 109.421 -16.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -177.91 146.72 0.43 Allowed 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.162 -1.586 . . . . 0.0 108.267 -164.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -149.52 -176.51 5.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.184 1.793 . . . . 0.0 109.232 -170.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.49 68.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.781 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.18 62.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.222 1.009 . . . . 0.0 113.189 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.72 -28.99 12.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.876 0.762 . . . . 0.0 110.286 177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.45 -54.84 38.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -29.85 71.06 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.885 1.274 . . . . 0.0 112.396 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.38 -55.25 12.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.606 1.162 . . . . 0.0 109.351 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.6 -31.44 72.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.743 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.2 mt -58.49 -58.06 10.2 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 123.835 0.854 . . . . 0.0 109.484 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -61.29 -29.19 69.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.043 1.292 . . . . 0.0 112.257 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.01 -60.56 3.3 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.148 -0.97 . . . . 0.0 110.333 168.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -23.3 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.319 0.963 . . . . 0.0 113.081 -171.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -57.21 -58.03 9.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.82 -30.0 56.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.525 -0.734 . . . . 0.0 112.354 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -65.35 1.02 Allowed 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.57 -25.55 64.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.984 0.514 . . . . 0.0 111.051 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.23 23.21 35.26 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-O 117.805 -1.553 . . . . 0.0 110.703 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 28.7 mmt . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.704 1.752 . . . . 0.0 110.47 -176.511 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -79.51 132.47 36.33 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.45 93.81 6.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.67 131.75 45.1 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.316 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 18' ' ' ARG . 64.6 t -132.52 119.36 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -130.95 63.53 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.699 1.599 . . . . 0.0 108.6 -174.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.29 159.1 33.72 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.792 -1.193 . . . . 0.0 108.5 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.47 -64.77 1.03 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.62 112.77 3.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -53.17 -41.61 65.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.857 1.208 . . . . 0.0 112.055 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -59.82 -31.8 70.06 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.757 -1.214 . . . . 0.0 111.773 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.0 92.62 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.562 1.074 . . . . 0.0 110.159 171.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD3' HG12 ' A' ' 10' ' ' VAL . 32.8 tpt85 -65.83 -36.69 84.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.299 1.04 . . . . 0.0 110.049 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -48.02 83.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.503 -0.761 . . . . 0.0 109.524 171.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.09 -58.36 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.32 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.9 t -52.29 -46.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.127 1.33 . . . . 0.0 110.206 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -60.75 -43.9 97.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.238 0.472 . . . . 0.0 111.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.27 -45.11 95.86 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.265 0.626 . . . . 0.0 111.133 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 113' ' ' ALA . 78.2 mt -65.41 -36.37 83.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.43 0.692 . . . . 0.0 111.062 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.91 -44.7 96.25 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.411 0.684 . . . . 0.0 110.09 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -41.65 98.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 116.994 -1.479 . . . . 0.0 111.462 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -57.07 -44.64 83.25 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 119.439 1.018 . . . . 0.0 110.51 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.14 -34.35 63.83 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.255 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.63 57.34 0.37 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.01 153.02 47.23 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.895 1.278 . . . . 0.0 107.824 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.81 178.9 7.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.785 1.634 . . . . 0.0 108.559 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 53.87 54.2 10.14 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.584 1.553 . . . . 0.0 111.683 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 m -68.68 164.36 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.122 159.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.46 174.81 10.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -136.71 147.81 46.97 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.11 167.44 12.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 164.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -68.37 -47.29 67.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 110.117 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.33 169.01 22.88 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 125.797 1.639 . . . . 0.0 109.171 -159.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.7 -41.05 49.69 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.953 1.263 . . . . 0.0 115.546 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -67.95 -44.66 84.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.97 1.885 . . . . 0.0 107.854 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.78 -26.17 68.51 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.173 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.81 -49.03 67.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.99 1.268 . . . . 0.0 110.14 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.02 -42.77 95.05 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.208 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.85 -47.37 85.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.479 1.112 . . . . 0.0 110.893 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.95 -46.43 78.56 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.802 0.841 . . . . 0.0 109.799 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 54' ' ' VAL . 2.1 mm? -57.33 -37.87 73.2 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.001 0.819 . . . . 0.0 111.342 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 4.6 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.16 82.0 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 119.715 -1.865 . . . . 0.0 110.399 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.49 104.4 1.24 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.773 1.177 . . . . 0.0 111.66 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.65 13.68 1.08 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.438 1.018 . . . . 0.0 115.134 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -69.43 167.28 16.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.214 1.507 . . . . 0.0 110.988 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.31 -19.21 0.88 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.561 167.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -131.84 144.0 50.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.536 1.668 . . . . 0.0 107.727 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HD13 ' A' ' 81' ' ' LEU . 15.3 t -134.37 62.41 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.74 135.36 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -144.92 168.91 19.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.019 0.827 . . . . 0.0 110.434 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.44 169.46 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.555 0.693 . . . . 0.0 109.359 159.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -74.08 -53.68 9.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.878 158.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.25 86.99 6.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.487 1.115 . . . . 0.0 111.54 -158.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.2 mmt -127.17 149.71 70.27 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.289 0.636 . . . . 0.0 111.2 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.96 147.1 60.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.492 2.128 . . . . 0.0 109.822 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 54.92 -84.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.283 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 41.4 ttm -88.19 97.64 11.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.941 1.296 . . . . 0.0 107.65 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.39 161.97 2.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.31 -33.68 53.04 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.558 -0.714 . . . . 0.0 111.847 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.57 -42.21 99.41 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.715 0.757 . . . . 0.0 109.942 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -81.19 -30.36 34.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.774 -0.579 . . . . 0.0 111.264 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.51 -52.1 67.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.16 0.984 . . . . 0.0 108.556 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.8 tp -51.13 -60.04 3.53 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.01 1.324 . . . . 0.0 109.463 173.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 24.3 mmtt -59.72 -40.34 87.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.523 1.056 . . . . 0.0 112.363 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.5 m -59.62 -49.05 79.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.631 0.772 . . . . 0.0 109.364 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.16 -39.37 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.15 -25.91 68.29 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.448 1.899 . . . . 0.0 112.234 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.556 175.22 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.8 mtm . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 p -50.97 -31.66 18.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.732 1.213 . . . . 0.0 112.422 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.7 65.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.983 1.313 . . . . 0.0 114.029 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 54' ' ' VAL . 17.5 mt -56.55 138.01 76.51 Favored Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.317 -171.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.03 84.21 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.616 2.211 . . . . 0.0 108.951 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -76.69 126.76 37.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tp -142.28 110.56 6.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -159.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -79.32 126.34 30.67 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.372 1.045 . . . . 0.0 108.423 -171.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.2 t -136.1 101.34 2.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.254 1.822 . . . . 0.0 106.646 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -149.26 164.6 34.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.363 0.601 . . . . 0.0 111.391 -159.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.11 -20.91 57.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.582 1.153 . . . . 0.0 111.689 161.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -76.38 87.76 3.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.967 1.307 . . . . 0.0 111.031 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.98 5.3 4.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.094 0.958 . . . . 0.0 113.287 172.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -48.4 112.81 0.64 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.144 1.777 . . . . 0.0 108.307 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.81 -43.28 80.83 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -56.21 -37.79 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.374 1.07 . . . . 0.0 112.287 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -66.99 -40.5 87.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.393 0.542 . . . . 0.0 109.541 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.91 -49.43 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.156 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.0 -58.52 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.07 -49.3 63.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.587 1.155 . . . . 0.0 111.011 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.96 95.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.181 0.901 . . . . 0.0 110.883 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.15 91.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.902 0.319 . . . . 0.0 111.166 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -60.51 -55.81 28.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.19 1.396 . . . . 0.0 110.052 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.636 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -59.33 -28.87 67.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 111.51 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.66 38.76 4.6 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.278 0.942 . . . . 0.0 111.933 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.44 153.3 27.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.818 0.809 . . . . 0.0 109.306 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -69.98 -14.88 62.91 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.01 171.46 37.01 Favored Glycine 0 N--CA 1.443 -0.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.673 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -137.06 135.23 37.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.357 1.463 . . . . 0.0 107.343 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.45 103.43 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 90' ' ' ALA . 3.0 t -74.13 144.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -60.67 154.17 58.37 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.826 1.251 . . . . 0.0 109.619 163.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.92 174.54 46.7 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.373 0.812 . . . . 0.0 111.329 -14.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -178.43 151.33 0.6 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -167.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 p -144.79 -171.69 3.68 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.441 1.096 . . . . 0.0 109.825 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.402 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.99 -30.99 72.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.446 -0.784 . . . . 0.0 109.583 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.97 -19.68 45.43 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.47 -27.4 9.03 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.493 1.042 . . . . 0.0 110.999 171.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.46 -50.61 62.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.225 1.375 . . . . 0.0 107.939 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -31.56 72.47 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.631 1.172 . . . . 0.0 112.151 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -77.27 -36.1 54.67 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.712 0.687 . . . . 0.0 110.591 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -64.96 -43.46 92.62 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.122 -0.986 . . . . 0.0 109.211 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -58.66 -56.76 18.02 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.715 1.206 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -52.1 -42.31 63.16 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.937 1.295 . . . . 0.0 111.329 176.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -52.82 -63.18 1.23 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.366 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 pt -68.48 -30.14 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 120.487 1.494 . . . . 0.0 114.402 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.88 -53.92 52.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -83.09 -34.46 26.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 121.282 -0.167 . . . . 0.0 110.577 -171.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -74.0 -74.1 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.831 1.253 . . . . 0.0 108.862 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.92 -20.93 62.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.697 0.799 . . . . 0.0 110.967 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.34 26.98 26.54 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.499 -172.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 C--O 1.249 1.079 0 CA-C-N 119.639 1.72 . . . . 0.0 111.678 -175.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.06 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 34' ' ' GLU . 12.3 tttt -82.47 135.45 35.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.336 -164.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.23 85.14 2.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -169.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.67 139.58 53.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.11 120.74 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -129.17 65.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.679 1.228 . . . . 0.0 107.949 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.24 111.32 22.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 7.0 t70 -47.74 -46.16 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.36 1.464 . . . . 0.0 112.59 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.5 -13.31 13.09 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t 76.34 -68.1 0.2 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.128 1.771 . . . . 0.0 108.42 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -55.87 -28.08 54.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.964 -1.085 . . . . 0.0 111.674 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.5 mtp -56.86 -46.57 81.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 116.854 -1.546 . . . . 0.0 111.011 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -22.88 63.13 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 121.645 2.021 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -65.7 -52.44 51.4 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.43 -60.51 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.736 1.214 . . . . 0.0 108.666 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.91 -49.19 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.239 1.016 . . . . 0.0 111.063 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -60.43 -42.97 97.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.768 1.167 . . . . 0.0 110.891 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -57.96 -53.12 61.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.09 -38.85 77.2 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.006 0.923 . . . . 0.0 111.902 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.24 -47.24 86.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.506 0.722 . . . . 0.0 110.087 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -64.89 -36.61 84.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.55 -41.24 89.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.652 1.569 . . . . 0.0 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.44 -54.04 10.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.76 62.86 0.07 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -137.52 156.96 47.53 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.347 1.059 . . . . 0.0 109.325 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 -175.33 4.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.378 1.071 . . . . 0.0 111.271 -168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 50.82 46.82 25.57 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.781 2.032 . . . . 0.0 111.45 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.31 161.9 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.0 -1.063 . . . . 0.0 109.474 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 3.4 mm-40 -145.52 171.72 14.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.713 2.005 . . . . 0.0 108.68 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.51 145.6 37.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -120.7 160.26 23.67 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.59 -39.45 93.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.711 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.99 165.77 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.558 1.143 . . . . 0.0 107.921 -161.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.48 68.67 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.828 1.649 . . . . 0.0 113.835 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.56 -44.87 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.964 -1.315 . . . . 0.0 109.63 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.93 -27.55 64.86 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.574 0.625 . . . . 0.0 110.737 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -59.99 -50.09 75.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.728 -1.232 . . . . 0.0 108.322 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -43.5 72.05 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.769 0.795 . . . . 0.0 111.375 175.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -65.79 -25.48 67.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 112.683 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 30.3 mmtm -74.88 -47.4 30.29 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.229 -1.545 . . . . 0.0 108.805 168.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 72' ' ' ILE . 17.3 mt -56.96 -35.98 69.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.176 1.353 . . . . 0.0 111.969 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -74.72 9.61 1.75 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.56 42.47 2.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.493 1.517 . . . . 0.0 111.171 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.17 -171.14 22.62 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 121.49 -0.756 . . . . 0.0 111.861 163.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.2 70.23 1.87 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -65.43 145.38 56.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.23 3.09 2.99 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.844 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.74 142.14 23.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.692 1.246 . . . . 0.0 108.854 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -138.4 78.68 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -173.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.7 141.52 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -152.35 158.22 42.41 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.735 -0.603 . . . . 0.0 111.041 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 23.1 t0 -77.26 169.81 17.67 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 164.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 66' ' ' LEU . 2.8 t-105 -79.34 -51.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.413 -0.804 . . . . 0.0 111.806 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -74.85 79.6 2.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.16 1.384 . . . . 0.0 110.232 -159.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.8 ptp -135.01 153.32 78.44 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 121.13 -0.981 . . . . 0.0 111.174 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.2 -172.1 1.07 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.04 2.493 . . . . 0.0 109.394 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 57.61 -104.26 0.21 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.917 1.687 . . . . 0.0 109.674 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.32 95.07 9.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.55 153.14 3.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.425 1.09 . . . . 0.0 109.779 170.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.39 -30.15 64.35 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.42 -0.8 . . . . 0.0 113.723 -167.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 2.1 tm? -72.26 -39.77 68.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.286 1.043 . . . . 0.0 110.02 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.81 -39.35 90.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.787 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.9 tp -57.79 -51.07 71.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.83 0.741 . . . . 0.0 109.917 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -50.08 -57.88 6.71 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 109.038 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 27.3 mttm -65.44 -27.39 68.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 m -59.96 -59.59 5.18 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 46' ' ' LEU . 24.3 mt -58.62 -40.99 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.23 1.412 . . . . 0.0 109.722 -174.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -13.35 26.68 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.623 1.569 . . . . 0.0 113.43 -170.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 119.656 1.116 . . . . 0.0 110.951 -177.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.3 mtt . . . . . 0 C--O 1.226 -0.167 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -55.54 -28.76 56.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.413 1.085 . . . . 0.0 111.579 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.26 -2.02 43.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.364 1.466 . . . . 0.0 113.398 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.703 HD13 HG21 ' A' ' 54' ' ' VAL . 40.8 mt -74.38 136.08 75.42 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 119.859 1.209 . . . . 0.0 110.18 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.13 89.0 0.8 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 108.614 164.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -71.17 111.01 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 164.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -115.35 113.38 23.72 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mmt -79.46 117.29 20.29 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.89 96.49 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -132.64 -166.47 1.75 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.761 0.824 . . . . 0.0 110.089 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.24 -3.08 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.833 2.053 . . . . 0.0 111.016 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -86.91 81.57 8.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.533 0.682 . . . . 0.0 109.554 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -65.83 -4.49 6.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.523 1.529 . . . . 0.0 113.776 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -46.78 123.9 5.6 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.617 1.567 . . . . 0.0 110.354 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -53.17 54.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.228 0.537 . . . . 0.0 110.869 -173.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.84 -26.92 66.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.91 -46.42 78.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.792 1.237 . . . . 0.0 109.547 171.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.87 -46.8 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.45 -53.79 36.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.82 -44.23 73.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.493 0.717 . . . . 0.0 110.619 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.47 88.2 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.846 0.748 . . . . 0.0 111.865 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.32 -41.11 81.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.386 0.539 . . . . 0.0 111.049 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -57.29 -46.49 83.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.542 1.937 . . . . 0.0 109.778 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.78 -34.09 76.11 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.899 0.48 . . . . 0.0 111.472 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.87 39.27 4.4 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.924 1.25 . . . . 0.0 111.544 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.71 143.45 50.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.539 1.17 . . . . 0.0 109.201 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -66.69 -19.73 65.82 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 170.04 41.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.97 130.83 27.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.315 1.446 . . . . 0.0 107.396 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.08 137.63 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 t -127.76 124.15 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -51.18 146.01 12.11 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.831 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.91 168.19 72.37 Favored 'Cis proline' 0 CA--C 1.534 0.509 0 CA-C-N 119.273 0.776 . . . . 0.0 111.913 -3.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -177.97 152.41 0.74 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.665 1.186 . . . . 0.0 109.104 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -148.37 -177.51 5.81 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.62 1.968 . . . . 0.0 109.751 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.13 -26.63 39.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.77 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.51 -53.02 51.54 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.743 1.217 . . . . 0.0 112.135 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.24 -33.77 61.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.059 0.845 . . . . 0.0 109.654 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -52.11 66.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.377 0.989 . . . . 0.0 109.318 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.57 -28.42 69.63 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.6 0.76 . . . . 0.0 111.867 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.67 -43.96 24.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.077 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -65.91 -30.49 71.09 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.429 -1.419 . . . . 0.0 110.015 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -58.75 -52.88 63.81 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.118 168.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -51.68 -48.51 63.45 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.768 1.167 . . . . 0.0 111.178 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -54.71 -51.01 66.93 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.494 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.88 -30.26 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.931 1.696 . . . . 0.0 113.043 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -58.04 -48.05 81.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.77 -23.99 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -170.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -68.68 0.77 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 mt -67.2 -26.64 66.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.709 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.54 39.47 18.08 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -165.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.245 0.851 0 CA-C-N 117.912 0.856 . . . . 0.0 109.558 175.597 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.119 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -69.31 123.24 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.28 159.35 16.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -121.62 137.04 54.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 164.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 t -134.34 114.1 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.68 72.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB2' ' H ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -80.1 165.84 22.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.643 1.177 . . . . 0.0 109.065 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.48 -9.69 59.76 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.819 -1.175 . . . . 0.0 111.047 166.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 16.3 t80 -132.95 107.75 8.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.34 -1.475 . . . . 0.0 108.807 -170.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -49.77 -45.62 49.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.879 0.763 . . . . 0.0 112.758 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 57.3 m -52.43 -36.77 55.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.811 0.844 . . . . 0.0 111.502 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 ttm -57.16 -34.63 68.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 116.791 -1.576 . . . . 0.0 110.386 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.79 -42.82 99.87 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.129 1.786 . . . . 0.0 110.954 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -63.53 -54.15 40.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.58 -63.37 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.613 1.565 . . . . 0.0 109.143 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.47 -51.9 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 119.704 1.138 . . . . 0.0 110.768 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.58 -40.93 84.52 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 118.676 0.671 . . . . 0.0 111.231 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.08 -53.5 37.42 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 118.732 0.696 . . . . 0.0 109.146 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.45 -36.25 68.83 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 124.143 0.977 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.45 -67.15 0.35 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.258 169.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -57.38 -27.93 62.74 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.521 1.055 . . . . 0.0 113.089 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -58.02 -20.58 39.85 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.741 1.155 . . . . 0.0 112.563 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.1 mt -108.83 -35.7 6.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.223 3.009 . . . . 0.0 111.612 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.8 177.62 28.31 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.428 1.489 . . . . 0.0 110.985 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 62.22 -177.8 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.914 1.286 . . . . 0.0 112.392 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 170.29 -167.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 130.581 3.552 . . . . 0.0 105.568 -164.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 56.12 46.65 21.15 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.751 1.62 . . . . 0.0 111.977 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -71.77 149.21 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.36 173.13 8.6 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.493 2.317 . . . . 0.0 106.523 166.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.75 176.7 8.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.986 1.314 . . . . 0.0 109.111 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.4 169.66 16.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.725 2.01 . . . . 0.0 106.696 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.93 -32.12 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.539 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -170.94 174.83 4.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.936 1.695 . . . . 0.0 107.558 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.65 -36.06 69.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.32 1.438 . . . . 0.0 114.75 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.08 -40.76 90.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -71.33 -34.81 70.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 110.713 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.19 66.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.408 1.083 . . . . 0.0 109.232 -175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.44 -42.65 64.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.542 0.737 . . . . 0.0 111.527 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.67 -28.57 65.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.055 0.542 . . . . 0.0 111.713 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.61 -53.21 59.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.801 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.44 -54.72 32.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.941 0.792 . . . . 0.0 110.616 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.45 11.89 0.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.93 86.6 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 158.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.33 88.73 0.34 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.498 1.523 . . . . 0.0 109.827 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.68 0.24 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.715 1.626 . . . . 0.0 111.014 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -54.32 141.14 31.08 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.128 0.971 . . . . 0.0 109.344 166.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.2 -18.14 5.11 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.769 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.21 147.53 27.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.718 1.259 . . . . 0.0 107.878 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 ' CG2' HD13 ' A' ' 81' ' ' LEU . 2.9 t -131.9 128.2 59.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -169.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.7 132.48 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 p -151.78 161.16 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.294 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.74 169.98 13.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 110.076 169.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -80.23 -57.7 3.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 159.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -77.51 111.37 13.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.417 0.687 . . . . 0.0 109.2 -159.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 16.9 mmm -119.42 170.55 6.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.808 0.843 . . . . 0.0 110.726 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.82 -3.63 10.52 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.59 2.86 . . . . 0.0 113.015 166.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.84 -91.83 0.06 Allowed 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -160.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.7 ttm -91.07 95.12 9.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.202 1.801 . . . . 0.0 107.613 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 11.4 m-20 -51.63 154.28 2.01 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 108.449 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.78 -24.5 26.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.031 0.824 . . . . 0.0 112.922 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.88 -52.23 31.83 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.564 1.182 . . . . 0.0 110.801 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -68.78 -32.37 72.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.179 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.31 -59.55 5.28 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 118.129 -0.938 . . . . 0.0 109.108 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.706 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -45.06 -55.51 5.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.761 1.224 . . . . 0.0 109.108 173.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -64.66 -27.55 69.0 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 117.868 -1.063 . . . . 0.0 113.286 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.9 m -69.19 -50.97 42.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 119.383 0.992 . . . . 0.0 109.04 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.2 mt -45.89 -57.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.384 1.088 . . . . 0.0 112.279 165.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.6 8.03 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.594 2.357 . . . . 0.0 112.839 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.255 0 CA-C-N 120.629 1.559 . . . . 0.0 110.868 177.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . 0.284 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.083 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.2 p -52.49 -31.97 37.71 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.33 -13.87 60.45 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.916 1.235 . . . . 0.0 112.745 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD13 ' CG2' ' A' ' 54' ' ' VAL . 11.5 mt -58.05 129.79 82.75 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 109.244 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.24 109.74 2.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.958 1.772 . . . . 0.0 108.938 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -90.12 94.66 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.182 0.993 . . . . 0.0 109.043 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tp -87.18 113.97 23.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.804 -1.185 . . . . 0.0 108.222 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mtt -84.8 124.61 31.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.5 114.91 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -147.25 -179.41 6.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.513 1.149 . . . . 0.0 109.904 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.05 -24.95 16.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 112.014 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -91.24 151.83 20.76 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 119.08 0.855 . . . . 0.0 111.152 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.61 -80.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.424 171.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? 52.55 100.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.422 1.489 . . . . 0.0 110.432 -167.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -54.46 -37.79 65.61 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.471 -1.393 . . . . 0.0 110.2 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -33.81 74.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 0.627 . . . . 0.0 112.553 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -65.14 -44.52 88.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.28 0.632 . . . . 0.0 109.442 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.73 -50.48 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.766 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.16 -56.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.62 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.14 95.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.415 0.552 . . . . 0.0 109.964 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.15 77.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.927 0.491 . . . . 0.0 112.129 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -69.7 -52.3 26.83 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.699 1.999 . . . . 0.0 111.086 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.15 77.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.35 41.94 1.01 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.432 1.491 . . . . 0.0 111.782 169.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.74 165.27 4.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.7 1.2 . . . . 0.0 110.695 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.0 t -51.41 -44.6 62.3 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.524 1.13 . . . . 0.0 108.712 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.35 172.7 39.08 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 169.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -100.86 141.36 33.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -131.19 128.27 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.17 139.2 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -58.29 139.96 83.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.526 168.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.51 131.31 23.49 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.4 1.179 . . . . 0.0 111.267 -1.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -131.5 159.15 38.96 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.164 0.985 . . . . 0.0 109.511 169.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 p -152.16 171.12 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.836 2.454 . . . . 0.0 108.364 -168.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.87 75.02 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.03 -15.27 12.56 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.31 -33.09 6.74 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.193 1.36 . . . . 0.0 110.869 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.94 -49.09 66.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.544 1.538 . . . . 0.0 108.65 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -57.07 -33.11 66.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 125.954 1.702 . . . . 0.0 112.689 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 32.9 tt0 -78.07 -33.62 50.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.412 0.285 . . . . 0.0 110.246 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -63.15 -43.4 98.41 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.823 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.9 mt -55.71 -52.91 62.26 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.94 -35.43 73.12 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 23.8 mtmt -61.77 -59.39 5.23 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.09 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 pt -65.25 -30.16 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.547 1.521 . . . . 0.0 112.869 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -55.3 -62.89 1.37 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.46 -35.45 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -81.51 -61.4 1.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.875 1.27 . . . . 0.0 109.193 -172.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.47 HD23 ' HD2' ' A' ' 126' ' ' LYS . 4.1 mt -79.66 -20.88 45.61 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.436 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.72 38.06 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.818 -169.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.7 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.059 -1.448 . . . . 0.0 109.966 -178.049 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp . . . . . 0 C--O 1.233 0.218 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -90.74 132.37 35.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.616 -165.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -107.68 104.44 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.6 134.15 38.28 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.36 118.7 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -133.85 56.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.312 1.445 . . . . 0.0 108.222 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.68 146.17 55.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -69.01 -58.24 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.782 0.833 . . . . 0.0 109.073 172.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.4 t80 -72.81 114.22 10.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 m -50.43 -51.45 46.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 112.337 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.497 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 24.8 m -61.6 -26.59 68.08 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.564 -1.208 . . . . 0.0 112.176 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 ttm -59.77 -44.55 93.82 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.629 1.559 . . . . 0.0 109.903 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -65.42 -36.94 85.44 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 119.267 0.939 . . . . 0.0 111.054 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.3 -42.79 99.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.189 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.84 -66.19 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 116.688 -1.625 . . . . 0.0 107.798 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.36 -49.55 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.309 1.868 . . . . 0.0 110.993 -172.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -57.92 -42.91 85.8 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.728 0.811 . . . . 0.0 110.607 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.93 -45.74 91.06 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.388 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 mt -59.49 -44.37 93.08 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.721 0.692 . . . . 0.0 109.296 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.49 -47.45 78.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.644 0.778 . . . . 0.0 111.131 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 3.0 mmpt? -60.99 -42.44 98.41 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.038 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.56 -44.5 85.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.78 1.232 . . . . 0.0 110.02 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.91 4.64 16.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.266 1.027 . . . . 0.0 112.234 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.01 -18.08 47.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.617 1.58 . . . . 0.0 114.53 166.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -67.74 156.95 35.8 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.015 1.408 . . . . 0.0 111.234 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -136.09 -172.72 3.19 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.352 1.861 . . . . 0.0 109.9 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.8 t30 55.17 58.68 4.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 127.177 2.191 . . . . 0.0 112.559 165.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.7 148.14 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.897 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -121.26 160.06 24.69 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.152 1.781 . . . . 0.0 108.187 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 28.2 tt0 -121.59 151.9 39.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.56 164.81 21.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -72.56 -35.82 68.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.516 0.327 . . . . 0.0 111.234 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.81 176.89 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.719 1.208 . . . . 0.0 109.797 -170.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.63 43.64 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.259 1.885 . . . . 0.0 115.866 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.5 -51.45 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.666 2.233 . . . . 0.0 107.981 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.29 -34.36 76.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.645 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.68 -47.97 82.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.665 -1.272 . . . . 0.0 110.197 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.32 -41.52 89.28 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.69 -30.0 69.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.353 0.661 . . . . 0.0 112.666 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 35' ' ' GLU . 4.3 mptp? -67.69 -42.34 82.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.357 -0.839 . . . . 0.0 110.167 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 46' ' ' LEU . 3.7 mm? -62.9 -39.02 93.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.732 1.151 . . . . 0.0 110.225 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -70.25 12.33 0.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.796 0.839 . . . . 0.0 112.673 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.03 16.54 7.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.122 2.169 . . . . 0.0 111.836 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.47 -178.68 38.16 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.525 1.511 . . . . 0.0 115.57 162.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.01 73.5 0.97 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -69.44 154.66 41.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.614 0.766 . . . . 0.0 109.659 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.87 -32.28 11.24 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.612 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -142.86 149.85 39.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 81' ' ' LEU . 21.2 t -139.42 64.57 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.32 132.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 153.98 37.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.787 0.435 . . . . 0.0 110.394 -169.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 13' ' ' ASP . 7.9 t0 -84.84 167.47 15.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 161.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.76 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 2.7 t-105 -73.08 -44.43 60.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.871 0.868 . . . . 0.0 110.325 164.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -68.61 29.38 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 131.403 3.881 . . . . 0.0 115.909 -158.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 38.0 mtt -65.94 170.54 4.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 127.891 2.476 . . . . 0.0 109.826 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.1 -39.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.825 2.35 . . . . 0.0 112.915 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -124.56 -76.94 0.59 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 123.924 0.889 . . . . 0.0 109.436 -167.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 tpt -72.75 103.78 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.36 164.14 19.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.332 0.587 . . . . 0.0 109.745 173.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.59 -25.54 67.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 121.069 -0.586 . . . . 0.0 114.111 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.76 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -73.63 -43.08 60.51 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.054 1.342 . . . . 0.0 108.919 177.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.55 -42.64 98.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.57 0.748 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -54.63 -52.4 62.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.856 0.753 . . . . 0.0 109.259 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.2 tp -51.7 -58.96 4.9 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 123.411 0.684 . . . . 0.0 110.179 174.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -63.26 -30.57 71.69 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.994 0.815 . . . . 0.0 112.39 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 68.9 m -69.07 -51.23 41.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.11 0.964 . . . . 0.0 108.426 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.4 mt -56.13 -47.51 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.533 0.733 . . . . 0.0 109.982 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -58.88 -23.62 61.21 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.428 1.491 . . . . 0.0 112.839 -175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 123.925 0.89 . . . . 0.0 111.568 -169.133 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.5 p -54.03 -47.33 71.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.414 0.686 . . . . 0.0 112.153 -166.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.04 7.32 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 54' ' ' VAL . 11.5 mt -54.35 142.78 48.6 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-N 119.839 1.2 . . . . 0.0 111.381 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 72.18 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.696 2.264 . . . . 0.0 109.803 160.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -64.46 137.45 24.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 158.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 tp -141.69 113.53 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.72 128.92 36.73 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 124.269 0.981 . . . . 0.0 108.444 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.63 110.49 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -153.13 167.96 27.51 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.578 -0.701 . . . . 0.0 110.3 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.72 -23.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.343 -0.848 . . . . 0.0 112.474 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.67 116.3 22.58 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.444 1.02 . . . . 0.0 109.329 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.53 -81.42 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.438 166.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.5 tptt 45.94 95.04 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.3 1.44 . . . . 0.0 111.213 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.71 -33.78 35.95 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 120.225 -1.547 . . . . 0.0 112.138 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -42.98 85.73 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.701 1.137 . . . . 0.0 112.491 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -59.56 -44.88 93.14 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.701 0.8 . . . . 0.0 109.098 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.41 -46.07 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.954 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -61.36 -52.51 60.47 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.576 1.08 . . . . 0.0 108.52 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.28 -45.93 69.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.521 1.055 . . . . 0.0 110.962 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.439 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -64.16 -46.85 82.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.332 0.653 . . . . 0.0 109.951 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.05 86.76 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.89 0.768 . . . . 0.0 110.609 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -55.31 -51.49 66.55 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 126.742 2.017 . . . . 0.0 110.857 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -21.01 66.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.09 25.18 8.51 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.849 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.8 136.39 57.97 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 p -74.55 -1.75 22.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . 172.75 169.05 34.89 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 121.182 -0.949 . . . . 0.0 111.619 172.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -139.72 92.7 2.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.026 1.331 . . . . 0.0 108.699 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.04 112.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.75 157.85 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -64.12 159.58 55.43 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.037 158.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.1 166.81 81.46 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.826 0.974 . . . . 0.0 110.097 -11.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -178.09 158.73 1.24 Allowed 'General case' 0 C--N 1.333 -0.135 0 O-C-N 121.266 -0.897 . . . . 0.0 111.285 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -154.86 -177.34 6.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.766 2.026 . . . . 0.0 109.026 -173.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.83 -23.55 53.24 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.753 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.32 -53.51 49.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.877 0.871 . . . . 0.0 112.075 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -30.5 60.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 0.0 109.935 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -53.84 53.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.407 1.003 . . . . 0.0 108.94 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.98 -39.77 87.25 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.533 0.606 . . . . 0.0 111.469 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.0 -47.83 74.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.171 0.989 . . . . 0.0 109.87 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 1.8 mmmp? -68.15 -37.48 81.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.15 -1.881 . . . . 0.0 112.336 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.45 -58.32 9.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.521 1.055 . . . . 0.0 108.207 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -58.19 -36.05 72.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.15 0.98 . . . . 0.0 109.937 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -56.94 -56.0 27.35 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 117.589 -1.196 . . . . 0.0 112.901 168.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.0 pt -68.95 -25.67 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 121.398 1.908 . . . . 0.0 112.934 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -57.87 -55.73 31.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.85 -47.13 79.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 122.547 0.339 . . . . 0.0 111.676 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HG3' HD23 ' A' ' 127' ' ' LEU . 11.3 tptt -78.23 -71.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.202 1.001 . . . . 0.0 109.727 -168.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 126' ' ' LYS . 13.1 mt -64.9 -20.67 66.56 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.211 -178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.88 42.36 16.73 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 -166.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.249 1.072 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.234 169.306 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 119.574 -0.251 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -81.57 149.96 28.39 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.884 0.874 . . . . 0.0 109.549 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.401 ' CZ ' ' CE1' ' A' ' 53' ' ' PHE . 12.0 m-85 -120.97 106.62 11.77 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.415 1.086 . . . . 0.0 109.528 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.77 136.15 43.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.611 1.55 . . . . 0.0 108.84 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -136.15 105.5 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.343 1.457 . . . . 0.0 107.3 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.29 70.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.239 1.016 . . . . 0.0 108.378 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.38 138.75 35.58 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 1.3 t70 -53.07 -33.08 50.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.939 2.095 . . . . 0.0 112.656 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -115.24 120.49 39.86 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 107.156 -168.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -53.07 -47.69 68.29 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.62 -175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.3 m -51.85 -44.64 63.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.625 1.102 . . . . 0.0 111.539 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.83 94.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -69.56 -44.16 71.42 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.913 1.285 . . . . 0.0 109.314 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -52.45 -52.34 54.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.13 2.172 . . . . 0.0 109.723 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.89 -62.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.218 -1.372 . . . . 0.0 108.261 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -52.03 -48.1 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 120.822 1.647 . . . . 0.0 110.761 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' HH11 ' A' ' 22' ' ' ARG . 0.2 OUTLIER -56.37 -49.86 73.23 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.674 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -60.39 -42.67 96.37 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 118.521 0.601 . . . . 0.0 110.713 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 113' ' ' ALA . 94.6 mt -63.69 -39.4 94.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.765 0.826 . . . . 0.0 111.013 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -64.84 -48.43 74.38 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 121.913 -0.492 . . . . 0.0 110.378 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -58.84 -39.76 82.22 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.07 0.948 . . . . 0.0 110.951 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.5 -51.04 68.33 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.36 1.064 . . . . 0.0 109.338 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.25 -48.21 80.95 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.06 3.14 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.4 1.953 . . . . 0.0 111.977 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.07 133.47 51.7 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 109.63 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 -176.38 5.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -167.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.7 t30 62.06 80.39 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 128.622 2.769 . . . . 0.0 108.76 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.06 160.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.354 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -114.31 147.08 39.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 158.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.37 164.31 12.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 158.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.75 167.86 14.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 158.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.44 -27.41 46.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.865 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -176.17 156.93 1.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.779 1.232 . . . . 0.0 108.084 -158.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.52 -45.33 5.47 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.107 1.337 . . . . 0.0 114.807 170.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.47 -36.87 78.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 119.608 1.704 . . . . 0.0 110.417 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -70.87 -31.97 68.82 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 122.763 0.425 . . . . 0.0 110.23 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.16 61.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -58.43 -40.12 81.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.779 0.432 . . . . 0.0 111.605 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -56.12 -51.35 68.26 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.971 0.508 . . . . 0.0 109.877 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -55.74 -46.68 77.74 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.184 0.994 . . . . 0.0 110.297 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 72' ' ' ILE . 11.5 mt -58.07 -46.99 84.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.958 0.799 . . . . 0.0 110.286 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -81.47 5.18 18.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.652 0.781 . . . . 0.0 112.423 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -57.22 12.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 159.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.26 88.89 0.07 OUTLIER Glycine 0 C--N 1.339 0.701 0 O-C-N 121.142 -0.974 . . . . 0.0 113.825 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.3 84.08 0.03 OUTLIER Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.946 1.736 . . . . 0.0 114.993 158.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -81.91 175.8 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.569 0.699 . . . . 0.0 112.649 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.45 -72.61 1.15 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 165.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE1' ' CZ ' ' A' ' 8' ' ' PHE . 27.1 m-85 -110.91 154.24 24.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.855 -171.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.28 91.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.37 129.39 52.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.3 p -151.38 162.2 41.34 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.655 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 18.0 t70 -72.89 -177.0 2.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 9.1 t-105 -116.11 -33.13 5.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.334 2.654 . . . . 0.0 112.366 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -76.2 21.48 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.306 2.242 . . . . 0.0 114.133 -159.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.406 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.27 147.06 79.01 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.342 1.057 . . . . 0.0 110.214 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.57 -172.21 1.24 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.014 2.476 . . . . 0.0 110.14 159.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 55.78 -105.86 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.613 1.965 . . . . 0.0 109.981 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.8 ttm -87.88 85.89 7.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.8 156.9 22.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.014 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.62 64.18 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.685 -169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.74 -35.59 44.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.32 1.56 . . . . 0.0 110.951 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -26.03 39.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.164 0.893 . . . . 0.0 111.254 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.14 -54.38 47.57 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.23 1.412 . . . . 0.0 108.622 164.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 8.1 tp -52.46 -58.51 6.51 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.088 0.955 . . . . 0.0 108.578 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 87.1 mttt -64.25 -28.15 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.352 1.433 . . . . 0.0 112.774 -174.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.3 m -62.22 -53.96 47.75 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.917 1.235 . . . . 0.0 108.354 168.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 46' ' ' LEU . 33.4 mt -56.29 -47.47 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.688 1.195 . . . . 0.0 107.853 -177.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -5.98 12.12 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.389 1.876 . . . . 0.0 113.652 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.304 0 CA-C-N 120.234 1.379 . . . . 0.0 109.858 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtm . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -42.72 -39.04 2.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.631 1.973 . . . . 0.0 112.421 159.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.53 -15.56 54.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 HG21 ' A' ' 54' ' ' VAL . 26.7 mt -64.39 131.91 95.2 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 120.116 1.325 . . . . 0.0 110.703 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.83 87.65 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.974 3.116 . . . . 0.0 109.779 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -67.24 104.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 128.516 2.726 . . . . 0.0 108.762 163.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.43 109.9 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.922 1.289 . . . . 0.0 108.198 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 59.6 mmm -87.78 129.84 35.05 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.25 94.51 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.16 1.784 . . . . 0.0 106.189 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -130.93 174.49 9.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.848 0.832 . . . . 0.0 111.09 -167.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.78 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.394 -0.816 . . . . 0.0 111.726 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.0 113.86 23.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.558 0.743 . . . . 0.0 111.73 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 8.48 1.63 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.495 1.518 . . . . 0.0 111.973 161.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -54.32 116.88 2.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.183 0.993 . . . . 0.0 108.452 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -60.87 -36.45 79.22 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.581 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -44.71 85.57 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.455 1.025 . . . . 0.0 109.531 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.64 -40.99 96.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 mt -64.89 -48.79 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.267 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.16 -51.65 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 120.009 1.277 . . . . 0.0 108.11 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.04 -42.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 110.904 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.605 0.762 . . . . 0.0 110.32 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.46 98.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.28 0.632 . . . . 0.0 110.722 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -57.07 -55.01 40.28 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 127.549 2.34 . . . . 0.0 108.83 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.73 -7.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.722 1.209 . . . . 0.0 113.234 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.41 30.81 56.16 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.302 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.87 143.55 36.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.899 1.349 . . . . 0.0 109.309 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 p -73.42 -14.85 61.34 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 122.15 -0.344 . . . . 0.0 111.908 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.34 167.55 38.75 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.84 137.88 40.19 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.24 125.68 51.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 170.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -96.2 150.35 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 166.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.65 69.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.538 -0.726 . . . . 0.0 109.79 166.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.84 175.43 44.8 Favored 'Cis proline' 0 CA--C 1.538 0.7 0 CA-C-N 119.846 0.981 . . . . 0.0 110.266 -15.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -178.07 159.01 1.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.528 1.531 . . . . 0.0 108.399 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.486 ' H ' HG22 ' A' ' 115' ' ' THR . 2.5 p -149.33 174.76 12.08 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.695 1.998 . . . . 0.0 109.297 -165.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -60.99 -34.34 74.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -6.15 2.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.287 1.835 . . . . 0.0 115.686 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 112' ' ' THR . 2.8 t -115.33 -34.56 4.92 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 121.395 1.907 . . . . 0.0 110.15 161.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.05 -56.92 5.64 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.643 1.577 . . . . 0.0 108.19 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -60.42 -31.61 70.57 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.03 1.332 . . . . 0.0 113.002 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 30.1 tt0 -72.54 -43.31 63.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.557 -0.715 . . . . 0.0 109.409 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 13.2 mmtp -68.81 -34.75 76.03 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.067 -1.02 . . . . 0.0 110.015 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.3 mt -55.04 -58.06 9.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.78 -35.36 68.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.711 0.687 . . . . 0.0 112.038 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 22.7 mttm -59.97 -47.49 85.61 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.369 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.06 -28.02 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.496 1.953 . . . . 0.0 114.033 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -60.47 -54.01 50.72 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.834 0.854 . . . . 0.0 109.101 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -67.63 -51.65 47.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.97 -0.456 . . . . 0.0 110.426 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -64.31 1.0 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -162.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.31 -22.01 66.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 119.429 -0.319 . . . . 0.0 110.903 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 26.81 50.25 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.931 -167.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.3 mmt . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.768 1.784 . . . . 0.0 110.411 177.328 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.695 HD11 ' HA3' ' A' ' 52' ' ' GLY . 5.9 tt . . . . . 0 CA--C 1.508 -0.639 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -83.89 131.37 34.87 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -83.8 138.46 33.23 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 158.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 42' ' ' ALA . 22.0 tp -111.07 135.75 51.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 169.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.11 122.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.77 48.0 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.99 157.49 21.77 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.493 -1.379 . . . . 0.0 108.727 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -33.32 71.18 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 121.493 -0.755 . . . . 0.0 111.182 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.1 t80 -102.43 127.84 49.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.058 1.343 . . . . 0.0 107.622 -171.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -49.04 79.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.362 0.601 . . . . 0.0 110.057 -172.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 8.8 m -63.04 -24.15 67.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.62 -0.705 . . . . 0.0 111.743 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 18.7 ttm -64.95 -34.09 77.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.362 1.437 . . . . 0.0 109.938 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -36.8 80.77 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 120.352 1.433 . . . . 0.0 110.565 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -52.01 -53.06 46.2 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 168.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.22 -63.71 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-O 117.439 -1.267 . . . . 0.0 108.673 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.5 t -52.71 -46.34 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.664 1.574 . . . . 0.0 110.65 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.78 91.12 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.82 1.191 . . . . 0.0 110.318 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.73 -39.54 91.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.309 0.959 . . . . 0.0 111.922 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.57 -41.33 96.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.036 0.934 . . . . 0.0 110.079 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.84 -45.75 92.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.075 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -63.43 -39.39 94.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.799 0.727 . . . . 0.0 110.802 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.61 -12.98 61.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.598 -171.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.84 13.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.35 -90.61 0.43 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.558 1.075 . . . . 0.0 111.197 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -147.69 175.47 10.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.198 0.999 . . . . 0.0 112.824 -159.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -118.74 171.61 8.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 128.43 2.692 . . . . 0.0 109.194 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 77.29 99.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 128.388 2.675 . . . . 0.0 113.228 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -121.1 154.87 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.566 0.698 . . . . 0.0 112.449 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -122.3 145.42 48.25 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 158.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -119.71 93.89 4.22 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -76.29 163.45 27.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.67 0.748 . . . . 0.0 111.079 -172.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.65 -33.05 60.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.308 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.36 160.97 1.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.343 1.457 . . . . 0.0 107.535 -163.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.4 -40.36 10.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.755 1.161 . . . . 0.0 115.156 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.1 t -65.77 -39.41 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.237 2.018 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.22 -29.77 65.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.142 0.977 . . . . 0.0 111.028 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HA ' HD21 ' A' ' 9' ' ' LEU . . . -61.24 -51.44 68.92 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.949 -1.095 . . . . 0.0 109.401 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.38 -41.06 83.98 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.317 1.047 . . . . 0.0 111.144 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -56.51 -50.8 70.76 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.297 1.039 . . . . 0.0 110.282 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -54.78 -49.67 70.35 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.126 175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 72' ' ' ILE . 15.4 mt -53.45 -43.84 68.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.074 1.306 . . . . 0.0 109.935 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.59 10.56 0.35 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -4.9 47.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.987 1.267 . . . . 0.0 112.764 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.92 163.16 8.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.229 1.395 . . . . 0.0 113.438 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.2 22.74 76.26 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.466 -1.02 . . . . 0.0 112.281 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -90.96 156.57 17.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.536 1.168 . . . . 0.0 107.974 170.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.695 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -159.81 9.54 0.15 Allowed Glycine 0 C--O 1.225 -0.445 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.23 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.06 132.26 17.4 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 81' ' ' LEU . 5.9 t -133.29 86.11 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 CA-C-O 122.436 1.112 . . . . 0.0 108.0 -171.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -97.76 131.61 44.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.194 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -151.86 145.6 25.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.854 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.91 162.17 27.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.91 0.862 . . . . 0.0 109.485 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -70.27 -52.75 20.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.78 1.232 . . . . 0.0 109.478 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.45 82.25 6.52 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.742 1.617 . . . . 0.0 108.656 -169.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.5 mmt -86.95 168.64 17.26 Favored Pre-proline 0 C--O 1.234 0.263 0 O-C-N 121.806 -0.558 . . . . 0.0 111.013 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.37 0.94 9.28 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.217 2.611 . . . . 0.0 113.023 165.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -150.73 -80.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 121.008 1.731 . . . . 0.0 112.05 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.5 ttm -90.73 94.28 9.61 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.43 148.82 0.86 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.855 2.062 . . . . 0.0 111.434 176.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.98 -36.04 41.91 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.521 1.058 . . . . 0.0 113.754 -172.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.36 -34.14 55.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.775 0.83 . . . . 0.0 110.417 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.82 -42.95 85.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.56 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.11 -49.02 79.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.476 1.035 . . . . 0.0 110.013 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 83' ' ' VAL . 2.1 tp -52.43 -56.72 13.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.95 -26.25 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 120.241 1.382 . . . . 0.0 113.243 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 m -65.3 -49.06 70.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.34 0.973 . . . . 0.0 108.609 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 46' ' ' LEU . 18.8 mt -61.35 -44.42 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.519 1.127 . . . . 0.0 109.261 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 10.21 2.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.249 1.819 . . . . 0.0 111.712 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.346 0 CA-C-N 119.602 1.092 . . . . 0.0 111.735 177.572 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.6 mtt . . . . . 0 C--O 1.232 0.163 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -59.76 -23.95 63.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -15.3 60.84 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.389 1.45 . . . . 0.0 113.538 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 54' ' ' VAL . 13.0 mt -55.52 135.38 70.67 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.961 0.904 . . . . 0.0 111.559 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.87 87.18 0.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.692 2.261 . . . . 0.0 108.942 162.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.573 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -77.0 140.88 16.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 162.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.17 118.56 14.71 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -172.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.3 mmt -78.28 127.01 31.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.63 110.44 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.7 t -155.71 172.15 18.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.932 0.787 . . . . 0.0 111.232 -168.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.71 -28.18 62.52 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.235 -0.916 . . . . 0.0 111.539 159.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.75 93.29 0.94 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -164.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.9 4.53 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.987 170.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -45.16 105.25 0.05 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.999 1.72 . . . . 0.0 108.524 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -50.7 -43.15 57.62 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 122.462 0.305 . . . . 0.0 110.218 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -49.32 -43.0 43.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.715 1.206 . . . . 0.0 113.317 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -69.59 -40.94 76.4 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.372 1.069 . . . . 0.0 109.802 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.91 -46.45 76.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.683 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.91 -55.99 17.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.73 76.75 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.735 0.698 . . . . 0.0 111.313 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.61 64.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.514 0.726 . . . . 0.0 110.536 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.67 97.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.041 0.536 . . . . 0.0 110.037 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -58.16 -53.84 53.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 126.787 2.035 . . . . 0.0 111.527 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.75 -38.27 78.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.112 0.565 . . . . 0.0 110.254 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.69 30.2 3.11 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.713 1.149 . . . . 0.0 112.298 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.3 150.16 22.65 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.678 1.239 . . . . 0.0 109.699 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -72.79 -18.51 61.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.964 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.2 43.15 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.77 139.52 47.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 77.3 t -133.25 137.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.921 2.088 . . . . 0.0 105.368 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 90' ' ' ALA . 2.5 t -121.5 152.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -62.22 149.64 86.52 Favored Pre-proline 0 CA--C 1.542 0.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.233 164.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.61 127.63 14.13 Favored 'Cis proline' 0 N--CA 1.456 -0.723 0 N-CA-C 109.538 -0.985 . . . . 0.0 109.538 -15.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -117.75 156.24 28.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -146.26 178.76 8.0 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 108.872 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.7 -25.49 67.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.215 -0.897 . . . . 0.0 109.216 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.69 -38.83 64.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.186 0.994 . . . . 0.0 112.575 170.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -31.9 20.79 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.828 1.195 . . . . 0.0 109.712 173.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.07 -48.77 75.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.713 1.142 . . . . 0.0 109.404 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.51 -36.14 81.6 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.349 0.66 . . . . 0.0 111.675 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 10.0 tt0 -66.38 -46.99 74.79 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.81 0.732 . . . . 0.0 109.189 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -44.94 89.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.203 -0.903 . . . . 0.0 108.769 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.05 -53.51 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.701 0.8 . . . . 0.0 110.183 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.93 -45.97 82.35 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.568 0.747 . . . . 0.0 110.997 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -53.27 -55.99 20.16 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.878 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -27.77 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.935 1.243 . . . . 0.0 112.574 -169.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -54.73 -60.36 3.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 165.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.8 -52.55 42.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 109.725 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.294 1.437 . . . . 0.0 110.983 -164.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.07 -32.13 71.36 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.05 44.45 5.98 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -162.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.1 mmt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 119.115 1.457 . . . . 0.0 109.996 169.268 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.8 tp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -81.55 129.01 34.51 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -111.31 109.76 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.654 1.182 . . . . 0.0 107.847 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.31 138.53 47.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.732 1.606 . . . . 0.0 109.012 171.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.93 109.22 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.291 1.036 . . . . 0.0 109.308 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -120.06 52.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -66.55 158.39 29.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.293 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.19 -43.03 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.797 -0.565 . . . . 0.0 111.486 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -92.0 114.66 27.26 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 116.739 -1.6 . . . . 0.0 108.958 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -53.14 -37.55 61.92 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 122.703 2.502 . . . . 0.0 114.622 -167.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 m -48.52 -38.42 20.25 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.578 -1.326 . . . . 0.0 111.708 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.0 ttm -65.36 -25.31 67.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.711 2.004 . . . . 0.0 111.572 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -56.42 22.1 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.452 1.933 . . . . 0.0 107.912 167.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -53.34 54.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.548 1.139 . . . . 0.0 108.584 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.9 -67.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 117.088 -1.434 . . . . 0.0 108.417 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.22 -48.27 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 120.673 1.579 . . . . 0.0 111.0 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -56.33 -48.79 76.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 109.837 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -63.04 -44.58 95.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 113' ' ' ALA . 85.2 mt -56.64 -44.17 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.17 0.988 . . . . 0.0 110.186 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.43 -42.84 96.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.639 0.776 . . . . 0.0 111.174 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -62.89 -35.13 79.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.57 -5.08 22.06 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.27 0.941 . . . . 0.0 111.464 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.67 15.58 8.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.258 2.623 . . . . 0.0 111.375 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.91 85.14 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.807 169.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -97.91 163.56 12.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.355 1.577 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -159.39 -160.28 0.82 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 110.197 -173.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.42 37.29 23.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.519 1.527 . . . . 0.0 113.085 165.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.44 146.51 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.582 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -110.26 167.17 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 158.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.65 168.86 11.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 163.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -126.28 164.5 20.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.73 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.997 0.519 . . . . 0.0 110.556 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.66 173.31 8.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.836 1.654 . . . . 0.0 108.54 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.93 -29.11 54.64 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.53 -49.77 56.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.537 2.168 . . . . 0.0 107.321 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -60.63 -32.37 71.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.29 0.636 . . . . 0.0 110.879 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.71 -52.65 59.6 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.728 -1.232 . . . . 0.0 109.042 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.42 -35.38 71.98 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.56 -44.62 93.58 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.34 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -62.58 -38.64 90.9 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.113 0.869 . . . . 0.0 111.528 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.48 HD21 HG13 ' A' ' 54' ' ' VAL . 11.0 mt -59.99 -46.68 88.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.3 1.409 . . . . 0.0 108.991 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -77.66 29.18 0.16 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.037 1.335 . . . . 0.0 111.486 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.77 32.8 4.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.559 1.944 . . . . 0.0 109.724 159.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.61 19.69 8.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.913 164.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.59 83.02 0.62 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.125 1.463 . . . . 0.0 109.528 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -69.56 170.33 10.88 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.158 0.583 . . . . 0.0 109.858 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 -40.62 26.34 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.668 -0.645 . . . . 0.0 112.565 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -139.73 155.84 47.12 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.328 0.564 . . . . 0.0 111.547 -166.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -134.3 71.08 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.56 129.37 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -150.42 157.67 43.3 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.262 -1.524 . . . . 0.0 110.525 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -73.76 171.96 12.36 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.668 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 5.1 t-105 -66.7 -59.15 3.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 159.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.55 71.36 5.01 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -158.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.82 154.35 47.79 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.3 160.04 45.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.8 1.666 . . . . 0.0 109.257 162.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.24 -79.07 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 C-N-CA 129.104 2.962 . . . . 0.0 114.227 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 ttp -88.45 79.79 7.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.86 150.17 2.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.026 1.73 . . . . 0.0 109.517 167.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.98 -27.93 71.2 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.205 -0.934 . . . . 0.0 113.785 -161.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.668 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -75.81 -31.42 59.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.974 0.887 . . . . 0.0 111.36 175.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.65 -40.54 84.53 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.792 0.723 . . . . 0.0 109.119 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.8 tp -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.521 0.6 . . . . 0.0 109.73 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tp -53.19 -56.98 12.15 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.946 0.898 . . . . 0.0 109.526 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.482 ' HE3' HD12 ' A' ' 66' ' ' LEU . 80.7 mttt -63.48 -30.17 71.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.026 0.83 . . . . 0.0 112.25 -174.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 m -62.18 -55.77 25.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 109.126 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 46' ' ' LEU . 25.2 mt -59.81 -44.04 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.125 1.37 . . . . 0.0 108.183 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -57.7 -26.24 61.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.999 1.719 . . . . 0.0 112.756 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 119.181 0.901 . . . . 0.0 112.311 179.486 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.49 ' HB3' HD12 ' A' ' 81' ' ' LEU . 43.9 mtt . . . . . 0 C--O 1.221 -0.441 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -57.23 -26.86 61.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.837 1.199 . . . . 0.0 111.264 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.62 -10.09 59.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.002 1.321 . . . . 0.0 113.975 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 54' ' ' VAL . 18.0 mt -68.58 143.5 95.25 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 119.625 1.102 . . . . 0.0 110.125 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.78 87.94 0.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.996 2.464 . . . . 0.0 110.099 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -76.85 88.77 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 126.321 1.848 . . . . 0.0 107.083 163.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.5 tp -96.26 118.33 32.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.62 122.76 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.2 t -132.55 99.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.412 1.885 . . . . 0.0 107.405 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -139.61 -173.54 3.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.132 0.968 . . . . 0.0 110.382 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.09 -15.02 15.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.116 1.367 . . . . 0.0 111.666 163.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.54 103.75 7.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.61 -73.58 0.11 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 39.98 92.7 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 126.433 1.893 . . . . 0.0 110.782 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -28.43 -57.75 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.071 1.348 . . . . 0.0 114.276 173.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 22.1 tt0 -54.73 -40.26 69.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.656 2.382 . . . . 0.0 113.654 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.04 -39.47 72.27 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.856 1.263 . . . . 0.0 110.474 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.97 -50.41 79.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.276 2.1 mt -53.9 -46.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 116.857 -1.544 . . . . 0.0 114.93 168.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.69 82.55 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 121.325 1.875 . . . . 0.0 110.488 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.66 -42.6 99.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.009 0.924 . . . . 0.0 110.729 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.58 78.79 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.565 -0.709 . . . . 0.0 112.394 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.44 -44.07 75.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.487 1.515 . . . . 0.0 110.091 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.13 58.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.548 0.739 . . . . 0.0 112.739 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.41 39.79 34.85 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.26 0.936 . . . . 0.0 112.453 173.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.62 150.4 31.97 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.428 0.614 . . . . 0.0 109.972 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -77.15 -14.33 59.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.96 0.904 . . . . 0.0 111.466 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.67 171.37 43.0 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 160.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -132.07 133.12 44.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.2 t -134.99 134.92 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.0 141.84 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -53.84 142.22 44.95 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.308 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.32 135.87 40.69 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.497 1.213 . . . . 0.0 110.77 -10.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.96 152.24 51.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 109.275 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 p -149.74 -176.71 5.52 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.66 1.584 . . . . 0.0 108.943 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -61.92 -32.89 73.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.402 -0.809 . . . . 0.0 108.901 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.46 -19.89 17.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.751 1.22 . . . . 0.0 114.218 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.58 -25.46 9.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.783 1.174 . . . . 0.0 111.668 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -47.59 81.21 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.17 -30.32 71.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 112.162 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -78.8 -43.36 25.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.465 0.706 . . . . 0.0 110.114 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -25.63 60.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.224 -1.369 . . . . 0.0 110.133 175.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 mt -57.52 -53.24 60.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.457 1.026 . . . . 0.0 108.677 166.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -50.09 -45.47 52.64 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.801 0.728 . . . . 0.0 111.302 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -62.67 1.5 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.316 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 pt -67.47 -27.03 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 120.319 1.418 . . . . 0.0 113.089 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -53.78 -62.51 1.61 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 167.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.02 -29.6 58.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -168.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -69.49 0.67 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.553 1.541 . . . . 0.0 107.829 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.97 -28.14 66.35 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.465 0.575 . . . . 0.0 111.546 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 43.16 6.52 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -162.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 38.2 mmt . . . . . 0 C--O 1.253 1.257 0 CA-C-N 118.66 1.23 . . . . 0.0 109.296 169.573 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 166.1 12.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.453 1.12 . . . . 0.0 111.263 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 33' ' ' VAL . 1.4 m-85 -124.17 161.67 25.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.25 139.38 43.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 158.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -127.87 104.24 11.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 42' ' ' ALA . 3.2 t -109.04 78.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.21 157.83 35.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 165.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -80.79 -23.21 39.43 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.48 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -83.41 -151.75 0.11 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.127 1.371 . . . . 0.0 109.575 178.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -139.78 -43.81 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.097 -1.002 . . . . 0.0 108.539 159.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.2 m -50.12 -31.93 14.68 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 169.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 ttm -64.72 -39.69 94.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.289 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -33.35 71.16 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 122.122 2.237 . . . . 0.0 110.937 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -56.43 -54.0 50.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.1 -60.25 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.51 1.124 . . . . 0.0 108.548 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.63 -46.92 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.597 1.089 . . . . 0.0 111.064 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.564 HH11 ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.24 -42.88 96.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.835 1.198 . . . . 0.0 109.914 -179.405 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.49 -53.96 51.34 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.195 0.907 . . . . 0.0 110.69 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.77 -37.46 71.12 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.157 0.983 . . . . 0.0 111.325 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -52.04 40.91 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.843 171.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' HH11 ' A' ' 22' ' ' ARG . 26.1 mttt -62.47 -23.84 67.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.324 1.42 . . . . 0.0 111.997 -172.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -52.22 -48.98 64.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.22 0.918 . . . . 0.0 110.324 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.1 mt -75.84 -50.09 16.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.554 1.542 . . . . 0.0 109.465 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.17 -163.43 31.02 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.622 1.105 . . . . 0.0 111.274 -174.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.533 ' HB2' HH22 ' A' ' 22' ' ' ARG . 61.4 m-85 59.2 174.48 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.209 1.803 . . . . 0.0 111.894 -171.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -170.89 -162.7 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.674 1.19 . . . . 0.0 108.378 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.69 27.57 17.3 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.876 2.071 . . . . 0.0 114.439 159.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 8' ' ' PHE . 7.5 m -70.08 174.14 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.104 0.562 . . . . 0.0 111.35 -175.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -136.98 177.05 8.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 108.064 164.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -132.09 177.19 7.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.777 1.231 . . . . 0.0 107.962 167.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 172.27 13.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.952 1.301 . . . . 0.0 108.005 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.69 -40.39 88.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.552 0.341 . . . . 0.0 111.181 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -174.74 172.04 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.517 1.927 . . . . 0.0 107.702 -163.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.53 -42.43 26.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.828 1.204 . . . . 0.0 115.539 178.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.47 -47.64 88.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 119.857 1.829 . . . . 0.0 108.517 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.35 -24.74 66.56 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.763 -0.585 . . . . 0.0 111.659 175.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.69 -53.63 44.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tp -51.75 -47.21 64.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.743 1.617 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -56.35 -42.08 77.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.496 1.518 . . . . 0.0 111.388 176.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.0 -45.46 88.89 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.645 -1.284 . . . . 0.0 111.246 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 72' ' ' ILE . 13.2 mt -55.12 -51.52 66.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.421 1.464 . . . . 0.0 109.521 -175.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.01 29.56 0.11 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.968 0.907 . . . . 0.0 113.172 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.34 18.03 12.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.735 1.614 . . . . 0.0 111.631 170.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.23 -6.53 0.7 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-O 117.984 -1.453 . . . . 0.0 114.904 166.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.83 107.57 0.73 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.381 1.591 . . . . 0.0 109.709 -174.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.91 164.41 14.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.036 1.335 . . . . 0.0 108.646 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.91 -28.87 27.56 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.479 -0.763 . . . . 0.0 112.625 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -145.98 159.46 43.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.192 1.797 . . . . 0.0 108.476 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.735 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -135.37 62.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.4 mt -69.52 131.76 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.62 141.43 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.599 0.359 . . . . 0.0 110.13 -163.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -62.89 165.19 7.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 164.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -80.96 -59.63 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 159.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.97 37.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.341 1.056 . . . . 0.0 112.55 -170.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.7 ptp -63.56 149.68 91.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 158.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.74 175.04 11.7 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.586 2.19 . . . . 0.0 110.607 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 m120 53.56 -92.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.992 2.117 . . . . 0.0 111.437 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -90.8 97.3 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.61 164.04 6.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.577 0.626 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.24 -38.38 56.63 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.641 0.639 . . . . 0.0 113.63 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.53 -38.92 92.7 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.976 0.888 . . . . 0.0 110.42 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.67 -35.58 52.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.13 0.572 . . . . 0.0 110.269 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.23 -49.93 74.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.568 0.747 . . . . 0.0 109.152 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -50.87 -56.57 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.597 1.159 . . . . 0.0 109.643 172.194 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -64.48 -31.34 72.51 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.109 1.322 . . . . 0.0 113.454 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.2 m -62.44 -51.5 67.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.37 1.068 . . . . 0.0 109.005 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 46' ' ' LEU . 28.3 mt -58.63 -43.54 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 126.217 1.807 . . . . 0.0 110.157 176.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -8.95 41.66 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.486 -172.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.441 0 C-N-CA 124.293 1.037 . . . . 0.0 111.561 -172.425 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.3 mtt . . . . . 0 C--O 1.22 -0.493 0 N-CA-C 111.112 0.042 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -35.28 11.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.356 2.262 . . . . 0.0 112.579 173.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.11 -7.17 58.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.656 1.582 . . . . 0.0 114.002 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 54' ' ' VAL . 17.2 mt -65.07 131.52 95.19 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 119.735 1.152 . . . . 0.0 108.674 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.98 83.65 0.9 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.452 1.434 . . . . 0.0 110.375 167.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -68.5 115.55 7.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 159.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tp -130.53 107.63 9.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -167.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -73.1 123.71 24.13 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.16 105.3 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -148.25 -166.47 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.35 -21.59 13.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.359 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -82.96 145.74 29.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.81 1.186 . . . . 0.0 110.868 176.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.31 -81.85 0.31 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.984 1.313 . . . . 0.0 109.809 172.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 tptm 46.33 110.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 130.078 3.351 . . . . 0.0 112.551 -164.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -47.57 -45.08 26.75 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 111.825 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -60.81 -31.45 70.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.964 1.256 . . . . 0.0 113.185 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -70.26 -37.39 74.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.747 1.158 . . . . 0.0 110.617 170.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.11 -47.8 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.409 1.004 . . . . 0.0 108.454 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.1 -58.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.88 -51.03 55.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.912 1.233 . . . . 0.0 111.336 -176.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.298 0.499 . . . . 0.0 110.295 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.31 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.441 0.564 . . . . 0.0 111.785 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -63.85 -47.19 81.71 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.615 1.966 . . . . 0.0 111.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.86 66.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.777 0.431 . . . . 0.0 112.002 172.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.48 47.15 9.15 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 125.9 1.714 . . . . 0.0 110.691 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.03 144.7 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -65.61 -21.23 66.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.664 0.269 . . . . 0.0 111.569 -178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 175.49 44.4 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -135.05 142.98 46.46 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.02 133.89 44.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 129.461 3.105 . . . . 0.0 104.302 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.02 147.55 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -50.29 134.97 23.89 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.098 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.22 147.39 85.41 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 120.557 1.235 . . . . 0.0 110.902 -6.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.86 145.12 32.09 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.841 -0.537 . . . . 0.0 112.06 176.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 115' ' ' THR . 2.3 p -141.36 174.58 10.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.244 1.818 . . . . 0.0 110.23 -170.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.29 67.62 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 175.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.89 66.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.181 1.392 . . . . 0.0 113.997 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 112' ' ' THR . 6.6 t -93.23 -40.77 10.26 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.569 1.077 . . . . 0.0 109.182 168.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -53.84 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.04 0.936 . . . . 0.0 109.483 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -28.6 70.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.71 1.204 . . . . 0.0 112.653 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.57 -46.58 31.08 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.031 0.933 . . . . 0.0 109.064 178.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -69.83 -32.94 71.62 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 109.823 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.5 -56.91 15.75 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.111 0.964 . . . . 0.0 109.424 167.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -57.17 -29.94 64.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -68.48 0.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 117.511 -1.233 . . . . 0.0 109.148 166.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.5 pt -62.13 -28.12 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 119.831 1.196 . . . . 0.0 112.726 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -59.46 -54.33 47.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.111 0.564 . . . . 0.0 109.797 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.14 -47.03 38.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.985 0.811 . . . . 0.0 110.942 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HG3' HD23 ' A' ' 127' ' ' LEU . 31.6 tptt -68.16 -73.27 0.15 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.774 1.629 . . . . 0.0 110.093 -172.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.462 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.9 mt -65.03 -21.2 66.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.541 0.61 . . . . 0.0 111.444 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.26 33.62 28.36 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.5 mmm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.057 179.513 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.462 HD11 ' HA3' ' A' ' 52' ' ' GLY . 1.1 tp . . . . . 0 C--O 1.235 0.337 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -70.03 130.54 42.42 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.83 160.51 17.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 162.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.72 137.5 51.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.12 103.59 6.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 125.683 1.593 . . . . 0.0 106.947 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.9 t -112.14 53.84 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.629 1.204 . . . . 0.0 107.872 -175.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.51 126.36 30.65 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.87 -45.1 93.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.989 0.516 . . . . 0.0 112.035 -174.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 29.0 t80 -75.61 106.18 7.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 t -58.05 -33.22 68.78 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.583 1.538 . . . . 0.0 112.885 -171.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 61.6 m -57.67 -36.84 72.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.406 -1.434 . . . . 0.0 110.851 174.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.1 tpp -55.29 -43.15 74.53 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.346 1.059 . . . . 0.0 109.539 173.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -66.6 -41.88 87.75 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.574 0.625 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -57.2 -47.06 82.24 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.028 173.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.85 -58.14 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.036 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.8 t -54.64 -50.6 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 125.34 1.456 . . . . 0.0 110.699 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -59.99 -41.73 92.69 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.826 0.739 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -64.39 -45.68 86.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.434 0.561 . . . . 0.0 111.346 176.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.29 -43.78 92.56 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.752 0.821 . . . . 0.0 110.269 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.34 -58.74 6.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.009 1.324 . . . . 0.0 110.558 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.492 ' HE2' ' OD1' ' A' ' 31' ' ' ASN . 11.5 ptmm? -66.27 -22.65 66.31 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 117.37 -1.3 . . . . 0.0 112.087 -177.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.45 90.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.391 1.451 . . . . 0.0 109.197 175.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.33 -42.4 23.04 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.436 1.094 . . . . 0.0 110.089 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.18 -25.13 0.19 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.258 -1.301 . . . . 0.0 115.757 169.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.93 101.59 5.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.425 2.113 . . . . 0.0 111.093 -174.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.492 ' OD1' ' HE2' ' A' ' 26' ' ' LYS . 45.8 m-80 -85.82 -27.4 25.15 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.235 -0.915 . . . . 0.0 112.985 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.54 76.38 2.24 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.297 1.522 . . . . 0.0 108.505 -159.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.23 108.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.813 2.045 . . . . 0.0 105.826 -162.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -86.4 -168.49 2.25 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.332 1.853 . . . . 0.0 109.894 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.92 172.35 1.67 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 130.589 3.555 . . . . 0.0 105.081 -167.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.96 175.75 9.99 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -168.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.78 -39.08 87.68 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.375 -0.828 . . . . 0.0 110.973 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.87 166.57 4.39 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -158.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.59 49.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.296 0.953 . . . . 0.0 112.554 171.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 t -57.81 -45.12 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.435 1.094 . . . . 0.0 110.536 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.93 -30.39 61.23 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.64 0.776 . . . . 0.0 109.633 176.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.91 -50.14 74.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.565 -0.71 . . . . 0.0 109.508 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.26 -45.61 76.08 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.144 0.578 . . . . 0.0 110.362 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.24 -38.0 87.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.051 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.26 -48.02 81.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.422 1.01 . . . . 0.0 109.512 171.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 72' ' ' ILE . 3.4 mt -60.82 -47.99 83.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 35.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.04 -49.28 4.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.64 153.91 20.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.047 1.784 . . . . 0.0 110.246 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -8.2 74.86 Favored Glycine 0 N--CA 1.466 0.685 0 O-C-N 121.047 -1.266 . . . . 0.0 114.03 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -72.7 161.8 30.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 159.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -134.21 3.79 4.46 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 117.758 -1.579 . . . . 0.0 113.544 164.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.38 141.89 31.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.855 1.828 . . . . 0.0 111.043 -174.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 81' ' ' LEU . 4.0 t -132.77 72.07 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -75.81 140.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 t -154.49 147.34 24.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.215 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -72.47 165.11 25.26 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 158.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 97' ' ' ALA . 7.3 t-105 -77.37 -52.53 8.99 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.467 1.507 . . . . 0.0 110.113 163.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.68 84.52 5.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.527 -158.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.71 162.95 51.96 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.391 1.476 . . . . 0.0 109.73 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.53 176.75 9.69 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.238 1.958 . . . . 0.0 111.166 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 58.41 -98.54 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.1 2.56 . . . . 0.0 110.796 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 9.6 ttm -91.21 104.84 17.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 172.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.08 158.12 14.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.605 0.717 . . . . 0.0 110.685 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.82 -26.04 73.09 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.939 -168.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -72.58 -38.2 67.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.861 1.33 . . . . 0.0 108.932 175.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -66.44 -40.08 89.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.545 0.611 . . . . 0.0 111.294 174.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.78 -49.61 74.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.07 0.85 . . . . 0.0 109.493 172.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.567 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.85 -58.2 8.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.073 174.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 29.6 mttt -61.99 -32.37 72.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.922 1.692 . . . . 0.0 112.414 -172.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.6 m -59.27 -49.1 79.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.186 0.995 . . . . 0.0 109.118 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 46' ' ' LEU . 21.3 mt -64.92 -46.87 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -20.6 62.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.485 1.114 . . . . 0.0 112.736 -174.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 CA-C-N 119.564 1.074 . . . . 0.0 110.739 172.884 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 p -55.52 -22.45 21.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.769 1.628 . . . . 0.0 113.317 171.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.53 63.02 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.25 0.932 . . . . 0.0 112.576 175.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 54' ' ' VAL . 26.1 mt -61.72 139.38 95.38 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 118.94 0.791 . . . . 0.0 111.65 -171.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.32 77.46 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.704 2.936 . . . . 0.0 109.008 159.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 69' ' ' LEU . 1.4 m -60.99 114.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.285 1.834 . . . . 0.0 107.546 159.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -132.81 114.22 13.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 109.483 -166.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mtp -91.25 119.45 31.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.45 101.5 8.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.911 1.685 . . . . 0.0 106.643 -174.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.28 172.12 13.6 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.455 -0.778 . . . . 0.0 111.127 -165.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.6 -13.88 36.22 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.142 -0.974 . . . . 0.0 113.027 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -91.1 123.35 34.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.07 0.948 . . . . 0.0 111.154 -174.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 20.74 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.784 0.833 . . . . 0.0 110.497 163.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -51.27 115.24 1.48 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.635 1.574 . . . . 0.0 108.825 -175.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -58.14 -41.95 84.8 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 119.139 -0.457 . . . . 0.0 109.976 -175.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.42 -32.35 70.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.876 173.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -68.67 -39.31 80.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.939 1.245 . . . . 0.0 109.422 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.81 -44.83 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 118.237 -0.887 . . . . 0.0 108.652 172.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.95 -58.7 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.239 0.927 . . . . 0.0 108.717 175.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HH2' ' A' ' 58' ' ' TRP . . . -58.57 -40.57 83.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.109 0.868 . . . . 0.0 111.055 -173.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.95 74.83 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.096 0.558 . . . . 0.0 110.348 172.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.82 87.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.317 0.508 . . . . 0.0 111.863 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -54.08 -55.54 26.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.608 1.963 . . . . 0.0 108.685 171.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.04 -13.46 61.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.89 1.276 . . . . 0.0 112.734 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.81 36.95 40.62 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.261 -1.299 . . . . 0.0 112.397 178.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.45 145.47 43.69 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.204 1.502 . . . . 0.0 109.564 176.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.5 p -71.05 -24.73 62.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 117.716 0.235 . . . . 0.0 111.528 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.8 163.71 36.84 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 118.109 0.413 . . . . 0.0 112.199 174.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -134.21 110.93 9.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.623 1.569 . . . . 0.0 107.988 -176.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.59 99.95 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 106.596 -163.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.59 144.47 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -56.78 162.25 3.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 0.0 111.281 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.09 108.8 0.92 Allowed 'Cis proline' 0 N--CA 1.457 -0.669 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 -21.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.68 76.3 7.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.686 0.794 . . . . 0.0 109.357 -169.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -64.67 172.47 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.257 1.423 . . . . 0.0 112.393 -173.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.75 70.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.09 -18.53 61.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.53 -31.4 9.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.091 1.314 . . . . 0.0 109.553 172.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -56.74 -47.36 80.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 108.382 175.372 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -42.56 73.3 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.073 0.949 . . . . 0.0 111.583 -176.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.03 -64.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.605 1.962 . . . . 0.0 109.177 168.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.181 -173.403 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.35 -53.83 46.48 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.284 0.947 . . . . 0.0 109.445 174.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -35.47 77.38 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.866 0.757 . . . . 0.0 110.044 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -51.75 -57.07 10.31 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.899 0.879 . . . . 0.0 110.652 171.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -17.52 11.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -57.28 -67.31 0.34 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 159.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.37 -36.72 79.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.785 -0.572 . . . . 0.0 112.434 -167.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -67.28 0.73 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -176.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.35 -29.61 67.45 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.8 -171.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.77 25.1 13.83 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 117.762 -1.577 . . . . 0.0 111.4 -166.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 C--O 1.249 1.072 0 CA-C-N 120.266 2.033 . . . . 0.0 111.291 179.213 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -91.07 152.9 20.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.721 0.772 . . . . 0.0 111.814 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.72 156.48 19.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 158.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 tp -119.33 143.19 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 t -137.34 93.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -171.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.07 57.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -174.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.9 131.4 37.47 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.61 -56.64 17.62 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.661 1.185 . . . . 0.0 111.76 177.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.4 t80 -69.6 114.37 7.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -48.89 76.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.377 0.99 . . . . 0.0 111.093 -170.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.523 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.7 m -58.53 -28.42 65.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.551 0.741 . . . . 0.0 111.574 176.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.0 ttp -63.89 -36.27 83.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.568 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -64.64 -42.17 95.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.729 1.604 . . . . 0.0 109.52 172.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -58.92 -37.91 77.73 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.871 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.41 -65.31 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.574 169.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.8 t -48.21 -52.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.686 2.039 . . . . 0.0 111.189 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG2' HG21 ' A' ' 33' ' ' VAL . 3.9 tmm_? -56.57 -47.5 79.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.941 177.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.35 -49.38 77.42 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.777 0.717 . . . . 0.0 111.533 176.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.77 -39.1 83.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 110.988 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -48.58 72.08 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.65 -0.656 . . . . 0.0 110.386 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.99 -28.39 68.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.831 178.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.16 -45.23 95.49 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 119.942 1.246 . . . . 0.0 109.488 173.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.54 -27.74 64.39 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 0.0 111.062 177.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 1.92 6.41 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.412 1.482 . . . . 0.0 113.959 169.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -70.14 170.13 12.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.359 1.08 . . . . 0.0 110.645 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -143.01 -178.79 6.0 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.062 1.345 . . . . 0.0 109.801 -172.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 75.5 -64.22 0.38 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.63 2.372 . . . . 0.0 113.92 170.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 22' ' ' ARG . 2.3 m 33.87 65.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.658 1.983 . . . . 0.0 113.984 162.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.28 -174.8 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.015 1.726 . . . . 0.0 110.614 175.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.59 169.55 21.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.386 1.874 . . . . 0.0 108.232 -172.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.94 166.43 26.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 170.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.26 -35.95 80.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.14 0.976 . . . . 0.0 111.33 176.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.17 176.16 3.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.927 2.091 . . . . 0.0 107.615 -169.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.62 -36.22 58.57 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.9 -51.72 69.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 120.396 2.098 . . . . 0.0 107.718 177.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.84 -35.28 77.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.963 0.505 . . . . 0.0 111.02 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.66 -47.68 79.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -42.9 80.25 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.777 0.673 . . . . 0.0 111.453 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.56 -46.86 85.98 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.453 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -55.84 -45.72 78.35 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.226 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 72' ' ' ILE . 8.9 mt -57.34 -38.55 74.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.846 1.203 . . . . 0.0 110.262 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -72.34 27.21 0.05 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.867 1.267 . . . . 0.0 113.951 173.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.65 -8.61 16.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.901 1.28 . . . . 0.0 111.313 158.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.22 169.68 4.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.075 1.321 . . . . 0.0 112.808 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.4 -1.92 17.81 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.633 -0.922 . . . . 0.0 113.21 -177.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.53 112.06 3.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 166.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.58 -9.56 71.86 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.334 171.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.8 145.09 21.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.815 1.308 . . . . 0.0 111.238 -166.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.687 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -136.86 111.42 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -114.35 136.22 51.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -146.48 162.52 38.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.109 0.413 . . . . 0.0 111.183 171.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 21.8 t70 -75.96 -167.73 0.78 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 158.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.457 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 10.2 t-105 -114.06 -52.84 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.405 2.282 . . . . 0.0 110.857 -175.197 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 86.58 0.15 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.531 2.332 . . . . 0.0 110.33 -167.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -142.99 153.12 60.13 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 124.916 1.287 . . . . 0.0 109.183 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -78.0 -179.22 5.24 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.481 2.12 . . . . 0.0 108.301 165.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 54.9 -94.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.29 1.836 . . . . 0.0 109.983 176.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.0 tpp -91.38 80.7 5.48 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.85 149.72 4.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 159.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.64 -27.62 61.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.284 -0.885 . . . . 0.0 113.34 -169.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -34.39 68.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.644 1.222 . . . . 0.0 110.513 176.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -66.06 -42.49 89.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.546 172.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.84 -50.04 75.47 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -51.71 -61.97 1.92 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.611 1.164 . . . . 0.0 109.199 173.848 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.54 -34.24 77.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.677 1.126 . . . . 0.0 112.522 -172.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.4 m -59.04 -48.38 81.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD11 HD11 ' A' ' 46' ' ' LEU . 30.5 mt -64.09 -48.7 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.412 1.085 . . . . 0.0 109.112 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -29.0 67.64 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.55 -171.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 124.463 1.105 . . . . 0.0 112.214 -175.865 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.223 -0.329 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.1 p -60.64 -22.04 63.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.786 0.834 . . . . 0.0 112.728 -174.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.68 -3.38 59.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.159 1.384 . . . . 0.0 113.553 174.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 54' ' ' VAL . 30.6 mt -68.33 130.47 92.28 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 119.911 1.232 . . . . 0.0 109.1 178.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.44 98.0 0.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 108.67 164.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -78.87 107.1 10.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.591 1.557 . . . . 0.0 107.742 164.85 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.15 116.45 31.95 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.092 1.357 . . . . 0.0 107.873 -176.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.0 mtp -88.11 120.19 29.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -130.42 105.19 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -171.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -146.67 173.72 12.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.805 0.812 . . . . 0.0 110.923 -167.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.71 -19.72 20.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.484 0.713 . . . . 0.0 112.107 175.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -90.11 139.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.939 0.79 . . . . 0.0 109.737 -177.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.09 -59.71 2.66 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 tptt 45.99 80.92 0.04 OUTLIER 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.775 1.63 . . . . 0.0 109.558 173.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -54.91 -35.04 63.72 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.845 -167.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 96' ' ' ILE . 6.2 mt-10 -65.64 -29.98 70.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.742 1.61 . . . . 0.0 113.385 174.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -65.47 -42.51 92.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 120.044 1.293 . . . . 0.0 109.412 167.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.1 mt -62.98 -52.25 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.868 0.758 . . . . 0.0 109.584 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' GLU 0.252 1.7 mt -54.6 -46.85 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 117.273 -1.346 . . . . 0.0 113.489 169.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.1 82.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.003 1.274 . . . . 0.0 110.472 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.6 -48.48 77.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.73 0.812 . . . . 0.0 110.918 175.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -22.86 63.09 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.84 -0.538 . . . . 0.0 112.394 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -77.15 -53.76 7.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.924 2.09 . . . . 0.0 108.772 171.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.35 -26.79 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.154 1.382 . . . . 0.0 112.659 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.56 34.3 5.05 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 124.677 1.132 . . . . 0.0 113.291 173.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.83 151.62 29.36 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.662 1.231 . . . . 0.0 110.576 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.7 p -77.08 -14.22 59.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.83 171.69 37.1 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 172.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -134.23 127.87 32.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.12 96.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 175.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.19 149.15 8.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 160.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -55.52 163.2 1.97 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 122.654 0.382 . . . . 0.0 110.45 160.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.08 137.06 47.44 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 -14.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -133.86 154.7 50.86 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.287 0.635 . . . . 0.0 110.567 -175.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 p -145.23 176.69 9.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.189 1.795 . . . . 0.0 109.367 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.68 -29.82 68.34 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.039 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.46 80.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.143 0.977 . . . . 0.0 112.475 175.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.08 -29.92 26.43 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.962 0.801 . . . . 0.0 110.291 175.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -55.92 25.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -27.33 69.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.216 0.606 . . . . 0.0 112.184 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.87 -43.8 87.27 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.607 -0.683 . . . . 0.0 110.255 172.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -66.66 -35.12 79.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.781 173.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.33 -53.09 61.74 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.556 1.071 . . . . 0.0 109.182 177.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.61 -34.44 72.77 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.204 0.457 . . . . 0.0 111.119 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -69.77 0.11 Allowed 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.112 0.965 . . . . 0.0 109.64 168.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 pt -74.12 -26.9 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 118.729 0.695 . . . . 0.0 112.444 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -58.75 -56.76 18.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -81.69 -38.01 26.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.585 -174.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -67.49 -74.51 0.11 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.59 1.156 . . . . 0.0 109.12 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.46 -31.34 72.37 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.218 0.463 . . . . 0.0 110.152 -175.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.84 37.64 8.44 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -165.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 C--O 1.248 1.006 0 CA-C-N 118.592 1.196 . . . . 0.0 109.104 164.888 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 134.06 34.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -95.53 98.75 10.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -76.74 140.06 40.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.52 115.52 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.33 1.052 . . . . 0.0 108.984 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.43 55.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.743 1.156 . . . . 0.0 109.928 -173.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.84 152.74 45.02 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.954 -1.092 . . . . 0.0 109.598 170.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.38 -47.63 17.23 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.413 1.085 . . . . 0.0 110.973 -173.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 6.3 t80 -77.84 117.28 19.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -56.07 -44.17 78.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.971 0.805 . . . . 0.0 110.637 -173.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 28.2 m -59.38 -38.32 80.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.028 -1.045 . . . . 0.0 111.283 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.14 -39.46 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.309 1.413 . . . . 0.0 110.121 171.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -65.67 -41.27 92.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.879 0.763 . . . . 0.0 109.872 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -46.26 88.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.504 174.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.58 -59.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 117.137 -1.411 . . . . 0.0 109.5 177.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.16 -52.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.87 1.668 . . . . 0.0 110.142 -177.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -61.63 -35.8 78.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.713 -0.617 . . . . 0.0 111.341 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -64.78 -44.47 89.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.709 1.141 . . . . 0.0 110.954 173.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.03 -38.7 92.24 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.503 1.121 . . . . 0.0 110.334 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.6 -45.22 94.82 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.021 0.928 . . . . 0.0 110.691 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -64.06 -28.01 69.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.77 -0.581 . . . . 0.0 111.417 174.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.33 -8.44 53.74 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.16 -1.587 . . . . 0.0 111.894 172.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.74 7.67 10.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.151 1.781 . . . . 0.0 112.025 -175.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 47.7 7.8 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 174.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.61 109.21 10.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.99 -7.8 8.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -78.52 49.2 0.84 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 166.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 33' ' ' VAL . 3.2 m -80.54 159.59 4.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.738 -1.226 . . . . 0.0 109.115 176.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.59 169.01 19.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.598 1.959 . . . . 0.0 107.401 167.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -132.71 166.27 22.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.85 168.82 18.82 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.527 0.731 . . . . 0.0 109.147 173.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.83 -33.13 57.96 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.91 178.09 1.0 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.916 2.486 . . . . 0.0 108.565 -177.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -50.68 -38.22 35.84 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.56 176.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 120.047 1.924 . . . . 0.0 108.433 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 32.7 t0 -65.56 -37.51 86.9 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.222 -0.299 . . . . 0.0 110.448 174.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.71 72.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.24 -43.2 74.38 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.672 0.789 . . . . 0.0 110.195 175.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.47 -24.31 65.59 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 3.4 mptp? -66.17 -54.57 23.71 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.595 1.089 . . . . 0.0 108.43 165.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 72' ' ' ILE . 2.7 mt -55.23 -48.0 74.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.623 0.647 . . . . 0.0 110.089 -169.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.63 0.82 28.56 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.07 -20.84 31.96 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.883 1.22 . . . . 0.0 111.71 163.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.07 154.49 24.58 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.059 1.314 . . . . 0.0 113.778 166.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.47 -13.77 65.66 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.283 2.373 . . . . 0.0 113.729 175.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.49 124.48 27.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.585 1.193 . . . . 0.0 107.975 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.77 -2.14 9.58 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.25 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.69 137.85 35.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.857 1.328 . . . . 0.0 108.438 173.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -130.91 80.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -171.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.19 125.96 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 p -145.87 165.15 29.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.507 0.594 . . . . 0.0 110.973 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.83 179.7 0.83 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.231 1.015 . . . . 0.0 110.284 161.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.622 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 3.5 t-105 -89.68 -49.96 6.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.948 157.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.08 137.53 47.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.107 0.867 . . . . 0.0 109.735 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.439 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -147.21 167.45 13.55 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 124.112 0.965 . . . . 0.0 109.064 168.862 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.25 -23.01 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.226 1.95 . . . . 0.0 112.951 172.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -139.14 -83.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.421 1.464 . . . . 0.0 111.121 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.7 ttm -78.08 96.23 5.08 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.11 161.15 9.01 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.328 1.018 . . . . 0.0 110.32 170.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.44 -30.03 73.25 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.599 0.619 . . . . 0.0 112.842 -172.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.622 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -72.37 -39.56 67.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.355 1.077 . . . . 0.0 109.799 177.482 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.6 -37.29 84.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.405 173.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.42 -54.08 50.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.896 1.225 . . . . 0.0 109.678 174.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 83' ' ' VAL . 3.4 tp -51.48 -51.8 52.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.401 1.08 . . . . 0.0 110.677 173.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -68.43 -25.07 64.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.174 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m -71.36 -50.3 33.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 46' ' ' LEU . 30.7 mt -58.4 -32.1 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.444 1.498 . . . . 0.0 108.596 -177.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -58.88 -20.2 49.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.761 1.624 . . . . 0.0 112.78 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.738 0 C-N-CA 127.262 2.225 . . . . 0.0 110.968 -161.902 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.625 ' HB3' HD12 ' A' ' 81' ' ' LEU . 23.2 mmt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 117.69 -1.147 . . . . 0.0 113.208 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -56.94 -26.14 58.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.799 1.636 . . . . 0.0 113.797 -165.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.79 65.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.954 0.902 . . . . 0.0 113.348 177.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 54' ' ' VAL . 13.2 mt -56.46 138.59 75.5 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.523 1.129 . . . . 0.0 111.022 -172.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.8 100.25 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.829 2.353 . . . . 0.0 108.379 169.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -92.72 111.86 25.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 125.898 1.679 . . . . 0.0 106.586 174.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.4 tp -120.5 112.1 18.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.066 0.946 . . . . 0.0 108.836 -168.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.87 117.54 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.86 104.19 9.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -149.05 174.08 12.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.819 0.819 . . . . 0.0 109.74 -164.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.63 -14.04 41.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.121 -0.987 . . . . 0.0 112.19 162.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.75 96.51 6.29 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.203 1.401 . . . . 0.0 108.215 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.38 -92.07 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 162.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 51.15 101.41 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.692 1.997 . . . . 0.0 111.108 -174.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -41.14 -47.06 3.18 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.338 -0.851 . . . . 0.0 111.745 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -61.79 -34.98 76.86 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.67 -43.32 93.95 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 172.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.63 -45.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.755 174.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 mt -58.85 -56.78 14.54 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.249 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.76 -41.24 70.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.321 1.419 . . . . 0.0 110.822 -174.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -57.76 -53.77 54.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.738 0.815 . . . . 0.0 110.249 173.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.58 83.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.26 0.624 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -56.0 -56.37 21.51 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.824 1.65 . . . . 0.0 109.71 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.72 -21.45 64.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.684 0.794 . . . . 0.0 112.2 178.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.68 33.61 6.65 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-O 118.628 -1.096 . . . . 0.0 111.785 175.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.93 148.98 41.86 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.468 1.134 . . . . 0.0 108.904 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -83.61 -6.69 59.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -172.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.17 175.22 35.64 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 119.082 0.855 . . . . 0.0 111.842 173.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.16 150.26 46.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.038 1.335 . . . . 0.0 108.847 -177.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.87 138.77 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 128.396 2.678 . . . . 0.0 104.846 166.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -118.59 143.39 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 156.92 14.45 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.803 170.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.82 154.32 97.75 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 N-CA-C 109.772 -0.895 . . . . 0.0 109.772 -16.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -158.75 160.54 36.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.561 0.744 . . . . 0.0 109.345 -169.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -147.49 -179.56 6.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.955 0.502 . . . . 0.0 110.429 -171.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.85 67.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.348 0.659 . . . . 0.0 109.438 176.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.28 -17.92 64.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 174.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 t -95.64 -37.83 10.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 121.407 1.912 . . . . 0.0 109.752 164.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -51.78 60.63 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -34.3 77.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.237 1.415 . . . . 0.0 112.455 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -71.43 -40.86 70.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 17.6 mmtp -65.3 -39.74 92.91 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 174.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.6 mt -54.96 -57.48 11.5 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -56.97 -33.77 67.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 24.9 mttm -56.71 -68.72 0.19 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 117.86 -1.067 . . . . 0.0 108.834 170.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -24.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 120.683 1.583 . . . . 0.0 113.339 -171.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -59.37 -49.19 78.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.98 1.312 . . . . 0.0 111.098 171.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.59 -54.84 5.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.611 0.642 . . . . 0.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.21 5.34 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.616 1.566 . . . . 0.0 108.561 -164.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -72.28 -54.14 10.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.35 15.87 2.96 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.682 -1.066 . . . . 0.0 112.347 -171.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.9 mmm . . . . . 0 C--O 1.247 0.921 0 CA-C-N 118.617 1.208 . . . . 0.0 111.495 -163.683 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -90.6 143.64 26.54 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.169 0.918 . . . . 0.0 110.387 -162.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -111.39 100.66 9.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.584 1.154 . . . . 0.0 109.087 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -74.08 142.83 45.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.981 0.81 . . . . 0.0 109.383 175.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.44 99.61 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.761 1.625 . . . . 0.0 107.219 170.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.74 87.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -91.62 109.2 20.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.656 1.182 . . . . 0.0 112.174 -162.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.91 -24.06 59.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -120.33 -7.09 9.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -158.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 m 68.46 -58.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 128.042 2.537 . . . . 0.0 110.263 -173.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.0 m -55.56 -24.9 35.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.47 1.508 . . . . 0.0 111.16 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.4 tpp -64.82 -37.56 88.01 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.929 1.695 . . . . 0.0 109.934 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -77.34 -33.07 55.5 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 121.126 1.785 . . . . 0.0 109.538 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -52.17 -58.06 7.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.842 1.201 . . . . 0.0 108.579 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.66 -67.75 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.509 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.32 -41.71 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 120.444 1.474 . . . . 0.0 110.392 -169.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -48.19 82.76 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 119.651 1.114 . . . . 0.0 109.445 174.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.59 -48.53 74.69 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.385 175.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.37 -43.14 96.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.024 0.829 . . . . 0.0 110.67 -176.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.76 -44.99 95.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.298 1.039 . . . . 0.0 110.104 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -63.87 -29.4 70.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.152 -1.404 . . . . 0.0 112.546 177.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.9 -62.36 1.93 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.061 1.3 . . . . 0.0 108.373 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.07 2.34 1.51 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.65 -108.62 3.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -151.38 175.95 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.314 2.246 . . . . 0.0 107.255 -164.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -138.09 -178.57 5.33 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.06 0.846 . . . . 0.0 112.085 -169.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 m120 59.72 75.91 0.38 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.953 2.901 . . . . 0.0 109.717 -167.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.18 166.17 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.041 168.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -135.5 174.24 10.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 156.05 42.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.77 151.38 40.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 163.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.36 -30.49 66.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.634 0.584 . . . . 0.0 111.211 176.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.28 156.91 14.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -161.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.97 -42.46 30.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.23 0.919 . . . . 0.0 114.381 171.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.96 -37.6 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 120.2 2.0 . . . . 0.0 109.438 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.22 -43.95 96.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.526 0.731 . . . . 0.0 109.47 171.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.48 80.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.693 1.597 . . . . 0.0 110.324 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.71 -43.24 72.39 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.717 0.636 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.17 -37.18 86.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.315 0.646 . . . . 0.0 110.985 176.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -57.42 -45.06 85.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.028 1.286 . . . . 0.0 110.043 170.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 72' ' ' ILE . 5.7 mt -58.69 -51.45 69.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -78.8 16.76 0.81 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.66 62.13 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.521 -1.362 . . . . 0.0 110.048 159.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.73 -88.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -175.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.74 86.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -173.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -64.81 166.68 8.61 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.008 1.323 . . . . 0.0 110.736 172.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.47 -20.0 10.71 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.561 -1.133 . . . . 0.0 113.37 172.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -146.49 142.4 28.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.72 1.208 . . . . 0.0 109.702 -174.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.47 70.02 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -177.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -78.59 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 155.65 44.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.252 0.933 . . . . 0.0 110.19 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.9 176.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 158.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 98' ' ' ALA . 4.4 t-105 -96.18 -60.57 1.6 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.215 1.006 . . . . 0.0 108.78 170.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.26 74.92 9.99 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.458 0.703 . . . . 0.0 109.868 -159.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.1 mmt -107.4 162.31 20.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.245 1.818 . . . . 0.0 109.942 175.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -69.94 177.77 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.375 2.717 . . . . 0.0 112.062 173.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 44.8 -110.8 0.21 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.062 2.145 . . . . 0.0 110.944 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.51 85.73 6.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -54.5 173.68 0.07 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.518 1.927 . . . . 0.0 112.498 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -27.91 60.58 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.143 -0.973 . . . . 0.0 113.423 -173.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -82.17 -35.77 28.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.186 0.993 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -67.15 -42.08 84.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.852 169.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.1 tp -50.82 -52.65 39.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.532 1.533 . . . . 0.0 109.301 172.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.0 -58.72 6.04 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.239 0.616 . . . . 0.0 109.794 173.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.33 -35.62 77.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.479 1.036 . . . . 0.0 111.552 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.1 m -58.04 -48.44 80.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.29 1.036 . . . . 0.0 108.843 175.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.479 HD11 HD11 ' A' ' 46' ' ' LEU . 29.6 mt -63.92 -51.42 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.44 66.85 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.226 1.81 . . . . 0.0 112.535 -176.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.358 0 C-N-CA 125.311 1.444 . . . . 0.0 112.415 178.475 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -10.06 2.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.738 1.615 . . . . 0.0 114.273 -177.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.017 1.281 . . . . 0.0 112.757 170.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 54' ' ' VAL . 33.6 mt -70.41 129.94 89.75 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 123.447 0.699 . . . . 0.0 110.978 -170.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.77 107.8 2.13 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.81 2.34 . . . . 0.0 108.859 163.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.96 140.08 16.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.28 111.14 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 -171.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 126.64 31.14 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.06 93.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -138.63 -174.28 3.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.869 0.868 . . . . 0.0 109.902 -166.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.8 -16.77 14.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.699 1.2 . . . . 0.0 112.851 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.25 117.27 28.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.339 1.056 . . . . 0.0 109.276 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.29 -81.73 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 tptt 54.11 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.236 1.814 . . . . 0.0 111.317 -176.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -50.28 -43.34 53.33 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.405 -1.434 . . . . 0.0 112.03 178.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -52.11 -35.43 48.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.953 0.901 . . . . 0.0 112.125 176.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -78.62 -37.86 41.24 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.838 1.255 . . . . 0.0 110.536 176.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.22 -50.75 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.966 1.257 . . . . 0.0 109.138 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.327 1.9 mt -51.3 -54.47 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.916 166.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.41 -44.11 72.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 121.086 1.766 . . . . 0.0 112.112 -178.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -59.05 -55.48 34.53 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 118.935 0.789 . . . . 0.0 110.448 174.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -27.89 69.25 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -71.78 -53.63 12.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.333 1.853 . . . . 0.0 109.665 174.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.27 -24.53 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.179 0.992 . . . . 0.0 112.18 176.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.82 34.79 6.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.756 1.17 . . . . 0.0 111.851 176.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -63.05 145.02 56.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 118.43 1.115 . . . . 0.0 108.092 177.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 p -76.01 -12.98 60.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.306 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.6 171.86 40.69 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.273 0.939 . . . . 0.0 111.075 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.26 134.71 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.53 1.532 . . . . 0.0 107.723 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.55 140.26 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 127.734 2.414 . . . . 0.0 106.96 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.99 145.31 28.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 145.59 89.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.963 0.801 . . . . 0.0 110.318 168.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 136.58 43.38 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 119.68 0.922 . . . . 0.0 111.139 -6.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -141.4 155.56 45.88 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 110.781 175.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -151.39 -178.29 6.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.494 1.118 . . . . 0.0 111.527 -171.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.06 -28.75 64.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.789 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.51 64.16 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 174.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 t -97.38 -30.58 12.85 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.208 0.913 . . . . 0.0 110.289 171.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -52.85 -53.19 52.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.459 1.027 . . . . 0.0 108.869 177.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.69 -35.23 74.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.754 1.222 . . . . 0.0 111.675 178.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -74.58 -41.61 60.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.477 -0.765 . . . . 0.0 109.672 -176.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -64.2 -39.34 93.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.805 176.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.5 mt -55.08 -58.34 8.05 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -55.68 -38.33 69.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.366 0.667 . . . . 0.0 112.331 -178.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -64.28 0.9 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.711 172.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.05 -29.59 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.184 1.356 . . . . 0.0 113.282 -173.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -56.88 -52.65 64.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.632 0.773 . . . . 0.0 109.026 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -73.39 -46.09 50.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.935 0.334 . . . . 0.0 111.287 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -69.27 -73.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.62 -23.64 64.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.02 0.528 . . . . 0.0 110.969 -175.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.33 31.42 19.48 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -166.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 116.491 -1.719 . . . . 0.0 110.457 -175.7 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--O 1.231 0.117 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -90.69 132.96 35.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.87 138.53 38.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 163.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.12 140.04 37.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.65 103.19 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.13 60.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.37 1.068 . . . . 0.0 108.816 -178.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 7.3 p-10 -82.76 146.23 29.1 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.357 -1.465 . . . . 0.0 110.746 169.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -67.15 -58.66 4.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.064 1.346 . . . . 0.0 110.03 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -83.87 83.23 8.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.231 -174.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 t -40.08 -27.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.49 2.316 . . . . 0.0 115.847 -166.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 m -43.52 -47.66 7.28 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 119.887 -1.758 . . . . 0.0 111.804 164.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -37.61 46.4 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 0.0 111.016 172.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -66.26 -44.02 84.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.4 1.454 . . . . 0.0 109.549 -178.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -58.08 9.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.497 1.119 . . . . 0.0 108.364 172.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.11 -61.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 124.509 1.124 . . . . 0.0 108.978 -176.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.5 t -54.82 -43.72 68.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 119.758 1.163 . . . . 0.0 110.452 -175.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -60.34 -48.2 82.76 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.204 1.365 . . . . 0.0 109.689 175.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.27 -42.72 91.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.205 1.002 . . . . 0.0 111.047 -178.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 113' ' ' ALA . 84.8 mt -63.76 -41.22 98.03 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.999 0.92 . . . . 0.0 110.067 175.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.04 -29.6 70.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.045 0.839 . . . . 0.0 111.405 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -73.53 -28.77 62.06 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.857 -1.152 . . . . 0.0 111.636 173.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.58 -48.98 67.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.28 0.946 . . . . 0.0 109.735 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.02 95.12 1.37 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 123.288 1.518 . . . . 0.0 108.375 -174.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -132.18 3.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.244 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -131.77 165.75 23.08 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.832 0.853 . . . . 0.0 111.883 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.34 -174.49 2.54 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.921 1.688 . . . . 0.0 110.195 173.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.46 81.63 0.15 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.464 2.306 . . . . 0.0 109.59 -175.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 146.33 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.64 176.15 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.576 1.551 . . . . 0.0 109.754 -177.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -131.47 166.36 21.51 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.143 0.977 . . . . 0.0 108.888 173.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.94 172.2 9.59 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 160.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.07 -41.09 82.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 174.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -170.94 177.17 3.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.793 2.037 . . . . 0.0 108.19 -169.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.39 -37.09 72.43 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.944 0.783 . . . . 0.0 113.111 -178.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -63.42 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 O-C-N 121.724 -0.868 . . . . 0.0 108.91 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.53 -29.31 64.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.523 174.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.57 85.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.726 1.21 . . . . 0.0 109.83 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 tp -58.26 -41.24 83.83 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.255 0.479 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -40.61 96.03 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.364 175.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -53.64 -54.94 30.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.996 172.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 72' ' ' ILE . 7.4 mt -57.76 -40.54 79.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.777 1.171 . . . . 0.0 110.89 -174.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -65.17 -19.56 66.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.55 6.03 34.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.265 1.826 . . . . 0.0 113.907 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.69 175.06 45.45 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 119.167 -1.492 . . . . 0.0 116.736 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.84 4.99 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.473 1.511 . . . . 0.0 109.968 177.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -75.96 72.27 2.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.462 1.505 . . . . 0.0 107.099 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.47 -4.29 37.37 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.405 1.002 . . . . 0.0 113.454 -172.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.79 136.5 48.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.089 1.355 . . . . 0.0 108.263 170.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.752 HG21 HD13 ' A' ' 81' ' ' LEU . 5.0 t -127.21 64.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.03 139.16 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.4 p -152.01 167.58 27.95 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.956 -0.465 . . . . 0.0 110.722 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 10.6 t70 -67.89 169.46 9.8 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 158.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CH2' HD23 ' A' ' 66' ' ' LEU . 68.1 t-105 -55.72 -64.45 0.85 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.824 -1.173 . . . . 0.0 107.87 163.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.86 165.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.79 2.436 . . . . 0.0 112.431 -166.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.1 75.73 12.7 Favored Pre-proline 0 N--CA 1.45 -0.455 0 O-C-N 119.63 -1.919 . . . . 0.0 107.497 167.322 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.07 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.895 2.397 . . . . 0.0 110.419 176.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -165.17 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 129.986 3.314 . . . . 0.0 104.102 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.2 ttp -72.98 89.19 1.41 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 160.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.78 168.8 4.62 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.11 0.964 . . . . 0.0 110.666 164.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.6 -19.76 60.77 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.677 -176.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -77.37 -49.0 15.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.256 1.528 . . . . 0.0 108.722 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.94 0.496 . . . . 0.0 110.551 174.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -56.14 -53.05 61.77 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.087 0.955 . . . . 0.0 109.306 175.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.4 tp -54.03 -55.79 24.0 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 110.574 175.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 72.4 mttt -63.96 -36.99 85.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.636 1.562 . . . . 0.0 112.301 -174.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.7 m -61.44 -39.25 90.13 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 109.718 175.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 46' ' ' LEU . 32.2 mt -71.17 -47.84 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.21 68.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.752 1.621 . . . . 0.0 111.449 -178.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.302 0 O-C-N 121.36 -0.837 . . . . 0.0 112.77 179.258 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HD12 ' A' ' 81' ' ' LEU . 56.3 mtt . . . . . 0 C--O 1.226 -0.175 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -59.03 -20.42 52.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.769 1.168 . . . . 0.0 112.227 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.76 60.01 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 54' ' ' VAL . 48.7 mt -68.6 138.46 91.04 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.914 1.234 . . . . 0.0 110.5 -170.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 82.71 1.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.564 2.176 . . . . 0.0 108.726 166.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 69' ' ' LEU . 1.8 m -65.54 108.83 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 159.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 tp -130.83 105.97 8.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -160.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.6 mmt -78.69 120.9 24.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -174.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.63 87.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.475 ' HB ' ' H ' ' A' ' 58' ' ' TRP . 3.8 t -129.19 170.52 13.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.601 0.715 . . . . 0.0 112.924 -159.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.11 57.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.789 0.835 . . . . 0.0 112.822 161.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.54 98.34 2.28 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.851 1.26 . . . . 0.0 111.424 -167.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.18 23.16 0.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.968 -1.083 . . . . 0.0 111.306 163.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -70.93 104.25 2.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.437 -1.414 . . . . 0.0 107.792 -174.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -31.93 -65.49 0.14 Allowed 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 125.716 1.606 . . . . 0.0 111.974 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.74 -29.17 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.743 -172.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -62.42 -46.29 89.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.392 0.996 . . . . 0.0 109.436 171.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.33 -46.4 95.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.55 -57.23 9.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.501 ' C ' HD21 ' A' ' 66' ' ' LEU . . . -56.56 -40.05 74.51 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.908 0.777 . . . . 0.0 111.215 -172.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.73 -52.16 53.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.572 1.149 . . . . 0.0 110.436 176.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 177.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -62.38 -50.92 69.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 111.345 177.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.39 61.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.482 1.113 . . . . 0.0 112.892 178.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.33 30.76 9.6 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.356 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.727 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.67 146.79 44.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.93 1.365 . . . . 0.0 108.135 175.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.1 p -70.39 -8.37 50.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.32 165.84 20.03 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -140.22 85.53 2.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.078 0.951 . . . . 0.0 109.755 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -85.21 141.29 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 169.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.19 157.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 171.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -56.22 137.32 74.64 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.657 159.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.3 159.47 97.64 Favored 'Cis proline' 0 C--N 1.348 0.503 0 CA-C-N 121.166 1.452 . . . . 0.0 112.327 -6.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -177.75 155.09 0.99 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.264 1.025 . . . . 0.0 109.909 -174.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -150.35 -174.02 4.62 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.6 1.16 . . . . 0.0 112.076 -168.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.484 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -54.04 -35.83 62.4 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -47.22 -30.79 3.21 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.006 2.122 . . . . 0.0 115.074 174.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.428 HG23 ' HE2' ' A' ' 119' ' ' LYS . 1.2 t -111.21 -19.79 12.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.968 0.507 . . . . 0.0 110.939 176.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.33 -55.94 25.71 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.738 -1.226 . . . . 0.0 108.226 167.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -44.84 79.07 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.909 1.283 . . . . 0.0 111.684 178.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -38.64 76.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.443 -0.785 . . . . 0.0 110.807 -177.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HE2' HG23 ' A' ' 115' ' ' THR . 46.2 mtmt -61.99 -39.25 91.56 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.151 -0.968 . . . . 0.0 110.3 173.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.12 -51.25 70.85 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.419 172.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.7 -36.53 72.1 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.097 1.317 . . . . 0.0 112.36 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -69.8 0.11 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.32 1.448 . . . . 0.0 108.382 169.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -22.29 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -171.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.49 -45.59 86.66 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.152 0.981 . . . . 0.0 109.679 174.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.19 -39.26 25.74 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.333 0.969 . . . . 0.0 110.979 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -74.59 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -171.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.84 -37.83 88.37 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.23 44.42 4.08 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -163.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.728 -1.129 . . . . 0.0 111.372 -175.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.54 143.18 30.35 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.139 -163.111 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.58 95.5 5.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 34' ' ' GLU . 21.5 tp -69.83 135.89 50.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.887 1.221 . . . . 0.0 108.464 174.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.32 114.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.194 1.398 . . . . 0.0 108.331 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.44 64.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 124.912 1.285 . . . . 0.0 108.032 -173.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.44 156.74 29.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.62 -51.92 66.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 108.766 170.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.44 108.64 19.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -51.33 -42.68 61.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.213 178.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -50.97 -45.77 61.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.181 1.355 . . . . 0.0 111.625 172.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.2 ttm -62.59 -25.19 67.95 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.701 0.801 . . . . 0.0 111.572 -178.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -68.8 -39.03 80.33 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.44 -1.413 . . . . 0.0 110.56 170.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -66.48 -36.59 83.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.16 178.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -47.06 -49.32 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.294 1.406 . . . . 0.0 110.883 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -57.0 -46.96 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.444 0.698 . . . . 0.0 110.74 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.4 -40.36 94.12 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.394 0.678 . . . . 0.0 111.131 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.55 -38.67 87.61 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.854 -0.529 . . . . 0.0 110.375 177.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.2 -26.71 67.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.366 0.53 . . . . 0.0 111.613 172.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -73.05 -38.28 66.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.736 1.153 . . . . 0.0 110.839 169.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.45 -36.7 85.01 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.339 0.972 . . . . 0.0 111.244 176.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -166.62 99.71 0.58 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.214 2.205 . . . . 0.0 108.81 177.268 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.2 -113.37 0.54 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.71 171.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -145.08 -176.97 5.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.101 1.76 . . . . 0.0 109.484 -162.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -133.92 -176.12 4.07 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.386 1.474 . . . . 0.0 109.932 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 54.5 63.65 2.08 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.836 1.654 . . . . 0.0 110.548 -171.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.11 160.29 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.485 165.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' HB3' HD12 ' A' ' 9' ' ' LEU . 2.9 tp10 -133.03 173.08 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.63 2.372 . . . . 0.0 106.106 175.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -139.2 166.88 23.38 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.95 169.39 17.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.97 1.308 . . . . 0.0 109.133 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.24 -40.63 77.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.549 0.74 . . . . 0.0 109.745 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -178.44 179.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.506 2.322 . . . . 0.0 108.426 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.65 -41.99 10.13 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.85 1.69 . . . . 0.0 115.432 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.85 -47.25 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.147 1.473 . . . . 0.0 108.642 179.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -67.98 -32.34 72.67 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 175.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.1 -43.21 91.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.792 -1.193 . . . . 0.0 110.071 177.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.702 0.683 . . . . 0.0 111.076 173.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.07 -43.37 77.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.919 0.887 . . . . 0.0 111.471 178.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -63.36 -52.77 60.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -55.2 -53.06 60.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.594 1.158 . . . . 0.0 112.565 -172.723 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.32 -1.69 3.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 112.257 -177.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.3 25.32 7.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.176 2.19 . . . . 0.0 111.412 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.64 168.43 38.23 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 121.107 1.776 . . . . 0.0 114.023 169.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.95 53.66 1.39 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 124.773 1.178 . . . . 0.0 110.355 -178.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -62.01 142.49 57.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.443 1.097 . . . . 0.0 110.117 -177.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.05 -29.76 9.44 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 119.491 -0.616 . . . . 0.0 111.689 173.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -138.19 149.07 45.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.384 1.074 . . . . 0.0 109.431 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG21 HD13 ' A' ' 81' ' ' LEU . 16.5 t -137.17 108.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.65 136.38 58.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.52 153.5 38.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.724 0.238 . . . . 0.0 110.931 -159.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -64.86 170.82 3.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.926 0.87 . . . . 0.0 111.194 163.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 42.0 t-105 -83.47 -76.46 0.28 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 160.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.97 -170.42 0.08 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.01 1.324 . . . . 0.0 110.999 176.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.3 ttp -162.89 75.67 1.96 Allowed Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 158.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.48 -71.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.117 2.545 . . . . 0.0 107.935 175.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -131.96 -67.97 0.65 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.231 1.412 . . . . 0.0 107.737 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 ttm -91.09 104.75 17.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.403 2.281 . . . . 0.0 107.614 161.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.73 171.44 5.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.513 0.597 . . . . 0.0 110.73 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.67 69.19 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.749 -0.594 . . . . 0.0 112.364 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.598 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.25 -40.94 74.12 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.998 0.899 . . . . 0.0 109.782 178.437 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.79 -32.3 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.886 1.274 . . . . 0.0 111.005 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -58.48 -55.54 33.78 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.42 -57.16 11.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.41 1.084 . . . . 0.0 109.491 174.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.8 -21.38 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.973 1.26 . . . . 0.0 113.83 -173.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -61.37 -64.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 163.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.0 mt -56.48 -36.6 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.917 1.287 . . . . 0.0 110.6 -174.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -22.54 61.86 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.446 1.899 . . . . 0.0 113.519 -177.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.339 0 CA-C-N 119.104 0.866 . . . . 0.0 111.385 -178.756 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.3 p -63.53 -18.28 63.67 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.42 1.009 . . . . 0.0 113.314 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.17 52.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.404 1.482 . . . . 0.0 113.277 172.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.591 HD13 HG21 ' A' ' 54' ' ' VAL . 24.9 mt -73.79 147.22 86.37 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 111.345 -175.126 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.55 56.36 1.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.605 2.87 . . . . 0.0 111.085 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG2' HD13 ' A' ' 69' ' ' LEU . 1.1 m -53.28 113.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 119.081 0.855 . . . . 0.0 110.242 176.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.7 122.97 48.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.589 1.156 . . . . 0.0 108.674 -169.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mmt -80.99 128.29 33.53 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 174.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.26 108.44 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -152.06 165.6 34.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.969 0.89 . . . . 0.0 112.017 -166.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.82 60.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.45 -0.781 . . . . 0.0 111.433 161.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.97 96.87 10.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.249 1.419 . . . . 0.0 109.414 -163.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -73.92 0.07 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.265 1.026 . . . . 0.0 110.781 177.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.5 tttt 39.25 93.37 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 127.151 2.18 . . . . 0.0 112.537 -175.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -44.29 -40.85 5.54 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.711 176.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.31 -45.28 76.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.3 0.955 . . . . 0.0 112.992 176.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.17 -37.71 81.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.329 1.452 . . . . 0.0 109.557 176.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.4 mt -64.52 -41.84 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.332 176.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -59.71 -48.38 87.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-N 120.61 1.55 . . . . 0.0 108.076 171.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.19 -43.8 74.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.089 1.313 . . . . 0.0 111.443 -177.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.87 85.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.859 0.464 . . . . 0.0 110.38 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.51 83.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.295 0.638 . . . . 0.0 112.105 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -64.51 -45.12 88.6 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.131 1.772 . . . . 0.0 110.721 174.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.78 -6.16 39.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.444 0.697 . . . . 0.0 112.298 170.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.03 64.84 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.351 -1.468 . . . . 0.0 113.049 172.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -51.88 160.21 0.73 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.465 1.106 . . . . 0.0 110.214 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -63.36 -30.7 71.79 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.361 -0.837 . . . . 0.0 111.575 176.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.46 -174.98 46.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 178.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -139.65 94.94 2.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 107.748 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.414 HG22 ' HE3' ' A' ' 119' ' ' LYS . 75.2 t -77.76 133.22 30.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.291 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 150.05 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -55.52 168.38 0.62 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 173.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.61 94.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.545 0 N-CA-C 107.442 -1.791 . . . . 0.0 107.442 -20.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -81.77 158.74 24.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.909 0.861 . . . . 0.0 111.613 -165.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.7 p -146.89 -179.05 6.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.589 1.556 . . . . 0.0 109.623 -172.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -34.14 65.67 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 110.046 176.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.18 58.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.819 0.848 . . . . 0.0 113.229 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -34.88 7.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.249 0.932 . . . . 0.0 110.506 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.04 -47.54 68.33 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.962 1.305 . . . . 0.0 108.995 176.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.01 74.57 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.411 1.084 . . . . 0.0 112.207 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.11 -44.11 89.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.862 1.21 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 107' ' ' VAL . 15.6 mmtt -67.62 -42.62 82.06 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.947 -176.116 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.72 -52.4 64.02 Favored 'General case' 0 C--O 1.221 -0.403 0 O-C-N 123.861 0.726 . . . . 0.0 110.216 172.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.99 -47.45 71.42 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.532 1.06 . . . . 0.0 111.251 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -56.23 -62.95 1.37 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.75 178.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -27.08 36.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 120.375 1.443 . . . . 0.0 113.633 -175.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.32 -50.57 73.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.31 -48.74 39.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -65.43 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.413 1.485 . . . . 0.0 108.509 -160.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.61 -41.23 96.35 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.287 0.949 . . . . 0.0 108.609 175.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.77 18.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.269 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-O 116.813 -1.565 . . . . 0.0 112.181 -163.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 mtt . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.24 50.95 1.69 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.561 1.528 . . . . 0.0 110.629 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.24 177.78 7.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.303 1.841 . . . . 0.0 109.527 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -11.92 61.22 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.966 -1.084 . . . . 0.0 111.405 159.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 44.78 33.98 1.09 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.637 2.375 . . . . 0.0 111.331 -173.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.6 108.56 0.65 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.341 1.057 . . . . 0.0 112.582 -159.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -89.71 132.01 35.39 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 34.9 m-85 -85.13 139.18 31.9 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 166.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -105.13 140.16 38.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 161.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -135.53 100.38 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.88 84.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 21.0 t70 -91.45 171.83 8.93 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.993 0.902 . . . . 0.0 111.516 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.91 -28.56 68.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.237 1.815 . . . . 0.0 112.259 165.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -131.95 113.82 13.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.904 1.681 . . . . 0.0 107.802 -163.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 m -50.37 -40.46 49.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.149 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 m -52.73 -37.63 59.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.184 0.994 . . . . 0.0 111.22 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -58.83 -41.34 86.62 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.663 1.12 . . . . 0.0 110.243 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.603 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -62.03 -48.39 80.47 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.338 0.972 . . . . 0.0 109.959 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.28 -58.19 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.69 1.196 . . . . 0.0 108.893 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.23 -50.64 70.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 124.323 1.049 . . . . 0.0 109.975 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -53.97 -48.57 70.19 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.852 0.751 . . . . 0.0 110.412 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.45 -46.01 84.96 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.682 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.8 mt -61.99 -40.27 95.06 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.383 0.992 . . . . 0.0 110.525 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -60.78 -37.75 82.94 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.72 0.808 . . . . 0.0 110.838 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -70.74 -35.45 72.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 117.735 -1.126 . . . . 0.0 111.927 174.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -60.07 -42.26 94.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 119.654 1.115 . . . . 0.0 108.892 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.5 mt -64.61 -56.34 14.53 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.281 0.632 . . . . 0.0 109.867 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.24 4.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.186 -1.341 . . . . 0.0 116.291 174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.97 171.98 12.49 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.897 1.848 . . . . 0.0 112.382 -173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.21 -179.95 6.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.206 1.802 . . . . 0.0 108.267 168.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.2 t30 65.15 82.34 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.073 2.549 . . . . 0.0 112.353 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.41 162.08 13.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -140.91 170.73 15.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.223 1.809 . . . . 0.0 110.362 167.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -122.17 168.27 12.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.941 2.496 . . . . 0.0 107.582 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.21 171.0 14.67 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.616 1.166 . . . . 0.0 109.308 169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.64 -35.64 65.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.938 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.26 178.38 0.71 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.473 1.909 . . . . 0.0 107.881 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.23 -43.37 4.59 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 126.31 1.91 . . . . 0.0 116.076 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.43 -47.29 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.865 1.833 . . . . 0.0 109.259 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -68.55 -37.23 79.77 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.1 -0.375 . . . . 0.0 110.85 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.9 -51.93 67.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.712 1.605 . . . . 0.0 109.818 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.62 -43.42 80.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.77 0.795 . . . . 0.0 110.54 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -71.74 -24.7 61.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -65.97 -42.07 90.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.376 166.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 72' ' ' ILE . 6.4 mt -56.03 -46.82 78.71 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.305 1.412 . . . . 0.0 108.249 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -73.37 10.81 0.9 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.733 1.213 . . . . 0.0 114.067 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.0 38.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.051 1.296 . . . . 0.0 110.988 160.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.49 -82.86 0.11 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.43 94.28 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -74.34 170.9 14.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.292 1.037 . . . . 0.0 110.484 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.09 -30.02 5.87 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.993 -0.893 . . . . 0.0 113.953 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 87.2 m-85 -146.55 148.58 32.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.258 1.023 . . . . 0.0 108.689 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -125.19 80.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 5.9 mt -91.73 130.84 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 -171.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.2 p -144.5 161.36 39.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.513 1.506 . . . . 0.0 114.957 -173.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 12' ' ' ASP . 1.6 p-10 -73.46 -158.25 0.06 Allowed 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.258 1.023 . . . . 0.0 110.278 159.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -134.08 -30.27 1.21 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.329 2.252 . . . . 0.0 112.528 -167.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.43 32.02 6.36 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.889 2.076 . . . . 0.0 112.094 -158.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.539 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 2.4 mpt? -44.69 154.33 0.43 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 127.32 2.248 . . . . 0.0 113.329 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.35 -25.74 35.81 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.127 2.551 . . . . 0.0 112.943 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -119.98 -99.57 0.44 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 108.826 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.2 ttt -78.35 106.17 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.13 161.03 7.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.469 1.108 . . . . 0.0 111.867 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.49 -25.33 73.83 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 119.48 -0.622 . . . . 0.0 112.483 -166.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -78.28 -34.59 48.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.896 0.879 . . . . 0.0 109.942 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.36 -37.56 71.65 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.046 0.938 . . . . 0.0 111.05 172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.48 -50.71 72.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.757 0.708 . . . . 0.0 109.354 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -52.58 -61.09 2.5 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.041 0.936 . . . . 0.0 108.717 173.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -61.33 -26.13 67.6 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 117.745 -1.122 . . . . 0.0 112.879 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.8 m -66.82 -48.36 69.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.582 1.083 . . . . 0.0 110.864 170.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.491 HD11 HD11 ' A' ' 46' ' ' LEU . 13.7 mt -60.89 -40.83 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.79 4.16 1.6 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.604 2.362 . . . . 0.0 113.572 174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.22 -11.4 57.32 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.238 1.381 . . . . 0.0 111.161 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 64.34 -176.35 0.17 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.952 2.501 . . . . 0.0 111.419 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.27 -32.1 1.57 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.291 1.424 . . . . 0.0 113.796 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.41 -72.02 0.68 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.786 1.634 . . . . 0.0 109.149 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 mtt -89.68 -6.51 56.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -33.82 -54.1 0.46 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.485 2.714 . . . . 0.0 113.827 -176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 -15.99 62.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.611 1.564 . . . . 0.0 114.383 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD13 HG21 ' A' ' 54' ' ' VAL . 19.1 mt -68.2 121.71 81.31 Favored Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 119.148 0.886 . . . . 0.0 109.452 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.51 106.81 1.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.871 1.714 . . . . 0.0 108.739 166.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -80.05 134.09 28.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 164.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 9.4 tp -131.65 106.28 8.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.9 mtp -82.14 117.75 22.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -171.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.94 105.05 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -145.49 172.61 12.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.932 0.872 . . . . 0.0 111.007 -164.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -11.45 59.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.44 -0.788 . . . . 0.0 112.918 169.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -88.24 107.98 19.07 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.203 2.201 . . . . 0.0 112.356 -165.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -91.4 3.91 53.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.52 120.32 6.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.243 1.383 . . . . 0.0 109.922 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -55.64 -44.31 77.03 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.324 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -63.68 -33.43 75.62 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 119.927 1.239 . . . . 0.0 111.023 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -58.02 -47.07 84.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.287 0.949 . . . . 0.0 109.373 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.58 -45.18 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.17 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.75 -56.82 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.83 -46.55 60.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.768 1.227 . . . . 0.0 110.146 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.82 71.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.523 0.729 . . . . 0.0 112.029 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.52 97.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -61.85 -46.47 89.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.818 1.647 . . . . 0.0 111.408 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.02 -16.21 59.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.788 0.835 . . . . 0.0 112.458 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.65 33.57 18.68 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 119.446 1.021 . . . . 0.0 111.722 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.06 142.74 53.53 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.0 p -72.91 -14.13 61.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.515 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.21 169.58 38.56 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -136.78 144.61 43.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.927 1.291 . . . . 0.0 107.922 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.98 140.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.978 2.111 . . . . 0.0 105.712 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 90' ' ' ALA . 10.8 t -123.24 144.64 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.52 149.4 21.17 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.053 169.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 140.67 67.19 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 N-CA-C 109.691 -0.927 . . . . 0.0 109.691 -16.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -134.73 167.14 21.39 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.997 -1.064 . . . . 0.0 111.041 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 p -137.2 172.78 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.644 1.178 . . . . 0.0 110.991 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.83 -33.47 64.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.817 1.247 . . . . 0.0 109.511 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.03 -54.52 38.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.718 1.207 . . . . 0.0 111.246 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -31.82 58.3 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.564 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -56.49 19.53 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -66.5 -21.1 66.17 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.758 -0.588 . . . . 0.0 112.464 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -68.49 -47.98 65.61 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.244 0.929 . . . . 0.0 109.526 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.6 mmtt -68.92 -38.36 79.51 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.651 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.5 mt -57.6 -54.51 46.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.254 0.934 . . . . 0.0 110.146 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -65.51 -30.2 70.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.754 0.706 . . . . 0.0 110.725 -175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -55.53 -58.24 8.58 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.933 165.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.82 -22.7 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 120.691 1.587 . . . . 0.0 113.619 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -57.83 -65.24 0.67 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -76.11 -30.6 58.3 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.18 -169.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -71.43 -68.17 0.47 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.319 1.048 . . . . 0.0 109.462 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mt -78.8 -31.59 45.99 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.354 1.062 . . . . 0.0 111.756 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.21 29.88 8.16 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.382 -1.232 . . . . 0.0 111.709 -165.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.7 mmt . . . . . 0 C--O 1.247 0.971 0 CA-C-N 119.868 1.834 . . . . 0.0 111.756 179.415 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.92 173.23 15.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.136 1.374 . . . . 0.0 108.497 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 2.5 m-20 -108.28 168.3 9.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -20.34 66.02 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.852 -0.53 . . . . 0.0 111.682 165.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 8.6 tt0 37.92 47.48 0.9 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.167 2.587 . . . . 0.0 111.551 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.43 126.37 26.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.9 155.1 19.0 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 110.371 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -104.33 101.64 11.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 164.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.47 133.9 46.19 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 117.361 -1.736 . . . . 0.0 106.727 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.4 t -132.06 105.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.41 58.02 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.055 1.342 . . . . 0.0 107.782 -174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.55 157.21 17.76 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.883 -0.511 . . . . 0.0 110.445 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.13 -28.21 68.94 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.879 1.271 . . . . 0.0 111.314 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -132.41 123.21 26.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.524 1.53 . . . . 0.0 107.488 -167.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 m -52.15 -52.77 49.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.715 0.689 . . . . 0.0 111.514 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.2 m -59.33 -29.8 67.91 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.546 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 ttt -61.94 -44.48 96.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.26 0.936 . . . . 0.0 109.957 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -39.88 94.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.329 0.968 . . . . 0.0 109.111 174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.5 -44.82 93.0 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.44 -62.22 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 117.068 -1.444 . . . . 0.0 108.342 172.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.01 -49.23 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 121.423 1.92 . . . . 0.0 111.13 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -48.61 76.74 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 124.443 1.097 . . . . 0.0 110.379 175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -56.22 -51.22 68.87 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.927 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.31 -36.31 79.74 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.496 1.518 . . . . 0.0 112.033 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.65 -52.4 60.91 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.712 -0.617 . . . . 0.0 109.659 171.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -64.74 -20.6 66.44 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.1 -52.32 56.19 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.261 1.424 . . . . 0.0 109.879 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.37 2.43 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 -166.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.86 -84.66 1.08 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 124.542 1.068 . . . . 0.0 110.997 -170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -151.28 175.44 12.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.205 1.402 . . . . 0.0 109.559 -169.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -139.09 -179.15 5.68 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.376 1.07 . . . . 0.0 109.944 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 64.39 77.17 0.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.996 2.519 . . . . 0.0 110.335 -165.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.97 172.36 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.069 160.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.39 174.29 10.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.723 2.009 . . . . 0.0 106.192 158.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.7 164.66 23.49 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.39 170.72 13.81 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.166 1.786 . . . . 0.0 106.817 166.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.1 -37.75 84.45 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.948 0.794 . . . . 0.0 110.389 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -172.64 166.92 5.47 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.985 1.314 . . . . 0.0 108.578 -160.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' H ' ' HG3' ' A' ' 60' ' ' MET . . . -49.35 -40.86 31.15 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.9 1.714 . . . . 0.0 113.966 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.02 -52.99 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.82 0.848 . . . . 0.0 108.77 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.63 -23.91 56.41 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.349 1.46 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.97 51.42 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.71 -46.2 70.69 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.895 0.747 . . . . 0.0 111.045 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.82 -46.58 74.56 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.475 1.51 . . . . 0.0 111.764 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.63 -48.36 82.14 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 117.741 -1.123 . . . . 0.0 109.736 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HD11 ' A' ' 72' ' ' ILE . 17.0 mt -53.83 -46.31 71.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.347 1.431 . . . . 0.0 110.81 -173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.91 7.55 2.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.39 -4.92 18.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.933 1.242 . . . . 0.0 113.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.88 32.06 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 120.418 1.463 . . . . 0.0 113.247 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.46 43.66 2.35 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.586 1.565 . . . . 0.0 113.614 -169.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -75.08 82.0 2.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.47 -1.12 78.57 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.928 1.251 . . . . 0.0 113.065 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.77 134.87 29.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.617 HG21 HD13 ' A' ' 81' ' ' LEU . 33.1 t -128.68 96.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.76 134.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.12 168.96 18.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.036 0.922 . . . . 0.0 110.012 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -46.93 -176.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 130.986 3.714 . . . . 0.0 113.304 158.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -115.98 -42.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.39 158.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.63 47.7 1.5 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.217 1.007 . . . . 0.0 111.691 -159.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.548 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -61.07 138.69 94.3 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.862 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 60' ' ' MET . 21.1 Cg_endo -61.12 26.67 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 125.265 3.976 . . . . 0.0 118.017 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -161.33 -71.89 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 122.058 2.208 . . . . 0.0 110.03 159.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.8 ttt -91.34 85.07 5.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.929 2.091 . . . . 0.0 107.164 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -47.07 153.55 0.43 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.006 1.322 . . . . 0.0 110.32 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.04 -27.53 62.53 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.429 -0.795 . . . . 0.0 112.167 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.81 -36.57 78.4 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.965 0.882 . . . . 0.0 110.29 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.18 -31.41 55.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.866 0.867 . . . . 0.0 110.795 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -57.86 -53.22 60.72 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.674 0.67 . . . . 0.0 109.272 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -52.56 -56.47 15.05 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.289 1.036 . . . . 0.0 108.701 174.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -63.44 -30.92 71.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.726 1.148 . . . . 0.0 112.703 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -69.22 -42.22 76.0 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.103 0.961 . . . . 0.0 110.053 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.606 HD11 HD11 ' A' ' 46' ' ' LEU . 31.6 mt -61.57 -50.62 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -60.09 -24.68 64.81 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 126.377 1.871 . . . . 0.0 112.334 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.88 -3.38 3.34 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.52 1.128 . . . . 0.0 112.627 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 t0 89.54 30.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.547 1.539 . . . . 0.0 112.525 158.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.72 43.32 1.37 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.34 1.924 . . . . 0.0 112.741 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 75.33 8.22 3.94 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 130.044 3.338 . . . . 0.0 112.419 -170.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 60.9 mtt -119.29 2.9 11.37 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.715 1.206 . . . . 0.0 112.363 -163.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 -36.55 67.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.941 1.297 . . . . 0.0 112.616 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.99 60.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.336 0.971 . . . . 0.0 113.146 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 54' ' ' VAL . 34.2 mt -57.95 135.01 83.68 Favored Pre-proline 0 C--O 1.238 0.458 0 CA-C-N 119.693 1.133 . . . . 0.0 111.49 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.67 109.84 2.74 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.764 2.309 . . . . 0.0 107.589 161.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG21 HD13 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -102.68 113.57 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 126.103 1.761 . . . . 0.0 107.364 177.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.73 111.9 19.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.219 1.008 . . . . 0.0 108.836 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -85.03 132.03 34.38 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.43 127.54 59.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -161.55 169.61 21.42 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 -172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.59 -12.98 47.09 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.254 -0.904 . . . . 0.0 111.409 167.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.32 119.61 25.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 119.973 1.261 . . . . 0.0 111.796 -165.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.06 11.04 14.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.537 0.735 . . . . 0.0 112.018 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -52.21 117.97 3.18 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 126.302 1.841 . . . . 0.0 110.62 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -52.83 -47.73 67.5 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.807 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -46.7 -46.12 19.96 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.17 0.988 . . . . 0.0 111.56 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -65.36 -43.82 89.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.03 -48.57 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -62.08 -54.44 34.36 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.26 -48.41 45.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.357 1.463 . . . . 0.0 110.84 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.19 -56.06 27.01 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.219 0.607 . . . . 0.0 109.701 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.75 66.86 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -73.39 -56.85 4.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.699 2.0 . . . . 0.0 109.641 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.41 -35.61 60.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.573 0.749 . . . . 0.0 110.18 175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.6 27.85 3.69 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 125.166 1.365 . . . . 0.0 111.545 170.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.72 138.59 55.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.112 0.956 . . . . 0.0 110.322 -172.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m -72.89 -5.53 38.97 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.59 1.556 . . . . 0.0 112.003 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.32 165.46 34.79 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 158.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -137.79 110.78 7.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.66 104.35 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.442 1.897 . . . . 0.0 106.23 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.62 147.83 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -66.91 147.14 99.15 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 162.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.65 139.7 58.79 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.195 1.105 . . . . 0.0 110.498 -3.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -140.81 148.09 40.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -144.97 -176.25 5.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 109.811 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.43 -33.23 43.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.936 1.294 . . . . 0.0 110.166 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.54 76.23 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.69 0.796 . . . . 0.0 112.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.01 -27.98 19.39 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.289 0.949 . . . . 0.0 110.003 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.92 -53.39 58.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.365 1.066 . . . . 0.0 109.374 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -37.48 85.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.63 1.172 . . . . 0.0 111.462 -177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.42 -45.38 69.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.677 1.591 . . . . 0.0 108.896 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.63 87.3 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.392 -1.766 . . . . 0.0 111.245 170.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.4 mt -62.23 -56.51 17.92 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.354 1.034 . . . . 0.0 109.281 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -59.54 -35.02 73.4 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.45 1.023 . . . . 0.0 111.109 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -54.93 -50.82 67.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.689 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.9 pt -80.18 -24.42 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.704 1.138 . . . . 0.0 113.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -56.68 -55.56 32.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -74.83 -46.52 36.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -68.49 -70.41 0.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.02 -26.64 66.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.127 -174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.63 37.03 12.46 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -164.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.5 mmt . . . . . 0 C--O 1.252 1.228 0 CA-C-N 118.998 1.399 . . . . 0.0 109.09 176.258 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.43 179.83 6.86 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.997 1.719 . . . . 0.0 107.277 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -66.7 172.52 4.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 159.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.02 -12.74 20.39 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.551 -1.343 . . . . 0.0 111.495 159.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.459 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 27.8 mt-10 46.87 49.19 14.68 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.6 1.96 . . . . 0.0 109.151 -176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.98 106.37 0.22 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.806 0.842 . . . . 0.0 109.458 -169.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -89.38 117.65 28.47 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.728 -162.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.13 152.56 41.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.6 tp -123.29 134.8 54.03 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.5 t -120.73 119.2 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.678 1.191 . . . . 0.0 108.306 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.09 61.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.35 156.85 36.94 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 164.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -62.05 -44.4 96.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.654 1.181 . . . . 0.0 110.485 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 12.2 t80 -116.08 132.59 56.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.107 1.363 . . . . 0.0 109.029 -159.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 m -51.28 -60.65 2.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.128 0.971 . . . . 0.0 111.97 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 64.4 m -51.22 -37.25 45.82 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.997 0.519 . . . . 0.0 110.936 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.59 -47.17 82.86 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.018 0.826 . . . . 0.0 111.045 174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.3 ptt85 -72.92 -27.43 61.86 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 120.997 1.726 . . . . 0.0 111.545 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -62.59 -40.95 98.55 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.467 -0.771 . . . . 0.0 109.431 171.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.23 -63.43 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -54.49 -42.63 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.804 1.184 . . . . 0.0 110.671 -171.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -60.56 -49.21 78.44 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-O 117.709 -1.138 . . . . 0.0 111.07 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -50.86 -54.68 21.81 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.377 0.989 . . . . 0.0 109.66 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -55.82 -42.62 75.95 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.099 0.96 . . . . 0.0 111.535 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -63.86 -47.63 79.94 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -69.52 -19.29 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.441 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.76 -33.08 74.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.178 1.354 . . . . 0.0 110.156 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.4 mt -87.05 -50.28 6.75 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.461 1.504 . . . . 0.0 108.738 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.94 -97.14 0.13 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 35.92 64.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 128.363 2.665 . . . . 0.0 112.316 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -68.41 1.48 2.98 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.83 100.47 4.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.894 1.679 . . . . 0.0 110.694 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.63 91.56 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 125.799 1.639 . . . . 0.0 107.64 -172.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 164.4 17.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.429 0.691 . . . . 0.0 109.56 169.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.82 166.31 22.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 158.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -113.54 178.58 4.23 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.368 1.067 . . . . 0.0 108.668 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -79.65 -43.1 23.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -167.24 164.03 15.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.264 1.826 . . . . 0.0 108.121 -161.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.88 -39.42 11.2 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.191 1.377 . . . . 0.0 114.034 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 118.018 0.909 . . . . 0.0 109.314 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.16 -26.15 66.51 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.171 0.589 . . . . 0.0 111.038 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.46 -54.6 43.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.802 1.183 . . . . 0.0 108.433 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.89 -39.87 82.75 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.337 0.589 . . . . 0.0 111.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -56.1 -47.11 78.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.435 1.094 . . . . 0.0 110.353 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -59.38 -48.83 80.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.941 1.297 . . . . 0.0 109.911 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 HD11 ' A' ' 72' ' ' ILE . 3.2 mt -57.91 -39.32 77.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.837 1.199 . . . . 0.0 109.755 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -76.25 10.07 2.21 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.15 -37.15 84.96 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.501 -1.375 . . . . 0.0 109.835 159.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 153.24 -19.68 0.73 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-O 118.112 -1.382 . . . . 0.0 116.136 167.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.01 86.42 0.06 OUTLIER Glycine 0 C--N 1.338 0.691 0 CA-C-N 120.389 2.095 . . . . 0.0 113.541 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.26 163.5 14.21 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.588 0.694 . . . . 0.0 109.925 166.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.42 -38.84 4.63 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.419 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -142.5 151.17 41.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.463 1.131 . . . . 0.0 109.113 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -129.27 79.09 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -97.31 120.62 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -169.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 m -151.65 156.54 40.59 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.114 1.324 . . . . 0.0 113.216 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -76.12 168.44 20.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.631 1.173 . . . . 0.0 110.051 168.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -82.28 -56.21 4.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.075 0.95 . . . . 0.0 113.409 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.19 67.23 4.96 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.699 0.799 . . . . 0.0 112.41 -158.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.0 mmt -66.89 147.63 99.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.712 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.45 -6.32 14.83 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 114.096 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -139.88 -89.95 0.18 Allowed 'General case' 0 C--N 1.34 0.176 0 CA-C-N 120.196 1.362 . . . . 0.0 111.746 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.7 ttm -82.0 95.85 7.54 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -50.77 155.66 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.89 -24.18 48.54 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.359 -0.838 . . . . 0.0 112.022 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.69 -35.45 57.89 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.609 1.204 . . . . 0.0 111.515 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.04 -40.24 75.26 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.098 0.959 . . . . 0.0 109.705 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.82 -54.08 48.93 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.211 1.404 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tp -53.07 -58.36 7.26 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.125 0.97 . . . . 0.0 109.719 174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 26.7 mttm -60.9 -31.76 71.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.389 0.995 . . . . 0.0 111.844 -173.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.5 m -65.28 -48.71 72.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.566 0.746 . . . . 0.0 110.608 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 HD11 HD11 ' A' ' 46' ' ' LEU . 28.0 mt -59.16 -45.03 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -7.08 13.16 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.896 1.678 . . . . 0.0 113.57 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.96 -16.78 46.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.741 1.155 . . . . 0.0 111.689 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.4 175.08 0.16 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.692 1.597 . . . . 0.0 111.635 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.47 -9.13 29.94 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 120.797 -1.19 . . . . 0.0 112.949 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.1 -28.01 0.33 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.7 mtt -145.25 6.31 1.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.194 0.998 . . . . 0.0 111.361 -171.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.0 -57.13 3.0 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.09 2.556 . . . . 0.0 112.966 -159.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.83 -9.97 59.04 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.254 -1.355 . . . . 0.0 113.874 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 54' ' ' VAL . 12.7 mt -56.8 117.78 19.38 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 120.181 1.355 . . . . 0.0 110.571 -172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.54 100.88 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.07 2.513 . . . . 0.0 109.098 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.514 HG21 HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -80.01 130.86 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 166.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.5 tp -131.17 112.22 12.64 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.735 1.214 . . . . 0.0 108.444 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.6 mmm -83.01 96.88 8.48 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -172.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -100.34 107.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -154.41 167.27 30.56 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.161 -0.962 . . . . 0.0 111.153 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.75 47.43 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.543 -0.723 . . . . 0.0 111.872 165.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -76.05 94.4 3.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.866 1.266 . . . . 0.0 110.737 -164.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -83.54 14.93 3.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.978 1.311 . . . . 0.0 112.974 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.55 118.98 4.62 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.579 1.152 . . . . 0.0 108.19 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -57.26 -43.38 82.96 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 119.431 1.014 . . . . 0.0 110.02 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.71 -29.48 69.37 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.766 1.166 . . . . 0.0 112.11 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -67.7 -45.24 75.71 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.715 0.689 . . . . 0.0 109.719 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.62 -48.12 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.251 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.87 -55.17 19.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.82 69.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.227 1.011 . . . . 0.0 110.38 -174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.31 -53.42 58.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.712 0.805 . . . . 0.0 110.763 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.66 93.08 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.312 0.505 . . . . 0.0 110.484 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -59.89 -49.67 76.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.951 2.1 . . . . 0.0 111.272 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -61.6 -31.24 71.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.471 1.108 . . . . 0.0 111.56 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.03 16.01 7.53 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.699 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.81 136.8 58.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 119.712 1.756 . . . . 0.0 108.553 -169.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.6 p -66.63 -19.57 65.8 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 123.313 0.383 . . . . 0.0 110.954 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.59 176.88 48.25 Favored Glycine 0 N--CA 1.439 -1.101 0 O-C-N 121.187 -0.946 . . . . 0.0 113.186 166.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -128.89 137.74 51.61 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.483 1.513 . . . . 0.0 107.34 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.0 85.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.513 2.325 . . . . 0.0 104.943 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 90' ' ' ALA . 23.5 t -70.73 144.82 13.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 167.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.05 155.03 6.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.192 0.997 . . . . 0.0 110.506 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.01 145.44 83.93 Favored 'Cis proline' 0 N--CA 1.452 -0.95 0 N-CA-C 109.464 -1.014 . . . . 0.0 109.464 -10.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -132.24 150.79 52.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.346 1.058 . . . . 0.0 110.055 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -147.28 169.46 19.35 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 127.182 2.193 . . . . 0.0 108.334 -164.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -33.19 74.12 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.69 -16.76 17.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.016 1.326 . . . . 0.0 114.313 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.63 -25.49 8.68 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.757 1.162 . . . . 0.0 110.892 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -57.7 11.67 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 170.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -32.07 71.56 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.22 -49.25 67.89 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.287 1.035 . . . . 0.0 109.425 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 3.8 mmpt? -68.53 -37.31 79.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 116.724 -1.607 . . . . 0.0 110.278 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.94 -57.36 12.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.307 0.958 . . . . 0.0 109.077 171.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -50.42 -45.27 55.64 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.058 0.943 . . . . 0.0 110.866 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.536 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 11.5 mtmm -59.43 -48.03 83.2 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 117.559 -1.21 . . . . 0.0 112.596 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 pt -75.05 -31.91 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.896 2.134 . . . . 0.0 113.283 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -55.4 -50.53 69.53 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.879 1.272 . . . . 0.0 108.82 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.04 -57.78 4.2 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.935 0.494 . . . . 0.0 109.916 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -58.65 3.16 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -159.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 129' ' ' MET . 6.6 mt -71.43 -26.33 62.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.45 40.69 8.86 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -169.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 127' ' ' LEU . 14.7 mmt . . . . . 0 C--O 1.253 1.243 0 CA-C-N 118.897 1.349 . . . . 0.0 108.135 171.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tmm? . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 122.369 1.081 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.07 165.41 35.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.986 2.514 . . . . 0.0 107.916 -171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -61.54 173.47 0.94 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.757 1.223 . . . . 0.0 109.491 170.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HE2' HD12 ' A' ' 6' ' ' LEU . 80.8 tttt -62.11 -29.79 70.57 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 120.348 -1.47 . . . . 0.0 110.109 159.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 46.99 47.11 15.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.904 1.282 . . . . 0.0 110.642 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD12 ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -53.22 109.43 0.43 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -75.0 135.09 41.32 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.407 ' CZ ' ' CD1' ' A' ' 53' ' ' PHE . 8.3 m-85 -92.78 149.44 21.29 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 166.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -121.78 138.29 54.43 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 166.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.26 108.09 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -124.51 57.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.37 162.69 5.87 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 159.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -47.83 13.48 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.376 -0.827 . . . . 0.0 110.167 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -64.17 -19.94 65.66 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -158.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 t 70.64 -47.27 0.64 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.926 2.491 . . . . 0.0 111.55 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.8 m -52.69 -36.95 58.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.467 -1.396 . . . . 0.0 109.29 160.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.2 ttp -67.92 -17.66 64.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.213 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.486 HH11 ' CG ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -62.24 -48.03 81.75 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 120.663 1.574 . . . . 0.0 108.327 168.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -56.85 -52.88 63.38 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 117.674 -1.155 . . . . 0.0 107.893 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.36 -68.47 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 124.059 0.849 . . . . 0.0 108.811 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.4 t -54.49 -46.66 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.995 0.816 . . . . 0.0 110.746 -170.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 -63.89 -35.52 80.92 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.156 0.889 . . . . 0.0 111.018 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -72.3 -32.98 67.04 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.52 1.055 . . . . 0.0 111.751 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.92 -36.8 80.78 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.978 -1.076 . . . . 0.0 109.868 172.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.54 -36.47 81.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.865 -0.522 . . . . 0.0 110.517 172.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -64.66 -34.49 78.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 117.52 -1.229 . . . . 0.0 111.728 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -56.66 -64.93 0.71 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.931 1.241 . . . . 0.0 110.925 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.67 28.53 1.05 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -165.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.03 -116.34 2.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.463 1.506 . . . . 0.0 110.226 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -141.54 176.4 8.92 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.461 1.105 . . . . 0.0 111.708 -159.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -120.42 -177.64 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.066 1.746 . . . . 0.0 110.391 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 60.05 74.29 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.118 2.167 . . . . 0.0 109.781 -174.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.28 125.06 73.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 172.87 7.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.697 1.199 . . . . 0.0 107.952 165.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -134.43 173.91 11.12 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.729 1.212 . . . . 0.0 107.992 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.38 177.19 8.06 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.111 0.964 . . . . 0.0 109.601 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.04 -38.59 52.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.883 0.473 . . . . 0.0 111.461 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.05 162.88 1.67 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.784 2.033 . . . . 0.0 107.131 -158.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -47.89 -42.31 22.09 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.077 1.322 . . . . 0.0 114.663 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.8 -36.56 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.067 1.933 . . . . 0.0 109.533 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.5 t70 -78.95 -36.3 41.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.556 1.542 . . . . 0.0 110.261 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.62 -46.96 83.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.262 1.425 . . . . 0.0 109.081 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -52.62 -47.91 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.22 1.408 . . . . 0.0 110.383 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -69.2 -19.8 63.98 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.114 0.965 . . . . 0.0 112.926 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HE2' ' OD1' ' A' ' 41' ' ' ASP . 4.2 mptp? -69.25 -49.03 59.97 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.388 -1.445 . . . . 0.0 110.094 162.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.61 HD11 HD11 ' A' ' 72' ' ' ILE . 5.5 mt -54.71 -54.69 38.58 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.113 1.324 . . . . 0.0 109.581 -174.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.51 -0.96 9.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.5 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 120.308 1.413 . . . . 0.0 110.52 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.39 -82.59 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.11 91.7 0.11 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -84.21 155.7 22.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 168.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.55 -66.99 0.5 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 7.2 m-85 -87.38 136.57 32.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.947 0.873 . . . . 0.0 108.821 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 81' ' ' LEU . 42.3 t -129.75 113.84 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.4 125.78 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.3 p -156.57 168.71 26.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.376 0.989 . . . . 0.0 112.907 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.78 167.54 21.62 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.768 0.827 . . . . 0.0 110.362 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 4.0 t-105 -78.93 -42.58 26.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 158.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -78.53 56.27 1.77 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.311 2.244 . . . . 0.0 112.327 -159.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.471 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -76.81 165.82 49.5 Favored Pre-proline 0 C--O 1.238 0.456 0 O-C-N 120.869 -1.144 . . . . 0.0 110.792 -177.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.82 -39.52 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.45 2.1 . . . . 0.0 110.84 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.82 -69.07 0.87 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.839 1.2 . . . . 0.0 112.295 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.2 ttm -91.14 83.48 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.93 140.6 1.02 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.918 2.087 . . . . 0.0 108.671 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.5 -20.81 66.14 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.052 -1.03 . . . . 0.0 114.77 -162.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.43 -38.38 74.53 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.104 0.952 . . . . 0.0 109.708 172.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.83 -41.14 83.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.008 0.923 . . . . 0.0 109.911 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.88 -51.08 71.55 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.496 1.044 . . . . 0.0 110.045 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.23 -56.35 17.22 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.821 173.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.56 -24.86 65.57 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 120.812 1.642 . . . . 0.0 113.666 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 m -64.01 -52.16 60.85 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.61 HD11 HD11 ' A' ' 46' ' ' LEU . 30.9 mt -64.29 -28.66 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 12.39 19.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.433 1.893 . . . . 0.0 111.22 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.49 -16.48 60.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.512 1.505 . . . . 0.0 112.412 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.6 t0 68.59 163.15 0.22 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 129.842 3.257 . . . . 0.0 111.803 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.29 2.97 22.43 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.001 -1.444 . . . . 0.0 113.756 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -165.85 82.02 0.31 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.916 1.858 . . . . 0.0 106.741 167.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.2 mtt 103.81 17.31 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.743 2.417 . . . . 0.0 114.657 164.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 p -57.66 -18.27 19.51 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.435 -1.415 . . . . 0.0 113.743 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.89 4.34 50.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.312 1.845 . . . . 0.0 113.386 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 54' ' ' VAL . 10.4 mt -73.27 127.9 88.38 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 120.334 -1.479 . . . . 0.0 108.988 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.86 62.82 8.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.339 4.026 . . . . 0.0 111.716 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.54 HG21 HD13 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -55.84 112.08 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.349 1.86 . . . . 0.0 111.675 177.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 114.52 27.17 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 125.367 1.467 . . . . 0.0 109.201 -174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 mmt -76.17 131.03 39.12 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -138.8 105.14 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.246 1.819 . . . . 0.0 106.401 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 t -139.99 178.84 6.98 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.008 0.909 . . . . 0.0 110.696 -171.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.05 -26.2 19.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.124 0.97 . . . . 0.0 111.788 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -91.17 134.95 34.12 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.201 0.91 . . . . 0.0 111.646 -168.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.34 -95.8 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.408 -0.806 . . . . 0.0 108.915 171.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 1.9 tpmt? 59.15 112.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.326 2.25 . . . . 0.0 111.789 -171.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -51.8 -47.42 64.28 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 117.576 -1.202 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -61.76 -28.33 69.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.599 1.545 . . . . 0.0 113.423 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -65.02 -47.35 77.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.606 1.094 . . . . 0.0 108.927 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.2 -51.64 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.71 -58.01 6.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.86 -47.72 76.8 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.027 0.931 . . . . 0.0 110.56 -172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.79 88.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.33 -39.28 92.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.591 0.632 . . . . 0.0 112.519 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -60.23 -54.75 42.04 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.929 1.691 . . . . 0.0 109.594 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.46 -12.18 29.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.035 1.334 . . . . 0.0 112.27 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.47 29.65 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 119.099 -0.834 . . . . 0.0 112.531 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.692 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.52 152.16 26.66 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.9 m -55.52 -34.94 65.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.145 0.978 . . . . 0.0 112.23 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.25 179.78 44.15 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.11 92.29 3.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.474 1.51 . . . . 0.0 107.874 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -81.93 137.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 170.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.42 144.14 38.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 156.92 43.19 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 118.426 0.557 . . . . 0.0 110.801 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.72 137.17 46.21 Favored 'Cis proline' 0 N--CA 1.453 -0.891 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 -12.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -139.07 155.02 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.986 0.422 . . . . 0.0 110.194 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.1 p -151.72 -172.3 4.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.73 1.612 . . . . 0.0 111.022 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.2 18.6 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.558 1.143 . . . . 0.0 110.475 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.1 87.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.705 0.802 . . . . 0.0 112.889 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 -34.55 22.22 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 119.767 1.167 . . . . 0.0 109.269 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.95 -55.96 19.5 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -41.28 99.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.688 1.195 . . . . 0.0 112.518 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.41 -45.11 73.5 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.829 -0.545 . . . . 0.0 110.04 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.36 -38.38 89.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.0 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.29 -60.39 3.47 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -59.7 -34.83 73.4 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.393 0.542 . . . . 0.0 111.766 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -68.73 0.16 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.966 0.906 . . . . 0.0 109.349 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -24.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -174.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -57.56 -64.03 1.03 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.55 0.74 . . . . 0.0 109.219 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.83 -54.73 12.2 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -59.39 -52.6 64.92 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.537 0.735 . . . . 0.0 111.97 -164.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.74 -47.44 11.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.398 0.679 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.52 19.51 3.1 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.257 1.408 . . . . 0.0 112.704 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.1 mmm . . . . . 0 C--O 1.253 1.254 0 CA-C-N 120.152 1.976 . . . . 0.0 112.837 -172.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 -163.54 0.43 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.265 1.426 . . . . 0.0 108.623 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.91 175.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.348 -0.845 . . . . 0.0 109.293 166.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -63.35 -16.7 61.22 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.877 -1.139 . . . . 0.0 112.999 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 49.4 57.6 6.31 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.576 1.15 . . . . 0.0 110.107 -172.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.23 111.56 1.4 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -90.62 131.98 36.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -86.74 159.48 19.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 167.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.1 tp -125.67 142.2 51.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.77 110.11 16.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.6 t -125.0 70.71 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 123.223 1.487 . . . . 0.0 107.346 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.54 173.23 10.67 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.34 1.856 . . . . 0.0 110.996 168.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.18 -18.38 24.54 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.361 2.264 . . . . 0.0 114.069 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.31 112.62 8.69 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.057 -1.652 . . . . 0.0 109.029 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.85 -46.31 1.96 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.272 1.396 . . . . 0.0 114.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.0 m -51.76 -45.81 63.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.607 1.094 . . . . 0.0 111.673 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.6 ttm -52.39 -41.16 62.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.155 1.382 . . . . 0.0 109.359 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 ttp-105 -71.2 -40.56 71.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.88 1.218 . . . . 0.0 111.479 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -54.7 -54.9 35.69 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.41 -65.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.926 1.291 . . . . 0.0 107.923 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.41 -45.41 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.603 1.547 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -64.75 -39.42 93.6 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.251 1.387 . . . . 0.0 110.698 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -58.56 -51.57 69.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.204 1.366 . . . . 0.0 110.601 171.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.39 -26.35 68.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.181 0.592 . . . . 0.0 111.994 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.9 mt -77.91 -45.95 22.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.344 1.057 . . . . 0.0 110.426 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -73.55 -9.63 58.88 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -56.16 -36.91 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.397 0.999 . . . . 0.0 109.925 158.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.93 -4.37 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.868 1.667 . . . . 0.0 111.597 -165.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.53 -110.2 1.54 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 125.999 1.761 . . . . 0.0 108.888 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 40.51 49.86 2.72 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.898 2.479 . . . . 0.0 112.972 165.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -70.67 -4.96 26.13 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.777 0.831 . . . . 0.0 113.241 -160.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -131.09 77.01 1.76 Allowed 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.354 1.461 . . . . 0.0 107.81 -169.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 m -88.69 161.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 164.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.87 171.9 12.64 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.78 2.032 . . . . 0.0 108.04 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -139.66 148.25 42.15 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.735 1.214 . . . . 0.0 107.733 -164.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -129.82 167.78 17.6 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.127 0.571 . . . . 0.0 109.891 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -74.3 -31.43 62.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.657 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.62 172.72 2.53 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.598 1.559 . . . . 0.0 107.873 -172.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.05 -39.63 26.77 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.796 1.188 . . . . 0.0 113.789 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.38 -45.27 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.6 -0.941 . . . . 0.0 109.892 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.02 -25.66 64.6 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.655 -0.653 . . . . 0.0 110.181 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.58 -55.07 34.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.517 1.053 . . . . 0.0 108.51 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.97 -42.36 76.15 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.682 0.753 . . . . 0.0 110.751 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.94 -40.49 84.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.541 0.737 . . . . 0.0 112.023 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.2 mmtm -62.15 -44.06 97.46 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.232 0.924 . . . . 0.0 109.285 173.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.459 HD11 HD11 ' A' ' 72' ' ' ILE . 10.5 mt -58.0 -43.94 86.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.11 0.868 . . . . 0.0 110.71 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -69.84 -13.54 62.31 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.52 48.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.774 1.23 . . . . 0.0 112.906 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.93 34.87 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 119.706 1.139 . . . . 0.0 110.882 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.7 76.19 1.09 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -70.91 159.0 35.47 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.2 -1.66 3.92 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 118.624 -1.098 . . . . 0.0 113.784 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.55 136.96 17.68 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.141 1.47 . . . . 0.0 108.839 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -134.88 80.22 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -87.07 139.94 16.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.3 p -148.96 167.44 25.75 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.511 0.596 . . . . 0.0 111.935 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.9 t70 -78.98 -157.6 0.12 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 158.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 16.3 t-105 -122.59 -42.01 2.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 127.33 2.252 . . . . 0.0 110.293 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.63 43.74 1.0 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 112.203 -159.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -91.79 144.1 28.87 Favored Pre-proline 0 CA--C 1.535 0.376 0 O-C-N 121.25 -0.906 . . . . 0.0 108.567 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.23 159.06 50.62 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.28 1.987 . . . . 0.0 111.379 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.82 -78.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 127.356 2.262 . . . . 0.0 111.862 -171.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.5 86.37 6.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -55.93 165.86 0.86 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 167.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.0 -30.32 53.86 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 120.809 -1.182 . . . . 0.0 112.416 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -79.54 -29.09 41.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.669 1.235 . . . . 0.0 111.645 -179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.45 -44.52 57.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.2 tp -52.86 -51.07 62.43 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.281 1.432 . . . . 0.0 109.178 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.7 tp -57.12 -58.75 6.85 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.417 1.087 . . . . 0.0 110.216 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 67.5 mttt -66.63 -28.88 68.84 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.472 1.487 . . . . 0.0 111.939 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.1 m -62.27 -55.41 28.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.467 1.03 . . . . 0.0 108.699 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.459 HD11 HD11 ' A' ' 46' ' ' LEU . 32.8 mt -50.66 -55.4 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.693 1.597 . . . . 0.0 108.564 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.43 -30.72 65.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.264 1.426 . . . . 0.0 112.266 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.24 8.2 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.207 1.003 . . . . 0.0 111.745 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -175.16 -161.92 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.335 1.854 . . . . 0.0 109.347 165.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.3 33.41 4.56 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 123.87 0.748 . . . . 0.0 111.414 163.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 69.74 -37.33 0.37 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 129.38 3.072 . . . . 0.0 111.492 -160.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.48 -16.61 48.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.52 1.528 . . . . 0.0 112.281 -176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.48 -34.12 1.96 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.117 2.167 . . . . 0.0 112.159 169.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.38 4.95 19.38 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.68 1.592 . . . . 0.0 113.705 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 54' ' ' VAL . 12.8 mt -66.13 125.63 90.5 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.89 124.64 11.66 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 N-CA-C 108.697 -1.309 . . . . 0.0 108.697 170.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 69' ' ' LEU . 2.2 m -104.79 142.1 18.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 169.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.9 tp -137.86 111.76 8.34 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.0 mmt -73.91 122.53 22.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.45 102.43 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.6 t -144.3 171.93 13.64 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.688 0.756 . . . . 0.0 112.565 -161.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.56 -24.36 39.28 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.312 1.045 . . . . 0.0 110.482 163.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.08 94.8 1.95 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.355 1.462 . . . . 0.0 110.514 -168.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.5 3.62 7.32 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.344 -0.848 . . . . 0.0 111.85 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -49.52 115.91 1.54 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.363 1.465 . . . . 0.0 109.598 -170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -49.09 -53.07 22.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.418 0.687 . . . . 0.0 111.326 -175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -60.99 -25.8 67.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -72.78 -40.21 66.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 119.326 0.966 . . . . 0.0 109.658 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.58 -49.64 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.7 -57.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.21 76.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.816 0.735 . . . . 0.0 111.105 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.907 0.483 . . . . 0.0 110.149 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -27.48 67.27 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -68.93 -54.55 14.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.756 1.623 . . . . 0.0 109.404 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.83 80.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.783 0.833 . . . . 0.0 110.881 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.24 35.08 2.78 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 124.691 1.138 . . . . 0.0 112.458 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.505 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.39 141.67 46.38 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -78.46 -4.84 50.44 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.978 0.174 . . . . 0.0 111.215 -172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.44 172.76 41.44 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 161.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -139.08 132.0 29.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.29 1.036 . . . . 0.0 108.519 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -132.97 130.67 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 127.065 2.146 . . . . 0.0 106.32 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.32 152.23 10.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -50.72 143.48 14.57 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 117.61 -1.186 . . . . 0.0 108.457 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.56 132.79 27.98 Favored 'Cis proline' 0 CA--C 1.534 0.484 0 CA-C-N 120.707 1.288 . . . . 0.0 111.012 -8.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -134.32 157.92 45.11 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.411 0.684 . . . . 0.0 111.243 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -155.51 171.91 19.13 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.516 1.927 . . . . 0.0 110.765 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.31 75.6 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.46 -50.5 31.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.937 1.295 . . . . 0.0 111.981 169.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.29 -35.3 48.13 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.808 -0.557 . . . . 0.0 109.749 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -57.65 11.01 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.257 1.023 . . . . 0.0 108.841 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.27 -29.69 70.59 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.042 0.937 . . . . 0.0 111.868 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.59 -45.45 65.29 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 122.564 0.346 . . . . 0.0 110.617 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.06 -35.33 80.81 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.954 -1.091 . . . . 0.0 110.306 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.3 mt -58.33 -56.71 18.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 109.729 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -50.71 -43.82 57.92 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.874 0.761 . . . . 0.0 110.916 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -51.68 -61.4 2.27 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.307 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 pt -70.96 -26.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.715 1.598 . . . . 0.0 114.531 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.67 -58.62 7.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -72.31 -41.74 66.25 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.876 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -68.38 -67.73 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.554 1.542 . . . . 0.0 108.77 -173.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.423 HD23 ' HD2' ' A' ' 126' ' ' LYS . 8.5 mt -72.9 -29.13 62.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.74 0.416 . . . . 0.0 110.374 -175.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.84 26.13 25.36 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 117.737 -1.59 . . . . 0.0 110.361 -161.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--O 1.242 0.692 0 CA-C-N 120.174 1.987 . . . . 0.0 109.801 175.347 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 mtt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.47 156.73 38.98 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 147.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -109.07 170.23 8.18 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 158.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -63.91 -19.22 64.93 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 45.88 37.24 3.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.275 1.83 . . . . 0.0 110.632 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.56 110.91 2.89 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.351 1.86 . . . . 0.0 108.878 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -91.11 138.5 31.55 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.087 0.555 . . . . 0.0 110.726 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.3 102.36 14.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.349 1.86 . . . . 0.0 107.747 165.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.89 136.75 54.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.3 106.16 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 42' ' ' ALA . 6.7 t -109.03 89.26 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.24 158.81 16.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.65 0.738 . . . . 0.0 110.734 170.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.79 -4.34 58.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.384 1.074 . . . . 0.0 112.685 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 10.0 t80 -131.52 -3.92 3.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.844 1.258 . . . . 0.0 112.309 -159.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 62.31 -60.18 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.214 2.205 . . . . 0.0 110.76 -159.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.422 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 68.8 m -62.63 -29.07 70.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 111.189 -171.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -27.02 64.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.648 1.567 . . . . 0.0 110.904 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.7 ttp85 -67.95 -43.86 78.11 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 121.288 1.858 . . . . 0.0 107.309 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.85 -45.63 67.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.239 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.08 -65.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.887 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.14 -47.53 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.204 1.365 . . . . 0.0 111.148 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.624 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.3 ttt180 -55.15 -49.5 71.65 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 109.755 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -60.17 -39.74 87.51 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.847 0.748 . . . . 0.0 110.744 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 113' ' ' ALA . 60.8 mt -66.45 -34.07 77.11 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.045 0.839 . . . . 0.0 110.989 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -67.27 -37.01 82.76 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.354 -0.841 . . . . 0.0 110.706 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -70.06 -29.2 66.15 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.538 -1.351 . . . . 0.0 111.084 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.34 -51.75 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.35 1.06 . . . . 0.0 110.582 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 47.37 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.613 0.721 . . . . 0.0 112.264 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.0 -111.72 0.83 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -138.6 158.27 44.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.178 0.989 . . . . 0.0 111.156 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -82.65 177.81 8.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.196 0.999 . . . . 0.0 109.357 159.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 60.78 79.25 0.25 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.745 2.018 . . . . 0.0 111.631 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.624 HG21 ' HG3' ' A' ' 22' ' ' ARG . 5.2 m -97.56 169.17 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.352 163.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -141.8 -179.6 6.29 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.97 1.708 . . . . 0.0 108.514 163.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -134.12 158.11 44.47 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.464 1.506 . . . . 0.0 107.775 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.59 159.14 40.37 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.598 1.559 . . . . 0.0 107.262 162.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -72.26 -24.13 61.31 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -171.5 168.68 6.37 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.468 1.507 . . . . 0.0 107.21 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.72 -37.89 21.57 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.291 0.948 . . . . 0.0 113.526 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.98 -51.22 47.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.261 1.024 . . . . 0.0 109.997 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -74.14 -28.23 61.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.143 1.377 . . . . 0.0 110.073 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.98 -50.84 71.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.492 1.117 . . . . 0.0 108.942 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.18 -37.76 75.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.353 0.261 . . . . 0.0 110.492 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -67.77 -36.11 79.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.277 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.8 mmtt -63.45 -40.1 96.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.874 1.215 . . . . 0.0 109.605 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.4 mm? -62.55 -39.1 92.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.763 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -71.26 5.96 1.94 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.95 -10.28 59.49 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.54 -1.35 . . . . 0.0 112.943 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 -105.31 0.29 Allowed Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.379 0.991 . . . . 0.0 110.698 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.31 87.37 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.364 0.983 . . . . 0.0 110.98 -172.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -67.69 164.82 18.47 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.365 1.066 . . . . 0.0 110.993 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.97 -43.71 3.76 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 119.044 -0.865 . . . . 0.0 111.221 167.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.05 145.59 44.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 117.894 0.847 . . . . 0.0 112.307 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 81' ' ' LEU . 14.1 t -136.09 81.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.135 1.374 . . . . 0.0 107.894 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.88 127.1 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -136.81 144.39 43.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -171.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.15 166.66 19.44 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 158.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -71.92 -45.58 60.69 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.578 0.751 . . . . 0.0 109.317 162.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -73.97 98.75 3.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.054 0.942 . . . . 0.0 112.17 -160.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 mmt -131.4 155.51 81.38 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.96 -45.11 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.469 2.113 . . . . 0.0 111.273 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -92.65 -99.36 0.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.428 1.091 . . . . 0.0 108.657 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.9 ttm -79.18 96.12 5.8 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -62.4 166.75 4.8 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.057 0.943 . . . . 0.0 111.291 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.95 -24.28 71.5 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 118.929 -0.928 . . . . 0.0 113.259 -171.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -43.88 34.9 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 119.118 1.459 . . . . 0.0 107.758 176.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.43 -41.13 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.576 0.75 . . . . 0.0 110.977 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.55 -49.54 77.39 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.066 0.946 . . . . 0.0 109.638 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -53.58 -56.01 20.8 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.719 -1.134 . . . . 0.0 109.448 175.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 45.2 mttt -64.13 -37.97 89.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.677 1.581 . . . . 0.0 111.192 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.9 m -56.89 -49.17 76.35 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.451 0.569 . . . . 0.0 109.798 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.9 mt -65.89 -42.82 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.41 0.684 . . . . 0.0 109.432 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.83 84.53 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 111.993 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.15 1.82 56.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.03 1.332 . . . . 0.0 111.479 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -69.64 155.79 39.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 162.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.89 -25.3 58.32 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.931 -0.927 . . . . 0.0 112.487 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.15 -47.44 2.94 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.975 1.31 . . . . 0.0 110.795 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.1 mtt -66.5 -14.21 61.95 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.9 p -57.99 -21.13 43.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.404 1.081 . . . . 0.0 112.825 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.29 -16.19 62.45 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 54' ' ' VAL . 45.2 mt -64.86 149.01 96.97 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 119.892 1.223 . . . . 0.0 112.299 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.14 86.7 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.535 2.823 . . . . 0.0 108.777 166.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -77.25 99.51 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.6 tp -107.97 110.6 22.37 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.382 1.073 . . . . 0.0 108.267 -171.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -72.53 123.24 22.75 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.94 96.65 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.3 t -134.46 -170.31 2.51 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.243 1.017 . . . . 0.0 109.88 -169.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.12 -12.13 14.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.844 1.258 . . . . 0.0 112.348 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -87.81 105.47 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.438 1.017 . . . . 0.0 110.761 -172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.93 4.44 8.2 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.812 0.845 . . . . 0.0 113.271 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -53.64 115.28 1.89 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.959 1.704 . . . . 0.0 109.724 -170.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -55.25 -45.03 76.07 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.011 0.924 . . . . 0.0 110.119 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.31 -41.91 39.87 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.56 1.144 . . . . 0.0 112.392 172.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.28 -34.38 63.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.583 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.75 -48.93 85.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.248 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mt -57.25 -50.31 77.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 CA-C-N 120.952 1.705 . . . . 0.0 109.336 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.26 -46.29 72.61 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 119.158 0.89 . . . . 0.0 110.304 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.81 -49.69 76.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.17 0.588 . . . . 0.0 110.867 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.41 99.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.388 0.995 . . . . 0.0 111.803 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -61.23 -48.36 81.85 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.51 1.924 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -62.56 -38.49 90.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.04 0.936 . . . . 0.0 110.923 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 33.51 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.851 1.215 . . . . 0.0 112.343 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.632 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.53 145.39 44.35 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 119.11 1.455 . . . . 0.0 109.217 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -73.41 -16.09 61.34 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 123.302 0.641 . . . . 0.0 111.736 -174.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.76 173.55 39.34 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.62 136.42 35.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.37 144.82 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.84 138.84 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -52.14 139.51 34.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 165.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.96 137.75 51.43 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 CA-C-N 119.963 1.022 . . . . 0.0 110.5 -8.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.07 150.92 46.3 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.481 0.712 . . . . 0.0 110.077 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -147.98 -173.3 4.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.298 0.639 . . . . 0.0 111.057 -176.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -50.54 -35.41 29.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.479 1.112 . . . . 0.0 109.669 173.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.81 -19.46 28.72 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -114.46 -23.36 9.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.24 0.927 . . . . 0.0 112.039 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -58.09 -50.59 72.95 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -47.34 74.68 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.287 1.035 . . . . 0.0 111.244 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -61.25 -52.8 63.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 122.991 0.516 . . . . 0.0 109.851 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -67.99 -33.17 74.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.222 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.34 -58.02 10.32 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.715 1.143 . . . . 0.0 109.69 173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -56.94 -40.01 75.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.867 0.758 . . . . 0.0 111.477 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -55.31 -56.46 19.76 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.031 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 -26.11 18.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 120.39 1.45 . . . . 0.0 112.812 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -53.96 -53.53 51.54 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.084 0.856 . . . . 0.0 108.912 169.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.3 -43.83 26.95 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.552 0.341 . . . . 0.0 110.737 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -73.88 -62.01 1.65 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.074 0.549 . . . . 0.0 110.045 -168.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mt -71.93 -43.22 65.62 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.972 0.509 . . . . 0.0 109.776 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.55 32.47 3.39 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.491 -163.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--O 1.253 1.282 0 CA-C-N 118.631 1.215 . . . . 0.0 111.239 172.293 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 mtp . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.62 163.13 24.43 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.432 0.693 . . . . 0.0 109.65 167.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 58.91 86.68 0.08 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 128.329 2.652 . . . . 0.0 108.532 -159.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -76.94 32.53 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.843 1.257 . . . . 0.0 111.937 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 42.86 59.01 3.0 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 128.604 2.762 . . . . 0.0 109.312 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.07 108.22 0.38 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.097 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 169.89 17.53 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.729 0.776 . . . . 0.0 111.779 -175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -136.95 101.9 4.71 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.988 1.715 . . . . 0.0 108.258 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.9 tp -71.01 131.08 43.13 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.3 99.74 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.37 70.12 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.492 1.917 . . . . 0.0 108.576 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.44 151.67 41.04 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.948 -1.095 . . . . 0.0 108.102 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.5 -42.13 65.18 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.138 -0.976 . . . . 0.0 110.793 169.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -90.96 115.97 28.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.618 1.567 . . . . 0.0 107.02 -173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.8 t -57.75 -47.61 81.97 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.262 0.483 . . . . 0.0 110.078 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -53.57 -40.88 65.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.75 0.705 . . . . 0.0 111.177 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 ttt -58.3 -39.96 80.71 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.546 0.738 . . . . 0.0 110.143 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HG2' ' HE ' ' A' ' 22' ' ' ARG . 14.1 ttp180 -62.13 -46.79 87.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.004 1.322 . . . . 0.0 109.797 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -55.81 -51.93 65.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.744 0.818 . . . . 0.0 108.887 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.51 -62.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.223 -1.37 . . . . 0.0 108.254 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.9 t -48.64 -44.23 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 120.828 1.649 . . . . 0.0 110.671 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HE ' ' HG2' ' A' ' 18' ' ' ARG . 59.5 mtt-85 -60.85 -45.44 94.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.669 1.122 . . . . 0.0 111.664 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -63.88 -42.5 97.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.758 0.708 . . . . 0.0 111.748 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -63.76 -32.41 73.9 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.922 0.889 . . . . 0.0 111.478 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.16 -56.76 11.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -64.79 -19.47 65.85 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -51.73 -33.44 34.65 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.898 1.226 . . . . 0.0 110.804 164.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.9 -41.4 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.975 2.11 . . . . 0.0 110.129 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.86 -139.27 6.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 64.86 60.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 123.173 1.464 . . . . 0.0 110.32 166.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.24 176.18 4.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.539 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 56.41 48.34 17.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 127.483 2.313 . . . . 0.0 113.477 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -55.51 161.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 121.13 -0.981 . . . . 0.0 111.369 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.04 157.5 44.85 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.279 1.832 . . . . 0.0 107.617 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.17 116.86 19.04 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.24 163.77 13.49 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 158.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.3 -37.04 58.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.006 0.821 . . . . 0.0 110.432 172.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -158.86 174.71 14.57 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.156 1.383 . . . . 0.0 109.237 -169.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.47 -35.31 71.78 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.945 1.138 . . . . 0.0 115.945 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.5 t -66.38 -48.87 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 120.822 2.311 . . . . 0.0 107.152 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.73 -28.86 70.17 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.816 0.847 . . . . 0.0 111.287 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.68 -56.37 14.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.947 1.699 . . . . 0.0 109.43 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.73 -45.62 74.13 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.105 0.562 . . . . 0.0 109.77 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -65.75 -28.92 69.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.15 0.58 . . . . 0.0 112.161 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -62.93 -52.56 62.58 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.074 0.95 . . . . 0.0 108.804 166.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 HG13 ' A' ' 54' ' ' VAL . 14.1 mt -53.86 -41.45 67.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.704 1.138 . . . . 0.0 111.131 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -72.12 -7.09 47.08 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -17.6 58.46 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.463 1.029 . . . . 0.0 111.653 167.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.08 169.96 16.85 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.546 1.067 . . . . 0.0 111.548 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.22 108.2 2.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.244 0.926 . . . . 0.0 113.279 -171.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.49 163.4 27.43 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.444 1.098 . . . . 0.0 108.749 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.53 -45.06 19.35 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 166.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -135.91 150.59 49.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.599 0.76 . . . . 0.0 112.437 -166.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.682 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -131.63 70.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.082 1.353 . . . . 0.0 108.687 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.18 130.97 34.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.5 m -150.39 158.77 44.53 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.614 -0.679 . . . . 0.0 110.979 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.91 169.08 18.97 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.458 166.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.0 t-105 -83.28 -48.92 9.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.719 1.608 . . . . 0.0 112.372 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.86 79.32 6.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.71 1.604 . . . . 0.0 109.582 -159.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.34 125.29 28.28 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.63 -40.57 29.27 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.125 2.55 . . . . 0.0 113.7 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -83.54 -101.91 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.6 ttp -79.78 106.97 12.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.79 160.61 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.19 -29.72 56.71 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.082 -1.011 . . . . 0.0 112.117 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -67.01 -43.01 83.97 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.764 0.782 . . . . 0.0 110.842 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -71.54 -37.55 71.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.611 0.765 . . . . 0.0 110.304 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.3 tp -53.06 -58.62 6.38 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.211 1.004 . . . . 0.0 108.701 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -48.09 -56.96 6.51 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.089 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -67.41 -24.68 65.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 120.035 1.289 . . . . 0.0 114.02 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -65.98 -48.27 71.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.257 6.3 mt -55.57 -57.83 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 167.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -23.86 67.49 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.163 1.385 . . . . 0.0 113.038 -165.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.25 -79.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.507 1.049 . . . . 0.0 110.264 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -168.79 8.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -161.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.73 23.73 1.03 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.99 1.281 . . . . 0.0 115.163 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 65.58 14.7 9.65 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 128.088 2.555 . . . . 0.0 112.251 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 63.0 mtm -126.71 3.52 6.74 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.9 1.68 . . . . 0.0 110.835 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.8 p -59.52 -25.03 64.14 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.092 0.957 . . . . 0.0 113.285 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -9.43 59.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.125 0.97 . . . . 0.0 113.618 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 54' ' ' VAL . 14.2 mt -56.59 144.22 65.15 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 119.199 0.909 . . . . 0.0 109.821 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.98 79.96 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.261 2.641 . . . . 0.0 109.042 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.91 110.37 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 128.627 2.771 . . . . 0.0 107.746 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.578 HD21 ' HD3' ' A' ' 119' ' ' LYS . 26.7 tp -135.94 113.21 10.6 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.263 -0.898 . . . . 0.0 111.935 -158.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -80.97 129.73 34.68 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.36 105.18 5.33 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -152.26 166.79 30.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.302 0.501 . . . . 0.0 110.831 -166.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.56 57.05 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.282 -0.886 . . . . 0.0 112.178 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -72.82 96.6 2.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.338 1.455 . . . . 0.0 110.084 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.59 -0.81 52.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.861 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HG2' ' H ' ' A' ' 94' ' ' ASN . 31.6 ttmt -50.71 118.03 2.85 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.559 1.072 . . . . 0.0 109.812 -174.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -50.71 -52.98 35.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.103 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.24 -29.85 69.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.422 1.01 . . . . 0.0 112.625 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.413 ' H ' ' HG2' ' A' ' 91' ' ' LYS . 69.6 m-20 -72.13 -36.33 69.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.203 0.91 . . . . 0.0 110.039 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -64.3 -44.5 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -58.66 -48.92 84.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.25 -44.55 83.99 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.427 1.012 . . . . 0.0 110.152 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.95 88.18 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 119.225 0.921 . . . . 0.0 111.236 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.73 92.7 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.272 0.487 . . . . 0.0 109.874 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -62.15 -49.91 73.97 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.926 2.491 . . . . 0.0 111.283 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.39 -22.1 62.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.608 1.163 . . . . 0.0 111.89 174.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.22 6.11 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.7 1.143 . . . . 0.0 110.327 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.596 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -65.52 142.46 58.12 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 63.6 p -66.4 -24.36 66.46 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.105 0.562 . . . . 0.0 111.093 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 169.45 38.3 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.92 126.18 28.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.224 1.41 . . . . 0.0 108.563 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 t -121.08 107.31 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.04 153.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 166.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -56.43 150.37 34.1 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.548 1.539 . . . . 0.0 109.105 160.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.51 147.75 79.22 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 CA-C-N 121.105 1.43 . . . . 0.0 109.903 -12.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -146.92 138.41 24.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -140.94 -174.75 4.08 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.559 1.544 . . . . 0.0 109.613 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.19 -25.64 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.304 -0.872 . . . . 0.0 110.153 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.12 53.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.202 1.001 . . . . 0.0 112.723 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 5.6 t -98.6 -27.0 14.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.839 0.745 . . . . 0.0 110.754 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -46.72 86.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.302 0.956 . . . . 0.0 108.797 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -38.53 91.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.717 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -67.62 -54.1 22.52 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 118.747 0.703 . . . . 0.0 110.355 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HD3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -58.72 -38.08 77.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.829 1.195 . . . . 0.0 111.042 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.98 -54.67 44.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.01 0.823 . . . . 0.0 110.629 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -54.82 -39.64 68.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.85 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -64.99 -45.49 85.4 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.332 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -19.63 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 121.041 1.746 . . . . 0.0 113.414 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -56.54 -62.9 1.41 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 159.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -72.54 -30.37 64.4 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.259 -0.9 . . . . 0.0 112.609 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -68.66 0.65 Allowed 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.95 -23.57 61.47 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 122.954 0.159 . . . . 0.0 110.89 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.86 30.53 23.26 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.532 -1.704 . . . . 0.0 110.056 -165.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-N 119.866 1.833 . . . . 0.0 110.476 172.356 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 117.616 -1.183 . . . . 0.0 108.078 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.73 36.65 0.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 121.533 1.969 . . . . 0.0 110.629 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.58 161.86 33.92 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.099 0.96 . . . . 0.0 109.29 -159.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -91.36 -1.7 57.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.276 0.63 . . . . 0.0 110.683 159.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 51.97 33.98 12.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.209 1.404 . . . . 0.0 111.325 -161.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.93 123.07 11.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.153 1.781 . . . . 0.0 110.415 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.271 2.4 ptpt -91.86 164.01 13.83 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.31 108.53 12.31 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.371 1.468 . . . . 0.0 108.77 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -82.43 139.33 34.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 120.79 1.632 . . . . 0.0 109.963 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -135.72 112.45 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.361 1.465 . . . . 0.0 108.448 -173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.27 41.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.081 1.352 . . . . 0.0 110.324 -170.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.32 154.67 7.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.955 -1.09 . . . . 0.0 108.959 164.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.08 -45.31 11.52 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.22 -1.55 . . . . 0.0 110.744 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -70.6 115.22 9.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.645 1.978 . . . . 0.0 107.636 173.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 t -59.64 -39.53 84.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.192 1.36 . . . . 0.0 111.884 -172.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.4 m -55.13 -32.41 62.05 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.74 0.7 . . . . 0.0 111.45 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 tpp -60.5 -42.46 96.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.231 -0.918 . . . . 0.0 109.947 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -66.18 -34.44 78.04 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.719 1.145 . . . . 0.0 111.124 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -59.79 -58.77 7.12 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.74 -63.26 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 C-N-CA 125.978 1.711 . . . . 0.0 109.05 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.78 -46.04 62.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 121.071 1.759 . . . . 0.0 111.267 -174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -65.51 -41.24 93.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 120.179 1.354 . . . . 0.0 111.518 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -58.15 -54.57 45.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.421 1.088 . . . . 0.0 109.437 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -52.26 -48.53 65.18 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.861 2.064 . . . . 0.0 110.829 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.1 mt -57.03 -44.15 82.6 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.318 0.647 . . . . 0.0 110.811 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -77.62 -17.24 57.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.51 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.81 -43.89 94.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.34 1.427 . . . . 0.0 109.287 166.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.07 -37.24 78.39 Favored 'General case' 0 N--CA 1.46 0.038 0 O-C-N 122.179 -0.325 . . . . 0.0 110.596 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.98 6.1 10.32 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.92 1.248 . . . . 0.0 113.885 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.24 155.82 39.77 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.7 1.75 . . . . 0.0 108.942 163.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -149.88 -167.53 2.85 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.322 1.049 . . . . 0.0 108.394 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 t30 55.15 37.93 29.66 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.108 1.363 . . . . 0.0 111.16 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.29 158.11 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -140.76 166.68 24.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.624 2.37 . . . . 0.0 107.478 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -128.78 155.11 45.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.91 167.75 10.38 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 161.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -42.97 89.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.68 0.792 . . . . 0.0 111.435 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.3 173.87 5.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.038 1.335 . . . . 0.0 108.835 -169.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.33 -42.01 72.98 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 119.923 1.238 . . . . 0.0 113.389 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.11 -51.42 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.86 1.264 . . . . 0.0 109.659 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -70.33 -35.65 73.75 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.754 0.821 . . . . 0.0 111.076 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.31 65.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.568 1.147 . . . . 0.0 109.409 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -54.61 -48.92 71.59 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.721 0.638 . . . . 0.0 111.6 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -66.3 -28.5 68.74 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -64.19 -46.56 83.39 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.372 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 54' ' ' VAL . 8.2 mt -57.55 -41.69 81.51 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 110.665 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 3.06 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.53 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 158.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.82 164.32 11.22 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.969 1.271 . . . . 0.0 111.395 -175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.17 14.53 78.99 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.035 0.826 . . . . 0.0 113.167 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -81.46 117.32 21.79 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.44 -25.11 26.78 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-O 118.833 -0.982 . . . . 0.0 113.225 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -148.94 149.7 31.65 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.17 0.988 . . . . 0.0 110.803 -169.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -133.99 85.44 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.27 127.22 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -152.03 163.64 38.89 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.082 -1.011 . . . . 0.0 110.308 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.35 173.58 5.66 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.795 0.807 . . . . 0.0 110.278 172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 60.1 t-105 -71.58 -60.69 2.1 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.664 158.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.258 23.7 p30 29.21 -157.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 130.392 3.477 . . . . 0.0 116.215 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 65.15 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.034 1.334 . . . . 0.0 112.504 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HG2' ' H ' ' A' ' 62' ' ' ASN . 58.3 Cg_endo -65.36 -66.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 121.796 1.664 . . . . 0.0 108.78 169.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 61' ' ' PRO . 5.7 m120 -155.61 -69.69 0.12 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.661 2.385 . . . . 0.0 104.953 172.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.0 ttm -70.01 88.36 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 160.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -65.61 172.01 3.72 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.793 0.837 . . . . 0.0 110.428 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.53 -32.75 53.43 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.988 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -70.46 -49.87 44.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.537 1.169 . . . . 0.0 110.579 179.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.61 -38.06 89.67 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 123.472 0.709 . . . . 0.0 110.874 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.0 tp -55.94 -61.31 2.46 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.115 1.366 . . . . 0.0 108.722 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -46.42 -53.52 10.91 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.843 1.257 . . . . 0.0 109.511 174.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 66.6 mttt -66.62 -26.25 66.99 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.126 0.875 . . . . 0.0 113.12 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.2 m -72.87 -43.36 62.64 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.361 1.064 . . . . 0.0 109.612 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.37 -45.79 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.969 1.308 . . . . 0.0 113.593 166.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -49.3 77.16 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.311 1.044 . . . . 0.0 109.529 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.97 14.3 1.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.088 0.955 . . . . 0.0 113.303 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -81.84 -165.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.474 1.033 . . . . 0.0 109.287 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.6 -41.84 0.08 OUTLIER Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.989 1.757 . . . . 0.0 110.865 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.88 -8.74 59.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.836 1.255 . . . . 0.0 112.642 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 mtm -126.33 -8.39 6.39 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 p -65.34 -17.29 64.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.492 1.042 . . . . 0.0 113.167 -171.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.7 59.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.526 1.13 . . . . 0.0 113.471 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 54' ' ' VAL . 19.5 mt -61.01 133.24 92.48 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 119.314 0.961 . . . . 0.0 110.271 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.01 125.3 12.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.011 1.807 . . . . 0.0 108.682 166.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.624 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -119.07 107.71 22.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 127.205 2.202 . . . . 0.0 106.804 -173.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 tp -125.12 115.2 20.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.341 1.057 . . . . 0.0 109.712 -164.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.38 122.35 26.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.92 113.59 24.87 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -156.0 168.9 25.8 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.259 -0.9 . . . . 0.0 110.626 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.32 -21.23 46.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.379 -0.825 . . . . 0.0 111.684 163.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.53 107.35 19.1 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.231 1.012 . . . . 0.0 111.227 -167.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -73.56 0.14 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.989 171.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.1 tttt 32.73 98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.828 2.451 . . . . 0.0 113.381 -167.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -52.45 -41.51 63.36 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.287 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.73 -36.27 69.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.151 1.342 . . . . 0.0 112.752 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.81 -36.41 70.24 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 121.536 -0.727 . . . . 0.0 110.085 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.1 mt -63.46 -39.17 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.642 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.3 -53.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.51 -46.45 70.09 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.987 0.812 . . . . 0.0 110.654 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.47 73.93 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.916 0.886 . . . . 0.0 110.741 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -42.88 99.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.43 0.692 . . . . 0.0 110.147 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -60.84 -50.89 71.63 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.312 1.845 . . . . 0.0 111.17 175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.46 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -59.62 -22.65 62.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.918 0.887 . . . . 0.0 112.267 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.78 11.73 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.544 -1.142 . . . . 0.0 112.281 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.04 134.96 57.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.415 1.107 . . . . 0.0 108.805 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 m -67.64 -10.08 49.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.201 1.001 . . . . 0.0 112.255 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.06 170.54 38.2 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.332 0.969 . . . . 0.0 111.345 166.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.14 132.32 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.276 1.43 . . . . 0.0 107.681 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -130.39 104.79 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 156.68 3.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -58.21 151.08 49.21 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 158.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.27 148.36 91.04 Favored 'Cis proline' 0 N--CA 1.457 -0.632 0 CA-C-N 119.653 0.912 . . . . 0.0 110.633 -9.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -149.44 154.47 38.89 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.322 0.649 . . . . 0.0 110.088 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 p -143.81 -175.19 4.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.363 1.065 . . . . 0.0 109.46 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.88 -29.62 60.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.599 0.76 . . . . 0.0 110.3 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.77 67.98 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.2 t -99.57 -27.61 13.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.85 1.204 . . . . 0.0 110.224 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -50.63 70.21 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -37.21 84.55 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.863 1.265 . . . . 0.0 112.249 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -57.98 -57.19 13.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.865 1.266 . . . . 0.0 109.14 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -66.01 -34.16 77.45 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.489 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 mt -59.54 -55.1 38.85 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 109.187 175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.465 ' HA ' ' CD2' ' A' ' 124' ' ' PHE . 18.7 t-20 -64.37 -30.56 71.6 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 118.283 0.492 . . . . 0.0 110.412 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -60.2 3.51 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.819 -1.086 . . . . 0.0 110.029 167.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.4 pt -71.15 -26.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.426 1.466 . . . . 0.0 113.86 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 121' ' ' ASN . 21.6 m-30 -59.47 -39.07 82.5 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 119.092 0.86 . . . . 0.0 109.918 170.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -84.58 -40.22 17.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.008 0.523 . . . . 0.0 110.71 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HG3' HD23 ' A' ' 127' ' ' LEU . 32.1 tptt -77.14 -71.7 0.39 Allowed 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.564 1.145 . . . . 0.0 108.125 -168.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.429 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.3 mt -68.28 -20.41 64.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.269 0.486 . . . . 0.0 111.105 177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 38.47 30.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -167.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 59.7 mmm . . . . . 0 C--O 1.25 1.093 0 CA-C-N 117.882 0.841 . . . . 0.0 109.377 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.62 -157.82 0.71 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.586 1.554 . . . . 0.0 108.676 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -84.53 -178.22 6.83 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.381 1.072 . . . . 0.0 108.747 164.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -14.85 61.77 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.909 158.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 50.01 61.19 3.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.676 1.991 . . . . 0.0 107.546 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tt -49.12 104.14 0.06 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.145 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 177.14 6.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.987 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.76 124.39 43.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.168 2.187 . . . . 0.0 106.091 174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.9 tp -84.13 134.52 34.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 158.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -133.66 92.54 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.5 t -95.84 51.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.24 105.24 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -47.99 -43.12 29.42 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.784 1.634 . . . . 0.0 112.103 -176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.75 116.72 26.1 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.304 1.041 . . . . 0.0 108.521 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -52.35 -51.45 58.76 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.164 0.986 . . . . 0.0 110.77 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.9 m -52.17 -39.35 59.95 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.417 -0.802 . . . . 0.0 111.346 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 ttp -61.43 -42.06 98.16 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -42.11 98.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.854 1.207 . . . . 0.0 109.944 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -57.46 -57.44 12.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -49.07 -60.81 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.772 1.629 . . . . 0.0 108.866 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.38 -51.1 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 120.388 1.449 . . . . 0.0 111.055 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -41.17 91.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.07 0.85 . . . . 0.0 111.052 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -62.27 -53.94 47.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -57.91 -34.28 69.67 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.586 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -60.09 -62.71 1.67 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.873 0.869 . . . . 0.0 109.314 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -65.24 -14.33 60.43 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -174.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.08 -7.98 34.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.425 1.49 . . . . 0.0 113.152 166.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 32.5 mt -126.01 7.79 7.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 129.485 3.114 . . . . 0.0 112.086 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 -144.13 22.67 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -169.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.33 40.39 18.28 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.189 1.495 . . . . 0.0 113.3 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.08 171.08 7.36 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.498 -0.751 . . . . 0.0 110.936 174.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 98.57 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.29 3.036 . . . . 0.0 107.139 169.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.754 -0.591 . . . . 0.0 110.156 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -132.14 175.43 9.25 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.81 2.044 . . . . 0.0 107.615 167.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -127.3 166.33 18.0 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.54 1.536 . . . . 0.0 107.379 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.68 168.36 9.84 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 159.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.75 -26.33 62.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.731 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.32 174.76 0.45 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.031 1.732 . . . . 0.0 107.674 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.25 -39.41 42.83 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.005 1.288 . . . . 0.0 115.428 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.57 -43.95 92.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 119.048 1.424 . . . . 0.0 109.918 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -75.07 -28.05 60.2 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.561 1.144 . . . . 0.0 110.652 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -62.11 -46.25 89.87 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.009 0.924 . . . . 0.0 110.102 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.11 -45.16 95.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.768 -0.635 . . . . 0.0 109.324 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -57.75 -44.55 86.16 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.646 0.657 . . . . 0.0 111.661 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -53.51 -50.87 64.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.751 0.82 . . . . 0.0 109.778 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -35.62 80.28 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.209 0.604 . . . . 0.0 112.017 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.02 -1.34 7.28 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.816 0.846 . . . . 0.0 112.19 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.6 12.93 7.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.572 1.949 . . . . 0.0 112.495 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.33 163.97 23.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 120.214 1.37 . . . . 0.0 113.857 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.97 78.96 1.85 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -70.76 119.62 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.61 -19.89 79.73 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.523 -168.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -132.09 150.46 52.15 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 127.046 2.138 . . . . 0.0 106.416 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 81' ' ' LEU . 13.4 t -137.56 72.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -77.33 143.73 12.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.9 p -149.71 163.13 38.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 118.659 0.663 . . . . 0.0 111.011 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.45 179.97 1.87 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 158.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.461 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 29.0 t-105 -71.04 -78.13 0.08 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 162.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.2 t30 43.1 178.16 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.956 2.902 . . . . 0.0 112.606 -164.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.2 mtm -140.33 68.26 32.63 Favored Pre-proline 0 CA--C 1.545 0.77 0 O-C-N 119.053 -2.28 . . . . 0.0 110.553 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.49 49.0 2.32 Favored 'Trans proline' 0 CA--C 1.543 0.964 1 C-N-CA 125.467 4.111 . . . . 0.0 110.791 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.88 -80.38 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.439 1.495 . . . . 0.0 108.709 -159.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.2 ttm -79.52 81.73 5.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.16 159.78 2.4 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.543 1.137 . . . . 0.0 110.675 167.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.96 59.33 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.136 -0.813 . . . . 0.0 113.369 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.461 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -74.39 -46.86 37.61 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.584 1.154 . . . . 0.0 109.313 174.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -64.27 -38.3 90.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.559 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.02 -53.81 54.07 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.301 0.955 . . . . 0.0 109.21 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -48.85 -56.1 9.72 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -66.17 -28.69 68.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 120.384 1.447 . . . . 0.0 114.078 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.5 m -71.98 -33.75 68.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.262 0.937 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.4 mt -73.36 -48.37 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 120.881 -1.137 . . . . 0.0 108.962 173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.66 24.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 129.508 3.123 . . . . 0.0 111.475 171.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.8 -72.42 0.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 108.146 172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p30 157.21 -11.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 129.398 3.079 . . . . 0.0 112.455 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 20.43 0.18 Allowed Glycine 0 CA--C 1.539 1.578 0 C-N-CA 126.946 2.212 . . . . 0.0 116.569 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 92.86 -12.31 0.17 Allowed 'General case' 0 N--CA 1.461 0.099 1 C-N-CA 133.37 4.668 . . . . 0.0 110.961 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.1 mtt -76.48 -18.87 58.54 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.649 -0.657 . . . . 0.0 110.815 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -61.53 -25.08 67.05 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.424 1.089 . . . . 0.0 113.341 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.33 -16.5 61.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 54' ' ' VAL . 32.8 mt -60.5 141.7 91.55 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-N 118.472 0.578 . . . . 0.0 111.465 -169.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 72.69 5.78 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.707 2.271 . . . . 0.0 108.423 166.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -60.53 137.77 22.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 160.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' CD1' ' HE3' ' A' ' 119' ' ' LYS . 2.9 tp -147.97 111.6 5.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -160.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.93 123.14 24.55 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.7 102.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -142.35 174.74 10.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.179 0.99 . . . . 0.0 110.281 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.78 -23.5 19.7 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.814 0.846 . . . . 0.0 111.617 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -86.5 111.32 20.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.756 0.707 . . . . 0.0 109.141 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.96 -73.52 0.07 Allowed 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 166.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.3 tptp 43.78 91.03 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 123.538 1.637 . . . . 0.0 112.432 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -52.16 -34.65 45.89 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.2 -0.938 . . . . 0.0 112.889 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -67.34 -36.03 80.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.293 1.406 . . . . 0.0 111.692 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -63.31 -38.91 93.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.236 171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.54 -49.99 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.565 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.46 -55.53 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 119.542 1.065 . . . . 0.0 108.341 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.12 79.37 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.924 0.489 . . . . 0.0 110.769 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.98 -42.16 90.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.919 -0.488 . . . . 0.0 110.543 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.45 77.22 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.562 0.619 . . . . 0.0 111.762 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -61.4 -49.99 74.65 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.718 1.607 . . . . 0.0 109.672 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.41 -28.19 69.07 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.927 0.491 . . . . 0.0 111.233 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.5 42.03 6.28 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 124.74 1.162 . . . . 0.0 111.338 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.18 156.87 11.44 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 172.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.403 ' HB2' ' CG2' ' A' ' 123' ' ' ILE . 72.8 p -64.93 -22.77 67.05 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.301 -0.874 . . . . 0.0 111.948 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 161.12 -175.95 37.73 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.69 1.614 . . . . 0.0 109.426 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -136.74 91.03 2.6 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.673 1.189 . . . . 0.0 108.046 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.7 t -75.3 125.97 35.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.88 144.15 16.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 167.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -75.8 162.34 72.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.554 0.616 . . . . 0.0 111.438 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -64.12 145.75 60.93 Favored 'Cis proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.714 0.934 . . . . 0.0 109.782 -12.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -139.2 162.16 35.66 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.086 0.955 . . . . 0.0 109.235 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 p -142.88 171.98 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.354 1.061 . . . . 0.0 110.109 -164.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.83 69.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 169.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.28 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.642 0.777 . . . . 0.0 112.401 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 t -81.76 -33.27 31.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.981 1.264 . . . . 0.0 110.119 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -50.99 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.552 1.069 . . . . 0.0 109.017 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -41.57 92.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 126.125 1.77 . . . . 0.0 111.073 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.95 -42.44 98.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.303 1.041 . . . . 0.0 109.156 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HE3' ' CD1' ' A' ' 84' ' ' LEU . 3.2 mmmp? -68.95 -29.72 68.02 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 116.712 -1.613 . . . . 0.0 112.384 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.28 -54.48 24.41 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -55.32 -42.92 74.41 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 118.225 0.466 . . . . 0.0 111.258 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -51.23 -60.04 3.55 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.39 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 104' ' ' SER . 15.4 pt -67.57 -32.66 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 121.343 1.883 . . . . 0.0 113.757 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -58.63 -45.09 90.01 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.701 0.682 . . . . 0.0 109.632 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.47 -34.17 15.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -76.1 -72.43 0.32 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -37.0 79.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.266 0.627 . . . . 0.0 109.333 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.01 41.58 4.58 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -164.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.246 0.9 0 CA-C-N 118.501 1.151 . . . . 0.0 110.883 175.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 tpt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.44 111.33 22.09 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.563 1.545 . . . . 0.0 109.367 -166.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -72.14 -9.29 58.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.25 0.62 . . . . 0.0 112.482 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -68.19 6.59 0.72 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.091 2.156 . . . . 0.0 114.468 -164.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -71.22 -21.96 62.07 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.641 1.11 . . . . 0.0 112.904 168.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.5 OUTLIER -52.13 123.27 10.19 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.595 1.158 . . . . 0.0 107.938 -174.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.93 161.71 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.574 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.8 95.28 3.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -69.31 138.91 54.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.0 1.273 . . . . 0.0 109.492 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -131.67 115.5 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.7 t -130.69 76.68 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.23 159.84 18.68 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.853 0.835 . . . . 0.0 111.342 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.55 97.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.199 1.4 . . . . 0.0 111.212 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD2' ' HB ' ' A' ' 16' ' ' THR . 1.2 t80 -90.0 -63.85 1.22 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.683 0.393 . . . . 0.0 110.528 -159.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.6 m 127.28 -59.35 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 1 C-N-CA 133.273 4.629 . . . . 0.0 106.875 -161.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 14' ' ' PHE . 91.8 m -65.59 -33.75 76.63 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.375 -0.828 . . . . 0.0 111.771 -174.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -61.5 -27.25 68.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.23 1.377 . . . . 0.0 110.207 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD3' ' HG3' ' A' ' 35' ' ' GLU . 13.3 ttm180 -63.47 -47.73 80.61 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.477 1.035 . . . . 0.0 109.589 174.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -48.43 80.94 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.762 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -53.89 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.36 -47.01 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 125.0 1.32 . . . . 0.0 111.228 -172.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -54.03 -50.75 65.98 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.063 0.945 . . . . 0.0 110.35 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.28 -43.44 91.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.235 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 mt -55.12 -43.14 73.83 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.244 0.929 . . . . 0.0 109.848 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.7 -48.81 70.78 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.548 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -64.85 -33.63 76.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.118 -0.944 . . . . 0.0 112.473 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -58.41 -30.76 67.12 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.491 1.041 . . . . 0.0 110.908 171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.96 12.25 37.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.24 1.816 . . . . 0.0 111.699 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.61 -33.67 5.04 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.641 1.591 . . . . 0.0 113.317 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -61.38 140.01 58.09 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.929 1.365 . . . . 0.0 110.633 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 177.47 7.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 122.075 0.94 . . . . 0.0 111.403 -168.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.251 21.4 t30 67.96 34.0 4.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.77 2.828 . . . . 0.0 113.503 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 154.97 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.474 0.654 . . . . 0.0 109.723 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.33 179.41 6.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 128.454 2.701 . . . . 0.0 108.019 -163.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 31.0 tt0 -145.88 152.27 39.21 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.848 -0.532 . . . . 0.0 111.614 -164.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.21 172.5 12.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.793 1.237 . . . . 0.0 108.93 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -68.46 -47.69 66.45 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.746 0.818 . . . . 0.0 112.726 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.84 168.01 10.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.85 2.06 . . . . 0.0 107.335 -158.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.6 -38.02 27.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.723 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.0 t -63.41 -51.01 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.706 2.253 . . . . 0.0 107.555 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.97 -28.69 69.99 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.972 0.909 . . . . 0.0 110.829 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -69.57 -42.9 73.92 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.947 1.699 . . . . 0.0 111.37 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -65.62 -43.54 89.26 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -56.52 -39.71 73.8 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.155 0.982 . . . . 0.0 111.058 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -61.31 -61.46 2.54 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.365 0.984 . . . . 0.0 109.252 170.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.37 -49.8 60.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -168.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.72 -2.87 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.4 -11.5 59.25 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.822 1.192 . . . . 0.0 112.969 172.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.71 5.82 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 119.199 2.44 . . . . 0.0 119.199 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.42 73.71 0.64 Allowed Glycine 0 CA--C 1.525 0.683 0 CA-C-N 120.603 2.202 . . . . 0.0 110.377 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -66.17 109.21 2.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.39 -10.75 24.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.338 -0.701 . . . . 0.0 114.398 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.4 144.68 42.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.143 1.377 . . . . 0.0 109.159 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -132.13 91.24 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mt -108.49 125.69 65.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.5 p -143.03 168.05 20.62 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.852 0.834 . . . . 0.0 110.896 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.83 170.18 10.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 158.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -84.91 -51.68 6.55 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.455 1.502 . . . . 0.0 108.307 162.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -87.24 72.49 9.88 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.61 1.564 . . . . 0.0 110.192 -159.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 tpt -124.77 125.51 25.45 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.82 -0.31 9.73 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.748 2.299 . . . . 0.0 115.067 -161.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -107.25 -96.24 0.37 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.3 ttm -91.07 89.9 7.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.28 155.11 5.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.089 172.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.78 -31.79 58.34 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.03 -0.872 . . . . 0.0 112.203 -172.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.03 -36.5 72.4 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.871 1.335 . . . . 0.0 110.982 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -68.09 -41.5 81.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.011 175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -59.63 -49.11 79.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.784 0.72 . . . . 0.0 109.575 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -50.59 -63.11 1.23 Allowed 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 124.836 1.254 . . . . 0.0 108.106 172.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -63.22 -27.48 69.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.94 1.246 . . . . 0.0 113.398 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.1 m -61.74 -53.87 50.13 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.394 0.997 . . . . 0.0 108.884 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.5 mt -62.51 -46.05 97.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.671 1.188 . . . . 0.0 110.21 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.58 7.91 0.56 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.698 1.999 . . . . 0.0 113.215 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.54 65.09 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 120.961 1.709 . . . . 0.0 111.862 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 130.35 -79.23 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.21 3.404 . . . . 0.0 107.998 171.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.95 39.85 2.06 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 126.502 2.001 . . . . 0.0 112.098 -170.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.89 -76.86 0.3 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 124.983 1.313 . . . . 0.0 108.055 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.571 ' HB3' HD12 ' A' ' 81' ' ' LEU . 37.1 mtm -142.6 15.03 1.97 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -158.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 m -55.06 -23.99 22.96 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 121.743 2.065 . . . . 0.0 114.451 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -9.57 53.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.596 1.089 . . . . 0.0 113.255 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 54' ' ' VAL . 16.9 mt -78.02 128.93 77.36 Favored Pre-proline 0 C--O 1.236 0.362 0 O-C-N 121.129 -0.982 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 91.02 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.387 2.058 . . . . 0.0 109.749 170.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 69' ' ' LEU . 2.7 m -75.76 107.85 7.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 167.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 tp -112.6 113.97 26.37 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.269 1.427 . . . . 0.0 108.562 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.9 mmt -85.67 125.93 33.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -135.03 88.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -122.62 174.21 7.22 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 113.657 -161.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.58 -21.69 26.7 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 111.662 164.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -86.18 106.74 17.5 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.781 1.232 . . . . 0.0 110.972 -170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.23 8.62 15.23 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.476 -0.765 . . . . 0.0 112.587 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -51.96 121.35 6.54 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.242 1.017 . . . . 0.0 108.927 -171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.08 -38.71 76.89 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.275 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.36 -32.32 64.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.489 1.04 . . . . 0.0 112.329 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.72 -39.56 61.82 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.732 0.696 . . . . 0.0 109.495 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.43 -46.96 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 171.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.36 -57.44 4.98 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.34 -45.44 80.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.335 1.054 . . . . 0.0 110.71 -172.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.78 -41.78 96.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.22 -15.25 61.0 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -75.05 -51.73 12.82 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.266 1.426 . . . . 0.0 108.011 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.53 78.04 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.501 0.72 . . . . 0.0 111.905 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.79 58.84 2.07 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.106 1.336 . . . . 0.0 110.502 -175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.61 162.35 5.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 117.398 0.599 . . . . 0.0 110.834 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.8 p -62.42 -43.06 99.73 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.41 173.18 46.1 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 125.472 1.51 . . . . 0.0 110.152 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.94 135.23 46.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.327 1.851 . . . . 0.0 107.288 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.0 t -134.47 145.86 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 128.327 2.651 . . . . 0.0 104.763 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 t -127.63 164.48 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -49.85 141.18 14.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.284 160.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -78.35 173.49 56.27 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 120.702 1.287 . . . . 0.0 109.337 -20.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -177.28 151.5 0.79 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 120.596 -1.315 . . . . 0.0 108.619 -175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -153.77 -179.33 7.72 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 127.285 2.234 . . . . 0.0 108.275 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.5 -29.7 62.13 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.321 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.59 33.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.857 1.263 . . . . 0.0 113.076 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.26 -30.8 13.25 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.808 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -48.74 79.08 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.751 1.16 . . . . 0.0 108.331 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -40.7 97.03 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.617 1.167 . . . . 0.0 111.51 -176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.3 -40.4 77.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.9 0.88 . . . . 0.0 109.042 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HE2' ' HE3' ' A' ' 122' ' ' LYS . 50.4 mmtt -65.7 -40.82 92.69 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.648 -1.282 . . . . 0.0 110.527 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.0 mt -55.44 -49.7 71.77 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.776 0.831 . . . . 0.0 108.968 170.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -61.81 -38.58 88.65 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.065 0.848 . . . . 0.0 112.612 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE3' ' HE2' ' A' ' 119' ' ' LYS . 9.2 mtmm -55.5 -52.49 63.49 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.027 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.7 pt -73.68 -24.78 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 120.192 1.36 . . . . 0.0 113.473 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -56.95 -59.55 4.88 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.24 -43.72 73.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.085 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -69.82 0.33 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.61 -29.38 65.76 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.7 30.53 13.11 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 117.907 -1.496 . . . . 0.0 109.756 -160.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.5 mmm . . . . . 0 C--O 1.247 0.95 0 CA-C-N 120.135 1.967 . . . . 0.0 109.417 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.12 -172.7 4.12 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -123.4 157.4 33.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.33 -23.32 66.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.199 171.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 47.66 60.34 3.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.496 1.918 . . . . 0.0 109.157 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 HD11 ' HA3' ' A' ' 52' ' ' GLY . 0.6 OUTLIER -41.53 108.82 0.1 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.563 1.545 . . . . 0.0 110.209 173.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.83 148.61 29.9 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.97 152.84 19.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.14 134.65 54.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 162.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.84 108.33 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.3 t -125.33 69.87 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 -177.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -75.02 156.85 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -67.11 -55.46 14.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.06 1.3 . . . . 0.0 109.258 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.412 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.2 t80 -70.9 115.82 10.49 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.95 -48.43 70.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.739 1.216 . . . . 0.0 111.326 -172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.412 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 25.1 m -62.66 -26.03 68.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.006 0.922 . . . . 0.0 111.82 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.3 ttm -58.42 -29.32 66.01 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 119.713 1.142 . . . . 0.0 109.893 175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -70.39 -30.76 67.74 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.032 0.833 . . . . 0.0 110.26 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -61.49 -51.22 69.54 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.447 1.021 . . . . 0.0 108.354 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.63 -60.38 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.34 0.656 . . . . 0.0 109.798 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.3 t -49.92 -52.81 12.53 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 C-N-CA 126.057 1.743 . . . . 0.0 109.774 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -56.47 -47.76 78.5 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 117.87 -1.062 . . . . 0.0 110.089 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -59.12 -44.75 92.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 119.933 1.242 . . . . 0.0 110.143 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.55 -36.87 83.73 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.605 0.762 . . . . 0.0 110.68 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -66.36 0.51 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.391 1.076 . . . . 0.0 109.996 169.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -25.59 68.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.502 1.121 . . . . 0.0 112.092 -167.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -15.11 51.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.684 1.129 . . . . 0.0 112.57 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -147.03 19.05 1.25 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.148 1.379 . . . . 0.0 112.103 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.48 -169.1 28.64 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.349 -0.844 . . . . 0.0 111.804 -161.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -57.37 123.35 15.14 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.981 1.712 . . . . 0.0 110.918 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -72.12 -3.06 20.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 112.916 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -118.74 128.48 54.53 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 125.019 1.327 . . . . 0.0 107.766 -158.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.79 165.67 7.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 125.77 1.628 . . . . 0.0 107.304 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -127.04 161.18 29.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -125.63 127.13 45.83 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -83.6 173.92 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 170.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.48 -46.46 66.58 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.4 -0.812 . . . . 0.0 110.568 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -168.24 175.25 6.6 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.024 1.73 . . . . 0.0 108.187 -163.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.75 -43.23 29.55 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.376 0.989 . . . . 0.0 114.111 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.78 -52.07 64.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 119.022 1.411 . . . . 0.0 108.694 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.67 -21.95 66.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.361 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.02 -47.42 68.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.347 1.431 . . . . 0.0 109.543 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.62 -46.02 87.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.319 0.581 . . . . 0.0 109.668 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -60.35 -44.78 95.24 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.719 0.807 . . . . 0.0 111.536 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 18.9 mmtm -59.41 -41.38 89.35 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.001 1.32 . . . . 0.0 110.219 172.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER -59.09 -43.9 91.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.344 0.975 . . . . 0.0 111.347 178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.66 -0.21 29.1 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.66 4.38 40.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.735 1.152 . . . . 0.0 112.958 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.14 -172.39 34.63 Favored Glycine 0 C--N 1.336 0.58 0 O-C-N 120.496 -1.377 . . . . 0.0 112.035 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.85 79.41 1.58 Allowed Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -75.53 165.48 25.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 159.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.46 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -139.52 -7.59 1.04 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.932 -0.927 . . . . 0.0 113.852 173.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -144.33 135.22 25.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.598 1.199 . . . . 0.0 108.423 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.72 117.96 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -165.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.83 134.04 67.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.727 1.611 . . . . 0.0 106.902 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.9 m -150.81 159.69 44.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.978 0.354 . . . . 0.0 111.432 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.98 157.92 32.54 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 166.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -67.99 -47.14 69.33 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 110.408 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.439 HD21 ' HG2' ' A' ' 89' ' ' GLU . 86.7 m-20 -80.81 59.04 3.55 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.674 1.19 . . . . 0.0 110.998 -159.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mmt -93.46 160.05 33.84 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 122.791 0.437 . . . . 0.0 110.661 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.34 162.39 36.32 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.803 2.335 . . . . 0.0 108.916 165.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 50.99 -89.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.298 1.839 . . . . 0.0 113.143 170.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 29.8 ttm -82.01 86.5 6.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.447 1.099 . . . . 0.0 108.313 168.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.12 154.81 1.46 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.192 1.397 . . . . 0.0 110.143 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -32.41 71.43 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.501 -1.374 . . . . 0.0 113.161 -172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.51 -33.61 71.38 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.313 1.057 . . . . 0.0 110.263 177.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -72.12 -35.11 69.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.894 . . . . 0.0 110.57 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -53.46 57.3 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.707 0.685 . . . . 0.0 109.582 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -50.17 -56.53 10.62 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 34.6 mttm -66.29 -27.97 68.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.742 1.156 . . . . 0.0 114.038 -172.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -70.77 -46.89 62.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.423 1.01 . . . . 0.0 108.742 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -56.41 -43.88 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.342 0.657 . . . . 0.0 109.356 172.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -24.03 60.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.218 1.407 . . . . 0.0 112.228 -176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.64 -1.1 23.05 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.765 1.226 . . . . 0.0 112.042 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.3 135.65 40.4 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 119.124 0.875 . . . . 0.0 108.721 174.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.19 -23.69 74.74 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.038 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.32 -60.53 1.92 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.294 1.047 . . . . 0.0 108.89 168.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.7 mmt -68.24 -8.67 41.22 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -160.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -48.13 -29.76 3.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.419 1.009 . . . . 0.0 112.098 165.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.05 -11.85 61.18 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -66.98 134.05 93.9 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 119.959 1.254 . . . . 0.0 109.077 -174.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 94.1 Cg_endo -78.78 56.6 6.03 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.726 1.617 . . . . 0.0 111.587 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.412 HG21 HD13 ' A' ' 69' ' ' LEU 0.254 2.4 m -47.58 107.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.213 1.005 . . . . 0.0 112.233 170.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -106.42 117.46 34.09 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.711 1.604 . . . . 0.0 107.839 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.44 123.08 31.99 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.98 107.06 11.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -144.78 178.42 8.01 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.016 0.912 . . . . 0.0 111.466 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.9 -29.39 32.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.084 0.953 . . . . 0.0 111.893 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' HG2' HD21 ' A' ' 59' ' ' ASN . 48.5 mm-40 -74.88 107.86 7.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.946 0.498 . . . . 0.0 110.237 -170.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -72.63 18.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.048 -1.033 . . . . 0.0 111.708 162.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.37 110.31 0.84 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 125.267 1.427 . . . . 0.0 109.001 -168.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -40.34 -59.26 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 112.621 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.05 -31.18 62.92 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.841 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.1 -38.67 61.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.709 1.14 . . . . 0.0 109.619 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.35 -55.87 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mt -59.97 -47.12 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.84 -41.26 77.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.098 1.317 . . . . 0.0 109.789 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.74 -53.28 59.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.801 0.728 . . . . 0.0 110.902 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.99 -27.15 67.92 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.325 0.65 . . . . 0.0 112.534 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -73.65 -52.89 11.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.704 2.002 . . . . 0.0 109.407 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -55.58 -40.36 71.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.684 0.794 . . . . 0.0 111.134 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.0 2.47 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.412 1.482 . . . . 0.0 113.217 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.98 156.6 6.63 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.536 1.168 . . . . 0.0 111.195 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 82' ' ' PRO . 5.2 p -70.83 -28.11 64.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.654 0.382 . . . . 0.0 110.966 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.71 171.7 38.42 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -130.78 139.22 50.21 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.009 1.324 . . . . 0.0 108.037 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.86 137.73 42.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 126.44 1.896 . . . . 0.0 106.004 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' A' ' 90' ' ' ALA . 48.3 t -130.22 144.06 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -173.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -52.46 145.85 18.88 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.105 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.61 10.09 60.82 Favored 'Cis proline' 0 C--N 1.348 0.508 0 N-CA-C 116.992 1.882 . . . . 0.0 116.992 8.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.8 p90 15.79 114.85 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 130.768 3.627 . . . . 0.0 116.564 -175.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -89.73 166.5 13.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.821 -1.174 . . . . 0.0 112.553 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.02 -33.83 73.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 166.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.36 -13.39 5.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.684 1.594 . . . . 0.0 115.013 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -28.67 7.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.497 1.499 . . . . 0.0 111.225 171.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.38 -51.13 71.1 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.292 1.037 . . . . 0.0 111.181 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -66.83 -44.18 81.77 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -66.92 -35.55 80.26 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 117.584 -1.198 . . . . 0.0 111.223 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.08 -57.9 11.01 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 124.039 0.935 . . . . 0.0 109.029 171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -47.74 -45.26 28.78 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.288 1.035 . . . . 0.0 111.049 176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -68.8 0.14 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.657 174.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.7 pt -66.94 -26.75 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 120.212 1.369 . . . . 0.0 113.704 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -56.22 -57.33 12.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -84.39 -34.02 23.66 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.788 -0.57 . . . . 0.0 111.326 -173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -64.23 -72.81 0.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.381 1.472 . . . . 0.0 109.739 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.5 mt -74.51 -38.49 62.82 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.417 1.087 . . . . 0.0 111.023 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.2 22.14 6.65 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.609 -1.106 . . . . 0.0 112.366 -166.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.3 mmt . . . . . 0 C--O 1.251 1.182 0 CA-C-N 119.587 1.694 . . . . 0.0 112.275 -175.182 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.07 147.88 6.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.388 1.475 . . . . 0.0 107.547 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.22 162.68 24.86 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.894 0.877 . . . . 0.0 112.034 -161.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -56.25 -9.84 0.75 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.395 1.878 . . . . 0.0 113.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.35 26.25 15.08 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.703 1.601 . . . . 0.0 111.663 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.66 116.22 2.79 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 108.99 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.67 165.2 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.856 0.463 . . . . 0.0 110.993 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -118.95 91.79 3.64 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 163.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -69.31 131.0 44.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -135.89 125.28 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.36 67.66 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -84.92 166.71 16.58 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.896 -1.128 . . . . 0.0 111.241 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -19.74 65.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.969 0.908 . . . . 0.0 113.355 -169.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.84 131.64 21.42 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.624 1.97 . . . . 0.0 105.894 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -52.55 -41.23 63.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.678 0.672 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.6 m -51.33 -47.11 62.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.647 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.1 mtm -59.7 -35.36 74.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.446 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -68.03 -31.11 70.56 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 120.055 1.298 . . . . 0.0 110.482 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -69.39 -50.21 48.15 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.93 -61.3 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.165 1.386 . . . . 0.0 109.643 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.6 t -51.9 -49.38 37.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.33 1.452 . . . . 0.0 109.793 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' HG3' HG21 ' A' ' 33' ' ' VAL . 22.4 ttt85 -54.95 -48.51 73.09 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 119.385 0.993 . . . . 0.0 110.635 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -52.7 63.72 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 123.479 0.712 . . . . 0.0 109.688 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 113' ' ' ALA . 75.1 mt -58.27 -42.41 86.45 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.373 1.069 . . . . 0.0 110.435 -176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.96 -48.49 81.33 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.695 0.798 . . . . 0.0 110.722 174.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -65.73 -33.48 75.96 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.599 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.79 -45.87 92.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.081 1.309 . . . . 0.0 109.224 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.4 mt -66.21 -43.26 87.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.757 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.38 -5.44 1.39 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.398 0.999 . . . . 0.0 114.226 170.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -73.85 152.52 40.2 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.765 1.226 . . . . 0.0 109.789 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -145.5 179.04 7.68 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.397 -0.814 . . . . 0.0 110.518 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 53.98 58.85 4.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.656 1.982 . . . . 0.0 111.463 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 22' ' ' ARG . 30.7 m -66.45 160.08 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.322 162.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.51 169.69 16.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 126.126 1.77 . . . . 0.0 108.367 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -130.05 142.15 50.65 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.547 1.939 . . . . 0.0 106.939 -173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -115.53 170.22 8.59 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 159.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -24.87 30.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.987 0.358 . . . . 0.0 111.228 170.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.69 175.57 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.307 1.443 . . . . 0.0 108.697 -170.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -62.89 -35.16 91.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.332 1.92 . . . . 0.0 114.606 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.02 -49.53 83.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 120.309 2.055 . . . . 0.0 107.934 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -58.57 -39.28 79.87 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.858 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.1 99.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.269 1.395 . . . . 0.0 111.547 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.41 -43.39 90.7 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -65.11 -42.55 93.85 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.388 -0.195 . . . . 0.0 111.469 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -52.94 -50.35 64.18 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 127.533 2.333 . . . . 0.0 108.854 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.97 -48.0 83.85 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.433 0.56 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.46 -11.04 56.91 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.87 24.23 12.92 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.763 2.425 . . . . 0.0 110.858 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.43 161.08 28.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 31.05 8.44 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 162.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -70.16 89.05 0.62 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.02 1.328 . . . . 0.0 109.069 -161.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.79 -3.44 50.22 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.555 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -138.98 129.87 26.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.601 1.2 . . . . 0.0 109.083 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 81' ' ' LEU . 11.4 t -133.98 124.42 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -168.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.76 134.32 60.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 127.379 2.272 . . . . 0.0 106.25 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.9 p -152.03 163.54 39.09 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.385 0.538 . . . . 0.0 111.069 173.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.4 159.98 28.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.032 160.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CH2' ' HG ' ' A' ' 66' ' ' LEU . 23.6 t-105 -72.64 -58.53 3.29 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.587 1.955 . . . . 0.0 111.422 169.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -74.5 19.39 0.13 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.998 2.119 . . . . 0.0 112.822 -160.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.558 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -61.68 129.21 91.24 Favored Pre-proline 0 N--CA 1.441 -0.902 0 C-N-CA 126.113 1.765 . . . . 0.0 107.553 -170.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.8 157.85 54.02 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 N-CA-C 109.402 -1.038 . . . . 0.0 109.402 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.77 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.249 1.42 . . . . 0.0 109.992 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.2 ttp -91.33 91.32 8.1 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.159 0.984 . . . . 0.0 108.878 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -49.88 153.47 1.29 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.321 1.048 . . . . 0.0 109.027 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.54 -31.54 63.53 Favored Glycine 0 CA--C 1.522 0.524 0 O-C-N 120.885 -1.134 . . . . 0.0 112.456 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.543 HD11 ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -68.78 -36.84 78.8 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.633 0.717 . . . . 0.0 110.644 176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -71.19 -41.65 70.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.047 0.939 . . . . 0.0 109.546 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp -56.39 -50.12 72.49 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.578 1.151 . . . . 0.0 109.469 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -52.69 -61.47 2.27 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 124.957 1.303 . . . . 0.0 108.866 173.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HE3' HD11 ' A' ' 66' ' ' LEU . 90.7 mttt -62.66 -27.66 69.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.903 1.229 . . . . 0.0 112.382 -173.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.3 m -64.46 -55.73 18.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.117 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.76 -36.45 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.323 1.449 . . . . 0.0 111.448 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -21.92 61.9 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 120.883 -1.135 . . . . 0.0 111.258 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.48 52.76 2.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.493 1.042 . . . . 0.0 110.108 171.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 61.53 -121.32 0.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.842 2.057 . . . . 0.0 112.066 169.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.65 17.9 55.07 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.605 1.093 . . . . 0.0 111.056 -158.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.74 2.87 3.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 129.001 2.92 . . . . 0.0 113.844 -164.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.1 mtt -93.04 -3.12 54.88 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.418 1.087 . . . . 0.0 113.442 -168.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 t -61.11 -21.17 63.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.119 1.327 . . . . 0.0 112.214 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.96 -2.01 25.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.849 1.26 . . . . 0.0 113.817 174.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 54' ' ' VAL . 83.7 mt -79.77 129.76 69.81 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 119.783 1.174 . . . . 0.0 109.471 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.47 58.02 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.128 2.552 . . . . 0.0 111.925 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -47.24 108.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.979 1.712 . . . . 0.0 111.028 177.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 tp -112.97 119.6 38.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.852 1.661 . . . . 0.0 108.901 -165.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.5 mmt -82.92 118.73 23.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -132.16 110.65 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.219 1.408 . . . . 0.0 108.47 -177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -157.62 169.76 23.92 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.555 0.693 . . . . 0.0 110.401 -167.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.76 -23.0 62.33 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.239 -0.913 . . . . 0.0 112.179 160.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -81.26 112.03 18.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.007 0.821 . . . . 0.0 112.001 -166.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.51 -88.25 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 160.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? 49.81 99.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.126 1.371 . . . . 0.0 111.2 -169.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -41.32 -48.83 3.71 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 121.4 -0.812 . . . . 0.0 111.765 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -58.87 -37.69 77.12 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -60.18 -43.99 95.43 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.031 0.832 . . . . 0.0 109.487 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.21 -43.69 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.18 -58.04 6.55 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.33 70.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 111.059 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.77 -48.82 80.08 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.047 0.939 . . . . 0.0 110.059 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.93 79.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.879 0.472 . . . . 0.0 111.162 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -61.16 -51.16 70.22 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.709 1.604 . . . . 0.0 110.495 173.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.18 -29.94 71.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.206 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.25 34.97 4.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.552 1.072 . . . . 0.0 112.804 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -60.78 159.41 11.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.109 1.454 . . . . 0.0 110.68 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.0 p -63.93 -35.68 81.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.45 0.568 . . . . 0.0 110.595 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.59 -177.57 45.1 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -137.23 132.32 33.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.07 102.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.99 154.54 4.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 166.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.26 155.39 79.92 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 120.93 -1.106 . . . . 0.0 110.452 159.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.13 151.28 96.79 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 N-CA-C 110.346 -0.675 . . . . 0.0 110.346 -7.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -151.94 157.55 41.94 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.428 0.691 . . . . 0.0 110.422 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -144.51 -173.02 3.92 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.891 0.876 . . . . 0.0 110.384 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -56.45 -29.24 61.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.397 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.8 -25.25 64.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 t -95.87 -39.19 9.94 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.043 1.292 . . . . 0.0 109.246 170.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.49 -50.14 53.57 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.061 0.944 . . . . 0.0 109.765 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.22 72.32 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.918 1.687 . . . . 0.0 112.772 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.83 -48.53 21.19 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -61.6 -37.66 84.72 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.687 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.14 -52.21 59.47 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.451 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.28 -42.47 86.64 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.291 0.95 . . . . 0.0 112.414 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -54.38 -53.09 58.7 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.374 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 pt -74.63 -20.89 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 117.568 -1.206 . . . . 0.0 114.0 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.83 -50.79 71.35 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.525 1.511 . . . . 0.0 108.097 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -77.29 -42.84 35.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -73.61 -62.07 1.62 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.959 0.504 . . . . 0.0 110.634 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -20.57 39.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.715 0.806 . . . . 0.0 110.446 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.17 36.75 12.2 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -170.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 35.4 mmt . . . . . 0 C--O 1.25 1.097 0 CA-C-N 118.192 0.996 . . . . 0.0 111.014 175.555 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.69 65.66 0.26 Allowed 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.206 -0.934 . . . . 0.0 109.253 165.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.04 160.06 17.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -75.33 -15.37 60.49 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.033 1.333 . . . . 0.0 112.357 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 49.14 31.82 3.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.779 1.632 . . . . 0.0 111.834 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.62 104.63 4.63 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.104 0.562 . . . . 0.0 109.894 -170.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -91.1 133.67 35.14 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.172 1.789 . . . . 0.0 110.239 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.66 106.9 18.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.286 1.834 . . . . 0.0 107.484 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -74.34 138.07 43.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.568 1.076 . . . . 0.0 108.175 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.15 105.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 42' ' ' ALA . 10.0 t -113.78 59.26 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 122.619 1.2 . . . . 0.0 107.768 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -85.96 108.97 18.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -174.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' H ' ' CB ' ' A' ' 57' ' ' ASP . 33.9 t70 -53.95 -45.27 71.23 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.422 1.089 . . . . 0.0 112.377 -170.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.24 101.39 1.88 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 164.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.23 -42.66 70.11 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.21 0.604 . . . . 0.0 111.378 -168.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 m -59.83 -33.77 72.2 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.583 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mtm -59.12 -32.22 69.64 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 120.111 1.323 . . . . 0.0 110.476 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 HH21 ' NH1' ' A' ' 19' ' ' ARG . 24.9 ttp85 -62.63 -43.5 98.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.889 1.222 . . . . 0.0 110.717 174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH1' HH21 ' A' ' 18' ' ' ARG . 8.9 mpt_? -59.69 -41.56 91.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.716 176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.21 -63.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.4 t -54.21 -43.48 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 125.899 1.68 . . . . 0.0 110.945 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -56.89 -48.36 78.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.799 1.24 . . . . 0.0 110.392 173.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.97 -44.13 97.8 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.956 0.798 . . . . 0.0 110.841 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.66 -38.39 90.92 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.196 1.398 . . . . 0.0 111.689 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.83 -57.94 10.73 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -56.64 -36.09 69.09 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 117.904 -1.046 . . . . 0.0 113.162 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.67 -22.06 65.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.109 1.322 . . . . 0.0 112.464 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.35 -75.45 0.24 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 164.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.75 -168.41 33.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 65.33 164.43 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.264 1.826 . . . . 0.0 111.925 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -151.16 -3.05 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.371 1.469 . . . . 0.0 112.063 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -96.69 98.96 10.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -122.59 158.65 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.92 -155.47 0.61 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.43 1.092 . . . . 0.0 109.088 167.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 43.1 tt0 -178.37 159.16 1.19 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -158.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.61 162.86 33.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.142 1.777 . . . . 0.0 106.362 170.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.33 -31.59 72.47 Favored 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 121.795 -0.565 . . . . 0.0 112.352 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.58 171.26 10.43 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.872 2.469 . . . . 0.0 105.955 -174.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' ' CE ' ' A' ' 60' ' ' MET . . . -57.52 -37.12 80.87 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.587 -1.119 . . . . 0.0 114.565 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.66 -42.99 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 120.969 2.385 . . . . 0.0 108.714 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.1 -28.22 69.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.333 -0.855 . . . . 0.0 111.725 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.7 -47.68 77.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.195 -1.566 . . . . 0.0 109.655 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.72 -41.25 73.6 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.409 1.084 . . . . 0.0 109.496 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -62.67 -44.1 97.12 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.694 1.197 . . . . 0.0 111.742 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.311 -0.868 . . . . 0.0 110.67 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -51.27 70.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -68.48 3.14 1.92 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.18 1.48 56.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.06 1.3 . . . . 0.0 112.947 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.04 -81.79 0.07 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 121.353 1.888 . . . . 0.0 115.249 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.07 82.38 0.05 OUTLIER Glycine 0 C--N 1.331 0.261 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -164.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -90.32 153.8 20.18 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.23 1.015 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.78 -20.98 15.11 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.757 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -145.27 148.96 34.04 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 125.051 1.34 . . . . 0.0 109.277 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 81' ' ' LEU . 13.5 t -137.26 67.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mt -75.93 144.25 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 153.32 31.6 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.665 -0.647 . . . . 0.0 110.462 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CB ' ' H ' ' A' ' 13' ' ' ASP . 45.5 t0 -74.13 149.97 40.74 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 164.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.771 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 33.5 t-105 -61.21 -58.75 7.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.837 0.855 . . . . 0.0 109.498 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.93 25.87 0.35 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.188 1.395 . . . . 0.0 113.366 -159.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.574 ' CE ' ' H ' ' A' ' 39' ' ' GLY . 8.4 ptm -60.12 159.41 21.59 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.159 -0.963 . . . . 0.0 110.97 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.81 -167.8 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.764 3.642 . . . . 0.0 111.192 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.1 m120 60.49 -146.71 0.46 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.419 1.488 . . . . 0.0 110.09 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.98 96.41 0.43 Allowed 'General case' 0 C--N 1.34 0.175 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 165.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.71 174.1 0.07 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.17 1.788 . . . . 0.0 113.561 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.11 -29.76 59.97 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.386 -0.821 . . . . 0.0 113.57 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.771 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -71.03 -42.78 69.08 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 117.957 0.879 . . . . 0.0 110.034 176.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.93 -40.1 83.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.148 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.14 -55.03 27.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.656 1.116 . . . . 0.0 110.024 169.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tp -50.31 -56.27 11.96 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.601 0.761 . . . . 0.0 109.085 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.09 -41.56 96.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.748 0.704 . . . . 0.0 111.126 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.7 m -57.57 -51.44 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.061 0.944 . . . . 0.0 109.293 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 mt -58.53 -45.22 90.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.646 0.778 . . . . 0.0 109.659 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.5 -27.37 69.09 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 125.629 1.572 . . . . 0.0 112.148 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.16 14.37 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.325 1.45 . . . . 0.0 114.565 -171.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 132.83 -107.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 131.033 3.733 . . . . 0.0 107.613 159.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.47 4.33 9.05 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.775 1.179 . . . . 0.0 114.905 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 54.41 25.01 5.63 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.18 1.49 . . . . 0.0 111.516 -158.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.3 mmt -113.48 -9.17 13.33 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.215 2.606 . . . . 0.0 111.053 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 p -52.29 -37.69 56.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.981 1.712 . . . . 0.0 111.953 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.73 62.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HG21 ' A' ' 54' ' ' VAL . 8.1 mt -52.52 141.18 34.85 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.517 1.053 . . . . 0.0 112.177 -162.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.03 74.0 3.02 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.489 2.126 . . . . 0.0 110.425 163.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 69' ' ' LEU . 1.9 m -70.42 116.26 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 158.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.63 111.72 15.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -168.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mmt -75.12 128.35 35.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 101.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -141.45 169.86 16.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.65 -169.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.06 -17.19 41.1 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.258 163.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -80.67 104.21 11.04 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.212 0.915 . . . . 0.0 111.615 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -82.88 16.03 2.45 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -57.84 110.13 0.85 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.348 0.977 . . . . 0.0 108.881 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.6 -47.76 66.71 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.677 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -53.25 -33.08 51.52 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.277 0.944 . . . . 0.0 113.18 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -84.33 -30.55 25.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.794 -0.566 . . . . 0.0 110.996 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.22 -44.23 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-O 118.362 -0.828 . . . . 0.0 108.989 161.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.51 -54.4 35.4 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-O 117.662 -1.161 . . . . 0.0 108.375 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.2 63.77 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 120.176 1.353 . . . . 0.0 110.774 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.56 -51.96 65.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.465 0.706 . . . . 0.0 110.21 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -46.32 85.22 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.257 0.623 . . . . 0.0 111.269 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -57.35 -50.65 72.28 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.723 2.009 . . . . 0.0 110.513 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.03 -18.58 65.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.614 0.766 . . . . 0.0 112.68 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.02 27.66 13.34 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.236 0.922 . . . . 0.0 112.527 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -59.81 140.44 56.57 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 118.847 1.324 . . . . 0.0 108.191 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 51.6 p -68.46 -18.76 64.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.145 -174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.57 173.87 40.13 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.6 104.83 4.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.73 144.88 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 90' ' ' ALA . 64.2 t -127.9 143.21 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 172.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.6 151.22 71.92 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.46 1.504 . . . . 0.0 111.463 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.92 173.3 37.89 Favored 'Cis proline' 0 C--N 1.345 0.378 0 N-CA-C 109.421 -1.031 . . . . 0.0 109.421 -16.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -177.91 146.72 0.43 Allowed 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 120.162 -1.586 . . . . 0.0 108.267 -164.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -149.52 -176.51 5.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.184 1.793 . . . . 0.0 109.232 -170.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.49 68.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.781 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.18 62.19 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.222 1.009 . . . . 0.0 113.189 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.72 -28.99 12.53 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.876 0.762 . . . . 0.0 110.286 177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.45 -54.84 38.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.871 0.868 . . . . 0.0 108.777 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -29.85 71.06 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.885 1.274 . . . . 0.0 112.396 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.38 -55.25 12.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.606 1.162 . . . . 0.0 109.351 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.6 -31.44 72.66 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.743 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.2 mt -58.49 -58.06 10.2 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 123.835 0.854 . . . . 0.0 109.484 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -61.29 -29.19 69.71 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.043 1.292 . . . . 0.0 112.257 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.01 -60.56 3.3 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.148 -0.97 . . . . 0.0 110.333 168.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.93 -23.3 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.319 0.963 . . . . 0.0 113.081 -171.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -57.21 -58.03 9.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.82 -30.0 56.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.525 -0.734 . . . . 0.0 112.354 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -65.35 1.02 Allowed 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.57 -25.55 64.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 122.984 0.514 . . . . 0.0 111.051 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.23 23.21 35.26 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-O 117.805 -1.553 . . . . 0.0 110.703 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 28.7 mmt . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.704 1.752 . . . . 0.0 110.47 -176.511 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 ttm . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.7 72.61 8.64 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.607 1.549 . . . . 0.0 107.738 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -116.23 158.58 23.11 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.399 0.619 . . . . 0.0 112.257 -160.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -51.51 -25.5 6.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.012 0.925 . . . . 0.0 112.433 167.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 39.15 53.54 2.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.726 2.41 . . . . 0.0 109.406 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.62 104.13 0.77 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.169 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? -79.51 132.47 36.33 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.45 93.81 6.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.67 131.75 45.1 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 118.222 -1.391 . . . . 0.0 107.316 168.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG12 ' HD3' ' A' ' 18' ' ' ARG . 64.6 t -132.52 119.36 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 105.599 -2.001 . . . . 0.0 105.599 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -130.95 63.53 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.699 1.599 . . . . 0.0 108.6 -174.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.29 159.1 33.72 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.792 -1.193 . . . . 0.0 108.5 170.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.47 -64.77 1.03 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -64.62 112.77 3.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -53.17 -41.61 65.35 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.857 1.208 . . . . 0.0 112.055 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 m -59.82 -31.8 70.06 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.757 -1.214 . . . . 0.0 111.773 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -44.0 92.62 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.562 1.074 . . . . 0.0 110.159 171.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD3' HG12 ' A' ' 10' ' ' VAL . 32.8 tpt85 -65.83 -36.69 84.19 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.299 1.04 . . . . 0.0 110.049 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -48.02 83.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.503 -0.761 . . . . 0.0 109.524 171.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.09 -58.36 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.32 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.9 t -52.29 -46.8 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 120.127 1.33 . . . . 0.0 110.206 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -60.75 -43.9 97.38 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.238 0.472 . . . . 0.0 111.16 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.27 -45.11 95.86 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.265 0.626 . . . . 0.0 111.133 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 113' ' ' ALA . 78.2 mt -65.41 -36.37 83.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.43 0.692 . . . . 0.0 111.062 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.91 -44.7 96.25 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.411 0.684 . . . . 0.0 110.09 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -41.65 98.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 116.994 -1.479 . . . . 0.0 111.462 176.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -57.07 -44.64 83.25 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 119.439 1.018 . . . . 0.0 110.51 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.14 -34.35 63.83 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 118.337 -0.839 . . . . 0.0 112.255 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.63 57.34 0.37 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.01 153.02 47.23 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.895 1.278 . . . . 0.0 107.824 171.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -140.81 178.9 7.03 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.785 1.634 . . . . 0.0 108.559 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 53.87 54.2 10.14 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.584 1.553 . . . . 0.0 111.683 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 m -68.68 164.36 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.122 159.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.46 174.81 10.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -136.71 147.81 46.97 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.11 167.44 12.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 164.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -68.37 -47.29 67.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.846 0.355 . . . . 0.0 110.117 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.33 169.01 22.88 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 125.797 1.639 . . . . 0.0 109.171 -159.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.7 -41.05 49.69 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.953 1.263 . . . . 0.0 115.546 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -67.95 -44.66 84.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 119.97 1.885 . . . . 0.0 107.854 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.78 -26.17 68.51 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.173 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.81 -49.03 67.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 119.99 1.268 . . . . 0.0 110.14 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.02 -42.77 95.05 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.667 0.746 . . . . 0.0 110.208 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.85 -47.37 85.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.479 1.112 . . . . 0.0 110.893 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -55.95 -46.43 78.56 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.802 0.841 . . . . 0.0 109.799 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 54' ' ' VAL . 2.1 mm? -57.33 -37.87 73.2 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.001 0.819 . . . . 0.0 111.342 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -66.25 4.6 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.16 82.0 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 119.715 -1.865 . . . . 0.0 110.399 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.49 104.4 1.24 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.773 1.177 . . . . 0.0 111.66 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.65 13.68 1.08 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.438 1.018 . . . . 0.0 115.134 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -69.43 167.28 16.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.214 1.507 . . . . 0.0 110.988 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.31 -19.21 0.88 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 117.974 -1.459 . . . . 0.0 113.561 167.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -131.84 144.0 50.59 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 119.536 1.668 . . . . 0.0 107.727 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HD13 ' A' ' 81' ' ' LEU . 15.3 t -134.37 62.41 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -74.74 135.36 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.6 p -144.92 168.91 19.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.019 0.827 . . . . 0.0 110.434 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -67.44 169.46 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.555 0.693 . . . . 0.0 109.359 159.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -74.08 -53.68 9.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.878 158.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.25 86.99 6.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.487 1.115 . . . . 0.0 111.54 -158.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.2 mmt -127.17 149.71 70.27 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.289 0.636 . . . . 0.0 111.2 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.96 147.1 60.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.492 2.128 . . . . 0.0 109.822 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 54.92 -84.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.283 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 41.4 ttm -88.19 97.64 11.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.941 1.296 . . . . 0.0 107.65 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.39 161.97 2.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.31 -33.68 53.04 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.558 -0.714 . . . . 0.0 111.847 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -62.57 -42.21 99.41 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.715 0.757 . . . . 0.0 109.942 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -81.19 -30.36 34.35 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.774 -0.579 . . . . 0.0 111.264 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.51 -52.1 67.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.16 0.984 . . . . 0.0 108.556 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.8 tp -51.13 -60.04 3.53 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 125.01 1.324 . . . . 0.0 109.463 173.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 24.3 mmtt -59.72 -40.34 87.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.523 1.056 . . . . 0.0 112.363 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.5 m -59.62 -49.05 79.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.631 0.772 . . . . 0.0 109.364 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.16 -39.37 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.15 -25.91 68.29 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.448 1.899 . . . . 0.0 112.234 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.39 -21.03 60.6 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.556 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -71.46 148.14 47.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.804 0.842 . . . . 0.0 110.917 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.26 -17.96 70.79 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.027 -0.874 . . . . 0.0 113.203 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.07 -50.81 1.03 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.122 1.369 . . . . 0.0 111.285 -174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.8 mtm -67.0 -13.69 62.15 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 p -50.97 -31.66 18.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.732 1.213 . . . . 0.0 112.422 174.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.7 65.86 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.983 1.313 . . . . 0.0 114.029 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 54' ' ' VAL . 17.5 mt -56.55 138.01 76.51 Favored Pre-proline 0 C--O 1.234 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.317 -171.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.03 84.21 1.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.616 2.211 . . . . 0.0 108.951 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 69' ' ' LEU . 2.7 m -76.69 126.76 37.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 159.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tp -142.28 110.56 6.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -159.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -79.32 126.34 30.67 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 124.372 1.045 . . . . 0.0 108.423 -171.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.2 t -136.1 101.34 2.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.254 1.822 . . . . 0.0 106.646 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 t -149.26 164.6 34.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.363 0.601 . . . . 0.0 111.391 -159.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.11 -20.91 57.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.582 1.153 . . . . 0.0 111.689 161.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -76.38 87.76 3.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.967 1.307 . . . . 0.0 111.031 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.98 5.3 4.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.094 0.958 . . . . 0.0 113.287 172.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.9 tptt -48.4 112.81 0.64 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.144 1.777 . . . . 0.0 108.307 -176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.81 -43.28 80.83 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -56.21 -37.79 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.374 1.07 . . . . 0.0 112.287 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -66.99 -40.5 87.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.393 0.542 . . . . 0.0 109.541 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.91 -49.43 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.156 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.0 -58.52 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.07 -49.3 63.79 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.587 1.155 . . . . 0.0 111.011 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.96 95.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.181 0.901 . . . . 0.0 110.883 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.15 91.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 117.902 0.319 . . . . 0.0 111.166 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -60.51 -55.81 28.96 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.19 1.396 . . . . 0.0 110.052 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.636 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -59.33 -28.87 67.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.04 0.936 . . . . 0.0 111.51 176.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.66 38.76 4.6 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.278 0.942 . . . . 0.0 111.933 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.44 153.3 27.52 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 117.818 0.809 . . . . 0.0 109.306 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 74.7 p -69.98 -14.88 62.91 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.01 171.46 37.01 Favored Glycine 0 N--CA 1.443 -0.835 0 O-C-N 121.565 -0.709 . . . . 0.0 111.673 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -137.06 135.23 37.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.357 1.463 . . . . 0.0 107.343 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.4 t -133.45 103.43 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 90' ' ' ALA . 3.0 t -74.13 144.17 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 159.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -60.67 154.17 58.37 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.826 1.251 . . . . 0.0 109.619 163.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.92 174.54 46.7 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.373 0.812 . . . . 0.0 111.329 -14.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -178.43 151.33 0.6 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -167.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.6 p -144.79 -171.69 3.68 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.441 1.096 . . . . 0.0 109.825 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.402 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.99 -30.99 72.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.446 -0.784 . . . . 0.0 109.583 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.97 -19.68 45.43 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.47 -27.4 9.03 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 119.493 1.042 . . . . 0.0 110.999 171.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.46 -50.61 62.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 120.225 1.375 . . . . 0.0 107.939 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -31.56 72.47 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.631 1.172 . . . . 0.0 112.151 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -77.27 -36.1 54.67 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.712 0.687 . . . . 0.0 110.591 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -64.96 -43.46 92.62 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.122 -0.986 . . . . 0.0 109.211 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.5 mt -58.66 -56.76 18.02 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.715 1.206 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -52.1 -42.31 63.16 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.937 1.295 . . . . 0.0 111.329 176.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -52.82 -63.18 1.23 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.366 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 pt -68.48 -30.14 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 120.487 1.494 . . . . 0.0 114.402 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -57.88 -53.92 52.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -83.09 -34.46 26.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 121.282 -0.167 . . . . 0.0 110.577 -171.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -74.0 -74.1 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.831 1.253 . . . . 0.0 108.862 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.92 -20.93 62.43 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.697 0.799 . . . . 0.0 110.967 -174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.34 26.98 26.54 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.499 -172.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 C--O 1.249 1.079 0 CA-C-N 119.639 1.72 . . . . 0.0 111.678 -175.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ttt . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.38 -156.8 0.75 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.762 1.225 . . . . 0.0 108.472 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -115.46 -177.6 3.18 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.879 2.071 . . . . 0.0 106.99 173.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -61.9 -38.37 88.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.551 1.069 . . . . 0.0 109.042 159.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 48.23 63.78 1.92 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.314 1.446 . . . . 0.0 107.123 -160.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.5 106.56 0.21 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 124.019 0.928 . . . . 0.0 109.116 -175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 34' ' ' GLU . 12.3 tttt -82.47 135.45 35.13 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.336 -164.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -110.23 85.14 2.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -169.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.8 tp -69.67 139.58 53.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.11 120.74 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -129.17 65.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 122.679 1.228 . . . . 0.0 107.949 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -91.24 111.32 22.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 7.0 t70 -47.74 -46.16 29.7 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.36 1.464 . . . . 0.0 112.59 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -60.5 -13.31 13.09 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t 76.34 -68.1 0.2 Allowed 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.128 1.771 . . . . 0.0 108.42 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -55.87 -28.08 54.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.964 -1.085 . . . . 0.0 111.674 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.5 mtp -56.86 -46.57 81.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 116.854 -1.546 . . . . 0.0 111.011 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -22.88 63.13 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 121.645 2.021 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -65.7 -52.44 51.4 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -52.43 -60.51 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.736 1.214 . . . . 0.0 108.666 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.91 -49.19 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.239 1.016 . . . . 0.0 111.063 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -60.43 -42.97 97.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.768 1.167 . . . . 0.0 110.891 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -57.96 -53.12 61.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.09 -38.85 77.2 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.006 0.923 . . . . 0.0 111.902 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.24 -47.24 86.1 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.506 0.722 . . . . 0.0 110.087 173.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -64.89 -36.61 84.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.55 -41.24 89.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 120.652 1.569 . . . . 0.0 109.952 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.44 -54.04 10.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.404 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.76 62.86 0.07 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -137.52 156.96 47.53 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.347 1.059 . . . . 0.0 109.325 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 -175.33 4.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.378 1.071 . . . . 0.0 111.271 -168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 48.3 t30 50.82 46.82 25.57 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.781 2.032 . . . . 0.0 111.45 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.31 161.9 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.0 -1.063 . . . . 0.0 109.474 174.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' CG ' ' HE2' ' A' ' 7' ' ' LYS . 3.4 mm-40 -145.52 171.72 14.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.713 2.005 . . . . 0.0 108.68 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -140.51 145.6 37.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 45' ' ' LYS . . . -120.7 160.26 23.67 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.59 -39.45 93.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.711 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.99 165.77 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.558 1.143 . . . . 0.0 107.921 -161.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.48 68.67 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.828 1.649 . . . . 0.0 113.835 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.9 t -60.56 -44.87 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.964 -1.315 . . . . 0.0 109.63 173.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.93 -27.55 64.86 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.574 0.625 . . . . 0.0 110.737 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -59.99 -50.09 75.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.728 -1.232 . . . . 0.0 108.322 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -43.5 72.05 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.769 0.795 . . . . 0.0 111.375 175.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -65.79 -25.48 67.26 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 112.683 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 30.3 mmtm -74.88 -47.4 30.29 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.229 -1.545 . . . . 0.0 108.805 168.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 72' ' ' ILE . 17.3 mt -56.96 -35.98 69.77 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.176 1.353 . . . . 0.0 111.969 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -74.72 9.61 1.75 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.56 42.47 2.87 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.493 1.517 . . . . 0.0 111.171 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.17 -171.14 22.62 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 121.49 -0.756 . . . . 0.0 111.861 163.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.2 70.23 1.87 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -65.43 145.38 56.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.23 3.09 2.99 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.844 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.74 142.14 23.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.692 1.246 . . . . 0.0 108.854 172.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.703 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -138.4 78.68 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -173.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -81.7 141.52 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -152.35 158.22 42.41 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.735 -0.603 . . . . 0.0 111.041 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 23.1 t0 -77.26 169.81 17.67 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 164.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 66' ' ' LEU . 2.8 t-105 -79.34 -51.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.413 -0.804 . . . . 0.0 111.806 169.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -74.85 79.6 2.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.16 1.384 . . . . 0.0 110.232 -159.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 21.8 ptp -135.01 153.32 78.44 Favored Pre-proline 0 C--O 1.238 0.47 0 O-C-N 121.13 -0.981 . . . . 0.0 111.174 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.2 -172.1 1.07 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.04 2.493 . . . . 0.0 109.394 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 57.61 -104.26 0.21 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.917 1.687 . . . . 0.0 109.674 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -91.32 95.07 9.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.55 153.14 3.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.425 1.09 . . . . 0.0 109.779 170.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.39 -30.15 64.35 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.42 -0.8 . . . . 0.0 113.723 -167.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 2.1 tm? -72.26 -39.77 68.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.286 1.043 . . . . 0.0 110.02 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -65.81 -39.35 90.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.717 0.807 . . . . 0.0 109.787 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.9 tp -57.79 -51.07 71.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.83 0.741 . . . . 0.0 109.917 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -50.08 -57.88 6.71 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 109.038 172.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 27.3 mttm -65.44 -27.39 68.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 m -59.96 -59.59 5.18 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.408 HD11 HD11 ' A' ' 46' ' ' LEU . 24.3 mt -58.62 -40.99 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.23 1.412 . . . . 0.0 109.722 -174.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -13.35 26.68 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.623 1.569 . . . . 0.0 113.43 -170.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -81.85 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.656 1.116 . . . . 0.0 110.951 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -172.6 -163.63 0.23 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.811 1.645 . . . . 0.0 108.839 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.79 29.62 46.8 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -162.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.73 -18.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 129.936 3.294 . . . . 0.0 114.523 -166.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.3 mtt -62.41 -19.21 63.22 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.328 0.967 . . . . 0.0 112.276 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.7 p -55.54 -28.76 56.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.413 1.085 . . . . 0.0 111.579 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.26 -2.02 43.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.364 1.466 . . . . 0.0 113.398 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.703 HD13 HG21 ' A' ' 54' ' ' VAL . 40.8 mt -74.38 136.08 75.42 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 119.859 1.209 . . . . 0.0 110.18 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.13 89.0 0.8 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.396 2.064 . . . . 0.0 108.614 164.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -71.17 111.01 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 164.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.1 tp -115.35 113.38 23.72 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mmt -79.46 117.29 20.29 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.89 96.49 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t -132.64 -166.47 1.75 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.761 0.824 . . . . 0.0 110.089 -168.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.24 -3.08 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.833 2.053 . . . . 0.0 111.016 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -86.91 81.57 8.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.533 0.682 . . . . 0.0 109.554 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -65.83 -4.49 6.81 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.523 1.529 . . . . 0.0 113.776 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -46.78 123.9 5.6 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.617 1.567 . . . . 0.0 110.354 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -53.17 54.06 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.228 0.537 . . . . 0.0 110.869 -173.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.84 -26.92 66.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.91 -46.42 78.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.792 1.237 . . . . 0.0 109.547 171.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.87 -46.8 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.45 -53.79 36.31 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.82 -44.23 73.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.493 0.717 . . . . 0.0 110.619 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.47 88.2 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.846 0.748 . . . . 0.0 111.865 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.32 -41.11 81.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.386 0.539 . . . . 0.0 111.049 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -57.29 -46.49 83.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.542 1.937 . . . . 0.0 109.778 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.78 -34.09 76.11 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.899 0.48 . . . . 0.0 111.472 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.87 39.27 4.4 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.924 1.25 . . . . 0.0 111.544 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.71 143.45 50.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.539 1.17 . . . . 0.0 109.201 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -66.69 -19.73 65.82 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 170.04 41.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -138.97 130.83 27.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.315 1.446 . . . . 0.0 107.396 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -127.08 137.63 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 t -127.76 124.15 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -51.18 146.01 12.11 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.831 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.91 168.19 72.37 Favored 'Cis proline' 0 CA--C 1.534 0.509 0 CA-C-N 119.273 0.776 . . . . 0.0 111.913 -3.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -177.97 152.41 0.74 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.665 1.186 . . . . 0.0 109.104 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.3 p -148.37 -177.51 5.81 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.62 1.968 . . . . 0.0 109.751 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.13 -26.63 39.65 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.77 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.51 -53.02 51.54 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.743 1.217 . . . . 0.0 112.135 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.24 -33.77 61.36 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.059 0.845 . . . . 0.0 109.654 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.91 -52.11 66.45 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.377 0.989 . . . . 0.0 109.318 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -64.57 -28.42 69.63 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.6 0.76 . . . . 0.0 111.867 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.67 -43.96 24.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.077 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -65.91 -30.49 71.09 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.429 -1.419 . . . . 0.0 110.015 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 mt -58.75 -52.88 63.81 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.118 168.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -51.68 -48.51 63.45 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.768 1.167 . . . . 0.0 111.178 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -54.71 -51.01 66.93 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.494 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.88 -30.26 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 120.931 1.696 . . . . 0.0 113.043 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -58.04 -48.05 81.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.77 -23.99 20.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -170.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -68.68 0.77 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 mt -67.2 -26.64 66.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.709 -176.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.54 39.47 18.08 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -165.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 29.6 mmt . . . . . 0 C--O 1.245 0.851 0 CA-C-N 117.912 0.856 . . . . 0.0 109.558 175.597 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 119.707 -0.187 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.26 98.19 6.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -125.23 28.57 6.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.248 1.019 . . . . 0.0 109.915 -174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' H ' ' CD ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -70.26 61.62 0.21 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.477 1.911 . . . . 0.0 109.933 168.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -178.93 24.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.776 3.23 . . . . 0.0 109.308 -162.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -43.42 115.04 0.71 Allowed 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.959 1.303 . . . . 0.0 109.327 164.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -69.31 123.24 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -91.28 159.35 16.07 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -121.62 137.04 54.91 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 164.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.4 t -134.34 114.1 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.68 72.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB2' ' H ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -80.1 165.84 22.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.643 1.177 . . . . 0.0 109.065 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.48 -9.69 59.76 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.819 -1.175 . . . . 0.0 111.047 166.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 16.3 t80 -132.95 107.75 8.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.34 -1.475 . . . . 0.0 108.807 -170.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.6 m -49.77 -45.62 49.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.879 0.763 . . . . 0.0 112.758 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 57.3 m -52.43 -36.77 55.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.811 0.844 . . . . 0.0 111.502 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 ttm -57.16 -34.63 68.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 116.791 -1.576 . . . . 0.0 110.386 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.79 -42.82 99.87 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.129 1.786 . . . . 0.0 110.954 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -63.53 -54.15 40.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -174.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.58 -63.37 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.613 1.565 . . . . 0.0 109.143 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.47 -51.9 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 119.704 1.138 . . . . 0.0 110.768 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.58 -40.93 84.52 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 118.676 0.671 . . . . 0.0 111.231 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -66.08 -53.5 37.42 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 118.732 0.696 . . . . 0.0 109.146 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.9 mt -56.45 -36.25 68.83 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 124.143 0.977 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.45 -67.15 0.35 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.258 169.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -57.38 -27.93 62.74 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.521 1.055 . . . . 0.0 113.089 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -58.02 -20.58 39.85 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.741 1.155 . . . . 0.0 112.563 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.1 mt -108.83 -35.7 6.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.223 3.009 . . . . 0.0 111.612 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.8 177.62 28.31 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 125.428 1.489 . . . . 0.0 110.985 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 62.22 -177.8 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.914 1.286 . . . . 0.0 112.392 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 170.29 -167.97 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 130.581 3.552 . . . . 0.0 105.568 -164.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 56.12 46.65 21.15 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.751 1.62 . . . . 0.0 111.977 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -71.77 149.21 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.36 173.13 8.6 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.493 2.317 . . . . 0.0 106.523 166.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -131.75 176.7 8.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.986 1.314 . . . . 0.0 109.111 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.4 169.66 16.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.725 2.01 . . . . 0.0 106.696 171.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.93 -32.12 65.07 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.539 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -170.94 174.83 4.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.936 1.695 . . . . 0.0 107.558 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.65 -36.06 69.9 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.32 1.438 . . . . 0.0 114.75 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.08 -40.76 90.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -71.33 -34.81 70.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 110.713 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.19 66.17 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.408 1.083 . . . . 0.0 109.232 -175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.44 -42.65 64.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.542 0.737 . . . . 0.0 111.527 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.67 -28.57 65.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.055 0.542 . . . . 0.0 111.713 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.61 -53.21 59.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.801 166.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.4 mt -53.44 -54.72 32.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.941 0.792 . . . . 0.0 110.616 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.45 11.89 0.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.93 86.6 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 158.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.33 88.73 0.34 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.498 1.523 . . . . 0.0 109.827 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.87 -29.68 0.24 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.715 1.626 . . . . 0.0 111.014 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -54.32 141.14 31.08 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.128 0.971 . . . . 0.0 109.344 166.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -118.2 -18.14 5.11 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.952 -0.915 . . . . 0.0 113.769 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -150.21 147.53 27.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.718 1.259 . . . . 0.0 107.878 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 ' CG2' HD13 ' A' ' 81' ' ' LEU . 2.9 t -131.9 128.2 59.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -169.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.7 132.48 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 p -151.78 161.16 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.294 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -70.74 169.98 13.38 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 110.076 169.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -80.23 -57.7 3.49 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 159.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -77.51 111.37 13.15 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.417 0.687 . . . . 0.0 109.2 -159.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . 16.9 mmm -119.42 170.55 6.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.808 0.843 . . . . 0.0 110.726 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -83.82 -3.63 10.52 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.59 2.86 . . . . 0.0 113.015 166.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.84 -91.83 0.06 Allowed 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -160.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.7 ttm -91.07 95.12 9.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.202 1.801 . . . . 0.0 107.613 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 60' ' ' MET . 11.4 m-20 -51.63 154.28 2.01 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.103 1.361 . . . . 0.0 108.449 172.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.78 -24.5 26.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.031 0.824 . . . . 0.0 112.922 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.88 -52.23 31.83 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.564 1.182 . . . . 0.0 110.801 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -68.78 -32.37 72.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.179 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.31 -59.55 5.28 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 118.129 -0.938 . . . . 0.0 109.108 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.706 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -45.06 -55.51 5.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.761 1.224 . . . . 0.0 109.108 173.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -64.66 -27.55 69.0 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 117.868 -1.063 . . . . 0.0 113.286 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 48.9 m -69.19 -50.97 42.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 119.383 0.992 . . . . 0.0 109.04 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.2 mt -45.89 -57.0 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.384 1.088 . . . . 0.0 112.279 165.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -69.6 8.03 0.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.594 2.357 . . . . 0.0 112.839 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.64 -28.39 67.68 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.629 1.559 . . . . 0.0 110.868 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 127.98 -74.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 1 C-N-CA 134.278 5.031 . . . . 0.0 107.044 175.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.43 25.41 1.1 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.667 1.127 . . . . 0.0 114.896 -172.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.22 34.17 2.1 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.273 1.829 . . . . 0.0 110.604 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . 0.284 0.5 OUTLIER 95.0 30.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.533 1.533 . . . . 0.0 111.083 168.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.2 p -52.49 -31.97 37.71 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.33 -13.87 60.45 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.916 1.235 . . . . 0.0 112.745 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD13 ' CG2' ' A' ' 54' ' ' VAL . 11.5 mt -58.05 129.79 82.75 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.17 0.988 . . . . 0.0 109.244 178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.24 109.74 2.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.958 1.772 . . . . 0.0 108.938 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -90.12 94.66 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.182 0.993 . . . . 0.0 109.043 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 tp -87.18 113.97 23.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.804 -1.185 . . . . 0.0 108.222 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.9 mtt -84.8 124.61 31.77 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -132.5 114.91 24.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t -147.25 -179.41 6.81 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.513 1.149 . . . . 0.0 109.904 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.05 -24.95 16.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.835 1.254 . . . . 0.0 112.014 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -91.24 151.83 20.76 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 119.08 0.855 . . . . 0.0 111.152 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.61 -80.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.424 171.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? 52.55 100.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.422 1.489 . . . . 0.0 110.432 -167.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -54.46 -37.79 65.61 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.471 -1.393 . . . . 0.0 110.2 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -33.81 74.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.579 0.627 . . . . 0.0 112.553 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -65.14 -44.52 88.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.28 0.632 . . . . 0.0 109.442 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.73 -50.48 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.766 175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.16 -56.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.62 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.14 95.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.415 0.552 . . . . 0.0 109.964 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.46 -34.15 77.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.927 0.491 . . . . 0.0 112.129 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -69.7 -52.3 26.83 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.699 1.999 . . . . 0.0 111.086 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.69 -46.15 77.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 171.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.35 41.94 1.01 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.432 1.491 . . . . 0.0 111.782 169.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.706 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.74 165.27 4.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.7 1.2 . . . . 0.0 110.695 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.0 t -51.41 -44.6 62.3 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.524 1.13 . . . . 0.0 108.712 170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.35 172.7 39.08 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 169.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -100.86 141.36 33.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.0 t -131.19 128.27 61.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.17 139.2 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -58.29 139.96 83.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 117.902 -1.047 . . . . 0.0 109.526 168.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.51 131.31 23.49 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.4 1.179 . . . . 0.0 111.267 -1.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -131.5 159.15 38.96 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.164 0.985 . . . . 0.0 109.511 169.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 p -152.16 171.12 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.836 2.454 . . . . 0.0 108.364 -168.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.52 -35.87 75.02 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.03 -15.27 12.56 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.31 -33.09 6.74 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.193 1.36 . . . . 0.0 110.869 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.94 -49.09 66.74 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.544 1.538 . . . . 0.0 108.65 172.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -57.07 -33.11 66.93 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 125.954 1.702 . . . . 0.0 112.689 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 32.9 tt0 -78.07 -33.62 50.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.412 0.285 . . . . 0.0 110.246 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -63.15 -43.4 98.41 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.777 -1.106 . . . . 0.0 108.823 171.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.9 mt -55.71 -52.91 62.26 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.94 -35.43 73.12 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 23.8 mtmt -61.77 -59.39 5.23 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.09 171.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 pt -65.25 -30.16 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.547 1.521 . . . . 0.0 112.869 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -55.3 -62.89 1.37 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.46 -35.45 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -170.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' HD23 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -81.51 -61.4 1.94 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.875 1.27 . . . . 0.0 109.193 -172.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.47 HD23 ' HD2' ' A' ' 126' ' ' LYS . 4.1 mt -79.66 -20.88 45.61 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.436 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.72 38.06 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.818 -169.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 32.7 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.059 -1.448 . . . . 0.0 109.966 -178.049 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.57 92.67 1.41 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -151.46 158.88 44.24 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.077 0.951 . . . . 0.0 109.063 -159.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -78.64 -10.04 59.6 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.492 0.717 . . . . 0.0 110.75 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 48.87 48.08 20.76 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 126.592 1.957 . . . . 0.0 109.281 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp -29.08 104.88 0.03 OUTLIER 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.571 1.548 . . . . 0.0 113.952 -158.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -90.74 132.37 35.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.616 -165.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -107.68 104.44 13.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 tp -77.6 134.15 38.28 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 167.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.36 118.7 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.4 t -133.85 56.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.312 1.445 . . . . 0.0 108.222 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.68 146.17 55.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' H ' ' HB2' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -69.01 -58.24 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.782 0.833 . . . . 0.0 109.073 172.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 21.4 t80 -72.81 114.22 10.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.5 m -50.43 -51.45 46.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 112.337 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.497 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 24.8 m -61.6 -26.59 68.08 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.564 -1.208 . . . . 0.0 112.176 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 ttm -59.77 -44.55 93.82 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.629 1.559 . . . . 0.0 109.903 168.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -65.42 -36.94 85.44 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 119.267 0.939 . . . . 0.0 111.054 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -61.3 -42.79 99.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.189 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.84 -66.19 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-O 116.688 -1.625 . . . . 0.0 107.798 170.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.36 -49.55 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.309 1.868 . . . . 0.0 110.993 -172.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -57.92 -42.91 85.8 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.728 0.811 . . . . 0.0 110.607 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.93 -45.74 91.06 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.388 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 mt -59.49 -44.37 93.08 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 118.721 0.692 . . . . 0.0 109.296 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.49 -47.45 78.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.644 0.778 . . . . 0.0 111.131 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 3.0 mmpt? -60.99 -42.44 98.41 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.038 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -57.56 -44.5 85.3 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.78 1.232 . . . . 0.0 110.02 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.91 4.64 16.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.266 1.027 . . . . 0.0 112.234 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.01 -18.08 47.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.617 1.58 . . . . 0.0 114.53 166.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -67.74 156.95 35.8 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.015 1.408 . . . . 0.0 111.234 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -136.09 -172.72 3.19 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.352 1.861 . . . . 0.0 109.9 -171.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.8 t30 55.17 58.68 4.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 127.177 2.191 . . . . 0.0 112.559 165.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.7 148.14 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.897 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -121.26 160.06 24.69 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.152 1.781 . . . . 0.0 108.187 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 28.2 tt0 -121.59 151.9 39.86 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.56 164.81 21.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -72.56 -35.82 68.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.516 0.327 . . . . 0.0 111.234 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.81 176.89 4.64 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.719 1.208 . . . . 0.0 109.797 -170.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.63 43.64 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.259 1.885 . . . . 0.0 115.866 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.5 -51.45 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 120.666 2.233 . . . . 0.0 107.981 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.29 -34.36 76.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.645 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -61.68 -47.97 82.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.665 -1.272 . . . . 0.0 110.197 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 tp -59.32 -41.52 89.28 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -67.69 -30.0 69.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.353 0.661 . . . . 0.0 112.666 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 35' ' ' GLU . 4.3 mptp? -67.69 -42.34 82.2 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.357 -0.839 . . . . 0.0 110.167 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 46' ' ' LEU . 3.7 mm? -62.9 -39.02 93.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.732 1.151 . . . . 0.0 110.225 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -70.25 12.33 0.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.796 0.839 . . . . 0.0 112.673 172.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.03 16.54 7.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.122 2.169 . . . . 0.0 111.836 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.47 -178.68 38.16 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.525 1.511 . . . . 0.0 115.57 162.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.01 73.5 0.97 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -69.44 154.66 41.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.614 0.766 . . . . 0.0 109.659 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.87 -32.28 11.24 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-O 119.097 -0.835 . . . . 0.0 112.612 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -142.86 149.85 39.09 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.588 1.155 . . . . 0.0 109.574 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 81' ' ' LEU . 21.2 t -139.42 64.57 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.32 132.73 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.06 153.98 37.37 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.787 0.435 . . . . 0.0 110.394 -169.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 13' ' ' ASP . 7.9 t0 -84.84 167.47 15.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 161.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.76 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 2.7 t-105 -73.08 -44.43 60.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.871 0.868 . . . . 0.0 110.325 164.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -68.61 29.38 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 131.403 3.881 . . . . 0.0 115.909 -158.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 38.0 mtt -65.94 170.54 4.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 127.891 2.476 . . . . 0.0 109.826 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.1 -39.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.825 2.35 . . . . 0.0 112.915 -173.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -124.56 -76.94 0.59 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 123.924 0.889 . . . . 0.0 109.436 -167.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 tpt -72.75 103.78 3.76 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 168.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -67.36 164.14 19.21 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.332 0.587 . . . . 0.0 109.745 173.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.59 -25.54 67.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 121.069 -0.586 . . . . 0.0 114.111 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.76 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -73.63 -43.08 60.51 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.054 1.342 . . . . 0.0 108.919 177.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.55 -42.64 98.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.57 0.748 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -54.63 -52.4 62.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.856 0.753 . . . . 0.0 109.259 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.2 tp -51.7 -58.96 4.9 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 123.411 0.684 . . . . 0.0 110.179 174.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -63.26 -30.57 71.69 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.994 0.815 . . . . 0.0 112.39 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 68.9 m -69.07 -51.23 41.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.11 0.964 . . . . 0.0 108.426 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.4 mt -56.13 -47.51 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.533 0.733 . . . . 0.0 109.982 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -58.88 -23.62 61.21 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.428 1.491 . . . . 0.0 112.839 -175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.07 -62.04 2.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.925 0.89 . . . . 0.0 111.568 -169.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -161.66 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.108 1.363 . . . . 0.0 108.604 166.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.56 1.92 5.24 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.627 2.06 . . . . 0.0 115.068 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.08 9.16 2.26 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.781 2.433 . . . . 0.0 112.329 -159.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt -96.8 -10.4 26.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.027 1.731 . . . . 0.0 111.092 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.5 p -54.03 -47.33 71.66 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.414 0.686 . . . . 0.0 112.153 -166.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.04 7.32 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 54' ' ' VAL . 11.5 mt -54.35 142.78 48.6 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-N 119.839 1.2 . . . . 0.0 111.381 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 72.18 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.696 2.264 . . . . 0.0 109.803 160.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 69' ' ' LEU . 2.3 m -64.46 137.45 24.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 158.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.4 tp -141.69 113.53 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.7 mmt -74.72 128.92 36.73 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 124.269 0.981 . . . . 0.0 108.444 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.63 110.49 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.4 t -153.13 167.96 27.51 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.578 -0.701 . . . . 0.0 110.3 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.72 -23.07 31.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.343 -0.848 . . . . 0.0 112.474 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.67 116.3 22.58 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-N 119.444 1.02 . . . . 0.0 109.329 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.53 -81.42 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.438 166.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.5 tptt 45.94 95.04 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.3 1.44 . . . . 0.0 111.213 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -51.71 -33.78 35.95 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 120.225 -1.547 . . . . 0.0 112.138 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -57.88 -42.98 85.73 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.701 1.137 . . . . 0.0 112.491 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -59.56 -44.88 93.14 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.701 0.8 . . . . 0.0 109.098 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.41 -46.07 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.954 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mt -61.36 -52.51 60.47 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.576 1.08 . . . . 0.0 108.52 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.28 -45.93 69.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.521 1.055 . . . . 0.0 110.962 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.439 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -64.16 -46.85 82.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.332 0.653 . . . . 0.0 109.951 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.87 -47.05 86.76 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.89 0.768 . . . . 0.0 110.609 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -55.31 -51.49 66.55 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 126.742 2.017 . . . . 0.0 110.857 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -21.01 66.01 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 101.09 25.18 8.51 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.849 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.8 136.39 57.97 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 p -74.55 -1.75 22.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . 172.75 169.05 34.89 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 121.182 -0.949 . . . . 0.0 111.619 172.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -139.72 92.7 2.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.026 1.331 . . . . 0.0 108.699 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.8 t -80.04 112.61 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.75 157.85 4.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 pttp -64.12 159.58 55.43 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.037 158.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.1 166.81 81.46 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.826 0.974 . . . . 0.0 110.097 -11.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -178.09 158.73 1.24 Allowed 'General case' 0 C--N 1.333 -0.135 0 O-C-N 121.266 -0.897 . . . . 0.0 111.285 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 p -154.86 -177.34 6.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 126.766 2.026 . . . . 0.0 109.026 -173.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.83 -23.55 53.24 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.753 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.32 -53.51 49.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.877 0.871 . . . . 0.0 112.075 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -30.5 60.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 0.0 109.935 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -53.84 53.6 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.407 1.003 . . . . 0.0 108.94 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -66.98 -39.77 87.25 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 118.533 0.606 . . . . 0.0 111.469 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.0 -47.83 74.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.171 0.989 . . . . 0.0 109.87 172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 1.8 mmmp? -68.15 -37.48 81.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 116.15 -1.881 . . . . 0.0 112.336 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.45 -58.32 9.0 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.521 1.055 . . . . 0.0 108.207 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -58.19 -36.05 72.52 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.15 0.98 . . . . 0.0 109.937 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -56.94 -56.0 27.35 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-O 117.589 -1.196 . . . . 0.0 112.901 168.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.0 pt -68.95 -25.67 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 121.398 1.908 . . . . 0.0 112.934 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -57.87 -55.73 31.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.85 -47.13 79.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 122.547 0.339 . . . . 0.0 111.676 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.468 ' HG3' HD23 ' A' ' 127' ' ' LEU . 11.3 tptt -78.23 -71.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.202 1.001 . . . . 0.0 109.727 -168.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 126' ' ' LYS . 13.1 mt -64.9 -20.67 66.56 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.758 -0.639 . . . . 0.0 111.211 -178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.88 42.36 16.73 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.404 -2.278 . . . . 0.0 107.404 -166.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.249 1.072 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.234 169.306 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.68 -142.77 0.17 Allowed 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 152.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -71.52 -178.06 2.05 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 162.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -53.24 -23.84 9.79 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.076 -1.015 . . . . 0.0 111.115 165.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 58.63 49.13 10.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.645 1.978 . . . . 0.0 107.643 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.53 112.1 2.33 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 110.511 -167.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -81.57 149.96 28.39 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.884 0.874 . . . . 0.0 109.549 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.401 ' CZ ' ' CE1' ' A' ' 53' ' ' PHE . 12.0 m-85 -120.97 106.62 11.77 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.415 1.086 . . . . 0.0 109.528 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.77 136.15 43.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 120.611 1.55 . . . . 0.0 108.84 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -136.15 105.5 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.343 1.457 . . . . 0.0 107.3 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.29 70.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.239 1.016 . . . . 0.0 108.378 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.38 138.75 35.58 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 1.3 t70 -53.07 -33.08 50.43 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.939 2.095 . . . . 0.0 112.656 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -115.24 120.49 39.86 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 107.156 -168.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.3 m -53.07 -47.69 68.29 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.62 -175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.3 m -51.85 -44.64 63.72 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.625 1.102 . . . . 0.0 111.539 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -41.83 94.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -69.56 -44.16 71.42 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.913 1.285 . . . . 0.0 109.314 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -52.45 -52.34 54.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 127.13 2.172 . . . . 0.0 109.723 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -55.89 -62.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 117.218 -1.372 . . . . 0.0 108.261 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -52.03 -48.1 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 120.822 1.647 . . . . 0.0 110.761 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HB3' HH11 ' A' ' 22' ' ' ARG . 0.2 OUTLIER -56.37 -49.86 73.23 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.674 175.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -60.39 -42.67 96.37 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 118.521 0.601 . . . . 0.0 110.713 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' H ' ' A' ' 113' ' ' ALA . 94.6 mt -63.69 -39.4 94.22 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.765 0.826 . . . . 0.0 111.013 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -64.84 -48.43 74.38 Favored 'General case' 0 C--N 1.333 -0.12 0 O-C-N 121.913 -0.492 . . . . 0.0 110.378 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -58.84 -39.76 82.22 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.07 0.948 . . . . 0.0 110.951 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -55.5 -51.04 68.33 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.36 1.064 . . . . 0.0 109.338 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.25 -48.21 80.95 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.32 -17.06 3.14 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.4 1.953 . . . . 0.0 111.977 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -65.07 133.47 51.7 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 109.63 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.28 -176.38 5.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -167.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 19.7 t30 62.06 80.39 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 128.622 2.769 . . . . 0.0 108.76 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.06 160.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.354 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -114.31 147.08 39.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.198 -2.89 . . . . 0.0 103.198 158.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.37 164.31 12.7 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 158.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.75 167.86 14.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 158.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.44 -27.41 46.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.865 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -176.17 156.93 1.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.779 1.232 . . . . 0.0 108.084 -158.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -42.52 -45.33 5.47 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.107 1.337 . . . . 0.0 114.807 170.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.47 -36.87 78.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 119.608 1.704 . . . . 0.0 110.417 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -70.87 -31.97 68.82 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 122.763 0.425 . . . . 0.0 110.23 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.16 61.47 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -58.43 -40.12 81.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.779 0.432 . . . . 0.0 111.605 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -56.12 -51.35 68.26 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.971 0.508 . . . . 0.0 109.877 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -55.74 -46.68 77.74 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.184 0.994 . . . . 0.0 110.297 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.52 HD11 HD11 ' A' ' 72' ' ' ILE . 11.5 mt -58.07 -46.99 84.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.958 0.799 . . . . 0.0 110.286 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -81.47 5.18 18.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.652 0.781 . . . . 0.0 112.423 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -57.22 12.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 159.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.26 88.89 0.07 OUTLIER Glycine 0 C--N 1.339 0.701 0 O-C-N 121.142 -0.974 . . . . 0.0 113.825 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 50.3 84.08 0.03 OUTLIER Glycine 0 C--N 1.336 0.569 0 C-N-CA 125.946 1.736 . . . . 0.0 114.993 158.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -81.91 175.8 10.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.569 0.699 . . . . 0.0 112.649 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.45 -72.61 1.15 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 165.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE1' ' CZ ' ' A' ' 8' ' ' PHE . 27.1 m-85 -110.91 154.24 24.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.855 -171.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.28 91.47 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.37 129.39 52.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.3 p -151.38 162.2 41.34 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.655 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 18.0 t70 -72.89 -177.0 2.21 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.503 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 9.1 t-105 -116.11 -33.13 5.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.334 2.654 . . . . 0.0 112.366 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -76.2 21.48 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.306 2.242 . . . . 0.0 114.133 -159.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.406 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -76.27 147.06 79.01 Favored Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.342 1.057 . . . . 0.0 110.214 179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.57 -172.21 1.24 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.014 2.476 . . . . 0.0 110.14 159.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 55.78 -105.86 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.613 1.965 . . . . 0.0 109.981 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.8 ttm -87.88 85.89 7.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.8 156.9 22.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.014 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.64 -22.62 64.18 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.685 -169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -78.74 -35.59 44.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.32 1.56 . . . . 0.0 110.951 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -26.03 39.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.164 0.893 . . . . 0.0 111.254 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.14 -54.38 47.57 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.23 1.412 . . . . 0.0 108.622 164.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 8.1 tp -52.46 -58.51 6.51 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.088 0.955 . . . . 0.0 108.578 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 101' ' ' ALA . 87.1 mttt -64.25 -28.15 69.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 120.352 1.433 . . . . 0.0 112.774 -174.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.3 m -62.22 -53.96 47.75 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.917 1.235 . . . . 0.0 108.354 168.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 46' ' ' LEU . 33.4 mt -56.29 -47.47 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.688 1.195 . . . . 0.0 107.853 -177.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -5.98 12.12 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.389 1.876 . . . . 0.0 113.652 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.72 -75.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.234 1.379 . . . . 0.0 109.858 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -167.22 -112.74 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.826 1.651 . . . . 0.0 108.167 161.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.59 22.29 52.09 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 120.052 1.296 . . . . 0.0 112.922 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.58 -6.97 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 127.874 2.47 . . . . 0.0 113.976 -165.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtm -71.71 -16.82 62.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.851 -1.156 . . . . 0.0 110.148 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -42.72 -39.04 2.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.631 1.973 . . . . 0.0 112.421 159.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.53 -15.56 54.5 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.711 HD13 HG21 ' A' ' 54' ' ' VAL . 26.7 mt -64.39 131.91 95.2 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 120.116 1.325 . . . . 0.0 110.703 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.83 87.65 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.974 3.116 . . . . 0.0 109.779 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -67.24 104.26 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 128.516 2.726 . . . . 0.0 108.762 163.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.43 109.9 19.03 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.922 1.289 . . . . 0.0 108.198 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 59.6 mmm -87.78 129.84 35.05 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.25 94.51 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.16 1.784 . . . . 0.0 106.189 -174.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -130.93 174.49 9.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.848 0.832 . . . . 0.0 111.09 -167.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.41 -22.78 23.55 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.394 -0.816 . . . . 0.0 111.726 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -87.0 113.86 23.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.558 0.743 . . . . 0.0 111.73 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.17 8.48 1.63 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.495 1.518 . . . . 0.0 111.973 161.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.0 tptm -54.32 116.88 2.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.183 0.993 . . . . 0.0 108.452 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -60.87 -36.45 79.22 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 117.541 -1.218 . . . . 0.0 110.581 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -44.71 85.57 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 119.455 1.025 . . . . 0.0 109.531 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.64 -40.99 96.87 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.2 mt -64.89 -48.79 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.267 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.1 mt -59.16 -51.65 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 120.009 1.277 . . . . 0.0 108.11 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.04 -42.25 76.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.8 0.84 . . . . 0.0 110.904 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.24 73.32 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.605 0.762 . . . . 0.0 110.32 176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.46 98.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.28 0.632 . . . . 0.0 110.722 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -57.07 -55.01 40.28 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 127.549 2.34 . . . . 0.0 108.83 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . . . -64.73 -7.39 10.66 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.722 1.209 . . . . 0.0 113.234 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.41 30.81 56.16 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.302 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.87 143.55 36.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.899 1.349 . . . . 0.0 109.309 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.5 p -73.42 -14.85 61.34 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 122.15 -0.344 . . . . 0.0 111.908 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.34 167.55 38.75 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.84 137.88 40.19 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.24 125.68 51.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 170.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -96.2 150.35 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 166.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 153.65 69.97 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 121.538 -0.726 . . . . 0.0 109.79 166.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.84 175.43 44.8 Favored 'Cis proline' 0 CA--C 1.538 0.7 0 CA-C-N 119.846 0.981 . . . . 0.0 110.266 -15.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -178.07 159.01 1.27 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.528 1.531 . . . . 0.0 108.399 -171.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.486 ' H ' HG22 ' A' ' 115' ' ' THR . 2.5 p -149.33 174.76 12.08 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.695 1.998 . . . . 0.0 109.297 -165.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -60.99 -34.34 74.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.62 -6.15 2.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.287 1.835 . . . . 0.0 115.686 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 112' ' ' THR . 2.8 t -115.33 -34.56 4.92 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 121.395 1.907 . . . . 0.0 110.15 161.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.05 -56.92 5.64 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.643 1.577 . . . . 0.0 108.19 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -60.42 -31.61 70.57 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.03 1.332 . . . . 0.0 113.002 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 30.1 tt0 -72.54 -43.31 63.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.557 -0.715 . . . . 0.0 109.409 176.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 13.2 mmtp -68.81 -34.75 76.03 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.067 -1.02 . . . . 0.0 110.015 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 32.3 mt -55.04 -58.06 9.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -56.78 -35.36 68.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.711 0.687 . . . . 0.0 112.038 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.458 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 22.7 mttm -59.97 -47.49 85.61 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.369 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.06 -28.02 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 121.496 1.953 . . . . 0.0 114.033 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -60.47 -54.01 50.72 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.834 0.854 . . . . 0.0 109.101 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -67.63 -51.65 47.59 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.97 -0.456 . . . . 0.0 110.426 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -64.31 1.0 Allowed 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -162.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.31 -22.01 66.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 119.429 -0.319 . . . . 0.0 110.903 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.44 26.81 50.25 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.931 -167.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.3 mmt . . . . . 0 C--O 1.25 1.119 0 CA-C-N 119.768 1.784 . . . . 0.0 110.411 177.328 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.314 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.59 -70.86 0.23 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.03 0.932 . . . . 0.0 110.544 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -140.9 -171.36 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.349 1.86 . . . . 0.0 108.209 -163.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -55.39 -32.09 62.35 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.156 -0.965 . . . . 0.0 110.623 159.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 51.66 46.13 27.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.286 1.434 . . . . 0.0 108.421 -171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.695 HD11 ' HA3' ' A' ' 52' ' ' GLY . 5.9 tt -44.67 127.27 6.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 125.909 1.683 . . . . 0.0 109.757 -176.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -83.89 131.37 34.87 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -83.8 138.46 33.23 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 158.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 42' ' ' ALA . 22.0 tp -111.07 135.75 51.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 169.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.11 122.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -132.77 48.0 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -62.99 157.49 21.77 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.493 -1.379 . . . . 0.0 108.727 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -33.32 71.18 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 121.493 -0.755 . . . . 0.0 111.182 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.1 t80 -102.43 127.84 49.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.058 1.343 . . . . 0.0 107.622 -171.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.92 -49.04 79.31 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.362 0.601 . . . . 0.0 110.057 -172.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 8.8 m -63.04 -24.15 67.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.62 -0.705 . . . . 0.0 111.743 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 18.7 ttm -64.95 -34.09 77.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 120.362 1.437 . . . . 0.0 109.938 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -36.8 80.77 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 120.352 1.433 . . . . 0.0 110.565 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -52.01 -53.06 46.2 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 168.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.22 -63.71 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 CA-C-O 117.439 -1.267 . . . . 0.0 108.673 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.5 t -52.71 -46.34 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 120.664 1.574 . . . . 0.0 110.65 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.78 91.12 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.82 1.191 . . . . 0.0 110.318 175.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.73 -39.54 91.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.309 0.959 . . . . 0.0 111.922 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.57 -41.33 96.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.036 0.934 . . . . 0.0 110.079 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.84 -45.75 92.45 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.245 0.618 . . . . 0.0 111.075 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -63.43 -39.39 94.37 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.799 0.727 . . . . 0.0 110.802 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -71.61 -12.98 61.62 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.598 -171.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.84 13.82 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.35 -90.61 0.43 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.558 1.075 . . . . 0.0 111.197 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -147.69 175.47 10.86 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.198 0.999 . . . . 0.0 112.824 -159.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -118.74 171.61 8.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 128.43 2.692 . . . . 0.0 109.194 177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 77.29 99.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 128.388 2.675 . . . . 0.0 113.228 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 m -121.1 154.87 24.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.566 0.698 . . . . 0.0 112.449 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -122.3 145.42 48.25 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 158.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -119.71 93.89 4.22 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -76.29 163.45 27.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.67 0.748 . . . . 0.0 111.079 -172.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -75.65 -33.05 60.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.308 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -177.36 160.97 1.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.343 1.457 . . . . 0.0 107.535 -163.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.4 -40.36 10.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.755 1.161 . . . . 0.0 115.156 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.1 t -65.77 -39.41 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.237 2.018 . . . . 0.0 109.066 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.22 -29.77 65.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.142 0.977 . . . . 0.0 111.028 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HA ' HD21 ' A' ' 9' ' ' LEU . . . -61.24 -51.44 68.92 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.949 -1.095 . . . . 0.0 109.401 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.38 -41.06 83.98 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.317 1.047 . . . . 0.0 111.144 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -56.51 -50.8 70.76 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.297 1.039 . . . . 0.0 110.282 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -54.78 -49.67 70.35 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.126 175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 72' ' ' ILE . 15.4 mt -53.45 -43.84 68.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.074 1.306 . . . . 0.0 109.935 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.59 10.56 0.35 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.53 -4.9 47.16 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.987 1.267 . . . . 0.0 112.764 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.92 163.16 8.79 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.229 1.395 . . . . 0.0 113.438 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.2 22.74 76.26 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.466 -1.02 . . . . 0.0 112.281 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -90.96 156.57 17.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.536 1.168 . . . . 0.0 107.974 170.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.695 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -159.81 9.54 0.15 Allowed Glycine 0 C--O 1.225 -0.445 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.23 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.06 132.26 17.4 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 81' ' ' LEU . 5.9 t -133.29 86.11 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 CA-C-O 122.436 1.112 . . . . 0.0 108.0 -171.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -97.76 131.61 44.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 126.275 1.83 . . . . 0.0 106.194 -171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -151.86 145.6 25.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.854 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -68.91 162.17 27.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.91 0.862 . . . . 0.0 109.485 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -70.27 -52.75 20.65 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.78 1.232 . . . . 0.0 109.478 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.45 82.25 6.52 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.742 1.617 . . . . 0.0 108.656 -169.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.5 mmt -86.95 168.64 17.26 Favored Pre-proline 0 C--O 1.234 0.263 0 O-C-N 121.806 -0.558 . . . . 0.0 111.013 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.37 0.94 9.28 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.217 2.611 . . . . 0.0 113.023 165.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -150.73 -80.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 121.008 1.731 . . . . 0.0 112.05 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.5 ttm -90.73 94.28 9.61 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -46.43 148.82 0.86 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.855 2.062 . . . . 0.0 111.434 176.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.98 -36.04 41.91 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.521 1.058 . . . . 0.0 113.754 -172.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.36 -34.14 55.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.775 0.83 . . . . 0.0 110.417 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.82 -42.95 85.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.56 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.11 -49.02 79.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.476 1.035 . . . . 0.0 110.013 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 83' ' ' VAL . 2.1 tp -52.43 -56.72 13.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.95 -26.25 67.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 120.241 1.382 . . . . 0.0 113.243 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 m -65.3 -49.06 70.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.34 0.973 . . . . 0.0 108.609 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 46' ' ' LEU . 18.8 mt -61.35 -44.42 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.519 1.127 . . . . 0.0 109.261 175.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 10.21 2.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.249 1.819 . . . . 0.0 111.712 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.81 -15.28 63.49 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.602 1.092 . . . . 0.0 111.735 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 59.86 -176.97 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.959 2.104 . . . . 0.0 110.574 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.24 -33.82 1.32 Allowed Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.26 -1.525 . . . . 0.0 110.797 -159.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.08 166.55 32.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.267 1.827 . . . . 0.0 108.113 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.6 mtt 72.45 -8.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 130.178 3.391 . . . . 0.0 116.209 158.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -59.76 -23.95 63.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.6 -15.3 60.84 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.389 1.45 . . . . 0.0 113.538 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 54' ' ' VAL . 13.0 mt -55.52 135.38 70.67 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.961 0.904 . . . . 0.0 111.559 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.87 87.18 0.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.692 2.261 . . . . 0.0 108.942 162.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.573 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -77.0 140.88 16.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 162.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.17 118.56 14.71 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -172.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.3 mmt -78.28 127.01 31.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.63 110.44 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.7 t -155.71 172.15 18.79 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.932 0.787 . . . . 0.0 111.232 -168.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.71 -28.18 62.52 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.235 -0.916 . . . . 0.0 111.539 159.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.75 93.29 0.94 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -164.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HB2' HG11 ' A' ' 108' ' ' VAL . . . -73.9 4.53 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.987 170.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -45.16 105.25 0.05 Allowed 'General case' 0 C--N 1.345 0.375 0 C-N-CA 125.999 1.72 . . . . 0.0 108.524 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -50.7 -43.15 57.62 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 122.462 0.305 . . . . 0.0 110.218 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -49.32 -43.0 43.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.715 1.206 . . . . 0.0 113.317 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -69.59 -40.94 76.4 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.372 1.069 . . . . 0.0 109.802 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.91 -46.45 76.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.683 172.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.91 -55.99 17.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.73 76.75 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.735 0.698 . . . . 0.0 111.313 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.61 64.76 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.514 0.726 . . . . 0.0 110.536 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.67 97.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.041 0.536 . . . . 0.0 110.037 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -58.16 -53.84 53.68 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 126.787 2.035 . . . . 0.0 111.527 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.75 -38.27 78.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.112 0.565 . . . . 0.0 110.254 175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.69 30.2 3.11 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.713 1.149 . . . . 0.0 112.298 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.3 150.16 22.65 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.678 1.239 . . . . 0.0 109.699 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -72.79 -18.51 61.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.964 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 172.2 43.15 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.77 139.52 47.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 77.3 t -133.25 137.4 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 126.921 2.088 . . . . 0.0 105.368 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 90' ' ' ALA . 2.5 t -121.5 152.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -62.22 149.64 86.52 Favored Pre-proline 0 CA--C 1.542 0.637 0 O-C-N 121.138 -0.976 . . . . 0.0 109.233 164.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.61 127.63 14.13 Favored 'Cis proline' 0 N--CA 1.456 -0.723 0 N-CA-C 109.538 -0.985 . . . . 0.0 109.538 -15.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -117.75 156.24 28.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -146.26 178.76 8.0 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.039 1.336 . . . . 0.0 108.872 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.7 -25.49 67.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.215 -0.897 . . . . 0.0 109.216 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -53.69 -38.83 64.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.186 0.994 . . . . 0.0 112.575 170.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -31.9 20.79 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.828 1.195 . . . . 0.0 109.712 173.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.07 -48.77 75.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.713 1.142 . . . . 0.0 109.404 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.51 -36.14 81.6 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 123.349 0.66 . . . . 0.0 111.675 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 122' ' ' LYS . 10.0 tt0 -66.38 -46.99 74.79 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.81 0.732 . . . . 0.0 109.189 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -44.94 89.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.203 -0.903 . . . . 0.0 108.769 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.1 mt -55.05 -53.51 54.92 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.701 0.8 . . . . 0.0 110.183 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.93 -45.97 82.35 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.568 0.747 . . . . 0.0 110.997 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HE2' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -53.27 -55.99 20.16 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.878 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -27.77 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 119.935 1.243 . . . . 0.0 112.574 -169.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -54.73 -60.36 3.47 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 165.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.8 -52.55 42.61 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 109.725 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.294 1.437 . . . . 0.0 110.983 -164.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.3 mt -69.07 -32.13 71.36 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.05 44.45 5.98 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -162.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 36.1 mmt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 119.115 1.457 . . . . 0.0 109.996 169.268 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.84 174.78 6.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 162.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.43 39.88 0.85 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.167 -0.958 . . . . 0.0 110.962 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -69.9 8.28 0.75 Allowed 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.388 -1.445 . . . . 0.0 113.714 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.4 71.37 1.38 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.8 tp -44.32 135.7 4.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.725 2.01 . . . . 0.0 111.696 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -81.55 129.01 34.51 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -111.31 109.76 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.654 1.182 . . . . 0.0 107.847 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.31 138.53 47.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.732 1.606 . . . . 0.0 109.012 171.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.93 109.22 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.291 1.036 . . . . 0.0 109.308 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 36' ' ' ALA . 2.4 t -120.06 52.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -66.55 158.39 29.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.293 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -89.19 -43.03 11.3 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.797 -0.565 . . . . 0.0 111.486 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -92.0 114.66 27.26 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 116.739 -1.6 . . . . 0.0 108.958 -171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 t -53.14 -37.55 61.92 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 122.703 2.502 . . . . 0.0 114.622 -167.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.4 m -48.52 -38.42 20.25 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.578 -1.326 . . . . 0.0 111.708 170.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.0 ttm -65.36 -25.31 67.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.711 2.004 . . . . 0.0 111.572 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -56.42 22.1 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.452 1.933 . . . . 0.0 107.912 167.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -53.34 54.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.548 1.139 . . . . 0.0 108.584 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -54.9 -67.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 117.088 -1.434 . . . . 0.0 108.417 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.22 -48.27 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 120.673 1.579 . . . . 0.0 111.0 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -56.33 -48.79 76.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 109.837 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -63.04 -44.58 95.48 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.715 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 113' ' ' ALA . 85.2 mt -56.64 -44.17 81.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.17 0.988 . . . . 0.0 110.186 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.43 -42.84 96.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.639 0.776 . . . . 0.0 111.174 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -62.89 -35.13 79.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.57 -5.08 22.06 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.27 0.941 . . . . 0.0 111.464 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.67 15.58 8.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.258 2.623 . . . . 0.0 111.375 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.91 85.14 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.599 -1.112 . . . . 0.0 114.807 169.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -97.91 163.56 12.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.355 1.577 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -159.39 -160.28 0.82 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.553 1.141 . . . . 0.0 110.197 -173.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 59.42 37.29 23.22 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.519 1.527 . . . . 0.0 113.085 165.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.44 146.51 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.582 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -110.26 167.17 10.39 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 158.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.65 168.86 11.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 163.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -126.28 164.5 20.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 159.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.73 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.997 0.519 . . . . 0.0 110.556 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -167.66 173.31 8.6 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.836 1.654 . . . . 0.0 108.54 -170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.93 -29.11 54.64 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.031 1.172 . . . . 0.0 116.031 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.53 -49.77 56.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 120.537 2.168 . . . . 0.0 107.321 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -60.63 -32.37 71.53 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.29 0.636 . . . . 0.0 110.879 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.71 -52.65 59.6 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 120.728 -1.232 . . . . 0.0 109.042 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.42 -35.38 71.98 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -63.56 -44.62 93.58 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.34 173.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -62.58 -38.64 90.9 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.113 0.869 . . . . 0.0 111.528 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.48 HD21 HG13 ' A' ' 54' ' ' VAL . 11.0 mt -59.99 -46.68 88.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.3 1.409 . . . . 0.0 108.991 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -77.66 29.18 0.16 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.037 1.335 . . . . 0.0 111.486 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.77 32.8 4.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.559 1.944 . . . . 0.0 109.724 159.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.61 19.69 8.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.36 -1.245 . . . . 0.0 113.913 164.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.59 83.02 0.62 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.125 1.463 . . . . 0.0 109.528 173.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -69.56 170.33 10.88 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.158 0.583 . . . . 0.0 109.858 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 -40.62 26.34 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 121.668 -0.645 . . . . 0.0 112.565 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -139.73 155.84 47.12 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.328 0.564 . . . . 0.0 111.547 -166.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -134.3 71.08 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.1 mt -85.56 129.37 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -150.42 157.67 43.3 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.262 -1.524 . . . . 0.0 110.525 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -73.76 171.96 12.36 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.668 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 5.1 t-105 -66.7 -59.15 3.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 159.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.55 71.36 5.01 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -158.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.82 154.35 47.79 Favored Pre-proline 0 C--O 1.237 0.427 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.3 160.04 45.77 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.8 1.666 . . . . 0.0 109.257 162.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.24 -79.07 0.01 OUTLIER 'General case' 0 C--O 1.233 0.216 0 C-N-CA 129.104 2.962 . . . . 0.0 114.227 177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.3 ttp -88.45 79.79 7.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 170.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.86 150.17 2.31 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.026 1.73 . . . . 0.0 109.517 167.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.98 -27.93 71.2 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.205 -0.934 . . . . 0.0 113.785 -161.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.668 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -75.81 -31.42 59.4 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.974 0.887 . . . . 0.0 111.36 175.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.65 -40.54 84.53 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.792 0.723 . . . . 0.0 109.119 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.8 tp -56.15 -51.42 68.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.521 0.6 . . . . 0.0 109.73 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 103' ' ' ALA . 4.0 tp -53.19 -56.98 12.15 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.946 0.898 . . . . 0.0 109.526 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.482 ' HE3' HD12 ' A' ' 66' ' ' LEU . 80.7 mttt -63.48 -30.17 71.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.026 0.83 . . . . 0.0 112.25 -174.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 51.6 m -62.18 -55.77 25.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.334 1.054 . . . . 0.0 109.126 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.469 HD11 HD11 ' A' ' 46' ' ' LEU . 25.2 mt -59.81 -44.04 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.125 1.37 . . . . 0.0 108.183 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -57.7 -26.24 61.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.999 1.719 . . . . 0.0 112.756 -174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.63 -21.7 28.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.181 0.901 . . . . 0.0 112.311 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.36 133.89 43.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.999 1.272 . . . . 0.0 110.488 -173.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.67 58.99 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.668 -0.645 . . . . 0.0 114.308 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.32 -58.71 1.86 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.696 1.248 . . . . 0.0 108.254 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.49 ' HB3' HD12 ' A' ' 81' ' ' LEU . 43.9 mtt -69.42 -12.75 61.91 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -164.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -57.23 -26.86 61.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.837 1.199 . . . . 0.0 111.264 168.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.62 -10.09 59.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.002 1.321 . . . . 0.0 113.975 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 54' ' ' VAL . 18.0 mt -68.58 143.5 95.25 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 119.625 1.102 . . . . 0.0 110.125 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.78 87.94 0.95 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.996 2.464 . . . . 0.0 110.099 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -76.85 88.77 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 126.321 1.848 . . . . 0.0 107.083 163.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.5 tp -96.26 118.33 32.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.62 122.76 34.47 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.2 t -132.55 99.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.412 1.885 . . . . 0.0 107.405 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -139.61 -173.54 3.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.132 0.968 . . . . 0.0 110.382 -172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.09 -15.02 15.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.116 1.367 . . . . 0.0 111.666 163.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.54 103.75 7.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.61 -73.58 0.11 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 164.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? 39.98 92.7 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 126.433 1.893 . . . . 0.0 110.782 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -28.43 -57.75 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.071 1.348 . . . . 0.0 114.276 173.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 92' ' ' LYS . 22.1 tt0 -54.73 -40.26 69.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.656 2.382 . . . . 0.0 113.654 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.04 -39.47 72.27 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.856 1.263 . . . . 0.0 110.474 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 mt -58.97 -50.41 79.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 175.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.276 2.1 mt -53.9 -46.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 116.857 -1.544 . . . . 0.0 114.93 168.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.69 82.55 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 121.325 1.875 . . . . 0.0 110.488 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.66 -42.6 99.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.009 0.924 . . . . 0.0 110.729 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.64 -36.58 78.79 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.565 -0.709 . . . . 0.0 112.394 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -68.44 -44.07 75.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.487 1.515 . . . . 0.0 110.091 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.13 58.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.548 0.739 . . . . 0.0 112.739 172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.41 39.79 34.85 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 119.26 0.936 . . . . 0.0 112.453 173.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.62 150.4 31.97 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.428 0.614 . . . . 0.0 109.972 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -77.15 -14.33 59.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.96 0.904 . . . . 0.0 111.466 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.67 171.37 43.0 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 160.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -132.07 133.12 44.0 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.2 t -134.99 134.92 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.0 141.84 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -53.84 142.22 44.95 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.308 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.32 135.87 40.69 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.497 1.213 . . . . 0.0 110.77 -10.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.96 152.24 51.56 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.935 0.894 . . . . 0.0 109.275 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.2 p -149.74 -176.71 5.52 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.66 1.584 . . . . 0.0 108.943 -170.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -61.92 -32.89 73.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.402 -0.809 . . . . 0.0 108.901 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.46 -19.89 17.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.751 1.22 . . . . 0.0 114.218 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.58 -25.46 9.13 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.783 1.174 . . . . 0.0 111.668 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -47.59 81.21 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.17 -30.32 71.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.372 1.069 . . . . 0.0 112.162 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -78.8 -43.36 25.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.465 0.706 . . . . 0.0 110.114 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -25.63 60.61 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.224 -1.369 . . . . 0.0 110.133 175.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 mt -57.52 -53.24 60.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.457 1.026 . . . . 0.0 108.677 166.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -50.09 -45.47 52.64 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.801 0.728 . . . . 0.0 111.302 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -62.67 1.5 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.316 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 pt -67.47 -27.03 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 120.319 1.418 . . . . 0.0 113.089 -172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -53.78 -62.51 1.61 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 167.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -76.02 -29.6 58.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -168.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.54 -69.49 0.67 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.553 1.541 . . . . 0.0 107.829 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.97 -28.14 66.35 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.465 0.575 . . . . 0.0 111.546 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.79 43.16 6.52 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -162.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 38.2 mmt . . . . . 0 C--O 1.253 1.257 0 CA-C-N 118.66 1.23 . . . . 0.0 109.296 169.573 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtt . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.37 19.58 3.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.661 1.573 . . . . 0.0 112.19 -172.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.29 61.81 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.066 1.747 . . . . 0.0 109.929 -159.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.53 -12.15 50.2 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.161 -0.962 . . . . 0.0 112.135 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.99 56.71 0.85 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.921 2.488 . . . . 0.0 106.347 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.46 120.54 7.31 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.605 2.362 . . . . 0.0 110.173 176.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 166.1 12.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 122.453 1.12 . . . . 0.0 111.263 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 33' ' ' VAL . 1.4 m-85 -124.17 161.67 25.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.25 139.38 43.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 158.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.1 t -127.87 104.24 11.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 42' ' ' ALA . 3.2 t -109.04 78.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.21 157.83 35.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 165.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -80.79 -23.21 39.43 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.48 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 0.8 OUTLIER -83.41 -151.75 0.11 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.127 1.371 . . . . 0.0 109.575 178.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -139.78 -43.81 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.097 -1.002 . . . . 0.0 108.539 159.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.2 m -50.12 -31.93 14.68 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.782 169.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.2 ttm -64.72 -39.69 94.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.289 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.47 -33.35 71.16 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 122.122 2.237 . . . . 0.0 110.937 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -56.43 -54.0 50.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.1 -60.25 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.51 1.124 . . . . 0.0 108.548 177.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.63 -46.92 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 119.597 1.089 . . . . 0.0 111.064 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.564 HH11 ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -64.24 -42.88 96.34 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 119.835 1.198 . . . . 0.0 109.914 -179.405 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -56.49 -53.96 51.34 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.195 0.907 . . . . 0.0 110.69 175.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.77 -37.46 71.12 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.157 0.983 . . . . 0.0 111.325 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mt -67.91 -52.04 40.91 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.843 171.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HG3' HH11 ' A' ' 22' ' ' ARG . 26.1 mttt -62.47 -23.84 67.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.324 1.42 . . . . 0.0 111.997 -172.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -52.22 -48.98 64.83 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.22 0.918 . . . . 0.0 110.324 166.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.1 mt -75.84 -50.09 16.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.554 1.542 . . . . 0.0 109.465 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.17 -163.43 31.02 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.622 1.105 . . . . 0.0 111.274 -174.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.533 ' HB2' HH22 ' A' ' 22' ' ' ARG . 61.4 m-85 59.2 174.48 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.209 1.803 . . . . 0.0 111.894 -171.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -170.89 -162.7 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.674 1.19 . . . . 0.0 108.378 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.69 27.57 17.3 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.876 2.071 . . . . 0.0 114.439 159.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 8' ' ' PHE . 7.5 m -70.08 174.14 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 123.104 0.562 . . . . 0.0 111.35 -175.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -136.98 177.05 8.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.438 1.495 . . . . 0.0 108.064 164.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -132.09 177.19 7.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.777 1.231 . . . . 0.0 107.962 167.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.95 172.27 13.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.952 1.301 . . . . 0.0 108.005 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.69 -40.39 88.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.552 0.341 . . . . 0.0 111.181 175.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -174.74 172.04 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.517 1.927 . . . . 0.0 107.702 -163.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.53 -42.43 26.94 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.828 1.204 . . . . 0.0 115.539 178.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.47 -47.64 88.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 119.857 1.829 . . . . 0.0 108.517 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.35 -24.74 66.56 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.763 -0.585 . . . . 0.0 111.659 175.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.69 -53.63 44.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 tp -51.75 -47.21 64.19 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.743 1.617 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -56.35 -42.08 77.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.496 1.518 . . . . 0.0 111.388 176.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.0 -45.46 88.89 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.645 -1.284 . . . . 0.0 111.246 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.541 HD11 HD11 ' A' ' 72' ' ' ILE . 13.2 mt -55.12 -51.52 66.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.421 1.464 . . . . 0.0 109.521 -175.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.01 29.56 0.11 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.968 0.907 . . . . 0.0 113.172 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.34 18.03 12.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.735 1.614 . . . . 0.0 111.631 170.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.23 -6.53 0.7 Allowed Glycine 0 C--N 1.337 0.599 0 CA-C-O 117.984 -1.453 . . . . 0.0 114.904 166.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.83 107.57 0.73 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.381 1.591 . . . . 0.0 109.709 -174.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.91 164.41 14.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.036 1.335 . . . . 0.0 108.646 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.91 -28.87 27.56 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.479 -0.763 . . . . 0.0 112.625 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -145.98 159.46 43.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.192 1.797 . . . . 0.0 108.476 -176.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.735 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -135.37 62.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.4 mt -69.52 131.76 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.397 -2.445 . . . . 0.0 104.397 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.62 141.43 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 122.599 0.359 . . . . 0.0 110.13 -163.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -62.89 165.19 7.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 164.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -80.96 -59.63 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 159.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.97 37.06 0.42 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.341 1.056 . . . . 0.0 112.55 -170.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.7 ptp -63.56 149.68 91.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 158.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.74 175.04 11.7 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.586 2.19 . . . . 0.0 110.607 -176.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 m120 53.56 -92.47 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.992 2.117 . . . . 0.0 111.437 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.8 ttm -90.8 97.3 11.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.61 164.04 6.42 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.577 0.626 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.24 -38.38 56.63 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.641 0.639 . . . . 0.0 113.63 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.53 -38.92 92.7 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 117.976 0.888 . . . . 0.0 110.42 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -77.67 -35.58 52.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.13 0.572 . . . . 0.0 110.269 -177.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.3 tp -57.23 -49.93 74.47 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.568 0.747 . . . . 0.0 109.152 169.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -50.87 -56.57 11.63 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.597 1.159 . . . . 0.0 109.643 172.194 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -64.48 -31.34 72.51 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 120.109 1.322 . . . . 0.0 113.454 -175.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.2 m -62.44 -51.5 67.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.37 1.068 . . . . 0.0 109.005 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 46' ' ' LEU . 28.3 mt -58.63 -43.54 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 126.217 1.807 . . . . 0.0 110.157 176.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -8.95 41.66 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 117.636 -1.173 . . . . 0.0 113.486 -172.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.36 -68.61 0.16 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.293 1.037 . . . . 0.0 111.561 -172.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 p30 170.98 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.281 1.432 . . . . 0.0 114.554 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -67.86 22.21 0.26 Allowed Glycine 0 CA--C 1.539 1.567 0 CA-C-N 120.821 1.646 . . . . 0.0 116.081 -173.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 75.3 -16.97 0.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 131.066 3.746 . . . . 0.0 111.484 -162.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.3 mtt -70.98 -11.95 61.26 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 123.168 0.587 . . . . 0.0 111.112 -177.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -35.28 11.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.356 2.262 . . . . 0.0 112.579 173.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.11 -7.17 58.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.656 1.582 . . . . 0.0 114.002 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 54' ' ' VAL . 17.2 mt -65.07 131.52 95.19 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 119.735 1.152 . . . . 0.0 108.674 -179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.98 83.65 0.9 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.452 1.434 . . . . 0.0 110.375 167.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 2.4 m -68.5 115.55 7.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 159.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.7 tp -130.53 107.63 9.35 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 -167.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 mmt -73.1 123.71 24.13 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.16 105.3 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -148.25 -166.47 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.35 -21.59 13.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.359 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -82.96 145.74 29.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.81 1.186 . . . . 0.0 110.868 176.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.31 -81.85 0.31 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.984 1.313 . . . . 0.0 109.809 172.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 tptm 46.33 110.65 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 130.078 3.351 . . . . 0.0 112.551 -164.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -47.57 -45.08 26.75 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 111.825 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -60.81 -31.45 70.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.964 1.256 . . . . 0.0 113.185 177.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -70.26 -37.39 74.89 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.747 1.158 . . . . 0.0 110.617 170.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.11 -47.8 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.409 1.004 . . . . 0.0 108.454 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.1 -58.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.331 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.88 -51.03 55.61 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.912 1.233 . . . . 0.0 111.336 -176.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.298 0.499 . . . . 0.0 110.295 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.31 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.441 0.564 . . . . 0.0 111.785 178.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -63.85 -47.19 81.71 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.615 1.966 . . . . 0.0 111.196 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.96 -20.86 66.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.777 0.431 . . . . 0.0 112.002 172.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.48 47.15 9.15 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 125.9 1.714 . . . . 0.0 110.691 -178.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -58.03 144.7 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -65.61 -21.23 66.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.664 0.269 . . . . 0.0 111.569 -178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.07 175.49 44.4 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 170.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -135.05 142.98 46.46 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.02 133.89 44.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 129.461 3.105 . . . . 0.0 104.302 178.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.02 147.55 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -50.29 134.97 23.89 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.098 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.22 147.39 85.41 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 120.557 1.235 . . . . 0.0 110.902 -6.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -143.86 145.12 32.09 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.841 -0.537 . . . . 0.0 112.06 176.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 115' ' ' THR . 2.3 p -141.36 174.58 10.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.244 1.818 . . . . 0.0 110.23 -170.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.29 67.62 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 175.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.77 -24.89 66.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.181 1.392 . . . . 0.0 113.997 176.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 112' ' ' THR . 6.6 t -93.23 -40.77 10.26 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.569 1.077 . . . . 0.0 109.182 168.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -53.84 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.04 0.936 . . . . 0.0 109.483 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -28.6 70.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.71 1.204 . . . . 0.0 112.653 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.57 -46.58 31.08 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.031 0.933 . . . . 0.0 109.064 178.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -69.83 -32.94 71.62 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 109.823 -178.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.5 -56.91 15.75 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 124.111 0.964 . . . . 0.0 109.424 167.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -57.17 -29.94 64.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -68.48 0.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 117.511 -1.233 . . . . 0.0 109.148 166.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.5 pt -62.13 -28.12 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 119.831 1.196 . . . . 0.0 112.726 -173.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -59.46 -54.33 47.91 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.111 0.564 . . . . 0.0 109.797 173.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.14 -47.03 38.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.985 0.811 . . . . 0.0 110.942 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HG3' HD23 ' A' ' 127' ' ' LEU . 31.6 tptt -68.16 -73.27 0.15 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.774 1.629 . . . . 0.0 110.093 -172.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.462 HD23 ' HG3' ' A' ' 126' ' ' LYS . 11.9 mt -65.03 -21.2 66.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.541 0.61 . . . . 0.0 111.444 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.26 33.62 28.36 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 21.5 mmm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.057 179.513 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 119.179 -0.438 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.57 67.22 0.81 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.746 2.018 . . . . 0.0 110.496 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -54.24 109.96 0.55 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.569 1.948 . . . . 0.0 111.043 -163.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -76.9 36.98 0.18 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.718 1.145 . . . . 0.0 110.477 171.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -140.47 33.29 1.86 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.479 2.311 . . . . 0.0 106.925 -171.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.462 HD11 ' HA3' ' A' ' 52' ' ' GLY . 1.1 tp -41.25 123.16 2.01 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 128.017 2.527 . . . . 0.0 110.573 -177.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -70.03 130.54 42.42 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -87.83 160.51 17.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 162.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.72 137.5 51.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 167.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.12 103.59 6.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 C-N-CA 125.683 1.593 . . . . 0.0 106.947 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 42' ' ' ALA . 2.9 t -112.14 53.84 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.629 1.204 . . . . 0.0 107.872 -175.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.51 126.36 30.65 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.87 -45.1 93.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.989 0.516 . . . . 0.0 112.035 -174.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 29.0 t80 -75.61 106.18 7.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.2 t -58.05 -33.22 68.78 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.583 1.538 . . . . 0.0 112.885 -171.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 61.6 m -57.67 -36.84 72.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.406 -1.434 . . . . 0.0 110.851 174.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.1 tpp -55.29 -43.15 74.53 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.346 1.059 . . . . 0.0 109.539 173.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -66.6 -41.88 87.75 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 118.574 0.625 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -57.2 -47.06 82.24 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.028 173.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.85 -58.14 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.036 178.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.8 t -54.64 -50.6 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 125.34 1.456 . . . . 0.0 110.699 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -59.99 -41.73 92.69 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.826 0.739 . . . . 0.0 110.573 -178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -64.39 -45.68 86.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.434 0.561 . . . . 0.0 111.346 176.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 mt -59.29 -43.78 92.56 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.752 0.821 . . . . 0.0 110.269 178.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.34 -58.74 6.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.009 1.324 . . . . 0.0 110.558 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.492 ' HE2' ' OD1' ' A' ' 31' ' ' ASN . 11.5 ptmm? -66.27 -22.65 66.31 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 117.37 -1.3 . . . . 0.0 112.087 -177.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.45 90.29 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.391 1.451 . . . . 0.0 109.197 175.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.33 -42.4 23.04 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.436 1.094 . . . . 0.0 110.089 177.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.18 -25.13 0.19 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.258 -1.301 . . . . 0.0 115.757 169.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -75.93 101.59 5.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 120.425 2.113 . . . . 0.0 111.093 -174.194 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.492 ' OD1' ' HE2' ' A' ' 26' ' ' LYS . 45.8 m-80 -85.82 -27.4 25.15 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.235 -0.915 . . . . 0.0 112.985 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.54 76.38 2.24 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.297 1.522 . . . . 0.0 108.505 -159.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -126.23 108.64 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.813 2.045 . . . . 0.0 105.826 -162.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -86.4 -168.49 2.25 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.332 1.853 . . . . 0.0 109.894 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.92 172.35 1.67 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 130.589 3.555 . . . . 0.0 105.081 -167.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.96 175.75 9.99 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -168.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -66.78 -39.08 87.68 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.375 -0.828 . . . . 0.0 110.973 175.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.87 166.57 4.39 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 -158.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.84 -33.59 49.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.296 0.953 . . . . 0.0 112.554 171.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 t -57.81 -45.12 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.435 1.094 . . . . 0.0 110.536 176.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.93 -30.39 61.23 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.64 0.776 . . . . 0.0 109.633 176.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -57.91 -50.14 74.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.565 -0.71 . . . . 0.0 109.508 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -55.26 -45.61 76.08 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.144 0.578 . . . . 0.0 110.362 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.24 -38.0 87.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.051 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.26 -48.02 81.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.422 1.01 . . . . 0.0 109.512 171.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 72' ' ' ILE . 3.4 mt -60.82 -47.99 83.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -172.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 35.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.04 -49.28 4.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.64 153.91 20.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.047 1.784 . . . . 0.0 110.246 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.45 -8.2 74.86 Favored Glycine 0 N--CA 1.466 0.685 0 O-C-N 121.047 -1.266 . . . . 0.0 114.03 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -72.7 161.8 30.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 159.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -134.21 3.79 4.46 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-O 117.758 -1.579 . . . . 0.0 113.544 164.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.38 141.89 31.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.855 1.828 . . . . 0.0 111.043 -174.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.785 HG21 HD13 ' A' ' 81' ' ' LEU . 4.0 t -132.77 72.07 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -75.81 140.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.7 t -154.49 147.34 24.43 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.215 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -72.47 165.11 25.26 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 158.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.511 ' HH2' ' HB3' ' A' ' 97' ' ' ALA . 7.3 t-105 -77.37 -52.53 8.99 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.467 1.507 . . . . 0.0 110.113 163.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.68 84.52 5.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.527 -158.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.71 162.95 51.96 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.391 1.476 . . . . 0.0 109.73 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.53 176.75 9.69 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.238 1.958 . . . . 0.0 111.166 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 58.41 -98.54 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.1 2.56 . . . . 0.0 110.796 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 9.6 ttm -91.21 104.84 17.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 172.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.08 158.12 14.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.605 0.717 . . . . 0.0 110.685 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.82 -26.04 73.09 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.975 -0.903 . . . . 0.0 112.939 -168.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 1.7 tm? -72.58 -38.2 67.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.861 1.33 . . . . 0.0 108.932 175.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -66.44 -40.08 89.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.545 0.611 . . . . 0.0 111.294 174.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.78 -49.61 74.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.07 0.85 . . . . 0.0 109.493 172.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.567 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.85 -58.2 8.13 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 117.886 -1.054 . . . . 0.0 109.073 174.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE2' ' HB2' ' A' ' 101' ' ' ALA . 29.6 mttt -61.99 -32.37 72.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.922 1.692 . . . . 0.0 112.414 -172.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.6 m -59.27 -49.1 79.12 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.186 0.995 . . . . 0.0 109.118 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 46' ' ' LEU . 21.3 mt -64.92 -46.87 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -20.6 62.6 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.485 1.114 . . . . 0.0 112.736 -174.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.15 -20.57 60.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.564 1.074 . . . . 0.0 110.739 172.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.12 154.09 35.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.744 0.702 . . . . 0.0 110.031 -173.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.95 -13.22 79.88 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.702 -178.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.25 -41.87 1.38 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.786 1.293 . . . . 0.0 111.967 -175.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 22.6 mmt -64.44 -12.92 48.28 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.194 0.906 . . . . 0.0 111.705 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 p -55.52 -22.45 21.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.769 1.628 . . . . 0.0 113.317 171.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.53 63.02 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.25 0.932 . . . . 0.0 112.576 175.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.785 HD13 HG21 ' A' ' 54' ' ' VAL . 26.1 mt -61.72 139.38 95.38 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 118.94 0.791 . . . . 0.0 111.65 -171.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.32 77.46 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.704 2.936 . . . . 0.0 109.008 159.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 69' ' ' LEU . 1.4 m -60.99 114.07 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.285 1.834 . . . . 0.0 107.546 159.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.8 tp -132.81 114.22 13.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 109.483 -166.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mtp -91.25 119.45 31.32 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.45 101.5 8.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.911 1.685 . . . . 0.0 106.643 -174.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.0 t -145.28 172.12 13.6 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.455 -0.778 . . . . 0.0 111.127 -165.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.6 -13.88 36.22 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.142 -0.974 . . . . 0.0 113.027 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -91.1 123.35 34.49 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.07 0.948 . . . . 0.0 111.154 -174.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.03 20.74 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.784 0.833 . . . . 0.0 110.497 163.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -51.27 115.24 1.48 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.635 1.574 . . . . 0.0 108.825 -175.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -58.14 -41.95 84.8 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 119.139 -0.457 . . . . 0.0 109.976 -175.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.42 -32.35 70.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.336 -0.84 . . . . 0.0 112.876 173.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -68.67 -39.31 80.66 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.939 1.245 . . . . 0.0 109.422 174.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.81 -44.83 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 118.237 -0.887 . . . . 0.0 108.652 172.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.95 -58.7 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.239 0.927 . . . . 0.0 108.717 175.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.511 ' HB3' ' HH2' ' A' ' 58' ' ' TRP . . . -58.57 -40.57 83.46 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.109 0.868 . . . . 0.0 111.055 -173.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -49.95 74.83 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.096 0.558 . . . . 0.0 110.348 172.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.86 -39.82 87.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.317 0.508 . . . . 0.0 111.863 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -54.08 -55.54 26.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.608 1.963 . . . . 0.0 108.685 171.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . . . -67.04 -13.46 61.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.89 1.276 . . . . 0.0 112.734 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.81 36.95 40.62 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.261 -1.299 . . . . 0.0 112.397 178.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -59.45 145.47 43.69 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.204 1.502 . . . . 0.0 109.564 176.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.5 p -71.05 -24.73 62.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 117.716 0.235 . . . . 0.0 111.528 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.8 163.71 36.84 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 118.109 0.413 . . . . 0.0 112.199 174.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -134.21 110.93 9.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.623 1.569 . . . . 0.0 107.988 -176.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -120.59 99.95 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.048 1.739 . . . . 0.0 106.596 -163.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.59 144.47 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -56.78 162.25 3.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.327 0.651 . . . . 0.0 111.281 175.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.09 108.8 0.92 Allowed 'Cis proline' 0 N--CA 1.457 -0.669 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 -21.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.68 76.3 7.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.686 0.794 . . . . 0.0 109.357 -169.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 p -64.67 172.47 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.257 1.423 . . . . 0.0 112.393 -173.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.75 70.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.09 -18.53 61.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 172.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.53 -31.4 9.46 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.091 1.314 . . . . 0.0 109.553 172.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HA ' ' HE3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -56.74 -47.36 80.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 108.382 175.372 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -42.56 73.3 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.073 0.949 . . . . 0.0 111.583 -176.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.03 -64.8 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.605 1.962 . . . . 0.0 109.177 168.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.181 -173.403 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -63.35 -53.83 46.48 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.284 0.947 . . . . 0.0 109.445 174.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -35.47 77.38 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.866 0.757 . . . . 0.0 110.044 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -51.75 -57.07 10.31 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.899 0.879 . . . . 0.0 110.652 171.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -17.52 11.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -172.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -57.28 -67.31 0.34 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 159.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.37 -36.72 79.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.785 -0.572 . . . . 0.0 112.434 -167.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -67.28 0.73 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -176.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.35 -29.61 67.45 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.8 -171.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.77 25.1 13.83 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 117.762 -1.577 . . . . 0.0 111.4 -166.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 83.3 mmm . . . . . 0 C--O 1.249 1.072 0 CA-C-N 120.266 2.033 . . . . 0.0 111.291 179.213 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 118.778 -0.63 . . . . 0.0 111.576 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -135.71 157.07 47.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 58.52 -172.85 0.1 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.089 1.356 . . . . 0.0 109.803 -165.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -85.04 -3.71 58.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.498 -1.376 . . . . 0.0 110.932 158.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 45.92 42.66 9.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.246 1.018 . . . . 0.0 109.984 -158.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.27 119.47 7.45 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.35 1.06 . . . . 0.0 109.313 -173.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -91.07 152.9 20.45 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.721 0.772 . . . . 0.0 111.814 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -107.72 156.48 19.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 158.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 tp -119.33 143.19 47.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.4 t -137.34 93.21 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -171.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.07 57.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -174.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.9 131.4 37.47 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.61 -56.64 17.62 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.661 1.185 . . . . 0.0 111.76 177.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.523 ' CE2' ' HB ' ' A' ' 16' ' ' THR . 30.4 t80 -69.6 114.37 7.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -48.89 76.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.377 0.99 . . . . 0.0 111.093 -170.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.523 ' HB ' ' CE2' ' A' ' 14' ' ' PHE . 27.7 m -58.53 -28.42 65.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.551 0.741 . . . . 0.0 111.574 176.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 37.0 ttp -63.89 -36.27 83.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.568 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -64.64 -42.17 95.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 120.729 1.604 . . . . 0.0 109.52 172.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -58.92 -37.91 77.73 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 118.52 -0.752 . . . . 0.0 109.871 178.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.41 -65.31 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 CA-C-O 116.993 -1.48 . . . . 0.0 108.574 169.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.8 t -48.21 -52.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 121.686 2.039 . . . . 0.0 111.189 -175.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG2' HG21 ' A' ' 33' ' ' VAL . 3.9 tmm_? -56.57 -47.5 79.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.941 177.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.35 -49.38 77.42 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 118.777 0.717 . . . . 0.0 111.533 176.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.77 -39.1 83.71 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 110.988 -178.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -48.58 72.08 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.65 -0.656 . . . . 0.0 110.386 175.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.99 -28.39 68.85 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.831 178.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.16 -45.23 95.49 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 119.942 1.246 . . . . 0.0 109.488 173.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.54 -27.74 64.39 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.015 0.526 . . . . 0.0 111.062 177.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.58 1.92 6.41 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.412 1.482 . . . . 0.0 113.959 169.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -70.14 170.13 12.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.359 1.08 . . . . 0.0 110.645 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -143.01 -178.79 6.0 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.062 1.345 . . . . 0.0 109.801 -172.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 75.5 -64.22 0.38 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.63 2.372 . . . . 0.0 113.92 170.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 22' ' ' ARG . 2.3 m 33.87 65.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.658 1.983 . . . . 0.0 113.984 162.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.28 -174.8 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.015 1.726 . . . . 0.0 110.614 175.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.59 169.55 21.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.386 1.874 . . . . 0.0 108.232 -172.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.94 166.43 26.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 170.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.26 -35.95 80.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.14 0.976 . . . . 0.0 111.33 176.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -173.17 176.16 3.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.927 2.091 . . . . 0.0 107.615 -169.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.62 -36.22 58.57 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 174.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.9 -51.72 69.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 120.396 2.098 . . . . 0.0 107.718 177.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -61.84 -35.28 77.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.963 0.505 . . . . 0.0 111.02 176.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.66 -47.68 79.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -42.9 80.25 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.777 0.673 . . . . 0.0 111.453 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.56 -46.86 85.98 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.453 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -55.84 -45.72 78.35 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.226 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.543 HD11 HD11 ' A' ' 72' ' ' ILE . 8.9 mt -57.34 -38.55 74.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.846 1.203 . . . . 0.0 110.262 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -72.34 27.21 0.05 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.867 1.267 . . . . 0.0 113.951 173.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.65 -8.61 16.84 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.901 1.28 . . . . 0.0 111.313 158.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.22 169.68 4.16 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.075 1.321 . . . . 0.0 112.808 -179.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.4 -1.92 17.81 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.633 -0.922 . . . . 0.0 113.21 -177.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.53 112.06 3.92 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 166.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.58 -9.56 71.86 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.334 171.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.8 145.09 21.99 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.815 1.308 . . . . 0.0 111.238 -166.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.687 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -136.86 111.42 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -114.35 136.22 51.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -146.48 162.52 38.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.109 0.413 . . . . 0.0 111.183 171.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 21.8 t70 -75.96 -167.73 0.78 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 158.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.457 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 10.2 t-105 -114.06 -52.84 2.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.405 2.282 . . . . 0.0 110.857 -175.197 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -67.1 86.58 0.15 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.531 2.332 . . . . 0.0 110.33 -167.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.3 mtt -142.99 153.12 60.13 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 124.916 1.287 . . . . 0.0 109.183 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -78.0 -179.22 5.24 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.481 2.12 . . . . 0.0 108.301 165.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 54.9 -94.61 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.29 1.836 . . . . 0.0 109.983 176.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.0 tpp -91.38 80.7 5.48 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.85 149.72 4.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 159.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.64 -27.62 61.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.284 -0.885 . . . . 0.0 113.34 -169.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -34.39 68.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.644 1.222 . . . . 0.0 110.513 176.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -66.06 -42.49 89.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.406 0.682 . . . . 0.0 109.546 172.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.84 -50.04 75.47 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -51.71 -61.97 1.92 Allowed 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.611 1.164 . . . . 0.0 109.199 173.848 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.54 -34.24 77.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.677 1.126 . . . . 0.0 112.522 -172.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.4 m -59.04 -48.38 81.79 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD11 HD11 ' A' ' 46' ' ' LEU . 30.5 mt -64.09 -48.7 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.412 1.085 . . . . 0.0 109.112 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -29.0 67.64 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.55 -171.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.49 -68.87 0.14 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.463 1.105 . . . . 0.0 112.214 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -173.33 -144.07 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.893 1.277 . . . . 0.0 109.657 -166.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.28 12.89 61.6 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 120.606 -1.309 . . . . 0.0 112.68 -176.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.21 8.75 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.585 2.354 . . . . 0.0 113.894 -159.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.88 -16.68 62.71 Favored 'General case' 0 C--O 1.223 -0.329 0 O-C-N 121.348 -0.845 . . . . 0.0 110.325 170.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.1 p -60.64 -22.04 63.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.786 0.834 . . . . 0.0 112.728 -174.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.68 -3.38 59.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.159 1.384 . . . . 0.0 113.553 174.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.687 HD13 HG21 ' A' ' 54' ' ' VAL . 30.6 mt -68.33 130.47 92.28 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-N 119.911 1.232 . . . . 0.0 109.1 178.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.44 98.0 0.82 Allowed 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.76 1.64 . . . . 0.0 108.67 164.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -78.87 107.1 10.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.591 1.557 . . . . 0.0 107.742 164.85 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.8 tp -107.15 116.45 31.95 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.092 1.357 . . . . 0.0 107.873 -176.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.0 mtp -88.11 120.19 29.22 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -177.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -130.42 105.19 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -171.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -146.67 173.72 12.1 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.805 0.812 . . . . 0.0 110.923 -167.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.71 -19.72 20.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.484 0.713 . . . . 0.0 112.107 175.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -90.11 139.76 30.32 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.939 0.79 . . . . 0.0 109.737 -177.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.09 -59.71 2.66 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 164.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 tptt 45.99 80.92 0.04 OUTLIER 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.775 1.63 . . . . 0.0 109.558 173.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -54.91 -35.04 63.72 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.845 -167.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 96' ' ' ILE . 6.2 mt-10 -65.64 -29.98 70.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.742 1.61 . . . . 0.0 113.385 174.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -65.47 -42.51 92.18 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 120.044 1.293 . . . . 0.0 109.412 167.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.1 mt -62.98 -52.25 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.868 0.758 . . . . 0.0 109.584 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' GLU 0.252 1.7 mt -54.6 -46.85 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 117.273 -1.346 . . . . 0.0 113.489 169.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.1 82.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.003 1.274 . . . . 0.0 110.472 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.6 -48.48 77.2 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.73 0.812 . . . . 0.0 110.918 175.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -22.86 63.09 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.84 -0.538 . . . . 0.0 112.394 -177.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -77.15 -53.76 7.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.924 2.09 . . . . 0.0 108.772 171.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.35 -26.79 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.154 1.382 . . . . 0.0 112.659 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.56 34.3 5.05 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 124.677 1.132 . . . . 0.0 113.291 173.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.83 151.62 29.36 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.662 1.231 . . . . 0.0 110.576 -177.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.7 p -77.08 -14.22 59.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.83 171.69 37.1 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 172.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -134.23 127.87 32.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.12 96.38 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 175.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.19 149.15 8.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 160.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -55.52 163.2 1.97 Allowed Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 122.654 0.382 . . . . 0.0 110.45 160.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.08 137.06 47.44 Favored 'Cis proline' 0 N--CA 1.459 -0.515 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 -14.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -133.86 154.7 50.86 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.287 0.635 . . . . 0.0 110.567 -175.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 p -145.23 176.69 9.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.189 1.795 . . . . 0.0 109.367 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.68 -29.82 68.34 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.039 178.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.46 80.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.143 0.977 . . . . 0.0 112.475 175.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.08 -29.92 26.43 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.962 0.801 . . . . 0.0 110.291 175.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -55.92 25.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -27.33 69.16 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.216 0.606 . . . . 0.0 112.184 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -65.87 -43.8 87.27 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.607 -0.683 . . . . 0.0 110.255 172.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -66.66 -35.12 79.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.781 173.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.33 -53.09 61.74 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.556 1.071 . . . . 0.0 109.182 177.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.61 -34.44 72.77 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.204 0.457 . . . . 0.0 111.119 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -69.77 0.11 Allowed 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.112 0.965 . . . . 0.0 109.64 168.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 pt -74.12 -26.9 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 118.729 0.695 . . . . 0.0 112.444 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -58.75 -56.76 18.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -81.69 -38.01 26.51 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.585 -174.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -67.49 -74.51 0.11 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.59 1.156 . . . . 0.0 109.12 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.46 -31.34 72.37 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.218 0.463 . . . . 0.0 110.152 -175.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.84 37.64 8.44 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -165.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 78.9 mmm . . . . . 0 C--O 1.248 1.006 0 CA-C-N 118.592 1.196 . . . . 0.0 109.104 164.888 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.24 168.71 19.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.051 1.34 . . . . 0.0 108.44 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.81 178.11 1.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.821 1.249 . . . . 0.0 108.978 167.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -54.8 -23.11 16.66 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.302 -0.874 . . . . 0.0 111.723 165.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 50.03 30.9 4.4 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.326 1.85 . . . . 0.0 111.968 -175.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 tt -54.68 118.58 4.33 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 175.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 134.06 34.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -173.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -95.53 98.75 10.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -76.74 140.06 40.66 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 174.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.4 t -135.52 115.52 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.33 1.052 . . . . 0.0 108.984 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.43 55.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.743 1.156 . . . . 0.0 109.928 -173.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.84 152.74 45.02 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.954 -1.092 . . . . 0.0 109.598 170.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.38 -47.63 17.23 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.413 1.085 . . . . 0.0 110.973 -173.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 16' ' ' THR . 6.3 t80 -77.84 117.28 19.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.4 t -56.07 -44.17 78.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.971 0.805 . . . . 0.0 110.637 -173.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 14' ' ' PHE . 28.2 m -59.38 -38.32 80.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.028 -1.045 . . . . 0.0 111.283 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.14 -39.46 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.309 1.413 . . . . 0.0 110.121 171.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -65.67 -41.27 92.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.879 0.763 . . . . 0.0 109.872 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -46.26 88.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.504 174.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.58 -59.4 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 117.137 -1.411 . . . . 0.0 109.5 177.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.16 -52.02 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.87 1.668 . . . . 0.0 110.142 -177.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -61.63 -35.8 78.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.713 -0.617 . . . . 0.0 111.341 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -64.78 -44.47 89.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.709 1.141 . . . . 0.0 110.954 173.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.03 -38.7 92.24 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.503 1.121 . . . . 0.0 110.334 179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -60.6 -45.22 94.82 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.021 0.928 . . . . 0.0 110.691 172.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -64.06 -28.01 69.5 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.77 -0.581 . . . . 0.0 111.417 174.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -71.33 -8.44 53.74 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.16 -1.587 . . . . 0.0 111.894 172.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.74 7.67 10.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.151 1.781 . . . . 0.0 112.025 -175.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.58 47.7 7.8 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 174.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -131.61 109.21 10.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.99 -7.8 8.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -78.52 49.2 0.84 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 166.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 33' ' ' VAL . 3.2 m -80.54 159.59 4.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.738 -1.226 . . . . 0.0 109.115 176.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -145.59 169.01 19.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.598 1.959 . . . . 0.0 107.401 167.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -132.71 166.27 22.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.85 168.82 18.82 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.527 0.731 . . . . 0.0 109.147 173.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -76.83 -33.13 57.96 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.94 0.896 . . . . 0.0 111.029 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.91 178.09 1.0 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.916 2.486 . . . . 0.0 108.565 -177.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 60' ' ' MET . . . -50.68 -38.22 35.84 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.56 176.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 120.047 1.924 . . . . 0.0 108.433 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 32.7 t0 -65.56 -37.51 86.9 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.222 -0.299 . . . . 0.0 110.448 174.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.71 72.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.24 -43.2 74.38 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.672 0.789 . . . . 0.0 110.195 175.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.47 -24.31 65.59 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 3.4 mptp? -66.17 -54.57 23.71 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.595 1.089 . . . . 0.0 108.43 165.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.477 HD11 HD11 ' A' ' 72' ' ' ILE . 2.7 mt -55.23 -48.0 74.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.623 0.647 . . . . 0.0 110.089 -169.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.63 0.82 28.56 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.07 -20.84 31.96 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.883 1.22 . . . . 0.0 111.71 163.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.07 154.49 24.58 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.059 1.314 . . . . 0.0 113.778 166.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.47 -13.77 65.66 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 127.283 2.373 . . . . 0.0 113.729 175.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -75.49 124.48 27.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.585 1.193 . . . . 0.0 107.975 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.77 -2.14 9.58 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.858 -0.968 . . . . 0.0 112.25 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.69 137.85 35.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.857 1.328 . . . . 0.0 108.438 173.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 HD13 ' A' ' 81' ' ' LEU . 2.3 t -130.91 80.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -171.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.19 125.96 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 p -145.87 165.15 29.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.507 0.594 . . . . 0.0 110.973 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.83 179.7 0.83 Allowed 'General case' 0 C--O 1.239 0.531 0 CA-C-O 122.231 1.015 . . . . 0.0 110.284 161.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.622 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 3.5 t-105 -89.68 -49.96 6.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.948 157.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.08 137.53 47.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.107 0.867 . . . . 0.0 109.735 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.439 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -147.21 167.45 13.55 Favored Pre-proline 0 C--O 1.234 0.272 0 C-N-CA 124.112 0.965 . . . . 0.0 109.064 168.862 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.25 -23.01 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.226 1.95 . . . . 0.0 112.951 172.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -139.14 -83.21 0.28 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.421 1.464 . . . . 0.0 111.121 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 56.7 ttm -78.08 96.23 5.08 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -176.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.11 161.15 9.01 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 124.328 1.018 . . . . 0.0 110.32 170.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.44 -30.03 73.25 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.599 0.619 . . . . 0.0 112.842 -172.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.622 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -72.37 -39.56 67.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.355 1.077 . . . . 0.0 109.799 177.482 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -66.6 -37.29 84.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.405 173.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.7 tp -59.42 -54.08 50.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.896 1.225 . . . . 0.0 109.678 174.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.725 HD13 HG21 ' A' ' 83' ' ' VAL . 3.4 tp -51.48 -51.8 52.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.401 1.08 . . . . 0.0 110.677 173.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.1 mttt -68.43 -25.07 64.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.174 -175.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m -71.36 -50.3 33.62 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.477 HD11 HD11 ' A' ' 46' ' ' LEU . 30.7 mt -58.4 -32.1 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.444 1.498 . . . . 0.0 108.596 -177.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -58.88 -20.2 49.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.761 1.624 . . . . 0.0 112.78 175.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.41 45.49 0.72 Allowed 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.262 2.225 . . . . 0.0 110.968 -161.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -127.15 -152.37 0.52 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.706 1.203 . . . . 0.0 111.742 -176.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.92 51.79 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 129.104 3.24 . . . . 0.0 112.699 174.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 60.99 20.6 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 128.305 2.642 . . . . 0.0 112.873 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.625 ' HB3' HD12 ' A' ' 81' ' ' LEU . 23.2 mmt -71.79 -2.64 18.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 117.69 -1.147 . . . . 0.0 113.208 -179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.7 p -56.94 -26.14 58.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.799 1.636 . . . . 0.0 113.797 -165.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.79 65.0 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.954 0.902 . . . . 0.0 113.348 177.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.655 HD13 HG21 ' A' ' 54' ' ' VAL . 13.2 mt -56.46 138.59 75.5 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.523 1.129 . . . . 0.0 111.022 -172.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.8 100.25 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.829 2.353 . . . . 0.0 108.379 169.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.725 HG21 HD13 ' A' ' 69' ' ' LEU . 2.8 m -92.72 111.86 25.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 125.898 1.679 . . . . 0.0 106.586 174.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.4 tp -120.5 112.1 18.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.066 0.946 . . . . 0.0 108.836 -168.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.87 117.54 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.86 104.19 9.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.9 t -149.05 174.08 12.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.819 0.819 . . . . 0.0 109.74 -164.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.63 -14.04 41.1 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.121 -0.987 . . . . 0.0 112.19 162.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.75 96.51 6.29 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.203 1.401 . . . . 0.0 108.215 -175.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.38 -92.07 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 162.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 75.2 tttt 51.15 101.41 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.692 1.997 . . . . 0.0 111.108 -174.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -41.14 -47.06 3.18 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.338 -0.851 . . . . 0.0 111.745 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -61.79 -34.98 76.86 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.67 -43.32 93.95 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 172.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.63 -45.01 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.755 174.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.3 mt -58.85 -56.78 14.54 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.249 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.76 -41.24 70.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.321 1.419 . . . . 0.0 110.822 -174.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -57.76 -53.77 54.45 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.738 0.815 . . . . 0.0 110.249 173.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.58 83.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.26 0.624 . . . . 0.0 111.513 -178.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -56.0 -56.37 21.51 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.824 1.65 . . . . 0.0 109.71 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.72 -21.45 64.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.684 0.794 . . . . 0.0 112.2 178.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.68 33.61 6.65 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-O 118.628 -1.096 . . . . 0.0 111.785 175.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.567 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -61.93 148.98 41.86 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.468 1.134 . . . . 0.0 108.904 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -83.61 -6.69 59.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.665 -172.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.17 175.22 35.64 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 119.082 0.855 . . . . 0.0 111.842 173.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.16 150.26 46.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.038 1.335 . . . . 0.0 108.847 -177.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.87 138.77 31.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 128.396 2.678 . . . . 0.0 104.846 166.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 t -118.59 143.39 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 156.92 14.45 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.803 170.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.82 154.32 97.75 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 N-CA-C 109.772 -0.895 . . . . 0.0 109.772 -16.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -158.75 160.54 36.44 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.561 0.744 . . . . 0.0 109.345 -169.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -147.49 -179.56 6.95 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 122.955 0.502 . . . . 0.0 110.429 -171.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.85 67.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.348 0.659 . . . . 0.0 109.438 176.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.28 -17.92 64.9 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 174.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 t -95.64 -37.83 10.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 121.407 1.912 . . . . 0.0 109.752 164.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.04 -51.78 60.63 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -34.3 77.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.237 1.415 . . . . 0.0 112.455 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -71.43 -40.86 70.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 122' ' ' LYS . 17.6 mmtp -65.3 -39.74 92.91 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 174.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.6 mt -54.96 -57.48 11.5 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -56.97 -33.77 67.4 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HE3' ' HE3' ' A' ' 119' ' ' LYS . 24.9 mttm -56.71 -68.72 0.19 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 117.86 -1.067 . . . . 0.0 108.834 170.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -24.0 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 120.683 1.583 . . . . 0.0 113.339 -171.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -59.37 -49.19 78.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.98 1.312 . . . . 0.0 111.098 171.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -80.59 -54.84 5.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 118.611 0.642 . . . . 0.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.27 -59.21 5.34 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 125.616 1.566 . . . . 0.0 108.561 -164.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -72.28 -54.14 10.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.35 15.87 2.96 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.682 -1.066 . . . . 0.0 112.347 -171.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 54.9 mmm . . . . . 0 C--O 1.247 0.921 0 CA-C-N 118.617 1.208 . . . . 0.0 111.495 -163.683 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.15 162.16 21.82 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.178 1.391 . . . . 0.0 108.139 165.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 9.8 m-20 -77.95 163.72 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -59.81 -13.01 8.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.388 159.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' H ' ' HB3' ' A' ' 3' ' ' ASP . 20.9 tt0 40.92 51.43 3.2 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 129.952 3.301 . . . . 0.0 110.524 176.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.63 111.43 2.07 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.596 -1.184 . . . . 0.0 108.961 -171.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -90.6 143.64 26.54 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.169 0.918 . . . . 0.0 110.387 -162.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -111.39 100.66 9.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.584 1.154 . . . . 0.0 109.087 -178.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.8 tp -74.08 142.83 45.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.981 0.81 . . . . 0.0 109.383 175.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.44 99.61 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.761 1.625 . . . . 0.0 107.219 170.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.74 87.74 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 173.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -91.62 109.2 20.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.656 1.182 . . . . 0.0 112.174 -162.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.91 -24.06 59.64 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 173.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -120.33 -7.09 9.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -158.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.4 m 68.46 -58.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 128.042 2.537 . . . . 0.0 110.263 -173.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.0 m -55.56 -24.9 35.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.47 1.508 . . . . 0.0 111.16 170.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.4 tpp -64.82 -37.56 88.01 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.929 1.695 . . . . 0.0 109.934 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -77.34 -33.07 55.5 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 121.126 1.785 . . . . 0.0 109.538 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -52.17 -58.06 7.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.842 1.201 . . . . 0.0 108.579 168.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.66 -67.75 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.509 -178.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.32 -41.71 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 120.444 1.474 . . . . 0.0 110.392 -169.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -48.19 82.76 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 119.651 1.114 . . . . 0.0 109.445 174.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.59 -48.53 74.69 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.385 175.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.37 -43.14 96.86 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.024 0.829 . . . . 0.0 110.67 -176.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.76 -44.99 95.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.298 1.039 . . . . 0.0 110.104 174.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -63.87 -29.4 70.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.152 -1.404 . . . . 0.0 112.546 177.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.9 -62.36 1.93 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.061 1.3 . . . . 0.0 108.373 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.07 2.34 1.51 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.65 -108.62 3.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -151.38 175.95 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.314 2.246 . . . . 0.0 107.255 -164.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -138.09 -178.57 5.33 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.06 0.846 . . . . 0.0 112.085 -169.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 m120 59.72 75.91 0.38 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.953 2.901 . . . . 0.0 109.717 -167.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.18 166.17 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.041 168.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -135.5 174.24 10.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 158.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.0 156.05 42.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.77 151.38 40.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 163.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.36 -30.49 66.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.634 0.584 . . . . 0.0 111.211 176.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.28 156.91 14.8 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -161.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.97 -42.46 30.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.23 0.919 . . . . 0.0 114.381 171.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.96 -37.6 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 120.2 2.0 . . . . 0.0 109.438 -178.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.22 -43.95 96.68 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.526 0.731 . . . . 0.0 109.47 171.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.48 80.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.693 1.597 . . . . 0.0 110.324 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.71 -43.24 72.39 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.717 0.636 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -65.17 -37.18 86.56 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.315 0.646 . . . . 0.0 110.985 176.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -57.42 -45.06 85.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.028 1.286 . . . . 0.0 110.043 170.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 72' ' ' ILE . 5.7 mt -58.69 -51.45 69.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -176.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -78.8 16.76 0.81 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.12 -23.66 62.13 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.521 -1.362 . . . . 0.0 110.048 159.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.73 -88.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -175.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.74 86.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -173.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -64.81 166.68 8.61 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.008 1.323 . . . . 0.0 110.736 172.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -104.47 -20.0 10.71 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.561 -1.133 . . . . 0.0 113.37 172.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -146.49 142.4 28.05 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.72 1.208 . . . . 0.0 109.702 -174.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 81' ' ' LEU . 2.4 t -127.47 70.02 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -177.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -78.59 129.81 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 155.65 44.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.252 0.933 . . . . 0.0 110.19 -177.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.9 176.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 158.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 98' ' ' ALA . 4.4 t-105 -96.18 -60.57 1.6 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.215 1.006 . . . . 0.0 108.78 170.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.26 74.92 9.99 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.458 0.703 . . . . 0.0 109.868 -159.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.1 mmt -107.4 162.31 20.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.245 1.818 . . . . 0.0 109.942 175.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -69.94 177.77 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.375 2.717 . . . . 0.0 112.062 173.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 44.8 -110.8 0.21 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.062 2.145 . . . . 0.0 110.944 178.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.51 85.73 6.59 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -54.5 173.68 0.07 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.518 1.927 . . . . 0.0 112.498 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.11 -27.91 60.58 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.143 -0.973 . . . . 0.0 113.423 -173.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -82.17 -35.77 28.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.186 0.993 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -67.15 -42.08 84.96 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.852 169.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.1 tp -50.82 -52.65 39.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.532 1.533 . . . . 0.0 109.301 172.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 4.6 tp -53.0 -58.72 6.04 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.239 0.616 . . . . 0.0 109.794 173.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -61.33 -35.62 77.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.479 1.036 . . . . 0.0 111.552 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.1 m -58.04 -48.44 80.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.29 1.036 . . . . 0.0 108.843 175.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.479 HD11 HD11 ' A' ' 46' ' ' LEU . 29.6 mt -63.92 -51.42 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.44 66.85 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.226 1.81 . . . . 0.0 112.535 -176.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -6.8 57.94 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.311 1.444 . . . . 0.0 112.415 178.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.86 138.51 37.8 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.639 1.109 . . . . 0.0 110.945 -174.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.15 -13.73 43.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.531 -1.15 . . . . 0.0 114.829 -175.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.37 -50.21 2.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.119 1.459 . . . . 0.0 111.635 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 70.0 mtm -60.51 -25.85 66.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.091 0.859 . . . . 0.0 111.959 -172.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -58.96 -10.06 2.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.738 1.615 . . . . 0.0 114.273 -177.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 120.017 1.281 . . . . 0.0 112.757 170.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 54' ' ' VAL . 33.6 mt -70.41 129.94 89.75 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 123.447 0.699 . . . . 0.0 110.978 -170.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.77 107.8 2.13 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.81 2.34 . . . . 0.0 108.859 163.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.96 140.08 16.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.28 111.14 8.2 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 -171.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 126.64 31.14 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.06 93.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -138.63 -174.28 3.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.869 0.868 . . . . 0.0 109.902 -166.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.8 -16.77 14.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.699 1.2 . . . . 0.0 112.851 174.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -90.25 117.27 28.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.339 1.056 . . . . 0.0 109.276 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.29 -81.73 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 166.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 tptt 54.11 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.236 1.814 . . . . 0.0 111.317 -176.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -50.28 -43.34 53.33 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.405 -1.434 . . . . 0.0 112.03 178.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -52.11 -35.43 48.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.953 0.901 . . . . 0.0 112.125 176.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -78.62 -37.86 41.24 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.838 1.255 . . . . 0.0 110.536 176.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.22 -50.75 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.966 1.257 . . . . 0.0 109.138 171.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.327 1.9 mt -51.3 -54.47 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.916 166.035 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.41 -44.11 72.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 121.086 1.766 . . . . 0.0 112.112 -178.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -59.05 -55.48 34.53 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 118.935 0.789 . . . . 0.0 110.448 174.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -27.89 69.25 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -71.78 -53.63 12.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.333 1.853 . . . . 0.0 109.665 174.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.27 -24.53 66.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.179 0.992 . . . . 0.0 112.18 176.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.82 34.79 6.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.756 1.17 . . . . 0.0 111.851 176.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -63.05 145.02 56.35 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 118.43 1.115 . . . . 0.0 108.092 177.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.2 p -76.01 -12.98 60.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.306 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.6 171.86 40.69 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.273 0.939 . . . . 0.0 111.075 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.26 134.71 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.53 1.532 . . . . 0.0 107.723 178.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.55 140.26 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 127.734 2.414 . . . . 0.0 106.96 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.99 145.31 28.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 173.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 145.59 89.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.963 0.801 . . . . 0.0 110.318 168.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.84 136.58 43.38 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 119.68 0.922 . . . . 0.0 111.139 -6.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -141.4 155.56 45.88 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.554 0.742 . . . . 0.0 110.781 175.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -151.39 -178.29 6.57 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.494 1.118 . . . . 0.0 111.527 -171.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.06 -28.75 64.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.789 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -27.51 64.16 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 174.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 t -97.38 -30.58 12.85 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.208 0.913 . . . . 0.0 110.289 171.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -52.85 -53.19 52.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.459 1.027 . . . . 0.0 108.869 177.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.69 -35.23 74.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.754 1.222 . . . . 0.0 111.675 178.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -74.58 -41.61 60.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 121.477 -0.765 . . . . 0.0 109.672 -176.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -64.2 -39.34 93.77 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.805 176.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.5 mt -55.08 -58.34 8.05 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -55.68 -38.33 69.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.366 0.667 . . . . 0.0 112.331 -178.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -64.28 0.9 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.711 172.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.05 -29.59 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.184 1.356 . . . . 0.0 113.282 -173.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -56.88 -52.65 64.32 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.632 0.773 . . . . 0.0 109.026 172.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -73.39 -46.09 50.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.935 0.334 . . . . 0.0 111.287 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -69.27 -73.73 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.62 -23.64 64.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.02 0.528 . . . . 0.0 110.969 -175.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.33 31.42 19.48 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -166.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.252 1.225 0 CA-C-O 116.491 -1.719 . . . . 0.0 110.457 -175.7 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.86 164.75 0.08 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 128.371 2.668 . . . . 0.0 114.482 -175.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.49 167.32 10.68 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.298 1.839 . . . . 0.0 107.937 -177.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -53.6 -29.01 35.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.862 0.865 . . . . 0.0 112.407 164.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 39.0 44.12 0.85 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.571 1.948 . . . . 0.0 112.242 -171.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.31 119.52 8.1 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 162.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -90.69 132.96 35.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.87 138.53 38.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 163.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.12 140.04 37.85 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 159.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.65 103.19 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.13 60.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.37 1.068 . . . . 0.0 108.816 -178.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HA ' ' H ' ' A' ' 57' ' ' ASP . 7.3 p-10 -82.76 146.23 29.1 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.357 -1.465 . . . . 0.0 110.746 169.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -67.15 -58.66 4.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.064 1.346 . . . . 0.0 110.03 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -83.87 83.23 8.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 117.55 -1.214 . . . . 0.0 108.231 -174.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.6 t -40.08 -27.65 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.49 2.316 . . . . 0.0 115.847 -166.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.3 m -43.52 -47.66 7.28 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 119.887 -1.758 . . . . 0.0 111.804 164.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.03 -37.61 46.4 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 0.0 111.016 172.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -66.26 -44.02 84.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 120.4 1.454 . . . . 0.0 109.549 -178.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -58.08 9.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.497 1.119 . . . . 0.0 108.364 172.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.11 -61.51 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 124.509 1.124 . . . . 0.0 108.978 -176.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.5 t -54.82 -43.72 68.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 119.758 1.163 . . . . 0.0 110.452 -175.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -60.34 -48.2 82.76 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.204 1.365 . . . . 0.0 109.689 175.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.27 -42.72 91.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.205 1.002 . . . . 0.0 111.047 -178.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 113' ' ' ALA . 84.8 mt -63.76 -41.22 98.03 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.999 0.92 . . . . 0.0 110.067 175.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.04 -29.6 70.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.045 0.839 . . . . 0.0 111.405 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -73.53 -28.77 62.06 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.857 -1.152 . . . . 0.0 111.636 173.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.58 -48.98 67.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.28 0.946 . . . . 0.0 109.735 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.02 95.12 1.37 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 123.288 1.518 . . . . 0.0 108.375 -174.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -132.18 3.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 114.007 -1.451 . . . . 0.0 112.244 -178.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -131.77 165.75 23.08 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.832 0.853 . . . . 0.0 111.883 -159.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -107.34 -174.49 2.54 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.921 1.688 . . . . 0.0 110.195 173.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.46 81.63 0.15 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.464 2.306 . . . . 0.0 109.59 -175.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 146.33 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -127.64 176.15 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.576 1.551 . . . . 0.0 109.754 -177.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -131.47 166.36 21.51 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.143 0.977 . . . . 0.0 108.888 173.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.94 172.2 9.59 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 160.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.07 -41.09 82.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 174.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -170.94 177.17 3.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.793 2.037 . . . . 0.0 108.19 -169.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.39 -37.09 72.43 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.944 0.783 . . . . 0.0 113.111 -178.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 t -63.42 -44.44 98.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 O-C-N 121.724 -0.868 . . . . 0.0 108.91 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.53 -29.31 64.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.523 174.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.57 85.49 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.726 1.21 . . . . 0.0 109.83 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 tp -58.26 -41.24 83.83 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.255 0.479 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -40.61 96.03 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.364 175.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -53.64 -54.94 30.61 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.996 172.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 72' ' ' ILE . 7.4 mt -57.76 -40.54 79.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.777 1.171 . . . . 0.0 110.89 -174.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -65.17 -19.56 66.04 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 177.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.55 6.03 34.34 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.265 1.826 . . . . 0.0 113.907 -175.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.69 175.06 45.45 Favored Glycine 0 C--N 1.34 0.778 0 C-N-CA 119.167 -1.492 . . . . 0.0 116.736 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.65 58.84 4.99 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.473 1.511 . . . . 0.0 109.968 177.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -75.96 72.27 2.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.462 1.505 . . . . 0.0 107.099 170.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.47 -4.29 37.37 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.405 1.002 . . . . 0.0 113.454 -172.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.79 136.5 48.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.089 1.355 . . . . 0.0 108.263 170.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.752 HG21 HD13 ' A' ' 81' ' ' LEU . 5.0 t -127.21 64.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.03 139.16 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.4 p -152.01 167.58 27.95 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.956 -0.465 . . . . 0.0 110.722 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 10.6 t70 -67.89 169.46 9.8 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 158.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.525 ' CH2' HD23 ' A' ' 66' ' ' LEU . 68.1 t-105 -55.72 -64.45 0.85 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.824 -1.173 . . . . 0.0 107.87 163.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.86 165.61 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.79 2.436 . . . . 0.0 112.431 -166.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.1 75.73 12.7 Favored Pre-proline 0 N--CA 1.45 -0.455 0 O-C-N 119.63 -1.919 . . . . 0.0 107.497 167.322 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.07 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.895 2.397 . . . . 0.0 110.419 176.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -165.17 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 129.986 3.314 . . . . 0.0 104.102 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.2 ttp -72.98 89.19 1.41 Allowed 'General case' 0 C--O 1.23 0.074 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 160.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.78 168.8 4.62 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.11 0.964 . . . . 0.0 110.666 164.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.6 -19.76 60.77 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 118.949 -0.917 . . . . 0.0 113.677 -176.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.525 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -77.37 -49.0 15.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.256 1.528 . . . . 0.0 108.722 177.287 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.62 -42.57 97.1 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.94 0.496 . . . . 0.0 110.551 174.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -56.14 -53.05 61.77 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.087 0.955 . . . . 0.0 109.306 175.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.727 HD22 ' HB2' ' A' ' 103' ' ' ALA . 2.4 tp -54.03 -55.79 24.0 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 124.147 0.979 . . . . 0.0 110.574 175.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HE3' ' CD1' ' A' ' 66' ' ' LEU . 72.4 mttt -63.96 -36.99 85.77 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.636 1.562 . . . . 0.0 112.301 -174.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.7 m -61.44 -39.25 90.13 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 109.718 175.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 46' ' ' LEU . 32.2 mt -71.17 -47.84 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.21 68.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.752 1.621 . . . . 0.0 111.449 -178.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.62 -8.33 59.61 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.36 -0.837 . . . . 0.0 112.77 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -83.45 152.71 24.84 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.308 0.958 . . . . 0.0 110.701 -171.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.49 -22.54 77.22 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.458 -0.776 . . . . 0.0 113.476 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.88 -55.98 2.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.822 1.249 . . . . 0.0 109.21 173.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.452 ' HB3' HD12 ' A' ' 81' ' ' LEU . 56.3 mtt -71.44 -9.17 57.75 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -159.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -59.03 -20.42 52.99 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.769 1.168 . . . . 0.0 112.227 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.88 -12.76 60.01 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.752 HD13 HG21 ' A' ' 54' ' ' VAL . 48.7 mt -68.6 138.46 91.04 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.914 1.234 . . . . 0.0 110.5 -170.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.99 82.71 1.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.564 2.176 . . . . 0.0 108.726 166.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 69' ' ' LEU . 1.8 m -65.54 108.83 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 159.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.6 tp -130.83 105.97 8.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -160.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.6 mmt -78.69 120.9 24.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -174.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.63 87.45 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.475 ' HB ' ' H ' ' A' ' 58' ' ' TRP . 3.8 t -129.19 170.52 13.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.601 0.715 . . . . 0.0 112.924 -159.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.5 -26.11 57.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.789 0.835 . . . . 0.0 112.822 161.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -72.54 98.34 2.28 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.851 1.26 . . . . 0.0 111.424 -167.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.18 23.16 0.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.968 -1.083 . . . . 0.0 111.306 163.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -70.93 104.25 2.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.437 -1.414 . . . . 0.0 107.792 -174.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -31.93 -65.49 0.14 Allowed 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 125.716 1.606 . . . . 0.0 111.974 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.74 -29.17 70.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.743 -172.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -62.42 -46.29 89.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.392 0.996 . . . . 0.0 109.436 171.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.33 -46.4 95.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -174.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.55 -57.23 9.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.501 ' C ' HD21 ' A' ' 66' ' ' LEU . . . -56.56 -40.05 74.51 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.908 0.777 . . . . 0.0 111.215 -172.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.73 -52.16 53.45 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.572 1.149 . . . . 0.0 110.436 176.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.53 -42.04 74.02 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 177.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -62.38 -50.92 69.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 111.345 177.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.39 61.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.482 1.113 . . . . 0.0 112.892 178.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.33 30.76 9.6 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 119.144 -0.809 . . . . 0.0 112.356 176.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.727 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -60.67 146.79 44.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.93 1.365 . . . . 0.0 108.135 175.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.1 p -70.39 -8.37 50.2 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -175.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.32 165.84 20.03 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -140.22 85.53 2.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.078 0.951 . . . . 0.0 109.755 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.4 t -85.21 141.29 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 169.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.19 157.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 171.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -56.22 137.32 74.64 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.657 159.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.3 159.47 97.64 Favored 'Cis proline' 0 C--N 1.348 0.503 0 CA-C-N 121.166 1.452 . . . . 0.0 112.327 -6.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -177.75 155.09 0.99 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.264 1.025 . . . . 0.0 109.909 -174.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 p -150.35 -174.02 4.62 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.6 1.16 . . . . 0.0 112.076 -168.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.484 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -54.04 -35.83 62.4 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -47.22 -30.79 3.21 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.006 2.122 . . . . 0.0 115.074 174.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.428 HG23 ' HE2' ' A' ' 119' ' ' LYS . 1.2 t -111.21 -19.79 12.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 122.968 0.507 . . . . 0.0 110.939 176.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.33 -55.94 25.71 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.738 -1.226 . . . . 0.0 108.226 167.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -44.84 79.07 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.909 1.283 . . . . 0.0 111.684 178.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.95 -38.64 76.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.443 -0.785 . . . . 0.0 110.807 -177.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HE2' HG23 ' A' ' 115' ' ' THR . 46.2 mtmt -61.99 -39.25 91.56 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.151 -0.968 . . . . 0.0 110.3 173.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.1 mt -59.12 -51.25 70.85 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.028 -0.987 . . . . 0.0 108.419 172.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -57.7 -36.53 72.1 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.097 1.317 . . . . 0.0 112.36 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -69.8 0.11 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.32 1.448 . . . . 0.0 108.382 169.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -22.29 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -171.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.49 -45.59 86.66 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.152 0.981 . . . . 0.0 109.679 174.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.19 -39.26 25.74 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.333 0.969 . . . . 0.0 110.979 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -74.59 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -171.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.84 -37.83 88.37 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.23 44.42 4.08 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 -163.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.728 -1.129 . . . . 0.0 111.372 -175.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.59 177.08 9.34 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 159.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -132.82 155.0 49.76 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.637 0.732 . . . . 0.0 110.34 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -49.7 -33.67 16.58 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 126.283 1.833 . . . . 0.0 111.238 167.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 41.73 55.67 3.56 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.944 1.697 . . . . 0.0 108.648 -170.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.27 107.89 0.21 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.341 2.257 . . . . 0.0 108.308 -176.547 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.54 143.18 30.35 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.139 -163.111 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -111.58 95.5 5.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 34' ' ' GLU . 21.5 tp -69.83 135.89 50.14 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.887 1.221 . . . . 0.0 108.464 174.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.7 t -132.32 114.13 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.194 1.398 . . . . 0.0 108.331 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.44 64.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 124.912 1.285 . . . . 0.0 108.032 -173.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.44 156.74 29.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 172.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.62 -51.92 66.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 108.766 170.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.44 108.64 19.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -174.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.9 m -51.33 -42.68 61.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.213 178.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -50.97 -45.77 61.02 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.181 1.355 . . . . 0.0 111.625 172.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 31.2 ttm -62.59 -25.19 67.95 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.701 0.801 . . . . 0.0 111.572 -178.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -68.8 -39.03 80.33 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 120.44 -1.413 . . . . 0.0 110.56 170.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -66.48 -36.59 83.13 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.16 178.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.46 -64.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.405 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 169.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -47.06 -49.32 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.294 1.406 . . . . 0.0 110.883 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -57.0 -46.96 81.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.444 0.698 . . . . 0.0 110.74 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -61.4 -40.36 94.12 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 123.394 0.678 . . . . 0.0 111.131 178.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.55 -38.67 87.61 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.854 -0.529 . . . . 0.0 110.375 177.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.2 -26.71 67.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.366 0.53 . . . . 0.0 111.613 172.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -73.05 -38.28 66.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.736 1.153 . . . . 0.0 110.839 169.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -64.45 -36.7 85.01 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.339 0.972 . . . . 0.0 111.244 176.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -166.62 99.71 0.58 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.214 2.205 . . . . 0.0 108.81 177.268 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.2 -113.37 0.54 Allowed Glycine 0 C--N 1.314 -0.672 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.71 171.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -145.08 -176.97 5.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.101 1.76 . . . . 0.0 109.484 -162.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -133.92 -176.12 4.07 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.386 1.474 . . . . 0.0 109.932 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 54.5 63.65 2.08 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.836 1.654 . . . . 0.0 110.548 -171.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.11 160.29 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.485 165.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' HB3' HD12 ' A' ' 9' ' ' LEU . 2.9 tp10 -133.03 173.08 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.63 2.372 . . . . 0.0 106.106 175.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -139.2 166.88 23.38 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.95 169.39 17.79 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.97 1.308 . . . . 0.0 109.133 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -69.24 -40.63 77.79 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.549 0.74 . . . . 0.0 109.745 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -178.44 179.03 0.8 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.506 2.322 . . . . 0.0 108.426 -175.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -45.65 -41.99 10.13 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.85 1.69 . . . . 0.0 115.432 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.85 -47.25 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.147 1.473 . . . . 0.0 108.642 179.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -67.98 -32.34 72.67 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 175.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.1 -43.21 91.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.792 -1.193 . . . . 0.0 110.071 177.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.702 0.683 . . . . 0.0 111.076 173.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -56.07 -43.37 77.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.919 0.887 . . . . 0.0 111.471 178.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -63.36 -52.77 60.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -55.2 -53.06 60.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.594 1.158 . . . . 0.0 112.565 -172.723 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -66.32 -1.69 3.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 112.257 -177.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.3 25.32 7.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.176 2.19 . . . . 0.0 111.412 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -163.64 168.43 38.23 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 121.107 1.776 . . . . 0.0 114.023 169.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.95 53.66 1.39 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 124.773 1.178 . . . . 0.0 110.355 -178.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -62.01 142.49 57.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.443 1.097 . . . . 0.0 110.117 -177.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.05 -29.76 9.44 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 119.491 -0.616 . . . . 0.0 111.689 173.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -138.19 149.07 45.48 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.384 1.074 . . . . 0.0 109.431 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG21 HD13 ' A' ' 81' ' ' LEU . 16.5 t -137.17 108.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -178.403 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.65 136.38 58.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 -172.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.52 153.5 38.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.724 0.238 . . . . 0.0 110.931 -159.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -64.86 170.82 3.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.926 0.87 . . . . 0.0 111.194 163.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.598 ' CZ3' HD23 ' A' ' 66' ' ' LEU . 42.0 t-105 -83.47 -76.46 0.28 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 160.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 55.97 -170.42 0.08 Allowed 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.01 1.324 . . . . 0.0 110.999 176.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 39.3 ttp -162.89 75.67 1.96 Allowed Pre-proline 0 C--O 1.237 0.424 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 158.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.48 -71.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.117 2.545 . . . . 0.0 107.935 175.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -131.96 -67.97 0.65 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.231 1.412 . . . . 0.0 107.737 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.7 ttm -91.09 104.75 17.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.403 2.281 . . . . 0.0 107.614 161.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -66.73 171.44 5.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.513 0.597 . . . . 0.0 110.73 168.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.23 -29.67 69.19 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.749 -0.594 . . . . 0.0 112.364 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.598 HD23 ' CZ3' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -70.25 -40.94 74.12 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.998 0.899 . . . . 0.0 109.782 178.437 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -73.79 -32.3 63.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.886 1.274 . . . . 0.0 111.005 177.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -58.48 -55.54 33.78 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 103' ' ' ALA . 1.9 tp -53.42 -57.16 11.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.41 1.084 . . . . 0.0 109.491 174.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -69.8 -21.38 63.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.973 1.26 . . . . 0.0 113.83 -173.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -61.37 -64.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 163.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.0 mt -56.48 -36.6 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.917 1.287 . . . . 0.0 110.6 -174.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -22.54 61.86 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.446 1.899 . . . . 0.0 113.519 -177.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.87 -1.94 17.51 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.104 0.866 . . . . 0.0 111.385 -178.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.39 150.56 46.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 159.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.83 -3.44 89.21 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.362 -1.244 . . . . 0.0 113.719 -174.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.57 -40.8 0.71 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.343 1.572 . . . . 0.0 111.035 -177.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 72.4 mtm -71.14 -8.87 56.46 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.305 -0.872 . . . . 0.0 113.147 -175.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.3 p -63.53 -18.28 63.67 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.42 1.009 . . . . 0.0 113.314 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.39 -8.17 52.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.404 1.482 . . . . 0.0 113.277 172.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.591 HD13 HG21 ' A' ' 54' ' ' VAL . 24.9 mt -73.79 147.22 86.37 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 119.266 0.939 . . . . 0.0 111.345 -175.126 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.55 56.36 1.81 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.605 2.87 . . . . 0.0 111.085 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG2' HD13 ' A' ' 69' ' ' LEU . 1.1 m -53.28 113.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 119.081 0.855 . . . . 0.0 110.242 176.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -108.7 122.97 48.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.589 1.156 . . . . 0.0 108.674 -169.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.3 mmt -80.99 128.29 33.53 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 174.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.26 108.44 4.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -152.06 165.6 34.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.969 0.89 . . . . 0.0 112.017 -166.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.82 60.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.45 -0.781 . . . . 0.0 111.433 161.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.97 96.87 10.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.249 1.419 . . . . 0.0 109.414 -163.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.76 -73.92 0.07 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.265 1.026 . . . . 0.0 110.781 177.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.5 tttt 39.25 93.37 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 127.151 2.18 . . . . 0.0 112.537 -175.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -44.29 -40.85 5.54 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.711 176.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -55.31 -45.28 76.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.3 0.955 . . . . 0.0 112.992 176.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.17 -37.71 81.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.329 1.452 . . . . 0.0 109.557 176.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.4 mt -64.52 -41.84 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.332 176.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.8 mt -59.71 -48.38 87.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-N 120.61 1.55 . . . . 0.0 108.076 171.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.19 -43.8 74.72 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.089 1.313 . . . . 0.0 111.443 -177.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.87 85.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.859 0.464 . . . . 0.0 110.38 179.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.51 83.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.295 0.638 . . . . 0.0 112.105 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -64.51 -45.12 88.6 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.131 1.772 . . . . 0.0 110.721 174.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.78 -6.16 39.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.444 0.697 . . . . 0.0 112.298 170.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.03 64.84 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.351 -1.468 . . . . 0.0 113.049 172.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -51.88 160.21 0.73 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.465 1.106 . . . . 0.0 110.214 176.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -63.36 -30.7 71.79 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.361 -0.837 . . . . 0.0 111.575 176.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.46 -174.98 46.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 178.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -139.65 94.94 2.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 107.748 -179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.414 HG22 ' HE3' ' A' ' 119' ' ' LYS . 75.2 t -77.76 133.22 30.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 172.291 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 150.05 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 167.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -55.52 168.38 0.62 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.019 0.928 . . . . 0.0 112.259 173.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.61 94.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.545 0 N-CA-C 107.442 -1.791 . . . . 0.0 107.442 -20.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -81.77 158.74 24.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.909 0.861 . . . . 0.0 111.613 -165.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.7 p -146.89 -179.05 6.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.589 1.556 . . . . 0.0 109.623 -172.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -34.14 65.67 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 110.046 176.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.21 -24.18 58.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.819 0.848 . . . . 0.0 113.229 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.08 -34.88 7.82 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.249 0.932 . . . . 0.0 110.506 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.04 -47.54 68.33 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.962 1.305 . . . . 0.0 108.995 176.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.23 -33.01 74.57 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.411 1.084 . . . . 0.0 112.207 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.11 -44.11 89.83 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 119.862 1.21 . . . . 0.0 109.066 177.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HE3' HG22 ' A' ' 107' ' ' VAL . 15.6 mmtt -67.62 -42.62 82.06 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 117.634 -1.174 . . . . 0.0 107.947 -176.116 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.9 mt -55.72 -52.4 64.02 Favored 'General case' 0 C--O 1.221 -0.403 0 O-C-N 123.861 0.726 . . . . 0.0 110.216 172.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.99 -47.45 71.42 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.532 1.06 . . . . 0.0 111.251 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -56.23 -62.95 1.37 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.75 178.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -27.08 36.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 120.375 1.443 . . . . 0.0 113.633 -175.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.32 -50.57 73.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.31 -48.74 39.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -65.43 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.413 1.485 . . . . 0.0 108.509 -160.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.61 -41.23 96.35 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.287 0.949 . . . . 0.0 108.609 175.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.77 18.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.269 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 CA-C-O 116.813 -1.565 . . . . 0.0 112.181 -163.536 . . . . . . . . 2 2 . 1 stop_ save_